Citrus Sinensis ID: 020016
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 332 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.783 | 0.666 | 0.579 | 9e-92 | |
| Q54TM7 | 1288 | Probable serine/threonine | yes | no | 0.689 | 0.177 | 0.372 | 8e-43 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.701 | 0.254 | 0.356 | 2e-42 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.680 | 0.169 | 0.335 | 1e-38 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.707 | 0.144 | 0.338 | 1e-37 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.804 | 0.415 | 0.315 | 4e-37 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.677 | 0.326 | 0.340 | 7e-37 | |
| Q54I36 | 1338 | Dual specificity protein | no | no | 0.746 | 0.185 | 0.321 | 1e-36 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.695 | 0.139 | 0.316 | 2e-35 | |
| Q9NYL2 | 800 | Mitogen-activated protein | no | no | 0.692 | 0.287 | 0.326 | 1e-34 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 337 bits (863), Expect = 9e-92, Method: Compositional matrix adjust.
Identities = 171/295 (57%), Positives = 203/295 (68%), Gaps = 35/295 (11%)
Query: 30 SWSKYLVSSGAEI----KGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKL 85
SWS L S E KGE EEW+AD+SQLFIG KFASG HSRIYRGIYKQR VA+K+
Sbjct: 56 SWSMILESENVETWEASKGE-REEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKM 114
Query: 86 VSQPEEDASLASMLEKQFTSEVALLFRLNHPHII-------------------------- 119
V P + LE+QF SEVALL RL HP+I+
Sbjct: 115 VRIPTHKEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRM 174
Query: 120 ----TEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175
EPYS+ + VL+LALDI+RGM+YLHSQG++HRDLKS NLLL ++M VKVADFG S
Sbjct: 175 YLNKKEPYSLSIETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTS 234
Query: 176 CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA 235
CLE+QC AKG GTYRWMAPEMIKEK +T+KVDVYSFGIVLWEL TAL PF MTP QA
Sbjct: 235 CLETQCREAKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQA 294
Query: 236 AFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 290
AFAV +KN RPP+P +C A ++LI RCWS +P +RP F IV++LE Y E +++
Sbjct: 295 AFAVAEKNERPPLPASCQPALAHLIKRCWSENPSKRPDFSNIVAVLEKYDECVKE 349
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (441), Expect = 8e-43, Method: Compositional matrix adjust.
Identities = 99/266 (37%), Positives = 149/266 (56%), Gaps = 37/266 (13%)
Query: 49 EWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVA 108
EW +S++ IG + G + +++RG ++ +VA+K++ + L S L K EV
Sbjct: 843 EWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRK----EVD 898
Query: 109 LLFRLNHPHII------TEPYS-----------------------VPLNLVLKLALDIAR 139
LL +L HP+I+ TEP S + L L+L D AR
Sbjct: 899 LLCKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCAR 958
Query: 140 GMQYLHSQG--ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE 197
GM YLHS+ I+HRDLK++NLL+ + VKVADFG++ ++S AK GT W+APE
Sbjct: 959 GMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHT-FAKTMCGTTGWVAPE 1017
Query: 198 MIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 257
++ E+ +T+K DVYS+ IVLWELLT L P+ Q ++ + R P+P CP ++
Sbjct: 1018 VLAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSI-DRGERLPMPAWCPPKYA 1076
Query: 258 YLISRCWSSSPDRRPHFDQIVSILEG 283
L++RCW + P RP F +I+ I+EG
Sbjct: 1077 ALMNRCWETDPTHRPSFPEILPIMEG 1102
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 173 bits (439), Expect = 2e-42, Method: Compositional matrix adjust.
Identities = 96/269 (35%), Positives = 151/269 (56%), Gaps = 36/269 (13%)
Query: 47 EEEWSADM----SQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQ 102
++++ +D+ S+L I K G +Y+G+++ VAIK + E+ + + + ++
Sbjct: 648 QQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINED---VNNQVLEE 704
Query: 103 FTSEVALLFRLNHPHII------TEPYS---------------------VPLNLVL--KL 133
F E+ +L RL HP+I+ T P + + +N+ L KL
Sbjct: 705 FRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKL 764
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW 193
A+ IA+GM YLH G++HRD+KS NLLL E M VK+ DFG+S L+S+ G+ W
Sbjct: 765 AIQIAQGMNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIGSPIW 824
Query: 194 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 253
M+PE++ + +T+KVDVY+FGI+LWEL T P+ + Q A AV K+ RPP+P P
Sbjct: 825 MSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWP 884
Query: 254 KAFSYLISRCWSSSPDRRPHFDQIVSILE 282
S+LI CW P +RP F +I+++L
Sbjct: 885 YQLSHLIQACWHQDPLKRPSFTEILNLLN 913
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 160 bits (406), Expect = 1e-38, Method: Composition-based stats.
Identities = 88/262 (33%), Positives = 141/262 (53%), Gaps = 36/262 (13%)
Query: 53 DMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR 112
+ S + I + G S++ +G +K +DVA+K ++ +D + M++ +F +EV LL
Sbjct: 1069 NYSDIKIDKEIGKGHFSKVLKGNWKGKDVAVKKLNS-NKDKAREEMIQ-EFKAEVELLGS 1126
Query: 113 LNHPHIIT-------------------------------EPYSVPLN--LVLKLALDIAR 139
L HP+++T + S+ L+ L+L +A DIAR
Sbjct: 1127 LQHPNLVTCYGYSLNPMCIVMEFLPSGNLFELIHSKPSEQQQSIKLDSTLILAIAFDIAR 1186
Query: 140 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI 199
GMQ+LH++ I+HRDLKS NLL+ + +K+AD GI+ E+ GT W APE++
Sbjct: 1187 GMQHLHTRNIIHRDLKSSNLLMDKHFNIKIADLGIA-RETSFTQTMTTIGTVAWTAPEIL 1245
Query: 200 KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 259
+ + + +K DVYS+ IVL+ELLT P+ + P A V K RP +P C + L
Sbjct: 1246 RHESYNQKADVYSYAIVLYELLTGEEPYQGIPPMNAGILVASKGLRPELPDNCDPNWKKL 1305
Query: 260 ISRCWSSSPDRRPHFDQIVSIL 281
+ CWS P++RP F++I + L
Sbjct: 1306 VVWCWSEDPNKRPSFEEITNYL 1327
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 157 bits (397), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 94/278 (33%), Positives = 140/278 (50%), Gaps = 43/278 (15%)
Query: 43 KGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQ 102
+ +W D S+L IG +G + +Y+ I+K +VA+KL+S ++ +E+
Sbjct: 772 RNTTNNDWEIDFSELEIGETLGTGGYGEVYKSIWKGTEVAVKLISSKH----VSKDMERS 827
Query: 103 FTSEVALLFRLNHPH---------------IITEPYS---------------VPLNLVLK 132
F EV ++ L HP+ I+ E S +P L +K
Sbjct: 828 FFEEVKIMTSLRHPNVVLFMAASTKSPNMCIVMEFMSLGSLYDLLGNELIPEIPYALKIK 887
Query: 133 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK---GFTG 189
+A ++GM +LHS GI+HRDLKS NLLL VKV+DFG++ ++S+ K G
Sbjct: 888 MAYQASKGMHFLHSSGIVHRDLKSLNLLLDSKWNVKVSDFGLTKVKSELDKKKTNDNIIG 947
Query: 190 TYRWMAPEMIKEKRHTKKV--DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 247
T W+APE++ + + DVYSFGI+LWELLT P+ MTP A +V + RPP
Sbjct: 948 TIHWIAPEILNDSTEVDYILADVYSFGIILWELLTREQPYKGMTPAAIAVSVIRDGMRPP 1007
Query: 248 VPPTCPKAFSY----LISRCWSSSPDRRPHFDQIVSIL 281
+ A S LI +CW S RP F +I++ L
Sbjct: 1008 ISDEAVTAHSIEYIDLIKQCWHSDTIIRPTFLEIMTRL 1045
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 155 bits (392), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 97/307 (31%), Positives = 157/307 (51%), Gaps = 40/307 (13%)
Query: 19 MLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ 78
L +R R+ + K + +IK +G++ D+ Q+ IG + G + +Y G ++
Sbjct: 340 FLLIRNRYRSSGYYKPDKNDYTQIK-DGKD---IDIHQIKIGVRIGKGNYGEVYLGTWRG 395
Query: 79 RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII------------------- 119
VA+K + + ++ K+F E+ L+ L HP++I
Sbjct: 396 SQVAVKKLPAHNINENIL----KEFHREINLMKNLRHPNVIQFLGSCLIPPDICICTEYM 451
Query: 120 ----------TEPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGEDMCV 167
+ + +L++K+ +D A+G+ YLH+ ILHRDLKS NLL+ E+ V
Sbjct: 452 PRGSLYSILHDQALQLQWSLLIKMMIDAAKGVIYLHNSTPVILHRDLKSHNLLVDENWKV 511
Query: 168 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
KVADFG+S +E Q G+ GT W +PE+++ +R+T+K DVYSFGI+LWE T P+
Sbjct: 512 KVADFGLSTIEQQ-GATMTACGTPCWTSPEVLRSQRYTEKADVYSFGIILWECATRQDPY 570
Query: 228 DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287
+ P Q FAV ++ RPPVP P + L+ C + +P RP +Q + LE S
Sbjct: 571 FGIPPFQVIFAVGREGMRPPVPQNGPPKYIQLLIDCLNENPSHRPTMEQCLERLESIDSS 630
Query: 288 LEQDPEF 294
D ++
Sbjct: 631 GYSDLQY 637
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 154 bits (390), Expect = 7e-37, Method: Compositional matrix adjust.
Identities = 89/261 (34%), Positives = 135/261 (51%), Gaps = 36/261 (13%)
Query: 53 DMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR 112
D Q+ IG + G +Y G ++ VA+K + + ++ K+F E+ L+
Sbjct: 387 DTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENIL----KEFHREINLMKN 442
Query: 113 LNHPHII-----------------------------TEPYSVPLNLVLKLALDIARGMQY 143
L HP++I E + +LV ++ +D A+G+ Y
Sbjct: 443 LRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGIIY 502
Query: 144 LHSQG--ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE 201
LH ILHRDLKS NLL+ E+ VKVADFG+S +E Q G+ GT W +PE+++
Sbjct: 503 LHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQ-GATMTACGTPCWTSPEVLRS 561
Query: 202 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 261
+R+T+K DVYSFGI+LWE T P+ + P Q FAV ++ RPP P P + L+
Sbjct: 562 QRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYIQLLK 621
Query: 262 RCWSSSPDRRPHFDQIVSILE 282
C + +P +RP +Q + ILE
Sbjct: 622 DCLNENPSQRPTMEQCLEILE 642
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54I36|PYK3_DICDI Dual specificity protein kinase pyk3 OS=Dictyostelium discoideum GN=pyk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 154 bits (389), Expect = 1e-36, Method: Compositional matrix adjust.
Identities = 92/286 (32%), Positives = 157/286 (54%), Gaps = 38/286 (13%)
Query: 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTS 105
G++E D ++ I K +G + ++ GI+ VAIK++ ++ S+++ +++F
Sbjct: 1048 GKKEIKFD--EVAIVEKVGAGSFANVFLGIWNGYKVAIKIL----KNESISN--DEKFIK 1099
Query: 106 EVALLFRLNHPHIIT------EP-------------YSV---------PLNLVLKLALDI 137
EV+ L + +HP+++T +P Y V PL ++ K+ D+
Sbjct: 1100 EVSSLIKSHHPNVVTFMGACIDPPCIFTEYLQGGSLYDVLHIQKIKLNPL-MMYKMIHDL 1158
Query: 138 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE 197
+ GM++LHS +LHRDL S+N+LL E +K+ADFG++ S + G T RW +PE
Sbjct: 1159 SLGMEHLHSIQMLHRDLTSKNILLDEFKNIKIADFGLATTLSDDMTLSGITNP-RWRSPE 1217
Query: 198 MIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 257
+ K + +KVDVYSFG+V++E+ T PF+ + +A +N RP +PP CP +
Sbjct: 1218 LTKGLVYNEKVDVYSFGLVVYEIYTGKIPFEGLDGTASAAKAAFENYRPAIPPDCPVSLR 1277
Query: 258 YLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPD 303
LI++CW+S P +RP F +I++ LE + F + I +PD
Sbjct: 1278 KLITKCWASDPSQRPSFTEILTELETMKSKFIKQLSFLNDLIQNPD 1323
|
Involved in the development. Negatively regulates tyrosine phosphorylation and activation state of dstC/STATc, probably by activating a dstC/STATc phosphatase. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 149 bits (377), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 86/272 (31%), Positives = 140/272 (51%), Gaps = 41/272 (15%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEV 107
++W D +L +G + +G +++G ++ +VA+K++S D ++ +E+ F EV
Sbjct: 777 DDWEIDFHELELGEQLGTGAFGEVHKGTWRGTEVAVKMIS---PDKTITKDIERNFKDEV 833
Query: 108 ALLFRLNHPHII------TEP------------------------YSVPLNLVLKLALDI 137
++ L HP+++ T+P +P L +K+A
Sbjct: 834 RVMTTLRHPNVVLFMAASTKPPKMCIVMEFMALGSLHDLLKNELIPDIPFALKVKIAYQA 893
Query: 138 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA--KGFTGTYRWMA 195
++GM +LHS GI HRDLKS NLLL VKV+DFG++ +S S + F GT +W A
Sbjct: 894 SKGMHFLHSSGITHRDLKSLNLLLDIKWNVKVSDFGLTKFKSDVKSINPEKFAGTIQWTA 953
Query: 196 PEMIKEKRHTKKV--DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT-- 251
PE++ E R + DVYSFGI++WEL+T P+ M+P A +V + N RP +
Sbjct: 954 PEILSEDREVDYILSDVYSFGIIMWELITRDQPYFGMSPAAIAVSVIRDNYRPVISDQLR 1013
Query: 252 --CPKAFSYLISRCWSSSPDRRPHFDQIVSIL 281
+ L++ CW P RP F +I++ L
Sbjct: 1014 SEVAPEYIELLTSCWHFDPTIRPTFLEIMTRL 1045
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9NYL2|MLTK_HUMAN Mitogen-activated protein kinase kinase kinase MLT OS=Homo sapiens GN=MLTK PE=1 SV=3 | Back alignment and function description |
|---|
Score = 147 bits (371), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 83/254 (32%), Positives = 137/254 (53%), Gaps = 24/254 (9%)
Query: 53 DMSQLFIGCKFASGRHSRIYRG--IYKQRDVAIKLVSQPEEDASLASML-EKQFTSEVAL 109
D Q F C G +YR I + ++VA+K + + E++A + S+L + +
Sbjct: 14 DDLQFFENC--GGGSFGSVYRAKWISQDKEVAVKKLLKIEKEAEILSVLSHRNIIQFYGV 71
Query: 110 LFRLNHPHIITEPYSV---------------PLNLVLKLALDIARGMQYLHSQG---ILH 151
+ + I+TE S+ ++ ++ A D+A+GM YLH + ++H
Sbjct: 72 ILEPPNYGIVTEYASLGSLYDYINSNRSEEMDMDHIMTWATDVAKGMHYLHMEAPVKVIH 131
Query: 152 RDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVY 211
RDLKS N+++ D +K+ DFG S + + GT+ WMAPE+I+ ++ D Y
Sbjct: 132 RDLKSRNVVIAADGVLKICDFGASRFHNHT-THMSLVGTFPWMAPEVIQSLPVSETCDTY 190
Query: 212 SFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 271
S+G+VLWE+LT PF + Q A+ V +KN R +P +CP++F+ L+ +CW + +R
Sbjct: 191 SYGVVLWEMLTREVPFKGLEGLQVAWLVVEKNERLTIPSSCPRSFAELLHQCWEADAKKR 250
Query: 272 PHFDQIVSILEGYS 285
P F QI+SILE S
Sbjct: 251 PSFKQIISILESMS 264
|
Stress-activated component of a protein kinase signal transduction cascade. Regulates the JNK and p38 pathways. Pro-apoptotic. Role in regulation of S and G2 cell cycle checkpoint by direct phosphorylation of CHEK2. Isoform 1, but not isoform 2, causes cell shrinkage and disruption of actin stress fibers. Isoform 1 may have role in neoplastic cell transformation and cancer development. Isoform 1, but not isoform 2, phosphorylates histone H3 at 'Ser-28'. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 332 | ||||||
| 147839113 | 741 | hypothetical protein VITISV_012751 [Viti | 0.945 | 0.423 | 0.766 | 1e-150 | |
| 255540687 | 354 | protein with unknown function [Ricinus c | 0.975 | 0.915 | 0.779 | 1e-150 | |
| 449469533 | 361 | PREDICTED: serine/threonine-protein kina | 0.981 | 0.903 | 0.739 | 1e-150 | |
| 356565010 | 352 | PREDICTED: serine/threonine-protein kina | 0.942 | 0.889 | 0.749 | 1e-147 | |
| 356513323 | 352 | PREDICTED: serine/threonine-protein kina | 0.942 | 0.889 | 0.743 | 1e-145 | |
| 357461999 | 387 | Fibroblast growth factor receptor [Medic | 0.981 | 0.842 | 0.727 | 1e-144 | |
| 356508663 | 357 | PREDICTED: serine/threonine-protein kina | 0.954 | 0.887 | 0.74 | 1e-143 | |
| 356516676 | 357 | PREDICTED: LOW QUALITY PROTEIN: serine/t | 0.975 | 0.907 | 0.728 | 1e-142 | |
| 357477361 | 391 | Fibroblast growth factor receptor [Medic | 0.969 | 0.823 | 0.698 | 1e-140 | |
| 359491247 | 379 | PREDICTED: serine/threonine-protein kina | 0.873 | 0.765 | 0.773 | 1e-138 |
| >gi|147839113|emb|CAN68094.1| hypothetical protein VITISV_012751 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 538 bits (1387), Expect = e-150, Method: Compositional matrix adjust.
Identities = 266/347 (76%), Positives = 283/347 (81%), Gaps = 33/347 (9%)
Query: 2 KNFHWFKQISINA---KPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLF 58
+NF WFK+IS N K E LSL EYRRAVSWSKYLVSSGAEIK EGE +WSADMSQLF
Sbjct: 385 RNFQWFKKISNNGIIGKSEGRLSLGEYRRAVSWSKYLVSSGAEIKEEGEGDWSADMSQLF 444
Query: 59 IGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI 118
IGCKFASGRHSRIYRGIYKQRDVAIKL+SQPEED SLA++LEKQFTSEVALLFRL HP+I
Sbjct: 445 IGCKFASGRHSRIYRGIYKQRDVAIKLISQPEEDESLANLLEKQFTSEVALLFRLRHPNI 504
Query: 119 IT------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQG 148
IT EP SVP +LVLK +LDIA GMQYLHSQG
Sbjct: 505 ITFVAACKKPPVFCIITEYLAGGSLRKFLHQQEPXSVPYDLVLKFSLDIACGMQYLHSQG 564
Query: 149 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 208
ILHRDLKSENLLLGEDMCVKVADFGISCLE+QCGSAKGFTGTYRWMAPEMIKEK HTKKV
Sbjct: 565 ILHRDLKSENLLLGEDMCVKVADFGISCLETQCGSAKGFTGTYRWMAPEMIKEKHHTKKV 624
Query: 209 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 268
DVYSFGIVLWELLTAL PFDNMTPEQ AFAV QKNARPP+ P CP AF +LISRCWSSS
Sbjct: 625 DVYSFGIVLWELLTALIPFDNMTPEQXAFAVSQKNARPPLDPACPMAFRHLISRCWSSSA 684
Query: 269 DRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCLPTCIA 315
D+RPHFD+IVSILE YSES +QDP+FFSS+ PS DH LRCLP CIA
Sbjct: 685 DKRPHFDEIVSILESYSESFKQDPDFFSSYKPSDDHAFLRCLPKCIA 731
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255540687|ref|XP_002511408.1| protein with unknown function [Ricinus communis] gi|223550523|gb|EEF52010.1| protein with unknown function [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 538 bits (1386), Expect = e-150, Method: Compositional matrix adjust.
Identities = 276/354 (77%), Positives = 298/354 (84%), Gaps = 30/354 (8%)
Query: 1 MKNFHWFKQISINAKPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFIG 60
MKN +WFKQIS N + R LSL EY+RAVSWSKYLVSSGAEIKGEGE EWSADMSQLFIG
Sbjct: 1 MKNLYWFKQISNNGRSGRRLSLGEYKRAVSWSKYLVSSGAEIKGEGEIEWSADMSQLFIG 60
Query: 61 CKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
KFASGRHSRIYRGIYKQRDVAIK+VSQPEED LA+MLEKQFTSEVALLFRL+HP+IIT
Sbjct: 61 NKFASGRHSRIYRGIYKQRDVAIKIVSQPEEDEDLAAMLEKQFTSEVALLFRLSHPNIIT 120
Query: 121 ------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGIL 150
EP+SVPLNLVLKLA+DIARGMQYLHSQGIL
Sbjct: 121 FVAACKKTPVYCIITEYLAGGSLRKYLHQQEPHSVPLNLVLKLAIDIARGMQYLHSQGIL 180
Query: 151 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 210
HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK HTKKVDV
Sbjct: 181 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKHHTKKVDV 240
Query: 211 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDR 270
YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP+PP CP AFS+LI+RCWSS+PD+
Sbjct: 241 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPLPPACPPAFSHLINRCWSSNPDK 300
Query: 271 RPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCLPTCIARHCCAHSKA 324
RPHFD+IV+ILE Y+ESLEQDPEFFS++ P H+ILRC P C A +C + KA
Sbjct: 301 RPHFDEIVAILEIYTESLEQDPEFFSNYKPHSGHSILRCFPICRAGNCYSSVKA 354
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449469533|ref|XP_004152474.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] gi|449487764|ref|XP_004157789.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 537 bits (1384), Expect = e-150, Method: Compositional matrix adjust.
Identities = 264/357 (73%), Positives = 287/357 (80%), Gaps = 31/357 (8%)
Query: 1 MKNFHWFKQISINAKPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFIG 60
M+N +WFK ISIN KP R LSL EY+RAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFIG
Sbjct: 1 MRNLNWFKPISINGKPGRRLSLGEYQRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFIG 60
Query: 61 CKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
KFA+GRHSRIYRG+YKQRDVAIKL+SQPEED +LA+ LE QF SEVALLFRL HP+IIT
Sbjct: 61 FKFATGRHSRIYRGVYKQRDVAIKLISQPEEDENLANFLENQFISEVALLFRLRHPNIIT 120
Query: 121 ------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGIL 150
EP+SVPLNLVLKLALDI+RGMQYLHSQGIL
Sbjct: 121 FIAACKKPPVFCIITEYMTGGSLRKYLHQQEPHSVPLNLVLKLALDISRGMQYLHSQGIL 180
Query: 151 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 210
HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK HTKKVDV
Sbjct: 181 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKHHTKKVDV 240
Query: 211 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDR 270
YSFGIVLWELLTALTPFDN+TPEQAAFAVCQKNARPP+P CP+AF +LI RCWS PD+
Sbjct: 241 YSFGIVLWELLTALTPFDNLTPEQAAFAVCQKNARPPLPSACPQAFRHLIKRCWSKKPDK 300
Query: 271 RPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTIL-RCLPTCIARHCCAHSKAKE 326
RPHFD+IVSILE Y ES +DPEFF ++PS I +CLP CI + A K +
Sbjct: 301 RPHFDEIVSILETYVESYNEDPEFFCHYVPSSSRYIAWKCLPKCITKQSSASLKPRN 357
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356565010|ref|XP_003550738.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 527 bits (1357), Expect = e-147, Method: Compositional matrix adjust.
Identities = 257/343 (74%), Positives = 282/343 (82%), Gaps = 30/343 (8%)
Query: 1 MKNFHWFKQISINAKPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFIG 60
MKN +WFK+IS N + R LSL EY+RAVSWSKYL+SSGA IKGEGEEEWSAD+SQLFIG
Sbjct: 1 MKNLYWFKEISNNVRSGRRLSLGEYKRAVSWSKYLISSGAAIKGEGEEEWSADLSQLFIG 60
Query: 61 CKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
KFASGRHSRIYRGIYK DVAIKLVSQPEED LA +LEKQFTSEVALLFRL HP+IIT
Sbjct: 61 SKFASGRHSRIYRGIYKHMDVAIKLVSQPEEDEELAVLLEKQFTSEVALLFRLRHPNIIT 120
Query: 121 ------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGIL 150
P+SVPL +VLKLALDIARGMQYLHSQGIL
Sbjct: 121 FVAACKKPPVFCIITEYLSGGSLRKYLVQEGPHSVPLRVVLKLALDIARGMQYLHSQGIL 180
Query: 151 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 210
HRDLKSENLLLGED+CVKVADFGISCLESQ GSAKGFTGTYRWMAPEMIKEKRHTKKVDV
Sbjct: 181 HRDLKSENLLLGEDLCVKVADFGISCLESQTGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 240
Query: 211 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDR 270
YSF IVLWELLT LTPFDNMTPEQAA+AV KN RPP+P CPKAFS+LI+RCWSS+PD+
Sbjct: 241 YSFAIVLWELLTGLTPFDNMTPEQAAYAVTHKNERPPLPCDCPKAFSHLINRCWSSNPDK 300
Query: 271 RPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCLPTC 313
RPHFD+IV+ILE Y+E+LEQDPEFFS++ P P++ ILRCL C
Sbjct: 301 RPHFDEIVAILESYTEALEQDPEFFSTYKPCPNNIILRCLSKC 343
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356513323|ref|XP_003525363.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 520 bits (1339), Expect = e-145, Method: Compositional matrix adjust.
Identities = 255/343 (74%), Positives = 279/343 (81%), Gaps = 30/343 (8%)
Query: 1 MKNFHWFKQISINAKPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFIG 60
MKN +WFK+IS N + R LSL EY+RAVSWSKYLVSSGA IKGEGEEEWSAD+SQLFIG
Sbjct: 1 MKNLYWFKEISNNVRSGRRLSLGEYKRAVSWSKYLVSSGAAIKGEGEEEWSADLSQLFIG 60
Query: 61 CKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
KFASGRHSRIYRGIYK DVAIKLVSQPEED LA +LEKQFTSEVALLFRL HP+IIT
Sbjct: 61 SKFASGRHSRIYRGIYKHMDVAIKLVSQPEEDEDLAVLLEKQFTSEVALLFRLRHPNIIT 120
Query: 121 ------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGIL 150
P+SV +VLKLALDIARGMQYLHSQGIL
Sbjct: 121 FVAACKKPPVFCIITEYLAGGSLRKYLVQQGPHSVTHKVVLKLALDIARGMQYLHSQGIL 180
Query: 151 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 210
HRDLKSENLLLGED+CVKVADFGISCLESQ GSAKGFTGTYRWMAPEMIKEKRHTKKVDV
Sbjct: 181 HRDLKSENLLLGEDLCVKVADFGISCLESQTGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 240
Query: 211 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDR 270
YSF IVLWELLT LTPFDNMTPEQAA+AV KN RPP+P CPKAFS+LI+RCWSS+PD+
Sbjct: 241 YSFAIVLWELLTGLTPFDNMTPEQAAYAVTHKNERPPLPCDCPKAFSHLINRCWSSNPDK 300
Query: 271 RPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCLPTC 313
RPHF++IV+ILE Y E+LEQDPEFFS++ P P++ ILRCL C
Sbjct: 301 RPHFNEIVTILESYIEALEQDPEFFSTYKPRPNNIILRCLSKC 343
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357461999|ref|XP_003601281.1| Fibroblast growth factor receptor [Medicago truncatula] gi|355490329|gb|AES71532.1| Fibroblast growth factor receptor [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 518 bits (1333), Expect = e-144, Method: Compositional matrix adjust.
Identities = 259/356 (72%), Positives = 284/356 (79%), Gaps = 30/356 (8%)
Query: 1 MKNFHWFKQISINAKPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFIG 60
MKN +W+KQIS + K R LSL EY+RAVSWSKYLVS GA IKGEGEEEWSADMSQL IG
Sbjct: 32 MKNLNWYKQISNSGKSGRRLSLGEYKRAVSWSKYLVSPGAAIKGEGEEEWSADMSQLLIG 91
Query: 61 CKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
KFASGRHSRIYRG+YKQ+DVAIKLVSQPEED LAS LEKQFTSEVALL RL HP+I+T
Sbjct: 92 SKFASGRHSRIYRGVYKQKDVAIKLVSQPEEDEDLASFLEKQFTSEVALLLRLRHPNILT 151
Query: 121 ------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGIL 150
EP+SVP LVLKLALDIARGM+YLHSQGIL
Sbjct: 152 FIAACKKPPVFCIITEYLAGGSLRKYLHQQEPHSVPHELVLKLALDIARGMKYLHSQGIL 211
Query: 151 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 210
HRDLKSENLLL EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI+EK HTKKVDV
Sbjct: 212 HRDLKSENLLLDEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIREKHHTKKVDV 271
Query: 211 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDR 270
YSFGIVLWELLTAL PFDNMTPEQAAFAV KNARPP+P CP AFS LI+RCWSS+P++
Sbjct: 272 YSFGIVLWELLTALIPFDNMTPEQAAFAVSYKNARPPLPSECPWAFSNLINRCWSSNPNK 331
Query: 271 RPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCLPTCIARHCCAHSKAKE 326
RPHF +IVSILE ++ESLE DP+FF+++ P P +TIL CLP C AR KAK+
Sbjct: 332 RPHFVEIVSILECFTESLELDPDFFTTYKPRPINTILGCLPKCKARQKSDTCKAKQ 387
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508663|ref|XP_003523074.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 514 bits (1325), Expect = e-143, Method: Compositional matrix adjust.
Identities = 259/350 (74%), Positives = 280/350 (80%), Gaps = 33/350 (9%)
Query: 1 MKNFHWFKQISINA-KPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFI 59
MKN W KQIS + K R LSL EY RAVSWSKYLVS GAEIKGEGEEEWSADMSQL I
Sbjct: 1 MKNLKWHKQISNSGNKLGRRLSLGEYNRAVSWSKYLVSPGAEIKGEGEEEWSADMSQLLI 60
Query: 60 GCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
G KFASGRHSRIYRG+YKQ+DVAIKL+SQPEED LA+ LEKQF SEV+LL RL HP+II
Sbjct: 61 GSKFASGRHSRIYRGVYKQKDVAIKLISQPEEDEDLAAFLEKQFASEVSLLLRLGHPNII 120
Query: 120 T------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGI 149
T +P +PL LVLKLALDIARGM+YLHSQGI
Sbjct: 121 TFIAACKKPPVFCIITEYLAGGSLGKFLHHQQPNILPLKLVLKLALDIARGMKYLHSQGI 180
Query: 150 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVD 209
LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK HTKKVD
Sbjct: 181 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKHHTKKVD 240
Query: 210 VYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 269
VYSFGIVLWELLT TPFDNMTPEQAA+AV KNARPP+P CP AFS LI+RCWSS+PD
Sbjct: 241 VYSFGIVLWELLTGKTPFDNMTPEQAAYAVSHKNARPPLPSKCPWAFSDLINRCWSSNPD 300
Query: 270 RRPHFDQIVSILEGYSESLEQDPEFFSSFIPSP--DHTILRCLPTCIARH 317
+RPHFD+IVSILE Y+ESL+QDPEFFS++ PSP +TIL CLP C ARH
Sbjct: 301 KRPHFDEIVSILEYYTESLQQDPEFFSTYKPSPTSSNTILGCLPKCNARH 350
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516676|ref|XP_003527019.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 512 bits (1318), Expect = e-142, Method: Compositional matrix adjust.
Identities = 260/357 (72%), Positives = 281/357 (78%), Gaps = 33/357 (9%)
Query: 1 MKNFHWFKQISINA-KPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFI 59
MKN W KQIS + K R LSL EY RAVSWSKYLVS GAEIKGEGEEEWSADMSQL I
Sbjct: 1 MKNLKWHKQISNSGNKLGRRLSLGEYNRAVSWSKYLVSPGAEIKGEGEEEWSADMSQLLI 60
Query: 60 GCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
G KFASGRHSRIYRG+YKQ+DVAIKL+SQPEED LA+ LEKQFTSEV+LL RL HP+II
Sbjct: 61 GSKFASGRHSRIYRGVYKQKDVAIKLISQPEEDEDLAAFLEKQFTSEVSLLLRLGHPNII 120
Query: 120 T------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGI 149
T +P +PL LVLKLALDIARGM+YLHSQGI
Sbjct: 121 TFIAACKKPPVFCIITEYLAGGSLGKFLHHQQPNILPLKLVLKLALDIARGMKYLHSQGI 180
Query: 150 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVD 209
LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG TGTYRWMAPEMIKEK HTKKVD
Sbjct: 181 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGXTGTYRWMAPEMIKEKHHTKKVD 240
Query: 210 VYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 269
VYSFGIVLWELLT TPFDNMTPEQAA+AV KNARPP+P CP AFS LI+RCWSS+PD
Sbjct: 241 VYSFGIVLWELLTGKTPFDNMTPEQAAYAVSHKNARPPLPSECPWAFSDLINRCWSSNPD 300
Query: 270 RRPHFDQIVSILEGYSESLEQDPEFFSSFIPSP--DHTILRCLPTCIARHCCAHSKA 324
+RPHFD+IVSILE Y+ESL+QDPEFFS++ PSP +TIL C P C ARH KA
Sbjct: 301 KRPHFDEIVSILEYYTESLQQDPEFFSTYKPSPSSSNTILGCFPKCNARHKFGACKA 357
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357477361|ref|XP_003608966.1| Fibroblast growth factor receptor [Medicago truncatula] gi|355510021|gb|AES91163.1| Fibroblast growth factor receptor [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 505 bits (1300), Expect = e-140, Method: Compositional matrix adjust.
Identities = 246/352 (69%), Positives = 278/352 (78%), Gaps = 30/352 (8%)
Query: 2 KNFHWFKQISINAKPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFIGC 61
KN HW K+IS N + R LSL EY+RAVSWSKYL SSGA IKG +++W+ADMSQLFIG
Sbjct: 3 KNLHWLKEISNNVRSGRRLSLGEYKRAVSWSKYLTSSGAAIKGNEQDDWNADMSQLFIGA 62
Query: 62 KFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT- 120
KF SGRHSRIYRGIYK DVAIKLVSQPEED LA++LEK FTSEVALLFRL HP+II+
Sbjct: 63 KFDSGRHSRIYRGIYKNMDVAIKLVSQPEEDEELAALLEKHFTSEVALLFRLRHPNIISF 122
Query: 121 -----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILH 151
P+SVPL LVL+LALDIARGMQYLHSQGILH
Sbjct: 123 VGACKKPPVFCIITEYMAGGSLRKYLLQQGPHSVPLKLVLELALDIARGMQYLHSQGILH 182
Query: 152 RDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVY 211
RDLKSENLLL E+MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI+EKRHTKKVDVY
Sbjct: 183 RDLKSENLLLDEEMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIREKRHTKKVDVY 242
Query: 212 SFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 271
SF IVLWEL+T LTPFDNMTPEQAA+AV KNARPP+PP CP A S LI RCWSS+P++R
Sbjct: 243 SFAIVLWELITGLTPFDNMTPEQAAYAVTHKNARPPLPPDCPLAISNLIKRCWSSNPNKR 302
Query: 272 PHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCLPTCIARHCCAHSK 323
PHF +IV ILE Y++SLEQDPEFFS++ PS + +++CLPTC A + +SK
Sbjct: 303 PHFTEIVKILEKYTDSLEQDPEFFSTYKPSSSNMLVKCLPTCNAGNEFTYSK 354
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491247|ref|XP_002279698.2| PREDICTED: serine/threonine-protein kinase HT1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 498 bits (1281), Expect = e-138, Method: Compositional matrix adjust.
Identities = 250/323 (77%), Positives = 266/323 (82%), Gaps = 33/323 (10%)
Query: 2 KNFHWFKQISINA---KPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLF 58
+NF WFK+IS N K E LSL EYRRAVSWSKYLVSSGAEIK EGE +WSADMSQLF
Sbjct: 47 ENFQWFKKISNNGIIGKSEGRLSLGEYRRAVSWSKYLVSSGAEIKEEGEGDWSADMSQLF 106
Query: 59 IGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI 118
IGCKFASGRHSRIYRGIYKQRDVAIKL+SQPEED SLA++LEKQFTSEVALLFRL HP+I
Sbjct: 107 IGCKFASGRHSRIYRGIYKQRDVAIKLISQPEEDESLANLLEKQFTSEVALLFRLRHPNI 166
Query: 119 IT------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQG 148
IT EPYSVP +LVLK +LDIA GMQYLHSQG
Sbjct: 167 ITFVAACKKPPVFCIITEYLAGGSLRKFLHQQEPYSVPYDLVLKFSLDIACGMQYLHSQG 226
Query: 149 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 208
ILHRDLKSENLLLGEDMCVKVADFGISCLE+QCGSAKGFTGTYRWMAPEMIKEK HTKKV
Sbjct: 227 ILHRDLKSENLLLGEDMCVKVADFGISCLETQCGSAKGFTGTYRWMAPEMIKEKHHTKKV 286
Query: 209 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 268
DVYSFGIVLWELLTAL PFDNMTPEQAAFAV QKNARPP+ P CP AF +LISRCWSSS
Sbjct: 287 DVYSFGIVLWELLTALIPFDNMTPEQAAFAVSQKNARPPLDPACPMAFRHLISRCWSSSA 346
Query: 269 DRRPHFDQIVSILEGYSESLEQD 291
D+RPHFD+IVSILE YSES +Q+
Sbjct: 347 DKRPHFDEIVSILESYSESFKQE 369
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 332 | ||||||
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.478 | 0.386 | 0.540 | 1.4e-60 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.478 | 0.385 | 0.540 | 3.8e-60 | |
| TAIR|locus:2102802 | 475 | AT3G46930 [Arabidopsis thalian | 0.539 | 0.376 | 0.472 | 5.4e-59 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.466 | 0.283 | 0.503 | 1.8e-50 | |
| TAIR|locus:2154573 | 525 | AT5G58950 [Arabidopsis thalian | 0.560 | 0.354 | 0.515 | 1.2e-49 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.5 | 0.288 | 0.470 | 2e-49 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.454 | 0.264 | 0.490 | 2.6e-49 | |
| TAIR|locus:2084193 | 411 | AT3G01490 [Arabidopsis thalian | 0.512 | 0.413 | 0.403 | 2.3e-48 | |
| TAIR|locus:2170106 | 385 | AT5G50000 [Arabidopsis thalian | 0.463 | 0.4 | 0.458 | 6e-48 | |
| TAIR|locus:2077244 | 391 | ATMRK1 [Arabidopsis thaliana ( | 0.490 | 0.416 | 0.432 | 8.6e-47 |
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 472 (171.2 bits), Expect = 1.4e-60, Sum P(2) = 1.4e-60
Identities = 86/159 (54%), Positives = 114/159 (71%)
Query: 124 SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183
+VPL L +K ALD+ARGM Y+H + +HRDLKS+NLL+ D +K+ADFG++ +E Q
Sbjct: 227 AVPLKLAVKQALDVARGMAYVHGRNFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 286
Query: 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 243
TGTYRWMAPEMI+ + + +KVDVYSFGIVLWEL+T L PF NMT QAAFAV +
Sbjct: 287 MTPETGTYRWMAPEMIQHRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRG 346
Query: 244 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
RP VP C S +++RCW ++P+ RP F ++V +LE
Sbjct: 347 VRPTVPNDCLPVLSDIMTRCWDANPEVRPCFVEVVKLLE 385
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 470 (170.5 bits), Expect = 3.8e-60, Sum P(2) = 3.8e-60
Identities = 86/159 (54%), Positives = 113/159 (71%)
Query: 124 SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183
+VPL L + ALD+ARGM Y+H + +HRDLKS+NLL+ D +K+ADFG++ +E Q
Sbjct: 228 AVPLKLAVMQALDVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEG 287
Query: 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 243
TGTYRWMAPEMI+ + +T+KVDVYSFGIVLWEL+T L PF NMT QAAFAV +
Sbjct: 288 MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRG 347
Query: 244 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
RP VP C +++RCW + P+ RP F +IV++LE
Sbjct: 348 VRPTVPADCLPVLGEIMTRCWDADPEVRPCFAEIVNLLE 386
|
|
| TAIR|locus:2102802 AT3G46930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 457 (165.9 bits), Expect = 5.4e-59, Sum P(2) = 5.4e-59
Identities = 86/182 (47%), Positives = 119/182 (65%)
Query: 121 EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180
E S+PL ++ LDIA+GM+Y+HS+ I+H+DLK EN+L+ D +K+ADFGI+C E
Sbjct: 254 EQKSLPLEQLIDFGLDIAKGMEYIHSREIVHQDLKPENVLIDNDFHLKIADFGIACEEEY 313
Query: 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAV 239
C GTYRWMAPE++K H +K DVYSFG++LWE++ P++ M EQ A+AV
Sbjct: 314 CDVLGDNIGTYRWMAPEVLKRIPHGRKCDVYSFGLLLWEMVAGALPYEEMKFAEQIAYAV 373
Query: 240 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFI 299
K RP +P CP A LI RCWSS D+RP F QIV +LE + +SL + + + +
Sbjct: 374 IYKKIRPVIPTDCPAAMKELIERCWSSQTDKRPEFWQIVKVLEHFKKSLTSEGKL--NLL 431
Query: 300 PS 301
PS
Sbjct: 432 PS 433
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 410 (149.4 bits), Expect = 1.8e-50, Sum P(2) = 1.8e-50
Identities = 79/157 (50%), Positives = 107/157 (68%)
Query: 127 LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG 186
L +LK+ALD+A+GM YLH I+HRDLK+ NLL+ E VKVADFG++ ++ + G
Sbjct: 381 LQTLLKVALDVAKGMSYLHQNNIIHRDLKTANLLMDEHGLVKVADFGVARVQIESGVMTA 440
Query: 187 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 246
TGTYRWMAPE+I+ K + K DV+S+ IVLWELLT P+ +TP QAA V QK RP
Sbjct: 441 ETGTYRWMAPEVIEHKPYNHKADVFSYAIVLWELLTGDIPYAFLTPLQAAVGVVQKGLRP 500
Query: 247 PVPP-TCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
+P T PK L+ RCW P++RP F++I+ +L+
Sbjct: 501 KIPKKTHPKVKG-LLERCWHQDPEQRPLFEEIIEMLQ 536
|
|
| TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 517 (187.1 bits), Expect = 1.2e-49, P = 1.2e-49
Identities = 98/190 (51%), Positives = 132/190 (69%)
Query: 102 QFTSEVALLFRLNHPHIITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 161
Q+ E +L L+ P E S+PL +++ A+DIARGM+Y+HS+ I+HRDLK EN+L+
Sbjct: 288 QYLPEGSLRSFLHKP----ENRSLPLKKLIEFAIDIARGMEYIHSRRIIHRDLKPENVLI 343
Query: 162 GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 221
E+ +K+ADFGI+C E C GTYRWMAPEMIK K H +K DVYSFG+VLWE++
Sbjct: 344 DEEFHLKIADFGIACEEEYCDMLADDPGTYRWMAPEMIKRKPHGRKADVYSFGLVLWEMV 403
Query: 222 TALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 281
P+++M P QAAFAV KN RP +P CP A LI +CWS +PD+RP F QIV +L
Sbjct: 404 AGAIPYEDMNPIQAAFAVVHKNIRPAIPGDCPVAMKALIEQCWSVAPDKRPEFWQIVKVL 463
Query: 282 EGYSESLEQD 291
E ++ SLE++
Sbjct: 464 EQFAISLERE 473
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 404 (147.3 bits), Expect = 2.0e-49, Sum P(2) = 2.0e-49
Identities = 79/168 (47%), Positives = 111/168 (66%)
Query: 127 LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG 186
L + K+A+DI +GM YLH I+HRDLK+ NLL+ E+ VKVADFG++ +++Q G
Sbjct: 385 LPTLFKVAIDICKGMSYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQTGVMTA 444
Query: 187 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 246
TGTYRWMAPE+I+ K + K DV+S+GIVLWELLT P++ MTP QAA V QK RP
Sbjct: 445 ETGTYRWMAPEVIEHKPYDHKADVFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQKGLRP 504
Query: 247 PVPP-TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPE 293
+P T PK + L+ R W +RP F +I+ L+ ++ + ++ E
Sbjct: 505 TIPKNTHPK-LAELLERLWEHDSTQRPDFSEIIEQLQEIAKEVGEEGE 551
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 399 (145.5 bits), Expect = 2.6e-49, Sum P(2) = 2.6e-49
Identities = 75/153 (49%), Positives = 105/153 (68%)
Query: 130 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG 189
+LK+ALD+++GM YLH I+HRDLK+ NLL+ E VKVADFG++ ++++ G TG
Sbjct: 390 LLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKVADFGVARVQTESGVMTAETG 449
Query: 190 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP 249
TYRWMAPE+I+ K + + DV+S+ IVLWELLT P+ +TP QAA V QK RP +P
Sbjct: 450 TYRWMAPEVIEHKPYDHRADVFSYAIVLWELLTGELPYSYLTPLQAAVGVVQKGLRPKIP 509
Query: 250 P-TCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 281
T PK + L+ +CW P RP+F +I+ +L
Sbjct: 510 KETHPK-LTELLEKCWQQDPALRPNFAEIIEML 541
|
|
| TAIR|locus:2084193 AT3G01490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 381 (139.2 bits), Expect = 2.3e-48, Sum P(2) = 2.3e-48
Identities = 69/171 (40%), Positives = 112/171 (65%)
Query: 118 IITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177
I T + +V++L+LD+ARG+ YLHSQ I+HRD+K+EN+LL + +K+ADFG++ L
Sbjct: 218 IKTRRRKLAFKVVIQLSLDLARGLSYLHSQKIVHRDVKTENMLLDKSRTLKIADFGVARL 277
Query: 178 E-SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA 236
E S G TGT +MAPE++ + +K DVYSFGI LWE+ P+ +++ +
Sbjct: 278 EASNPNDMTGETGTLGYMAPEVLNGSPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 337
Query: 237 FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287
AV ++N RP +P CP + + ++ RCW ++P++RP +++V++LE S
Sbjct: 338 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPEKRPEMEEVVAMLEAIDTS 388
|
|
| TAIR|locus:2170106 AT5G50000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 392 (143.0 bits), Expect = 6.0e-48, Sum P(2) = 6.0e-48
Identities = 71/155 (45%), Positives = 107/155 (69%)
Query: 129 LVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE-SQCGSAKGF 187
+V++LALD+ARG+ YLHSQ I+HRD+K+EN+LL + VK+ADFG++ +E S G
Sbjct: 203 IVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGE 262
Query: 188 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 247
TGT +MAPE++ + +K DVYSFGI LWE+ P+ ++T + AV ++N RP
Sbjct: 263 TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLTFSEVTSAVVRQNLRPD 322
Query: 248 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
+P CP A + ++ RCW ++PD+RP D++V +LE
Sbjct: 323 IPRCCPSALAAVMKRCWDANPDKRPEMDEVVPMLE 357
|
|
| TAIR|locus:2077244 ATMRK1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 392 (143.0 bits), Expect = 8.6e-47, Sum P(2) = 8.6e-47
Identities = 71/164 (43%), Positives = 111/164 (67%)
Query: 125 VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS- 183
+P+ V++LALD+ARG+ YLHS+ I+HRD+KSEN+LL + +K+ADFG++ +E+Q
Sbjct: 205 LPIKDVIQLALDLARGLSYLHSKAIVHRDVKSENMLLQPNKTLKIADFGVARVEAQNPQD 264
Query: 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 243
G TGT +MAPE+++ K + +K DVYSFG+ LWE+ P+ + + + + AV +N
Sbjct: 265 MTGETGTLGYMAPEVLEGKPYNRKCDVYSFGVCLWEIYCCDMPYADCSFAEISHAVVHRN 324
Query: 244 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287
RP +P CP A + ++ RCW +PDRRP +++V +LE S
Sbjct: 325 LRPEIPKCCPHAVANIMKRCWDPNPDRRPEMEEVVKLLEAIDTS 368
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_LG_XII000286 | hypothetical protein (323 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 332 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-62 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-61 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-55 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-54 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-53 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-45 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-37 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-36 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-36 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-35 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-35 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-35 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-35 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-35 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-34 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-34 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-33 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-32 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-32 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-32 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-32 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-31 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-31 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-31 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-31 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-30 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-29 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-29 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-29 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-29 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-29 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-29 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-28 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-28 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-28 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-28 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-28 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-27 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-27 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-27 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-27 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-27 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-27 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-26 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-26 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-26 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-26 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-26 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-26 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-26 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-25 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-25 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-25 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-25 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-25 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-25 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-24 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-24 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-24 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-24 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-24 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-24 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-24 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-24 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-24 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-23 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-23 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-23 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-21 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-21 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-21 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-20 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-20 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-20 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-20 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-20 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-20 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-19 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-19 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-19 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-19 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-19 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-19 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-18 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-18 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-18 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-17 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-17 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-17 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-16 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-16 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-16 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-15 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-15 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-14 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-12 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-10 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-07 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.002 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 4e-62
Identities = 83/264 (31%), Positives = 129/264 (48%), Gaps = 45/264 (17%)
Query: 57 LFIGCKFASGRHSRIYRGIYKQR------DVAIKLVSQPEEDASLASMLEKQFTSEVALL 110
L +G K G +Y+G K + +VA+K + + + + L E ++
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLR-----EARIM 55
Query: 111 FRLNHPHII------------------------------TEPYSVPLNLVLKLALDIARG 140
+L+HP+I+ P + L+ +L AL IARG
Sbjct: 56 RKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 141 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG--SAKGFTGTYRWMAPEM 198
M+YL S+ +HRDL + N L+GE++ VK++DFG+S KG RWMAPE
Sbjct: 116 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPES 175
Query: 199 IKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 257
+KE + T K DV+SFG++LWE+ T P+ M+ + + +K R P PP CP
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL-KKGYRLPKPPNCPPELY 234
Query: 258 YLISRCWSSSPDRRPHFDQIVSIL 281
L+ +CW+ P+ RP F ++V IL
Sbjct: 235 KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 196 bits (501), Expect = 2e-61
Identities = 82/263 (31%), Positives = 131/263 (49%), Gaps = 44/263 (16%)
Query: 57 LFIGCKFASGRHSRIYRGIYKQR------DVAIKLVSQPEEDASLASMLEKQFTSEVALL 110
L +G K G +Y+G K + +VA+K + + + ++F E ++
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQ-----QIEEFLREARIM 55
Query: 111 FRLNHPHIIT--------EPY---------------------SVPLNLVLKLALDIARGM 141
+L+HP+++ EP + L+ +L AL IARGM
Sbjct: 56 RKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115
Query: 142 QYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG--SAKGFTGTYRWMAPEMI 199
+YL S+ +HRDL + N L+GE++ VK++DFG+S +G RWMAPE +
Sbjct: 116 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL 175
Query: 200 KEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 258
KE + T K DV+SFG++LWE+ T P+ M+ E+ + + R P PP CP
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL-KNGYRLPQPPNCPPELYD 234
Query: 259 LISRCWSSSPDRRPHFDQIVSIL 281
L+ +CW+ P+ RP F ++V IL
Sbjct: 235 LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 1e-55
Identities = 80/269 (29%), Positives = 128/269 (47%), Gaps = 59/269 (21%)
Query: 59 IGCKFASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR 112
+G K G +Y+G K + VA+K + +E AS E F E +++ +
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL---KEGASEEEREE--FLEEASIMKK 57
Query: 113 LNHPHI---------------ITE--------------PYSVPLNLVLKLALDIARGMQY 143
L+HP+I +TE + L +L++AL IA+GM+Y
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 144 LHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY----------RW 193
L S+ +HRDL + N L+ E++ VK++DFG+S Y +W
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLS-------RDIYEDDYYRKRGGGKLPIKW 170
Query: 194 MAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 252
MAPE +K+ + T K DV+SFG++LWE+ T P+ M+ E+ + + R P P C
Sbjct: 171 MAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENC 229
Query: 253 PKAFSYLISRCWSSSPDRRPHFDQIVSIL 281
P L+ +CW+ P+ RP F ++V L
Sbjct: 230 PDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 1e-54
Identities = 82/264 (31%), Positives = 124/264 (46%), Gaps = 52/264 (19%)
Query: 65 SGRHSRIYRGIYKQ-----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
G +Y+G K +VA+K + EDAS K F E ++ +L HP+++
Sbjct: 5 EGAFGEVYKGKLKGKDGKTTEVAVKTLK---EDASEEER--KDFLKEARVMKKLGHPNVV 59
Query: 120 -------------------------------------TEPYSVPLNLVLKLALDIARGMQ 142
E ++ L +L A+ IA+GM+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 143 YLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---RWMAPEMI 199
YL S+ +HRDL + N L+GED+ VK++DFG+S + TG RWMAPE +
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 200 KEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 258
K+ T K DV+SFG++LWE+ T TP+ ++ E+ + +K R P P CP
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL-RKGYRLPKPEYCPDELYE 238
Query: 259 LISRCWSSSPDRRPHFDQIVSILE 282
L+ CW P+ RP F ++V LE
Sbjct: 239 LMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-53
Identities = 68/251 (27%), Positives = 107/251 (42%), Gaps = 37/251 (14%)
Query: 59 IGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
I K G ++Y K + VAIK++ + + ++ E+ +L +L HP
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD-----RERILREIKILKKLKHP 57
Query: 117 HI----------------------------ITEPYSVPLNLVLKLALDIARGMQYLHSQG 148
+I + + + + I ++YLHS+G
Sbjct: 58 NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 149 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 208
I+HRDLK EN+LL ED VK+ADFG++ F GT +MAPE++ K + K V
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV 177
Query: 209 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP--TCPKAFSYLISRCWSS 266
D++S G++L+ELLT PF F K P PP LI +
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVK 237
Query: 267 SPDRRPHFDQI 277
P++R ++
Sbjct: 238 DPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 4e-50
Identities = 79/253 (31%), Positives = 124/253 (49%), Gaps = 45/253 (17%)
Query: 65 SGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120
SG +Y+ +K + VA+K++ + E S ++ E+ +L RL+HP+I+
Sbjct: 9 SGSFGTVYKAKHKGTGKIVAVKILKKRSEK----SKKDQTARREIRILRRLSHPNIVRLI 64
Query: 121 -------EPY-------------------SVPLNLVLKLALDIARGMQYLHSQGILHRDL 154
Y + + K+AL I RG++YLHS GI+HRDL
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDL 124
Query: 155 KSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVY 211
K EN+LL E+ VK+ADFG++ +S S F GT +MAPE++ + KVDV+
Sbjct: 125 KPENILLDENGVVKIADFGLAKKLLKSS-SSLTTFVGTPWYMAPEVLLGGNGYGPKVDVW 183
Query: 212 SFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS------YLISRCWS 265
S G++L+ELLT PF + ++ PP+ PK S LI +C +
Sbjct: 184 SLGVILYELLTGKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLN 242
Query: 266 SSPDRRPHFDQIV 278
P +RP ++I+
Sbjct: 243 KDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 7e-45
Identities = 67/251 (26%), Positives = 108/251 (43%), Gaps = 72/251 (28%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI---- 118
G +Y K+ + VAIK++ + + L ++ E+ +L +LNHP+I
Sbjct: 3 EGGFGTVYLARDKKTGKKVAIKIIKKEDSS-----SLLEELLREIEILKKLNHPNIVKLY 57
Query: 119 -----------ITEPYS--------------VPLNLVLKLALDIARGMQYLHSQGILHRD 153
+ E + + +L++ L I G++YLHS GI+HRD
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 154 LKSENLLLGED-MCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDV 210
LK EN+LL D VK+ADFG+S L S K GT +MAPE++ K + ++K D+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 211 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDR 270
+S G++L+EL LI + P++
Sbjct: 178 WSLGVILYEL---------------------------------PELKDLIRKMLQKDPEK 204
Query: 271 RPHFDQIVSIL 281
RP +I+ L
Sbjct: 205 RPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-38
Identities = 76/265 (28%), Positives = 126/265 (47%), Gaps = 43/265 (16%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVAL 109
W+ + +L +G G + G Y+ + VA+K + ++D++ A + F +E ++
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCL---KDDSTAA----QAFLAEASV 53
Query: 110 LFRLNHP---------------HIITEPYSVPLNLV----------------LKLALDIA 138
+ L HP +I+TE Y +LV L ALD+
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLYIVTE-YMAKGSLVDYLRSRGRAVITLAQQLGFALDVC 112
Query: 139 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEM 198
GM+YL + +HRDL + N+L+ ED+ KV+DFG++ SQ + +W APE
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL--PVKWTAPEA 170
Query: 199 IKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 257
++EK+ + K DV+SFGI+LWE+ + P+ + + V +K R P CP
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV-EKGYRMEAPEGCPPEVY 229
Query: 258 YLISRCWSSSPDRRPHFDQIVSILE 282
++ CW P +RP F Q+ L
Sbjct: 230 KVMKDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-37
Identities = 65/254 (25%), Positives = 106/254 (41%), Gaps = 42/254 (16%)
Query: 60 GCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH 117
G G +Y + K +A+K V + LE+ E+ +L L HP+
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALER----EIRILSSLQHPN 60
Query: 118 IIT------EPYSVPLNLVL------------------------KLALDIARGMQYLHSQ 147
I+ + LN+ L K I G+ YLHS
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120
Query: 148 GILHRDLKSENLLLGEDMCVKVADFGIS----CLESQCGSAKGFTGTYRWMAPEMIKEKR 203
GI+HRD+K N+L+ D VK+ADFG + +E+ G+ GT WMAPE+I+ +
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT-GSVRGTPYWMAPEVIRGEE 179
Query: 204 HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA-FAVCQKNARPPVPPTCPKAFSYLISR 262
+ + D++S G + E+ T P+ + AA + + P +P + + +
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK 239
Query: 263 CWSSSPDRRPHFDQ 276
C P +RP D+
Sbjct: 240 CLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-36
Identities = 74/259 (28%), Positives = 118/259 (45%), Gaps = 42/259 (16%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQ-FTSEV 107
W + + K SG ++ G++K + VAIK++ +L++Q F EV
Sbjct: 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKS-------DDLLKQQDFQKEV 53
Query: 108 ALLFRLNHPHIIT--------EPY----------------------SVPLNLVLKLALDI 137
L RL H H+I+ EP +P+ ++ +A +
Sbjct: 54 QALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQV 113
Query: 138 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAP 196
A GM YL Q +HRDL + N+L+GED+ KVADFG++ ++ + Y+W AP
Sbjct: 114 AEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAP 173
Query: 197 EMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255
E + K DV+SFGI+L+E+ T P+ M + R P P CP+
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQITAGYRMPCPAKCPQE 232
Query: 256 FSYLISRCWSSSPDRRPHF 274
++ CW++ P+ RP F
Sbjct: 233 IYKIMLECWAAEPEDRPSF 251
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 6e-36
Identities = 74/259 (28%), Positives = 129/259 (49%), Gaps = 33/259 (12%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLV-----SQP--EEDASLASMLEKQ 102
W ++ +L +G G + +G Y + VA+K + +Q EE A + + K
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKN 60
Query: 103 FTSEVALLFRLNHPHIITEPYS---------------VPLNLVLKLALDIARGMQYLHSQ 147
+ ++ N +I+ E S V + +L+ +LD+A GM+YL S+
Sbjct: 61 LVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK 119
Query: 148 GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT---YRWMAPEMIKEKRH 204
++HRDL + N+L+ ED KV+DFG++ + S G + +W APE +K K+
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGS-----MGVDNSKLPVKWTAPEALKHKKF 174
Query: 205 TKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263
+ K DV+S+G++LWE+ + P+ M+ ++ V +K R P CP L++ C
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV-EKGYRMEPPEGCPADVYVLMTSC 233
Query: 264 WSSSPDRRPHFDQIVSILE 282
W + P +RP F ++ LE
Sbjct: 234 WETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 6e-36
Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 38/211 (18%)
Query: 105 SEVALLFRLNHPHIIT----------------------------------EPYSVPLNLV 130
+EV +L +LNHP+II +P+ +
Sbjct: 48 NEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE--EQI 105
Query: 131 LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTG 189
L + + ++YLHS+ ILHRD+K +N+ L + VK+ DFGIS L S AK G
Sbjct: 106 LDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVG 165
Query: 190 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP 249
T +++PE+ + K + K D++S G VL+EL T PF+ + A + + PP+P
Sbjct: 166 TPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-YPPIP 224
Query: 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280
L+S P+ RP QI+
Sbjct: 225 SQYSSELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 69/245 (28%), Positives = 113/245 (46%), Gaps = 36/245 (14%)
Query: 59 IGCKFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+G G +Y+G+ + VAIK +S E ++ K E+ LL L HP
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISL--EKIKEEAL--KSIMQEIDLLKNLKHP 59
Query: 117 HIITEPYSVP----LNLVLKLALD------------------------IARGMQYLHSQG 148
+I+ S+ L ++L+ A + + +G+ YLH QG
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 149 ILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 207
++HRD+K+ N+L +D VK+ADFG++ L GT WMAPE+I+ +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTA 179
Query: 208 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 267
D++S G + ELLT P+ ++ P A F + Q + PP+P + +C+
Sbjct: 180 SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-DDHPPLPEGISPELKDFLMQCFQKD 238
Query: 268 PDRRP 272
P+ RP
Sbjct: 239 PNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 1e-35
Identities = 73/263 (27%), Positives = 127/263 (48%), Gaps = 43/263 (16%)
Query: 53 DMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLF 111
D S+L + SG+ ++ G ++ + DVAIK++ + +M E F E ++
Sbjct: 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIRE-------GAMSEDDFIEEAKVMM 54
Query: 112 RLNHPHIITEPYSV-----PLNLV-------------------------LKLALDIARGM 141
+L+HP+++ + Y V P+ +V L + D+ M
Sbjct: 55 KLSHPNLV-QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAM 113
Query: 142 QYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMI 199
+YL S G +HRDL + N L+GED VKV+DFG++ L+ Q S++G +W PE+
Sbjct: 114 EYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVF 173
Query: 200 KEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 258
R + K DV+SFG+++WE+ + P++ + + +V R P P
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV-SAGYRLYRPKLAPTEVYT 232
Query: 259 LISRCWSSSPDRRPHFDQIVSIL 281
++ CW P+ RP F +++S L
Sbjct: 233 IMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-35
Identities = 76/256 (29%), Positives = 128/256 (50%), Gaps = 42/256 (16%)
Query: 62 KFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII- 119
K G +Y+G+ K +VA+K +L L+++F E +L + +HP+I+
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRS-----TLPPDLKRKFLQEAEILKQYDHPNIVK 56
Query: 120 -------TEPYSVPLNLV---------------------LKLALDIARGMQYLHSQGILH 151
+P + + LV L+++LD A GM+YL S+ +H
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIH 116
Query: 152 RDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT----YRWMAPEMIKEKRHTKK 207
RDL + N L+GE+ +K++DFG+S E + G G +W APE + R+T +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMS-REEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 208 VDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 266
DV+S+GI+LWE + TP+ M+ +Q + + R P P CP+ L+ +CW+
Sbjct: 176 SDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-ESGYRMPAPQLCPEEIYRLMLQCWAY 234
Query: 267 SPDRRPHFDQIVSILE 282
P+ RP F +I + L+
Sbjct: 235 DPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 7e-35
Identities = 78/269 (28%), Positives = 125/269 (46%), Gaps = 42/269 (15%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIY-KQRDVAIKLVSQPEEDASLASMLEKQFTSEVA 108
W L + K +G+ ++ G + VA+K + +M + F E
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKP-------GTMSPEAFLQEAQ 53
Query: 109 LLFRLNHPH---------------IITEPYS---------------VPLNLVLKLALDIA 138
++ +L H I+TE S + L ++ +A IA
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIA 113
Query: 139 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAP 196
GM YL S+ +HRDL + N+L+GE++ K+ADFG++ L + + + +G +W AP
Sbjct: 114 EGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAP 173
Query: 197 EMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255
E R T K DV+SFGI+L E++T P+ MT + V ++ R P PP CP+
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV-ERGYRMPRPPNCPEE 232
Query: 256 FSYLISRCWSSSPDRRPHFDQIVSILEGY 284
L+ +CW P+ RP F+ + S LE Y
Sbjct: 233 LYDLMLQCWDKDPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 7e-35
Identities = 79/270 (29%), Positives = 127/270 (47%), Gaps = 44/270 (16%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIY-KQRDVAIKLVSQPEEDASLASMLEKQFTSEVA 108
W D + + + K +G+ ++ G++ VA+K + +M K F +E
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKP-------GTMDPKDFLAEAQ 53
Query: 109 LLFRLNHPHIITEPYSV-----PLNLVLKL--------------------------ALDI 137
++ +L HP +I + Y+V P+ +V +L A +
Sbjct: 54 IMKKLRHPKLI-QLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 138 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMA 195
A GM YL +Q +HRDL + N+L+GE+ KVADFG++ + E + +G +W A
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTA 172
Query: 196 PEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254
PE R + K DV+SFGI+L E++T P+ MT + V + R P PP CPK
Sbjct: 173 PEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-DQGYRMPCPPGCPK 231
Query: 255 AFSYLISRCWSSSPDRRPHFDQIVSILEGY 284
++ CW PD RP F+ + LE +
Sbjct: 232 ELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 82/281 (29%), Positives = 119/281 (42%), Gaps = 66/281 (23%)
Query: 53 DMSQLFIGCKFASGRHSRIYRGIYKQR-----DVAIKLVSQPEEDASLASMLEKQ---FT 104
D S + I G + RG K DVAIK + A +KQ F
Sbjct: 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLK--------AGSSDKQRLDFL 53
Query: 105 SEVALLFRLNHPHII------------------------------TEPYSVPLNLVLKLA 134
+E +++ + +HP+II + LV +
Sbjct: 54 TEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLV-GML 112
Query: 135 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY-- 191
IA GM+YL +HRDL + N+L+ ++ KV+DFG+S LE TY
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED-------SEATYTT 165
Query: 192 -------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 243
RW APE I ++ T DV+SFGIV+WE+++ P+ +M+ + AV +
Sbjct: 166 KGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV-EDG 224
Query: 244 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284
R P P CP A L+ CW + RP F QIVS L+
Sbjct: 225 YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-34
Identities = 81/281 (28%), Positives = 120/281 (42%), Gaps = 53/281 (18%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLE-- 100
W ++ + + G +Y G+ K VAIK V+ E+AS+ +E
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFL 57
Query: 101 ------KQFTSE--VALL---FRLNHPHIITE----------------------PYSVP- 126
K+F V LL ++ E P
Sbjct: 58 NEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPT 117
Query: 127 LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG----ISCLESQCG 182
L +++A +IA GM YL ++ +HRDL + N ++ ED+ VK+ DFG I +
Sbjct: 118 LQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 183 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQ 241
KG RWMAPE +K+ T K DV+SFG+VLWE+ T A P+ ++ E+ V
Sbjct: 178 GGKGLL-PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236
Query: 242 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
P CP L+ CW +P RP F +IVS L+
Sbjct: 237 GGHLDL-PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-33
Identities = 65/253 (25%), Positives = 114/253 (45%), Gaps = 42/253 (16%)
Query: 66 GRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII- 119
G+ +Y+G+Y + VA+K + S + + ++F E ++ + +HPHI+
Sbjct: 17 GQFGDVYQGVYMSPENEKIAVAVKTC---KNCTSPS--VREKFLQEAYIMRQFDHPHIVK 71
Query: 120 ---------------------------TEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 152
YS+ L ++ + ++ + YL S+ +HR
Sbjct: 72 LIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHR 131
Query: 153 DLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY--RWMAPEMIKEKRHTKKVDV 210
D+ + N+L+ CVK+ DFG+S K G +WMAPE I +R T DV
Sbjct: 132 DIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDV 191
Query: 211 YSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 269
+ FG+ +WE+L + PF + + R P+PP CP L+++CW+ P
Sbjct: 192 WMFGVCMWEILMLGVKPFQGVKNNDV-IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPS 250
Query: 270 RRPHFDQIVSILE 282
+RP F ++ + L
Sbjct: 251 KRPRFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 4e-33
Identities = 78/257 (30%), Positives = 125/257 (48%), Gaps = 43/257 (16%)
Query: 62 KFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP---- 116
K +G+ ++ G Y VAIK + Q SM + F +E L+ +L HP
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQ-------GSMSPEAFLAEANLMKQLQHPRLVR 65
Query: 117 ----------HIITE---------------PYSVPLNLVLKLALDIARGMQYLHSQGILH 151
+IITE + +N ++ +A IA GM ++ + +H
Sbjct: 66 LYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIH 125
Query: 152 RDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVD 209
RDL++ N+L+ E +C K+ADFG++ L +++ + +G +W APE I T K D
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185
Query: 210 VYSFGIVLWELLT-ALTPFDNMT-PEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 267
V+SFGI+L E++T P+ MT PE ++ R P P CP+ L+ CW
Sbjct: 186 VWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLERGYRMPRPDNCPEELYELMRLCWKEK 243
Query: 268 PDRRPHFDQIVSILEGY 284
P+ RP F+ + S+LE +
Sbjct: 244 PEERPTFEYLRSVLEDF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 9e-33
Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 58/253 (22%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII------TEPYSVPLNLV---- 130
VA+K ++ E+ + F E+ +L L+H +I+ +P L L+
Sbjct: 36 VAVKSLNHSGEEQHRSD-----FEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYL 90
Query: 131 ---------------------LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 169
L + I +GM YL SQ +HRDL + N+L+ + VK+
Sbjct: 91 PSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKI 150
Query: 170 ADFGISCLESQCGSAKGFTGTY------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA 223
+DFG++ + + + W APE ++ + + DV+SFG+ L+EL T
Sbjct: 151 SDFGLAKVLPE--DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTY 208
Query: 224 LTPF--------DNMTPEQAAFAVCQ------KNARPPVPPTCPKAFSYLISRCWSSSPD 269
P + Q V + + R P PP+CP L+ CW + P
Sbjct: 209 GDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQ 268
Query: 270 RRPHFDQIVSILE 282
RP F ++ I++
Sbjct: 269 DRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-32
Identities = 65/236 (27%), Positives = 109/236 (46%), Gaps = 42/236 (17%)
Query: 71 IYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--EPYSVP 126
+Y+ +K ++VAIK++ ++ ++ +E+ +L + HP+I+ Y
Sbjct: 16 VYKARHKRTGKEVAIKVIKLESKEKK------EKIINEIQILKKCKHPNIVKYYGSYLKK 69
Query: 127 LNL--------------VLK-------------LALDIARGMQYLHSQGILHRDLKSENL 159
L +LK + ++ +G++YLHS GI+HRD+K+ N+
Sbjct: 70 DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANI 129
Query: 160 LLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 219
LL D VK+ DFG+S S + GT WMAPE+I K + K D++S GI E
Sbjct: 130 LLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIE 189
Query: 220 LLTALTPFDNMTPEQAAFAVCQKNARPPV---PPTCPKAFSYLISRCWSSSPDRRP 272
L P+ + P +A F + PP P F + +C +P++RP
Sbjct: 190 LAEGKPPYSELPPMKALFKIATNG--PPGLRNPEKWSDEFKDFLKKCLQKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 5e-32
Identities = 63/245 (25%), Positives = 114/245 (46%), Gaps = 46/245 (18%)
Query: 71 IYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120
+Y+ + ++VAIK + L ++ +E+ ++ HP+I+
Sbjct: 35 VYKATDRATGKEVAIKKMR-------LRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG 87
Query: 121 -------------------EPYSVPLN--LVLKLALDIARGMQYLHSQGILHRDLKSENL 159
V +N + + ++ +G++YLHSQ ++HRD+KS+N+
Sbjct: 88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNI 147
Query: 160 LLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 218
LL +D VK+ADFG + L + GT WMAPE+IK K + KVD++S GI+
Sbjct: 148 LLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCI 207
Query: 219 ELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL----ISRCWSSSPDRRPHF 274
E+ P+ P +A F + K P P+ +S +++C P++RP
Sbjct: 208 EMAEGEPPYLREPPLRALFLITTK---GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSA 264
Query: 275 DQIVS 279
++++
Sbjct: 265 EELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 6e-32
Identities = 77/245 (31%), Positives = 122/245 (49%), Gaps = 39/245 (15%)
Query: 66 GRHSRIYRGIYKQRD-VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120
G +++G K + VA+K +ED L L+ +F SE +L + +HP+I+
Sbjct: 6 GNFGEVFKGTLKDKTPVAVKTC---KED--LPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 121 ----EPYSVPLNLV---------------------LKLALDIARGMQYLHSQGILHRDLK 155
+P + + LV +K ALD A GM YL S+ +HRDL
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLA 120
Query: 156 SENLLLGEDMCVKVADFGISCLESQ-CGSAKGFTGT-YRWMAPEMIKEKRHTKKVDVYSF 213
+ N L+GE+ +K++DFG+S E S+ G +W APE + R++ + DV+S+
Sbjct: 121 ARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSY 180
Query: 214 GIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 272
GI+LWE + + P+ MT +QA V +K R P CP ++ RCW P+ RP
Sbjct: 181 GILLWETFSLGVCPYPGMTNQQAREQV-EKGYRMSCPQKCPDDVYKVMQRCWDYKPENRP 239
Query: 273 HFDQI 277
F ++
Sbjct: 240 KFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-32
Identities = 58/175 (33%), Positives = 90/175 (51%), Gaps = 21/175 (12%)
Query: 120 TEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179
P +PL +LK +DIA GM+YL ++ +HRDL + N +L EDM V VADFG+
Sbjct: 105 GLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL----- 159
Query: 180 QCGSAKGFTGTY-----------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPF 227
S K ++G Y +W+A E + ++ +T K DV++FG+ +WE+ T TP+
Sbjct: 160 ---SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216
Query: 228 DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
+ + + N R P C L+ CW + P RP F ++ +LE
Sbjct: 217 PGVENHEIYDYLRHGN-RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 73/258 (28%), Positives = 126/258 (48%), Gaps = 47/258 (18%)
Query: 53 DMSQLFIGCKFASGRHSRIYRGIYKQRD-VAIKLVSQPEEDASLASMLEKQFTSEVALLF 111
S+L + + SG+ ++ G + ++ VAIK + + +M E+ F E ++
Sbjct: 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE-------GAMSEEDFIEEAQVMM 54
Query: 112 RLNHPHIITEPYSV-----PLNLV-------------------------LKLALDIARGM 141
+L+HP ++ + Y V P+ LV L + LD+ GM
Sbjct: 55 KLSHPKLV-QLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGM 113
Query: 142 QYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMI 199
YL S ++HRDL + N L+GE+ VKV+DFG++ L+ Q S+ G +W +PE+
Sbjct: 114 AYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVF 173
Query: 200 KEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA--RPPVPPTCPKAF 256
+++ K DV+SFG+++WE+ + TP++N + + V NA R P ++
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVETINAGFRLYKPRLASQSV 230
Query: 257 SYLISRCWSSSPDRRPHF 274
L+ CW P+ RP F
Sbjct: 231 YELMQHCWKERPEDRPSF 248
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 74/278 (26%), Positives = 120/278 (43%), Gaps = 69/278 (24%)
Query: 66 GRHSRIYRGIY------KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
G RI+ GI K+ +V +K V + + +L E LL+ L+H +I+
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLL-----QESCLLYGLSHQNIL 71
Query: 120 ------TEPYSVPL---------NL----------------------VLKLALDIARGMQ 142
E P NL ++ +A+ IA GM
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 143 YLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY----------- 191
YLH +G++H+D+ + N ++ E++ VK+ D + L S F Y
Sbjct: 132 YLHKRGVIHKDIAARNCVIDEELQVKITD---NAL-----SRDLFPMDYHCLGDNENRPV 183
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 250
+WMA E + K ++ DV+SFG++LWEL+T TP+ + P + A A + R P
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA-AYLKDGYRLAQPI 242
Query: 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 288
CP +++ CW+ P+ RP F Q+V L + L
Sbjct: 243 NCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 73/257 (28%), Positives = 112/257 (43%), Gaps = 57/257 (22%)
Query: 74 GIY-----KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII-------TE 121
G+Y K+ +VA+K + Q A +K+F E +++ +L+HP I+ E
Sbjct: 14 GVYLMKSGKEVEVAVKTLKQEHIAA-----GKKEFLREASVMAQLDHPCIVRLIGVCKGE 68
Query: 122 PYSV--------PLNLVLK------------LALDIARGMQYLHSQGILHRDLKSENLLL 161
P + PL LK LA +A GM YL S+ +HRDL + N+LL
Sbjct: 69 PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL 128
Query: 162 GEDMCVKVADFGISCLESQCGSAKGFTGTY-----------RWMAPEMIKEKRHTKKVDV 210
K++DFG+S A G Y +W APE I + + K DV
Sbjct: 129 VNRHQAKISDFGMS-------RALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDV 181
Query: 211 YSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 269
+S+G+ LWE + P+ M + A+ + R P P CP+ ++ CW P+
Sbjct: 182 WSYGVTLWEAFSYGAKPYGEMKGAE-VIAMLESGERLPRPEECPQEIYSIMLSCWKYRPE 240
Query: 270 RRPHFDQIVSILEGYSE 286
RP F ++ S E
Sbjct: 241 DRPTFSELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 7e-31
Identities = 76/268 (28%), Positives = 126/268 (47%), Gaps = 43/268 (16%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDASLASMLEKQFTSEV 107
W + + + + K G++ +Y G++K+ VA+K + +ED M ++F E
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDT----MEVEEFLKEA 53
Query: 108 ALLFRLNHP---------------HIITE--PY-------------SVPLNLVLKLALDI 137
A++ + HP +IITE Y V ++L +A I
Sbjct: 54 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI 113
Query: 138 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMA 195
+ M+YL + +HRDL + N L+GE+ VKVADFG+S L + G +W A
Sbjct: 114 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 173
Query: 196 PEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254
PE + + + K DV++FG++LWE+ T ++P+ + Q + + +K R P CP
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKGYRMERPEGCPP 232
Query: 255 AFSYLISRCWSSSPDRRPHFDQIVSILE 282
L+ CW +P RP F +I E
Sbjct: 233 KVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 7e-31
Identities = 58/174 (33%), Positives = 93/174 (53%), Gaps = 21/174 (12%)
Query: 121 EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180
EP+++PL +++ +DIA GM+YL S+ +HRDL + N +L E+M V VADFG+
Sbjct: 106 EPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL------ 159
Query: 181 CGSAKGFTGTY-----------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFD 228
S K ++G Y +W+A E + + +T DV++FG+ +WE++T TP+
Sbjct: 160 --SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA 217
Query: 229 NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
+ + + K R PP C + L+ +CWS P RP F + LE
Sbjct: 218 GVENSE-IYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-30
Identities = 53/168 (31%), Positives = 83/168 (49%), Gaps = 17/168 (10%)
Query: 109 LLFRLNHPHIITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 168
L L+ +E A +I ++YLHS GI++RDLK EN+LL D +K
Sbjct: 80 LFSHLSKEGRFSEE------RARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIK 133
Query: 169 VADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
+ DFG++ L S+ F GT ++APE++ K + K VD +S G++L+E+LT PF
Sbjct: 134 LTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF 193
Query: 228 DNMTPEQAAFAVCQKNARPPVPPTCPKAFSY----LISRCWSSSPDRR 271
++ + +K + P P+ S LIS P +R
Sbjct: 194 YAEDRKE----IYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 76/257 (29%), Positives = 111/257 (43%), Gaps = 52/257 (20%)
Query: 61 CKFASGRHSRIYRGIY--KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI 118
G + +Y I VAIK + + S+ + + EV + + NHP++
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRK-----EVQAMSQCNHPNV 61
Query: 119 ITEPYSV----PLNLVLKL-----ALDIAR----------------------GMQYLHSQ 147
+ S L LV+ LDI + G++YLHS
Sbjct: 62 VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121
Query: 148 GILHRDLKSENLLLGEDMCVKVADFGIS-CLE----SQCGSAKGFTGTYRWMAPEMIKEK 202
G +HRD+K+ N+LLGED VK+ADFG+S L K F GT WMAPE++++
Sbjct: 122 GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 203 R-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT------CPKA 255
+ K D++SFGI EL T P+ P + Q + PP T K+
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND--PPSLETGADYKKYSKS 239
Query: 256 FSYLISRCWSSSPDRRP 272
F +IS C P +RP
Sbjct: 240 FRKMISLCLQKDPSKRP 256
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-30
Identities = 68/253 (26%), Positives = 112/253 (44%), Gaps = 40/253 (15%)
Query: 58 FIGCKFASGRHSRIYRGIYKQRD----VAIKLVSQPEEDASLASMLEKQFTSEVALLFRL 113
+G SG +Y G+ D A+K VS ++ + + KQ E+ALL +L
Sbjct: 7 LLG----SGSFGSVYEGL--NLDDGDFFAVKEVSLADDGQTGQEAV-KQLEQEIALLSKL 59
Query: 114 NHPHII----TEPYSVPLNLVLKL--------------ALD----------IARGMQYLH 145
HP+I+ TE L + L+L + I G++YLH
Sbjct: 60 QHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH 119
Query: 146 SQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK-RH 204
+ +HRD+K N+L+ + VK+ADFG++ + AK F G+ WMAPE+I ++ +
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGY 179
Query: 205 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 264
D++S G + E+ T P+ + A F + + PP+P I +C
Sbjct: 180 GLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL 239
Query: 265 SSSPDRRPHFDQI 277
P RP ++
Sbjct: 240 QRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 72/220 (32%), Positives = 111/220 (50%), Gaps = 38/220 (17%)
Query: 100 EKQ---FTSEVALLFRLNHPHII--------TEPYSVPLNLVLKLALD------------ 136
EKQ F SE +++ + +HP+II ++P + + +LD
Sbjct: 46 EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV 105
Query: 137 ---------IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKG 186
IA GM+YL G +HRDL + N+L+ ++ KV+DFG+S LE +A
Sbjct: 106 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 165
Query: 187 FTG---TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQK 242
G RW APE I ++ T DV+S+GIV+WE+++ P+ M+ + A+ ++
Sbjct: 166 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI-EE 224
Query: 243 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
R P P CP A L+ CW + RP F+QIVSIL+
Sbjct: 225 GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-29
Identities = 70/234 (29%), Positives = 104/234 (44%), Gaps = 43/234 (18%)
Query: 81 VAIKLVSQP----EEDASLASMLEKQFTSEVALLFRLNHPHIIT--------EPYSVPL- 127
+A+K V P S + K SE+ L L+H +I+ E S+ L
Sbjct: 29 MAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLE 88
Query: 128 -------------------NLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 168
LV + G+ YLHS+GILHRDLK++NLL+ D K
Sbjct: 89 YVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICK 148
Query: 169 VADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKR--HTKKVDVYSFGIVLWELLTA 223
++DFGIS G+ WMAPE+I ++ KVD++S G V+ E+
Sbjct: 149 ISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG 208
Query: 224 LTPFDNMTPEQAAFAVCQKNARPPVPP-----TCPKAFSYLISRCWSSSPDRRP 272
P+ + A F + K + PP+PP P A +L + C++ +PD RP
Sbjct: 209 RRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFL-NACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-29
Identities = 77/271 (28%), Positives = 123/271 (45%), Gaps = 47/271 (17%)
Query: 53 DMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEKQFTSEV 107
D+S + I +G + RG K VAIK + + + F SE
Sbjct: 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLK-----SGYTEKQRRDFLSEA 56
Query: 108 ALLFRLNHPHII--------TEPYSVPLNLVLKLALD---------------------IA 138
+++ + +HP+II + P + + ALD IA
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIA 116
Query: 139 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY------R 192
GM+YL +HRDL + N+L+ ++ KV+DFG+S S +T + R
Sbjct: 117 AGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176
Query: 193 WMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 251
W APE I ++ T DV+S+GIV+WE+++ P+ +M+ + A+ +++ R P P
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-EQDYRLPPPMD 235
Query: 252 CPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
CP A L+ CW + RP F QIVS L+
Sbjct: 236 CPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-29
Identities = 57/156 (36%), Positives = 83/156 (53%), Gaps = 5/156 (3%)
Query: 131 LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS---CLESQCGSAKGF 187
L +A +A GM YL + +HRDL + N L+GE+M VK+ADFG+S +++
Sbjct: 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEND 192
Query: 188 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 246
RWM PE I R+T + DV+++G+VLWE+ + + P+ M E+ + V N
Sbjct: 193 AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL- 251
Query: 247 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
P CP L+ CWS P RP F I IL+
Sbjct: 252 SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 7e-29
Identities = 70/257 (27%), Positives = 115/257 (44%), Gaps = 52/257 (20%)
Query: 55 SQLF-IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLF 111
++F I K G + +Y+ I+K+ + VAIK+V E+ + K E+++L
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEI----IK----EISILK 53
Query: 112 RLNHPHI---------------------------ITEPYSVPLN-----LVLKLALDIAR 139
+ + P+I I + + L +L L +
Sbjct: 54 QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTL---K 110
Query: 140 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEM 198
G++YLHS +HRD+K+ N+LL E+ K+ADFG+S L GT WMAPE+
Sbjct: 111 GLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEV 170
Query: 199 IKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP---VPPTCPKA 255
I+E + K D++S GI E+ P+ ++ P +A F + N PP P
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--PNKPPPTLSDPEKWSPE 228
Query: 256 FSYLISRCWSSSPDRRP 272
F+ + +C P+ RP
Sbjct: 229 FNDFVKKCLVKDPEERP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 8e-29
Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 38/223 (17%)
Query: 94 SLASMLEKQFTSEVALLFRLNHPHII--------TEPYSVPLNLV--------------- 130
+L L+ +F E +L + +HP+I+ +P + + LV
Sbjct: 31 TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR 90
Query: 131 ------LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 184
+++ + A GM+YL S+ +HRDL + N L+ E +K++DFG+S E A
Sbjct: 91 LKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA 150
Query: 185 KGFTGTYR-----WMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFA 238
TG + W APE + R++ + DV+SFGI+LWE + P+ N++ +Q A
Sbjct: 151 S--TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA 208
Query: 239 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 281
+ ++ R P P CP A L+ RCW P +RP F + L
Sbjct: 209 I-EQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 52/153 (33%), Positives = 88/153 (57%), Gaps = 5/153 (3%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG---T 190
A +ARGM++L S+ +HRDL + N+L+ ED +K+ADFG++ + T
Sbjct: 138 AYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLP 197
Query: 191 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 249
+WMAPE + ++ +T + DV+SFG++LWE+ T +P+ + E+ F + ++ R P
Sbjct: 198 VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-LFKLLKEGYRMEKP 256
Query: 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
C + +L+ CW P +RP F Q+V L+
Sbjct: 257 QNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-28
Identities = 75/268 (27%), Positives = 125/268 (46%), Gaps = 41/268 (15%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVA 108
W L + K +G+ ++ G + VA+K + +P +M + F E
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KP------GTMSPESFLEEAQ 53
Query: 109 LLFRLNHP--------------HIITEPYS---------------VPLNLVLKLALDIAR 139
++ +L H +I+TE S + L ++ +A +A
Sbjct: 54 IMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 113
Query: 140 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPE 197
GM Y+ +HRDL+S N+L+G+ + K+ADFG++ L +++ + +G +W APE
Sbjct: 114 GMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 198 MIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 256
R T K DV+SFGI+L EL+T P+ M + V ++ R P P CP +
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV-ERGYRMPCPQDCPISL 232
Query: 257 SYLISRCWSSSPDRRPHFDQIVSILEGY 284
L+ +CW P+ RP F+ + S LE Y
Sbjct: 233 HELMLQCWKKDPEERPTFEYLQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-28
Identities = 56/157 (35%), Positives = 87/157 (55%), Gaps = 13/157 (8%)
Query: 135 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGT-- 190
L +A+GM+YL S+ +HRDL + N +L E VKVADFG++ + + S TG
Sbjct: 105 LQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164
Query: 191 -YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQ---KNAR 245
+WMA E ++ ++ T K DV+SFG++LWEL+T P+ P+ +F + + R
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY----PDVDSFDITVYLLQGRR 220
Query: 246 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
P CP ++ CW P+ RP F ++VS +E
Sbjct: 221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 6e-28
Identities = 58/173 (33%), Positives = 90/173 (52%), Gaps = 21/173 (12%)
Query: 122 PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181
P +P +++K DIA GM+YL S+ +HRDL + N +L E+M V VADFG+
Sbjct: 106 PQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGL------- 158
Query: 182 GSAKGFTGTY-----------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 229
S K + G Y +W+A E + ++ +T K DV+SFG+ +WE+ T TP+
Sbjct: 159 -SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217
Query: 230 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
+ + + ++ R PP C L+S CW +P RP F+ + LE
Sbjct: 218 VENSE-IYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 7e-28
Identities = 58/158 (36%), Positives = 90/158 (56%), Gaps = 4/158 (2%)
Query: 130 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGF 187
++ +A IA GM Y+ +HRDL++ N+L+G+++ K+ADFG++ L +++ + +G
Sbjct: 104 LVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA 163
Query: 188 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 246
+W APE R T K DV+SFGI+L EL+T P+ M + V ++ R
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV-ERGYRM 222
Query: 247 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284
P P CP++ L+ CW PD RP F+ I S LE Y
Sbjct: 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 9e-28
Identities = 73/261 (27%), Positives = 117/261 (44%), Gaps = 43/261 (16%)
Query: 60 GCKFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDASL----ASMLEKQFTSEVALLFRL 113
G SG +Y G+ +A+K V P AS SML+ E+ALL L
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDA-LAREIALLKEL 63
Query: 114 NHPHII----------------------------TEPYSVPLNLVLKLALDIARGMQYLH 145
H +I+ + LV I +G+ YLH
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 146 SQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAK------GFTGTYRWMAPEM 198
++GI+HRD+K N+L+ +K++DFGIS LE+ S K G+ WMAPE+
Sbjct: 124 NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183
Query: 199 IKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 258
+K+ +T+K D++S G ++ E+LT PF + T QA F + + NA P +P
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPSNISSEAID 242
Query: 259 LISRCWSSSPDRRPHFDQIVS 279
+ + + ++RP +++
Sbjct: 243 FLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-27
Identities = 59/244 (24%), Positives = 101/244 (41%), Gaps = 57/244 (23%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII--------------TE----- 121
VA+K + L+ +++ F E A++ L+H ++I TE
Sbjct: 26 VAVKCLK----SDKLSDIMD-DFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG 80
Query: 122 ----------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVAD 171
++ + A+ IA GM+YL S+ +HRDL + N+LL D VK+ D
Sbjct: 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGD 140
Query: 172 FGIS---CLESQCGSAKGFTGTYR----------WMAPEMIKEKRHTKKVDVYSFGIVLW 218
FG+ Y W APE ++ + + DV+ FG+ LW
Sbjct: 141 FGLMRALPQNEDH---------YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLW 191
Query: 219 ELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 277
E+ T P+ ++ Q + ++ R P CP+ ++ +CW+ +P RP F +
Sbjct: 192 EMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAAL 251
Query: 278 VSIL 281
L
Sbjct: 252 REFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-27
Identities = 78/261 (29%), Positives = 125/261 (47%), Gaps = 27/261 (10%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVS----QPEEDASLASMLEKQFT 104
W L + K G ++ G + VAIK + PE A +++K
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH 60
Query: 105 SEVALLFRL--NHP-HIITE-------------PYSVPLNL--VLKLALDIARGMQYLHS 146
++ L+ + P +I+TE L L ++ +A IA GM Y+
Sbjct: 61 EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 147 QGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIKEKRH 204
+HRDL++ N+L+GE++ KVADFG++ L +++ + +G +W APE R
Sbjct: 121 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 205 TKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263
T K DV+SFGI+L EL T P+ M + V ++ R P PP CP++ L+ +C
Sbjct: 181 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDLMCQC 239
Query: 264 WSSSPDRRPHFDQIVSILEGY 284
W P+ RP F+ + + LE Y
Sbjct: 240 WRKEPEERPTFEYLQAFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-27
Identities = 78/260 (30%), Positives = 119/260 (45%), Gaps = 51/260 (19%)
Query: 65 SGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQ---FTSEVALLFRLNHP 116
+G ++RGI K + VAIK + EKQ F SE +++ + +H
Sbjct: 15 AGEFGEVFRGILKMPGRKEVAVAIKTLK--------PGYTEKQRQDFLSEASIMGQFSHH 66
Query: 117 HIIT--------EPYSVPLNLVLKLALD---------------------IARGMQYLHSQ 147
+II +P + + ALD IA GM+YL
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM 126
Query: 148 GILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTG---TYRWMAPEMIKEKR 203
+HRDL + N+L+ ++ KV+DFG+S LE +G RW APE I ++
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 204 HTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 262
T DV+SFGIV+WE+++ P+ +M+ + A+ R P P CP A L+ +
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-NDGFRLPAPMDCPSAVYQLMLQ 245
Query: 263 CWSSSPDRRPHFDQIVSILE 282
CW RRP F IV++L+
Sbjct: 246 CWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 71/255 (27%), Positives = 109/255 (42%), Gaps = 71/255 (27%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII--------TEPY--------- 123
VA+K++ D + F EV +L RL+ P+I P
Sbjct: 49 VAVKVLRPDASDNARED-----FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMEN 103
Query: 124 ----------------------SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 161
S+ + +L +A IA GM+YL S +HRDL + N L+
Sbjct: 104 GDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163
Query: 162 GEDMCVKVADFGISCLESQCGSAKGFTGTY-----------RWMAPEMIKEKRHTKKVDV 210
G++ +K+ADFG+ S ++ Y RWMA E + + T K DV
Sbjct: 164 GKNYTIKIADFGM--------SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215
Query: 211 YSFGIVLWELLT--ALTPFDNMTPEQA---AFAVCQKNARP---PVPPTCPKAFSYLISR 262
++FG+ LWE+LT P++++T +Q A + + R P PP CPK L+
Sbjct: 216 WAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLE 275
Query: 263 CWSSSPDRRPHFDQI 277
CW + RP F +I
Sbjct: 276 CWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-27
Identities = 67/237 (28%), Positives = 112/237 (47%), Gaps = 40/237 (16%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP---------------HIITEP 122
Q DVAIK++ + SM E +F E ++ +L+H +I+TE
Sbjct: 28 QYDVAIKMIKE-------GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80
Query: 123 YS--VPLNLV------------LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 168
S LN + L++ D+ GM YL S+ +HRDL + N L+ + CVK
Sbjct: 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVK 140
Query: 169 VADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALT 225
V+DFG+S L+ + S+ G RW PE++ + + K DV++FG+++WE+ +
Sbjct: 141 VSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKM 200
Query: 226 PFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
P++ + V Q R P + ++ CW + RP F Q++S +E
Sbjct: 201 PYERFNNSETVEKVSQ-GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-27
Identities = 55/162 (33%), Positives = 85/162 (52%), Gaps = 5/162 (3%)
Query: 126 PLNLVLKLAL--DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQC 181
PL+ K+AL IA GM +L + +HRDL + N L+ VKV+ +S S+
Sbjct: 113 PLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY 172
Query: 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVC 240
+ RW+APE ++E + K DV+SFG+++WE+ T PF ++ E+ +
Sbjct: 173 YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ 232
Query: 241 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
PVP CP L++RCW+ +P RP F ++VS L
Sbjct: 233 AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-27
Identities = 64/259 (24%), Positives = 102/259 (39%), Gaps = 44/259 (16%)
Query: 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR 112
S L G +Y+ +K + A+K + + KQ E+ L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD-----EEFRKQLLRELKTLRS 55
Query: 113 LNHPHIIT--EPYSVP--LNLVL------------------------KLALDIARGMQYL 144
P+++ + +++VL +A I +G+ YL
Sbjct: 56 CESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYL 115
Query: 145 HSQ-GILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEK 202
H++ I+HRD+K NLL+ VK+ADFGIS LE+ F GT +M+PE I+ +
Sbjct: 116 HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE 175
Query: 203 RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF-----AVCQKNARPPVPPTCPKAFS 257
++ D++S G+ L E PF P Q +F A+C F
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLP--PGQPSFFELMQAICDGPPPSLPAEEFSPEFR 233
Query: 258 YLISRCWSSSPDRRPHFDQ 276
IS C P +RP +
Sbjct: 234 DFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 53/153 (34%), Positives = 87/153 (56%), Gaps = 5/153 (3%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG---T 190
A +ARGM+YL S+ +HRDL + N+L+ ED +K+ADFG++ K +
Sbjct: 140 AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLP 199
Query: 191 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 249
+WMAPE + ++ +T + DV+SFGI++WE+ T +P+ + P + F + ++ R P
Sbjct: 200 VKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEELFKLLREGHRMDKP 258
Query: 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
C L+ CW + P +RP F Q+V L+
Sbjct: 259 SNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 57/232 (24%), Positives = 96/232 (41%), Gaps = 33/232 (14%)
Query: 79 RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII------TEPYSVPL----- 127
R++A+K V + D+ E+ LL L H I+ + ++ +
Sbjct: 28 RELAVKQV-PFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86
Query: 128 -----------------NLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVA 170
+ K I G++YLHS I+HRD+K N+L VK+
Sbjct: 87 PGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLG 146
Query: 171 DFGIS----CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP 226
DFG S + S K TGT WM+PE+I + + +K DV+S G + E+LT P
Sbjct: 147 DFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
Query: 227 FDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 278
+ A F + + P +P + R + + +RP ++++
Sbjct: 207 WAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 65/237 (27%), Positives = 107/237 (45%), Gaps = 45/237 (18%)
Query: 71 IYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120
+Y+ I K + VAIK++ E + + + + E+ L + P+I
Sbjct: 17 VYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ-----EIQFLSQCRSPYITKYYGSFLKG 71
Query: 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 161
+P + + + ++ G++YLH +G +HRD+K+ N+LL
Sbjct: 72 SKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL 131
Query: 162 GEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 220
E+ VK+ADFG+S L S F GT WMAPE+IK+ + +K D++S GI EL
Sbjct: 132 SEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIEL 191
Query: 221 LTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP-----KAFSYLISRCWSSSPDRRP 272
P ++ P + F + + N PP+ K F +S C + P RP
Sbjct: 192 AKGEPPLSDLHPMRVLFLIPKNN-----PPSLEGNKFSKPFKDFVSLCLNKDPKERP 243
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 2e-26
Identities = 74/268 (27%), Positives = 124/268 (46%), Gaps = 49/268 (18%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVAL 109
W+ +M +L + G + G Y+ VA+K + + DA+ + F +E ++
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI---KNDAT-----AQAFLAEASV 52
Query: 110 LFRLNHP----------------HIITEPYSVPLNLV----------------LKLALDI 137
+ +L H +I+TE Y +LV LK +LD+
Sbjct: 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTE-YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111
Query: 138 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY--RWMA 195
M+YL + +HRDL + N+L+ ED KV+DFG+ ++ S+ TG +W A
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGL----TKEASSTQDTGKLPVKWTA 167
Query: 196 PEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254
PE ++EK+ + K DV+SFGI+LWE+ + P+ + P + +K + P CP
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPP 226
Query: 255 AFSYLISRCWSSSPDRRPHFDQIVSILE 282
++ +CW RP F Q+ LE
Sbjct: 227 VVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 55/164 (33%), Positives = 90/164 (54%), Gaps = 7/164 (4%)
Query: 124 SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC----LES 179
++ + ++ A I+RGMQYL ++HRDL + N+L+ E +K++DFG+S +S
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 180 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFA 238
+KG +WMA E + + +T + DV+SFG++LWE++T P+ + PE+ F
Sbjct: 183 YVKRSKGRIPV-KWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-LFN 240
Query: 239 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
+ + R P C + L+ CW PD+RP F I LE
Sbjct: 241 LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 69/240 (28%), Positives = 113/240 (47%), Gaps = 36/240 (15%)
Query: 72 YRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFT-SEVALLFRLNHPHIIT--------- 120
Y +YK +R + + E D S E++ +E+ +L +NHP+II+
Sbjct: 13 YGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGN 72
Query: 121 --------EPYS---------------VPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 157
P+ +P + ++ + + RG+Q LH Q ILHRDLKS
Sbjct: 73 KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSA 132
Query: 158 NLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVL 217
N+LL + VK+ D GIS + + AK GT +MAPE+ K + ++ K D++S G +L
Sbjct: 133 NILLVANDLVKIGDLGISKVLKK-NMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLL 191
Query: 218 WELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 277
+E+ T PF+ + + + V + PP+PP + I P RP+ D+I
Sbjct: 192 YEMATFAPPFEARSMQDLRYKVQRGKY-PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 70/264 (26%), Positives = 124/264 (46%), Gaps = 44/264 (16%)
Query: 54 MSQLFIGCKFASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSEV 107
++L SG +Y+G++ + VAIK++ E+ S + K+ E
Sbjct: 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL---REETSPKA--NKEILDEA 60
Query: 108 ALLFRLNHPHI--------------ITE--PYSVPLNLV------------LKLALDIAR 139
++ ++HPH+ IT+ P L+ V L + IA+
Sbjct: 61 YVMASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK 120
Query: 140 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAP 196
GM YL + ++HRDL + N+L+ VK+ DFG++ L + + A+G +WMA
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180
Query: 197 EMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255
E I + +T K DV+S+G+ +WEL+T P++ + P + +K R P PP C
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERLPQPPICTID 239
Query: 256 FSYLISRCWSSSPDRRPHFDQIVS 279
++ +CW + RP F ++++
Sbjct: 240 VYMVLVKCWMIDAESRPTFKELIN 263
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 3e-26
Identities = 58/158 (36%), Positives = 86/158 (54%), Gaps = 5/158 (3%)
Query: 126 PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSA 184
L ++++A +IA GM YL++ +HRDL + N ++ ED VK+ DFG++ +
Sbjct: 117 SLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 176
Query: 185 KGFTGTY--RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQ 241
KG G RWM+PE +K+ T DV+SFG+VLWE+ T A P+ M+ EQ V +
Sbjct: 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236
Query: 242 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279
P CP L+ CW +P RP F +I+S
Sbjct: 237 GGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 66/249 (26%), Positives = 119/249 (47%), Gaps = 34/249 (13%)
Query: 63 FASGRHSRIYRGIYKQRDVAIKL-VSQPEEDASLASMLEKQFTSEVALLFRLNHPHI--- 118
SG +Y+G++ +K+ V+ E + + K+ E ++ +++PH+
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 119 -----------ITE--PYSVPLNLV------------LKLALDIARGMQYLHSQGILHRD 153
IT+ P+ L+ V L + IA+GM YL + ++HRD
Sbjct: 75 LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRD 134
Query: 154 LKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 210
L + N+L+ VK+ DFG++ L + + A+G +WMA E I + +T + DV
Sbjct: 135 LAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDV 194
Query: 211 YSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 269
+S+G+ +WEL+T P+D + P ++ +K R P PP C ++ +CW D
Sbjct: 195 WSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDAD 253
Query: 270 RRPHFDQIV 278
RP F +++
Sbjct: 254 SRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 73/275 (26%), Positives = 116/275 (42%), Gaps = 77/275 (28%)
Query: 66 GRHSRIYRG-------IYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI 118
G ++Y+G VAIK + +E+A ++++F E L+ L HP+I
Sbjct: 16 GAFGKVYKGELTGPNERLSATSVAIKTL---KENAEPK--VQQEFRQEAELMSDLQHPNI 70
Query: 119 IT--------EPYSV------------------PLNLV------------------LKLA 134
+ +P + P + V L +A
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 135 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY--- 191
+ IA GM+YL S +HRDL + N L+GE + VK++DFG+S ++ Y
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD--------IYSADYYRV 182
Query: 192 --------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQK 242
RWM PE I + T + D++SFG+VLWE+ + L P+ + ++ + +
Sbjct: 183 QSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI-RS 241
Query: 243 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 277
P P CP L+ CW+ P RRP F I
Sbjct: 242 RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 73/247 (29%), Positives = 109/247 (44%), Gaps = 56/247 (22%)
Query: 72 YRGIYKQRD------VAIKLVS-QPEEDASLASMLEKQFTSEVALLFRLNHPHI------ 118
Y +YK RD VAIK++ +P +D + E+++L HP+I
Sbjct: 16 YGDVYKARDIATGELVAIKVIKLEPGDDF-------EIIQQEISMLKECRHPNIVAYFGS 68
Query: 119 ------------------ITEPYSV---PLN-----LVLKLALDIARGMQYLHSQGILHR 152
+ + Y V PL+ V + L +G+ YLH G +HR
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL---KGLAYLHETGKIHR 125
Query: 153 DLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKR---HTKKV 208
D+K N+LL ED VK+ADFG+S L + K F GT WMAPE+ +R + K
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKC 185
Query: 209 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV---PPTCPKAFSYLISRCWS 265
D+++ GI EL P ++ P +A F + + N PP F I +C +
Sbjct: 186 DIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLT 245
Query: 266 SSPDRRP 272
P +RP
Sbjct: 246 KDPKKRP 252
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-26
Identities = 50/152 (32%), Positives = 79/152 (51%), Gaps = 8/152 (5%)
Query: 125 VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGS 183
+P + V + + I G+ +LHS+ ILHRD+KS NL L VK+ D G++ L
Sbjct: 98 LPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157
Query: 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 243
A GT +++PE+ ++K + +K DV++ G+VL+E T PFD A+ K
Sbjct: 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD----ANNQGALILKI 213
Query: 244 AR---PPVPPTCPKAFSYLISRCWSSSPDRRP 272
R PPV + + LI +C + +RP
Sbjct: 214 IRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-25
Identities = 52/163 (31%), Positives = 89/163 (54%), Gaps = 4/163 (2%)
Query: 125 VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCG 182
V L ++ + IA GM Y+ + +HRDL++ N+L+ E + K+ADFG++ + +++
Sbjct: 100 VLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159
Query: 183 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQ 241
+ +G +W APE I T K DV+SFGI+L+E++T P+ M+ A+ Q
Sbjct: 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-Q 218
Query: 242 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284
+ R P CP ++ CW + RP FD + S+L+ +
Sbjct: 219 RGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 53/153 (34%), Positives = 87/153 (56%), Gaps = 5/153 (3%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG---T 190
A +ARGM+YL S+ +HRDL + N+L+ ED +K+ADFG++ K T
Sbjct: 146 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205
Query: 191 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 249
+WMAPE + ++ +T + DV+SFG++LWE+ T +P+ + P + F + ++ R P
Sbjct: 206 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGHRMDKP 264
Query: 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
C ++ CW + P +RP F Q+V L+
Sbjct: 265 SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 64/260 (24%), Positives = 108/260 (41%), Gaps = 58/260 (22%)
Query: 60 GCKFASGRHSRIYRGIYKQ--RDVAIKLVS-QPEEDASLASMLEKQFTSEVALLFRLNHP 116
G K G ++Y + +A+K + Q + ++ K+ E+ +L L HP
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTI-----KEIADEMKVLELLKHP 59
Query: 117 HIITEPYSV-----------------------------PLNLVLKLALDIARGMQYLHSQ 147
+++ Y V +++ L + G+ YLHS
Sbjct: 60 NLVKY-YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 148 GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA-----KGFTGTYRWMAPEMIKEK 202
GI+HRD+K N+ L + +K+ DFG + + + GT +MAPE+I
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 203 R---HTKKVDVYSFGIVLWELLTALTPFDNMTPE-QAAFAVCQKNARPPVP------PTC 252
+ H + D++S G V+ E+ T P+ + E Q F V + +PP+P P
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-KPPIPDSLQLSPEG 237
Query: 253 PKAFSYLISRCWSSSPDRRP 272
K F + RC S P +RP
Sbjct: 238 -KDF---LDRCLESDPKKRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG---T 190
A +ARGM+YL SQ +HRDL + N+L+ ED +K+ADFG++ K T
Sbjct: 140 AYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLP 199
Query: 191 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 249
+WMAPE + ++ +T + DV+SFG++LWE+ T +P+ + P + F + ++ R P
Sbjct: 200 VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKP 258
Query: 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRC 309
C ++ CW + P +RP F Q+V L+ D E+ +P ++
Sbjct: 259 ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTD-EYLDLSVPFEQYS---- 313
Query: 310 LPTCIARHCCAHSKAKELF 328
P C S +F
Sbjct: 314 -PGCPDSPSSCSSGDDSVF 331
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 70/275 (25%), Positives = 109/275 (39%), Gaps = 73/275 (26%)
Query: 66 GRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI 118
G +Y G+Y+ RD VA+K + E S E F E ++ + NH +I
Sbjct: 17 GAFGEVYEGLYRGRDGDAVELQVAVKTLP---ESCSEQD--ESDFLMEALIMSKFNHQNI 71
Query: 119 I--------TEPYSVPLNL---------------------------VLKLALDIARGMQY 143
+ P + L L +L A D+A+G +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 144 LHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGT--YR------ 192
L +HRD+ + N LL G K+ADFG+ A+ YR
Sbjct: 132 LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM---------ARDIYRASYYRKGGRAM 182
Query: 193 ----WMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPP 247
WM PE + T K DV+SFG++LWE+ + P+ T ++ V R
Sbjct: 183 LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG-GGRLD 241
Query: 248 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
P CP +++ CW +P+ RP+F I+ ++
Sbjct: 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-25
Identities = 77/279 (27%), Positives = 117/279 (41%), Gaps = 64/279 (22%)
Query: 57 LFIGCKFASGRHSRIYRGIYKQRD--------VAIKLVSQPEEDASLASMLEKQFTSEVA 108
F+G SG +Y G VA+K + + D +K+F E
Sbjct: 1 NFLG----SGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-----KKEFLKEAH 51
Query: 109 LLFRLNHPHII--------TEPYSVPLNL---------------------------VLKL 133
L+ NHP+I+ EP + + L +L +
Sbjct: 52 LMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDI 111
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGE-----DMCVKVADFGIS--CLESQCGSAKG 186
LD+A+G YL +HRDL + N L+ E D VK+ DFG++ +S +G
Sbjct: 112 CLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG 171
Query: 187 FTG--TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 243
G RWMAPE + + + T + DV+SFG+++WE+LT P+ + Q
Sbjct: 172 -EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN-NQEVLQHVTAG 229
Query: 244 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
R P CP L++ CW+ P RP FD+I IL+
Sbjct: 230 GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-25
Identities = 70/256 (27%), Positives = 102/256 (39%), Gaps = 68/256 (26%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------EPYSV------ 125
VA+K + + + K F E LL H +I+ P V
Sbjct: 38 VAVKTLKETASND-----ARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEH 92
Query: 126 -------------------------PLNLV--LKLALDIARGMQYLHSQGILHRDLKSEN 158
L L L++A+ IA GM YL SQ +HRDL + N
Sbjct: 93 GDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRN 152
Query: 159 LLLGEDMCVKVADFGISCLESQCGSAKGFTGTY-----------RWMAPEMIKEKRHTKK 207
L+G D+ VK+ DFG+ S +T Y RWM PE I ++ T +
Sbjct: 153 CLVGYDLVVKIGDFGM--------SRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE 204
Query: 208 VDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 266
DV+SFG+VLWE+ T P+ ++ E+ + Q P TCP ++ CW
Sbjct: 205 SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR-PRTCPSEVYDIMLGCWKR 263
Query: 267 SPDRRPHFDQIVSILE 282
P +R + I L+
Sbjct: 264 DPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-25
Identities = 65/263 (24%), Positives = 120/263 (45%), Gaps = 43/263 (16%)
Query: 53 DMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLF 111
+ S+L + SG+ ++ G ++ Q VAIK +++ +M E+ F E ++
Sbjct: 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINE-------GAMSEEDFIEEAKVMM 54
Query: 112 RLNHPHIITEPYSV-----PLNLV-------------------------LKLALDIARGM 141
+L+HP ++ + Y V PL +V L + D+ GM
Sbjct: 55 KLSHPKLV-QLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGM 113
Query: 142 QYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMI 199
+YL +HRDL + N L+ VKV+DFG++ L+ + S+ G +W PE+
Sbjct: 114 EYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVF 173
Query: 200 KEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 258
+++ K DV+SFG+++WE+ T PF+ + + + + R P
Sbjct: 174 NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF-RLYRPKLASMTVYE 232
Query: 259 LISRCWSSSPDRRPHFDQIVSIL 281
++ CW P+ RP F +++ +
Sbjct: 233 VMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-25
Identities = 56/161 (34%), Positives = 90/161 (55%), Gaps = 7/161 (4%)
Query: 127 LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSA 184
L ++++A +IA GM YL+++ +HRDL + N ++ D VK+ DFG++ E+
Sbjct: 118 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY-YR 176
Query: 185 KGFTGTY--RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQ 241
KG G RWMAPE +K+ T D++SFG+VLWE+ + A P+ ++ EQ
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-VLKFVM 235
Query: 242 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
P CP+ + L+ CW +P RP F +IV++L+
Sbjct: 236 DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-25
Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 31/199 (15%)
Query: 106 EVALLFRLNHPHIITEPYSVP----LNLVLKLAL------------------------DI 137
E +L LNHP ++ YS + LV+ L L +I
Sbjct: 50 ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEI 109
Query: 138 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE 197
++YLHS+GI+HRD+K +N+LL E V + DF I+ + +GT +MAPE
Sbjct: 110 VLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPE 169
Query: 198 MIKEKRHTKKVDVYSFGIVLWELLTALTPFDN--MTPEQAAFAVCQKNARPPVPPTCPKA 255
++ + ++ VD +S G+ +E L P+ T A Q+ A P T
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK-QETADVLYPATWSTE 228
Query: 256 FSYLISRCWSSSPDRRPHF 274
I++ P +R
Sbjct: 229 AIDAINKLLERDPQKRLGD 247
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 9e-25
Identities = 56/182 (30%), Positives = 84/182 (46%), Gaps = 35/182 (19%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL-------ESQCGSAKG--- 186
I ++YLHS+GI+HRDLK EN+LL +DM +K+ DFG + + ES G A
Sbjct: 111 ILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 187 -----------FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA 235
F GT +++PE++ EK K D+++ G +++++LT PF
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE--- 227
Query: 236 AFAVCQK--NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPE 293
+ QK PP P LI + P R + EGY + L+ P
Sbjct: 228 -YLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRL------GVNEGY-DELKAHP- 278
Query: 294 FF 295
FF
Sbjct: 279 FF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 53/167 (31%), Positives = 94/167 (56%), Gaps = 4/167 (2%)
Query: 121 EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--E 178
E PL ++ + IA GM ++ + +HRDL++ N+L+ + K+ADFG++ + +
Sbjct: 95 EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 154
Query: 179 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAF 237
++ + +G +W APE I T K DV+SFGI+L E++T P+ M+ +
Sbjct: 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 214
Query: 238 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284
A+ ++ R P P CP+ ++ RCW + P+ RP F+ I S+L+ +
Sbjct: 215 AL-ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 55/149 (36%), Positives = 81/149 (54%), Gaps = 2/149 (1%)
Query: 130 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG 189
+L+ A D+A GMQYL + +HRDL + N+L+GE++ K+ADFG+S E
Sbjct: 121 LLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL 180
Query: 190 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 248
RWMA E + +T K DV+SFG++LWE+++ TP+ MT + + + R
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRMEK 239
Query: 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQI 277
P C L+ +CW P RP F QI
Sbjct: 240 PRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 51/150 (34%), Positives = 86/150 (57%), Gaps = 5/150 (3%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG---TYRW 193
+ARGM+YL SQ +HRDL + N+L+ E+ +K+ADFG++ + K T +W
Sbjct: 146 VARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKW 205
Query: 194 MAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 252
MAPE + ++ +T + DV+SFG+++WE+ T +P+ + P + F + ++ R P C
Sbjct: 206 MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPANC 264
Query: 253 PKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
++ CW + P RP F Q+V L+
Sbjct: 265 TNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-24
Identities = 59/171 (34%), Positives = 83/171 (48%), Gaps = 27/171 (15%)
Query: 130 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG 189
+L +AL IA GM+YL S +HRDL + N L+GE++ +K+ADFG+ S + G
Sbjct: 140 LLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGM--------SRNLYAG 191
Query: 190 TY-----------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTAL--TPFDNMTPEQAA 236
Y RWMA E I + T DV++FG+ LWE+L P+ +T EQ
Sbjct: 192 DYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVI 251
Query: 237 ------FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 281
F + PP CP+ L+ +CWS RP F I + L
Sbjct: 252 ENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-24
Identities = 54/170 (31%), Positives = 87/170 (51%), Gaps = 9/170 (5%)
Query: 130 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKG 186
+L + IA+GM YL ++HRDL + N+L+ VK+ DFG++ L + A G
Sbjct: 111 LLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG 170
Query: 187 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 245
+WMA E I +R T + DV+S+G+ +WEL+T P+D + P + + +K R
Sbjct: 171 GKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGER 229
Query: 246 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFF 295
P PP C ++ +CW + RP F ++V + +DP F
Sbjct: 230 LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEF----SRMARDPSRF 275
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 4e-24
Identities = 59/187 (31%), Positives = 86/187 (45%), Gaps = 28/187 (14%)
Query: 123 YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS------- 175
+ + L +L A I GM YLHSQ +HRDL + N+LL D VK+ DFG++
Sbjct: 102 HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161
Query: 176 --CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP------- 226
+ G + F W A E +KE + + DV+SFG+ L+ELLT
Sbjct: 162 EYYRVREDGDSPVF-----WYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK 216
Query: 227 FDNMT-PEQAAFAVC------QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279
F+ M P+Q V ++ R P P CP+ L+ CW + RP F ++
Sbjct: 217 FEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276
Query: 280 ILEGYSE 286
IL+
Sbjct: 277 ILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 4e-24
Identities = 64/254 (25%), Positives = 115/254 (45%), Gaps = 45/254 (17%)
Query: 62 KFASGRHSRIYRGIYKQR----DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH 117
+ SG + +G+YK R DVAIK++ E + M+ E ++ +L++P+
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMM-----REAEIMHQLDNPY 56
Query: 118 II----------------------------TEPYSVPLNLVLKLALDIARGMQYLHSQGI 149
I+ + + ++ V++L ++ GM+YL +
Sbjct: 57 IVRMIGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 150 LHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTG---TYRWMAPEMIKEKRHT 205
+HRDL + N+LL K++DFG+S L + K + +W APE I ++ +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 206 KKVDVYSFGIVLWELLT-ALTPFDNMT-PEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263
+ DV+S+GI +WE + P+ M PE +F ++ R P CP L+ C
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF--IEQGKRLDCPAECPPEMYALMKDC 234
Query: 264 WSSSPDRRPHFDQI 277
W + RP+F ++
Sbjct: 235 WIYKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 5e-24
Identities = 52/149 (34%), Positives = 78/149 (52%), Gaps = 2/149 (1%)
Query: 130 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG 189
+L A D+ARGM YL + +HRDL + N+L+GE+ K+ADFG+S +
Sbjct: 114 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 173
Query: 190 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 248
RWMA E + +T DV+S+G++LWE+++ TP+ MT + + + R
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRLEK 232
Query: 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQI 277
P C L+ +CW P RP F QI
Sbjct: 233 PLNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 5e-24
Identities = 70/283 (24%), Positives = 128/283 (45%), Gaps = 45/283 (15%)
Query: 63 FASGRHSRIYRGIYKQRDVAIKL-VSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT- 120
SG +Y+GI+ +K+ V+ + + +F E ++ ++HPH++
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 121 ---------------EPYSVPL------------NLVLKLALDIARGMQYLHSQGILHRD 153
P+ L L+L + IA+GM YL + ++HRD
Sbjct: 75 LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRD 134
Query: 154 LKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 210
L + N+L+ VK+ DFG++ L + + +A G +WMA E I ++ T + DV
Sbjct: 135 LAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDV 194
Query: 211 YSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 269
+S+G+ +WEL+T P+D + P + + +K R P PP C ++ +CW D
Sbjct: 195 WSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDAD 253
Query: 270 RRPHFDQIVSILEGYSESLEQDPEFFSSF-------IPSPDHT 305
RP F ++ + + +DP+ + +PSP+ +
Sbjct: 254 SRPKFKELAAEF----SRMARDPQRYLVIQGDDRMKLPSPNDS 292
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 6e-24
Identities = 51/151 (33%), Positives = 78/151 (51%), Gaps = 5/151 (3%)
Query: 131 LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT 190
L +A+ IA GM+YL S +H+DL + N+L+GE + VK++D G+S + +
Sbjct: 127 LHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 191 Y---RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 246
RWM PE I + + D++SFG+VLWE+ + L P+ + Q + +K
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-NQEVIEMVRKRQLL 245
Query: 247 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 277
P CP L++ CW P RRP F I
Sbjct: 246 PCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-23
Identities = 50/160 (31%), Positives = 83/160 (51%), Gaps = 4/160 (2%)
Query: 127 LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSA 184
L +L + +A+GM +L S+ +HRDL + N+LL VK+ DFG++ +
Sbjct: 140 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVV 199
Query: 185 KGFTG-TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQK 242
KG +WMAPE I +T + DV+S+GI+LWE+ + P+ M + + + ++
Sbjct: 200 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259
Query: 243 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
R P P ++ CW + P +RP F QIV ++
Sbjct: 260 GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 99.4 bits (246), Expect = 1e-23
Identities = 66/251 (26%), Positives = 103/251 (41%), Gaps = 50/251 (19%)
Query: 59 IGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI 118
I K G +Y + + VA+K++++ E S ++F E+ +L LNHP
Sbjct: 4 ILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSK---EVERFLREIQILASLNHPPN 59
Query: 119 ITEPYSV--------------------------------PLNLVLKLALDIARGMQYLHS 146
I + Y + L + I ++YLHS
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 147 QGILHRDLKSENLLLGED-MCVKVADFGISCLESQCGSA-------KGFTGTYRWMAPEM 198
+GI+HRD+K EN+LL D VK+ DFG++ L GS GT +MAPE+
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 199 IKEKRH---TKKVDVYSFGIVLWELLTALTPF---DNMTPEQAAFAVCQKNARPPVPPTC 252
+ + D++S GI L+ELLT L PF N + + + P +
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239
Query: 253 PKAFSYLISRC 263
+ LIS+
Sbjct: 240 SPSNPELISKA 250
|
Length = 384 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-23
Identities = 69/260 (26%), Positives = 114/260 (43%), Gaps = 43/260 (16%)
Query: 62 KFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH 117
+ SG + +G+YK ++ VA+K++ D +L L + E ++ +L++P+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR----EANVMQQLDNPY 57
Query: 118 I-----ITEPYSV----------PLNLVLK------------LALDIARGMQYLHSQGIL 150
I I E S PLN L+ L ++ GM+YL +
Sbjct: 58 IVRMIGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFV 117
Query: 151 HRDLKSENLLLGEDMCVKVADFGIS---CLESQCGSAKGFTGTY--RWMAPEMIKEKRHT 205
HRDL + N+LL K++DFG+S + AK G + +W APE + + +
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT-HGKWPVKWYAPECMNYYKFS 176
Query: 206 KKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 264
K DV+SFG+++WE + P+ M + + + R P CP L+ CW
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT-QMIESGERMECPQRCPPEMYDLMKLCW 235
Query: 265 SSSPDRRPHFDQIVSILEGY 284
+ D RP F + L Y
Sbjct: 236 TYGVDERPGFAVVELRLRNY 255
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 7e-23
Identities = 55/152 (36%), Positives = 81/152 (53%), Gaps = 6/152 (3%)
Query: 130 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG 189
+L A D+ARGM YL + +HRDL + N+L+GE+ K+ADFG+S Q K G
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS--RGQEVYVKKTMG 183
Query: 190 TY--RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 246
RWMA E + +T DV+S+G++LWE+++ TP+ MT + + + R
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRL 242
Query: 247 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 278
P C L+ +CW P RP F QI+
Sbjct: 243 EKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 8e-23
Identities = 57/161 (35%), Positives = 85/161 (52%), Gaps = 9/161 (5%)
Query: 127 LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSA 184
L+ +L +A IA GM YL SQ +HRDL + N L+G ++ VK+ DFG+S +
Sbjct: 122 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181
Query: 185 KGFTG-TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQK 242
G T RWM PE I ++ T + DV+SFG++LWE+ T P+ ++ + + Q
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241
Query: 243 NA--RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 281
RP V CPK ++ CW P +R + +I IL
Sbjct: 242 RVLERPRV---CPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 9e-23
Identities = 64/203 (31%), Positives = 84/203 (41%), Gaps = 44/203 (21%)
Query: 106 EVALLFRLNHPHIIT--------------------------EPYSVPLNLVLKLAL--DI 137
EV L +L HP+ I E + PL V A+
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGA 124
Query: 138 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE 197
+G+ YLHS +HRD+K+ N+LL E VK+ADFG + L A F GT WMAPE
Sbjct: 125 LQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL---VSPANSFVGTPYWMAPE 181
Query: 198 MI---KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254
+I E ++ KVDV+S GI EL P NM A + + Q + PT
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-----SPTLSS 236
Query: 255 -----AFSYLISRCWSSSPDRRP 272
F + C P RP
Sbjct: 237 NDWSDYFRNFVDSCLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 9e-23
Identities = 62/246 (25%), Positives = 108/246 (43%), Gaps = 47/246 (19%)
Query: 72 YRGIYKQRDV------AIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII------ 119
+ Y+ RDV A+K V+ +S + + E+ L+ RLNHPHII
Sbjct: 13 FSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT 72
Query: 120 --TEPYSVPL--------------------NLVLKLALDIARGMQYLHSQGILHRDLKSE 157
+++ + +++ + RG+ YLH I+HRD+K
Sbjct: 73 CEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGA 132
Query: 158 NLLL---GEDMCVKVADFGISC-LESQ---CGSAKG-FTGTYRWMAPEMIKEKRHTKKVD 209
NLL+ G+ +++ADFG + L ++ G +G GT +MAPE+++ +++ + D
Sbjct: 133 NLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCD 190
Query: 210 VYSFGIVLWELLTALTPFDNMTPE---QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 266
V+S G V+ E+ TA P++ F + P +P + RC
Sbjct: 191 VWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLEL 250
Query: 267 SPDRRP 272
P+ RP
Sbjct: 251 QPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-22
Identities = 51/160 (31%), Positives = 86/160 (53%), Gaps = 4/160 (2%)
Query: 127 LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSA 184
+L +ARGM++L S+ +HRDL + N+LL + VK+ DFG++ + +
Sbjct: 236 TLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS 295
Query: 185 KGFTG-TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQK 242
KG T +WMAPE I + +T DV+S+GI+LWE+ + TP+ M + + +
Sbjct: 296 KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS 355
Query: 243 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
R P + ++ +CW+S P++RP F + I+E
Sbjct: 356 GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-22
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 32/204 (15%)
Query: 106 EVALLFRLNHPHIITEPYSVPLNLVLKLALDIARG------------------------- 140
E+ +L L HP+II + L + ++ A G
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108
Query: 141 -----MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWM 194
+ Y+H GILHRD+K+ N+ L + +K+ DFGIS L S+ A+ GT +M
Sbjct: 109 QIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYM 168
Query: 195 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254
+PE+ + ++ K D+++ G VL+ELLT FD P + Q N PV
Sbjct: 169 SPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-YTPVVSVYSS 227
Query: 255 AFSYLISRCWSSSPDRRPHFDQIV 278
L+ P++RP D+++
Sbjct: 228 ELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-22
Identities = 53/188 (28%), Positives = 88/188 (46%), Gaps = 48/188 (25%)
Query: 75 IYKQRD------VAIKLVSQPEEDASLASMLEKQFTS--EVALLFRLNHPHII------- 119
+YK RD VA+K + E+ + S T+ E++LL L HP+I+
Sbjct: 15 VYKARDKKTGEIVALKKIRLDNEEEGIPS------TALREISLLKELKHPNIVKLLDVIH 68
Query: 120 ---------------------TEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 158
P + NL+ + + RG+ Y HS ILHRDLK +N
Sbjct: 69 TERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQN 128
Query: 159 LLLGEDMCVKVADFGIS---CLESQCGSAKGFTGTYRWMAPEMI-KEKRHTKKVDVYSFG 214
+L+ D +K+ADFG++ + + + + T YR APE++ K ++ VD++S G
Sbjct: 129 ILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR--APEILLGSKHYSTAVDIWSVG 186
Query: 215 IVLWELLT 222
+ E++T
Sbjct: 187 CIFAEMIT 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 3e-22
Identities = 52/169 (30%), Positives = 79/169 (46%), Gaps = 18/169 (10%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS---CLESQCG------SAKGF 187
I ++YLHS GI+HRDLK +N+L+ + +K+ DFG+S + Q K
Sbjct: 102 IVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 188 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 247
GT ++APE+I + H+K VD +S G +L+E L + PF TPE+ + P
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP 221
Query: 248 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFS 296
LIS+ P++R I E ++ P FF
Sbjct: 222 EDVEVSDEAIDLISKLLVPDPEKRLGAKSI--------EEIKNHP-FFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 4e-22
Identities = 58/170 (34%), Positives = 89/170 (52%), Gaps = 5/170 (2%)
Query: 122 PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLES 179
P + + +L +A IA GM YL SQ +HRDL + N L+GE++ VK+ DFG+S +
Sbjct: 114 PAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST 173
Query: 180 QCGSAKGFTG-TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAF 237
G T RWM PE I ++ T + DV+S G+VLWE+ T P+ ++ +
Sbjct: 174 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233
Query: 238 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287
+ Q P TCPK L+ CW P R + +I S+L+ +++
Sbjct: 234 CITQGRVLQR-PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 5e-22
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 33/205 (16%)
Query: 106 EVALLFRLNHPHIITEPYS-------------------------------VPLNLVLKLA 134
E LL +L HP+I+ S +P N V++
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108
Query: 135 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRW 193
+ IA +QYLH + ILHRDLK++N+ L +KV D GI+ LE+QC A GT +
Sbjct: 109 VQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYY 168
Query: 194 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 253
M+PE+ K + K DV++ G ++E+ T F+ + + + PP+P
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PPMPKDYS 227
Query: 254 KAFSYLISRCWSSSPDRRPHFDQIV 278
LI+ S P++RP I+
Sbjct: 228 PELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 8e-22
Identities = 50/140 (35%), Positives = 85/140 (60%), Gaps = 5/140 (3%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG--FTGTY 191
A +I G+Q+LH +GI++RDLK +N+LL +D +K+ADFG+ C E+ G K F GT
Sbjct: 102 AAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGM-CKENMNGEGKASTFCGTP 160
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 251
++APE++K +++ + VD +SFG++L+E+L +PF ++ ++ N RP P
Sbjct: 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL--NDRPHFPRW 218
Query: 252 CPKAFSYLISRCWSSSPDRR 271
K +S+ + P +R
Sbjct: 219 ISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-21
Identities = 69/260 (26%), Positives = 119/260 (45%), Gaps = 48/260 (18%)
Query: 62 KFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
K G+ S +Y+ I R VA+K V E + A + E+ LL +L+HP++I
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKA---RQDCLKEIDLLKQLDHPNVI 65
Query: 120 TEPYSV----PLNLVLKLA----------------------------LDIARGMQYLHSQ 147
S LN+VL+LA + + ++++HS+
Sbjct: 66 KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK 125
Query: 148 GILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTK 206
I+HRD+K N+ + VK+ D G+ S+ +A GT +M+PE I E +
Sbjct: 126 RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 185
Query: 207 KVDVYSFGIVLWELLTALTPF--DNMTPEQAAFAVCQKNARPPVPPTCPKAFS----YLI 260
K D++S G +L+E+ +PF D M +++C+K + PP +S L+
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEKCDYPPLPADHYSEELRDLV 241
Query: 261 SRCWSSSPDRRPHFDQIVSI 280
SRC + P++RP ++ +
Sbjct: 242 SRCINPDPEKRPDISYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-21
Identities = 54/189 (28%), Positives = 87/189 (46%), Gaps = 27/189 (14%)
Query: 112 RLNHPHIITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVAD 171
+ ++ + ++ +A IA GM+YL S +HRDL + N L+G++ +K+AD
Sbjct: 114 EPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIAD 173
Query: 172 FGISCLESQCGSAKGFTGTY-----------RWMAPEMIKEKRHTKKVDVYSFGIVLWEL 220
FG+ S ++G Y RWM+ E I + T DV++FG+ LWE+
Sbjct: 174 FGM--------SRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
Query: 221 LTAL--TPFDNMTPEQAA------FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 272
LT P+ ++ EQ F + P P CP + L+ CW + RP
Sbjct: 226 LTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERP 285
Query: 273 HFDQIVSIL 281
F +I + L
Sbjct: 286 SFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 55/177 (31%), Positives = 87/177 (49%), Gaps = 29/177 (16%)
Query: 130 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ--------- 180
+L A I +GM+YL S+ +HRDL + N+L+ + VK+ DFG++ + Q
Sbjct: 110 LLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVRE 169
Query: 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT----ALTP----FDNMTP 232
G + F W APE + E + + DV+SFG+VL+EL T + +P M
Sbjct: 170 PGESPIF-----WYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGN 224
Query: 233 E-QAAFAVC------QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
+ Q V + N R P PP CP ++ CW++ P +RP F ++ +E
Sbjct: 225 DKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-21
Identities = 64/241 (26%), Positives = 108/241 (44%), Gaps = 36/241 (14%)
Query: 62 KFASGRHSRIYRGI--YKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI- 118
+ G +Y+GI + VAIK++ E + + + + E+ +L + + P+I
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQ-----EITVLSQCDSPYIT 65
Query: 119 --------------------------ITEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 152
+ +P + + + +I +G+ YLHS+ +HR
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHR 125
Query: 153 DLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVY 211
D+K+ N+LL E VK+ADFG++ L F GT WMAPE+IK+ + K D++
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIW 185
Query: 212 SFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 271
S GI EL P ++ P + F + KN+ P + K F + C + P R
Sbjct: 186 SLGITAIELAKGEPPNSDLHPMRVLFLI-PKNSPPTLEGQYSKPFKEFVEACLNKDPRFR 244
Query: 272 P 272
P
Sbjct: 245 P 245
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-21
Identities = 62/195 (31%), Positives = 90/195 (46%), Gaps = 30/195 (15%)
Query: 102 QFTSEVALLFRLNHPHIITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 161
QF S+ + H + I SV + +L +A+ IA GM+YL S +HRDL + N L+
Sbjct: 106 QFLSQREIESTFTHANNIP---SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162
Query: 162 GEDMCVKVADFGISCLESQCGSAKGFTGTY-----------RWMAPEMIKEKRHTKKVDV 210
G +K+ADFG+ S ++G Y RWMA E I + T DV
Sbjct: 163 GNHYTIKIADFGM--------SRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDV 214
Query: 211 YSFGIVLWELLTALT--PFDNMTPEQAA------FAVCQKNARPPVPPTCPKAFSYLISR 262
++FG+ LWE+ T P+ ++ EQ F + P CP L+ R
Sbjct: 215 WAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMR 274
Query: 263 CWSSSPDRRPHFDQI 277
CWS RP F++I
Sbjct: 275 CWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 3e-21
Identities = 67/251 (26%), Positives = 110/251 (43%), Gaps = 37/251 (14%)
Query: 53 DMSQLFIGC-KFASGRHSRIYRGI--YKQRDVAIKLVSQPEEDASLASMLEKQFTSEVAL 109
D +LF K G +++GI Q+ VAIK++ E + + + + E+ +
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ-----EITV 55
Query: 110 LFRLNHPHI---------------------------ITEPYSVPLNLVLKLALDIARGMQ 142
L + + P++ + EP + + + +I +G+
Sbjct: 56 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLD 115
Query: 143 YLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKE 201
YLHS+ +HRD+K+ N+LL E VK+ADFG++ L F GT WMAPE+IK+
Sbjct: 116 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 202 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 261
+ K D++S GI EL P + P + F + KN P + K +
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI-PKNNPPTLEGNYSKPLKEFVE 234
Query: 262 RCWSSSPDRRP 272
C + P RP
Sbjct: 235 ACLNKEPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-21
Identities = 54/179 (30%), Positives = 90/179 (50%), Gaps = 12/179 (6%)
Query: 112 RLNHPHIITEPYSVPLNL--VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 169
N P + + PL + ++ + +ARGM++L S+ +HRDL + N+LL E+ VK+
Sbjct: 156 STNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKI 215
Query: 170 ADFGIS------CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT- 222
DFG++ + GSA+ +WMAPE I +K +T + DV+SFG++LWE+ +
Sbjct: 216 CDFGLARDIYKDPDYVRKGSAR---LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL 272
Query: 223 ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 281
+P+ + + + R P ++ CW P RP F +V IL
Sbjct: 273 GASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 4e-21
Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 14/153 (9%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS---CLESQCGSA----KGFTG 189
I G+ YLH+ ++HRD+K N++L + +K+ DFG + G+ K G
Sbjct: 111 ILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 190 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP 249
T WMAPE+I E + +K D++S G ++E+ T P +M A F + R +P
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI--GAHRGLMP 228
Query: 250 PTCPKAFSY----LISRCWSSSPDRRPHFDQIV 278
P +FS ++ C + RP Q++
Sbjct: 229 RL-PDSFSAAAIDFVTSCLTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 4e-21
Identities = 52/224 (23%), Positives = 89/224 (39%), Gaps = 44/224 (19%)
Query: 97 SMLEK---QFTSEVALLFRLNHPHIIT--------------------------------- 120
+M EK Q SEV +L L HP+I+
Sbjct: 37 NMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCK 96
Query: 121 -EPYSVPLNLVLKLALDIARGMQYLH-----SQGILHRDLKSENLLLGEDMCVKVADFGI 174
E + + ++ + + H +LHRDLK N+ L + VK+ DFG+
Sbjct: 97 KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGL 156
Query: 175 S-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE 233
+ L AK + GT +M+PE + + +K D++S G +++EL PF
Sbjct: 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL 216
Query: 234 QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 277
Q A + + R +P + +I + PD+RP +++
Sbjct: 217 QLASKIKEGKFR-RIPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 4e-21
Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 5/160 (3%)
Query: 127 LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSA 184
L +L +A IA GM YL S +HRDL + N L+G+ + VK+ DFG+S +
Sbjct: 121 LGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180
Query: 185 KGFTG-TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQK 242
G T RWM PE I ++ T + D++SFG+VLWE+ T P+ ++ +A + Q
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG 240
Query: 243 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
P TCP ++ CW P +R I S L+
Sbjct: 241 RELER-PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-21
Identities = 54/156 (34%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 132 KLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTG 189
K+A + +G+ YLHS+ I+HRD+K N+LL VK+ DFG+S + S A FTG
Sbjct: 109 KIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL---AGTFTG 165
Query: 190 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF-----DNMTP-EQAAFAVCQKN 243
T +MAPE I+ K ++ DV+S G+ L E+ PF + P E ++ V N
Sbjct: 166 TSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV---N 222
Query: 244 ARPPVPPTCP-------KAFSYLISRCWSSSPDRRP 272
P P + F I +C P RRP
Sbjct: 223 MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 6e-21
Identities = 56/171 (32%), Positives = 97/171 (56%), Gaps = 14/171 (8%)
Query: 121 EPYSVPLNL--VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--- 175
E Y PL L ++ + +ARGM++L S+ +HRDL + N+LL E+ VK+ DFG++
Sbjct: 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 223
Query: 176 ---CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMT 231
+ G A+ +WMAPE I +K +T + DV+SFG++LWE+ + +P+ +
Sbjct: 224 YKDPDYVRKGDARL---PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280
Query: 232 PEQAAFAVCQKNARPPVPP-TCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 281
++ ++ R P P+ +S ++ CW ++P+ RP F ++V IL
Sbjct: 281 IDEEFCRRLKEGTRMRAPEYATPEIYSIMLD-CWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 9e-21
Identities = 54/178 (30%), Positives = 85/178 (47%), Gaps = 17/178 (9%)
Query: 108 ALLFRLNHPHIITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 167
+++ L +TEP V + L+ + +LHS ++HRDLK+ N+LL D V
Sbjct: 91 SIMLELERG--LTEPQIRY---VCRQMLE---ALNFLHSHKVIHRDLKAGNILLTLDGDV 142
Query: 168 KVADFGISC-LESQCGSAKGFTGTYRWMAPEMI-----KEKRHTKKVDVYSFGIVLWELL 221
K+ADFG+S +S F GT WMAPE++ K+ + K D++S GI L EL
Sbjct: 143 KLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELA 202
Query: 222 TALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSYLISRCWSSSPDRRPHFDQI 277
P + P + + K+ P + P +F+ + C PD RP ++
Sbjct: 203 QMEPPHHELNPMRVLLKI-LKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 9e-21
Identities = 51/138 (36%), Positives = 73/138 (52%), Gaps = 2/138 (1%)
Query: 136 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWM 194
+I +G+ YLHS+ +HRD+K+ N+LL E VK+ADFG++ L F GT WM
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWM 168
Query: 195 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254
APE+I++ + K D++S GI EL P +M P + F + KN P + K
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-PKNNPPTLTGEFSK 227
Query: 255 AFSYLISRCWSSSPDRRP 272
F I C + P RP
Sbjct: 228 PFKEFIDACLNKDPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-20
Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 31/237 (13%)
Query: 67 RHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITEPYSVP 126
+ I R +Y + V K + + + ++E + + N I
Sbjct: 55 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKI-------N 107
Query: 127 LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG 186
L LK A+ I +GM YL S+ +HRDL + N+L+ + VK+ DFG L + K
Sbjct: 108 LKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG---LTKAIETDKE 164
Query: 187 F-------TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-------ALTPFDNMT- 231
+ W APE + + + DV+SFG+ L+ELLT +T F M
Sbjct: 165 YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIG 224
Query: 232 PEQAAFAVC------QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
P V ++ R P PP CP+ L+ +CW P +R F ++ E
Sbjct: 225 PTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-20
Identities = 50/158 (31%), Positives = 84/158 (53%), Gaps = 6/158 (3%)
Query: 130 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG 189
+L + +A+GM +L S+ +HRDL + N+LL K+ DFG++ + + S G
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA-RDIRNDSNYVVKG 274
Query: 190 TYR----WMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 244
R WMAPE I +T + DV+S+GI+LWE+ + +P+ M + + + ++
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY 334
Query: 245 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
R P P ++ CW + P +RP F QIV ++E
Sbjct: 335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 2e-20
Identities = 39/117 (33%), Positives = 70/117 (59%), Gaps = 3/117 (2%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK--GFTGTY 191
A +I G+Q+LH +GI++RDLK +N+LL + +K+ADFG+ C E G F GT
Sbjct: 102 AAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGM-CKEGILGGVTTSTFCGTP 160
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 248
++APE++ + + VD ++ G++L+E+L +PF+ ++ ++ + R P
Sbjct: 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR 217
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 2e-20
Identities = 50/140 (35%), Positives = 84/140 (60%), Gaps = 5/140 (3%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK--GFTGTY 191
A +I G+Q+LHS+GI++RDLK +N+LL D +K+ADFG+ C E+ G AK F GT
Sbjct: 102 AAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGM-CKENMLGDAKTCTFCGTP 160
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 251
++APE++ +++ VD +SFG++L+E+L +PF E+ ++ N P P
Sbjct: 161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--PCYPRW 218
Query: 252 CPKAFSYLISRCWSSSPDRR 271
+ ++ + + P+RR
Sbjct: 219 LTREAKDILVKLFVREPERR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 2e-20
Identities = 39/87 (44%), Positives = 54/87 (62%)
Query: 141 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK 200
+YLH++GI++RDLK ENLLL + VK+ DFG + F GT ++APE+I
Sbjct: 106 FEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIIL 165
Query: 201 EKRHTKKVDVYSFGIVLWELLTALTPF 227
K + VD +S GI+L+ELLT PF
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 4/157 (2%)
Query: 130 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGF 187
++ + +A GM++L S+ +HRDL + N+L+ E VK+ DFG++ + +KG
Sbjct: 241 LVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGS 300
Query: 188 TG-TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 245
T +WMAPE I +T DV+SFGI+LWE+ T TP+ + + + ++ R
Sbjct: 301 TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR 360
Query: 246 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
P ++ +CW + RP F Q+V ++
Sbjct: 361 MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 4e-20
Identities = 47/137 (34%), Positives = 75/137 (54%), Gaps = 6/137 (4%)
Query: 139 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAP 196
+ +++LHS ++HRD+KS+N+LLG D VK+ DFG C + +K T GT WMAP
Sbjct: 126 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF-CAQITPEQSKRSTMVGTPYWMAP 184
Query: 197 EMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCPK 254
E++ K + KVD++S GI+ E++ P+ N P +A + + N P P
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSA 243
Query: 255 AFSYLISRCWSSSPDRR 271
F ++RC ++R
Sbjct: 244 IFRDFLNRCLEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-20
Identities = 65/244 (26%), Positives = 113/244 (46%), Gaps = 22/244 (9%)
Query: 41 EIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLE 100
++ G+ EEE +++ L K++ R+ Y G + +++ P D L ++E
Sbjct: 40 DVTGDEEEEIKQEINML---KKYSHHRNIATYYGAFIKKN-------PPGMDDQLWLVME 89
Query: 101 KQFTSEVALLFRLNHPHIITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 160
V L + + + E + + + +I RG+ +LH ++HRD+K +N+L
Sbjct: 90 FCGAGSVTDLIKNTKGNTLKEEW------IAYICREILRGLSHLHQHKVIHRDIKGQNVL 143
Query: 161 LGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFG 214
L E+ VK+ DFG+S L+ G F GT WMAPE+I + + K D++S G
Sbjct: 144 LTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 203
Query: 215 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHF 274
I E+ P +M P +A F + + A K F I C + +RP
Sbjct: 204 ITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTT 263
Query: 275 DQIV 278
+Q++
Sbjct: 264 EQLM 267
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-20
Identities = 49/148 (33%), Positives = 74/148 (50%), Gaps = 19/148 (12%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGE-DMCVKVADFGIS--------CLESQCGSAKGF 187
I G++YLH I+HRD+K +N+L+ VK++DFG S C E+ F
Sbjct: 117 ILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-------F 169
Query: 188 TGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA-FAVCQKNA 244
TGT ++MAPE+I + + + D++S G + E+ T PF + QAA F V
Sbjct: 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI 229
Query: 245 RPPVPPTCPKAFSYLISRCWSSSPDRRP 272
P +P + I RC+ PD+R
Sbjct: 230 HPEIPESLSAEAKNFILRCFEPDPDKRA 257
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 6e-20
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 36/209 (17%)
Query: 106 EVALLFRLNHPHIITEPYSVPLNLVLKLALD----------------------------- 136
EV LL ++ HP+I+T S N L + ++
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108
Query: 137 -IARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGIS-CLESQCGSAKGFTGTYRW 193
I+ G++++H + ILHRD+KS+N+ L ++ M K+ DFGI+ L A GT +
Sbjct: 109 QISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYY 168
Query: 194 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 253
++PE+ + + + K D++S G VL+EL T PF+ Q +CQ P+ P
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-PISPNFS 227
Query: 254 KAFSYLISRCWSSSPDRRPHFDQIVSILE 282
+ LIS+ + SP RP I SIL+
Sbjct: 228 RDLRSLISQLFKVSPRDRP---SITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 6e-20
Identities = 45/155 (29%), Positives = 80/155 (51%), Gaps = 5/155 (3%)
Query: 129 LVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT 188
+L + IA+GM YL ++HR+L + N+LL D V++ADFG++ L ++
Sbjct: 110 RLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYS 169
Query: 189 ---GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 244
+WMA E I R+T + DV+S+G+ +WE+++ P+ M P + + +K
Sbjct: 170 EHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-DLLEKGE 228
Query: 245 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279
R P C ++ +CW + RP F ++ +
Sbjct: 229 RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 7e-20
Identities = 49/170 (28%), Positives = 88/170 (51%), Gaps = 8/170 (4%)
Query: 120 TEPYSVPLNL--VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177
S PL+L +L+ + +A+GM +L S+ +HRD+ + N+LL + K+ DFG++
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLA-R 260
Query: 178 ESQCGSAKGFTGTYR----WMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTP 232
+ S G R WMAPE I + +T + DV+S+GI+LWE+ + +P+ +
Sbjct: 261 DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320
Query: 233 EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
+ + ++ + P P ++ CW+ P RP F QI +++
Sbjct: 321 NSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 8e-20
Identities = 45/126 (35%), Positives = 79/126 (62%), Gaps = 9/126 (7%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG--SAKGFTGTY 191
A +IA G+ +LHS+GI++RDLK +N++L + +K+ADFG+ C E+ G + + F GT
Sbjct: 107 AAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGM-CKENIFGGKTTRTFCGTP 165
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 251
++APE+I + + K VD ++FG++L+E+L PFD ++ ++ + N +
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN------VS 219
Query: 252 CPKAFS 257
PK+ S
Sbjct: 220 YPKSLS 225
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 9e-20
Identities = 49/137 (35%), Positives = 75/137 (54%), Gaps = 6/137 (4%)
Query: 139 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAP 196
+ + +LHS ++HRD+KS+N+LLG D VK+ DFG C + +K T GT WMAP
Sbjct: 126 QALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF-CAQITPEQSKRSTMVGTPYWMAP 184
Query: 197 EMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPK 254
E++ K + KVD++S GI+ E++ P+ N P +A + + N P + P
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQNPERLSA 243
Query: 255 AFSYLISRCWSSSPDRR 271
F ++RC DRR
Sbjct: 244 VFRDFLNRCLEMDVDRR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-19
Identities = 70/260 (26%), Positives = 119/260 (45%), Gaps = 48/260 (18%)
Query: 54 MSQLFIGCKFASGRHSRIYRG--IYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLF 111
++ I K G+ S +YR + ++ VA+K V E + + + E+ LL
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFE---MMDAKARQDCVKEIDLLK 57
Query: 112 RLNHPHIITEPYSV----PLNLVLKLA----------------------------LDIAR 139
+LNHP++I S LN+VL+LA + +
Sbjct: 58 QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 140 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEM 198
++++HS+ ++HRD+K N+ + VK+ D G+ S+ +A GT +M+PE
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 199 IKEKRHTKKVDVYSFGIVLWELLTALTPF--DNMTPEQAAFAVCQKNARPPVPPTCPKAF 256
I E + K D++S G +L+E+ +PF D M F++CQK + PP + +
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKIEQCDYPPLPTEHY 233
Query: 257 SY----LISRCWSSSPDRRP 272
S L+S C PD+RP
Sbjct: 234 SEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 53/152 (34%), Positives = 77/152 (50%), Gaps = 31/152 (20%)
Query: 106 EVALLFRLNHPHIITEPYSVPLNLVLKLALDIARG------------------------- 140
E +L +NHP I+ Y+ L L LD RG
Sbjct: 48 ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 107
Query: 141 ---MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK--GFTGTYRWMA 195
+ +LHS GI++RDLK EN+LL E+ +K+ DFG+S ES K F GT +MA
Sbjct: 108 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS-KESIDHEKKAYSFCGTVEYMA 166
Query: 196 PEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
PE++ + HT+ D +SFG++++E+LT PF
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 50/149 (33%), Positives = 76/149 (51%), Gaps = 11/149 (7%)
Query: 132 KLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFT 188
K+A+ + +G+ YLH + I+HRD+K N+L+ +K+ DFG+S + S AK F
Sbjct: 104 KIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL---AKTFV 160
Query: 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQK--NAR 245
GT +MAPE I+ ++ K D++S G+ L EL T P+ P F + Q N
Sbjct: 161 GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP 220
Query: 246 PPVPPT--CPKAFSYLISRCWSSSPDRRP 272
PP P+ F ++ C P RP
Sbjct: 221 PPRLPSGKFSPDFQDFVNLCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 50/146 (34%), Positives = 82/146 (56%), Gaps = 10/146 (6%)
Query: 133 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTG 189
L + + + ++HS+ ++HRD+KS N+LL + VK+ DFG S + + S + F G
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG 207
Query: 190 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR---P 246
T ++APE+ + K ++KK D++S G++L+ELLT PFD E+ V K
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE----VMHKTLAGRYD 263
Query: 247 PVPPTCPKAFSYLISRCWSSSPDRRP 272
P+PP+ +++ SS P RRP
Sbjct: 264 PLPPSISPEMQEIVTALLSSDPKRRP 289
|
Length = 496 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-19
Identities = 54/250 (21%), Positives = 105/250 (42%), Gaps = 40/250 (16%)
Query: 70 RIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII---------- 119
IY+GI+ ++V I+ + + +L +E+ L R++ +I+
Sbjct: 35 SIYKGIFNNKEVIIRTFKKFHKGHK---VLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91
Query: 120 -TEPY-SVPLNLVLK--------------------LALDIARGMQYLH-SQGILHRDLKS 156
P S+ L + +A+D +G+ L+ +++L S
Sbjct: 92 DDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTS 151
Query: 157 ENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFG 214
+ L+ E+ +K+ G+ + S Y + +M+ + +T K D+YS G
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYF--SYKMLNDIFSEYTIKDDIYSLG 209
Query: 215 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHF 274
+VLWE+ T PF+N+T ++ + KN +P CP ++ C S +RP+
Sbjct: 210 VVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNI 269
Query: 275 DQIVSILEGY 284
+I+ L Y
Sbjct: 270 KEILYNLSLY 279
|
Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 3e-19
Identities = 56/155 (36%), Positives = 82/155 (52%), Gaps = 17/155 (10%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMA 195
RG+ YLH ++HRD+K +N+LL ++ VK+ DFG+S L+S G F GT WMA
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181
Query: 196 PEMI--KEKR---HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP 250
PE+I E+ + + DV+S GI EL P +M P +A F K R P PP
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF----KIPRNP-PP 236
Query: 251 TC------PKAFSYLISRCWSSSPDRRPHFDQIVS 279
T K F+ IS C + ++RP ++++
Sbjct: 237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 3e-19
Identities = 41/114 (35%), Positives = 67/114 (58%), Gaps = 6/114 (5%)
Query: 139 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI-SCLESQCGSAKGFTGTYRWMAPE 197
+ + +LH+QG++HRD+KS+++LL D VK++DFG + + + K GT WMAPE
Sbjct: 126 KALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE 185
Query: 198 MIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 251
+I + +VD++S GI++ E++ P+ N P QA K R +PP
Sbjct: 186 VISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-----MKRIRDNLPPK 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-19
Identities = 48/142 (33%), Positives = 73/142 (51%), Gaps = 6/142 (4%)
Query: 136 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRW 193
+I + +LH GI++RD+K EN+LL + V + DFG+S L + A F GT +
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEY 172
Query: 194 MAPEMIK--EKRHTKKVDVYSFGIVLWELLTALTPF--DNMTPEQAAFAVCQKNARPPVP 249
MAPE+I+ H K VD +S G++ +ELLT +PF D Q+ + ++PP P
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP 232
Query: 250 PTCPKAFSYLISRCWSSSPDRR 271
T I + P +R
Sbjct: 233 KTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 4e-19
Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 8/140 (5%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW 193
A + ++YLHS I++RDLK ENLLL D +K+ DFG + G GT +
Sbjct: 107 AAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK--GRTYTLCGTPEY 164
Query: 194 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK--NARPPVPPT 251
+APE+I K + K VD ++ GI+++E+L PF + P + +K + P
Sbjct: 165 LAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP----IQIYEKILEGKVRFPSF 220
Query: 252 CPKAFSYLISRCWSSSPDRR 271
LI +R
Sbjct: 221 FSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-19
Identities = 40/112 (35%), Positives = 62/112 (55%), Gaps = 7/112 (6%)
Query: 125 VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCG 182
+P + + ++ G++ LH +GI+HRD+K ENLL+ + +K+ DFG+S LE+
Sbjct: 94 LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN--- 150
Query: 183 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 234
K F GT ++APE I K D +S G V++E L PF TP+
Sbjct: 151 --KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-19
Identities = 47/147 (31%), Positives = 82/147 (55%), Gaps = 7/147 (4%)
Query: 139 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPE 197
+G+ YLHS+G +HRD+K N+LL ++ VK+ADFG+S + + K F GT WMAPE
Sbjct: 117 QGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPE 176
Query: 198 MIKEKR---HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254
+ +R + + D+++ GI EL P ++ P +A F + + N +PP K
Sbjct: 177 VAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK 236
Query: 255 ---AFSYLISRCWSSSPDRRPHFDQIV 278
+F + + + +P +RP ++++
Sbjct: 237 WSNSFHHFVKMALTKNPKKRPTAEKLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 8e-19
Identities = 52/144 (36%), Positives = 74/144 (51%), Gaps = 8/144 (5%)
Query: 139 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEM 198
+G+ YLHS ++HRD+K+ N+LL E VK+ADFG + + S A F GT WMAPE+
Sbjct: 136 QGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS---PANSFVGTPYWMAPEV 192
Query: 199 I---KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT-CPK 254
I E ++ KVDV+S GI EL P NM A + + Q N P +
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPTLQSNEWSD 251
Query: 255 AFSYLISRCWSSSPDRRPHFDQIV 278
F + C P RP ++++
Sbjct: 252 YFRNFVDSCLQKIPQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 9e-19
Identities = 52/158 (32%), Positives = 83/158 (52%), Gaps = 14/158 (8%)
Query: 119 ITEPY-SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177
I E Y SV + VL +AL +Y+H G++HRD+K+ N+L+ VK+ DFG++ L
Sbjct: 98 IAEKYISVIIREVL-VAL------KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAAL 150
Query: 178 ESQCGSAKG-FTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA 235
+Q S + F GT WMAPE+I E K + K D++S GI ++E+ T P+ ++ +A
Sbjct: 151 LNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA 210
Query: 236 AFAVCQKNARPPVPP--TCPKAFSYLISRCWSSSPDRR 271
+ + +PP K ++ C P R
Sbjct: 211 MMLIPKS--KPPRLEDNGYSKLLREFVAACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 9e-19
Identities = 48/153 (31%), Positives = 86/153 (56%), Gaps = 6/153 (3%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTG-T 190
+ +A+GM++L S+ +HRDL + N+LL E+ VK+ DFG++ + KG
Sbjct: 185 SFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 191 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 249
+WMAPE I ++ +T + DV+SFG++LWE+ + +P+ + ++ ++ R P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP 304
Query: 250 P-TCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 281
T P+ + ++ CW P +RP F ++V L
Sbjct: 305 DYTTPEMYQTMLD-CWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 9e-19
Identities = 44/136 (32%), Positives = 73/136 (53%), Gaps = 4/136 (2%)
Query: 139 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPE 197
+ +++LHS ++HRD+KS+N+LLG D VK+ DFG + + GT WMAPE
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 198 MIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKA 255
++ K + KVD++S GI+ E++ P+ N P +A + + N P + P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSAI 245
Query: 256 FSYLISRCWSSSPDRR 271
F ++RC ++R
Sbjct: 246 FRDFLNRCLDMDVEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 9e-19
Identities = 55/182 (30%), Positives = 83/182 (45%), Gaps = 27/182 (14%)
Query: 109 LLFRLNHPHIITEPYSVPLNLVLKLALDIARGMQYL-HSQGILHRDLKSENLLLGEDMCV 167
LL R+ P +P +++ K+ + I + + YL G++HRD+K N+LL V
Sbjct: 103 LLKRIQGP--------IPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNV 154
Query: 168 KVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKK----VDVYSFGIVLWELL 221
K+ DFGIS ++S+ + G +MAPE I K DV+S GI L EL
Sbjct: 155 KLCDFGISGRLVDSKAKTRSA--GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELA 212
Query: 222 TALTPFDNMTPEQAAFAVCQK--NARPPVPPTCPKAFSYL----ISRCWSSSPDRRPHFD 275
T P+ N E F V K PP P + FS + C + +RP +
Sbjct: 213 TGQFPYKNCKTE---FEVLTKILQEEPPSLPP-NEGFSPDFCSFVDLCLTKDHRKRPKYR 268
Query: 276 QI 277
++
Sbjct: 269 EL 270
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 41/96 (42%), Positives = 68/96 (70%), Gaps = 3/96 (3%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG--FTGTY 191
A +I G+Q+LHS+GI++RDLK +N++L D +K+ADFG+ C E+ G + F GT
Sbjct: 102 AAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGM-CKENVFGDNRASTFCGTP 160
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
++APE+++ ++T VD +SFG++L+E+L +PF
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-18
Identities = 32/94 (34%), Positives = 57/94 (60%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW 193
A I G+++LH + I++RDLK EN+LL + V+++D G++ KG GT +
Sbjct: 101 AAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160
Query: 194 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
MAPE+++ + + VD ++ G L+E++ +PF
Sbjct: 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 50/137 (36%), Positives = 69/137 (50%), Gaps = 6/137 (4%)
Query: 139 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEM 198
+G+ YLHS ++HRD+K+ N+LL E VK+ADFG + S A F GT WMAPE+
Sbjct: 132 QGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSFVGTPYWMAPEV 188
Query: 199 I---KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255
I E ++ KVDV+S GI EL P NM A + + Q ++ +
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDS 248
Query: 256 FSYLISRCWSSSPDRRP 272
F + C P RP
Sbjct: 249 FRGFVDYCLQKIPQERP 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 42/122 (34%), Positives = 70/122 (57%), Gaps = 6/122 (4%)
Query: 130 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFT 188
+ + L + R + YLH+QG++HRD+KS+++LL D +K++DFG + + K
Sbjct: 120 IATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV 179
Query: 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 248
GT WMAPE+I + +VD++S GI++ E++ P+ N P QA + R +
Sbjct: 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-----MRRIRDNL 234
Query: 249 PP 250
PP
Sbjct: 235 PP 236
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-18
Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 12/152 (7%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYR---- 192
+A GM+YL G +H+ L + +L+ D+ K++ F Q ++ T
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR----RLQEDKSEAIYTTMSGKSP 171
Query: 193 --WMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 249
W APE I+ + DV+SFGIV+WE+++ P+ +M+ + AV + R P P
Sbjct: 172 VLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-EDGFRLPAP 230
Query: 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 281
CP L+ CW RP F QI SIL
Sbjct: 231 RNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-18
Identities = 44/157 (28%), Positives = 80/157 (50%), Gaps = 3/157 (1%)
Query: 125 VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGS 183
+ N V + + + G+ Y+H + ILHRDLK++N+ L ++ +K+ DFG+S L C
Sbjct: 103 LSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDL 161
Query: 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 243
A FTGT +M+PE +K + + K D++S G +L+E+ F+ + +
Sbjct: 162 ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP 221
Query: 244 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280
P +P T + + ++ + P RP +I+
Sbjct: 222 T-PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 54/199 (27%)
Query: 75 IYKQRD------VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII--------- 119
+YK RD VAIK + E + + E+ LL LNHP+II
Sbjct: 15 VYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIKLLDVFRHK 70
Query: 120 -------------------TEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 160
+P +L+ + +G+ + HS GILHRDLK ENLL
Sbjct: 71 GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLL 130
Query: 161 LGEDMCVKVADFGISCLESQCGSAKGFTGTY------RWM-APE-MIKEKRHTKKVDVYS 212
+ + +K+ADFG+ S Y RW APE ++ +K ++ VD++S
Sbjct: 131 INTEGVLKLADFGL------ARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWS 184
Query: 213 FGIVLWELLT--ALTPFDN 229
G + ELL+ L P +
Sbjct: 185 VGCIFAELLSRRPLFPGKS 203
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 3e-18
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 32/205 (15%)
Query: 99 LEKQFTSEVALLFRLNHPHIIT-----------------------EPY-SVPLNLVLKLA 134
L+KQ SE+ +L++ + P+II + Y +P +++ ++A
Sbjct: 42 LQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIA 101
Query: 135 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWM 194
+ + +G+ YL S ILHRD+K N+L+ VK+ DFG+S + AK + GT +M
Sbjct: 102 VAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVST-QLVNSIAKTYVGTNAYM 160
Query: 195 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA-----VCQKNARPPVP 249
APE I +++ DV+S GI EL P+ + Q + C + PPV
Sbjct: 161 APERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL 220
Query: 250 PT--CPKAFSYLISRCWSSSPDRRP 272
P + F + I++C P RP
Sbjct: 221 PVGQFSEKFVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 3e-18
Identities = 60/182 (32%), Positives = 85/182 (46%), Gaps = 41/182 (22%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII------------------ 119
R VAIK +S +D A K+ E+ LL L H +II
Sbjct: 25 GRKVAIKKISNVFDDLIDA----KRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80
Query: 120 --TEPYSVPLNLVLK----LALD--------IARGMQYLHSQGILHRDLKSENLLLGEDM 165
TE L+ V+K L D I RG++YLHS ++HRDLK N+L+ +
Sbjct: 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC 140
Query: 166 CVKVADFGISCLESQCGSAKGFTGTY---RWM-APE-MIKEKRHTKKVDVYSFGIVLWEL 220
+K+ DFG++ KGF Y RW APE ++ R+TK +D++S G + EL
Sbjct: 141 DLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL 200
Query: 221 LT 222
LT
Sbjct: 201 LT 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-18
Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 7/159 (4%)
Query: 131 LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT 190
+ + IA GM++L S ++H+DL + N+L+ + + VK++D G+ E G
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL-FREVYAADYYKLMGN 185
Query: 191 ----YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 245
RWM+PE I + + D++S+G+VLWE+ + L P+ + Q + +
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-NQDVIEMIRNRQV 244
Query: 246 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284
P P CP L+ CW+ P RRP F I S L +
Sbjct: 245 LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-18
Identities = 46/122 (37%), Positives = 64/122 (52%), Gaps = 4/122 (3%)
Query: 132 KLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGF--- 187
K I GM YLHS I+HRD+K N+L VK+ DFG S L++ C S G
Sbjct: 110 KYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV 169
Query: 188 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 247
TGT WM+PE+I + + +K DV+S G + E+LT P+ A F + + P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQ 229
Query: 248 VP 249
+P
Sbjct: 230 LP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 8e-18
Identities = 47/142 (33%), Positives = 75/142 (52%), Gaps = 6/142 (4%)
Query: 136 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRW 193
+I +++LH GI++RD+K EN+LL + V + DFG+S E + A F GT +
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172
Query: 194 MAPEMIK--EKRHTKKVDVYSFGIVLWELLTALTPF--DNMTPEQAAFAVCQKNARPPVP 249
MAP++++ + H K VD +S G++++ELLT +PF D QA + + PP P
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 232
Query: 250 PTCPKAFSYLISRCWSSSPDRR 271
+I R P +R
Sbjct: 233 QEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 9e-18
Identities = 42/116 (36%), Positives = 66/116 (56%), Gaps = 6/116 (5%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMA 195
+ + + YLHSQG++HRD+KS+++LL D VK++DFG + K GT WMA
Sbjct: 126 VLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMA 185
Query: 196 PEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 251
PE+I + +VD++S GI++ E++ P+ + +P QA K R PP
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-----MKRLRDSPPPK 236
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-18
Identities = 63/258 (24%), Positives = 112/258 (43%), Gaps = 44/258 (17%)
Query: 62 KFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITE 121
K G+ S +YR V + L D + + E+ LL +LNHP++I
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 122 PYSV----PLNLVLKLA----------------------------LDIARGMQYLHSQGI 149
S LN+VL+LA + + ++++HS+ +
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV 127
Query: 150 LHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 208
+HRD+K N+ + VK+ D G+ S+ +A GT +M+PE I E + K
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKS 187
Query: 209 DVYSFGIVLWELLTALTPF--DNMTPEQAAFAVCQKNARPPVPPTCPKAFS----YLISR 262
D++S G +L+E+ +PF D M +++C+K + PP +S L++
Sbjct: 188 DIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 243
Query: 263 CWSSSPDRRPHFDQIVSI 280
C + P++RP + +
Sbjct: 244 CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 9e-18
Identities = 67/249 (26%), Positives = 114/249 (45%), Gaps = 32/249 (12%)
Query: 41 EIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLE 100
++ + EEE +++ L K++ R+ Y G + ++ S P D L ++E
Sbjct: 50 DVTEDEEEEIKLEINML---KKYSHHRNIATYYGAFIKK-------SPPGHDDQLWLVME 99
Query: 101 KQFTSEVALLFRLNHPHIITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 160
V L + + + E + + + +I RG+ +LH+ ++HRD+K +N+L
Sbjct: 100 FCGAGSVTDLVKNTKGNALKEDW------IAYICREILRGLAHLHAHKVIHRDIKGQNVL 153
Query: 161 LGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFG 214
L E+ VK+ DFG+S L+ G F GT WMAPE+I + + + D++S G
Sbjct: 154 LTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLG 213
Query: 215 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTC-----PKAFSYLISRCWSSSPD 269
I E+ P +M P +A F + R P PP K F I C +
Sbjct: 214 ITAIEMAEGAPPLCDMHPMRALFLI----PRNP-PPKLKSKKWSKKFIDFIEGCLVKNYL 268
Query: 270 RRPHFDQIV 278
RP +Q++
Sbjct: 269 SRPSTEQLL 277
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 46/141 (32%), Positives = 84/141 (59%), Gaps = 9/141 (6%)
Query: 109 LLFRLNHPHIITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 168
L++++ EP++V A +IA G+ +LHS+GI++RDLK +N++L + +K
Sbjct: 88 LMYQIQQVGRFKEPHAV------FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIK 141
Query: 169 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP 226
+ADFG+ C E+ + K F GT ++APE+I + + K VD ++FG++L+E+L P
Sbjct: 142 IADFGM-CKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200
Query: 227 FDNMTPEQAAFAVCQKNARPP 247
F+ ++ ++ + N P
Sbjct: 201 FEGEDEDELFQSIMEHNVAYP 221
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-17
Identities = 48/144 (33%), Positives = 71/144 (49%), Gaps = 6/144 (4%)
Query: 139 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEM 198
+G+ YLHS ++HRD+K+ N+LL E VK+ DFG + + + A F GT WMAPE+
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEV 182
Query: 199 I---KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255
I E ++ KVDV+S GI EL P NM A + + Q + +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242
Query: 256 FSYLISRCWSSSPDRRPHFDQIVS 279
F + C P RP + ++
Sbjct: 243 FRNFVDSCLQKIPQDRPTSEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 37/90 (41%), Positives = 58/90 (64%), Gaps = 3/90 (3%)
Query: 140 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK--GFTGTYRWMAPE 197
G+QYLH I++RDLK +NLLL + VK+ADFG+ C E + F GT ++APE
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGL-CKEGMGFGDRTSTFCGTPEFLAPE 171
Query: 198 MIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
++ E +T+ VD + G++++E+L +PF
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 60/185 (32%), Positives = 88/185 (47%), Gaps = 43/185 (23%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII---------------TEP 122
R VAIK +S+P + A A K+ E+ LL ++H ++I +
Sbjct: 40 GRKVAIKKLSRPFQSAIHA----KRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95
Query: 123 YSVP------LNLVLK-----------LALDIARGMQYLHSQGILHRDLKSENLLLGEDM 165
Y V LN ++K L I RG++Y+HS GI+HRDLK N+ + ED
Sbjct: 96 YLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 155
Query: 166 CVKVADFGISCLESQCGSA-KGFTGTYRW-MAPEMIKEKRH-TKKVDVYSFGIVLWELLT 222
+K+ DFG L G+ T RW APE++ H + VD++S G ++ ELLT
Sbjct: 156 ELKILDFG---LARHTDDEMTGYVAT-RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 211
Query: 223 ALTPF 227
T F
Sbjct: 212 GKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 46/148 (31%), Positives = 80/148 (54%), Gaps = 7/148 (4%)
Query: 139 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPE 197
+G+ YLHS+G +HRD+K N+LL ++ VK+ADFG++ + + K F GT WMAPE
Sbjct: 117 QGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPE 176
Query: 198 MI---KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254
+ K + + D+++ GI EL P ++ P +A F + + N +PP K
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTK 236
Query: 255 ---AFSYLISRCWSSSPDRRPHFDQIVS 279
F + + +P +RP +++++
Sbjct: 237 WSSTFHNFVKISLTKNPKKRPTAERLLT 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-17
Identities = 46/137 (33%), Positives = 76/137 (55%), Gaps = 6/137 (4%)
Query: 139 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAP 196
+ +++LH+ ++HRD+KS+N+LLG D VK+ DFG C + +K T GT WMAP
Sbjct: 126 QALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGF-CAQITPEQSKRSTMVGTPYWMAP 184
Query: 197 EMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPK 254
E++ K + KVD++S GI+ E++ P+ N P +A + + N P + P
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSP 243
Query: 255 AFSYLISRCWSSSPDRR 271
F ++RC ++R
Sbjct: 244 IFRDFLNRCLEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-17
Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 35/208 (16%)
Query: 106 EVALLFRLNHPHIITEPYSVPLNLVLKLALD----------------------------- 136
EVA+L + HP+I+ S N L + +D
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108
Query: 137 -IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWM 194
I ++++H + ILHRD+KS+N+ L +D +K+ DFGI+ L S A+ GT ++
Sbjct: 109 QICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYL 168
Query: 195 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254
+PE+ + + + K D+++ G VL+E+ T F+ + + + + PPV
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSY 227
Query: 255 AFSYLISRCWSSSPDRRPHFDQIVSILE 282
L+S+ + +P RP + SILE
Sbjct: 228 DLRNLVSQLFKRNPRDRP---SVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 50/176 (28%), Positives = 91/176 (51%), Gaps = 20/176 (11%)
Query: 115 HPHIITEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFG 173
+ + + ++P +++ K+A+ I + ++YLHS+ ++HRD+K N+L+ + VK+ DFG
Sbjct: 90 YKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFG 149
Query: 174 IS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTK----KVDVYSFGIVLWELLTALTPF 227
IS ++S + G +MAPE I + + K K DV+S GI + EL T P+
Sbjct: 150 ISGYLVDSVAKTID--AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY 207
Query: 228 DNM-TPEQAAFAVCQKNARPPVPPTCPKA-----FSYLISRCWSSSPDRRPHFDQI 277
D+ TP Q V ++ P P F +++C + RP++ ++
Sbjct: 208 DSWKTPFQQLKQVVEEP-----SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-17
Identities = 41/119 (34%), Positives = 68/119 (57%), Gaps = 6/119 (5%)
Query: 133 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTY 191
+ L + + + LH+QG++HRD+KS+++LL D VK++DFG + + K GT
Sbjct: 121 VCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTP 180
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP 250
WMAPE+I + +VD++S GI++ E++ P+ N P +A K R +PP
Sbjct: 181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-----MKMIRDNLPP 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-17
Identities = 46/127 (36%), Positives = 67/127 (52%), Gaps = 4/127 (3%)
Query: 128 NLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKG 186
N+ K I G+ YLHS I+HRD+K N+L VK+ DFG S L++ C S G
Sbjct: 106 NVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG 165
Query: 187 F---TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 243
TGT WM+PE+I + + +K D++S G + E+LT P+ A F + +
Sbjct: 166 MKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP 225
Query: 244 ARPPVPP 250
P +PP
Sbjct: 226 TNPVLPP 232
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 6e-17
Identities = 47/141 (33%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 136 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRW 193
+I +++LH GI++RD+K EN+LL + V + DFG+S L + F GT +
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172
Query: 194 MAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR--PPVPP 250
MAPE+I+ K H K VD +S GI+++ELLT +PF V ++ + PP P
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS 232
Query: 251 TCPKAFSYLISRCWSSSPDRR 271
L+ + P +R
Sbjct: 233 FIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-17
Identities = 47/155 (30%), Positives = 85/155 (54%), Gaps = 2/155 (1%)
Query: 126 PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-A 184
P + +L+ + + G+Q++H + +LHRD+KS+N+ L ++ VK+ DFG + L + G+ A
Sbjct: 98 PEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157
Query: 185 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 244
+ GT ++ PE+ + + K D++S G +L+EL T PF + + VCQ +
Sbjct: 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY 217
Query: 245 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279
+ P+P LI + + +P RP I+S
Sbjct: 218 K-PLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-17
Identities = 62/240 (25%), Positives = 104/240 (43%), Gaps = 40/240 (16%)
Query: 73 RGIYKQRDVAIKL--VSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITEPYSVPLNLV 130
R Q+ V IK V Q +D LA+ +E +L L+HP+II + +
Sbjct: 20 RRKADQKLVIIKQIPVEQMTKDERLAAQ------NECQVLKLLSHPNIIEYYENFLEDKA 73
Query: 131 LKLALDIARG------------------------------MQYLHSQGILHRDLKSENLL 160
L + ++ A G + ++H++ ILHRDLK++N+L
Sbjct: 74 LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNIL 133
Query: 161 LGE-DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 219
L + M VK+ DFGIS + S A GT +++PE+ + K + +K D+++ G VL+E
Sbjct: 134 LDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYE 193
Query: 220 LLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279
L + F+ + P+ LI + P +RP QI++
Sbjct: 194 LASLKRAFEAANLPALVLKI-MSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 7e-17
Identities = 38/101 (37%), Positives = 64/101 (63%), Gaps = 6/101 (5%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTY 191
A +I ++YLHS+ I++RDLK EN+LL ++ +K+ DFG ++ + +T GT
Sbjct: 107 ASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGF----AKKLRDRTWTLCGTP 162
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP 232
++APE+I+ K H K VD ++ GI+++E+L PF + P
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 7e-17
Identities = 41/130 (31%), Positives = 72/130 (55%), Gaps = 9/130 (6%)
Query: 102 QFTSEVALLFRLNHPHIITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 161
++ + L F L+ + +E + + AL YLHS +++RDLK ENL+L
Sbjct: 75 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALG------YLHSCDVVYRDLKLENLML 128
Query: 162 GEDMCVKVADFGISCLE--SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 219
+D +K+ DFG+ C E S + K F GT ++APE++++ + + VD + G+V++E
Sbjct: 129 DKDGHIKITDFGL-CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 187
Query: 220 LLTALTPFDN 229
++ PF N
Sbjct: 188 MMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 9e-17
Identities = 39/94 (41%), Positives = 58/94 (61%), Gaps = 3/94 (3%)
Query: 136 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK--GFTGTYRW 193
+I+ +++LH QGI++RDLK EN+LL VK+ DFG+ C ES F GT +
Sbjct: 108 EISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGL-CKESIHEGTVTHTFCGTIEY 166
Query: 194 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
MAPE++ H K VD +S G +++++LT PF
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 40/93 (43%), Positives = 58/93 (62%), Gaps = 6/93 (6%)
Query: 142 QYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMI 199
+YLHS+ I++RDLK ENLLL VKV DFG ++ + FT GT ++APE+I
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGF----AKKVPDRTFTLCGTPEYLAPEVI 187
Query: 200 KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP 232
+ K H K VD ++ G++L+E + PF + TP
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220
|
Length = 329 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 48/144 (33%), Positives = 75/144 (52%), Gaps = 15/144 (10%)
Query: 140 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK----GFTGTYRWMA 195
G+Q+LH+ I+HRD+K N+LL + VK+ DFG+S +Q S + GT WMA
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS---AQLTSTRLRRNTSVGTPFWMA 196
Query: 196 PEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV-- 248
PE+I + + + DV+S GI EL P +M P + F + +N P +
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI-PRNPPPTLLH 255
Query: 249 PPTCPKAFSYLISRCWSSSPDRRP 272
P ++F++ IS+C + RP
Sbjct: 256 PEKWCRSFNHFISQCLIKDFEARP 279
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 67/258 (25%), Positives = 107/258 (41%), Gaps = 59/258 (22%)
Query: 65 SGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP------ 116
SG +Y+ I++ R A+K++ ED + +Q E+ +L +NHP
Sbjct: 84 SGAGGTVYKVIHRPTGRLYALKVIYGNHEDT-----VRRQICREIEILRDVNHPNVVKCH 138
Query: 117 ------------------------HIITEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 152
HI E + + +A I G+ YLH + I+HR
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQF------LADVARQILSGIAYLHRRHIVHR 192
Query: 153 DLKSENLLLGEDMCVKVADFGISCLESQ----CGSAKGFTGTYRWMAPEMIKEKRHTKKV 208
D+K NLL+ VK+ADFG+S + +Q C S+ GT +M+PE I +
Sbjct: 193 DIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYMSPERINTDLNHGAY 249
Query: 209 -----DVYSFGIVLWELLTALTPFD-NMTPEQAAF--AVCQKNARPPVPPTCPKAFSYLI 260
D++S G+ + E PF + A+ A+C P P T + F + I
Sbjct: 250 DGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP-PEAPATASREFRHFI 308
Query: 261 SRCWSSSPDRRPHFDQIV 278
S C P +R Q++
Sbjct: 309 SCCLQREPAKRWSAMQLL 326
|
Length = 353 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 39/116 (33%), Positives = 72/116 (62%), Gaps = 3/116 (2%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG--SAKGFTGTY 191
A +I+ G+ +LH +GI++RDLK +N++L + +K+ADFG+ C E + + F GT
Sbjct: 107 AAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGM-CKEHMVDGVTTRTFCGTP 165
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 247
++APE+I + + K VD +++G++L+E+L PFD ++ ++ + N P
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP 221
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-16
Identities = 46/162 (28%), Positives = 73/162 (45%), Gaps = 17/162 (10%)
Query: 125 VPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183
+P+ ++ K+A+ + G+ YL++ I+HRD+K N+L+ +K+ DFG+S E
Sbjct: 100 IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG-ELINSI 158
Query: 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV---- 239
A F GT +M+PE I+ ++T K DV+S GI + EL PF
Sbjct: 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF--SNIDDDGQDDPM 216
Query: 240 -------CQKNARPPVPPTC--PKAFSYLISRCWSSSPDRRP 272
PP P+ P+ + C P RP
Sbjct: 217 GILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-16
Identities = 53/173 (30%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 108 ALLFRLNHPHIITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 167
A++ L P +TEP + +V K L+ + YLH I+HRDLK+ N+L D +
Sbjct: 91 AVMLELERP--LTEP---QIRVVCKQTLE---ALNYLHENKIIHRDLKAGNILFTLDGDI 142
Query: 168 KVADFGISCLESQCGSAK-GFTGTYRWMAPEMI-----KEKRHTKKVDVYSFGIVLWELL 221
K+ADFG+S ++ + F GT WMAPE++ K++ + K DV+S GI L E+
Sbjct: 143 KLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 202
Query: 222 TALTPFDNMTPEQAAFAVCQKNARPPV---PPTCPKAFSYLISRCWSSSPDRR 271
P + P + + + + PP P F + +C + D R
Sbjct: 203 QIEPPHHELNPMRVLLKIAK--SEPPTLAQPSRWSSEFKDFLKKCLEKNVDAR 253
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 5e-16
Identities = 36/101 (35%), Positives = 65/101 (64%), Gaps = 3/101 (2%)
Query: 136 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE--SQCGSAKGFTGTYRW 193
+I ++YLHS+ +++RD+K ENL+L +D +K+ DFG+ C E S + K F GT +
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL-CKEGISDGATMKTFCGTPEY 161
Query: 194 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 234
+APE++++ + + VD + G+V++E++ PF N E+
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 5e-16
Identities = 43/138 (31%), Positives = 76/138 (55%), Gaps = 5/138 (3%)
Query: 136 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE--SQCGSAKGFTGTYRW 193
+I + YLHS I++RDLK ENL+L +D +K+ DFG+ C E + + K F GT +
Sbjct: 103 EIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGL-CKEGITDAATMKTFCGTPEY 161
Query: 194 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 253
+APE++++ + + VD + G+V++E++ PF N E+ + ++ + P T
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK--FPRTLS 219
Query: 254 KAFSYLISRCWSSSPDRR 271
L+S P++R
Sbjct: 220 ADAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 5e-16
Identities = 51/171 (29%), Positives = 83/171 (48%), Gaps = 34/171 (19%)
Query: 79 RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII----------------TEP 122
++VAIK + +P LA K+ E+ LL L H +II TE
Sbjct: 36 QNVAIKKIMKPFSTPVLA----KRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91
Query: 123 YSVPLNLVLK-----------LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVAD 171
L+ +L I RG++Y+HS G++HRDLK N+L+ E+ +K+ D
Sbjct: 92 LGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICD 151
Query: 172 FGISCLESQCGSAKGFTGTYRWMAPE-MIKEKRHTKKVDVYSFGIVLWELL 221
FG++ Q G+ T + APE M+ +++ +VD++S G + E+L
Sbjct: 152 FGLA--RIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 60/183 (32%), Positives = 86/183 (46%), Gaps = 6/183 (3%)
Query: 133 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTG 189
L I + +HS+ ++HRDLKS N+ L +K+ DFG S S S A F G
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233
Query: 190 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP 249
T ++APE+ + KR++KK D++S G++L+ELLT PF + + V P P
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK-YDPFP 292
Query: 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSI-LEGYSESLEQDPEFFSSFIPSPDHT-IL 307
L+ S +P RP Q++ Y +L QD S I D IL
Sbjct: 293 CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIVRHSETISPHDREEIL 352
Query: 308 RCL 310
R L
Sbjct: 353 RQL 355
|
Length = 478 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-16
Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 17/150 (11%)
Query: 141 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK-GFTGTYRWMAPEMI 199
+QYLHS I+HRDLK+ N+LL D +K+ADFG+S + + F GT WMAPE++
Sbjct: 123 LQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVV 182
Query: 200 -----KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT--C 252
K+ + K D++S GI L E+ P + P + + + PPT
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-----PPTLSQ 237
Query: 253 PKAFSY----LISRCWSSSPDRRPHFDQIV 278
P +S + P+ RP Q++
Sbjct: 238 PSKWSMEFRDFLKTALDKHPETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 7e-16
Identities = 54/158 (34%), Positives = 70/158 (44%), Gaps = 43/158 (27%)
Query: 106 EVALLFRLNHPHIITEPYSV-----PLNLVLKLA------------------------LD 136
E+ LL L HP+II V +NLV + L
Sbjct: 52 EIKLLQELKHPNII-GLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLM 110
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG------FTGT 190
RG++YLHS ILHRDLK NLL+ D +K+ADFG++ GS T
Sbjct: 111 TLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR---SFGSPNRKMTHQVVTRW 167
Query: 191 YRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPF 227
YR APE++ RH VD++S G + ELL PF
Sbjct: 168 YR--APELLFGARHYGVGVDMWSVGCIFAELLLR-VPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 8e-16
Identities = 39/96 (40%), Positives = 58/96 (60%), Gaps = 3/96 (3%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS--AKGFTGTY 191
A +IA + YLHS I++RDLK EN+LL V + DFG+ C E S F GT
Sbjct: 102 AAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGL-CKEGIEHSKTTSTFCGTP 160
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
++APE+++++ + + VD + G VL+E+L L PF
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-16
Identities = 43/126 (34%), Positives = 67/126 (53%), Gaps = 4/126 (3%)
Query: 128 NLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKG 186
N+ + I +G+ YLHS I+HRD+K N+L VK+ DFG S +++ C S G
Sbjct: 106 NVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG 165
Query: 187 F---TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 243
TGT WM+PE+I + + +K DV+S + E+LT P+ A F + +
Sbjct: 166 IKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP 225
Query: 244 ARPPVP 249
+P +P
Sbjct: 226 TKPMLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 9e-16
Identities = 34/92 (36%), Positives = 60/92 (65%), Gaps = 1/92 (1%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMA 195
I G+++LH + I++RDLK EN+LL D V+++D G++ L+ KG+ GT +MA
Sbjct: 106 IISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMA 165
Query: 196 PEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
PE+++ + + VD ++ G+ L+E++ A PF
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 38/91 (41%), Positives = 56/91 (61%), Gaps = 5/91 (5%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---RW 193
I RG++Y+HS +LHRDLK NLLL + +K+ DFG++ + GF Y RW
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174
Query: 194 M-APE-MIKEKRHTKKVDVYSFGIVLWELLT 222
APE M+ K +TK +D++S G +L E+L+
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 40/155 (25%), Positives = 79/155 (50%), Gaps = 5/155 (3%)
Query: 128 NLVLKLALDIARGMQYLHSQG-ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG 186
N+ +++ L ++YLH + I+HRDL N++LGED V + DFG++ +
Sbjct: 117 NIFVQMVL----ALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS 172
Query: 187 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 246
GT + PE++K + + +K DV++FG +L+++ T PF + A + + P
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP 232
Query: 247 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 281
+ + +I+ C + + RP Q+ +++
Sbjct: 233 LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 49/187 (26%), Positives = 76/187 (40%), Gaps = 60/187 (32%)
Query: 101 KQFTSEVALLFRLNHPHIIT-------EPYSV---------PLNLVLK------LALDIA 138
K+ +E +L L+HP + T E Y L +L+ L+ ++A
Sbjct: 46 KRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVA 105
Query: 139 R--------GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA------ 184
R ++YLH GI++RDLK EN+LL E + ++DF +S
Sbjct: 106 RFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALR 165
Query: 185 ------------------------KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 220
F GT ++APE+I H VD ++ GI+L+E+
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225
Query: 221 LTALTPF 227
L TPF
Sbjct: 226 LYGTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 38/98 (38%), Positives = 54/98 (55%), Gaps = 9/98 (9%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-----LESQCGSAKGFTGTY 191
I G++Y+HS +LHRDLK NLL+ D +K+ DFG++ G + T
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT- 172
Query: 192 RWM-APE-MIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
RW APE M+ + +TK +DV+S G +L ELL P
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 42/126 (33%), Positives = 67/126 (53%), Gaps = 24/126 (19%)
Query: 133 LALDIAR--------GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL------- 177
L +D+AR ++YLH+ GI+HRDLK +NLL+ +K+ DFG+S +
Sbjct: 98 LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157
Query: 178 ---------ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 228
+++ K GT ++APE+I + + K VD ++ GI+L+E L PF
Sbjct: 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217
Query: 229 NMTPEQ 234
TPE+
Sbjct: 218 GDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-15
Identities = 31/98 (31%), Positives = 59/98 (60%)
Query: 130 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG 189
L A +I G++ LH + ++RDLK EN+LL + ++++D G++ + S +G G
Sbjct: 104 ALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVG 163
Query: 190 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
T +MAPE++ +R+T D + G +++E++ +PF
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 3e-15
Identities = 34/91 (37%), Positives = 50/91 (54%), Gaps = 2/91 (2%)
Query: 144 LHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR 203
LH G +HRDLK EN L+ +K+ DFG+S + A G+ +MAPE+++ K
Sbjct: 117 LHELGYIHRDLKPENFLIDASGHIKLTDFGLS--KGIVTYANSVVGSPDYMAPEVLRGKG 174
Query: 204 HTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 234
+ VD +S G +L+E L PF TP +
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 34/91 (37%), Positives = 54/91 (59%), Gaps = 6/91 (6%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY---R 192
+ RG++Y+HS ++HRDLK NLL+ ED +++ DFG++ L S K F Y R
Sbjct: 116 LLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 193 WM-APE-MIKEKRHTKKVDVYSFGIVLWELL 221
W APE ++ +T +D++S G + E+L
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 4e-15
Identities = 47/197 (23%), Positives = 81/197 (41%), Gaps = 53/197 (26%)
Query: 66 GRHSRIYRGIYKQRD--VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--- 120
G H +++ ++ VA+K V+ + + + + E+ L HP+++
Sbjct: 11 GAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR----EIKALQACQHPYVVKLLD 66
Query: 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 155
E +P V + +G+ Y+H+ GI+HRDLK
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLK 126
Query: 156 SENLLLGEDMCVKVADFGISCLES---------QCGSAKGFTGTYRW-MAPEMIKEKRH- 204
NLL+ D +K+ADFG++ L S Q + RW APE++ R
Sbjct: 127 PANLLISADGVLKIADFGLARLFSEEEPRLYSHQVAT--------RWYRAPELLYGARKY 178
Query: 205 TKKVDVYSFGIVLWELL 221
VD+++ G + ELL
Sbjct: 179 DPGVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 5e-15
Identities = 64/255 (25%), Positives = 108/255 (42%), Gaps = 65/255 (25%)
Query: 71 IYRGIYKQRDVAIKL--VSQPEEDASLASMLEKQFTSEVALLFRLNHPHII------TEP 122
+RG+ K R V +L + P+E + F EV LNHP+++ E
Sbjct: 16 AHRGMSKARVVVKELRASATPDE--------QLLFLQEVQPYRELNHPNVLQCLGQCIE- 66
Query: 123 YSVPLNLVL-----------------------------KLALDIARGMQYLHSQGILHRD 153
S+P LVL ++A ++A G+ +LH +H D
Sbjct: 67 -SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSD 125
Query: 154 LKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEM-------IKEKR 203
L N L D+ VK+ D+G++ E + RW+APE+ + K
Sbjct: 126 LALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKD 185
Query: 204 HTKKVDVYSFGIVLWELLTALT-PFDNMTPEQA-AFAVCQKNARPPVP----PTCPKAFS 257
TKK +++S G+ +WEL TA P+ +++ EQ V +++ + P P + +
Sbjct: 186 QTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYE 245
Query: 258 YLISRCWSSSPDRRP 272
++ CW P+ RP
Sbjct: 246 -VMQFCW-LDPETRP 258
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 7e-15
Identities = 35/91 (38%), Positives = 54/91 (59%), Gaps = 7/91 (7%)
Query: 139 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY----RW 193
+ ++Y+HS ++HRDLK N+LL D VK+ADFG++ L + + T RW
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177
Query: 194 M-APE-MIKEKRHTKKVDVYSFGIVLWELLT 222
APE ++ R+TK VD++S G +L E+L
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 33/94 (35%), Positives = 61/94 (64%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW 193
A +I G++ LH + I++RDLK EN+LL + ++++D G++ + + KG GT +
Sbjct: 108 AAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGY 167
Query: 194 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
MAPE++K +R+T D ++ G +L+E++ +PF
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 31/94 (32%), Positives = 60/94 (63%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW 193
A +I G++ LH + I++RDLK EN+LL + ++++D G++ + + +G GT +
Sbjct: 108 AAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGY 167
Query: 194 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
MAPE++K +R+T D + G +++E++ +PF
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 60/194 (30%), Positives = 84/194 (43%), Gaps = 52/194 (26%)
Query: 72 YRGIYKQRD------VAIKLVS-QPEEDASLASMLEKQFTSEVALLFRLNHPHII----- 119
Y +Y+ RD VA+K V E D S L E+ LL L HP+I+
Sbjct: 20 YGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-----EITLLLNLRHPNIVELKEV 74
Query: 120 ---------------------------TEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 152
P+S V L L + RG+QYLH I+HR
Sbjct: 75 VVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQ--VKCLMLQLLRGLQYLHENFIIHR 132
Query: 153 DLKSENLLLGEDMCVKVADFGIS-CLESQCG--SAKGFTGTYRWMAPEMI-KEKRHTKKV 208
DLK NLLL + C+K+ADFG++ + K T YR APE++ +T +
Sbjct: 133 DLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYR--APELLLGCTTYTTAI 190
Query: 209 DVYSFGIVLWELLT 222
D+++ G +L ELL
Sbjct: 191 DMWAVGCILAELLA 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 42/103 (40%), Positives = 61/103 (59%), Gaps = 7/103 (6%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE----SQCGSAKGFTGTYR 192
I RG++YLHS GILHRD+K NLL+ + +K+ DFG++ +E S+ + + T YR
Sbjct: 112 ILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYR 171
Query: 193 WMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQ 234
APE++ RH T VD++S G + ELL F +P Q
Sbjct: 172 --APEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 37/96 (38%), Positives = 58/96 (60%), Gaps = 3/96 (3%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE--SQCGSAKGFTGTY 191
A ++A + YLHS I++RDLK EN+LL V + DFG+ C E + F GT
Sbjct: 102 AAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGL-CKEGVEPEETTSTFCGTP 160
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
++APE+++++ + + VD + G VL+E+L L PF
Sbjct: 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 56/185 (30%), Positives = 79/185 (42%), Gaps = 43/185 (23%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII-------TEPY------- 123
+VAIKL+ DA +F E AL RL HP+I+ P
Sbjct: 3 GHEVAIKLL---RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFE 59
Query: 124 SVP---LNLVL------------KLALDIARGMQYLHSQGILHRDLKSENLLL---GEDM 165
VP L VL +L L + + H+QGI+HRDLK +N+++ G
Sbjct: 60 YVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP 119
Query: 166 CVKVADFGISCLESQCGSAKGFT--------GTYRWMAPEMIKEKRHTKKVDVYSFGIVL 217
KV DFGI L A T GT + APE ++ + T D+Y++G++
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 218 WELLT 222
E LT
Sbjct: 180 LECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 35/97 (36%), Positives = 60/97 (61%), Gaps = 3/97 (3%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG--SAKGFTGTY 191
A +I + +LH +GI++RDLK +N+LL + K+ADFG+ C E + F GT
Sbjct: 102 AAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM-CKEGIFNGKTTSTFCGTP 160
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 228
++APE+++E + VD ++ G++L+E+L PF+
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 40/96 (41%), Positives = 59/96 (61%), Gaps = 3/96 (3%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE--SQCGSAKGFTGTY 191
A +IA + YLHS I++RDLK EN+LL V + DFG+ C E +Q + F GT
Sbjct: 102 AAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGL-CKEGIAQSDTTTTFCGTP 160
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
++APE+I+++ + VD + G VL+E+L L PF
Sbjct: 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 46/141 (32%), Positives = 70/141 (49%), Gaps = 9/141 (6%)
Query: 140 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEM 198
G+Q+LH +HRD+K N+LL + VK+ DFG+S L S GT WMAPE+
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195
Query: 199 IK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPT 251
I + + + DV+S GI EL P ++ P +A F + +N P + P
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI-PRNPPPTLHQPEL 254
Query: 252 CPKAFSYLISRCWSSSPDRRP 272
F+ I +C + ++RP
Sbjct: 255 WSNEFNDFIRKCLTKDYEKRP 275
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-14
Identities = 41/144 (28%), Positives = 70/144 (48%), Gaps = 28/144 (19%)
Query: 106 EVALLFRLNHPHII--------------------TEPYS--------VPLNLVLKLALDI 137
E LL +NHP +I ++ Y+ +P++ L + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQI 166
Query: 138 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE 197
G++YLH+Q I+HRD+K+EN+ + + V + D G + + G GT APE
Sbjct: 167 LEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE 226
Query: 198 MIKEKRHTKKVDVYSFGIVLWELL 221
++ ++ K D++S GIVL+E+L
Sbjct: 227 VLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 5e-14
Identities = 45/139 (32%), Positives = 77/139 (55%), Gaps = 6/139 (4%)
Query: 136 DIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISCLE--SQCGSAKGFTGTYR 192
+I + YLHS+ +++RDLK ENL+L +D +K+ DFG+ C E + K F GT
Sbjct: 103 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL-CKEGIKDGATMKTFCGTPE 161
Query: 193 WMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTC 252
++APE++++ + + VD + G+V++E++ PF N E+ + + R P
Sbjct: 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP-RTLS 220
Query: 253 PKAFSYLISRCWSSSPDRR 271
P+A S L+S P +R
Sbjct: 221 PEAKS-LLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-14
Identities = 38/96 (39%), Positives = 59/96 (61%), Gaps = 3/96 (3%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES--QCGSAKGFTGTY 191
A +IA + YLHS I++RDLK EN+LL + + DFG+ C E+ G+ F GT
Sbjct: 102 AAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL-CKENIEHNGTTSTFCGTP 160
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
++APE++ ++ + + VD + G VL+E+L L PF
Sbjct: 161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 33/100 (33%), Positives = 60/100 (60%), Gaps = 9/100 (9%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG-----FT 188
A ++ + +LH G+++RDLK +N+LL + K+ADFG+ C E G G F
Sbjct: 102 AAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGM-CKE---GILNGVTTTTFC 157
Query: 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 228
GT ++APE+++E + VD ++ G++++E++ PF+
Sbjct: 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-13
Identities = 37/96 (38%), Positives = 55/96 (57%), Gaps = 3/96 (3%)
Query: 133 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYR 192
L I RG++Y+HS I+HRDLK NL + ED +K+ DFG++ G+ T
Sbjct: 125 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRW 182
Query: 193 WMAPE-MIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
+ APE M+ + + VD++S G ++ ELLT T F
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 47/156 (30%), Positives = 70/156 (44%), Gaps = 46/156 (29%)
Query: 106 EVALLFRLNHPHIIT--------------------------------EPYSVPLNLVLKL 133
E+ +L +L HP+I+T +P+ V L
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSE--VKCL 111
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-AKGFTGT-- 190
L + G+ +LH ILHRDLK+ NLLL +K+ DFG L + GS K +T
Sbjct: 112 MLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFG---LAREYGSPLKPYTQLVV 168
Query: 191 ---YRWMAPE-MIKEKRHTKKVDVYSFGIVLWELLT 222
YR APE ++ K ++ +D++S G + ELLT
Sbjct: 169 TLWYR--APELLLGAKEYSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 44/179 (24%), Positives = 75/179 (41%), Gaps = 38/179 (21%)
Query: 133 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS----------------- 175
LALD +H G +HRD+K +N+L+ D +K+ADFG+
Sbjct: 112 LALD------SVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSH 165
Query: 176 CLESQCGSAKGFT-------------GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT 222
L + GT ++APE+++ + + D +S G++L+E+L
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225
Query: 223 ALTPFDNMTPEQAAFAVC--QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279
PF + T ++ + +++ R P P LI R DR F++I S
Sbjct: 226 GFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKS 284
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 34/100 (34%), Positives = 56/100 (56%), Gaps = 2/100 (2%)
Query: 125 VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 184
+ + +L + + R +QYLH I+HRD+K+EN+ + V + DFG +C +
Sbjct: 179 IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238
Query: 185 K--GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT 222
K G+ GT APE++ + VD++S GIVL+E+ T
Sbjct: 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 56/218 (25%), Positives = 86/218 (39%), Gaps = 53/218 (24%)
Query: 58 FIGCKFASGRHSRIYRGIYKQ----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL 113
GC G + R+Y+ K ++ AIK +E + S E+ALL L
Sbjct: 4 IEGC-IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQ---SACREIALLREL 59
Query: 114 NHPHII----------------------------------TEPYSVPLNLVLKLALDIAR 139
H +++ + S+P ++V L I
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 140 GMQYLHSQGILHRDLKSENLLL----GEDMCVKVADFGISCLESQCGSAKGFTG-----T 190
G+ YLHS +LHRDLK N+L+ E VK+ D G++ L T
Sbjct: 120 GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-FNAPLKPLADLDPVVVT 178
Query: 191 YRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPF 227
+ APE++ RH TK +D+++ G + ELLT F
Sbjct: 179 IWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 31/103 (30%), Positives = 60/103 (58%)
Query: 127 LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG 186
+ V+ + I G+ +LHS I++RD+K EN+LL + +++D G++ +
Sbjct: 94 MERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQ 153
Query: 187 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 229
GT +MAPE++KE+ ++ VD ++ G ++E++ TPF +
Sbjct: 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 3e-13
Identities = 36/98 (36%), Positives = 56/98 (57%), Gaps = 11/98 (11%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTG---T-- 190
+ G+QYLHS GILHRD+K N+L+ D +K+ADFG++ + ++ +T T
Sbjct: 109 LLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR--NSADYTNRVITLW 166
Query: 191 YRWMAPEMI-KEKRHTKKVDVYSFGIVLWELLTALTPF 227
YR PE++ R+ +VD++S G +L EL F
Sbjct: 167 YR--PPELLLGATRYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 39/123 (31%), Positives = 70/123 (56%), Gaps = 10/123 (8%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES--QCGSAKGFTGTY 191
A +I + +LH +GI++RDLK +N+LL D +K+ D+G+ C E + F GT
Sbjct: 102 AAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGM-CKEGLGPGDTTSTFCGTP 160
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD------NMTPEQAAFAVC-QKNA 244
++APE+++ + + VD ++ G++++E++ +PFD +M E F V +K
Sbjct: 161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI 220
Query: 245 RPP 247
R P
Sbjct: 221 RIP 223
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 41/184 (22%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------------- 120
VAIK + E+D ++K EV +L +L H +I+
Sbjct: 29 VAIKKFKESEDD----EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER 84
Query: 121 --------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 172
P +P + V + + + Y HS I+HRD+K EN+L+ E +K+ DF
Sbjct: 85 TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDF 144
Query: 173 GISCLESQCGSAKGFTGTY---RWM-APE-MIKEKRHTKKVDVYSFGIVLWELLT--ALT 225
G + + A T Y RW APE ++ + + K VDV++ G ++ ELL L
Sbjct: 145 GFARA-LRARPASPLT-DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202
Query: 226 PFDN 229
P D+
Sbjct: 203 PGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-13
Identities = 32/89 (35%), Positives = 55/89 (61%), Gaps = 2/89 (2%)
Query: 141 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE-SQCGSAKGFTGTYRWMAPE-M 198
+++LH I++RDLK EN+LL + + DFG+S + + F GT ++APE +
Sbjct: 109 LEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 199 IKEKRHTKKVDVYSFGIVLWELLTALTPF 227
+ EK +TK VD +S G++++E+ +PF
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 5e-13
Identities = 40/147 (27%), Positives = 63/147 (42%), Gaps = 32/147 (21%)
Query: 89 PEEDASLASMLEKQFTSEVALLFRLNHPHIITEPYSVPLNLVLKLALDIARGMQYLHSQG 148
P D L+ +LE +L I + L+ G+ YLH
Sbjct: 95 PYMDHDLSGLLENP-------SVKLTESQI---------KCYMLQLLE---GINYLHENH 135
Query: 149 ILHRDLKSENLLLGEDMCVKVADFGISCLESQC---------GSAKGFTG--TYRWM-AP 196
ILHRD+K+ N+L+ +K+ADFG++ G + +T RW P
Sbjct: 136 ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPP 195
Query: 197 EMI-KEKRHTKKVDVYSFGIVLWELLT 222
E++ E+R+T VD++ G V E+ T
Sbjct: 196 ELLLGERRYTTAVDIWGIGCVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 6e-13
Identities = 43/145 (29%), Positives = 71/145 (48%), Gaps = 21/145 (14%)
Query: 102 QFTSEVALLFRLNHPHIITEPYSVPLNLVLK-----------LALDIARGMQYLHSQGIL 150
T +V L LN +I+ E L VL+ + RG++Y+HS +L
Sbjct: 77 DLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVL 136
Query: 151 HRDLKSENLLLG-EDMCVKVADFGISCLESQCGSAKGF------TGTYRWMAPEMIKEKR 203
HRDLK N+ + ED+ +K+ DFG++ + S KG+ T YR +P ++
Sbjct: 137 HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR--SPRLLLSPN 194
Query: 204 H-TKKVDVYSFGIVLWELLTALTPF 227
+ TK +D+++ G + E+LT F
Sbjct: 195 NYTKAIDMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 37/97 (38%), Positives = 57/97 (58%), Gaps = 5/97 (5%)
Query: 133 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA-KGFTGTY 191
L + +G++Y+H+ GI+HRDLK NL + ED +K+ DFG L Q S G+ T
Sbjct: 123 LVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFG---LARQTDSEMTGYVVTR 179
Query: 192 RWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPF 227
+ APE+I +T+ VD++S G ++ E+LT F
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-13
Identities = 44/161 (27%), Positives = 80/161 (49%), Gaps = 16/161 (9%)
Query: 132 KLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFT 188
++A +IA G+ +LH +H DL N LL D+ VK+ D+G+S E +
Sbjct: 104 RMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLW 163
Query: 189 GTYRWMAPEMIKEKR-------HTKKVDVYSFGIVLWELLTALT-PFDNMTPEQA-AFAV 239
RW+APE++ E TK+ +V+S G+ +WEL + P+ +++ EQ + V
Sbjct: 164 VPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV 223
Query: 240 CQKNARPPVPP---TCPKAFSYLISRCWSSSPDRRPHFDQI 277
++ + P P + ++ CW P++RP +++
Sbjct: 224 REQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 65/208 (31%)
Query: 72 YRGIYKQRD------VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI------- 118
Y +YK R+ VA+K + E + S + E++LL LNHP+I
Sbjct: 13 YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKELNHPNIVKLLDVI 68
Query: 119 ----------------------ITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKS 156
+ +PL L+ + +G+ + HS +LHRDLK
Sbjct: 69 HTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 128
Query: 157 ENLLLGEDMCVKVADFGISCLESQCGSAKGF------------TGTYRWMAPE-MIKEKR 203
+NLL+ + +K+ADFG+ A+ F T YR APE ++ K
Sbjct: 129 QNLLINTEGAIKLADFGL---------ARAFGVPVRTYTHEVVTLWYR--APEILLGCKY 177
Query: 204 HTKKVDVYSFGIVLWELLT--ALTPFDN 229
++ VD++S G + E++T AL P D+
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 31/95 (32%), Positives = 61/95 (64%), Gaps = 3/95 (3%)
Query: 136 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES--QCGSAKGFTGTYRW 193
+I+ + YLH +GI++RDLK +N+LL + +K+ D+G+ C E + F GT +
Sbjct: 104 EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM-CKEGLRPGDTTSTFCGTPNY 162
Query: 194 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 228
+APE+++ + + VD ++ G++++E++ +PFD
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 36/91 (39%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---RW 193
+ RG++Y+HS +LHRDLK NLLL + +K+ DFG++ S+ G F Y RW
Sbjct: 117 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG---DFMTEYVVTRW 173
Query: 194 M-APEMI-KEKRHTKKVDVYSFGIVLWELLT 222
APE++ +T +DV+S G + ELL
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 39/179 (21%)
Query: 85 LVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITEPYSV--PLNLVLKLAL------- 135
+VS+ E +LA E +L ++N P I+ +S P L L LA
Sbjct: 31 IVSRSEVTHTLA---------ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELF 81
Query: 136 ---------DIAR----------GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 176
D++R ++ LH +++RDLK EN+LL + + DFG+
Sbjct: 82 HHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCK 141
Query: 177 LE-SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF-DNMTPE 233
L F GT ++APE++ +TK VD ++ G++L+E+LT L PF D E
Sbjct: 142 LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE 200
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 1e-12
Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 10/95 (10%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---RW 193
I +G+ ++H G HRDLK ENLL+ VK+ADFG L + S +T Y RW
Sbjct: 108 ILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFG---LAREIRSRPPYT-DYVSTRW 163
Query: 194 M-APEMI-KEKRHTKKVDVYSFGIVLWELLTALTP 226
APE++ + ++ VD+++ G ++ EL T L P
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMAELYT-LRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 36/96 (37%), Positives = 55/96 (57%), Gaps = 3/96 (3%)
Query: 133 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYR 192
L + G++Y+HS GI+HRDLK NL + ED +K+ DFG++ G+ T
Sbjct: 122 LVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA--RHADAEMTGYVVTRW 179
Query: 193 WMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPF 227
+ APE+I H + VD++S G ++ E+LT T F
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLF 215
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 34/110 (30%), Positives = 67/110 (60%), Gaps = 13/110 (11%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG-----FT 188
+ +I+ + +LH +GI++RDLK +N+LL + +K+ D+G+ C E G G F
Sbjct: 102 SAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGM-CKE---GIRPGDTTSTFC 157
Query: 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD----NMTPEQ 234
GT ++APE+++ + + VD ++ G++++E++ +PFD + P+Q
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 7e-12
Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 16/168 (9%)
Query: 129 LVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAK 185
L+ ++A +IA G+ ++H LH DL N L D+ VKV D+GI E +
Sbjct: 100 LLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED 159
Query: 186 GFTGTYRWMAPEMIKEKR-------HTKKVDVYSFGIVLWELL-TALTPFDNMTPEQAAF 237
RW+APE++ E TK +V++ G+ LWEL A P+ +++ +
Sbjct: 160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN 219
Query: 238 AVCQKNARPPVPPTCPKAFS----YLISRCWSSSPDRRPHFDQIVSIL 281
V + P +S ++ CW SP++R +++ +L
Sbjct: 220 HVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 7e-12
Identities = 48/175 (27%), Positives = 86/175 (49%), Gaps = 35/175 (20%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII---------------TEP 122
++VAIK +S+P ++ + A K+ E+ L+ +NH +II +
Sbjct: 41 GQNVAIKKLSRPFQNVTHA----KRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV 96
Query: 123 YSV------PLNLVLKLALDIAR----------GMQYLHSQGILHRDLKSENLLLGEDMC 166
Y V L V+++ LD R G+++LHS GI+HRDLK N+++ D
Sbjct: 97 YLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 156
Query: 167 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 221
+K+ DFG++ + T + APE+I + + VD++S G ++ E++
Sbjct: 157 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 8e-12
Identities = 45/147 (30%), Positives = 72/147 (48%), Gaps = 35/147 (23%)
Query: 106 EVALLFRLNHPHII--------------------TEPYSV------PLNL--VLKLALDI 137
E LL RL+HP ++ ++ Y+ PL L V +A +
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQL 269
Query: 138 ARGMQYLHSQGILHRDLKSENLLLG--EDMCVKVADFGISCLESQCGSAK---GFTGTYR 192
+ Y+H +GI+HRD+K+EN+L+ ED+C + DFG +C S G GT
Sbjct: 270 LSAIDYIHGEGIIHRDIKTENVLVNGPEDIC--LGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 193 WMAPEMIKEKRHTKKVDVYSFGIVLWE 219
APE++ +T VD++S G+V++E
Sbjct: 328 TNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 34/105 (32%), Positives = 62/105 (59%), Gaps = 6/105 (5%)
Query: 125 VPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGIS--CLESQC 181
+P N++ K+++ + RG+ YL + I+HRD+K N+L+ +K+ DFG+S ++S
Sbjct: 96 IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154
Query: 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP 226
A F GT +M+PE ++ +T + D++S G+ L E+ P
Sbjct: 155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 48/174 (27%), Positives = 85/174 (48%), Gaps = 35/174 (20%)
Query: 79 RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------------ 120
R+VAIK +S+P ++ + A K+ E+ L+ +NH +II+
Sbjct: 43 RNVAIKKLSRPFQNQTHA----KRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVY 98
Query: 121 ---EPYSVPLNLVLKLALDIAR----------GMQYLHSQGILHRDLKSENLLLGEDMCV 167
E L V+++ LD R G+++LHS GI+HRDLK N+++ D +
Sbjct: 99 LVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 158
Query: 168 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 221
K+ DFG++ + T + APE+I + + VD++S G ++ E++
Sbjct: 159 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 49/167 (29%), Positives = 85/167 (50%), Gaps = 20/167 (11%)
Query: 125 VPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISC-LESQCG 182
+P +++ ++ + +G+++L + I+HRD+K N+L+ + VK+ DFG+S L +
Sbjct: 99 IPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157
Query: 183 SAKGFTGTYRWMAPEMIKEK------RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA 236
AK G +MAPE IK +T + DV+S G+ + E+ P+ PE A
Sbjct: 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY---PPETYA 213
Query: 237 --FAVCQKNARPPVPPTCPKAFSY----LISRCWSSSPDRRPHFDQI 277
FA PPT P +S +++C + P+RRP + Q+
Sbjct: 214 NIFAQLSAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQL 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 45/173 (26%), Positives = 82/173 (47%), Gaps = 34/173 (19%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP---------------HIITE---- 121
VAIK + E+D M++K E+ +L +L H +++ E
Sbjct: 29 VAIKKFLESEDD----KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH 84
Query: 122 ---------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 172
P + + V K I RG+++ HS I+HRD+K EN+L+ + VK+ DF
Sbjct: 85 TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDF 144
Query: 173 GIS-CLESQCGSAKGFTGTYRWMAPEM-IKEKRHTKKVDVYSFGIVLWELLTA 223
G + L + + T + APE+ + + ++ + VD+++ G ++ E+LT
Sbjct: 145 GFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 31/107 (28%), Positives = 54/107 (50%), Gaps = 3/107 (2%)
Query: 124 SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183
+PL + + + + YLH +GI+HRD+K+EN+ L E + DFG +C
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240
Query: 184 AK---GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
G++GT +PE++ + K D++S G+VL+E+
Sbjct: 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 60/268 (22%), Positives = 112/268 (41%), Gaps = 65/268 (24%)
Query: 65 SGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEK------QFTSEVALLFRLNHPHI 118
G + IY+G+ + + + +V +E + + +L F +L+ +L+H H+
Sbjct: 5 QGTFTNIYKGVLRVQS-DLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHL 63
Query: 119 I----------------------------TEPYSVPLNLVLKLALDIARGMQYLHSQGIL 150
+ E +V L+ L +A +A + YL + ++
Sbjct: 64 VKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLV 123
Query: 151 HRDLKSENLLL-------GEDMCVKVADFGIS-CLESQCGSAKGFTGTYR-----WMAPE 197
H ++ +N+L+ G +K++D GI + S+ R W+APE
Sbjct: 124 HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR---------EERVERIPWIAPE 174
Query: 198 MIK--EKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTP-EQAAFAVCQKNARPPVPPTCP 253
I+ + T D +SFG L E+ + P ++ E+ F Q R P+ P C
Sbjct: 175 CIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY--QDQHRLPM-PDCA 231
Query: 254 KAFSYLISRCWSSSPDRRPHFDQIVSIL 281
+ + LI++CW+ P +RP F I+ L
Sbjct: 232 ELAN-LINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 35/175 (20%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII------------------ 119
+R+VAIK +S+P ++ + A K+ E+ L+ +NH +II
Sbjct: 49 ERNVAIKKLSRPFQNQTHA----KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104
Query: 120 ---TEPYSVPLNLVLKLALDIAR----------GMQYLHSQGILHRDLKSENLLLGEDMC 166
E L V+++ LD R G+++LHS GI+HRDLK N+++ D
Sbjct: 105 YIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 164
Query: 167 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 221
+K+ DFG++ + T + APE+I + + VD++S G ++ E++
Sbjct: 165 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 35/100 (35%), Positives = 58/100 (58%), Gaps = 5/100 (5%)
Query: 133 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYR 192
L + RG++Y+HS GI+HRDLK N+ + ED +++ DFG++ G+ T
Sbjct: 123 LIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA--RQADDEMTGYVATRW 180
Query: 193 WMAPE-MIKEKRHTKKVDVYSFGIVLWELL--TALTPFDN 229
+ APE M+ + + VD++S G ++ ELL AL P ++
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 59/215 (27%)
Query: 60 GCKFASGRHSRIYRGIYKQ----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH 115
GCK G + +Y+ K RD A+K + + + E+ALL L H
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIE--------GTGISMSACREIALLRELKH 57
Query: 116 PHIIT--------------------------------------EPYSVPLNLVLKLALDI 137
P++I+ +P +P +V L I
Sbjct: 58 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 117
Query: 138 ARGMQYLHSQGILHRDLKSENLLL----GEDMCVKVADFGISCLESQ----CGSAKGFTG 189
G+ YLH+ +LHRDLK N+L+ E VK+AD G + L +
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 190 TYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTA 223
T+ + APE++ RH TK +D+++ G + ELLT+
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 36/105 (34%), Positives = 61/105 (58%), Gaps = 20/105 (19%)
Query: 133 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES------QCGSAKG 186
LALD +HS G +HRD+K +N+LL + +K+ADFG +C++ +C +A
Sbjct: 153 LALDA------IHSMGFIHRDVKPDNMLLDKSGHLKLADFG-TCMKMDANGMVRCDTA-- 203
Query: 187 FTGTYRWMAPEMIKEKRHT----KKVDVYSFGIVLWELLTALTPF 227
GT +++PE++K + ++ D +S G+ L+E+L TPF
Sbjct: 204 -VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 55/210 (26%), Positives = 85/210 (40%), Gaps = 63/210 (30%)
Query: 79 RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII--------------TEPY- 123
R VA+K + ED S +L+K+F E + L HP I+ T PY
Sbjct: 28 RRVALKKI---REDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYI 84
Query: 124 ----------------SVPLNL--------VLKLALDIARGMQYLHSQGILHRDLKSENL 159
S+ L L + I ++Y+HS+G+LHRDLK +N+
Sbjct: 85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNI 144
Query: 160 LLGEDMCVKVADFGI--------------------SCLESQCGSAKGFTGTYRWMAPEMI 199
LLG V + D+G C S K GT +MAPE +
Sbjct: 145 LLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGK-IVGTPDYMAPERL 203
Query: 200 KEKRHTKKVDVYSFGIVLWELLTALTPFDN 229
++ D+Y+ G++L+++LT P+
Sbjct: 204 LGVPASESTDIYALGVILYQMLTLSFPYRR 233
|
Length = 932 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 28/94 (29%), Positives = 58/94 (61%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW 193
A ++ G++ L + I++RDLK EN+LL + ++++D G++ + + +G GT +
Sbjct: 108 AAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGY 167
Query: 194 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
MAPE+I +++T D + G +++E++ +PF
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 45/167 (26%), Positives = 76/167 (45%), Gaps = 16/167 (9%)
Query: 125 VPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISC-LESQCG 182
+P ++ K+A+ + + YL + I+HRD+K N+LL + +K+ DFGIS L
Sbjct: 104 IPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163
Query: 183 SAKGFTGTYRWMAPEMIKEKRHTK---KVDVYSFGIVLWELLTALTPFDNMTP--EQAAF 237
+ G +MAPE I + DV+S GI L+E+ T P+ +Q
Sbjct: 164 KTRD-AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQ 222
Query: 238 AVCQKNARPPV-PPTCPKAFSY----LISRCWSSSPDRRPHFDQIVS 279
V PP+ + + FS I+ C +RP + +++
Sbjct: 223 VV---KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 4e-11
Identities = 34/113 (30%), Positives = 64/113 (56%), Gaps = 6/113 (5%)
Query: 117 HIITEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGIS 175
++ E +P ++ K+++ + RG+ YL + I+HRD+K N+L+ +K+ DFG+S
Sbjct: 92 QVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVS 151
Query: 176 --CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP 226
++S A F GT +M+PE ++ ++ + D++S G+ L EL P
Sbjct: 152 GQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 6/96 (6%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTY 191
A I +YL S I++RDLK ENLLL +D +K+ DFG ++ + +T GT
Sbjct: 137 AAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGF----AKVVDTRTYTLCGTP 192
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
++APE++ H K D ++ GI ++E+L PF
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 53/195 (27%), Positives = 84/195 (43%), Gaps = 51/195 (26%)
Query: 72 YRGIYKQRD------VAIKLVSQP--EEDASLASMLEKQFTSEVALLFRL---NHPHII- 119
Y +YK RD VA+K V E+ L+++ EVALL RL +HP+I+
Sbjct: 13 YGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTV------REVALLKRLEAFDHPNIVR 66
Query: 120 ---------------------------------TEPYSVPLNLVLKLALDIARGMQYLHS 146
P +P + L RG+ +LH+
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 147 QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTK 206
I+HRDLK EN+L+ VK+ADFG++ + S + T + APE++ + +
Sbjct: 127 NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYAT 186
Query: 207 KVDVYSFGIVLWELL 221
VD++S G + E+
Sbjct: 187 PVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-11
Identities = 32/95 (33%), Positives = 59/95 (62%), Gaps = 2/95 (2%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW 193
A +I G++++H++ +++RDLK N+LL E V+++D G++C S+ GT+ +
Sbjct: 103 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGY 161
Query: 194 MAPEMI-KEKRHTKKVDVYSFGIVLWELLTALTPF 227
MAPE++ K + D +S G +L++LL +PF
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 65/278 (23%), Positives = 105/278 (37%), Gaps = 78/278 (28%)
Query: 64 ASGRHSRIYRG--IYKQRDVAIKLVSQPEEDASL-ASMLEKQFTSEVALLFRL---NHPH 117
G + +Y+ + R VA+K V P + + S L E+ALL +L HP+
Sbjct: 8 GEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-----EIALLKQLESFEHPN 62
Query: 118 II----------TE------------------------PYSVPLNLVLKLALDIARGMQY 143
I+ T+ +P + L + RG+ +
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 144 LHSQGILHRDLKSENLLLGEDMCVKVADFGIS---CLESQCGSAKGFTGTYRWMAPEMIK 200
LHS I+HRDLK +N+L+ D VK+ADFG++ E S T YR APE++
Sbjct: 123 LHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVV-VTLWYR--APEVLL 179
Query: 201 EKRHTKKVDVYSFGIVLWEL--LTAL------------------TPFDNMTPEQAAF--- 237
+ + VD++S G + EL L P + P +
Sbjct: 180 QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS 239
Query: 238 AVCQKNARPP---VPPTCPKAFSYLISRCWSSSPDRRP 272
+ R VP C + L+ + + +P +R
Sbjct: 240 SFPSYTPRSFKSFVPEICEEGLD-LLKKMLTFNPHKRI 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 6e-11
Identities = 49/179 (27%), Positives = 84/179 (46%), Gaps = 35/179 (19%)
Query: 80 DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------------- 120
+VA+K +S+P ++ + A K+ E+ LL +NH +II+
Sbjct: 48 NVAVKKLSRPFQNQTHA----KRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYL 103
Query: 121 --EPYSVPLNLVLKLALDIAR----------GMQYLHSQGILHRDLKSENLLLGEDMCVK 168
E L V+ + LD R G+++LHS GI+HRDLK N+++ D +K
Sbjct: 104 VMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 163
Query: 169 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
+ DFG++ + T + APE+I + + VD++S G ++ EL+ F
Sbjct: 164 ILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-11
Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 59/215 (27%)
Query: 60 GCKFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH 115
GCK G + +Y+ K +++ A+K + + + E+ALL L H
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIE--------GTGISMSACREIALLRELKH 57
Query: 116 PHIIT--------------------------------------EPYSVPLNLVLKLALDI 137
P++I +P +P ++V L I
Sbjct: 58 PNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117
Query: 138 ARGMQYLHSQGILHRDLKSENLLL----GEDMCVKVADFGISCLESQ----CGSAKGFTG 189
G+ YLH+ +LHRDLK N+L+ E VK+AD G + L +
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 190 TYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTA 223
T+ + APE++ RH TK +D+++ G + ELLT+
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 34/111 (30%), Positives = 61/111 (54%), Gaps = 6/111 (5%)
Query: 123 YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 182
Y VP ++ + +HS G++HRD+K +N+LL + +K+ADFG + G
Sbjct: 137 YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196
Query: 183 SAKGFT--GTYRWMAPEMIKEK----RHTKKVDVYSFGIVLWELLTALTPF 227
+ T GT +++PE++K + + ++ D +S G+ L+E+L TPF
Sbjct: 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 35/115 (30%), Positives = 64/115 (55%), Gaps = 14/115 (12%)
Query: 123 YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES--- 179
Y VP ++ + +HS G +HRD+K +N+LL + +K+ADFG +C++
Sbjct: 137 YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG-TCMKMNKE 195
Query: 180 ---QCGSAKGFTGTYRWMAPEMIKEK----RHTKKVDVYSFGIVLWELLTALTPF 227
+C +A GT +++PE++K + + ++ D +S G+ L+E+L TPF
Sbjct: 196 GMVRCDTA---VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 32/95 (33%), Positives = 59/95 (62%), Gaps = 2/95 (2%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW 193
A +I G++++H++ +++RDLK N+LL E V+++D G++C S+ GT+ +
Sbjct: 103 ATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGY 161
Query: 194 MAPEMI-KEKRHTKKVDVYSFGIVLWELLTALTPF 227
MAPE++ K + D +S G +L++LL +PF
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 37/205 (18%)
Query: 62 KFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
K G ++ +Y+G K D VA+K + E+ + + + EV+LL L H +I+
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-----EVSLLKDLKHANIV 67
Query: 120 TEPYSV----PLNLV-------LKLALD-----------------IARGMQYLHSQGILH 151
T + L LV LK LD + RG+ Y H + +LH
Sbjct: 68 TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLH 127
Query: 152 RDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE--MIKEKRHTKKVD 209
RDLK +NLL+ E +K+ADFG++ +S W P ++ ++ ++D
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQID 187
Query: 210 VYSFGIVLWELLTALTPFDNMTPEQ 234
++ G + +E+ T F T E+
Sbjct: 188 MWGVGCIFYEMSTGRPLFPGSTVEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 29/97 (29%), Positives = 54/97 (55%)
Query: 125 VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 184
VP + + + RG+ +LHS ++HRDLK +N+L+ +K+ADFG++ + S +
Sbjct: 107 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL 166
Query: 185 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 221
T + APE++ + + VD++S G + E+
Sbjct: 167 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 41/119 (34%), Positives = 60/119 (50%), Gaps = 8/119 (6%)
Query: 140 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL----ESQCGSAKGFTGTYRWMA 195
G+ Y H + LHRD+K N+LL +K+ADFG++ L ES+ + K T YR
Sbjct: 128 GLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYR--P 185
Query: 196 PE-MIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 253
PE ++ E+R+ +DV+S G +L EL T P E A + + P P P
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGELFTK-KPIFQANQELAQLELISRLCGSPCPAVWP 243
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 42/188 (22%)
Query: 72 YRGIYKQRD------VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP--------- 116
Y ++K R+ VAIK + E+D +++K E+ +L +L HP
Sbjct: 14 YGVVFKCRNRETGQIVAIKKFVESEDDP----VIKKIALREIRMLKQLKHPNLVNLIEVF 69
Query: 117 ------HIITE-------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 157
H++ E P VP +L+ K+ + + + H +HRD+K E
Sbjct: 70 RRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPE 129
Query: 158 NLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWM-APEMI-KEKRHTKKVDVYSFG 214
N+L+ + +K+ DFG + L + T RW APE++ + ++ VDV++ G
Sbjct: 130 NILITKQGQIKLCDFGFARILTGPGDDYTDYVAT-RWYRAPELLVGDTQYGPPVDVWAIG 188
Query: 215 IVLWELLT 222
V ELLT
Sbjct: 189 CVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 5e-10
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 60/206 (29%)
Query: 62 KFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
K G + +Y+G K + VA+K + E+ + S + E++LL L HP+I+
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR----EISLLKELQHPNIV 62
Query: 120 ---------TEPYSV--PLNLVLKLALD-------------------IARGMQYLHSQGI 149
+ Y + L++ LK LD I +G+ + HS+ +
Sbjct: 63 CLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRV 122
Query: 150 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGF------------TGTYRWMAPE 197
LHRDLK +NLL+ +K+ADFG+ A+ F T YR APE
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGL---------ARAFGIPVRVYTHEVVTLWYR--APE 171
Query: 198 -MIKEKRHTKKVDVYSFGIVLWELLT 222
++ R++ VD++S G + E+ T
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-10
Identities = 54/194 (27%), Positives = 90/194 (46%), Gaps = 46/194 (23%)
Query: 72 YRGIYKQRD------VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITEPYSV 125
Y ++K ++ VA+K V ++D + S + E+ LL L H +I+ Y V
Sbjct: 13 YGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIV-RLYDV 67
Query: 126 -----PLNLV-------LKLALD-----------------IARGMQYLHSQGILHRDLKS 156
L LV LK D + +G+ + HS +LHRDLK
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKP 127
Query: 157 ENLLLGEDMCVKVADFGIS---CLESQCGSAKGFTGTYRWMAPE-MIKEKRHTKKVDVYS 212
+NLL+ ++ +K+ADFG++ + +C SA+ T YR P+ + K ++ +D++S
Sbjct: 128 QNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYR--PPDVLFGAKLYSTSIDMWS 185
Query: 213 FGIVLWELLTALTP 226
G + EL A P
Sbjct: 186 AGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 6e-10
Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 55/174 (31%)
Query: 96 ASMLEKQFTS--------EVALLFRLN-HPHIIT------EPYSVPLNLVLKLALD---- 136
++K F S E+ L RL+ HP+I+ + + L LV +L +D
Sbjct: 29 IKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL-MDMNLY 87
Query: 137 ---------------------IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175
+ + + ++H GI HRD+K EN+L+ +D +K+ADFG S
Sbjct: 88 ELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFG-S 145
Query: 176 CLESQCG--SAKGFTGTY---RWM-APE-MIKEKRHTKKVDVYSFGIVLWELLT 222
C G S +T Y RW APE ++ + + K+D+++ G V +E+L+
Sbjct: 146 C----RGIYSKPPYT-EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 7e-10
Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 9/114 (7%)
Query: 122 PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGISCLESQ 180
+P + + +G+ + H G++HRDLK +NLL+ + +K+AD G+ S
Sbjct: 104 GRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163
Query: 181 CGSAKGFTG---TYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLT--ALTPFD 228
K +T T + APE++ H + VD++S G + E+ L P D
Sbjct: 164 --PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 7e-10
Identities = 41/136 (30%), Positives = 64/136 (47%), Gaps = 17/136 (12%)
Query: 139 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYR------ 192
RG+ YLH G +HR++K+ ++L+ D V ++ G+S L S + + Y
Sbjct: 112 RGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFST 169
Query: 193 ----WMAPEMIKEKRH--TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 246
W++PE++++ + K D+YS GI EL T PF +M Q + QK P
Sbjct: 170 SVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ---MLLQKLKGP 226
Query: 247 PVPPTCPKAFSYLISR 262
P P F SR
Sbjct: 227 PYSPLDITTFPCEESR 242
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 8e-10
Identities = 44/202 (21%), Positives = 89/202 (44%), Gaps = 43/202 (21%)
Query: 62 KFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
K G ++ +Y+G + VA+K + E+ + ++ + E++L+ L H +I+
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-----EISLMKELKHENIV 61
Query: 120 T------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGI 149
++ N V + +G+ + H +
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV 121
Query: 150 LHRDLKSENLLLGEDMCVKVADFGIS---CLESQCGSAKGFTGTYRWMAPEMIKEKR-HT 205
LHRDLK +NLL+ + +K+ADFG++ + S + T YR AP+++ R ++
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYR--APDVLLGSRTYS 179
Query: 206 KKVDVYSFGIVLWELLTALTPF 227
+D++S G ++ E++T F
Sbjct: 180 TSIDIWSVGCIMAEMITGRPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 9e-10
Identities = 45/148 (30%), Positives = 69/148 (46%), Gaps = 41/148 (27%)
Query: 61 CKFASGRHSRIYRGIYK--QRDVAIKLVS-QPEEDASLASMLEKQFTS--EVALLFRLNH 115
K G ++ +Y+G K + VA+K + + EE A FT+ E +LL L H
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP--------FTAIREASLLKDLKH 62
Query: 116 PHIITEPYSV----PLNLV-------LKLALD-----------------IARGMQYLHSQ 147
+I+T + L LV LK +D + RG+ Y H +
Sbjct: 63 ANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR 122
Query: 148 GILHRDLKSENLLLGEDMCVKVADFGIS 175
+LHRDLK +NLL+ E +K+ADFG++
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 40/154 (25%), Positives = 75/154 (48%), Gaps = 12/154 (7%)
Query: 125 VPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGIS--CLESQC 181
+P ++ K+++ + +G+ YL + I+HRD+K N+L+ +K+ DFG+S ++S
Sbjct: 100 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158
Query: 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA---LTPFDNMTPEQAAFA 238
A F GT +M+PE ++ ++ + D++S G+ L E+ + P D E
Sbjct: 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGC 216
Query: 239 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 272
+ + P+ +S S PD RP
Sbjct: 217 PVEGDPAESETSPRPRPPGRPLS---SYGPDSRP 247
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 67/201 (33%)
Query: 72 YRGIYKQRD------VAIKLVSQPEEDASLASMLEKQFTS--EVALLFRLNHPHII---- 119
Y +YK RD VA+K + ED + S T+ E++LL LNHP+I+
Sbjct: 12 YGVVYKARDKLTGEIVALKKIRLETEDEGVPS------TAIREISLLKELNHPNIVRLLD 65
Query: 120 -----TEPYSV--PLNLVLKLALD------------------IARGMQYLHSQGILHRDL 154
+ Y V L+L LK +D + +G+ Y HS +LHRDL
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDL 125
Query: 155 KSENLLLGEDMCVKVADFGISCLESQCGSAKGF------------TGTYRWMAPEMIKEK 202
K +NLL+ + +K+ADFG+ A+ F T YR APE++
Sbjct: 126 KPQNLLIDREGALKLADFGL---------ARAFGVPVRTYTHEVVTLWYR--APEILLGS 174
Query: 203 RH-TKKVDVYSFGIVLWELLT 222
R + VD++S G + E++
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 51/180 (28%), Positives = 81/180 (45%), Gaps = 42/180 (23%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP------HIITEP--------YSV- 125
VAIK ++ E S A+ + + E+ LL L HP HI+ P Y V
Sbjct: 28 VAIKKINDVFEHVSDATRILR----EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83
Query: 126 -----PLNLVLKLALDIA------------RGMQYLHSQGILHRDLKSENLLLGEDMCVK 168
L+ V+K D+ R ++Y+H+ + HRDLK +N+L D +K
Sbjct: 84 ELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLK 143
Query: 169 VADFGISCLESQCGSAKGFTGTY---RWM-APEMIKE--KRHTKKVDVYSFGIVLWELLT 222
+ DFG++ + F Y RW APE+ ++T +D++S G + E+LT
Sbjct: 144 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 203
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 63/270 (23%), Positives = 114/270 (42%), Gaps = 74/270 (27%)
Query: 66 GRHSRIYRGIYKQRD--------------VAIKLVSQPEEDASLA-----SMLEKQFTSE 106
G ++IY GI +D V +K++ D SLA SM+ +
Sbjct: 6 GTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKH 65
Query: 107 VALLFRL---NHPHIITEPYSV--PLNLVL-------------KLALDIARGMQYLHSQG 148
+ LL+ + + +I+ E + PL+L + K+A +A + YL +
Sbjct: 66 IVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD 125
Query: 149 ILHRDLKSENLLLGEDMC-------VKVADFGI--------SCLESQCGSAKGFTGTYRW 193
++H ++ ++N+LL + +K++D GI C+E W
Sbjct: 126 LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVER-----------IPW 174
Query: 194 MAPEMIKEKRH-TKKVDVYSFGIVLWEL-LTALTPF-DNMTPEQAAF--AVCQKNARPPV 248
+APE +++ ++ + D +SFG LWE+ P D E+ F C V
Sbjct: 175 IAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCM-----LV 229
Query: 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQIV 278
P+C K + L++ C + P++RP F I+
Sbjct: 230 TPSC-KELADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 5e-09
Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 37/204 (18%)
Query: 62 KFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
K G ++ +++G K + VA+K + E+ + + + EV+LL L H +I+
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-----EVSLLKDLKHANIV 67
Query: 120 TEPYSV----PLNLV-------LKLALD-----------------IARGMQYLHSQGILH 151
T V L LV LK +D I RG+ Y H + +LH
Sbjct: 68 TLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLH 127
Query: 152 RDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE--MIKEKRHTKKVD 209
RDLK +NLL+ E +K+ADFG++ +S W P ++ ++ ++D
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQID 187
Query: 210 VYSFGIVLWELLTALTPFDNMTPE 233
++ G + +E+ + F T E
Sbjct: 188 MWGVGCIFFEMASGRPLFPGSTVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 6e-09
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 41/208 (19%)
Query: 62 KFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDA------SLASMLEKQFTSEVALL--- 110
K G ++ +Y+GI + VA+K++S E+ AS+L+ + + LL
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 111 --------FRLNHPHIITEPYSV-------PLNLVLKLALDIARGMQYLHSQGILHRDLK 155
F + H Y + P N+ L + RG+ Y+H Q ILHRDLK
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQHILHRDLK 130
Query: 156 SENLL---LGEDMCVKVADFGIS---CLESQCGSAKGFTGTYRWMAPE-MIKEKRHTKKV 208
+NLL LGE +K+ADFG++ + SQ S++ T YR P+ ++ ++ +
Sbjct: 131 PQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVVTLWYR--PPDVLLGATDYSSAL 185
Query: 209 DVYSFGIVLWELLTALTPFDNMT--PEQ 234
D++ G + E+L F ++ EQ
Sbjct: 186 DIWGAGCIFIEMLQGQPAFPGVSDVFEQ 213
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 37/202 (18%)
Query: 62 KFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
K G ++ +++G K + VA+K + E+ + + + EV+LL L H +I+
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-----EVSLLKNLKHANIV 66
Query: 120 TEPYSV----PLNLV-------LKLALD-----------------IARGMQYLHSQGILH 151
T + L LV LK LD + RG+ Y H + ILH
Sbjct: 67 TLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILH 126
Query: 152 RDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE--MIKEKRHTKKVD 209
RDLK +NLL+ E +K+ADFG++ +S W P ++ ++ +D
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPID 186
Query: 210 VYSFGIVLWELLTALTPFDNMT 231
++ G +L+E+ T F T
Sbjct: 187 MWGVGCILYEMATGRPMFPGST 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 4/137 (2%)
Query: 122 PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181
P VP V + + + + H I+HRD+K ENLL+ + +K+ DFG + S+
Sbjct: 94 PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153
Query: 182 GSAK--GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV 239
+A + T + +PE++ + K VD++S G +L EL F + F +
Sbjct: 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213
Query: 240 CQKNARPPVPPTCPKAF 256
+ P+P K F
Sbjct: 214 --QKVLGPLPAEQMKLF 228
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 45/196 (22%), Positives = 86/196 (43%), Gaps = 27/196 (13%)
Query: 62 KFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDAS------LASMLEKQFTSEVALLFRL 113
K G ++ +Y+G K + VA+K++ EE+ + AS+L+ + + LL +
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 114 NHP-----------------HIITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKS 156
H ++ P + V + RG+ Y+H + ILHRDLK
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKP 131
Query: 157 ENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE--MIKEKRHTKKVDVYSFG 214
+NLL+ + +K+ADFG++ +S W P ++ ++ +D++ G
Sbjct: 132 QNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVG 191
Query: 215 IVLWELLTALTPFDNM 230
+ E++ + F M
Sbjct: 192 CIFVEMIQGVAAFPGM 207
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 34/110 (30%), Positives = 57/110 (51%), Gaps = 20/110 (18%)
Query: 123 YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVADFGISCLESQC 181
+++PL LV + + R + Y+HS+ I HRDLK +NLL+ + +K+ DF
Sbjct: 165 HALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF--------- 215
Query: 182 GSAKGFTGTYR---------WMAPE-MIKEKRHTKKVDVYSFGIVLWELL 221
GSAK R + APE M+ +T +D++S G ++ E++
Sbjct: 216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 28/89 (31%), Positives = 52/89 (58%), Gaps = 6/89 (6%)
Query: 140 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG--FTG---TYRWM 194
G+ Y+H ILHRD+K+ N+L+ +D +K+ADFG++ S ++K +T T +
Sbjct: 131 GLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 195 APEMIKEKRH-TKKVDVYSFGIVLWELLT 222
PE++ +R +D++ G ++ E+ T
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 51/231 (22%), Positives = 83/231 (35%), Gaps = 79/231 (34%)
Query: 140 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI------------------------- 174
++ +H G +HRD+K +N+L+ D +K+ DFG+
Sbjct: 113 AVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMD 172
Query: 175 ---------SCLESQCGS-----------------AKGFTGTYRWMAPEMIKEKRHTKKV 208
+C +CG A GT ++APE++ +T+
Sbjct: 173 FSNEWGDPANC---RCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 229
Query: 209 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTC---PKAFSYLISRCWS 265
D +S G++L+E+L PF TP + V +PP P+A +I C
Sbjct: 230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-- 287
Query: 266 SSPDRR------------PHFDQIVSILEGYSESLEQDPEFFSSFIPSPDH 304
P+ R P F I +S L Q + +IP H
Sbjct: 288 RGPEDRLGKNGADEIKAHPFFKTI-----DFSSDLRQQS---APYIPKITH 330
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 5e-08
Identities = 28/102 (27%), Positives = 49/102 (48%), Gaps = 4/102 (3%)
Query: 129 LVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC-VKVADFGISCLESQCGSAKGF 187
V K+ + + LH I+H D+K EN+L + + D+G+ + G+ +
Sbjct: 110 EVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII---GTPSCY 166
Query: 188 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 229
GT + +PE IK + D ++ G++ +ELLT PF
Sbjct: 167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208
|
Length = 267 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 57/192 (29%), Positives = 87/192 (45%), Gaps = 48/192 (25%)
Query: 72 YRGIYKQRD------VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII------ 119
Y +YK RD +A+K + +ED + S + E++LL + H +I+
Sbjct: 15 YGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR----EISLLKEMQHGNIVRLQDVV 70
Query: 120 ---TEPYSV--PLNLVLKLALD------------------IARGMQYLHSQGILHRDLKS 156
Y V L+L LK +D I RG+ Y HS +LHRDLK
Sbjct: 71 HSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKP 130
Query: 157 ENLLLGEDM-CVKVADFGISCLESQCG-SAKGFTG---TYRWMAPEMIKEKRH-TKKVDV 210
+NLL+ +K+ADFG L G + FT T + APE++ RH + VD+
Sbjct: 131 QNLLIDRRTNALKLADFG---LARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDI 187
Query: 211 YSFGIVLWELLT 222
+S G + E++
Sbjct: 188 WSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 7e-08
Identities = 26/92 (28%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 144 LHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS--AKGFTGTYRWMAPEMIK- 200
+H G +HRD+K EN+L+ +K+ADFG + + +K GT ++APE++
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177
Query: 201 -----EKRHTKKVDVYSFGIVLWELLTALTPF 227
+ + + D +S G++ +E++ +PF
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 40/164 (24%), Positives = 73/164 (44%), Gaps = 16/164 (9%)
Query: 125 VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL--------GEDMCVKVADFGISC 176
+ ++ L++A +A + +L +G+ H ++ ++N+LL G +K++D GIS
Sbjct: 97 INISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156
Query: 177 LESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALT-PFDNMTPEQ 234
+ W+ PE I+ ++ + D +SFG LWE+ + P + Q
Sbjct: 157 ---TVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-Q 212
Query: 235 AAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 278
+ + P P A LI++C PD RP F I+
Sbjct: 213 KKLQFYEDRHQLPAPKWTELAN--LINQCMDYEPDFRPSFRAII 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 40/182 (21%), Positives = 70/182 (38%), Gaps = 51/182 (28%)
Query: 136 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI--------------------- 174
++ ++ +H G +HRD+K +N+L+ D +K+ DFG+
Sbjct: 109 ELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQ 168
Query: 175 ----------SCLESQCGS-----------------AKGFTGTYRWMAPEMIKEKRHTKK 207
+CG A GT ++APE++ K +T+
Sbjct: 169 DSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL 228
Query: 208 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT---CPKAFSYLISRCW 264
D +S G++L+E+L PF TP + V +PP P+A + C
Sbjct: 229 CDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCC 288
Query: 265 SS 266
S+
Sbjct: 289 SA 290
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 36/146 (24%), Positives = 59/146 (40%), Gaps = 36/146 (24%)
Query: 144 LHSQGILHRDLKSENLLLGEDMCVKVADFGISC-----------------------LESQ 180
+H G +HRD+K +NLLL VK++DFG+ ++
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 181 CGSAKGFT-------------GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
K T GT ++APE+ + + K D +S G++++E+L PF
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 228 DNMTPEQAAFAVCQKNARPPVPPTCP 253
+ TP++ V PP P
Sbjct: 237 CSETPQETYKKVMNWKETLIFPPEVP 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 33/112 (29%), Positives = 63/112 (56%), Gaps = 17/112 (15%)
Query: 132 KLALDIAR--------GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE-SQCG 182
+L D+AR + +H +HRD+K +N+LL + +++ADFG SCL+ +Q G
Sbjct: 98 RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDG 156
Query: 183 SAKG--FTGTYRWMAPEMIKEK-----RHTKKVDVYSFGIVLWELLTALTPF 227
+ + GT +++PE+++ ++ + D +S G+ ++E+L TPF
Sbjct: 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 31/94 (32%), Positives = 55/94 (58%), Gaps = 13/94 (13%)
Query: 144 LHSQGILHRDLKSENLLLGEDMC--VKVADFGISCLE-SQCGSAKGF--TGTYRWMAPEM 198
+H G +HRD+K +N+LL D +++ADFG SCL G+ + GT +++PE+
Sbjct: 118 VHQLGYVHRDIKPDNVLL--DKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 199 IK-----EKRHTKKVDVYSFGIVLWELLTALTPF 227
++ + R+ + D +S G+ ++E+L TPF
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-07
Identities = 37/148 (25%), Positives = 57/148 (38%), Gaps = 20/148 (13%)
Query: 133 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYR 192
+ L ++ LH Q KS N+LL D +K+ G S + + Y
Sbjct: 22 VCLQCLGALRELHRQA------KSGNILLTWDGLLKL--DG-SV--AFKTPEQSRPDPY- 69
Query: 193 WMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTC 252
+MAPE+I+ + +T+K D+YS GI L+E L P++ A + P
Sbjct: 70 FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDR 129
Query: 253 PKAFSYL--------ISRCWSSSPDRRP 272
+ C S P RR
Sbjct: 130 SNLEGVSAARSFEDFMRLCASRLPQRRE 157
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 37/146 (25%), Positives = 60/146 (41%), Gaps = 36/146 (24%)
Query: 144 LHSQGILHRDLKSENLLLGEDMCVKVADFGI---------------------SCLESQCG 182
+H G +HRD+K +NLLL VK++DFG+ S Q
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 183 SAK---------------GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
++K GT ++APE+ + + K D +S G++++E+L PF
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 228 DNMTPEQAAFAVCQKNARPPVPPTCP 253
+ TP++ V PP P
Sbjct: 237 CSETPQETYRKVMNWKETLVFPPEVP 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 32/137 (23%), Positives = 55/137 (40%), Gaps = 46/137 (33%)
Query: 141 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL----------------------- 177
++ +H G +HRD+K +N+L+ D +K+ DFG+ C
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL-CTGFRWTHDSKYYQKGDHHRQDSME 172
Query: 178 -------ESQCG---------------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGI 215
+C A GT ++APE++ +T+ D +S G+
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232
Query: 216 VLWELLTALTPFDNMTP 232
+L+E+L PF TP
Sbjct: 233 ILYEMLVGQPPFLADTP 249
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 9e-07
Identities = 29/109 (26%), Positives = 49/109 (44%), Gaps = 10/109 (9%)
Query: 136 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC--------LESQCGSAKGF 187
D+ + Y+HS+G +HR +K+ ++LL D V ++ S K
Sbjct: 109 DVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168
Query: 188 TGTYRWMAPEMIKEKRH--TKKVDVYSFGIVLWELLTALTPFDNMTPEQ 234
W++PE++++ +K D+YS GI EL PF +M Q
Sbjct: 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 9e-07
Identities = 37/144 (25%), Positives = 69/144 (47%), Gaps = 19/144 (13%)
Query: 141 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK--GFTGTYRWMAPEM 198
++Y+H + ++HRD+K EN+ L D + + DFG + + A G+ GT +PE+
Sbjct: 280 VEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEI 339
Query: 199 IKEKRHTKKVDVYSFGIVLWELLTA-LTPFDNMT--PEQA------AFAVCQKNARPPVP 249
+ + + D++S G++L ++L+ P + P + + +VC + P P
Sbjct: 340 LAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEF--PDP 397
Query: 250 PTCPKAFSYLISRCWSSSPDRRPH 273
P K F Y+ S+ D H
Sbjct: 398 PC--KLFDYI----DSAEIDHAGH 415
|
Length = 501 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 9e-07
Identities = 31/112 (27%), Positives = 60/112 (53%), Gaps = 17/112 (15%)
Query: 132 KLALDIAR--------GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL---ESQ 180
+L D+AR + +H +HRD+K +N+L+ + +++ADFG SCL E
Sbjct: 98 RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDG 156
Query: 181 CGSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPF 227
+ GT +++PE+++ + ++ + D +S G+ ++E+L TPF
Sbjct: 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 38/134 (28%), Positives = 62/134 (46%), Gaps = 10/134 (7%)
Query: 99 LEKQFTSEVALLFRLNHPH------IITEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 152
L K SE ++ L H I++ ++P V + A ++ + LH +GI+ R
Sbjct: 50 LHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCR 109
Query: 153 DLKSENLLLGEDMCVKVADFG-ISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVY 211
DL N+LL + +++ F S +E C + Y APE+ T+ D +
Sbjct: 110 DLNPNNILLDDRGHIQLTYFSRWSEVEDSCDG-EAVENMY--CAPEVGGISEETEACDWW 166
Query: 212 SFGIVLWELLTALT 225
S G +L+ELLT T
Sbjct: 167 SLGAILFELLTGKT 180
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 34/118 (28%), Positives = 53/118 (44%), Gaps = 28/118 (23%)
Query: 135 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG------------ 182
L I G+ LH +HRDL N+ + K+ADFG++ + G
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA---RRYGYPPYSDTLSKDE 182
Query: 183 --------SAKGFTGTYRWMAPEMI-KEKRHTKKVDVYSFGIVLWELLT--ALTPFDN 229
++K T YR APE++ +++ VD++S G + ELLT L P +N
Sbjct: 183 TMQRREEMTSKVVTLWYR--APELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
|
Length = 335 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 19/45 (42%), Positives = 31/45 (68%)
Query: 131 LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175
+K ++A + YLH GI+HRDLK +N+L+ + +K+ DFG+S
Sbjct: 107 VKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 47/172 (27%), Positives = 78/172 (45%), Gaps = 33/172 (19%)
Query: 125 VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL-------GEDMCVKVADFGISCL 177
VP+ + +A +A + YL + ++H ++ ++N+LL G +K++D G+S
Sbjct: 114 VPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-- 171
Query: 178 ESQCGSAKGFTGTYR--------WMAPEMIKEKRH-TKKVDVYSFGIVLWEL-LTALTPF 227
FT R W+APE + + D +SFG L E+ P
Sbjct: 172 ---------FTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPL 222
Query: 228 DNMTP-EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 278
TP E+ F +K R P P+C + + LIS+C + P +RP F I+
Sbjct: 223 KERTPSEKERFY--EKKHRLP-EPSCKE-LATLISQCLTYEPTQRPSFRTIL 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 31/104 (29%), Positives = 60/104 (57%), Gaps = 15/104 (14%)
Query: 132 KLALDIARGMQYLH---SQGILHRDLKSENLLL-GED---MCVKVADFGISCLESQCGSA 184
K+A+ IA+ +++LH S ++ +L E +++ G+D + + + G+ C +++C +
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLP--GLLCTDTKCFIS 841
Query: 185 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 228
+ +APE + K T+K D+Y FG++L ELLT +P D
Sbjct: 842 SAY------VAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 10/96 (10%)
Query: 85 LVSQPEEDASLASMLEKQFTSEVALL--FRLNHPHIITEPYSVP-----LNLVLKLALDI 137
LV + E DA+L L+ + L F + I P ++P +N++ + +
Sbjct: 262 LVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKI---PDNMPQDKRDINVIKGVMRQV 318
Query: 138 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 173
G++ LH GI+HRD+K ENLL+ D VK+ DFG
Sbjct: 319 LTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 33/138 (23%), Positives = 58/138 (42%), Gaps = 43/138 (31%)
Query: 144 LHSQGILHRDLKSENLLLGEDMCVKVADFG----------------------------IS 175
+H G +HRD+K +NLLL +K++DFG IS
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176
Query: 176 CLESQCGSAKGF-----------TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTAL 224
S A+ + GT ++APE+ + + K+ D +S G++++E+L
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236
Query: 225 TPFDNMTPEQAAFAVCQK 242
PF + P++ +K
Sbjct: 237 PPFCSDNPQET----YRK 250
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 8e-05
Identities = 19/46 (41%), Positives = 31/46 (67%)
Query: 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 234
GT ++APE++ K H VD ++ G+ L+E LT + PF++ TP+Q
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQ 587
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 1e-04
Identities = 41/171 (23%), Positives = 71/171 (41%), Gaps = 37/171 (21%)
Query: 135 LDIAR----GMQYLHS-------QGILHRDLKSENLLLGEDM-----------------C 166
+DI R + Y H+ + +LHRDLK +N+ L +
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 167 VKVADFGIS---CLESQCGSAKGFTGTYRWMAPEMI--KEKRHTKKVDVYSFGIVLWELL 221
K+ DFG+S +ES S GT + +PE++ + K + K D+++ G +++EL
Sbjct: 181 AKIGDFGLSKNIGIESMAHSC---VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 222 TALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 272
+ TPF + ++ P+ K + LI + S RP
Sbjct: 238 SGKTPFHKANNFSQLISELKRGPDLPIKGK-SKELNILIKNLLNLSAKERP 287
|
Length = 1021 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 28/112 (25%), Positives = 49/112 (43%), Gaps = 14/112 (12%)
Query: 135 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA---------- 184
+ + + Y+H G +HR +K+ ++L+ D KV G+ S
Sbjct: 108 QGVLKALDYIHHMGYVHRSVKASHILISVDG--KVYLSGLRSNLSMINHGQRLRVVHDFP 165
Query: 185 KGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 234
K W++PE++++ + + K D+YS GI EL PF +M Q
Sbjct: 166 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 332 | |||
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.62 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.61 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.4 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.24 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.19 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.16 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.14 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.14 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.1 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.04 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.99 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.82 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.8 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.78 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.74 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.66 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.61 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.6 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.56 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.39 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.36 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.32 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.01 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.82 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.81 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.81 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.74 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.7 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.59 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.34 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.97 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.94 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.91 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.84 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.79 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.76 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 96.72 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.72 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.67 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.51 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.44 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.39 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.81 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 95.4 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.37 | |
| PLN02236 | 344 | choline kinase | 94.87 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 94.84 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.81 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.81 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.51 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 94.44 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.42 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.4 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.86 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.33 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.03 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.78 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 92.66 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 92.56 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 92.53 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 92.11 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 91.85 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 91.75 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 91.7 | |
| PTZ00296 | 442 | choline kinase; Provisional | 90.26 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 90.23 |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-49 Score=361.95 Aligned_cols=242 Identities=45% Similarity=0.785 Sum_probs=220.9
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEEECCee-EEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~-vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
....|.++..++.+.+.||+|+||+||+|.+.|+. ||||++......... .+.|.+|+.+|.+++|||||.
T Consensus 32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~----~~~f~~E~~il~~l~HpNIV~f~G~ 107 (362)
T KOG0192|consen 32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES----RKAFRREASLLSRLRHPNIVQFYGA 107 (362)
T ss_pred cccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH----HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 34679999999999999999999999999999988 999999886554432 578999999999999999987
Q ss_pred -------------------------C--CCCCCHHHHHHHHHHHHHHHHHHHHCC-CccccccccceeecCCC-eEEEee
Q 020016 121 -------------------------E--PYSVPLNLVLKLALDIARGMQYLHSQG-ILHRDLKSENLLLGEDM-CVKVAD 171 (332)
Q Consensus 121 -------------------------~--~~~l~~~~~~~i~~qi~~~L~~LH~~~-iiH~dlkp~NIll~~~~-~~kl~D 171 (332)
. ...+++..++.++.||+.||.|||+++ ||||||||+|||++.++ ++||+|
T Consensus 108 ~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~D 187 (362)
T KOG0192|consen 108 CTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIAD 187 (362)
T ss_pred EcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECC
Confidence 2 578999999999999999999999999 99999999999999997 999999
Q ss_pred cccccccccC-CCCCCcccccccCChhhhh--cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 020016 172 FGISCLESQC-GSAKGFTGTYRWMAPEMIK--EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 248 (332)
Q Consensus 172 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (332)
||+++..... .......||+.|||||++. ...|+.++||||||+++|||+||+.||.+..+.+....+.....++.+
T Consensus 188 FGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~ 267 (362)
T KOG0192|consen 188 FGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI 267 (362)
T ss_pred CccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 9999876654 3444578999999999999 568999999999999999999999999999998888899889999999
Q ss_pred CCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 020016 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 291 (332)
Q Consensus 249 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~ 291 (332)
|..+++.+..||..||..||..||++.+++..|+.+.......
T Consensus 268 p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~ 310 (362)
T KOG0192|consen 268 PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA 310 (362)
T ss_pred CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence 9999999999999999999999999999999999998877753
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=355.10 Aligned_cols=220 Identities=27% Similarity=0.440 Sum_probs=199.5
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
..|..++.||.|||++||++++. |+.||+|++.+..... ....+.+.+|+++.++|+|||||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k---~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVY 94 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK---PKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVY 94 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC---cchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceE
Confidence 57999999999999999999993 8999999998843221 223577899999999999999997
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-CC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GS 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~ 183 (332)
..++++|.+++.+++||+.||.|||+++|+|||||..|+|++++.++||+|||+|...... ..
T Consensus 95 ivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 5689999999999999999999999999999999999999999999999999999887754 67
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHc
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 263 (332)
..+.+|||.|+|||++.....+..+||||+||+||-||+|++||...+-.+....+. ...-.+|..++.+.++||.++
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik--~~~Y~~P~~ls~~A~dLI~~l 252 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK--LNEYSMPSHLSAEAKDLIRKL 252 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH--hcCcccccccCHHHHHHHHHH
Confidence 788999999999999999999999999999999999999999999988888877774 445567779999999999999
Q ss_pred cccCCCCCCCHHHHHH
Q 020016 264 WSSSPDRRPHFDQIVS 279 (332)
Q Consensus 264 l~~dp~~Rps~~ell~ 279 (332)
|+.||.+|||+++|+.
T Consensus 253 L~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 253 LRPNPSERPSLDEVLD 268 (592)
T ss_pred hcCCcccCCCHHHHhc
Confidence 9999999999999986
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=351.33 Aligned_cols=235 Identities=30% Similarity=0.608 Sum_probs=211.9
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEEECCe-eEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQR-DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~-~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
..+.|+++.+.+++.+.||+|.||.||.|.+++. +||+|.+...... .++|.+|+++|++|+|+|||+
T Consensus 197 ~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~-------~~~f~~Ea~iMk~L~H~~lV~l~gV 269 (468)
T KOG0197|consen 197 ARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS-------PEAFLREAQIMKKLRHEKLVKLYGV 269 (468)
T ss_pred ccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC-------hhHHHHHHHHHHhCcccCeEEEEEE
Confidence 3788999999999999999999999999999965 9999999875433 367999999999999999997
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+...+.+.++.||++|++||+++++|||||.++||||+++..+||+|||+
T Consensus 270 ~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGL 349 (468)
T KOG0197|consen 270 CTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGL 349 (468)
T ss_pred EecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccc
Confidence 356788999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC--CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 020016 175 SCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 251 (332)
Q Consensus 175 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (332)
++...+.. .......+..|.|||.+..+.++.+||||||||+||||+| |+.||.+++..+....+ ..+.+.+.|..
T Consensus 350 Ar~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l-e~GyRlp~P~~ 428 (468)
T KOG0197|consen 350 ARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL-ERGYRLPRPEG 428 (468)
T ss_pred ccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH-hccCcCCCCCC
Confidence 99544332 2234456789999999999999999999999999999999 99999999999988776 57889999999
Q ss_pred CcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 020016 252 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 288 (332)
Q Consensus 252 ~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 288 (332)
||+++.++|..||+.+|++|||++.+...|+++...-
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 9999999999999999999999999999999886543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=330.02 Aligned_cols=222 Identities=29% Similarity=0.447 Sum_probs=196.2
Q ss_pred ccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
.+..+++..++.||+|..|+||+++++ ++.+|+|++....... ..+++.+|+++++..+||+||.
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~-----~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPA-----LQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHH-----HHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 344568888999999999999999998 8899999995543332 3688999999999999999997
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
..+.+++.....++.++++||.|||. ++|+||||||+|||++..|.+||||||.+...
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 33568999999999999999999995 89999999999999999999999999999877
Q ss_pred ccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcCCCCCCCCC-C
Q 020016 179 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM-----TPEQAAFAVCQKNARPPVPPT-C 252 (332)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~-~ 252 (332)
.+. ...+++||..|||||.+.+..|+.++||||||++++|+++|+.||... ...+....+. ....+.+|.. +
T Consensus 230 vnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~~~f 307 (364)
T KOG0581|consen 230 VNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPEGEF 307 (364)
T ss_pred hhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCcccC
Confidence 665 567899999999999999999999999999999999999999999874 5556666665 4556677776 9
Q ss_pred cHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 253 PKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
++++++|+..||++||.+||++.++++
T Consensus 308 S~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 308 SPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 999999999999999999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=348.17 Aligned_cols=241 Identities=36% Similarity=0.652 Sum_probs=208.1
Q ss_pred cCCCccccccccCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--
Q 020016 43 KGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120 (332)
Q Consensus 43 ~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-- 120 (332)
......+|+|..++..++..||+|.||+||+|.|.| +||||++........ ..+.|++|+.++++-+|.||+-
T Consensus 380 ~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~----qlqaFKnEVa~lkkTRH~NIlLFM 454 (678)
T KOG0193|consen 380 ASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPE----QLQAFKNEVAVLKKTRHENILLFM 454 (678)
T ss_pred CCccccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHH----HHHHHHHHHHHHhhcchhhheeee
Confidence 334568999999999999999999999999999977 689999988655543 3588999999999999999975
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....++....+.|+.||++|+.|||.++|||+|||..|||+.+++.|||+|||+
T Consensus 455 G~~~~p~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 455 GACMNPPLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred hhhcCCceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccc
Confidence 345788899999999999999999999999999999999999999999999999
Q ss_pred ccccccC---CCCCCcccccccCChhhhhc---CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-
Q 020016 175 SCLESQC---GSAKGFTGTYRWMAPEMIKE---KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP- 247 (332)
Q Consensus 175 a~~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~- 247 (332)
+...... .......|...|||||+++. .+|+..+||||||+++|||+||..||.....+++.+.+..+...+.
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~ 614 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL 614 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc
Confidence 8654332 22345568899999999974 4689999999999999999999999998788888887766644443
Q ss_pred --CCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 020016 248 --VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 288 (332)
Q Consensus 248 --~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 288 (332)
...+++.++++|+..||.+++++||.+.+|+..|+.+..++
T Consensus 615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 615 SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 34677889999999999999999999999999999887754
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=319.69 Aligned_cols=225 Identities=27% Similarity=0.423 Sum_probs=195.0
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
..+|+|.++||.|.||+||++.+. |..||.|.+.-...+ ....++...|+.+|++|+|||||+
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md----~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMD----AKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhcc----HHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 468999999999999999999886 889999998853332 333688999999999999999997
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHH--CC--CccccccccceeecCCCeEEEeecc
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHS--QG--ILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~--~~--iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
....+++..+|+++.|++.||..+|+ .. |+||||||.||+++.+|.+||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 56678999999999999999999999 44 9999999999999999999999999
Q ss_pred cccccccCC-CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-CC
Q 020016 174 ISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP-PT 251 (332)
Q Consensus 174 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~-~~ 251 (332)
+++.+.... .....+|||.||+||.+.+.+|+.++||||+||++|||+.-..||.+.+-.+....+... ..+++| ..
T Consensus 174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~p~~~ 252 (375)
T KOG0591|consen 174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPLPDEH 252 (375)
T ss_pred hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCCcHHH
Confidence 998876543 345789999999999999999999999999999999999999999998777777777654 444455 77
Q ss_pred CcHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 020016 252 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 283 (332)
Q Consensus 252 ~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~ 283 (332)
+|.++..||..|+.+||+.||+...++..+..
T Consensus 253 YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 253 YSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred hhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 89999999999999999999986555544443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-46 Score=318.23 Aligned_cols=221 Identities=25% Similarity=0.411 Sum_probs=192.6
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|....++|+|+||.||+++++ |+.||||+|..+..+.. +.+-.++|+.+|++|.|||+|.
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~----VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklh 77 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPV----VKKIALREIRMLKQLKHENLVNLIEVFRRKRKLH 77 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHH----HHHHHHHHHHHHHhcccchHHHHHHHHHhcceeE
Confidence 57888999999999999999997 89999999988766543 3566789999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc-cCCC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES-QCGS 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~-~~~~ 183 (332)
.+..++.+.+.++++|++.|+.|||+++++||||||+||||+.+|.+||||||+|+... +...
T Consensus 78 LVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 78 LVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred EEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 56788999999999999999999999999999999999999999999999999999877 5555
Q ss_pred CCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----------------
Q 020016 184 AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR----------------- 245 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~----------------- 245 (332)
.+.++.|..|.|||.+.+ ..|+..+|||++||++.||++|.+.|++.++-+..+.+......
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 667889999999999987 68999999999999999999999999999888877766542111
Q ss_pred --CCCC----------CCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 246 --PPVP----------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 246 --~~~~----------~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+.+ +.++..+.+|+..||+.||++|++.++++.
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111 234567889999999999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=332.75 Aligned_cols=226 Identities=27% Similarity=0.415 Sum_probs=190.7
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHH-HHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLA-SMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
.+.|.+.+.||+|+||.|-+|..+ ++.||||++++........ ..-...+.+|+++|++|+|||||+
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 467999999999999999999886 8999999998865443221 111233579999999999999997
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC---CeEEEeecccccccc
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED---MCVKVADFGISCLES 179 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~---~~~kl~Dfg~a~~~~ 179 (332)
..+.+.+.....+++|++.|+.|||++||+||||||+|||+..+ -.+||+|||+|....
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g 330 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG 330 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc
Confidence 56778899999999999999999999999999999999999765 789999999999988
Q ss_pred cCCCCCCcccccccCChhhhhcCCC---CCccchhHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCC--CCCCCCCCc
Q 020016 180 QCGSAKGFTGTYRWMAPEMIKEKRH---TKKVDVYSFGIVLWELLTALTPFDNMTPEQ-AAFAVCQKNA--RPPVPPTCP 253 (332)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwSlG~il~elltG~~pf~~~~~~~-~~~~~~~~~~--~~~~~~~~~ 253 (332)
......+.|||+.|.|||++.+..+ ..++|+||+||++|-+++|.+||.+..... ...++..+.. .+.....++
T Consensus 331 ~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Is 410 (475)
T KOG0615|consen 331 EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRIS 410 (475)
T ss_pred cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhh
Confidence 8788899999999999999987654 458899999999999999999998866555 4445543322 223446789
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 254 KAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 254 ~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+..+||.+||..||++||+++|+++
T Consensus 411 eea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 411 EEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 99999999999999999999999986
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=322.45 Aligned_cols=217 Identities=25% Similarity=0.374 Sum_probs=191.2
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
+..++|.+.+.||.|+||+||.++.+ ++.+|+|++++..-... ...+....|..+|..++||.||+
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~---~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~ 98 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK---KEVRHTKAERNILSKIKHPFIVKLIYSFQTEE 98 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh---hhHHHHHHHHHHHHhCCCCcEeeeEEecccCC
Confidence 34689999999999999999999886 78999999988543322 22466889999999999999997
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc-cc
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE-SQ 180 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~-~~ 180 (332)
..+.+++..++-++.+|+.||.|||++||+||||||+|||+|.+|+++|+|||++... ..
T Consensus 99 kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 5678999999999999999999999999999999999999999999999999999854 33
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 260 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 260 (332)
......++||+.|||||++.+..|+.++|+||||+++|||++|.+||.+.+.......+.... .+..|..++.+.++++
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~ardll 257 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEEARDLL 257 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHHHHHHH
Confidence 445667899999999999999999999999999999999999999999999888877775433 3555666999999999
Q ss_pred HHccccCCCCCC
Q 020016 261 SRCWSSSPDRRP 272 (332)
Q Consensus 261 ~~cl~~dp~~Rp 272 (332)
.++|..||++|.
T Consensus 258 ~~LL~rdp~~RL 269 (357)
T KOG0598|consen 258 KKLLKRDPRQRL 269 (357)
T ss_pred HHHhccCHHHhc
Confidence 999999999995
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=319.10 Aligned_cols=222 Identities=28% Similarity=0.491 Sum_probs=193.5
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
..+|.+.+.||+|+||+||+|+++ +..||||.+...... ....+.+..|+.+|+.++|||||.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~----~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN----KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI 84 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC----HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence 478999999999999999999997 789999999886422 223567889999999999999997
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC------CeEEEeecccccc
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED------MCVKVADFGISCL 177 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~------~~~kl~Dfg~a~~ 177 (332)
..+.+++..++.++.||+.||++||+++|+||||||+|||++.. -.+||+|||+|+.
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 45689999999999999999999999999999999999999765 4689999999999
Q ss_pred cccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHH
Q 020016 178 ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAF 256 (332)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 256 (332)
........+.+|++-|||||+++...|+.|+|+||+|+++|++++|+.||...+..+....+..... .+.++..++..+
T Consensus 165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~ 244 (429)
T KOG0595|consen 165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPL 244 (429)
T ss_pred CCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCch
Confidence 9887778889999999999999999999999999999999999999999999999988876654433 334455667778
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+++...++.+|..|.++.+-..
T Consensus 245 ~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 245 RELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred hhhhhHHHhcCccccCchHHhhh
Confidence 89999999999999987765543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=334.90 Aligned_cols=238 Identities=37% Similarity=0.639 Sum_probs=218.0
Q ss_pred cccCCCccccccccCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec
Q 020016 41 EIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120 (332)
Q Consensus 41 ~~~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 120 (332)
+.+....+.|+|+++.+.-++.||+|+.|.||+|+.+++.||||+++. .-..+++-|++|+|||||.
T Consensus 110 e~k~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~e-------------lkETdIKHLRkLkH~NII~ 176 (904)
T KOG4721|consen 110 EHKQQQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRE-------------LKETDIKHLRKLKHPNIIT 176 (904)
T ss_pred ehhhhhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhh-------------hhhhhHHHHHhccCcceee
Confidence 455567789999999999999999999999999999999999999754 2235889999999999986
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeec
Q 020016 121 ----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 172 (332)
Q Consensus 121 ----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Df 172 (332)
....+.......|..+|+.|+.|||.+.|||||||.-||||..+..|||+||
T Consensus 177 FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDF 256 (904)
T KOG4721|consen 177 FKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDF 256 (904)
T ss_pred EeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccc
Confidence 5667899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 020016 173 GISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTC 252 (332)
Q Consensus 173 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (332)
|.++......+...+.||..|||||+++..+.+.|+|||||||+|||||||..||...+...+.+.+....+..+.|..+
T Consensus 257 GTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstc 336 (904)
T KOG4721|consen 257 GTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTC 336 (904)
T ss_pred cchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccC
Confidence 99988777667778999999999999999999999999999999999999999999999988888888888889999999
Q ss_pred cHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 020016 253 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 291 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~ 291 (332)
++.++-||+.||+-.|.+||++.+++..|+-+...+-.-
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~ 375 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLST 375 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcc
Confidence 999999999999999999999999999998776655433
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=323.14 Aligned_cols=222 Identities=25% Similarity=0.380 Sum_probs=195.2
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCceec----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIIT---------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~---------- 120 (332)
.++|++.++||.|+||.||+|... +..||||.++.....-.. -.=.+|+..|++|+ |||||+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-----~~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-----CMNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-----HHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 578999999999999999999886 789999999876544221 22368999999999 999997
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
.+..+++..+..|++||++||+|+|.+|+.|||+||+|||+..+..+||+|||+|+.....
T Consensus 84 ~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 84 ILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence 6778999999999999999999999999999999999999999999999999999988877
Q ss_pred CCCCCcccccccCChhhh-hcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-------------
Q 020016 182 GSAKGFTGTYRWMAPEMI-KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------------- 247 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~------------- 247 (332)
...+.++.|..|.|||++ +.+.|+.+.|+|++|||++|+.+-++.|++.+..+..+.++.-...+.
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 777889999999999987 567789999999999999999999999999999888888776433332
Q ss_pred ---------------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 248 ---------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 248 ---------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
+-+..+.++.+||.+|+.+||++|||+.++++.
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 113367889999999999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=317.06 Aligned_cols=224 Identities=27% Similarity=0.487 Sum_probs=193.0
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
..++..++.||+|+||+||++.+. |+..|||.+....... .+.+.+|+.+|++++|||||+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~------~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~ 89 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT------SESLEREIRILSRLNHPNIVQYYGSSSSREND 89 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh------HHHHHHHHHHHHhCCCCCEEeeCCccccccCe
Confidence 457888999999999999999997 6899999998763322 366889999999999999997
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC-CCeEEEeecccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMCVKVADFGISCLES 179 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~ 179 (332)
.++.+++..+..+++||++||.|||++||+|+||||+|||++. ++.+||+|||++....
T Consensus 90 ~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 90 EYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 2227999999999999999999999999999999999999999 7999999999987655
Q ss_pred c----CCCCCCcccccccCChhhhhcCC-CCCccchhHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCCCCc
Q 020016 180 Q----CGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDN-MTPEQAAFAVCQKNARPPVPPTCP 253 (332)
Q Consensus 180 ~----~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~ 253 (332)
. ........||+.|||||++.++. ...++|||||||++.||+||+.||.. ....+....+......|.+|..++
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls 249 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLS 249 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccC
Confidence 2 22334578999999999999643 34699999999999999999999998 566666666666666778999999
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 020016 254 KAFSYLISRCWSSSPDRRPHFDQIVSILEG 283 (332)
Q Consensus 254 ~~l~~li~~cl~~dp~~Rps~~ell~~L~~ 283 (332)
++.++++.+|+..||.+|||++++++..-.
T Consensus 250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 250 DEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 999999999999999999999999986544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=324.34 Aligned_cols=222 Identities=27% Similarity=0.375 Sum_probs=194.7
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT---------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~---------- 120 (332)
.++|.+++.||.|+|++|++|+.. ++.||||++.+...-. +.-.+-+..|-++|.+| .||.|++
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik---e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK---EKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh---hcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 578999999999999999999997 7899999998743322 22234567788999999 8999997
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 182 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 182 (332)
.-+.+++..++.++.||+.||.|||++|||||||||+|||+|.++.++|+|||.|.......
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 56789999999999999999999999999999999999999999999999999987643221
Q ss_pred ------------CC--CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 020016 183 ------------SA--KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 248 (332)
Q Consensus 183 ------------~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (332)
.. ..++||..|.+||++.....+..+|+|+||||+|+|+.|.+||.+.+.--+.+.++ ...-.+
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~--~l~y~f 306 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ--ALDYEF 306 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH--HhcccC
Confidence 11 45889999999999999999999999999999999999999999988877777775 456678
Q ss_pred CCCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 249 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
|+.+++.+.+|+++.|..||.+|++.++|-+.
T Consensus 307 p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 307 PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred CCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 89999999999999999999999999988874
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=320.90 Aligned_cols=232 Identities=26% Similarity=0.510 Sum_probs=192.1
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec-
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~- 120 (332)
|.++.++|.+.+.||.|+||.||+|.+. ++.||||++....... ..+.+.+|+.++..+ +||||++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~ 76 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATAS-----EHKALMSELKILIHIGNHLNVVNL 76 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchH-----HHHHHHHHHHHHHHhccCcceeeE
Confidence 8888999999999999999999999752 3579999987543322 135689999999999 8999986
Q ss_pred ------------------C-------------------------------------------------------------
Q 020016 121 ------------------E------------------------------------------------------------- 121 (332)
Q Consensus 121 ------------------~------------------------------------------------------------- 121 (332)
.
T Consensus 77 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (338)
T cd05102 77 LGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGS 156 (338)
T ss_pred EeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcc
Confidence 0
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC---CCCCc
Q 020016 122 -----------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG---SAKGF 187 (332)
Q Consensus 122 -----------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~ 187 (332)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... .....
T Consensus 157 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 157 TNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred cccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCC
Confidence 0136677888899999999999999999999999999999999999999999987543211 11233
Q ss_pred ccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHcccc
Q 020016 188 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 266 (332)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 266 (332)
.++..|+|||++.+..++.++||||||+++|||++ |..||.+....+..............+..+++.+.+++.+||+.
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 316 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQG 316 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 45678999999999999999999999999999998 99999886654444444444555566778899999999999999
Q ss_pred CCCCCCCHHHHHHHHHhhhh
Q 020016 267 SPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 267 dp~~Rps~~ell~~L~~~~~ 286 (332)
||.+||++.++++.|+.+..
T Consensus 317 dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 317 DPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred ChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=322.41 Aligned_cols=229 Identities=27% Similarity=0.439 Sum_probs=197.9
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCceec----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIIT---------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~---------- 120 (332)
.+.|.+++.||+|+||+|++|.+. +..||||++......... ....+.+.+|+.+++.++ ||||++
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS-QKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc-cccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 479999999999999999999886 799999988775222111 122456678999999999 999987
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC-CeEEEeeccccccc-cc
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGISCLE-SQ 180 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~a~~~-~~ 180 (332)
..+++.+..+..++.|+++|++|||++||+||||||+|||++.+ +++||+|||++... ..
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~ 174 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGE 174 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCC
Confidence 45789999999999999999999999999999999999999999 99999999999877 45
Q ss_pred CCCCCCcccccccCChhhhhcCC-C-CCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC-cHHHH
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKR-H-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTC-PKAFS 257 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~-~-~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~ 257 (332)
.......+||+.|+|||++.+.. | +.++||||+||+||.|++|..||...+.......+ ......+|..+ ++++.
T Consensus 175 ~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki--~~~~~~~p~~~~S~~~~ 252 (370)
T KOG0583|consen 175 DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI--RKGEFKIPSYLLSPEAR 252 (370)
T ss_pred CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH--hcCCccCCCCcCCHHHH
Confidence 56778899999999999999877 7 58999999999999999999999997777766664 45566778888 99999
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 020016 258 YLISRCWSSSPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 258 ~li~~cl~~dp~~Rps~~ell~~L~~~~~ 286 (332)
.|+.+||..||.+|+++.+++ .-.-+..
T Consensus 253 ~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 253 SLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred HHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 999999999999999999999 4444443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=310.90 Aligned_cols=230 Identities=27% Similarity=0.471 Sum_probs=195.9
Q ss_pred CCccccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--
Q 020016 45 EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120 (332)
Q Consensus 45 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-- 120 (332)
.....|..+.+.|.+.+.||.|..++||+|+.. ++.||||+++....... .+.+.+|+..++.++||||++
T Consensus 16 ~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-----ld~l~kE~~~msl~~HPNIv~~~ 90 (516)
T KOG0582|consen 16 SSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-----LDALRKEVQTMSLIDHPNIVTYH 90 (516)
T ss_pred cccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-----HHHHHHHHHHhhhcCCCCcceEE
Confidence 345789999999999999999999999999996 89999999998766554 467899999999999999987
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeec
Q 020016 121 ----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 172 (332)
Q Consensus 121 ----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Df 172 (332)
....+++..+..|+++++.||.|||.+|.||||||+.||||+.+|.|||+||
T Consensus 91 ~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadF 170 (516)
T KOG0582|consen 91 CSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADF 170 (516)
T ss_pred EEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCc
Confidence 4556999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCC-----CCCcccccccCChhhhhc--CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Q 020016 173 GISCLESQCGS-----AKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 245 (332)
Q Consensus 173 g~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~ 245 (332)
|.+......+. ....+||+.|||||+++. ..|+.|+||||||++..||++|..||..+.+.+.......+...
T Consensus 171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp 250 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPP 250 (516)
T ss_pred eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCC
Confidence 98754433221 156689999999999643 56899999999999999999999999999998876655433221
Q ss_pred C--------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 246 P--------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 246 ~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
. .....++..+++++..||+.||.+|||++++++
T Consensus 251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1 111345678999999999999999999999987
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=316.34 Aligned_cols=221 Identities=24% Similarity=0.349 Sum_probs=187.6
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.+.|..+++||+|+||.||+|++. |+.||+|.++........ .....+||.||++|+|||||+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~----~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGF----PITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcc----hHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 467899999999999999999996 889999999886544332 355789999999999999987
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
..-.+++.++..++.||+.||.|||++||+|||||..|||||.+|.+||+|||+|++....
T Consensus 192 siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 192 SIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred eEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 3457899999999999999999999999999999999999999999999999999976544
Q ss_pred C--CCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--------C--
Q 020016 182 G--SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--------V-- 248 (332)
Q Consensus 182 ~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~--------~-- 248 (332)
. ..+..+.|..|.|||++.+. .|+.++|+||.||||.||++|++.|++.+..+....+...-..+. +
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 3 34567789999999999875 689999999999999999999999999888776665543211110 1
Q ss_pred -----------------CCCCcHHHHHHHHHccccCCCCCCCHHHHH
Q 020016 249 -----------------PPTCPKAFSYLISRCWSSSPDRRPHFDQIV 278 (332)
Q Consensus 249 -----------------~~~~~~~l~~li~~cl~~dp~~Rps~~ell 278 (332)
-..++....+|+..+|..||++|.|+.+++
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 133577888999999999999999999887
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=314.35 Aligned_cols=228 Identities=26% Similarity=0.366 Sum_probs=192.6
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHH--------HHHHHHHHHHHHHHHcCCCCceec---
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLA--------SMLEKQFTSEVALLFRLNHPHIIT--- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~--- 120 (332)
.++|++++.||+|.||.|-+|++. ++.||||++.+........ ..-.+...+|+.+|+++.|||||+
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 689999999999999999999997 7899999998753322111 011357899999999999999997
Q ss_pred --------------------------CCCC-CCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecc
Q 020016 121 --------------------------EPYS-VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 121 --------------------------~~~~-l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
..++ +++.+++.++++++.||.|||.+||+||||||+|+|++++|++||+|||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFG 255 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFG 255 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccc
Confidence 3344 8999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC------CCCcccccccCChhhhhcCC----CCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Q 020016 174 ISCLESQCGS------AKGFTGTYRWMAPEMIKEKR----HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 243 (332)
Q Consensus 174 ~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~ 243 (332)
.+........ .....|||.|+|||+..++. .+.+.||||+||+||.|+.|+.||-+....+....+....
T Consensus 256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~p 335 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDP 335 (576)
T ss_pred eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCc
Confidence 9876533211 12367999999999987733 2679999999999999999999999988888888887665
Q ss_pred CCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 020016 244 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 281 (332)
Q Consensus 244 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L 281 (332)
...+..+.+.+.+++||.+||++||+.|.++.+|....
T Consensus 336 L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 336 LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 55555566899999999999999999999999887644
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=289.36 Aligned_cols=222 Identities=24% Similarity=0.330 Sum_probs=188.0
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
.+|...++||+|.||.||+|++. |+.||||.+......+.. .....+|+..|+.++|+||+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi----~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~ 77 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI----NRTALREIKLLQELKHPNIIELIDVFPHKSNLS 77 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc----cHHHHHHHHHHHHccCcchhhhhhhccCCCceE
Confidence 57888999999999999999996 899999999887554332 356789999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 184 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 184 (332)
....++...+..++.++++||+|||++.|+||||||.|+||+++|.+||+|||+++........
T Consensus 78 lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 78 LVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred EEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 4567889999999999999999999999999999999999999999999999999987655433
Q ss_pred -CCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---------------
Q 020016 185 -KGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--------------- 247 (332)
Q Consensus 185 -~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~--------------- 247 (332)
...+.|..|.|||.+.| ..|+..+|+||.|||+.||+-|.+-|++.++-+....+......+.
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 33478999999998866 4689999999999999999999999999887776655544322221
Q ss_pred -----------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 248 -----------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 248 -----------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
+-+..+.+..+|+.+||..||.+|++++|++++
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 113346778999999999999999999998863
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=318.02 Aligned_cols=220 Identities=26% Similarity=0.462 Sum_probs=196.4
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
...|....+||+|+.|.||.|... ++.||||.+....... ++-+++|+.+|+...|+|||.
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~------keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK------KELLLNEILVMRDLHHPNIVNFLDSYLVGDEL 345 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc------hhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence 467888999999999999999886 6889999999876654 467899999999999999987
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-C
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-S 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~ 183 (332)
....+++.++..|++++++||+|||.+||+|||||.+|||++.+|.+||+|||++....... .
T Consensus 346 WVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred EEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 44568899999999999999999999999999999999999999999999999997766544 4
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHH
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~ 262 (332)
....+|||.|||||++....|+.++||||||++++||+-|++||-..++-...+.+...+. ....+..+++.+++|+.+
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence 5678999999999999999999999999999999999999999998888777776654333 334568899999999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~ 279 (332)
||+.|+++|+++.|+|+
T Consensus 506 cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 506 CLVVDVEQRASAKELLE 522 (550)
T ss_pred HhhcchhcCCCHHHHhc
Confidence 99999999999999996
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=303.60 Aligned_cols=232 Identities=22% Similarity=0.373 Sum_probs=197.0
Q ss_pred cccccCCeeee--eeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 50 WSADMSQLFIG--CKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 50 ~~~~~~~y~i~--~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
+.++.+++... ..||+|++|.||+|.++|+.||||.+....... ....+.|.+|+.+|++++||||++
T Consensus 13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 89 (283)
T PHA02988 13 KCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGH---KVLIDITENEIKNLRRIDSNNILKIYGFIID 89 (283)
T ss_pred eecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEecccccccc---HHHHHHHHHHHHHHHhcCCCCEEEEeeeEEe
Confidence 34445555555 679999999999999999999999998653322 222467889999999999999986
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccccccceeecCCCeEEEeeccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 90 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~ 169 (283)
T PHA02988 90 IVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGL 169 (283)
T ss_pred cccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccch
Confidence 234578888999999999999999985 999999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCChhhhhc--CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 020016 175 SCLESQCGSAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTC 252 (332)
Q Consensus 175 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (332)
+...... .....++..|+|||++.+ ..++.++||||||+++|||++|..||...+..+....+.....++..+..+
T Consensus 170 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (283)
T PHA02988 170 EKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDC 247 (283)
T ss_pred Hhhhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcC
Confidence 8754332 224567899999999976 678999999999999999999999999988887777776666677777789
Q ss_pred cHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 020016 253 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 286 (332)
++.+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 248 ~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 248 PLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred cHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999999998753
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=293.10 Aligned_cols=211 Identities=24% Similarity=0.341 Sum_probs=191.4
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||.|+||+|.+++.+ +..+|+|++++... ..-...+...+|..+|+.+.||.+++
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v---VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l 119 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV---VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL 119 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHH---HHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence 578999999999999999999997 78999999987432 22333567889999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
..+++++..++-++.||+.||.|||+++|++|||||+|||+|.+|.+||+|||+|......
T Consensus 120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 5678999999999999999999999999999999999999999999999999999876653
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHc
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 263 (332)
..+.||||.|+|||.+....+..++|.|||||++|||+.|.+||...++.++...+... ...+|..+++++++|+.++
T Consensus 198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~--~v~fP~~fs~~~kdLl~~L 275 (355)
T KOG0616|consen 198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG--KVKFPSYFSSDAKDLLKKL 275 (355)
T ss_pred EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC--cccCCcccCHHHHHHHHHH
Confidence 66789999999999999999999999999999999999999999999998888888644 5668889999999999999
Q ss_pred cccCCCCC
Q 020016 264 WSSSPDRR 271 (332)
Q Consensus 264 l~~dp~~R 271 (332)
|+.|-.+|
T Consensus 276 L~vD~t~R 283 (355)
T KOG0616|consen 276 LQVDLTKR 283 (355)
T ss_pred HhhhhHhh
Confidence 99999999
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=315.06 Aligned_cols=219 Identities=28% Similarity=0.465 Sum_probs=193.9
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|.||+||+|+.+ .+.||+|.+.+....... .+.+.+|+++++.++|||||.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~----l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~ 77 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKE----LKNLRQEVRILRSLKHPNIVEMLESFETSAHLW 77 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHH----HHHHHHHHHHHHhcCCcchhhHHHhhcccceEE
Confidence 68999999999999999999998 578999999886543321 466889999999999999986
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-CC
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-SA 184 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~ 184 (332)
..+.++++.+..++.+++.||.|||+.+|+|||+||.|||++..|.+|++|||+++...... ..
T Consensus 78 vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 78 VVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred EEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 67899999999999999999999999999999999999999999999999999998765533 23
Q ss_pred CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHcc
Q 020016 185 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 264 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 264 (332)
....|||-|||||.+.++.|+..+|.||+||++||+.+|++||......+....+. ......|...+..+..++..+|
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~--~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL--KDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh--cCCCCCcccccHHHHHHHHHHh
Confidence 45679999999999999999999999999999999999999999877777766664 3344556689999999999999
Q ss_pred ccCCCCCCCHHHHHH
Q 020016 265 SSSPDRRPHFDQIVS 279 (332)
Q Consensus 265 ~~dp~~Rps~~ell~ 279 (332)
.+||..|.+-.+++.
T Consensus 236 ~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLG 250 (808)
T ss_pred hcChhhcccHHHHhc
Confidence 999999999999886
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=302.44 Aligned_cols=219 Identities=26% Similarity=0.346 Sum_probs=187.3
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||.||+|.+. ++.||||++....... ....+.+.+|+.+++.++||||++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 77 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR---LKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLY 77 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh---hHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEE
Confidence 47899999999999999999997 7899999997642211 112456889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 184 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 184 (332)
....+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++..... ..
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~--~~ 155 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--RT 155 (291)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC--Cc
Confidence 334678999999999999999999999999999999999999999999999999876543 22
Q ss_pred CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHcc
Q 020016 185 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 264 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 264 (332)
....||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+... ...++..+++.+.+|+.+||
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l 233 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--KLEFPRHLDLYAKDLIKKLL 233 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcCCCccCCHHHHHHHHHHc
Confidence 3457899999999999988999999999999999999999999998877766665433 45667788999999999999
Q ss_pred ccCCCCCCC-----HHHHHHH
Q 020016 265 SSSPDRRPH-----FDQIVSI 280 (332)
Q Consensus 265 ~~dp~~Rps-----~~ell~~ 280 (332)
+.||.+||+ ++++++.
T Consensus 234 ~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 234 VVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCCHHHccCCccCCHHHHhcC
Confidence 999999995 8887764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=301.16 Aligned_cols=221 Identities=18% Similarity=0.254 Sum_probs=182.0
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
.|.+.+.||+|+||.||+|.+. ++.||||.+....... ......+.+|+.++..++|+||+.
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~l 77 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---RKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCL 77 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh---hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEE
Confidence 4788999999999999999885 7899999987643221 111345789999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 223578999999999999999999999999999999999999999999999999876544333
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hcCCCCCCCCCCcHHHHHHHH
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC--QKNARPPVPPTCPKAFSYLIS 261 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~ 261 (332)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||...........+. .......++..+++.+.+|+.
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence 445678999999999999999999999999999999999999998755432221111 123334566778999999999
Q ss_pred HccccCCCCCCC-----HHHHHH
Q 020016 262 RCWSSSPDRRPH-----FDQIVS 279 (332)
Q Consensus 262 ~cl~~dp~~Rps-----~~ell~ 279 (332)
+||+.||.+||+ ++++++
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 238 MLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred HHhhcCHHHhcCCCCCCHHHHhc
Confidence 999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=328.51 Aligned_cols=235 Identities=30% Similarity=0.553 Sum_probs=207.8
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEECC-------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCcee
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 119 (332)
....++..++..+.+.||+|+||+||+|+..+ ..||||.++...... ..++|.+|++++..|+|||||
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~-----~~~dF~REaeLla~l~H~nIV 552 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQ-----ARQDFRREAELLAELQHPNIV 552 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHH-----HHHHHHHHHHHHHhccCCCeE
Confidence 34567788999999999999999999998852 579999998765543 258899999999999999999
Q ss_pred c------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccccc
Q 020016 120 T------------------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 157 (332)
Q Consensus 120 ~------------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~ 157 (332)
+ .+.+++..+.+.|+.|||.||.||-++.++||||..+
T Consensus 553 rLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATR 632 (774)
T KOG1026|consen 553 RLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATR 632 (774)
T ss_pred EEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhh
Confidence 7 1445899999999999999999999999999999999
Q ss_pred ceeecCCCeEEEeecccccccccCCCCC---CcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHH
Q 020016 158 NLLLGEDMCVKVADFGISCLESQCGSAK---GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPE 233 (332)
Q Consensus 158 NIll~~~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~ 233 (332)
|+||.++..|||+|||+++.....+... ...-..+|||||.+..++|+.++||||+||+|||+++ |+.||.+.++.
T Consensus 633 NCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~ 712 (774)
T KOG1026|consen 633 NCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ 712 (774)
T ss_pred hceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence 9999999999999999997654433222 2334789999999999999999999999999999999 99999999999
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 234 QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
+....+..+.. .+.|..+|.++++||..||+.+|.+||+++||-.+|+.....
T Consensus 713 EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 713 EVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 99988876665 889999999999999999999999999999999999987544
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=285.74 Aligned_cols=225 Identities=27% Similarity=0.467 Sum_probs=201.0
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
..|. .++|.+++.||.|.||.||.|+.+ +-.||+|++.+++ .....+..++.+|++|-+.|+||||++
T Consensus 17 ~~~~--l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq---i~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 17 KTWT--LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ---ILKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred cccc--hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH---HHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 4566 479999999999999999999997 5789999998854 334555788999999999999999986
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
....+++.....++.|++.||.|+|.++|+||||||+|+|++..|.+||+|||-+
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGws 171 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWS 171 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCce
Confidence 4456899999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 020016 176 CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255 (332)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (332)
.... .+...+.+||..|++||+..+..++..+|+|++|++.||++.|.+||...+..+....+. ..+..+|..++.+
T Consensus 172 V~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~--k~~~~~p~~is~~ 248 (281)
T KOG0580|consen 172 VHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR--KVDLKFPSTISGG 248 (281)
T ss_pred eecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH--HccccCCcccChh
Confidence 6655 556678999999999999999999999999999999999999999999988777777764 4556677999999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 020016 256 FSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
.+++|.+|+..+|.+|.+..+++..
T Consensus 249 a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 249 AADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHHHHHHHhccCccccccHHHHhhh
Confidence 9999999999999999999998763
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=319.48 Aligned_cols=221 Identities=25% Similarity=0.374 Sum_probs=198.7
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
+-|++++.||.|+.|.|-+|.+. |+.+|||++.+...- .......+.+|+-+|+.+.||||+.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~---s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSEL---SSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeecccccc---ccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence 55789999999999999999996 999999999886211 1112355778999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 184 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 184 (332)
..+++++.++.++++||+.|+.|||..+|+||||||+|+|+|..+++||+|||+|.........
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL 168 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence 6789999999999999999999999999999999999999999999999999999887777777
Q ss_pred CCcccccccCChhhhhcCCC-CCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHc
Q 020016 185 KGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 263 (332)
.+.||+|.|.+||++++.+| +.++||||-|||||.||||+.||++.+...++..+. .....+|..+++++++||.+|
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~--~G~f~MPs~Is~eaQdLLr~m 246 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQ--RGVFEMPSNISSEAQDLLRRM 246 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHH--cCcccCCCcCCHHHHHHHHHH
Confidence 88999999999999999998 789999999999999999999999988888877774 455677899999999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 020016 264 WSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 264 l~~dp~~Rps~~ell~~ 280 (332)
|..||.+|.|+++|++.
T Consensus 247 l~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 247 LDVDPSTRITTEEILKH 263 (786)
T ss_pred hccCccccccHHHHhhC
Confidence 99999999999999984
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=295.07 Aligned_cols=227 Identities=29% Similarity=0.564 Sum_probs=193.2
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
|.++.++|++.++||+|+||.||+|.+. +..||+|.+...... .+.+.+|+.+++.++|+||++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-------VQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchh-------HHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 7888999999999999999999999986 678999998653321 357889999999999999986
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVI 153 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceec
Confidence 2345778889999999999999999999999999999999999999999999998765
Q ss_pred ccCCC--CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 020016 179 SQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255 (332)
Q Consensus 179 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (332)
..... .....++..|+|||.+.+..++.++||||||+++|+|+| |..||...........+. .....+.+..++.+
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 232 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRMPRMENCPDE 232 (261)
T ss_pred CCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 43221 122345678999999998889999999999999999998 999999887776665554 33444555678999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 256 FSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
+.+++.+||..+|++||+++++.+.|+++
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 233 LYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=306.41 Aligned_cols=220 Identities=26% Similarity=0.382 Sum_probs=187.8
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||.||+|.+. ++.||||++...... .....+.+.+|+.++.+++||||++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL---KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh---hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 579999999999999999999996 789999999753211 1122467889999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence 3456789999999999999999999999999999999999999999999999998765432
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHc
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 263 (332)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.. ....+|..++..+.+|+.+|
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~~ 249 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA--GRLKFPNWFDGRARDLVKGL 249 (329)
T ss_pred cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc--CCcCCCCCCCHHHHHHHHHH
Confidence 2345789999999999999999999999999999999999999998887666665543 34566777899999999999
Q ss_pred cccCCCCCCC-----HHHHHHH
Q 020016 264 WSSSPDRRPH-----FDQIVSI 280 (332)
Q Consensus 264 l~~dp~~Rps-----~~ell~~ 280 (332)
|+.||.+||+ +.+++..
T Consensus 250 L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 250 LQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred hhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999996 6777643
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=308.60 Aligned_cols=219 Identities=27% Similarity=0.470 Sum_probs=192.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
..|+..+.||+|.||.||+|.+. ++.||+|++........ .+++.+|+.+|.+++++||.+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de-----Iediqqei~~Ls~~~~~~it~yygsyl~g~~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE-----IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchh-----hHHHHHHHHHHHhcCcchHHhhhhheeecccHH
Confidence 56777899999999999999997 78999999998665543 467889999999999999965
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-C
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-S 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~ 183 (332)
....+++..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+....... .
T Consensus 88 iiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred HHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 33445899999999999999999999999999999999999999999999999987665443 3
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHc
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 263 (332)
..+++||+.|||||++.+..|+.++||||||++.+||++|.+|+....+....+.+ .+...|.+...+++.+++|+..|
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-pk~~PP~L~~~~S~~~kEFV~~C 246 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-PKSAPPRLDGDFSPPFKEFVEAC 246 (467)
T ss_pred cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-cCCCCCccccccCHHHHHHHHHH
Confidence 37889999999999999889999999999999999999999999998885554444 24555666678999999999999
Q ss_pred cccCCCCCCCHHHHHH
Q 020016 264 WSSSPDRRPHFDQIVS 279 (332)
Q Consensus 264 l~~dp~~Rps~~ell~ 279 (332)
|..||+.||++.++++
T Consensus 247 L~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 247 LDKNPEFRPSAKELLK 262 (467)
T ss_pred hhcCcccCcCHHHHhh
Confidence 9999999999999986
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=315.22 Aligned_cols=219 Identities=25% Similarity=0.371 Sum_probs=195.2
Q ss_pred ccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCceec-------
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIIT------- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~------- 120 (332)
.+..++|.+.+.||.|.||+|+++..+ ++.+|||++++..--. ....+..+.|..|+...+ ||.++.
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~---~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT 440 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ---RDEVESLMCEKRIFELANRHPFLVNLFSCFQT 440 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec---cccHHHHHHHHHHHHHhccCCeEeeccccccc
Confidence 455789999999999999999999997 6789999998853321 122466788888888885 999886
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc-
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES- 179 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~- 179 (332)
....+++..+.-++..++.||.|||++||||||||.+|||+|.+|.+||+|||+++..-
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 45789999999999999999999999999999999999999999999999999998654
Q ss_pred cCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 020016 180 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 259 (332)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 259 (332)
....+.+++|||.|+|||++.+..|+.++|+|||||+|||||.|..||.+.+.+++...+. ...+.+|..++.+..++
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~--~d~~~yP~~ls~ea~~i 598 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV--NDEVRYPRFLSKEAIAI 598 (694)
T ss_pred CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCCCCCCcccHHHHHH
Confidence 5567788999999999999999999999999999999999999999999999999988885 55677888999999999
Q ss_pred HHHccccCCCCCCCH
Q 020016 260 ISRCWSSSPDRRPHF 274 (332)
Q Consensus 260 i~~cl~~dp~~Rps~ 274 (332)
++++|..+|++|..+
T Consensus 599 l~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 599 MRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHhccCcccccCC
Confidence 999999999999865
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=310.11 Aligned_cols=233 Identities=26% Similarity=0.498 Sum_probs=193.0
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCce
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHI 118 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 118 (332)
...|.++.++|.+++.||.|+||+||+|.+. +..||||++....... ..+.+.+|+.++..+ +||||
T Consensus 27 ~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~-----~~~~~~~Ei~il~~l~~HpnI 101 (375)
T cd05104 27 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLT-----EREALMSELKVLSYLGNHINI 101 (375)
T ss_pred ccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcH-----HHHHHHHHHHHHHHhcCCcce
Confidence 4578888899999999999999999999752 4589999997543322 135788999999999 89999
Q ss_pred ecC-----------------------------------------------------------------------------
Q 020016 119 ITE----------------------------------------------------------------------------- 121 (332)
Q Consensus 119 v~~----------------------------------------------------------------------------- 121 (332)
++.
T Consensus 102 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 181 (375)
T cd05104 102 VNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPT 181 (375)
T ss_pred eeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccc
Confidence 861
Q ss_pred --------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccc
Q 020016 122 --------------------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 122 --------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
...+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 261 (375)
T cd05104 182 KADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA 261 (375)
T ss_pred ccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccc
Confidence 013677888999999999999999999999999999999999999999999998
Q ss_pred cccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 020016 176 CLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 251 (332)
Q Consensus 176 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (332)
........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.................+...+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (375)
T cd05104 262 RDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPEC 341 (375)
T ss_pred eeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCC
Confidence 75433221 112334667999999999999999999999999999998 99999887665555555555555556667
Q ss_pred CcHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 252 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 252 ~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
.+.++.+|+.+||+.||++||++.+|++.|+..
T Consensus 342 ~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 342 APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 789999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=294.06 Aligned_cols=221 Identities=25% Similarity=0.385 Sum_probs=187.6
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
.|.-.+.+|+|+||.||+|... +..||||......... .+|+++|+.++|||||+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----------NRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----------cHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 5778899999999999999986 6899999987654322 36999999999999997
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC-CeEEEeeccccc
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGISC 176 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~a~ 176 (332)
.+..++.-.+.-+.+||.+||+|||+.||+||||||.|+|+|.+ |.+||||||.|.
T Consensus 95 ~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 95 VYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred hHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 35677777888899999999999999999999999999999987 999999999999
Q ss_pred ccccCCCCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--------
Q 020016 177 LESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-------- 247 (332)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~-------- 247 (332)
..........+..|..|.|||.+.+. .|+.+.||||.||++.||+-|++.|++.+..+....+..-...+.
T Consensus 175 ~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 175 VLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred eeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 98887778888999999999998764 689999999999999999999999999887766655543222211
Q ss_pred -------------------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH--HHHhhhh
Q 020016 248 -------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYSE 286 (332)
Q Consensus 248 -------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~--~L~~~~~ 286 (332)
+....++++.+|+.++|..+|.+|.++.+++. .++.+.+
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 33557899999999999999999999998885 3444433
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=298.80 Aligned_cols=221 Identities=23% Similarity=0.340 Sum_probs=179.1
Q ss_pred CCeeeeeeecccCceEEEEEEEC---CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC---CCCceec--------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL---NHPHIIT-------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~-------- 120 (332)
++|.+.+.||+|+||.||+|.+. ++.||||++......... ...+.+|+.+++.+ +||||++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~ 76 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM----PLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 76 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc----hHHHHHHHHHHHhhcccCCCCcceEEEEEecc
Confidence 37999999999999999999873 578999998764432211 23455677766665 7999986
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+
T Consensus 77 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 77 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred cCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 123478899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------
Q 020016 175 SCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP-------- 246 (332)
Q Consensus 175 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~-------- 246 (332)
+.............+|+.|+|||.+.+..++.++||||||+++|+|++|..||.+....+....+......+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred eEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 876554444455678999999999998899999999999999999999999999887766555443221100
Q ss_pred -----------------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 -----------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 -----------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...+.+++.+.+++.+||+.||++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 011356788899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=309.99 Aligned_cols=234 Identities=24% Similarity=0.498 Sum_probs=194.8
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCce
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHI 118 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 118 (332)
...|.++.++|.+++.||+|+||.||+|.+. +..||||++........ ...+.+|+.+++.+ +|+||
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~il~~l~~h~nI 104 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDE-----REALMSELKILSHLGQHKNI 104 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHH-----HHHHHHHHHHHHhhccCCce
Confidence 4678889999999999999999999999863 24799999976543321 35688999999999 89999
Q ss_pred ec------------------C-----------------------------------------------------------
Q 020016 119 IT------------------E----------------------------------------------------------- 121 (332)
Q Consensus 119 v~------------------~----------------------------------------------------------- 121 (332)
++ .
T Consensus 105 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (374)
T cd05106 105 VNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEM 184 (374)
T ss_pred eeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccccc
Confidence 86 0
Q ss_pred ---------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 122 ---------------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 122 ---------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
..++++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 185 RPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred CCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 01367788899999999999999999999999999999999999999999999865432
Q ss_pred CCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 020016 181 CGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 256 (332)
Q Consensus 181 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (332)
... .....++..|+|||++.+..++.++||||||+++|+|++ |..||.....................+..+++++
T Consensus 265 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 344 (374)
T cd05106 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEI 344 (374)
T ss_pred CcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHH
Confidence 211 112234568999999998899999999999999999998 9999988766555555555555666677789999
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVSILEGYS 285 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~~L~~~~ 285 (332)
.+++.+||+.||.+||++.++++.|+++.
T Consensus 345 ~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 345 YSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 99999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=294.61 Aligned_cols=221 Identities=25% Similarity=0.352 Sum_probs=184.1
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
..|...+.||.|+||.|..+.++ |+.||||.+......... .+...+|+.+|+.++|+||+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~----akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQID----AKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHH----HHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 45666899999999999999997 899999999865544443 356789999999999999985
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
.+..++...+..+++||+.||.|+|+.||+||||||.|++++.+..+||+|||+|+....
T Consensus 98 f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 98 FNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred cceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 445599999999999999999999999999999999999999999999999999987753
Q ss_pred ---CCCCCCcccccccCChhhhh-cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--------------
Q 020016 181 ---CGSAKGFTGTYRWMAPEMIK-EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK-------------- 242 (332)
Q Consensus 181 ---~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-------------- 242 (332)
....+.++.|..|.|||++. ...|+.+.||||+|||+.||++|++.|++.+.-.....+...
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 33446678899999999874 567899999999999999999999999987654433332221
Q ss_pred ----------CCCCC-----CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 243 ----------NARPP-----VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 243 ----------~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...+. .-+..++...+|+.+||..||.+|+|++|.++
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111 12467889999999999999999999999886
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=312.82 Aligned_cols=242 Identities=31% Similarity=0.574 Sum_probs=212.3
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEEEC---C--ee-EEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCcee
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK---Q--RD-VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~---~--~~-vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 119 (332)
.-..|++..++..+.++||+|+||.||+|..+ + .. ||||....... ........|++|+++|++++|||||
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~---~~~~~~~e~m~EArvMr~l~H~NVV 224 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE---LTKEQIKEFMKEARVMRQLNHPNVV 224 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc---ccHHHHHHHHHHHHHHHhCCCCCEE
Confidence 45789999999999999999999999999886 2 23 89999875221 1233468899999999999999999
Q ss_pred c-----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEe
Q 020016 120 T-----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVA 170 (332)
Q Consensus 120 ~-----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~ 170 (332)
+ ....++..+...++.+.+.||+|||+++++||||..+|+|++.++.+||+
T Consensus 225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeC
Confidence 7 33469999999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCCCC-CcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 020016 171 DFGISCLESQCGSAK-GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 248 (332)
Q Consensus 171 Dfg~a~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (332)
|||+++......... ...-+..|+|||.+..+.++.++|||||||++||+++ |..||.+....+....+.....+.+.
T Consensus 305 DFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~ 384 (474)
T KOG0194|consen 305 DFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI 384 (474)
T ss_pred ccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC
Confidence 999987654322222 2246789999999999999999999999999999999 89999999999999998888889999
Q ss_pred CCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 020016 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 290 (332)
Q Consensus 249 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~ 290 (332)
+...+.++..++.+||..+|++||+|.++.+.|+.+......
T Consensus 385 ~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 385 PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 999999999999999999999999999999999998877664
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=295.68 Aligned_cols=221 Identities=23% Similarity=0.319 Sum_probs=181.0
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||.||+|+++ ++.||||++....... ...+.+.+|+.+++.++||||++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE----EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLY 76 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc----cchhhHHHHHHHHHhCCCccccchhhhEecCCEEE
Confidence 47999999999999999999996 6889999997643322 12456788999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC--
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-- 182 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 182 (332)
....+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 77 LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 23568899999999999999999999999999999999999999999999999987654322
Q ss_pred CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------------------
Q 020016 183 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA------------------ 244 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~------------------ 244 (332)
......+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 22345689999999999988899999999999999999999999998765544332221100
Q ss_pred -C-C----------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 245 -R-P----------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 245 -~-~----------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
. + .....++.++.+|+.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 0 011236788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=291.61 Aligned_cols=227 Identities=30% Similarity=0.596 Sum_probs=193.3
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
|+++..+|.+.+.||+|+||.||+|.+. ++.||+|.+...... ...+.+|+.+++.++|+||++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLLGVCTR 73 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchH-------HHHHHHHHHHHHhCCCCChhheEEEEcC
Confidence 6788889999999999999999999986 789999998754321 356889999999999999986
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccc
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
....+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++..
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence 223578899999999999999999999999999999999999999999999999876
Q ss_pred cccCCCC--CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 020016 178 ESQCGSA--KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254 (332)
Q Consensus 178 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (332)
....... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+ ........+..++.
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 232 (263)
T cd05052 154 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKGYRMERPEGCPP 232 (263)
T ss_pred cccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCCCCCCCCCCH
Confidence 5432211 12234568999999998899999999999999999998 99999987776655444 34455667788999
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 255 AFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 255 ~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
.+.+++.+||+.+|++||++.++++.|+.+
T Consensus 233 ~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 233 KVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=292.67 Aligned_cols=227 Identities=27% Similarity=0.485 Sum_probs=191.2
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC-----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
++..+|++.+.||+|+||.||+|.++ +..||+|.+....... ....|.+|+.++.+++||||++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 76 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK-----QRRGFLAEALTLGQFDHSNIVRLEGVIT 76 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHH-----HHHHHHHHHHHHhcCCCCCcCeEEEEEe
Confidence 56688999999999999999999864 4689999998653322 1356899999999999999986
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccc
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
....+++..++.++.|++.||+|||++|++||||||+||+++.++.++++|||.+..
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 77 RGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred cCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 235689999999999999999999999999999999999999999999999998754
Q ss_pred cccCCC--CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 020016 178 ESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254 (332)
Q Consensus 178 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (332)
...... .....++..|+|||.+.+..++.++||||||+++|++++ |..||...+..+....+. .....+.+..++.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFRLPAPRNCPN 235 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCH
Confidence 322211 112335678999999999999999999999999999876 999999888776655553 4445567788999
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 255 AFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 255 ~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
.+.+++.+||+.+|.+||++++|++.|.++
T Consensus 236 ~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 236 LLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=297.00 Aligned_cols=222 Identities=23% Similarity=0.328 Sum_probs=180.3
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
+.++|.+.+.||.|+||+||+|.+. ++.||+|++........ ...+.+|+.++++++||||++
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-----PCTAIREVSLLKNLKHANIVTLHDIIHTERC 77 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCc-----chhHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 3578999999999999999999986 78999999976432221 245778999999999999987
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 181 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 181 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 78 LTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred EEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 2334788999999999999999999999999999999999999999999999998654322
Q ss_pred CCCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------------
Q 020016 182 GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP-------------- 246 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~-------------- 246 (332)
.......+++.|+|||.+.+ ..++.++||||+|+++|+|+||+.||.+.+..+....+......+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 22334568999999999875 467999999999999999999999998877665544332211100
Q ss_pred --------------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 --------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 --------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...+.+++++.+|+.+||+.||.+|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 011346788999999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=303.69 Aligned_cols=214 Identities=23% Similarity=0.328 Sum_probs=180.7
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------------
Q 020016 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------------ 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 120 (332)
+.||+|+||.||++.++ ++.||||++...... .......+.+|+.+++.++||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII---AKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh---hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCC
Confidence 46999999999999986 789999999763211 1122356788999999999999986
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc-CCCCCCccc
Q 020016 121 ----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKGFTG 189 (332)
Q Consensus 121 ----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~~~~~~~~g 189 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... ........|
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 345688999999999999999999999999999999999999999999999999865322 223345679
Q ss_pred ccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCC
Q 020016 190 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 269 (332)
Q Consensus 190 t~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 269 (332)
|+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.. ....++..+++++.++|.+||+.||+
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 9999999999999999999999999999999999999988777666555532 34567788999999999999999999
Q ss_pred CCC-----CHHHHHH
Q 020016 270 RRP-----HFDQIVS 279 (332)
Q Consensus 270 ~Rp-----s~~ell~ 279 (332)
+|| ++.++++
T Consensus 236 ~R~~~~~~~~~~ll~ 250 (323)
T cd05571 236 QRLGGGPEDAKEIME 250 (323)
T ss_pred HcCCCCCCCHHHHHc
Confidence 999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=304.78 Aligned_cols=233 Identities=26% Similarity=0.519 Sum_probs=193.1
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 120 (332)
.|.++.++|++.+.||.|+||.||+|.+. ++.||+|++........ .+.+.+|+.++.++ +|+||++
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~-----~~~~~~E~~~~~~l~~h~niv~ 75 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASE-----YKALMTELKILIHIGHHLNVVN 75 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHH-----HHHHHHHHHHHHhhccCcchhh
Confidence 38888999999999999999999999753 36799999976433221 35678899999999 8999875
Q ss_pred C-------------------------------------------------------------------------------
Q 020016 121 E------------------------------------------------------------------------------- 121 (332)
Q Consensus 121 ~------------------------------------------------------------------------------- 121 (332)
.
T Consensus 76 ~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (337)
T cd05054 76 LLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD 155 (337)
T ss_pred eeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhh
Confidence 0
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC---CCCCc
Q 020016 122 -----------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG---SAKGF 187 (332)
Q Consensus 122 -----------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~ 187 (332)
...+++..+..++.||+.||.|||++||+||||||.||+++.++.++|+|||++....... .....
T Consensus 156 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~ 235 (337)
T cd05054 156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235 (337)
T ss_pred cccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCC
Confidence 0256888899999999999999999999999999999999999999999999987643221 12233
Q ss_pred ccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHcccc
Q 020016 188 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 266 (332)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 266 (332)
.++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+..............+...++++.+++.+||+.
T Consensus 236 ~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~ 315 (337)
T cd05054 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHN 315 (337)
T ss_pred CCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccC
Confidence 45678999999999999999999999999999998 99999876554444444445555566677889999999999999
Q ss_pred CCCCCCCHHHHHHHHHhhhh
Q 020016 267 SPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 267 dp~~Rps~~ell~~L~~~~~ 286 (332)
+|++||++.++++.|+.+..
T Consensus 316 ~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 316 NPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=303.36 Aligned_cols=220 Identities=23% Similarity=0.338 Sum_probs=175.7
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|.+.+.||+|+||.||+|.+. ++.||||.+........ ....+.+|+.+++.++||||++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 76 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS----DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 76 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccch----hHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCC
Confidence 5899999999999999999986 78999999875322211 1246889999999999999975
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 77 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 77 KDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred ceEEEEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 2345889999999999999999999999999999999999999999999999998653221
Q ss_pred C----CCCCcccccccCChhhhhc--CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------
Q 020016 182 G----SAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ-------------- 241 (332)
Q Consensus 182 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~-------------- 241 (332)
. ......+|+.|+|||++.+ ..++.++|||||||++|+|+||+.||.+.+.......+..
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 1134578999999999876 5789999999999999999999999987654332211100
Q ss_pred ------------cCCCCC---CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 242 ------------KNARPP---VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 242 ------------~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...... ..+.+++.+.+++.+||+.||++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 11346788999999999999999999999996
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=299.06 Aligned_cols=229 Identities=26% Similarity=0.536 Sum_probs=190.6
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--Ce----eEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QR----DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
..+|.+.+.||+|+||.||+|.+. +. .||||++....... ..+.+.+|+.+++.++||||++
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-----ANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHH-----HHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 467999999999999999999874 33 48999987543222 1367889999999999999987
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 23457888899999999999999999999999999999999999999999999997654
Q ss_pred cCCCC---CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 020016 180 QCGSA---KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255 (332)
Q Consensus 180 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (332)
..... ....++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+.. .+.......+.+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPICTID 239 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCCCCCCCCCHH
Confidence 32221 22334678999999999999999999999999999998 99999887766543 344455566667788999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 020016 256 FSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 288 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 288 (332)
+.+++.+||..+|++||++.+++..|..+....
T Consensus 240 ~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 240 VYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 999999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=290.53 Aligned_cols=227 Identities=32% Similarity=0.632 Sum_probs=193.9
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
|++..++|++.++||+|+||.||+|... ++.||+|.+...... ...+.+|+.+++.++|+||++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 73 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-------PEAFLAEANLMKQLQHPRLVRLYAVVTQE 73 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc-------HHHHHHHHHHHHhcCCcCeeeEEEEEccC
Confidence 6778899999999999999999999986 688999998765433 256889999999999999986
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 23467889999999999999999999999999999999999999999999999986554
Q ss_pred cCCC--CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 020016 180 QCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 256 (332)
Q Consensus 180 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (332)
.... .....++..|+|||++....++.++||||||+++|++++ |..||.+.+..+....+. .....+.+..++.++
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEEL 232 (260)
T ss_pred CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCCCCCCCCCHHH
Confidence 2211 123345678999999998889999999999999999999 999999877766655443 344556677788999
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
.+++.+||..+|++||++++++..|+.+
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 233 YELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred HHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 9999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=305.00 Aligned_cols=223 Identities=24% Similarity=0.314 Sum_probs=180.7
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceecC----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITE---------- 121 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~---------- 121 (332)
.++|.+.+.||+|+||.||++.+. +..||||++........ ....+.+|+.+++.++||||++.
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT----HAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchh----HHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 478999999999999999999986 78999999976433221 13567899999999999999860
Q ss_pred ---------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 122 ---------------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 122 ---------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 96 EEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred cccceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 12367888999999999999999999999999999999999999999999999876544
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------------
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA---------------- 244 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~---------------- 244 (332)
........+|+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+.....
T Consensus 176 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (359)
T cd07876 176 NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN 255 (359)
T ss_pred CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 3344456789999999999999999999999999999999999999987665433222111100
Q ss_pred ----CCC--------------------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 245 ----RPP--------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 245 ----~~~--------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
.+. .....++.+.+||.+||..||++|||+.|++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 111245778999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=302.08 Aligned_cols=221 Identities=21% Similarity=0.266 Sum_probs=186.0
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||.||+|.+. ++.||||++....... ......+.+|+.++..++||||++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~ 77 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK---LNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLY 77 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh---hhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEE
Confidence 47999999999999999999996 7899999997642211 112466889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 184 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 184 (332)
....+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++..... ..
T Consensus 78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~ 155 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YA 155 (333)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--cc
Confidence 345688999999999999999999999999999999999999999999999999875443 33
Q ss_pred CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC------CCCcHHHHH
Q 020016 185 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP------PTCPKAFSY 258 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~ 258 (332)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.........+ ..+++++.+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~ 235 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence 45678999999999999999999999999999999999999999888777665554322211111 256899999
Q ss_pred HHHHccccCCCCCCCHHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~~ 280 (332)
++.+||..+|.+||++.++++.
T Consensus 236 li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 236 LITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHhhChhhhcCCHHHHHhC
Confidence 9999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=289.39 Aligned_cols=227 Identities=33% Similarity=0.617 Sum_probs=192.4
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
|+++.++|.+.+.||+|++|.||+|.+. ++.||||.+...... .+.+.+|+.++++++||||++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-------PKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc-------HHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence 6778899999999999999999999986 678999998764332 256889999999999999986
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 74 EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVI 153 (261)
T ss_pred CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence 1235889999999999999999999999999999999999999999999999998765
Q ss_pred ccCCCC--CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 020016 179 SQCGSA--KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255 (332)
Q Consensus 179 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (332)
...... .....+..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.........+. .......+..++..
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 232 (261)
T cd05068 154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKE 232 (261)
T ss_pred cCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHH
Confidence 432111 12223457999999998889999999999999999999 999999888766665553 33445566778999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 256 FSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 233 ~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 233 LYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=303.25 Aligned_cols=227 Identities=24% Similarity=0.309 Sum_probs=191.6
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEEC---CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--- 120 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--- 120 (332)
...+.++.++|.+.+.||.|+||.||+|.+. +..||+|++...... .....+.+.+|+.++..++||||++
T Consensus 22 ~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~Iv~~~~ 98 (340)
T PTZ00426 22 KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII---KQKQVDHVFSERKILNYINHPFCVNLYG 98 (340)
T ss_pred ccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh---hhhhHHHHHHHHHHHHhCCCCCCcceEE
Confidence 3445667889999999999999999999875 257999998753211 1122456889999999999999986
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
....+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++
T Consensus 99 ~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a 178 (340)
T PTZ00426 99 SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178 (340)
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCC
Confidence 3456889999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 020016 176 CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255 (332)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (332)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+... ...+|..+++.
T Consensus 179 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~ 254 (340)
T PTZ00426 179 KVVDT--RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG--IIYFPKFLDNN 254 (340)
T ss_pred eecCC--CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHH
Confidence 76533 233567899999999999988999999999999999999999999988877666665433 34567788999
Q ss_pred HHHHHHHccccCCCCCC-----CHHHHHHH
Q 020016 256 FSYLISRCWSSSPDRRP-----HFDQIVSI 280 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rp-----s~~ell~~ 280 (332)
+.+++.+||+.||.+|+ +++++++.
T Consensus 255 ~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 255 CKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 99999999999999995 78888764
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=289.11 Aligned_cols=224 Identities=29% Similarity=0.557 Sum_probs=192.0
Q ss_pred cccccCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
|.++..+|.+.+.||+|+||.||++...+..||+|.+..... .+.+.+|+.++++++|+|+++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCch--------HHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 778889999999999999999999999999999999865322 356889999999999999986
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 73 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152 (256)
T ss_pred CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceec
Confidence 1123778899999999999999999999999999999999999999999999998654
Q ss_pred ccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 020016 179 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 257 (332)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 257 (332)
... .....++..|+|||++.+..++.++||||||+++|+|++ |+.||......+....+. ....+..+..+++.+.
T Consensus 153 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 229 (256)
T cd05082 153 SST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVY 229 (256)
T ss_pred ccc--CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHH
Confidence 332 223345678999999998889999999999999999998 999998877766655543 3445566678899999
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 258 YLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 258 ~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
+++.+||+.+|++||++.++++.|+.+
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=289.29 Aligned_cols=226 Identities=31% Similarity=0.583 Sum_probs=192.7
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
|+++.++|++.++||+|+||.||+|.+. +..||+|.+...... .+.+.+|+.++++++|+|+++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~E~~~l~~l~~~~i~~~~~~~~~~ 73 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-------PESFLEEAQIMKKLRHDKLVQLYAVVSEE 73 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC-------HHHHHHHHHHHHhcCCCceEEEEeEECCC
Confidence 7788899999999999999999999886 578999998764432 256889999999999999976
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 74 PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIE 153 (260)
T ss_pred CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeecc
Confidence 12357889999999999999999999999999999999999999999999999987644
Q ss_pred cCCC--CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 020016 180 QCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 256 (332)
Q Consensus 180 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (332)
.... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+. .....+.+...+..+
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPISL 232 (260)
T ss_pred CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHH
Confidence 3221 122335668999999988889999999999999999999 999998877766655543 344556677889999
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHh
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVSILEG 283 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~~L~~ 283 (332)
.+++.+||..+|++|||+.++.+.|+.
T Consensus 233 ~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 233 HELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=312.68 Aligned_cols=223 Identities=24% Similarity=0.350 Sum_probs=181.1
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
..+|.+++.||+|+||.||+|.+. ++.||||++.... ....+|+.+++.++|||||+
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----------QYKNRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----------chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 468999999999999999999985 7899999886532 12346999999999999975
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC-eEEEee
Q 020016 121 ----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVAD 171 (332)
Q Consensus 121 ----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~-~~kl~D 171 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 135 ~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred cCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence 124577888999999999999999999999999999999998764 799999
Q ss_pred cccccccccCCCCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----
Q 020016 172 FGISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR----- 245 (332)
Q Consensus 172 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~----- 245 (332)
||++.............+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+......
T Consensus 215 FGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 215 FGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ 294 (440)
T ss_pred cccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 9999766544444456789999999998764 6899999999999999999999999987765554443321111
Q ss_pred ----------------------CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH--HHHhhhh
Q 020016 246 ----------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYSE 286 (332)
Q Consensus 246 ----------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~--~L~~~~~ 286 (332)
..+|...++++.+||.+||..||.+|||+.++++ .++.+..
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 1134456789999999999999999999999985 4554433
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=294.47 Aligned_cols=227 Identities=31% Similarity=0.590 Sum_probs=191.2
Q ss_pred cccCCeeeeeeecccCceEEEEEEECC-------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
++.++|++.+.||+|+||.||+|.+.+ ..||+|.+....... ....|.+|+.++..++||||++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~-----~~~~~~~ei~~l~~l~h~~i~~~~~~ 76 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK-----VQQEFRQEAELMSDLQHPNIVCLLGV 76 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHH-----HHHHHHHHHHHHHhcCCcccceEEEE
Confidence 456789999999999999999998752 569999987543322 2467899999999999999986
Q ss_pred ------------------------C----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccccccee
Q 020016 121 ------------------------E----------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 160 (332)
Q Consensus 121 ------------------------~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIl 160 (332)
. ...+++..+..++.|++.||.|||++|++|+||||+||+
T Consensus 77 ~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil 156 (283)
T cd05048 77 CTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCL 156 (283)
T ss_pred EcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEE
Confidence 0 045778888999999999999999999999999999999
Q ss_pred ecCCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 020016 161 LGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAA 236 (332)
Q Consensus 161 l~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~ 236 (332)
++.++.++|+|||++....... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+....+..
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236 (283)
T ss_pred EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999999986543221 1233456788999999998899999999999999999998 99999988887766
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 237 FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
..+. .......+..+++++.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 237 ~~i~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 237 EMIR-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHH-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 5554 4445566788999999999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=295.04 Aligned_cols=226 Identities=32% Similarity=0.526 Sum_probs=181.6
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC------------------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK------------------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN 114 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~------------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 114 (332)
..++|.+.++||+|+||.||+|.+. +..||||++....... ....|.+|+.++.+++
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~ 77 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKN-----ARNDFLKEVKILSRLK 77 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHH-----HHHHHHHHHHHHhhcC
Confidence 3468999999999999999999863 2369999987643322 2467899999999999
Q ss_pred CCceec------------------CC-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHC
Q 020016 115 HPHIIT------------------EP-----------------------------YSVPLNLVLKLALDIARGMQYLHSQ 147 (332)
Q Consensus 115 h~niv~------------------~~-----------------------------~~l~~~~~~~i~~qi~~~L~~LH~~ 147 (332)
||||++ .. ..+++..+..++.||+.||.|||+.
T Consensus 78 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 78 DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred CCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 999986 01 1356678899999999999999999
Q ss_pred CCccccccccceeecCCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh--
Q 020016 148 GILHRDLKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-- 222 (332)
Q Consensus 148 ~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-- 222 (332)
||+||||||+|||++.++.+||+|||++....... ......++..|+|||++.++.++.++||||||+++|+|++
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 99999999999999999999999999986543221 1223345788999999998899999999999999999987
Q ss_pred CCCCCCCCCHHHHHHHHHh------cCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 020016 223 ALTPFDNMTPEQAAFAVCQ------KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 283 (332)
Q Consensus 223 G~~pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~ 283 (332)
+..||...+..+....... .......++.++..+.+|+.+||+.||.+|||+.+|.+.|++
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 6678887776554433321 111223456788999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=303.13 Aligned_cols=223 Identities=23% Similarity=0.290 Sum_probs=181.3
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||.||++.+. ++.||||++........ ....+.+|+.+++.++||||++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChH----HHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 579999999999999999999886 78999999976543322 1356788999999999999986
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 92 ~~~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 92 EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred cccceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 012367788889999999999999999999999999999999999999999999976554
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------------
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR--------------- 245 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~--------------- 245 (332)
........+|+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+...........
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T cd07874 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_pred ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHH
Confidence 44445567899999999999989999999999999999999999999876654433222110000
Q ss_pred -------------------------CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 246 -------------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 246 -------------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
...+...+..+.+||.+||..||++|||+.++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00112235678999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=288.76 Aligned_cols=228 Identities=32% Similarity=0.586 Sum_probs=191.9
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
|.++.++|.+.++||+|+||.||+|.+. ...||+|++...... .+.|.+|+.+++.++||||++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~-------~~~~~~E~~~l~~l~~~~i~~~~~~~~~~ 73 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-------PEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC-------HHHHHHHHHHHHhCCCCCcceEEEEECCC
Confidence 6778889999999999999999999886 457999999763332 246889999999999999876
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 153 (262)
T ss_pred CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecc
Confidence 12347888999999999999999999999999999999999999999999999987554
Q ss_pred cCCC--CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 020016 180 QCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 256 (332)
Q Consensus 180 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (332)
.... .....++..|+|||...+..++.++||||||+++|+|+| |..||......+....+. .......+..++..+
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 232 (262)
T cd05071 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESL 232 (262)
T ss_pred ccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-cCCCCCCccccCHHH
Confidence 3221 123345678999999988889999999999999999999 899998877766555443 333445567789999
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVSILEGYS 285 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~~L~~~~ 285 (332)
.+++.+||+.+|++||++.++++.|+.+.
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 233 HDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 99999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=287.13 Aligned_cols=223 Identities=24% Similarity=0.306 Sum_probs=188.7
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.....|++|+||.||+|+++ ++.||+|.++........ .-.-++|+.+|.+++|||||.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GF----PItsLREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGF----PITSLREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCC----cchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 478999999999999999999997 789999999886544332 234578999999999999986
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
-..++...++..++.|++.|++|||.+.|+|||||++|+|++..|.+||+|||+|+.++..
T Consensus 151 ~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 151 KIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 3468899999999999999999999999999999999999999999999999999877654
Q ss_pred -CCCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC------------
Q 020016 182 -GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------------ 247 (332)
Q Consensus 182 -~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~------------ 247 (332)
...+..+.|..|.|||.+.+. .|+.+.|+||+|||+.||+++++.|++.+..+....+......+.
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 345567889999999998875 589999999999999999999999999887776666554222221
Q ss_pred -----------------CCCC-CcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 248 -----------------VPPT-CPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 248 -----------------~~~~-~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
++.. ++..-.+|+..+|..||.+|.|+++.++.
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1111 45777899999999999999999998763
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=312.73 Aligned_cols=224 Identities=25% Similarity=0.414 Sum_probs=190.2
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
...++|.+.+.||+|+||+||+|.+. ++.||||++........ ....+.+|+.++..++|+||++
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~----~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEA----DKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHH----HHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 34579999999999999999999885 78999999976543221 1356789999999999999874
Q ss_pred -------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEE
Q 020016 121 -------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 169 (332)
Q Consensus 121 -------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl 169 (332)
....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEE
Confidence 1235778889999999999999999999999999999999999999999
Q ss_pred eecccccccccC---CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Q 020016 170 ADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 246 (332)
Q Consensus 170 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~ 246 (332)
+|||++...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+.. ....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-~~~~ 263 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-GRYD 263 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCC
Confidence 999998754322 223456799999999999999999999999999999999999999998887766655543 3345
Q ss_pred CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 247 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 247 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
+++..+++++.+++.+||+.||.+||++.+++..
T Consensus 264 ~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 264 PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 6778899999999999999999999999999863
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=294.40 Aligned_cols=226 Identities=27% Similarity=0.520 Sum_probs=189.2
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
++.++|.+.+.||.|+||.||+|.+. +..||||++....... ..+.+.+|+.++..++||||++
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~~~~l~h~~iv~~~~~ 76 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGP-----LREEFKHEAMMRSRLQHPNIVCLLGV 76 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHH-----HHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 45678999999999999999999874 3679999998654321 2466889999999999999985
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccccccee
Q 020016 121 ----------------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 160 (332)
Q Consensus 121 ----------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIl 160 (332)
....+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 77 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil 156 (283)
T cd05091 77 VTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL 156 (283)
T ss_pred EcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheE
Confidence 0124678888999999999999999999999999999999
Q ss_pred ecCCCeEEEeecccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 020016 161 LGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAA 236 (332)
Q Consensus 161 l~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~ 236 (332)
++.++.+||+|||++........ .....+++.|+|||.+.++.++.++||||||+++|||++ |..||.+....+..
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred ecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999865432211 123345789999999988889999999999999999998 89999988777665
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 020016 237 FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 283 (332)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~ 283 (332)
..+. .......+..++..+.+++..||+.+|.+||++.+|+..|+.
T Consensus 237 ~~i~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIR-NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHH-cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 5554 344456678899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=303.62 Aligned_cols=222 Identities=21% Similarity=0.324 Sum_probs=187.0
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||+||+|.+. ++.||||++...... .......+.+|+.++..++||||++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 77 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI---KRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLY 77 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh---hccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEE
Confidence 47999999999999999999997 889999999763211 1122466889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC--
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-- 182 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 182 (332)
....+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 23578999999999999999999999999999999999999999999999999987544322
Q ss_pred ----------------------------CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHH
Q 020016 183 ----------------------------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 234 (332)
Q Consensus 183 ----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~ 234 (332)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 2234568999999999999999999999999999999999999999988777
Q ss_pred HHHHHHhcCCCCCC--CCCCcHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 020016 235 AAFAVCQKNARPPV--PPTCPKAFSYLISRCWSSSPDRRPH-FDQIVSI 280 (332)
Q Consensus 235 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~Rps-~~ell~~ 280 (332)
....+........+ ...+++.+.++|.+||. ||.+||+ +.++++.
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 66666552222233 33469999999999998 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=325.76 Aligned_cols=233 Identities=30% Similarity=0.561 Sum_probs=203.6
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC---Ce----eEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK---QR----DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~---~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
++.++.++.+.||+|+||.||.|... +. .||||.+........ ..+|.+|..+|+.++|||||+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~-----~~~Fl~Ea~~m~~f~HpNiv~liGv 763 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQE-----VSDFLKEALLMSKFDHPNIVSLIGV 763 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHH-----HHHHHHHHHHHhcCCCcceeeEEEe
Confidence 55788999999999999999999986 32 389999887544432 578999999999999999997
Q ss_pred -------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEE
Q 020016 121 -------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 169 (332)
Q Consensus 121 -------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl 169 (332)
....++....+.++.||++|+.||+++++|||||..+|+|++....+||
T Consensus 764 ~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 764 CLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred ecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEE
Confidence 3567899999999999999999999999999999999999999999999
Q ss_pred eecccccccccCCC--C-CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCC
Q 020016 170 ADFGISCLESQCGS--A-KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 245 (332)
Q Consensus 170 ~Dfg~a~~~~~~~~--~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 245 (332)
+|||+|+....... . ....-...|||||.+..+.++.++|||||||++||++| |..||.+.++.++...+...+ +
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-R 922 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-R 922 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-c
Confidence 99999984332221 1 11244679999999999999999999999999999999 999999999999887676555 9
Q ss_pred CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 020016 246 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 290 (332)
Q Consensus 246 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~ 290 (332)
.+.|..|+..+.++|..||+.+|++||++..|++.+..+......
T Consensus 923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 999999999999999999999999999999999999987776653
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=301.40 Aligned_cols=223 Identities=21% Similarity=0.334 Sum_probs=191.2
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
-.++|.+++.||+|+||.||+|+-+ |..+|+|+++++.- ......+.+..|-++|...++|+||+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M---~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEM---LKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHH---HhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 4689999999999999999999876 89999999988533 22333567889999999999999998
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc--
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-- 180 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-- 180 (332)
..+.|+++.+..++.+++.|+..+|+.|+|||||||+|+|||..|++||+|||++.....
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 567899999999999999999999999999999999999999999999999999842100
Q ss_pred --------------------CC-C-------------------------CCCcccccccCChhhhhcCCCCCccchhHHH
Q 020016 181 --------------------CG-S-------------------------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFG 214 (332)
Q Consensus 181 --------------------~~-~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG 214 (332)
.. . ....+|||.|+|||++.+..|+..+|+||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 00 0 0124599999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHccccCCCCCCC---HHHHHH
Q 020016 215 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYLISRCWSSSPDRRPH---FDQIVS 279 (332)
Q Consensus 215 ~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rps---~~ell~ 279 (332)
|||||||.|.+||.+.++.+....+........+| ..++++..+||.+||. ||++|.. ++||-+
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 99999999999999999999999888877555555 4578999999999999 9999975 555554
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=302.06 Aligned_cols=225 Identities=27% Similarity=0.433 Sum_probs=181.1
Q ss_pred ccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
....++|.+.+.||.|+||.||+|.+. ++.||||++....... ....+.+|+.+++.++|+||++
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDT-----VRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHH-----HHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 344678999999999999999999986 7899999996543322 2467889999999999999987
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-C
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-S 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~ 183 (332)
......+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 145 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred CeEEEEEecCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 12235677888999999999999999999999999999999999999999999987654322 2
Q ss_pred CCCcccccccCChhhhhc-----CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcCCCCCCCCCCcHHH
Q 020016 184 AKGFTGTYRWMAPEMIKE-----KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA--AFAVCQKNARPPVPPTCPKAF 256 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l 256 (332)
.....||..|+|||++.. ...+.++|||||||++|+|++|+.||......+. .............+..++.++
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 304 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF 304 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence 234578999999998743 2345689999999999999999999974332221 111112334455667889999
Q ss_pred HHHHHHccccCCCCCCCHHHHHHH
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
.+||.+||+.||++||++.++++.
T Consensus 305 ~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 305 RHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999974
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=297.02 Aligned_cols=221 Identities=27% Similarity=0.413 Sum_probs=196.9
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
.+|.+.+.||.|.||.|-+|... |+.||||.+++....... -.-.+.+|++||+.|+||||+.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeq---DlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQ---DLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHH---HHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 68999999999999999999885 899999999885443321 1345789999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 184 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 184 (332)
..+.+++.+++.+++||++|+.|||.++++|||||.+|||+|.++++||+|||++..+......
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFL 209 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHH
Confidence 5678999999999999999999999999999999999999999999999999999888887778
Q ss_pred CCcccccccCChhhhhcCCC-CCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHc
Q 020016 185 KGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 263 (332)
.++||++-|.+||++.+.+| ++.+|.||||++||.|+.|..||++.+....+.++..+..+.+ .-+....-||++|
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP---~~PSdA~gLIRwm 286 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP---ETPSDASGLIRWM 286 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC---CCCchHHHHHHHH
Confidence 89999999999999999988 7899999999999999999999999999888888876655543 2345678899999
Q ss_pred cccCCCCCCCHHHHHHHH
Q 020016 264 WSSSPDRRPHFDQIVSIL 281 (332)
Q Consensus 264 l~~dp~~Rps~~ell~~L 281 (332)
|-.||++|.|+.+|....
T Consensus 287 LmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 287 LMVNPERRATIEDIASHW 304 (668)
T ss_pred HhcCcccchhHHHHhhhh
Confidence 999999999999998754
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=289.36 Aligned_cols=228 Identities=31% Similarity=0.553 Sum_probs=192.3
Q ss_pred cccccCCeeeeeeecccCceEEEEEEECC-------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-- 120 (332)
|+++.++|.+.+.||.|+||.||+|.+.+ ..||+|.+....... ....+.+|+.+++.++||||++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~ 75 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR-----ERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHH-----HHHHHHHHHHHHHhCCCCceeEEE
Confidence 77888999999999999999999998852 679999987543222 1356889999999999999986
Q ss_pred ----------------C--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC
Q 020016 121 ----------------E--------------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED 164 (332)
Q Consensus 121 ----------------~--------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~ 164 (332)
. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.+
T Consensus 76 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~ 155 (277)
T cd05032 76 GVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED 155 (277)
T ss_pred EEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC
Confidence 0 1235677889999999999999999999999999999999999
Q ss_pred CeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 020016 165 MCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVC 240 (332)
Q Consensus 165 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~ 240 (332)
+.++|+|||++....... ......++..|+|||.+.++.++.++||||||+++|++++ |..||...+..+....+.
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 999999999986543322 1223446789999999998889999999999999999998 999999888777666554
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 020016 241 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 283 (332)
Q Consensus 241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~ 283 (332)
.......+..++..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 236 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 -DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 445566778889999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=296.16 Aligned_cols=221 Identities=24% Similarity=0.336 Sum_probs=175.4
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||.|+||.||+|.+. ++.||||++........ ...+.+|+.+++.++||||++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-----PFTAIREASLLKGLKHANIVLLHDIIHTKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc-----chhHHHHHHHHhhCCCCCcCeEEEEEecCCeE
Confidence 368999999999999999999996 78999999976433221 235678999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-C
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-G 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~ 182 (332)
....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 79 TLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred EEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 2356889999999999999999999999999999999999999999999999998654322 2
Q ss_pred CCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCCC--------------
Q 020016 183 SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-AAFAVCQKNARP-------------- 246 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~-~~~~~~~~~~~~-------------- 246 (332)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ....+......+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 2334568999999999865 457889999999999999999999998754322 211111100000
Q ss_pred -------CCC---------CCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 -------PVP---------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 -------~~~---------~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..+ ...++.+.+|+.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000 123467889999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=297.53 Aligned_cols=212 Identities=24% Similarity=0.358 Sum_probs=177.6
Q ss_pred ecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------------
Q 020016 63 FASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------------- 120 (332)
Q Consensus 63 lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------------- 120 (332)
||+|+||.||+|.+. ++.||+|++...... .......+.+|+.++.+++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV---SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCC
Confidence 699999999999996 678999998753211 1122456788999999999999986
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc-CCCCCCccccc
Q 020016 121 --------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKGFTGTY 191 (332)
Q Consensus 121 --------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~ 191 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..... ........||+
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 345688999999999999999999999999999999999999999999999999875322 22234567999
Q ss_pred ccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCC
Q 020016 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 271 (332)
Q Consensus 192 ~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 271 (332)
.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+. .....++..+++.+.+++.+||+.||.+|
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dp~~R 235 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL--QEPLRFPDGFDRDAKDLLIGLLSRDPTRR 235 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHcCCCHHHc
Confidence 9999999999999999999999999999999999999887776665554 33456677899999999999999999999
Q ss_pred CCH---HHHHH
Q 020016 272 PHF---DQIVS 279 (332)
Q Consensus 272 ps~---~ell~ 279 (332)
|++ .+++.
T Consensus 236 ~~~~~~~e~l~ 246 (312)
T cd05585 236 LGYNGAQEIKN 246 (312)
T ss_pred CCCCCHHHHHc
Confidence 864 55543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=290.99 Aligned_cols=218 Identities=34% Similarity=0.648 Sum_probs=184.0
Q ss_pred eeeeeecccCceEEEEEEEC------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 58 FIGCKFASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 58 ~i~~~lg~G~~g~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.+.+.||.|.||.||+|.+. +..|+||.+........ .+.|.+|++.+++++||||++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~-----~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEE-----EEEFLNEIQILRKLRHPNIVKLYGFCIENEPL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHH-----HHHHHHHHHHHHTHSBTTBE-EEEEEESSSSE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccccccc-----ceeeeecccccccccccccccccccccccccc
Confidence 56789999999999999997 57899999965433221 477999999999999999987
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..|+.||+.||.|||+++++|+||+++||+++.++.+||+|||++......
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2468999999999999999999999999999999999999999999999999998765221
Q ss_pred C---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 020016 182 G---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 257 (332)
Q Consensus 182 ~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 257 (332)
. ..........|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+ ....+...+..++..+.
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIY 235 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHH
Confidence 1 1233456789999999999999999999999999999999 78999999888877666 45666777888999999
Q ss_pred HHHHHccccCCCCCCCHHHHHHHH
Q 020016 258 YLISRCWSSSPDRRPHFDQIVSIL 281 (332)
Q Consensus 258 ~li~~cl~~dp~~Rps~~ell~~L 281 (332)
+++..||..+|.+||++.++++.|
T Consensus 236 ~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 236 SLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHhcC
Confidence 999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=301.60 Aligned_cols=223 Identities=23% Similarity=0.294 Sum_probs=182.1
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceecC----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITE---------- 121 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~---------- 121 (332)
.++|.+.+.||+|+||.||++.+. ++.||||++......... ...+.+|+.+++.++||||+..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH----AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchh----HHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence 478999999999999999999986 789999999764332221 3567889999999999999861
Q ss_pred ---------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 122 ---------------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 122 ---------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 99 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 99 EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred cccCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 12357788899999999999999999999999999999999999999999999976655
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------------
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR--------------- 245 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~--------------- 245 (332)
........+|..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (364)
T cd07875 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 258 (364)
T ss_pred CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence 44445567899999999999999999999999999999999999999887765544333221110
Q ss_pred -----CC--------------------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 246 -----PP--------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 246 -----~~--------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
+. .....+..+.+||.+||+.||.+|||+.++++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 011134678999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=285.86 Aligned_cols=227 Identities=32% Similarity=0.594 Sum_probs=191.1
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
|+++.++|.+.+.||.|++|.||+|.+. +..+|+|.+...... .+.+.+|+.+++.++|+|+++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 73 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-------PEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc-------HHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 6677789999999999999999999987 457999988654322 356889999999999999886
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIE 153 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEcc
Confidence 12347888899999999999999999999999999999999999999999999986543
Q ss_pred cCCC--CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 020016 180 QCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 256 (332)
Q Consensus 180 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (332)
.... .....++..|+|||...+..++.++|+||||+++|+|+| |..||.+....+....+. .......+...+..+
T Consensus 154 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (260)
T cd05069 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESL 232 (260)
T ss_pred CCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHH
Confidence 3221 122345678999999998889999999999999999999 999999877766555443 344455667789999
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
.+++.+||..||.+||+++++++.|+++
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 233 HELMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 9999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=298.94 Aligned_cols=215 Identities=24% Similarity=0.331 Sum_probs=180.9
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------------
Q 020016 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------------ 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 120 (332)
+.||+|+||.||++.+. ++.||||++...... .......+.+|+.+++.++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII---AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCC
Confidence 46999999999999986 789999999763221 1122456889999999999999986
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc-CCCCCCccc
Q 020016 121 ----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKGFTG 189 (332)
Q Consensus 121 ----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~~~~~~~~g 189 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........|
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 345688999999999999999999999999999999999999999999999999865322 222344679
Q ss_pred ccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCC
Q 020016 190 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 269 (332)
Q Consensus 190 t~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 269 (332)
|+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..+++++.+++.+||..||.
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEDIKFPRTLSADAKSLLSGLLIKDPN 235 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc--cCCccCCCCCCHHHHHHHHHHcCCCHH
Confidence 999999999999899999999999999999999999998877766555443 334567788999999999999999999
Q ss_pred CCC-----CHHHHHHH
Q 020016 270 RRP-----HFDQIVSI 280 (332)
Q Consensus 270 ~Rp-----s~~ell~~ 280 (332)
+|+ ++.++++.
T Consensus 236 ~R~~~~~~~~~~il~h 251 (328)
T cd05593 236 KRLGGGPDDAKEIMRH 251 (328)
T ss_pred HcCCCCCCCHHHHhcC
Confidence 997 88888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=297.54 Aligned_cols=218 Identities=24% Similarity=0.356 Sum_probs=180.0
Q ss_pred eeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHH---HcCCCCceec-----------
Q 020016 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALL---FRLNHPHIIT----------- 120 (332)
Q Consensus 57 y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~----------- 120 (332)
|.+.+.||+|+||.||+|.+. ++.||||++....... ....+.+.+|+.++ ..++||||++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA---RDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEE
Confidence 678999999999999999986 7899999997532111 11134566665554 5678999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc-CCC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGS 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~~~ 183 (332)
....+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++..... ...
T Consensus 78 ~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCc
Confidence 345789999999999999999999999999999999999999999999999998864322 223
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHc
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 263 (332)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+... ...++..+++.+.++|.+|
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~ 235 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND--EVRYPRFLSREAISIMRRL 235 (324)
T ss_pred ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHH
Confidence 34567899999999999999999999999999999999999999988877766665433 3456778899999999999
Q ss_pred cccCCCCCC-----CHHHHHH
Q 020016 264 WSSSPDRRP-----HFDQIVS 279 (332)
Q Consensus 264 l~~dp~~Rp-----s~~ell~ 279 (332)
|+.||.+|| ++.++++
T Consensus 236 L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 236 LRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred hhcCHhHcCCCCCCCHHHHhh
Confidence 999999999 4666665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=286.32 Aligned_cols=226 Identities=34% Similarity=0.581 Sum_probs=190.3
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC-----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
+.++|++.+.||+|+||+||+|.+. ...||||.+....... ....|.+|+.+++.++||||++
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDK-----QRLDFLTEASIMGQFDHPNIIRLEGVVTK 76 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChH-----HHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence 4578999999999999999999885 2479999987644322 2467889999999999999976
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
..+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 2346889999999999999999999999999999999999999999999999998765
Q ss_pred ccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 020016 179 SQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254 (332)
Q Consensus 179 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (332)
.... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+. .....+.+..++.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDCPS 235 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 4211 1112334678999999998899999999999999999998 999998887776655553 3344455677899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 255 AFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 255 ~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
.+.+++.+||+.+|++||++.++++.|+++
T Consensus 236 ~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 236 ALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=285.17 Aligned_cols=222 Identities=26% Similarity=0.521 Sum_probs=186.9
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
+|.++|++.+.||+|+||.||++.++ +..+|+|.+...... .+.|.+|+.+++.++||||++
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (256)
T cd05114 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-------EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKP 73 (256)
T ss_pred CCHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc-------HHHHHHHHHHHHHCCCCCceeEEEEEccCCC
Confidence 35678999999999999999999987 568999988654322 256889999999999999986
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 74 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 74 LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 2245788999999999999999999999999999999999999999999999988654322
Q ss_pred CC--CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 020016 182 GS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 258 (332)
Q Consensus 182 ~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 258 (332)
.. .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+.. ......+...+..+.+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~ 232 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRPKLASMTVYE 232 (256)
T ss_pred ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHH
Confidence 11 122345668999999998889999999999999999999 9999998887776666543 3344556667889999
Q ss_pred HHHHccccCCCCCCCHHHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVSIL 281 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~~L 281 (332)
++.+||..+|++||++.++++.|
T Consensus 233 li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 233 VMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHccCCcccCcCHHHHHHhh
Confidence 99999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=290.81 Aligned_cols=220 Identities=25% Similarity=0.336 Sum_probs=177.0
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC---CCCceec----------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL---NHPHIIT---------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~---------- 120 (332)
+|.+.+.||+|+||+||+|.+. ++.||+|.+......... ...+.+|+.+++.+ +||||++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~ 76 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL----PLSTVREVALLKRLEAFDHPNIVRLMDVCATSRT 76 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC----chHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC
Confidence 5889999999999999999986 789999998764322211 12345677666655 7999885
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccc
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
....+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.
T Consensus 77 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 77 DRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred CCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 12347899999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----------
Q 020016 177 LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR----------- 245 (332)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~----------- 245 (332)
............+|..|+|||++.+..++.++|||||||++|+|++|.+||......+....+......
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred cccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 665444444567899999999999889999999999999999999999999887665544433221100
Q ss_pred --------------CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 246 --------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 246 --------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
....+.++..+.+++.+||+.||.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0012356788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=284.49 Aligned_cols=227 Identities=33% Similarity=0.619 Sum_probs=192.6
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
|+++.++|.+.+.||+|+||.||+|.++ +..||||.+...... .+.+.+|+.+++.++|+||++
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-------PEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC-------HHHHHHHHHHHhhCCCCCEeeeeeeeecC
Confidence 7788899999999999999999999987 578999998864432 256889999999999999986
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 74 ~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 74 EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceec
Confidence 1235788999999999999999999999999999999999999999999999998654
Q ss_pred ccCCC--CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 020016 179 SQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255 (332)
Q Consensus 179 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (332)
..... ......+..|+|||.+.+..++.++|+||||+++|++++ |+.||.+.+.......+. .......+...+..
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 232 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEE 232 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 42111 112234568999999998889999999999999999999 999998887766655553 34455666778999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 256 FSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
+.+++.+||..+|.+||++.++.+.|+.+
T Consensus 233 ~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 233 LYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 99999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=300.89 Aligned_cols=221 Identities=20% Similarity=0.278 Sum_probs=183.7
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||.|+||+||+|.+. ++.||||++...... .......+.+|+.++..++||||++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 77 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML---EKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLY 77 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEE
Confidence 47999999999999999999996 789999999753211 1222456788999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC--
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-- 182 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 182 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 34568999999999999999999999999999999999999999999999999986432110
Q ss_pred -------------------------------------CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCC
Q 020016 183 -------------------------------------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALT 225 (332)
Q Consensus 183 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~ 225 (332)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0112468999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHccccCCCCCCC---HHHHHH
Q 020016 226 PFDNMTPEQAAFAVCQKNARPPVPP--TCPKAFSYLISRCWSSSPDRRPH---FDQIVS 279 (332)
Q Consensus 226 pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~~Rps---~~ell~ 279 (332)
||...+..+....+........++. .+++.+.++|.+|+. +|.+|++ +.++++
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999888776666654443334443 468999999999997 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=283.73 Aligned_cols=225 Identities=31% Similarity=0.609 Sum_probs=193.2
Q ss_pred cccccCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
|.++.++|.+.+.||.|+||.||+|...++.||||.+..... ..+.+.+|+.+++.++|+||++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 73 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGN 73 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCC
Confidence 566778999999999999999999999999999999976543 1467899999999999999986
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccc
Confidence 11268899999999999999999999999999999999999999999999999987653
Q ss_pred cCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 020016 180 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 258 (332)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 258 (332)
.... ....+..|+|||.+.++.++.++||||||+++|+|++ |..||......+....+. .......+..+++.+.+
T Consensus 154 ~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 230 (256)
T cd05039 154 QGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYK 230 (256)
T ss_pred cccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCccCCCHHHHH
Confidence 3222 3344668999999988889999999999999999998 999998887766554443 33445566778999999
Q ss_pred HHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 259 LISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
++.+||..+|++||++.+++++|+.+
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHHhccChhhCcCHHHHHHHHhcC
Confidence 99999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=284.63 Aligned_cols=218 Identities=27% Similarity=0.551 Sum_probs=183.9
Q ss_pred eecccCceEEEEEEEC----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------------
Q 020016 62 KFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------------- 120 (332)
Q Consensus 62 ~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 120 (332)
+||+|+||.||+|.++ +..||+|++....... ...+.+.+|+.+++.++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP----ALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcH----HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecC
Confidence 6899999999999763 5789999987654322 22467899999999999999885
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC----CCC
Q 020016 121 ----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS----AKG 186 (332)
Q Consensus 121 ----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~----~~~ 186 (332)
....+++..+..++.|++.||.|||++|++||||||.||+++.++.++|+|||++........ ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 234678999999999999999999999999999999999999999999999999875443221 122
Q ss_pred cccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccc
Q 020016 187 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 265 (332)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 265 (332)
..++..|+|||.+....++.++|+||||+++|||++ |..||......+....+. ....+..+..+++++.++|.+||+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHhc
Confidence 234578999999988888999999999999999998 999999877766655543 445567788899999999999999
Q ss_pred cCCCCCCCHHHHHHHHHhh
Q 020016 266 SSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 266 ~dp~~Rps~~ell~~L~~~ 284 (332)
.||++||++++|.+.|+.+
T Consensus 237 ~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 237 YGVDERPGFAVVELRLRNY 255 (257)
T ss_pred cCchhCcCHHHHHHHHhcc
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=297.30 Aligned_cols=214 Identities=22% Similarity=0.337 Sum_probs=179.9
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------------
Q 020016 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------------ 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 120 (332)
+.||+|+||.||++.+. ++.||+|++...... .......+.+|+.+++.++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII---AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh---hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCC
Confidence 46999999999999986 789999999763211 1122356788999999999999986
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc-CCCCCCccc
Q 020016 121 ----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKGFTG 189 (332)
Q Consensus 121 ----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~~~~~~~~g 189 (332)
....+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..... ........|
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 345689999999999999999999999999999999999999999999999999865322 222334678
Q ss_pred ccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCC
Q 020016 190 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 269 (332)
Q Consensus 190 t~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 269 (332)
|+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.. ....++..+++++.+++.+||..||.
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 9999999999999999999999999999999999999998877766655543 23456778999999999999999999
Q ss_pred CCC-----CHHHHHH
Q 020016 270 RRP-----HFDQIVS 279 (332)
Q Consensus 270 ~Rp-----s~~ell~ 279 (332)
+|| ++.++++
T Consensus 236 ~R~~~~~~~~~~~l~ 250 (323)
T cd05595 236 QRLGGGPSDAKEVME 250 (323)
T ss_pred HhCCCCCCCHHHHHc
Confidence 998 7888775
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=287.44 Aligned_cols=228 Identities=31% Similarity=0.552 Sum_probs=187.3
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-- 120 (332)
|.+..++|++.+.||+|+||.||+|.+. +..||||++....... ....|.+|+.+++.++||||++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~iv~~~ 75 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR-----ERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHH-----HHHHHHHHHHHHHhCCCCCeeeEE
Confidence 6777899999999999999999999875 3579999986533211 1356889999999999999986
Q ss_pred ----------------C--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC
Q 020016 121 ----------------E--------------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED 164 (332)
Q Consensus 121 ----------------~--------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~ 164 (332)
. ...+++..+..++.|++.||.|||+.|++|+||||+||+++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 76 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 155 (277)
T ss_pred EEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC
Confidence 0 1124567788999999999999999999999999999999999
Q ss_pred CeEEEeecccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 020016 165 MCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVC 240 (332)
Q Consensus 165 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~ 240 (332)
+.++|+|||++........ .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+.
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999864432211 112345778999999998889999999999999999999 799999887766555443
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 020016 241 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 283 (332)
Q Consensus 241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~ 283 (332)
.......+..++..+.+++.+||+.+|++||++.++++.|+.
T Consensus 236 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 -EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 333445667789999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=301.80 Aligned_cols=239 Identities=33% Similarity=0.530 Sum_probs=187.8
Q ss_pred cCCCccccccccCCeeeeeeecccCceEEEEEEECC-eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-
Q 020016 43 KGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT- 120 (332)
Q Consensus 43 ~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~- 120 (332)
..+...+....+++|.-...||+|+||.||+|...+ +.||||.+....... ..+|.+|+.++.+++|||+|+
T Consensus 63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~------~~eF~~Ei~~ls~l~H~Nlv~L 136 (361)
T KOG1187|consen 63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG------EREFLNEVEILSRLRHPNLVKL 136 (361)
T ss_pred ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc------hhHHHHHHHHHhcCCCcCcccE
Confidence 334556666678899999999999999999999985 899999887755431 145999999999999999997
Q ss_pred -----------------------------CCC-CCCHHHHHHHHHHHHHHHHHHHHCC---CccccccccceeecCCCeE
Q 020016 121 -----------------------------EPY-SVPLNLVLKLALDIARGMQYLHSQG---ILHRDLKSENLLLGEDMCV 167 (332)
Q Consensus 121 -----------------------------~~~-~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~NIll~~~~~~ 167 (332)
... .++|..+.+|+.++|.||+|||... |+|||||+.|||+|++.++
T Consensus 137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 122 7899999999999999999999864 9999999999999999999
Q ss_pred EEeeccccccccc-CCCCCCc-ccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCC---H---HHHHHHH
Q 020016 168 KVADFGISCLESQ-CGSAKGF-TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT---P---EQAAFAV 239 (332)
Q Consensus 168 kl~Dfg~a~~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~---~---~~~~~~~ 239 (332)
||+|||+|..... ....... .||.+|+|||++..+..+.++||||||++|+|++||+.+.+... . .+.....
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 9999999966554 3322223 89999999999999999999999999999999999998877532 1 1111111
Q ss_pred Hhc-CC----CCCCC-CCCc-----HHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 240 CQK-NA----RPPVP-PTCP-----KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 240 ~~~-~~----~~~~~-~~~~-----~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
... .. .+.+. ...+ ..+..+..+|++.+|.+||+|.+|++.|+.+...
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 111 11 11221 2223 2256788899999999999999999999665443
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=298.52 Aligned_cols=222 Identities=20% Similarity=0.273 Sum_probs=182.5
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|++.+.||+|+||+||++.+. ++.||||++...... .......+.+|+.++..++|+||++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~ 77 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML---EKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLY 77 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH---HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEE
Confidence 47899999999999999999986 789999999763211 1222456888999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC--
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-- 182 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 182 (332)
....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 34678999999999999999999999999999999999999999999999999986432110
Q ss_pred ----------------------------------CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCC
Q 020016 183 ----------------------------------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 228 (332)
Q Consensus 183 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~ 228 (332)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 0123579999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHccccCCC---CCCCHHHHHHH
Q 020016 229 NMTPEQAAFAVCQKNARPPVPP--TCPKAFSYLISRCWSSSPD---RRPHFDQIVSI 280 (332)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~---~Rps~~ell~~ 280 (332)
+.+..+....+........+|+ .+++++.+++.+++. +|. .||+++++++.
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 8888777776665444444443 468899999998654 344 46899999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=285.87 Aligned_cols=223 Identities=30% Similarity=0.531 Sum_probs=184.4
Q ss_pred eeeeeeecccCceEEEEEEEC--C--eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 57 LFIGCKFASGRHSRIYRGIYK--Q--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 57 y~i~~~lg~G~~g~Vy~~~~~--~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
|.+++.||+|+||.||+|.+. + ..||||.+........ ..+.+.+|+.+++.++|+||++
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRS----EMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE 76 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHH----HHHHHHHHHHHHHhCCCCCcceEEEEEccCCccc
Confidence 357889999999999999986 2 2699999876532222 1467889999999999999886
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeec
Q 020016 121 ----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 172 (332)
Q Consensus 121 ----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Df 172 (332)
....+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+||
T Consensus 77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCC
Confidence 0123678889999999999999999999999999999999999999999999
Q ss_pred ccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 020016 173 GISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 248 (332)
Q Consensus 173 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (332)
|++........ .....+++.|++||.+.+..++.++||||||+++|+|++ |..||......+....+. .......
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~ 235 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-QGNRLKQ 235 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCCCC
Confidence 99876543221 122345678999999999899999999999999999999 899999877766655543 3344456
Q ss_pred CCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 249 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 236 PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 678899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=301.01 Aligned_cols=230 Identities=23% Similarity=0.296 Sum_probs=189.5
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
..+.+..++|.+.+.||+|+||.||++.+. ++.||||++...... .......+.+|+.+++.++||||++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~il~~~~h~~iv~~~~~~ 112 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI---KRSDSAFFWEERDIMAHANSEWIVQLHYAF 112 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh---hhhhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 345667789999999999999999999986 789999999752211 1112345788999999999999986
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 113 QDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred ecCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 2345788999999999999999999999999999999999999999999999998764
Q ss_pred ccCC--CCCCcccccccCChhhhhcC----CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC--
Q 020016 179 SQCG--SAKGFTGTYRWMAPEMIKEK----RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP-- 250 (332)
Q Consensus 179 ~~~~--~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 250 (332)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+........++.
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI 272 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcC
Confidence 4322 22346799999999998653 378999999999999999999999999887776666655443444444
Q ss_pred CCcHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 020016 251 TCPKAFSYLISRCWSSSPDR--RPHFDQIVSI 280 (332)
Q Consensus 251 ~~~~~l~~li~~cl~~dp~~--Rps~~ell~~ 280 (332)
.++.++.++|.+||..+|.+ |++++++++.
T Consensus 273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 57999999999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=301.80 Aligned_cols=235 Identities=27% Similarity=0.490 Sum_probs=195.8
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCc
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPH 117 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n 117 (332)
....|+++.++|.+++.||.|+||.||+|.+. +..||||++....... ..+.+.+|+.++.++. |||
T Consensus 28 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~-----~~~~~~~Ei~~l~~l~~Hpn 102 (400)
T cd05105 28 YDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSS-----EKQALMSELKIMTHLGPHLN 102 (400)
T ss_pred CCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChH-----HHHHHHHHHHHHHhcCCCCC
Confidence 34689999999999999999999999999874 2369999997653322 1367899999999996 999
Q ss_pred eec------------------CC---------------------------------------------------------
Q 020016 118 IIT------------------EP--------------------------------------------------------- 122 (332)
Q Consensus 118 iv~------------------~~--------------------------------------------------------- 122 (332)
|++ ..
T Consensus 103 Iv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (400)
T cd05105 103 IVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQ 182 (400)
T ss_pred eeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccc
Confidence 987 00
Q ss_pred -------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 020016 123 -------------------------------------------------YSVPLNLVLKLALDIARGMQYLHSQGILHRD 153 (332)
Q Consensus 123 -------------------------------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~d 153 (332)
..+++..+..++.|++.||.|||+.+++|+|
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~d 262 (400)
T cd05105 183 ADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRD 262 (400)
T ss_pred ccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 1366777889999999999999999999999
Q ss_pred ccccceeecCCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCC
Q 020016 154 LKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 229 (332)
Q Consensus 154 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~ 229 (332)
|||+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 263 ikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 263 LAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred CChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 99999999999999999999986543221 1223346788999999998889999999999999999998 9999988
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 020016 230 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 285 (332)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~ 285 (332)
...............+...+..++..+.+++.+||+.||++||++.+|.+.|+.+.
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 343 MIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred cchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 76555554444555566677788999999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=294.17 Aligned_cols=222 Identities=23% Similarity=0.385 Sum_probs=181.9
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
..++|.+.+.||+|+||.||++.+. +..||+|++....... ..+.+.+|++++++++||||++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPA-----IRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 77 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHH-----HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 4578999999999999999999997 7889999997643221 2467899999999999999986
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.++|+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 235678899999999999999999986 6999999999999999999999999998655332
Q ss_pred CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------------
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ-------------------- 241 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~-------------------- 241 (332)
......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+..
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 23445789999999999998999999999999999999999999987655433221110
Q ss_pred -------------------------cCCCCCC-CCCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 242 -------------------------KNARPPV-PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 242 -------------------------~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
....+.. ...+++++.+||.+||+.||++||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0111111 12467899999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=300.43 Aligned_cols=223 Identities=21% Similarity=0.289 Sum_probs=181.3
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
+.|.+++.||+|+||+||+|.+. ++.||||++...... .....+.+.+|+.++..++||||++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~---~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 77 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL---NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLY 77 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh---hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEE
Confidence 36899999999999999999986 689999999763221 1222467899999999999999987
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC--
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-- 182 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 182 (332)
....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 78 FVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 33567889999999999999999999999999999999999999999999999874321000
Q ss_pred ----------------------------------------------CCCCcccccccCChhhhhcCCCCCccchhHHHHH
Q 020016 183 ----------------------------------------------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIV 216 (332)
Q Consensus 183 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~i 216 (332)
.....+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 0123569999999999998889999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHH--ccccCCCCCCCHHHHHHH
Q 020016 217 LWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYLISR--CWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 217 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~--cl~~dp~~Rps~~ell~~ 280 (332)
+|||++|..||...+..+....+.........+ ..+++++.+||.+ |+..++..||++.+++..
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999999999888766665554433333333 3578999999998 445566669999999873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=292.56 Aligned_cols=230 Identities=22% Similarity=0.337 Sum_probs=183.4
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||.||+|.+. ++.||||.+........ ...+.+|+.+++.++||||++
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 79 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIVHTDKSL 79 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc-----chhHHHHHHHHHhCCCCCcceEEEEEeeCCeE
Confidence 478999999999999999999986 67899999876433221 245778999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 182 (332)
....+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 80 TLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 23457889999999999999999999999999999999999999999999999986543222
Q ss_pred CCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------------
Q 020016 183 SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR---------------- 245 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~---------------- 245 (332)
......+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||.+.+..+....+......
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 2234567899999999865 45789999999999999999999999887765544333211000
Q ss_pred ----C--------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH--HHHhhhhhh
Q 020016 246 ----P--------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYSESL 288 (332)
Q Consensus 246 ----~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~--~L~~~~~~~ 288 (332)
+ ...+.+++++.+++.+||+.||.+|||+.++++ .++.+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~ 296 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRI 296 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccccc
Confidence 0 011346888999999999999999999999987 455444333
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=286.26 Aligned_cols=227 Identities=32% Similarity=0.613 Sum_probs=192.6
Q ss_pred ccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
+-...+|++.+.||.|+||.||+|.+. +..+|+|++....... ...+.+|+.+++.++||||++
T Consensus 2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 75 (261)
T cd05148 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK------QQDFQKEVQALKRLRHKHLISLFAVCSVGE 75 (261)
T ss_pred cCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhh------HHHHHHHHHHHhcCCCcchhheeeeEecCC
Confidence 334568999999999999999999987 6889999987654322 356889999999999999886
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 76 PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 23457899999999999999999999999999999999999999999999999986543
Q ss_pred cCCC-CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 020016 180 QCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 257 (332)
Q Consensus 180 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 257 (332)
.... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. ...+.+.+..+++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (261)
T cd05148 156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIY 234 (261)
T ss_pred CccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHH
Confidence 3221 123345678999999988889999999999999999999 899998887766666554 4455666778899999
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 258 YLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 258 ~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
+++.+||+.||.+||++.++++.|+.+
T Consensus 235 ~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 235 KIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=284.97 Aligned_cols=228 Identities=26% Similarity=0.411 Sum_probs=185.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||.|+||.||+|.+. ++.||||.+....... ......+.+|+.+++.++||||++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD---AKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELN 78 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCC---HHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEE
Confidence 58999999999999999999985 7899999886532211 112467889999999999999986
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 123478889999999999999999999999999999999999999999999998876543
Q ss_pred CC-CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcCCCCCCCCCCcHHHH
Q 020016 181 CG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP--EQAAFAVCQKNARPPVPPTCPKAFS 257 (332)
Q Consensus 181 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~ 257 (332)
.. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ......+......+..+..++..+.
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 22 12235688899999999988899999999999999999999999965432 2333333222222233346788999
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHhhh
Q 020016 258 YLISRCWSSSPDRRPHFDQIVSILEGYS 285 (332)
Q Consensus 258 ~li~~cl~~dp~~Rps~~ell~~L~~~~ 285 (332)
+++.+||..+|++||++.++++.|+.+.
T Consensus 239 ~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 239 ELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 9999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=287.73 Aligned_cols=223 Identities=27% Similarity=0.383 Sum_probs=187.2
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCc-eec----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH-IIT---------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~---------- 120 (332)
...|...++||+|+||+||+|+.+ |+.||+|+++.....+. ......+|+.+|+.|+|+| ||.
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG----~P~taiREisllk~L~~~~~iv~L~dv~~~~~~ 85 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG----VPSTAIREISLLKRLSHANHIVRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC----CCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence 467888899999999999999997 88999999998755322 2345689999999999999 875
Q ss_pred ------------------------CC---CCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecc
Q 020016 121 ------------------------EP---YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 121 ------------------------~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
.. ..++...+..+++||+.||+|||+++|+||||||.||+|+++|.+||+|||
T Consensus 86 ~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccc
Confidence 11 467778999999999999999999999999999999999999999999999
Q ss_pred ccccccc-CCCCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC----
Q 020016 174 ISCLESQ-CGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP---- 247 (332)
Q Consensus 174 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~---- 247 (332)
+|+...- .......++|..|.|||++.+. .|+...|+||+|||++||+++++.|++.+..+....+......+.
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 9986653 3335567789999999999876 689999999999999999999999999998877777655333221
Q ss_pred ------------CC------------CCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 248 ------------VP------------PTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 248 ------------~~------------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
++ +..+++..+++.+||+.+|.+|.|+..++..
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 10 1223578899999999999999999998874
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=302.16 Aligned_cols=215 Identities=26% Similarity=0.427 Sum_probs=171.7
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
....|.+.+.||.|+||.||++.+. ++.||||.... ..+.+|+.++++++||||++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 157 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------------GGTATEAHILRAINHPSIIQLKGTFTYNKF 157 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence 3468999999999999999999996 78999997532 34678999999999999987
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC--
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-- 181 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 181 (332)
....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 158 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 158 TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred eEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 2346789999999999999999999999999999999999999999999999998653221
Q ss_pred CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHH--------------
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT-------PEQAAFAVC-------------- 240 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~-------~~~~~~~~~-------------- 240 (332)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+.
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 22334679999999999999899999999999999999999998764321 111111110
Q ss_pred ------------hcCCCCC--C-----CCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 241 ------------QKNARPP--V-----PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 241 ------------~~~~~~~--~-----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
......+ . ...++.++.+||.+||+.||.+|||+.|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 0 0134668999999999999999999999985
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=282.60 Aligned_cols=221 Identities=26% Similarity=0.380 Sum_probs=191.6
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|.|+.||++.+. |+.+|+|+++....... .-+.+.+|+.|-+.|+|||||.
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~----~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc----cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 68999999999999999999886 88999998876433322 2367889999999999999997
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC---CCeEEEeecccccccccC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~ 181 (332)
.....++..+...++||+++|.|+|.+||+|||+||.|+++-+ ..-+||+|||++...+..
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 2234577888889999999999999999999999999999953 346999999999888865
Q ss_pred CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHHH
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYL 259 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 259 (332)
...-+..|||.|||||+++..+|+..+|||+-||+||-++.|.+||.+.+...+..++.......+ .-+.++++.++|
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L 246 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL 246 (355)
T ss_pred cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence 566678999999999999999999999999999999999999999999998888888876655433 446889999999
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 020016 260 ISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~ 279 (332)
+++||..||.+|.|+.|.++
T Consensus 247 vrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 247 IRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHHhccChhhhccHHHHhC
Confidence 99999999999999988764
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=285.82 Aligned_cols=227 Identities=28% Similarity=0.529 Sum_probs=189.0
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--Ce----eEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QR----DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
.++|.+.+.||.|+||+||+|.+. +. .||+|++....... ....+.+|+.++..+.||||+.
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-----ANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHH-----HHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 468999999999999999999874 33 58999987643322 1366889999999999999974
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 23468999999999999999999999999999999999999999999999999987654
Q ss_pred cCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 020016 180 QCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255 (332)
Q Consensus 180 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (332)
.... .....++..|+|||...+..++.++||||||+++|||++ |..||...........+ ......+.+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 239 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL-EKGERLPQPPICTID 239 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCCCCccCCHH
Confidence 3221 112334678999999998899999999999999999999 99999887766554433 344555667788999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 020016 256 FSYLISRCWSSSPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 286 (332)
+.+++.+||..||++||++.++++.|+.+..
T Consensus 240 ~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 240 VYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 9999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=283.23 Aligned_cols=223 Identities=26% Similarity=0.533 Sum_probs=186.9
Q ss_pred cccCCeeeeeeecccCceEEEEEEECC-eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYKQ-RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
++.++|++.+.||+|+||+||+|.+.+ ..||||.+...... .+.|.+|+.++++++||||++
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (256)
T cd05113 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-------EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRP 73 (256)
T ss_pred CChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc-------HHHHHHHHHHHhcCCCCCeeeEEEEEccCCC
Confidence 356789999999999999999998874 46999998754322 256889999999999999987
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||.+......
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 1336889999999999999999999999999999999999999999999999998654332
Q ss_pred CC--CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 020016 182 GS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 258 (332)
Q Consensus 182 ~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 258 (332)
.. .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+. ...+...+...+..+.+
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 232 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYA 232 (256)
T ss_pred ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-cCCCCCCCCCCCHHHHH
Confidence 21 112335678999999998889999999999999999999 999998887766555554 34445556677899999
Q ss_pred HHHHccccCCCCCCCHHHHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVSILE 282 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~~L~ 282 (332)
++.+||+.+|.+||++.++++.|+
T Consensus 233 li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 233 IMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHcCCCcccCCCHHHHHHhhC
Confidence 999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=283.37 Aligned_cols=225 Identities=27% Similarity=0.421 Sum_probs=189.6
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||.|++|.||++.+. ++.||+|.+......... ....+.+.+|+.++++++||||++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPET-KKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhh-HHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence 57899999999999999999875 789999998765432221 122357889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 184 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 184 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 2345788889999999999999999999999999999999999999999999998654322111
Q ss_pred ----CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 020016 185 ----KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 260 (332)
Q Consensus 185 ----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 260 (332)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||....................++..++..+.+++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 2345788999999999988999999999999999999999999887776666666555566677888999999999
Q ss_pred HHccccCCCCCCCHHHHHHH
Q 020016 261 SRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 261 ~~cl~~dp~~Rps~~ell~~ 280 (332)
.+||..+|.+||++.++++.
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHhhcCcccCCCHHHHhhC
Confidence 99999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=287.01 Aligned_cols=229 Identities=30% Similarity=0.538 Sum_probs=190.9
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
|+.++|.+.+.||+|+||.||++.+. +..+|+|.+...... ..+.+.+|++++++++||||++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~ 75 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN------ARKDFHREAELLTNLQHEHIVKFYGV 75 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHH------HHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 34578999999999999999999852 356899998764322 2467899999999999999986
Q ss_pred ------------------------C-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC
Q 020016 121 ------------------------E-------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 163 (332)
Q Consensus 121 ------------------------~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~ 163 (332)
. ...+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~ 155 (288)
T cd05093 76 CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 155 (288)
T ss_pred EecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 0 123889999999999999999999999999999999999999
Q ss_pred CCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 020016 164 DMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAV 239 (332)
Q Consensus 164 ~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~ 239 (332)
++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+
T Consensus 156 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i 235 (288)
T cd05093 156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235 (288)
T ss_pred CCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999986543221 1223345778999999998889999999999999999999 99999988877766655
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 240 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
.. ......+..++.++.+++.+||+.||.+||++.++++.|+++...
T Consensus 236 ~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 236 TQ-GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred Hc-CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 43 333445667889999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=281.56 Aligned_cols=227 Identities=29% Similarity=0.588 Sum_probs=191.0
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
|++..++|.+.+.||+|+||.||++.+. +..+|+|.+...... .+.+.+|+.+++.++|+||++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 73 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-------VEAFLAEANVMKTLQHDKLVKLHAVVTKE 73 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhH-------HHHHHHHHHHHHhcCCCCcceEEEEEcCC
Confidence 7888999999999999999999999876 577999988753221 356889999999999999986
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 12346788899999999999999999999999999999999999999999999986543
Q ss_pred cCCC--CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 020016 180 QCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 256 (332)
Q Consensus 180 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (332)
.... .....++..|+|||++....++.++|+||||+++|+++| |..||...+.......+. .....+.+...+.++
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEEL 232 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCcccCCHHH
Confidence 3221 122345678999999998889999999999999999999 999999877766655443 333445567788999
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
.+++.+||+.+|++||++.++++.|+.+
T Consensus 233 ~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 233 YNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 9999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=288.24 Aligned_cols=222 Identities=19% Similarity=0.273 Sum_probs=182.9
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|++.+.||+|+||+||++.+. ++.||||++....... ......+.+|+.+++.++||||+.
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh---hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEE
Confidence 4888999999999999999986 7899999987533221 112356788999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 224588999999999999999999999999999999999999999999999999876544333
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCCCCCCCCCcHHHHHHHH
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ--KNARPPVPPTCPKAFSYLIS 261 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~ 261 (332)
.....|++.|+|||.+.+..++.++||||+|+++|+|++|..||.+.........+.. ......++..++..+.+|+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICR 237 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHH
Confidence 3455789999999999988899999999999999999999999987655332222211 23344566778999999999
Q ss_pred HccccCCCCCC-----CHHHHHHH
Q 020016 262 RCWSSSPDRRP-----HFDQIVSI 280 (332)
Q Consensus 262 ~cl~~dp~~Rp-----s~~ell~~ 280 (332)
+||..||.+|| ++.++++.
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 238 QLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHccCCHHHhcCCCCCCHHHHhcC
Confidence 99999999999 88888663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=294.78 Aligned_cols=215 Identities=23% Similarity=0.356 Sum_probs=179.4
Q ss_pred eeecccCceEEEEEEEC-----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------------
Q 020016 61 CKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------------- 120 (332)
+.||+|+||.||++.+. ++.||||++........ ......+.+|+.+++.++||||++
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRN--QKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhh--hhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence 68999999999999862 67899999976322111 112356788999999999999986
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc-CCCCCC
Q 020016 121 -------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKG 186 (332)
Q Consensus 121 -------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~~~~~~ 186 (332)
..+.+.+..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... ......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT 159 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccc
Confidence 334578888999999999999999999999999999999999999999999999864322 222344
Q ss_pred cccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHcccc
Q 020016 187 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 266 (332)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 266 (332)
..||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+.. ....++..+++.+.++|.+||+.
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK--GKLNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred cCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHccc
Confidence 5789999999999988899999999999999999999999998887766655543 34567788899999999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 020016 267 SPDRRP-----HFDQIVS 279 (332)
Q Consensus 267 dp~~Rp-----s~~ell~ 279 (332)
+|++|| ++.++++
T Consensus 238 ~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CHhHcCCCCCCCHHHHhc
Confidence 999999 7888776
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=298.18 Aligned_cols=221 Identities=24% Similarity=0.355 Sum_probs=178.7
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|.+.+.||+|+||.||++.+. ++.||||++........ ..+.+.+|+.+++.++||||++
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 76 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV----SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPF 76 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchH----HHHHHHHHHHHHHhCCCCCcCCHhheecCCCcccc
Confidence 4788999999999999999985 78999999875432211 1356889999999999999976
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++......
T Consensus 77 ~~~~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 77 EEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred ceEEEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 2356789999999999999999999999999999999999999999999999998754322
Q ss_pred C--CCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------------
Q 020016 182 G--SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK---------------- 242 (332)
Q Consensus 182 ~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~---------------- 242 (332)
. ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 1 22334678999999998774 4789999999999999999999999887765543333211
Q ss_pred -------CCCC-------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 243 -------NARP-------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 243 -------~~~~-------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
...+ ......++++.+||.+||+.||.+|||+.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 1111 1234467889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=296.84 Aligned_cols=220 Identities=22% Similarity=0.334 Sum_probs=179.0
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||.|+||+||+|.+. ++.||||++....... ...+.+.+|+.+++.++||||++
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL----IHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh----HHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 478999999999999999999886 6789999987643221 11355778999999999999986
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 90 ~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 90 ENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cccCcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 22468899999999999999999999999999999999999999999999999987654
Q ss_pred cCCCCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------------
Q 020016 180 QCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR------------- 245 (332)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~------------- 245 (332)
. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 170 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 170 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred C--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence 3 2334578999999999876 56799999999999999999999999876654443333221100
Q ss_pred --------CCC--------CCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 246 --------PPV--------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 246 --------~~~--------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+.. ....++.+.+|+.+||+.||.+|||+.+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 1235667889999999999999999999996
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=299.72 Aligned_cols=222 Identities=18% Similarity=0.245 Sum_probs=180.9
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||.|+||.||++.+. ++.||||++..... ......+.+.+|++++..++||||++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~ 77 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM---FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLY 77 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH---HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeE
Confidence 47899999999999999999886 78999999865321 11223467889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC--
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-- 182 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 182 (332)
....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 34567889999999999999999999999999999999999999999999999985321100
Q ss_pred ----------------------------------------------CCCCcccccccCChhhhhcCCCCCccchhHHHHH
Q 020016 183 ----------------------------------------------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIV 216 (332)
Q Consensus 183 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~i 216 (332)
.....+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0012468999999999999899999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 020016 217 LWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP--TCPKAFSYLISRCWSSSPDRR---PHFDQIVSI 280 (332)
Q Consensus 217 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~~R---ps~~ell~~ 280 (332)
+|||++|..||...+..+....+........++. .++.++.+||.+||. +|.+| +++.+++..
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 9999999999998887766665554333334443 578999999999998 67765 589888874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=284.59 Aligned_cols=227 Identities=26% Similarity=0.459 Sum_probs=187.9
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--Ce----eEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QR----DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
.++|.+.+.||.|+||+||+|.+. ++ .|++|.+....... ....+..|+.++..++||||++
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~~~~~l~~l~h~~iv~~~~~~~~ 80 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQ-----TFQEITDHMLAMGSLDHAYIVRLLGICPG 80 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchH-----HHHHHHHHHHHHhcCCCCCcceEEEEECC
Confidence 468899999999999999999984 43 47888875432221 2356788999999999999986
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++....
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 34568899999999999999999999999999999999999999999999999987543
Q ss_pred cCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 020016 180 QCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255 (332)
Q Consensus 180 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (332)
... ......++..|+|||.+.++.++.++||||||+++||+++ |..||.+......... .........+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 239 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-LEKGERLAQPQICTID 239 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHCCCcCCCCCCCCHH
Confidence 322 1223456778999999998899999999999999999998 9999988776554333 3445555666678889
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 020016 256 FSYLISRCWSSSPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 286 (332)
+.+++.+||..+|++||++.++++.|..+..
T Consensus 240 ~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 240 VYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=286.51 Aligned_cols=233 Identities=27% Similarity=0.516 Sum_probs=194.4
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEECC-------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCce
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHI 118 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 118 (332)
...|.++.++|.+.+.||+|+||.||++.+.+ ..+|+|.+....... ....+.+|+.++..+ +|+||
T Consensus 4 ~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~i 78 (293)
T cd05053 4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-----DLSDLVSEMEMMKMIGKHKNI 78 (293)
T ss_pred CcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHH-----HHHHHHHHHHHHHhhcCCCCe
Confidence 35688899999999999999999999998752 579999987643322 135688999999999 89999
Q ss_pred ec--------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccc
Q 020016 119 IT--------------------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 154 (332)
Q Consensus 119 v~--------------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dl 154 (332)
++ ....+++..++.++.|++.||.|||+.|++||||
T Consensus 79 ~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dl 158 (293)
T cd05053 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDL 158 (293)
T ss_pred eeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence 86 0235778888999999999999999999999999
Q ss_pred cccceeecCCCeEEEeecccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCC
Q 020016 155 KSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 230 (332)
Q Consensus 155 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~ 230 (332)
||+||+++.++.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 159 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 159 AARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred ceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 99999999999999999999876443221 122334678999999988889999999999999999998 99999987
Q ss_pred CHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 020016 231 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 285 (332)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~ 285 (332)
...+....+. .......+..++..+.+|+.+||..||.+|||+.++++.|+++.
T Consensus 239 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 239 PVEELFKLLK-EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 7766555443 44455667788999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=292.90 Aligned_cols=214 Identities=23% Similarity=0.325 Sum_probs=179.2
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCc-eec------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH-IIT------------ 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~------------ 120 (332)
+|.+.+.||+|+||.||+|.+. ++.||||++...... .....+.+..|..++..+.|++ |+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII---QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 77 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEE
Confidence 5889999999999999999987 578999999763211 1112356788999999998765 443
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc-cCCC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES-QCGS 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~-~~~~ 183 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.... ....
T Consensus 78 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 78 FVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 23457899999999999999999999999999999999999999999999999986432 2222
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHc
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 263 (332)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+..+....+. .....++..+++.+.+++.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~ 235 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICKGL 235 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHH
Confidence 334578999999999999999999999999999999999999999888777766664 344567778999999999999
Q ss_pred cccCCCCCCCH
Q 020016 264 WSSSPDRRPHF 274 (332)
Q Consensus 264 l~~dp~~Rps~ 274 (332)
|..||.+|++.
T Consensus 236 l~~~P~~R~~~ 246 (324)
T cd05587 236 LTKHPAKRLGC 246 (324)
T ss_pred hhcCHHHcCCC
Confidence 99999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=282.46 Aligned_cols=221 Identities=29% Similarity=0.588 Sum_probs=185.9
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
+..+|.+.+.||+|+||.||++.++ +..+|+|++...... ...+.+|+.++++++||||++
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-------EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPI 74 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC-------HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCce
Confidence 4568999999999999999999887 568999998754332 246888999999999999986
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 182 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 182 (332)
....+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred EEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 13457889999999999999999999999999999999999999999999999986543321
Q ss_pred C--CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 020016 183 S--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 259 (332)
Q Consensus 183 ~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 259 (332)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. ...+...+..++..+.++
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 233 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTI 233 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHH
Confidence 1 112223457999999998899999999999999999999 899998877766655543 344556677789999999
Q ss_pred HHHccccCCCCCCCHHHHHHHH
Q 020016 260 ISRCWSSSPDRRPHFDQIVSIL 281 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~~L 281 (332)
+.+||..+|++||++.++++.|
T Consensus 234 i~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 234 MYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHhcCChhhCcCHHHHHHHh
Confidence 9999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=284.87 Aligned_cols=226 Identities=30% Similarity=0.554 Sum_probs=187.4
Q ss_pred cccCCeeeeeeecccCceEEEEEEE------CCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIY------KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
++.++|++.+.||+|+||+||+|.+ .+..||+|.+........ ...+.+|+.+++.++||||++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~ 76 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ-----WGEFQQEASLMAELHHPNIVCLLGVV 76 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHH-----HHHHHHHHHHHhhCCCCCeeeEEEEE
Confidence 3467899999999999999999985 247899999975433221 356889999999999999986
Q ss_pred -------------C---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccccccee
Q 020016 121 -------------E---------------------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 160 (332)
Q Consensus 121 -------------~---------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIl 160 (332)
. ...+++..+..++.|++.||.|||++|++|+||||+||+
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nil 156 (283)
T cd05090 77 TQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNIL 156 (283)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEE
Confidence 0 123677888999999999999999999999999999999
Q ss_pred ecCCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 020016 161 LGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAA 236 (332)
Q Consensus 161 l~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~ 236 (332)
++.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.......
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999999986543221 1233445678999999988889999999999999999999 99999887765554
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 020016 237 FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 283 (332)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~ 283 (332)
..+. ....+..+..+++.+.+++.+||+.||.+||++.+|++.|..
T Consensus 237 ~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 EMVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 4443 344456677889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=282.31 Aligned_cols=223 Identities=31% Similarity=0.537 Sum_probs=186.0
Q ss_pred eeeeeeecccCceEEEEEEEC-----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 57 LFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 57 y~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
|++++.||+|+||.||+|.+. +..||||.+........ ....+.+|+.+++.++||||++
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 76 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS----EIEEFLSEAACMKDFDHPNVMKLIGVCFEASSL 76 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHH----HHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcc
Confidence 578899999999999999875 26799999876433221 1356899999999999999986
Q ss_pred -----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEee
Q 020016 121 -----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVAD 171 (332)
Q Consensus 121 -----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~D 171 (332)
....+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|
T Consensus 77 ~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 77 QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECC
Confidence 012468888999999999999999999999999999999999999999999
Q ss_pred cccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCC
Q 020016 172 FGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPP 247 (332)
Q Consensus 172 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 247 (332)
||++........ ......+..|+|||.+.+..++.++||||||+++|||++ |..||.+....+....+. ......
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~ 235 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR-HGNRLK 235 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCC
Confidence 999875443221 112234678999999988889999999999999999999 999998887766655543 344556
Q ss_pred CCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 248 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 248 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
.+..++..+.+++.+||+.||.+||++.++++.|+.+
T Consensus 236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 7788999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=282.48 Aligned_cols=223 Identities=31% Similarity=0.624 Sum_probs=189.9
Q ss_pred cccccCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
|-++.++|++.+.||+|+||.||++...++.||+|.+..... .+.+.+|+.+++.++||||++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~--------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVT--------AQAFLEETAVMTKLHHKNLVRLLGVILHNG 72 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcch--------HHHHHHHHHHHHhCCCCCcCeEEEEEcCCC
Confidence 556678999999999999999999998899999999865322 256889999999999999986
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus 73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM 152 (254)
T ss_pred cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc
Confidence 123578899999999999999999999999999999999999999999999999865432
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 259 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 259 (332)
. ......+..|+|||.+.++.++.++|+||||+++|+|++ |..||...+..+....+. ...+...+..++..+.++
T Consensus 153 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 229 (254)
T cd05083 153 G--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVL 229 (254)
T ss_pred c--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-CCCCCCCCCcCCHHHHHH
Confidence 1 122334678999999998899999999999999999998 999999887766554443 344555567789999999
Q ss_pred HHHccccCCCCCCCHHHHHHHHHh
Q 020016 260 ISRCWSSSPDRRPHFDQIVSILEG 283 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~~L~~ 283 (332)
+.+||+.+|++||++.++++.|++
T Consensus 230 i~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 230 MTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHcCCChhhCcCHHHHHHHHcc
Confidence 999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=286.93 Aligned_cols=230 Identities=31% Similarity=0.520 Sum_probs=188.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--C--eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec---------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--Q--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT--------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------- 120 (332)
++|.+.+.||.|+||.||+|.++ + ..+++|.+....... ..+.+.+|+.++.++ +||||++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEN-----DHRDFAGELEVLCKLGHHPNIINLLGACENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHH-----HHHHHHHHHHHHHhhcCCCchhheEEEEccCC
Confidence 68999999999999999999886 2 247888877432221 135688999999999 7999976
Q ss_pred -------------------C----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC
Q 020016 121 -------------------E----------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM 165 (332)
Q Consensus 121 -------------------~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~ 165 (332)
. ...+++..++.++.|++.||.|||++|++||||||+||+++.++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL 156 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC
Confidence 0 02477888999999999999999999999999999999999999
Q ss_pred eEEEeecccccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCC
Q 020016 166 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 244 (332)
Q Consensus 166 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~ 244 (332)
.+||+|||++..............+..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. ...
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~-~~~ 235 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGY 235 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCC
Confidence 999999999854322111222233567999999988889999999999999999998 999999888776655543 334
Q ss_pred CCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 020016 245 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 290 (332)
Q Consensus 245 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~ 290 (332)
....+..++..+.+|+.+||+.+|.+||+++++++.|+.+......
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 4556677899999999999999999999999999999988776543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=285.70 Aligned_cols=225 Identities=30% Similarity=0.538 Sum_probs=187.9
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
..++|.+.+.||+|+||.||+|.+. +..||||.+....... ..+.+.+|+++++.++|+||++
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~ 77 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND-----ARKDFEREAELLTNFQHENIVKFYGVC 77 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHH-----HHHHHHHHHHHHHhcCCCCchheeeEE
Confidence 3568999999999999999999874 3679999987654432 2467899999999999999886
Q ss_pred -------------C------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC
Q 020016 121 -------------E------------------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 163 (332)
Q Consensus 121 -------------~------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~ 163 (332)
. ...+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 78 TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157 (280)
T ss_pred ecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence 0 124678889999999999999999999999999999999999
Q ss_pred CCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 020016 164 DMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAV 239 (332)
Q Consensus 164 ~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~ 239 (332)
++.++|+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 9999999999986532211 1223345788999999999999999999999999999999 99999887777766555
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 020016 240 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 283 (332)
Q Consensus 240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~ 283 (332)
. .......+..++..+.+++.+||+.||++||++.|+++.|++
T Consensus 238 ~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 T-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred H-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 4 333444566789999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=272.68 Aligned_cols=232 Identities=21% Similarity=0.280 Sum_probs=188.3
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
...-|+-++|.|.+.||+|||+-||++..- +..+|+|.+.....+. .+..++|++..++++||||++
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~------~e~~~rEid~~rkf~s~~vl~l~dh~ 87 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQED------IEEALREIDNHRKFNSPNVLRLVDHQ 87 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHH------HHHHHHHHHHHHhhCCcchHHHHHHH
Confidence 344567799999999999999999999863 7899999998866333 466889999999999999986
Q ss_pred --------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccccccceeecCCCe
Q 020016 121 --------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGEDMC 166 (332)
Q Consensus 121 --------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~NIll~~~~~ 166 (332)
.+..+++.+++.|+.++++||.+||... +.||||||.|||+.+.+.
T Consensus 88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~ 167 (302)
T KOG2345|consen 88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL 167 (302)
T ss_pred HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc
Confidence 4557999999999999999999999998 999999999999999999
Q ss_pred EEEeecccccccccCCCC----------CCcccccccCChhhhhcC---CCCCccchhHHHHHHHHHHhCCCCCCCCCH-
Q 020016 167 VKVADFGISCLESQCGSA----------KGFTGTYRWMAPEMIKEK---RHTKKVDVYSFGIVLWELLTALTPFDNMTP- 232 (332)
Q Consensus 167 ~kl~Dfg~a~~~~~~~~~----------~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~elltG~~pf~~~~~- 232 (332)
++|.|||.+....-.-.. .....|..|.|||.+.-. ..+.++|||||||++|.|+.|..||...-.
T Consensus 168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~ 247 (302)
T KOG2345|consen 168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ 247 (302)
T ss_pred eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence 999999998643211111 123478999999998643 458999999999999999999999974221
Q ss_pred -HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 020016 233 -EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 285 (332)
Q Consensus 233 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~ 285 (332)
.....++......-+....++..+.++|.+||+.||.+||++.+++..++++.
T Consensus 248 GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11222232223333334558999999999999999999999999999998764
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=283.30 Aligned_cols=230 Identities=28% Similarity=0.539 Sum_probs=191.3
Q ss_pred cccCCeeeeeeecccCceEEEEEEECC------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYKQ------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
++.++|.+.+.||+|+||.||+|.+.+ ..||+|.+....... ..+.+.+|+.+++.++||||++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~-----~~~~~~~e~~~l~~l~h~ni~~~~~~~ 77 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEI-----QVTLLLQESCLLYGLSHQNILPILHVC 77 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHH-----HHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 456899999999999999999999853 789999886533222 2466889999999999999986
Q ss_pred ---------------------------C-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEE
Q 020016 121 ---------------------------E-----PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 168 (332)
Q Consensus 121 ---------------------------~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~k 168 (332)
. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++
T Consensus 78 ~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred ecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEE
Confidence 0 14578999999999999999999999999999999999999999999
Q ss_pred EeecccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCC
Q 020016 169 VADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 244 (332)
Q Consensus 169 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~ 244 (332)
|+|||+++....... .....++..|+|||.+.+..++.++||||||+++|++++ |+.||...++.+....+. ...
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~ 236 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-DGY 236 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-cCC
Confidence 999999865432211 122345678999999998889999999999999999999 999999877766544433 344
Q ss_pred CCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 245 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 245 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
....+..+++++.+++.+||..+|++||++.++++.|+++.+.
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 237 RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 4455667889999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=311.57 Aligned_cols=233 Identities=31% Similarity=0.535 Sum_probs=208.5
Q ss_pred ccccCCeeeeeeecccCceEEEEEEEC--C---eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYK--Q---RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~---~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
+||.+..+|.+.||.|.||.||+|+.+ + ..||||.++....+. .+.+|+.|+.||-+++||||+.
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytek-----qrrdFL~EAsIMGQFdHPNIIrLEGVV 699 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEK-----QRRDFLSEASIMGQFDHPNIIRLEGVV 699 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHH-----HHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence 678899999999999999999999997 3 579999998865543 3688999999999999999986
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccc
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
..+.++..+...|++.|+.|+.||-..|++||||..+|||++.+..+|++|||+++
T Consensus 700 Tks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 700 TKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred ecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecccccee
Confidence 55778899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCC----CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 020016 177 LESQCGSA----KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 251 (332)
Q Consensus 177 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (332)
...+.... .+..-..+|.|||.+...+++.++||||+|++|||.++ |..||.++++.+....+. .+.+.+.|.+
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~gyRLPpPmD 858 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QGYRLPPPMD 858 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hccCCCCCCC
Confidence 77554311 12223579999999999999999999999999999998 999999999999888774 6778888999
Q ss_pred CcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 252 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 252 ~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
||..|.+||..||++|-.+||.+.+|+..|+++..+..
T Consensus 859 CP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 859 CPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred CcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 99999999999999999999999999999999987765
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=299.85 Aligned_cols=222 Identities=21% Similarity=0.281 Sum_probs=181.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|++.+.||+|+||.||++.+. ++.||||++..... ........+.+|++++..++||||++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~---~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 77 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV---LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLY 77 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH---HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEE
Confidence 47999999999999999999986 78999999865321 11122456889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC---
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC--- 181 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--- 181 (332)
..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 3356788999999999999999999999999999999999999999999999987422100
Q ss_pred -----------------------------------------CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHH
Q 020016 182 -----------------------------------------GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 220 (332)
Q Consensus 182 -----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~el 220 (332)
.......||+.|+|||++.+..++.++|||||||++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 001134689999999999999999999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 020016 221 LTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSYLISRCWSSSPDRRP---HFDQIVSI 280 (332)
Q Consensus 221 ltG~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~Rp---s~~ell~~ 280 (332)
++|..||.+....+....+......... ...+++.+.++|.+|+ .+|.+|+ ++.++++.
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999988877665555433333333 3467899999999977 5999999 88888864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=287.28 Aligned_cols=232 Identities=26% Similarity=0.503 Sum_probs=193.1
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCcee
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHII 119 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 119 (332)
..|.+..++|.+.+.||.|+||.||++.+. +..||||.+....... ..+.+.+|+.+++++ +||||+
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~iv 102 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS-----EREALMSELKIMSHLGNHENIV 102 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChH-----HHHHHHHHHHHHHhccCCCCcc
Confidence 457788889999999999999999999752 3479999987643322 135789999999999 899998
Q ss_pred c------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEE
Q 020016 120 T------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 169 (332)
Q Consensus 120 ~------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl 169 (332)
+ ....+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|
T Consensus 103 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l 182 (302)
T cd05055 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKI 182 (302)
T ss_pred eEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEE
Confidence 6 1123789999999999999999999999999999999999999999999
Q ss_pred eecccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCC
Q 020016 170 ADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 245 (332)
Q Consensus 170 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 245 (332)
+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||..................
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 262 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR 262 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc
Confidence 99999865433211 122345778999999999999999999999999999998 99999887766555555444545
Q ss_pred CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 246 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 246 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
...+...++.+.+++.+||..+|++||++.++++.|+++
T Consensus 263 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 556667889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=289.88 Aligned_cols=237 Identities=27% Similarity=0.506 Sum_probs=195.3
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEEC---------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCC
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK---------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHP 116 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 116 (332)
..+|++...+|++++.||+|+||.||++.+. +..||+|.+....... ..+.+.+|+.++.++ +||
T Consensus 4 ~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~ 78 (334)
T cd05100 4 DPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK-----DLSDLVSEMEMMKMIGKHK 78 (334)
T ss_pred CcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHH-----HHHHHHHHHHHHHhhcCCC
Confidence 3578888899999999999999999999763 1368999887543222 136788999999999 899
Q ss_pred ceec----------------------------C----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 020016 117 HIIT----------------------------E----------------PYSVPLNLVLKLALDIARGMQYLHSQGILHR 152 (332)
Q Consensus 117 niv~----------------------------~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~ 152 (332)
||++ . ...+++..+..++.|++.||.|||++|++||
T Consensus 79 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~ 158 (334)
T cd05100 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHR 158 (334)
T ss_pred CeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 9986 0 0136677888999999999999999999999
Q ss_pred cccccceeecCCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCC
Q 020016 153 DLKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFD 228 (332)
Q Consensus 153 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~ 228 (332)
||||+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 159 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 238 (334)
T cd05100 159 DLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238 (334)
T ss_pred ccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence 999999999999999999999986543321 1122334567999999999999999999999999999999 899999
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 229 NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
+....+....+. .......+..++..+.+++.+||+.+|.+||++.++++.|+.+.....
T Consensus 239 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 239 GIPVEELFKLLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred CCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 887766655543 344556677888999999999999999999999999999998875444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=297.79 Aligned_cols=221 Identities=22% Similarity=0.312 Sum_probs=180.8
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
+.|.+.+.||+|+||+||+|.+. ++.||||++..... ........+.+|+.++..++||||++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~---~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~ 77 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV---LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 77 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh---hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEE
Confidence 36899999999999999999986 68899999875321 11223467889999999999999987
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC---
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC--- 181 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--- 181 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||++......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 3356789999999999999999999999999999999999999999999999987422100
Q ss_pred ---------------------------------------------CCCCCcccccccCChhhhhcCCCCCccchhHHHHH
Q 020016 182 ---------------------------------------------GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIV 216 (332)
Q Consensus 182 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~i 216 (332)
......+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 00123468999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHccccCCCCCCC---HHHHHH
Q 020016 217 LWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYLISRCWSSSPDRRPH---FDQIVS 279 (332)
Q Consensus 217 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rps---~~ell~ 279 (332)
+|||++|..||...++.+....+.........| ..+++++.++|.+|+ .+|.+|++ +.+++.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 999999999999888777666655433333333 467899999999976 59999987 777765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=287.49 Aligned_cols=236 Identities=26% Similarity=0.507 Sum_probs=194.3
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEECC---------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCc
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQ---------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPH 117 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 117 (332)
..|++..++|.+++.||+|+||.||++.+.+ ..+|+|.+........ ...+.+|+.++..+ +|||
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~e~~~l~~l~~h~~ 85 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKD-----LSDLISEMEMMKMIGKHKN 85 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHH-----HHHHHHHHHHHHHhcCCCC
Confidence 4678888999999999999999999998642 4699999986432221 35688899999999 7999
Q ss_pred eec----------------------------C----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 020016 118 IIT----------------------------E----------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRD 153 (332)
Q Consensus 118 iv~----------------------------~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~d 153 (332)
|++ . ...+++..++.++.|++.||.|||++|++|||
T Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~d 165 (307)
T cd05098 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRD 165 (307)
T ss_pred EeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 986 0 02478889999999999999999999999999
Q ss_pred ccccceeecCCCeEEEeecccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCC
Q 020016 154 LKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 229 (332)
Q Consensus 154 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~ 229 (332)
|||+||+++.++.++|+|||.+........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 166 lkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~ 245 (307)
T cd05098 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245 (307)
T ss_pred ccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 999999999999999999999865432211 112234568999999998889999999999999999998 8999988
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 230 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
....+....+ ........+..++.++.+++.+||..+|++||++.++++.|+.+.....
T Consensus 246 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 246 VPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred CCHHHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 7765554444 3444556777889999999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=294.87 Aligned_cols=215 Identities=24% Similarity=0.336 Sum_probs=180.0
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------------
Q 020016 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------------ 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 120 (332)
+.||+|+||.||++.+. ++.||+|++...... .......+.+|+.++..++||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV---AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 46999999999999985 789999999763221 1112356788999999999999976
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccccccceeecCCCeEEEeeccccccccc-CCCCCCcc
Q 020016 121 ----------EPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKGFT 188 (332)
Q Consensus 121 ----------~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~~~~~~~~ 188 (332)
....+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++..... ........
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence 34568999999999999999999997 7999999999999999999999999999864322 22233457
Q ss_pred cccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCC
Q 020016 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 268 (332)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 268 (332)
||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+. .....++..+++++.+++.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~L~~dP 235 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLSGLLKKDP 235 (325)
T ss_pred CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 9999999999999999999999999999999999999999887766655543 33445677899999999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 020016 269 DRRP-----HFDQIVSI 280 (332)
Q Consensus 269 ~~Rp-----s~~ell~~ 280 (332)
.+|+ ++.++++.
T Consensus 236 ~~R~~~~~~~~~~il~h 252 (325)
T cd05594 236 KQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHhCCCCCCCHHHHhcC
Confidence 9997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=284.14 Aligned_cols=226 Identities=27% Similarity=0.466 Sum_probs=181.2
Q ss_pred CCe-eeeeeecccCceEEEEEEEC------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 55 SQL-FIGCKFASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 55 ~~y-~i~~~lg~G~~g~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
++| ++.+.||.|+||+||++.+. +..||+|.+....... ....|.+|+++++.++||||++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ-----NTSGWKKEINILKTLYHENIVKYKGCCSE 77 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 345 89999999999999887542 5689999987653321 1356889999999999999986
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 78 QGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred CCCceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 2235889999999999999999999999999999999999999999999999998754
Q ss_pred ccCCC----CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHH--------------HHHHHHH
Q 020016 179 SQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE--------------QAAFAVC 240 (332)
Q Consensus 179 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~--------------~~~~~~~ 240 (332)
..... .....++..|+|||.+.+..++.++||||||+++|+|+||..||...... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 43211 12234566799999998888999999999999999999999998653321 0111112
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 020016 241 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 285 (332)
Q Consensus 241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~ 285 (332)
......+.+..++..+.+++.+||+.+|++||+++++++.|+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 223334456778899999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=277.56 Aligned_cols=238 Identities=23% Similarity=0.379 Sum_probs=200.4
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchh--HHHHHHHHHHHHHHHHHHcC-CCCceec---------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDA--SLASMLEKQFTSEVALLFRL-NHPHIIT--------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l-~h~niv~--------- 120 (332)
.+|.-.+.||.|..++|-++.++ +..+|+|++....... .....+.+.-.+|+.||+++ .||+|++
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 57888899999999999999887 7889999987643211 12456677888999999998 7999997
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++...+.|++|+..|+.|||.++|+||||||+|||++++.+++|+|||+++.....
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 4557899999999999999999999999999999999999999999999999999999888
Q ss_pred CCCCCcccccccCChhhhhc------CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCc
Q 020016 182 GSAKGFTGTYRWMAPEMIKE------KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCP 253 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~ 253 (332)
......+|||+|+|||.+.. ..|+..+|.|+.|||||.++.|.+||......-....++.+.... +.-.+++
T Consensus 177 ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis 256 (411)
T KOG0599|consen 177 EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADIS 256 (411)
T ss_pred hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhcc
Confidence 88888999999999999864 357889999999999999999999998866666666666655443 3346788
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH--HHHhhhhhhcCCc
Q 020016 254 KAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYSESLEQDP 292 (332)
Q Consensus 254 ~~l~~li~~cl~~dp~~Rps~~ell~--~L~~~~~~~~~~~ 292 (332)
...++||.+||+.||.+|.|++|++. ++..+..+-..++
T Consensus 257 ~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~m 297 (411)
T KOG0599|consen 257 ATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQM 297 (411)
T ss_pred ccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhccccc
Confidence 99999999999999999999999987 3444444444443
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=302.33 Aligned_cols=233 Identities=30% Similarity=0.613 Sum_probs=204.8
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEEC----C--eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK----Q--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT- 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~----~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~- 120 (332)
..++++.+...+.++||.|.||.||+|.+. | -.||||..+.....+. .+.|+.|.-+|++++|||||+
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-----tekflqEa~iMrnfdHphIikL 456 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-----TEKFLQEASIMRNFDHPHIIKL 456 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-----HHHHHHHHHHHHhCCCcchhhe
Confidence 467778888889999999999999999986 2 2589999887544332 478999999999999999987
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecc
Q 020016 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 121 ---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
....++......+++||..||+|||+..++||||..+|||+....-+||+|||
T Consensus 457 IGv~~e~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 457 IGVCVEQPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred eeeeeccceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccc
Confidence 55678888999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCC--CcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 020016 174 ISCLESQCGSAK--GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 250 (332)
Q Consensus 174 ~a~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (332)
+++......... ...-+..|||||.+.-..++.++|||.|||+|||++. |..||.+..+.+....+ ..+.+++.|+
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-EnGeRlP~P~ 615 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-ENGERLPCPP 615 (974)
T ss_pred hhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-cCCCCCCCCC
Confidence 999877654332 3345678999999999999999999999999999999 99999998877765544 4688999999
Q ss_pred CCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 020016 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 251 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 286 (332)
.||+.+..|+.+||..+|.+||.+.++...|.++..
T Consensus 616 nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 616 NCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 999999999999999999999999999999988776
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=297.18 Aligned_cols=235 Identities=26% Similarity=0.487 Sum_probs=196.1
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCc
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPH 117 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n 117 (332)
....|+++.++|.+++.||+|+||.||+|.+. +..||||++........ .+.+.+|+.+|.++. |||
T Consensus 28 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~-----~~~~~~E~~~l~~l~~H~n 102 (401)
T cd05107 28 YDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSE-----KQALMSELKIMSHLGPHLN 102 (401)
T ss_pred CCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhH-----HHHHHHHHHHHHhcCCCCC
Confidence 44579999999999999999999999999874 25799999986533221 356889999999997 999
Q ss_pred eec------------------CC---------------------------------------------------------
Q 020016 118 IIT------------------EP--------------------------------------------------------- 122 (332)
Q Consensus 118 iv~------------------~~--------------------------------------------------------- 122 (332)
|++ ..
T Consensus 103 iv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (401)
T cd05107 103 IVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMS 182 (401)
T ss_pred eEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccC
Confidence 986 00
Q ss_pred ---------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 020016 123 ---------------------------------------------------YSVPLNLVLKLALDIARGMQYLHSQGILH 151 (332)
Q Consensus 123 ---------------------------------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH 151 (332)
..+++..++.++.||+.||.|||+.+++|
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH 262 (401)
T cd05107 183 KDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVH 262 (401)
T ss_pred CccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCc
Confidence 12456677889999999999999999999
Q ss_pred ccccccceeecCCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCC
Q 020016 152 RDLKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPF 227 (332)
Q Consensus 152 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf 227 (332)
|||||+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus 263 rdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~ 342 (401)
T cd05107 263 RDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342 (401)
T ss_pred ccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999987543211 1123356788999999998889999999999999999998 89999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 020016 228 DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 285 (332)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~ 285 (332)
......+..........++..+..++.++.+|+.+||..+|.+||++.+|+..|+.+.
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 343 PELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 8776666555555556666777888999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=302.16 Aligned_cols=228 Identities=26% Similarity=0.497 Sum_probs=200.7
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEEC---C--eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK---Q--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~---~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-- 120 (332)
....|..++..+.++||+|.||.|++|.|+ | -.||||.+....... ...+|++|+.+|.+|+|||+|+
T Consensus 103 lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-----~mddflrEas~M~~L~H~hliRLy 177 (1039)
T KOG0199|consen 103 LKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-----IMDDFLREASHMLKLQHPHLIRLY 177 (1039)
T ss_pred cceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-----hHHHHHHHHHHHHhccCcceeEEe
Confidence 445677788999999999999999999997 3 368999998765543 2588999999999999999987
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecc
Q 020016 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 121 ---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
....+.......++.||+.||.||.++++|||||..+|+++-....+||+|||
T Consensus 178 GvVl~qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFG 257 (1039)
T KOG0199|consen 178 GVVLDQPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFG 257 (1039)
T ss_pred eeeccchhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccc
Confidence 34556778888999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCC----CcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 020016 174 ISCLESQCGSAK----GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 248 (332)
Q Consensus 174 ~a~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (332)
+.+.+....... ...-...|+|||.++...++.++|||++||++|||+| |..||.+....+++..+. .+.+.+-
T Consensus 258 LmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpR 336 (1039)
T KOG0199|consen 258 LMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPR 336 (1039)
T ss_pred ceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCC
Confidence 998776544332 2334678999999999999999999999999999999 999999999999998886 7888899
Q ss_pred CCCCcHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 020016 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 281 (332)
Q Consensus 249 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L 281 (332)
|+.|+.++++++..||..+|.+||++..|.+.+
T Consensus 337 Pk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 337 PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 999999999999999999999999999997544
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=304.56 Aligned_cols=219 Identities=27% Similarity=0.359 Sum_probs=185.6
Q ss_pred cCCeeeeeeecccCceEEEEEEEC---CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
...|.+.+.||.|++|.||+|... ++.||+|.+....... ...+.+|+.++..++|||||+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~------~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQ------AAYARSELHCLAACDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHH------HHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence 345999999999999999999875 4678999775543221 245778999999999999986
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 1235788899999999999999999999999999999999999999999999999765
Q ss_pred ccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 020016 179 SQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255 (332)
Q Consensus 179 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (332)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+... ...+.+..++.+
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~s~~ 298 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG-KYDPFPCPVSSG 298 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCccCCHH
Confidence 4322 234456999999999999999999999999999999999999999988877766665543 334566788999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 020016 256 FSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+.++|.+||..||++||++.+++.
T Consensus 299 ~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 299 MKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHHHHhccChhhCcCHHHHHh
Confidence 999999999999999999999875
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=286.72 Aligned_cols=238 Identities=28% Similarity=0.530 Sum_probs=196.2
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEEC---------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCc
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK---------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPH 117 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 117 (332)
..|.++.++|.+++.||+|+||.||++.+. ...||+|.+........ ...+.+|+.+++++ +|||
T Consensus 5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~E~~~l~~l~~h~~ 79 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD-----LADLISEMELMKLIGKHKN 79 (314)
T ss_pred ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHH-----HHHHHHHHHHHHhccCCCC
Confidence 468888899999999999999999999753 34699999876433221 35688999999999 6999
Q ss_pred eec----------------------------C----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 020016 118 IIT----------------------------E----------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRD 153 (332)
Q Consensus 118 iv~----------------------------~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~d 153 (332)
|++ . ...+++..+..++.|++.||.|||++|++|||
T Consensus 80 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~d 159 (314)
T cd05099 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRD 159 (314)
T ss_pred eeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 986 0 12477888899999999999999999999999
Q ss_pred ccccceeecCCCeEEEeecccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCC
Q 020016 154 LKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 229 (332)
Q Consensus 154 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~ 229 (332)
|||+||+++.++.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred ccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999875433211 112234567999999998889999999999999999999 9999988
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 020016 230 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 291 (332)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~ 291 (332)
....+....+. .......+..++.++.+++.+||..+|.+||++.++++.|+.+.......
T Consensus 240 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~ 300 (314)
T cd05099 240 IPVEELFKLLR-EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEE 300 (314)
T ss_pred CCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCC
Confidence 77766555443 34445567788999999999999999999999999999999988766543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=291.57 Aligned_cols=214 Identities=23% Similarity=0.320 Sum_probs=178.9
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCceec------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIIT------------ 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~------------ 120 (332)
+|.+.+.||+|+||.||+|.+. ++.||||++....... ....+.+..|..++..+. |++|+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ---DDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLY 77 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEE
Confidence 5889999999999999999987 5789999997642211 112345677888888774 677654
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc-CCC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGS 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~~~ 183 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 78 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 78 FVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 335688999999999999999999999999999999999999999999999999865332 223
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHc
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 263 (332)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+.......+.. ....+|..++.++.+++.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~~ 235 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEAVAICKGL 235 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCcCCHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999888777766654 34456778999999999999
Q ss_pred cccCCCCCCCH
Q 020016 264 WSSSPDRRPHF 274 (332)
Q Consensus 264 l~~dp~~Rps~ 274 (332)
|+.||++|++.
T Consensus 236 l~~~p~~R~~~ 246 (323)
T cd05616 236 MTKHPGKRLGC 246 (323)
T ss_pred cccCHHhcCCC
Confidence 99999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=286.55 Aligned_cols=231 Identities=29% Similarity=0.505 Sum_probs=186.3
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--Ce--eEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec-------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QR--DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~--~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~------- 120 (332)
.+++|.+.+.||.|+||.||+|.+. +. .+|+|.+....... ....+.+|+.++.++ +||||++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~ 79 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-----DHRDFAGELEVLCKLGHHPNIINLLGACEH 79 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHH-----HHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence 3568999999999999999999875 33 46777766432221 246788999999999 8999986
Q ss_pred -----------C--------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC
Q 020016 121 -----------E--------------------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 163 (332)
Q Consensus 121 -----------~--------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~ 163 (332)
. ...+++..++.++.|++.||.|||++|++||||||+||+++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 159 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC
Confidence 0 124688899999999999999999999999999999999999
Q ss_pred CCeEEEeecccccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 020016 164 DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQK 242 (332)
Q Consensus 164 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~ 242 (332)
++.++|+|||++.............++..|+|||.+.+..++.++||||||+++|+|+| |..||...+..+..... ..
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~ 238 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-PQ 238 (303)
T ss_pred CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH-hc
Confidence 99999999999854322112222334678999999988889999999999999999998 99999887766554443 23
Q ss_pred CCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 243 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
......+..+++.+.+|+.+||+.+|++||++.+++..|+.+...-.
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 33445566788999999999999999999999999999987655443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=294.13 Aligned_cols=221 Identities=20% Similarity=0.264 Sum_probs=183.8
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||+||++.+. ++.||||++...... .....+.+.+|+.++..++||||++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~ 77 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL---AQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLY 77 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEE
Confidence 47999999999999999999986 789999999864221 1223466889999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
....+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 225789999999999999999999999999999999999999999999999999876543222
Q ss_pred --CCCcccccccCChhhhh------cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCc
Q 020016 184 --AKGFTGTYRWMAPEMIK------EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCP 253 (332)
Q Consensus 184 --~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~ 253 (332)
.....||+.|+|||++. ...++.++||||||+++|+|++|..||...+.......+........++ ..++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVS 237 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCC
Confidence 22346899999999986 4567899999999999999999999999888777666655433333333 4578
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 254 KAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 254 ~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+.+.+|+.+||. +|.+||++.+++.
T Consensus 238 ~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 238 SDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 999999999998 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=295.30 Aligned_cols=228 Identities=23% Similarity=0.308 Sum_probs=186.6
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
+....++|++.+.||+|+||.||++.+. ++.||+|++....... ....+.+.+|+.+++.++||||++
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK---RSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 4455689999999999999999999996 6889999986522111 112355788999999999999987
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 233578899999999999999999999999999999999999999999999999876543
Q ss_pred CC--CCCCcccccccCChhhhhcCC----CCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC--CC
Q 020016 181 CG--SAKGFTGTYRWMAPEMIKEKR----HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP--TC 252 (332)
Q Consensus 181 ~~--~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~ 252 (332)
.. ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+........++. .+
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 274 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEI 274 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccC
Confidence 22 223567999999999997543 78899999999999999999999998887777666665444444444 56
Q ss_pred cHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 020016 253 PKAFSYLISRCWSSSPDR--RPHFDQIVSI 280 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~--Rps~~ell~~ 280 (332)
+..+.+++..||..++.+ |+++.++++.
T Consensus 275 s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 275 SKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 899999999999865543 8899999885
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=281.42 Aligned_cols=228 Identities=25% Similarity=0.406 Sum_probs=185.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||.|+||.||++.+. +..||||.+....... ......+.+|+.+++.++||||++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 78 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD---AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 78 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhh---HHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEE
Confidence 57899999999999999999975 7899999887643221 122467889999999999999986
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 134578899999999999999999999999999999999999999999999998865543
Q ss_pred CCC-CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCCCCCCCCCcHHHH
Q 020016 181 CGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE--QAAFAVCQKNARPPVPPTCPKAFS 257 (332)
Q Consensus 181 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~ 257 (332)
... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.... .....+......+..+..++..+.
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence 221 23456889999999999888999999999999999999999999764432 222222222222223345788999
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHhhh
Q 020016 258 YLISRCWSSSPDRRPHFDQIVSILEGYS 285 (332)
Q Consensus 258 ~li~~cl~~dp~~Rps~~ell~~L~~~~ 285 (332)
+++.+||..+|++|||+.+|++.++++.
T Consensus 239 ~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 239 QLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 9999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=292.45 Aligned_cols=234 Identities=24% Similarity=0.490 Sum_probs=190.1
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 120 (332)
.|.+..++|.+++.||.|+||.||+|.+. ++.||||++........ ...+.+|+.++.++ +||||++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~h~niv~ 75 (343)
T cd05103 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLNVVN 75 (343)
T ss_pred CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHH-----HHHHHHHHHHHHhccCCccHhh
Confidence 37888899999999999999999999752 57899999976433221 35688999999999 6899875
Q ss_pred C-------------------------------------------------------------------------------
Q 020016 121 E------------------------------------------------------------------------------- 121 (332)
Q Consensus 121 ~------------------------------------------------------------------------------- 121 (332)
.
T Consensus 76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (343)
T cd05103 76 LLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEE 155 (343)
T ss_pred hcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCC
Confidence 0
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC--
Q 020016 122 -----------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-- 182 (332)
Q Consensus 122 -----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 182 (332)
...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 235 (343)
T cd05103 156 KSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235 (343)
T ss_pred CccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch
Confidence 0125667788899999999999999999999999999999999999999999986542211
Q ss_pred -CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 020016 183 -SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 260 (332)
Q Consensus 183 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 260 (332)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....................+..+++++.+++
T Consensus 236 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (343)
T cd05103 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM 315 (343)
T ss_pred hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence 1122345678999999988889999999999999999997 99999876544434444444555566667789999999
Q ss_pred HHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 261 SRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 261 ~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
..||+.+|.+||++.+|++.|+.+.+.
T Consensus 316 ~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 316 LDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=295.24 Aligned_cols=210 Identities=26% Similarity=0.392 Sum_probs=177.1
Q ss_pred eeecccCceEEEEEEE-----CCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------------
Q 020016 61 CKFASGRHSRIYRGIY-----KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------------- 120 (332)
+.||+|+||.||++.+ .++.||+|++....... .....+.+|+.++.+++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV----RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh----hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEE
Confidence 5799999999999876 26899999997633211 11345778999999999999987
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-CCCCC
Q 020016 121 -------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GSAKG 186 (332)
Q Consensus 121 -------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~~~~ 186 (332)
....+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++...... .....
T Consensus 78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 157 (318)
T cd05582 78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 157 (318)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceec
Confidence 2346899999999999999999999999999999999999999999999999998654433 22334
Q ss_pred cccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHcccc
Q 020016 187 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 266 (332)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 266 (332)
..|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+.. ....++..+++.+.+++.+||+.
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~~l~~ 235 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK--AKLGMPQFLSPEAQSLLRALFKR 235 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHhhc
Confidence 6789999999999988899999999999999999999999998887776665543 33456778899999999999999
Q ss_pred CCCCCCCHHH
Q 020016 267 SPDRRPHFDQ 276 (332)
Q Consensus 267 dp~~Rps~~e 276 (332)
||.+||++.+
T Consensus 236 ~P~~R~~a~~ 245 (318)
T cd05582 236 NPANRLGAGP 245 (318)
T ss_pred CHhHcCCCCC
Confidence 9999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=292.18 Aligned_cols=220 Identities=25% Similarity=0.346 Sum_probs=177.5
Q ss_pred CeeeeeeecccCceEEEEEEEC-----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec---------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT--------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------- 120 (332)
+|.+.+.||+|+||+||++... ++.||+|++....... .....+.+..|+.++..+ +||||+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ--KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh--hhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence 5889999999999999999863 6789999997532111 112245678899999999 5899875
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 3456899999999999999999999999999999999999999999999999998754322
Q ss_pred C--CCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCCCCCCCCcH
Q 020016 182 G--SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMT----PEQAAFAVCQKNARPPVPPTCPK 254 (332)
Q Consensus 182 ~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 254 (332)
. ......||+.|+|||++.+. .++.++|||||||++|+|+||..||.... .......+ ....+.++..+++
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 236 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--LKCDPPFPSFIGP 236 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--hcCCCCCCCCCCH
Confidence 2 22345789999999999865 47889999999999999999999997432 22222222 2345567778999
Q ss_pred HHHHHHHHccccCCCCCC-----CHHHHHH
Q 020016 255 AFSYLISRCWSSSPDRRP-----HFDQIVS 279 (332)
Q Consensus 255 ~l~~li~~cl~~dp~~Rp-----s~~ell~ 279 (332)
.+.+++.+||+.||++|| +++++++
T Consensus 237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 999999999999999999 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=290.12 Aligned_cols=209 Identities=22% Similarity=0.312 Sum_probs=175.2
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec-----------------
Q 020016 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT----------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----------------- 120 (332)
+.||+|+||+||+|.++ ++.||||++...... .....+.+..|..++..+ +||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL---QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh---hccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence 46999999999999986 688999998753211 111235677888888876 7999986
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc-cCCCCCCcc
Q 020016 121 -----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES-QCGSAKGFT 188 (332)
Q Consensus 121 -----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~-~~~~~~~~~ 188 (332)
....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.... .........
T Consensus 78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 34568899999999999999999999999999999999999999999999999986532 222334567
Q ss_pred cccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCC
Q 020016 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 268 (332)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 268 (332)
||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.. .....+..++.++.+++.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~L~~dP 235 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--DEVVYPTWLSQDAVDILKAFMTKNP 235 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHcccCH
Confidence 89999999999998999999999999999999999999999888776666543 3445667789999999999999999
Q ss_pred CCCCCH
Q 020016 269 DRRPHF 274 (332)
Q Consensus 269 ~~Rps~ 274 (332)
.+||++
T Consensus 236 ~~R~~~ 241 (320)
T cd05590 236 TMRLGS 241 (320)
T ss_pred HHCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=282.28 Aligned_cols=229 Identities=28% Similarity=0.532 Sum_probs=188.1
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-- 120 (332)
|+++.++|.+.+.||+|+||.||+|..+ +..||+|.+........ ...+.+|+.+++.++||||++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~ 75 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE-----RIEFLNEASVMKGFTCHHVVRLL 75 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHH-----HHHHHHHHHHHHhCCCCCeeeEE
Confidence 7889999999999999999999999754 34799999875432211 345789999999999999986
Q ss_pred ----------------C--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC
Q 020016 121 ----------------E--------------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED 164 (332)
Q Consensus 121 ----------------~--------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~ 164 (332)
. ...++...+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~ 155 (288)
T cd05061 76 GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD 155 (288)
T ss_pred EEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC
Confidence 0 1223556788899999999999999999999999999999999
Q ss_pred CeEEEeecccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 020016 165 MCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVC 240 (332)
Q Consensus 165 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~ 240 (332)
+.++|+|||++........ .....++..|+|||.+.++.++.++||||||+++|||++ |..||.+....+....+.
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999865432111 122345678999999998899999999999999999999 899998887766554443
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 241 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
.......+..+++.+.+++.+||+.+|++||++.++++.|++.
T Consensus 236 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 236 -DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 3334455667889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=285.35 Aligned_cols=233 Identities=26% Similarity=0.504 Sum_probs=192.9
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEEC---------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCc
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK---------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPH 117 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 117 (332)
..|.+..++|.+++.||+|+||.||+|.+. +..||+|.+........ .+.+.+|+.+++.+ +|||
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~-----~~~~~~E~~~l~~l~~h~~ 82 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD-----LSDLVSEMEMMKMIGKHKN 82 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHH-----HHHHHHHHHHHHhhccCCC
Confidence 357788899999999999999999999752 34799999875432221 35688999999999 8999
Q ss_pred eec----------------------------C----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 020016 118 IIT----------------------------E----------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRD 153 (332)
Q Consensus 118 iv~----------------------------~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~d 153 (332)
|++ . ...+++..+..++.||+.||.|||++|++|||
T Consensus 83 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~d 162 (304)
T cd05101 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRD 162 (304)
T ss_pred chheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 986 0 12467778899999999999999999999999
Q ss_pred ccccceeecCCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCC
Q 020016 154 LKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 229 (332)
Q Consensus 154 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~ 229 (332)
|||+||+++.++.++|+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+
T Consensus 163 lkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 242 (304)
T cd05101 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242 (304)
T ss_pred cccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999987554322 1222345678999999998889999999999999999999 8899988
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 020016 230 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 286 (332)
.+..+....+. ...+...+..++..+.+++.+||..+|.+||++.++++.|+.+..
T Consensus 243 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 243 IPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred CCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 87766655543 344555667889999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=278.12 Aligned_cols=217 Identities=28% Similarity=0.580 Sum_probs=182.3
Q ss_pred eecccCceEEEEEEEC----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------------
Q 020016 62 KFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------------- 120 (332)
Q Consensus 62 ~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 120 (332)
.||+|+||.||+|.+. +..||+|++....... ..+.|.+|+.++++++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~ 76 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKS-----VRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMA 76 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChH-----HHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeC
Confidence 4899999999999874 4569999987653321 2467899999999999999986
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC----CC
Q 020016 121 -----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS----AK 185 (332)
Q Consensus 121 -----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~----~~ 185 (332)
....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++........ ..
T Consensus 77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 245689999999999999999999999999999999999999999999999999865432211 11
Q ss_pred CcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHcc
Q 020016 186 GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 264 (332)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 264 (332)
...++..|+|||.+....++.++||||||+++|++++ |..||......+....+ ....+...+..+++++.+++.+||
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~c~ 235 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI-EQGKRLDCPAECPPEMYALMKDCW 235 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCCCCCCCCCCCHHHHHHHHHHc
Confidence 2233578999999988889999999999999999997 99999988776665444 345566777888999999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhh
Q 020016 265 SSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 265 ~~dp~~Rps~~ell~~L~~~ 284 (332)
..+|++||++.+|.+.|+.+
T Consensus 236 ~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 236 IYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCChhhCcCHHHHHHHHhhh
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=288.71 Aligned_cols=214 Identities=28% Similarity=0.400 Sum_probs=175.8
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHc-CCCCceec-----------------
Q 020016 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR-LNHPHIIT----------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~----------------- 120 (332)
+.||+|+||.||+|.+. ++.||||++....... ....+.+..|..++.. .+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE---DDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 46999999999999986 6789999997632111 1112445567677765 48999986
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc-CCCCCCcc
Q 020016 121 -----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKGFT 188 (332)
Q Consensus 121 -----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~~~~~~~~ 188 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... ........
T Consensus 78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 345688999999999999999999999999999999999999999999999999865332 22334567
Q ss_pred cccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCC
Q 020016 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 268 (332)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 268 (332)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. ...+.++..++.++.+++.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~ll~~~l~~~P 235 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFERDP 235 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 8999999999999899999999999999999999999999888777666553 34566778899999999999999999
Q ss_pred CCCCCHH-HHHH
Q 020016 269 DRRPHFD-QIVS 279 (332)
Q Consensus 269 ~~Rps~~-ell~ 279 (332)
.+||++. ++++
T Consensus 236 ~~R~~~~~~l~~ 247 (316)
T cd05592 236 TKRLGVDGDIRQ 247 (316)
T ss_pred HHcCCChHHHHc
Confidence 9999875 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=281.61 Aligned_cols=221 Identities=19% Similarity=0.262 Sum_probs=181.2
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
.|+..+.||.|+||+||+|.+. ++.||+|.+....... ......+.+|+++++.++|+||+.
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~l 77 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK---RKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh---hhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEE
Confidence 3778899999999999999996 7899999987643221 112345788999999999999976
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
....+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 223688999999999999999999999999999999999999999999999999865443333
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCCCCCCCCCcHHHHHHHH
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ--KNARPPVPPTCPKAFSYLIS 261 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~ 261 (332)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.. ......++..++..+.+|+.
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK 237 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence 3455789999999999988999999999999999999999999988765443333222 12233456678899999999
Q ss_pred HccccCCCCCCC-----HHHHHH
Q 020016 262 RCWSSSPDRRPH-----FDQIVS 279 (332)
Q Consensus 262 ~cl~~dp~~Rps-----~~ell~ 279 (332)
+||+.||.+||+ +.+++.
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 238 MLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred HHccCCHhHcCCCcccChHHHHc
Confidence 999999999999 667766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=279.31 Aligned_cols=224 Identities=26% Similarity=0.419 Sum_probs=186.5
Q ss_pred CeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 120 (332)
+|++++.||.|+||.||+|... ++.+|||.+................+.+|+++++.++|+||++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4788999999999999999885 7889999987654433333344567899999999999999986
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-----
Q 020016 121 --------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC----- 181 (332)
Q Consensus 121 --------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~----- 181 (332)
....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT 160 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccc
Confidence 2356789999999999999999999999999999999999999999999999988653211
Q ss_pred --CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCCCCCCCcHHHHH
Q 020016 182 --GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK-NARPPVPPTCPKAFSY 258 (332)
Q Consensus 182 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ 258 (332)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+... ...+..+..++..+.+
T Consensus 161 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06631 161 HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAID 240 (265)
T ss_pred ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHH
Confidence 1122356889999999999888999999999999999999999999887665544443332 3345567788999999
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~ 279 (332)
++++||+.+|.+||++.++++
T Consensus 241 ~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 241 FVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHhcCCcccCCCHHHHhc
Confidence 999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=282.90 Aligned_cols=225 Identities=30% Similarity=0.552 Sum_probs=187.1
Q ss_pred CeeeeeeecccCceEEEEEEECC-------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
+|++.+.||+|+||.||+|.+.. ..+|+|.+........ .+.+.+|+.+++.++||||++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE-----LRDLLSEFNLLKQVNHPHVIKLYGACSQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHH-----HHHHHHHHHHHhhCCCCCEeeEEEEEecC
Confidence 47889999999999999998742 4689998876543221 357889999999999999986
Q ss_pred ----------C----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccc
Q 020016 121 ----------E----------------------------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKS 156 (332)
Q Consensus 121 ----------~----------------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp 156 (332)
. ...+++..++.++.|++.||.|||+.|++||||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp 155 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA 155 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhh
Confidence 0 02367888899999999999999999999999999
Q ss_pred cceeecCCCeEEEeecccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCH
Q 020016 157 ENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTP 232 (332)
Q Consensus 157 ~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~ 232 (332)
+||+++.++.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..+
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999865432211 223345678999999988889999999999999999999 9999988877
Q ss_pred HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 020016 233 EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 286 (332)
....... ........+..++.++.+++.+||+.+|.+||++.++++.|+++..
T Consensus 236 ~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ERLFNLL-KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHH-hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 6655443 3445556677889999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=289.98 Aligned_cols=215 Identities=20% Similarity=0.296 Sum_probs=178.5
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec-----------------
Q 020016 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT----------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----------------- 120 (332)
+.||+|+||.||+|.+. ++.||||++...... .....+.+..|..++..+ +||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL---QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh---hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence 46999999999999987 679999999763211 111235577888998866 8999976
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc-CCCCCCcc
Q 020016 121 -----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKGFT 188 (332)
Q Consensus 121 -----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~~~~~~~~ 188 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..... ........
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 335678899999999999999999999999999999999999999999999999865322 22234567
Q ss_pred cccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCC
Q 020016 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 268 (332)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 268 (332)
||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+... ...+|..++.++.+++.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~ll~~~L~~dp 235 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVLYPVWLSKEAVSILKAFMTKNP 235 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhccCH
Confidence 899999999999989999999999999999999999999998887777666533 345566789999999999999999
Q ss_pred CCCC-------CHHHHHHH
Q 020016 269 DRRP-------HFDQIVSI 280 (332)
Q Consensus 269 ~~Rp-------s~~ell~~ 280 (332)
++|| ++.++++.
T Consensus 236 ~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 236 NKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHcCCCCCCCCCHHHHhcC
Confidence 9999 77777753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=297.10 Aligned_cols=233 Identities=30% Similarity=0.609 Sum_probs=206.6
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
.+.|+.+..++....+||.|.||.||.|.|+ .-.||||.++..... .++|++|+.+|+.+.|||+|+
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-------veEFLkEAAvMKeikHpNLVqLLGV 331 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLLGV 331 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-------HHHHHHHHHHHHhhcCccHHHHhhh
Confidence 5899999999999999999999999999998 578999998764322 478999999999999999987
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....++.-..+.|+.||.+|+.||..+++|||||..+|+|+.++..+|++|||+
T Consensus 332 CT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 332 CTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred hccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccch
Confidence 344567777899999999999999999999999999999999999999999999
Q ss_pred ccccccCCC--CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 020016 175 SCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 251 (332)
Q Consensus 175 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (332)
+++...... ..+......|.|||-+....++.++|||+|||+|||+.| |..||++.+-.+ ++.+..++.+..-|..
T Consensus 412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-VY~LLEkgyRM~~PeG 490 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYGLLEKGYRMDGPEG 490 (1157)
T ss_pred hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-HHHHHhccccccCCCC
Confidence 987654332 223445789999999999999999999999999999999 999999987755 4567788999999999
Q ss_pred CcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 252 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 252 ~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
|++.+.+||+.||++.|.+||++.|+-+.|+.+..+
T Consensus 491 CPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 491 CPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred CCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 999999999999999999999999999999876543
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=279.82 Aligned_cols=226 Identities=32% Similarity=0.550 Sum_probs=187.7
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--C---eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--Q---RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~---~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
+...|.+.+.||+|+||.||+|.+. + ..||||++....... ....|..|+.+++.++||||++
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 76 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEK-----QRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHH-----HHHHHHHHHHHHHhCCCcCcceEEEEECC
Confidence 4567999999999999999999985 2 369999987643221 2467899999999999999986
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
..+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 2345788999999999999999999999999999999999999999999999998654
Q ss_pred ccCCCCCC------cccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 020016 179 SQCGSAKG------FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 251 (332)
Q Consensus 179 ~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (332)
........ ...+..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+. .....+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~ 235 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMD 235 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCccc
Confidence 33221111 112457999999998899999999999999999997 999998887766655553 3444555678
Q ss_pred CcHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 252 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 252 ~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
++..+.+++.+||..+|++||++.+++..|+.+
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 236 CPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=294.16 Aligned_cols=231 Identities=23% Similarity=0.309 Sum_probs=186.9
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
.++.+..++|.+.+.||+|+||.||++.++ ++.||+|++...... .....+.+.+|+.++..++||||++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~---~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~ 112 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI---KRSDSAFFWEERDIMAFANSPWVVQLFYAF 112 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh---hhHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 345666789999999999999999999997 689999998653211 1112355788999999999999986
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 113 QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 2345788889999999999999999999999999999999999999999999998765
Q ss_pred ccCC--CCCCcccccccCChhhhhcCC----CCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--C
Q 020016 179 SQCG--SAKGFTGTYRWMAPEMIKEKR----HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--P 250 (332)
Q Consensus 179 ~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~ 250 (332)
.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+........++ .
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (371)
T cd05622 193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 272 (371)
T ss_pred CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcC
Confidence 4322 223567999999999997543 7889999999999999999999999888777666665444333333 4
Q ss_pred CCcHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 020016 251 TCPKAFSYLISRCWSSSPDR--RPHFDQIVSIL 281 (332)
Q Consensus 251 ~~~~~l~~li~~cl~~dp~~--Rps~~ell~~L 281 (332)
.++..+.++|..||..++.+ |+++.++++..
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 273 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 68999999999999844433 77899888743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=295.30 Aligned_cols=222 Identities=23% Similarity=0.370 Sum_probs=201.7
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|..++.+|.|+||.+++.+++ +..+++|.+......... ++...+|+.+++++.|||||.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~----r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~ 78 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE----RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQL 78 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh----hHHHHHHHHHHHhccCCCeeeeccchhcCCce
Confidence 478999999999999999999887 678999999876543322 457789999999999999986
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
.+..++++.+..++.|++.|+.|||++.|+|||||+.|||++.++.|+|+|||+|+....
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 446789999999999999999999999999999999999999999999999999998877
Q ss_pred CC-CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 020016 181 CG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 259 (332)
Q Consensus 181 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 259 (332)
.. ......||+.|++||++.+.+|..|+|+|||||++|||++-+++|.+.+.......+.... ..+.|..++.+++.+
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSL 237 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHH
Confidence 65 6678899999999999999999999999999999999999999999999998888887544 677889999999999
Q ss_pred HHHccccCCCCCCCHHHHHHH
Q 020016 260 ISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~~ 280 (332)
|..||..+|..||++.+++..
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhC
Confidence 999999999999999999986
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=277.95 Aligned_cols=219 Identities=26% Similarity=0.438 Sum_probs=186.1
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|.+.+.||.|+||.||++.+. +..||+|.+....... ..+.+.+|+.+++.++|+||++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSS-----AVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchH-----HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEE
Confidence 5889999999999999999986 7899999987643322 1356788999999999999976
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 182 (332)
....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 23457889999999999999999999999999999999999999999999999986554322
Q ss_pred CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 020016 183 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 262 (332)
......+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+. .....+.+..++..+.+++.+
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 234 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIKQ 234 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHHH
Confidence 2234568899999999998889999999999999999999999999877766655554 344455677889999999999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~~ 280 (332)
||+.||++||++.+++..
T Consensus 235 ~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 235 MFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHhCCcccCCCHHHHhhc
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=283.49 Aligned_cols=225 Identities=32% Similarity=0.518 Sum_probs=184.3
Q ss_pred ccCCeeeeeeecccCceEEEEEEECC------------------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYKQ------------------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN 114 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~~------------------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 114 (332)
..++|.+.+.||+|+||.||+|.+.+ ..||+|.+....... ..+.+.+|+.++.+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~~e~~~l~~l~ 77 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDN-----AREDFLKEVKILSRLS 77 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHH-----HHHHHHHHHHHHHhcC
Confidence 35789999999999999999998752 458999988654332 2467899999999999
Q ss_pred CCceec----------------------------CC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Q 020016 115 HPHIIT----------------------------EP-----------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 155 (332)
Q Consensus 115 h~niv~----------------------------~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlk 155 (332)
||||++ .. ..+++..++.++.|++.||.|||+.|++|+|||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 78 DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred CCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 999976 11 158899999999999999999999999999999
Q ss_pred ccceeecCCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh--CCCCCCCC
Q 020016 156 SENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT--ALTPFDNM 230 (332)
Q Consensus 156 p~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--G~~pf~~~ 230 (332)
|+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999999999999999999986543221 1223456778999999998889999999999999999998 77899877
Q ss_pred CHHHHHHHHHhc------CCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 020016 231 TPEQAAFAVCQK------NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282 (332)
Q Consensus 231 ~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~ 282 (332)
...+........ ......+..++.++.+++.+||+.||.+||++.+|++.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 766655444322 1112334567899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=278.86 Aligned_cols=230 Identities=28% Similarity=0.619 Sum_probs=191.8
Q ss_pred cccCCeeeeeeecccCceEEEEEEECC-----eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYKQ-----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
++.++|.+.+.||.|+||.||+|.+.+ ..||||......... ..+.+.+|+.+++.++||||++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~-----~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 77 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPS-----VREKFLQEAYIMRQFDHPHIVKLIGVIT 77 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHH-----HHHHHHHHHHHHHhCCCCchhceeEEEc
Confidence 445789999999999999999998752 368999987654322 2467899999999999999987
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 78 ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred CCCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 2335789999999999999999999999999999999999999999999999998654
Q ss_pred ccCCC--CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 020016 179 SQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255 (332)
Q Consensus 179 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (332)
..... .....++..|+|||.+....++.++||||||+++|++++ |..||...+..+....+ ........+..++..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 236 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPPT 236 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HcCCcCCCCCCCCHH
Confidence 43221 112234568999999988889999999999999999997 99999988776655444 344455677888999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 256 FSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
+.+++.+||..+|++||++.++++.|+++..+
T Consensus 237 ~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 237 LYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=289.56 Aligned_cols=222 Identities=22% Similarity=0.403 Sum_probs=179.4
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
+..++|++.++||.|+||.||++.+. +..+|+|++....... ....+.+|+++++.++||||++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPA-----IRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHH-----HHHHHHHHHHHHHHCCCCcccceeEEEEECC
Confidence 34578999999999999999999997 6789999987643222 2467889999999999999987
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
..+.+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 77 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 234678888999999999999999985 799999999999999999999999999865433
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH---------------------
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV--------------------- 239 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~--------------------- 239 (332)
. ......++..|+|||.+.+..++.++|||||||++|+|++|+.||............
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 157 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred h-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 2 223457899999999999888999999999999999999999999865443322111
Q ss_pred ----------------------HhcCCCCCCC-CCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 240 ----------------------CQKNARPPVP-PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 240 ----------------------~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
......+..+ ..++.++.+|+.+||+.||++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0011111121 235788999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=277.38 Aligned_cols=216 Identities=31% Similarity=0.576 Sum_probs=179.2
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------------
Q 020016 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------------ 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 120 (332)
+.||+|+||.||+|.+. ++.||+|.+....... ....+.+|+++++.++||||++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPD-----LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHH-----HHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeec
Confidence 46999999999999885 7899999886543222 2467899999999999999986
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCC---CC
Q 020016 121 -----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA---KG 186 (332)
Q Consensus 121 -----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~---~~ 186 (332)
....+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......... ..
T Consensus 76 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 76 QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred cCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 2345789999999999999999999999999999999999999999999999998654321111 11
Q ss_pred cccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccc
Q 020016 187 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 265 (332)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 265 (332)
...+..|+|||.+.++.++.++||||||+++|+|++ |..||...........+. .......+..++..+.+++.+||+
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 234 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWE 234 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCcccCCHHHHHHHHHHcC
Confidence 123457999999998899999999999999999998 999998777655444433 344556677889999999999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 020016 266 SSPDRRPHFDQIVSILE 282 (332)
Q Consensus 266 ~dp~~Rps~~ell~~L~ 282 (332)
.+|++||++.++++.|+
T Consensus 235 ~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 235 YDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CChhhCcCHHHHHHHHh
Confidence 99999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=288.95 Aligned_cols=214 Identities=22% Similarity=0.328 Sum_probs=178.5
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec-----------------
Q 020016 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT----------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----------------- 120 (332)
+.||+|+||+||++.+. ++.||||++....... ......+..|..++..+ +||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ---DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh---hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 46999999999999996 6789999997632111 11235577888999888 7999986
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc-cCCCCCCcc
Q 020016 121 -----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES-QCGSAKGFT 188 (332)
Q Consensus 121 -----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~-~~~~~~~~~ 188 (332)
....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.... .........
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 23478999999999999999999999999999999999999999999999999986422 222233456
Q ss_pred cccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCC
Q 020016 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 268 (332)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 268 (332)
|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.. ....++..++..+.+||.+||+.||
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~dP 235 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE--DEVRYPRWLSKEAKSILKSFLTKNP 235 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc--CCCCCCCcCCHHHHHHHHHHccCCH
Confidence 89999999999999999999999999999999999999998887666655543 3445677889999999999999999
Q ss_pred CCCCCH-----HHHHH
Q 020016 269 DRRPHF-----DQIVS 279 (332)
Q Consensus 269 ~~Rps~-----~ell~ 279 (332)
.+||++ .++++
T Consensus 236 ~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 236 EKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHcCCCCCCCHHHHhc
Confidence 999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=277.38 Aligned_cols=219 Identities=28% Similarity=0.554 Sum_probs=184.0
Q ss_pred eeecccCceEEEEEEEC--C---eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------------
Q 020016 61 CKFASGRHSRIYRGIYK--Q---RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~---~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------------- 120 (332)
++||+|+||.||+|.+. + ..||+|.+...... ...+.+.+|+.+++.++|+||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-----AGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVME 75 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEE
Confidence 47999999999999875 2 57999999865443 12467899999999999999987
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCC----
Q 020016 121 ------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA---- 184 (332)
Q Consensus 121 ------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~---- 184 (332)
....+++..+..++.|++.||.|||..+++|+||||+||+++.++.++|+|||++.........
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 2345889999999999999999999999999999999999999999999999998755432221
Q ss_pred CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHc
Q 020016 185 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 263 (332)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. .......+..++..+.+++.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIMLSC 234 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHH
Confidence 11223467999999998899999999999999999998 999999887766555443 3445567778899999999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhh
Q 020016 264 WSSSPDRRPHFDQIVSILEGYS 285 (332)
Q Consensus 264 l~~dp~~Rps~~ell~~L~~~~ 285 (332)
|..+|++||++.++++.|+++.
T Consensus 235 l~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 235 WKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred hcCChhhCcCHHHHHHHHHhcc
Confidence 9999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=279.10 Aligned_cols=227 Identities=32% Similarity=0.579 Sum_probs=188.7
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC-----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
++.++|++.+.||+|+||.||+|.+. +..+|+|.+....... ..+.+.+|+.++++++||||++
T Consensus 1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (267)
T cd05066 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK-----QRRDFLSEASIMGQFDHPNIIHLEGVVT 75 (267)
T ss_pred CCHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHH-----HHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 35678999999999999999999874 2379999987643322 1467899999999999999987
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccc
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 76 KSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred cCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 234578899999999999999999999999999999999999999999999999875
Q ss_pred cccCCC----CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 020016 178 ESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 252 (332)
Q Consensus 178 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (332)
...... .....++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+. ...+.+.+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAPMDC 234 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh-CCCcCCCCCCC
Confidence 443211 112223568999999998889999999999999999887 999998877766555543 33445556678
Q ss_pred cHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 253 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
++.+.+++.+||+.+|.+||++.++++.|+++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 99999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=291.53 Aligned_cols=210 Identities=25% Similarity=0.356 Sum_probs=173.0
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHH-HHHcCCCCceec-----------------
Q 020016 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVA-LLFRLNHPHIIT----------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~----------------- 120 (332)
+.||+|+||+||+|.+. ++.||||++....... ......+..|.. +++.++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK---KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh---hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcC
Confidence 47999999999999996 7899999997632211 111234455544 567899999986
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc-CCCCCCcc
Q 020016 121 -----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKGFT 188 (332)
Q Consensus 121 -----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~~~~~~~~ 188 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 345688999999999999999999999999999999999999999999999999865322 22334567
Q ss_pred cccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCC
Q 020016 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 268 (332)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 268 (332)
||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+... ....++.+++.+.+++.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p 235 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK--PLRLKPNISVSARHLLEGLLQKDR 235 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCH
Confidence 899999999999999999999999999999999999999988877766665432 344566789999999999999999
Q ss_pred CCCCCHH
Q 020016 269 DRRPHFD 275 (332)
Q Consensus 269 ~~Rps~~ 275 (332)
.+||++.
T Consensus 236 ~~R~~~~ 242 (323)
T cd05575 236 TKRLGAK 242 (323)
T ss_pred HhCCCCC
Confidence 9999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=282.11 Aligned_cols=220 Identities=20% Similarity=0.290 Sum_probs=179.9
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|.+.+.||.|+||.||++.+. ++.||||.+....... ......+.+|+.++++++|+||+.
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~l 77 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---RKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCL 77 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc---hHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEE
Confidence 4778899999999999999996 7899999987643221 112345778999999999999985
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
....+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 223578889999999999999999999999999999999999999999999999866544333
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE---QAAFAVCQKNARPPVPPTCPKAFSYLI 260 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li 260 (332)
.....|+..|+|||++.+..++.++||||||+++|+|++|..||...... ....... .......+..+++++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHHHHH
Confidence 34457899999999999999999999999999999999999999865432 1222221 2223345677899999999
Q ss_pred HHccccCCCCCCC-----HHHHHH
Q 020016 261 SRCWSSSPDRRPH-----FDQIVS 279 (332)
Q Consensus 261 ~~cl~~dp~~Rps-----~~ell~ 279 (332)
.+||+.||.+||+ +.++++
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHc
Confidence 9999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=274.36 Aligned_cols=219 Identities=28% Similarity=0.440 Sum_probs=185.9
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|.+.+.||+|++|.||+|.+. ++.|++|.+........ ..+.+.+|+.+++.++||||++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR----EREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNI 76 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHH----HHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEE
Confidence 4788999999999999999986 78999999876433221 2467889999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 182 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 23568889999999999999999999999999999999999999999999999987544322
Q ss_pred CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 020016 183 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 262 (332)
......+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+. ....+..+..++..+.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPPVSQMYSQQLAQLIDQ 235 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCccccCHHHHHHHHH
Confidence 2234568899999999999989999999999999999999999999887666555543 334455666789999999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~ 279 (332)
||+.+|++||++.++++
T Consensus 236 ~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 236 CLTKDYRQRPDTFQLLR 252 (256)
T ss_pred HccCCcccCcCHHHHhh
Confidence 99999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=279.79 Aligned_cols=224 Identities=27% Similarity=0.538 Sum_probs=184.7
Q ss_pred ccCCeeeeeeecccCceEEEEEEECC-------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
..++|.+.+.||+|++|.||+|.+.+ ..||+|.+....... ....|.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ-----DESDFLMEALIMSKFNHQNIVRLIGVS 78 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34689999999999999999998853 578999886543322 1356889999999999999986
Q ss_pred ------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC---eE
Q 020016 121 ------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM---CV 167 (332)
Q Consensus 121 ------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~---~~ 167 (332)
....+++..+..++.||+.||.|||+++++|+||+|+||+++.++ .+
T Consensus 79 ~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 79 FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred ccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence 012578899999999999999999999999999999999998754 69
Q ss_pred EEeecccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC
Q 020016 168 KVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 243 (332)
Q Consensus 168 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~ 243 (332)
+|+|||++........ ......+..|+|||++.+..++.++|||||||++|+|++ |..||...+.......+ ...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~-~~~ 237 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV-TGG 237 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HcC
Confidence 9999999876532211 112233568999999998999999999999999999997 99999987776655444 344
Q ss_pred CCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 020016 244 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282 (332)
Q Consensus 244 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~ 282 (332)
.....+..++..+.+++.+||+.+|++||++.+|++.|+
T Consensus 238 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 455667888999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=280.88 Aligned_cols=225 Identities=30% Similarity=0.540 Sum_probs=186.4
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
++..+|.+.++||+|+||.||++... +..+|+|.+....... .+.+.+|+++++.++|+||++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~ 75 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA------RQDFQREAELLTVLQHQHIVRFYGV 75 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHH------HHHHHHHHHHHhcCCCCCCceEEEE
Confidence 45678999999999999999999642 4578999887543322 467899999999999999986
Q ss_pred ------------------------C---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee
Q 020016 121 ------------------------E---------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 161 (332)
Q Consensus 121 ------------------------~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll 161 (332)
. ...+++..+..++.|++.||+|||+.|++||||||+||++
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~ 155 (280)
T cd05092 76 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV 155 (280)
T ss_pred EecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE
Confidence 0 0247889999999999999999999999999999999999
Q ss_pred cCCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 020016 162 GEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAF 237 (332)
Q Consensus 162 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~ 237 (332)
+.++.++|+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+...
T Consensus 156 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05092 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235 (280)
T ss_pred cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 999999999999986443211 1122335678999999999999999999999999999998 999998877766655
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 020016 238 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 283 (332)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~ 283 (332)
... .......+..+++.+.+++.+||+.||.+||++.+|++.|+.
T Consensus 236 ~~~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 236 CIT-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHH-cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 543 333455667889999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=281.49 Aligned_cols=227 Identities=30% Similarity=0.533 Sum_probs=188.9
Q ss_pred cCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
..+|.+.+.||+|+||.||+|.+. +..+++|.+....... .+.+.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA------RKDFQREAELLTNLQHEHIVKFYGVCG 77 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHH------HHHHHHHHHHHhcCCCCCcceEEEEEc
Confidence 467999999999999999999853 3468999987543322 356889999999999999986
Q ss_pred ----------------------C----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeec
Q 020016 121 ----------------------E----------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 162 (332)
Q Consensus 121 ----------------------~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~ 162 (332)
. ...+++..++.++.||+.||+|||++|++||||||+||+++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 0 12378889999999999999999999999999999999999
Q ss_pred CCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 020016 163 EDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFA 238 (332)
Q Consensus 163 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~ 238 (332)
.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|+| |..||...........
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999986543221 1223456788999999999999999999999999999999 9999988777665544
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 239 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
+ ........+..++..+.+++.+||+.+|.+||++.++++.|+++...
T Consensus 238 ~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 238 I-TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred H-hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 4 33444455667889999999999999999999999999999998553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=290.56 Aligned_cols=214 Identities=24% Similarity=0.344 Sum_probs=173.9
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHH-HHHHcCCCCceec-----------------
Q 020016 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEV-ALLFRLNHPHIIT----------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~----------------- 120 (332)
+.||+|+||+||+|.+. ++.||+|++....... ......+..|. .+++.++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK---KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh---hhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeC
Confidence 47999999999999996 6789999997632211 11123344444 4578899999986
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc-cCCCCCCcc
Q 020016 121 -----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES-QCGSAKGFT 188 (332)
Q Consensus 121 -----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~-~~~~~~~~~ 188 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.... .........
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 33567888999999999999999999999999999999999999999999999986432 222334567
Q ss_pred cccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCC
Q 020016 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 268 (332)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 268 (332)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+... ...+++.+++.+.+++.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p 235 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKPNITNSARHLLEGLLQKDR 235 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CcCCCCCCCHHHHHHHHHHcccCH
Confidence 999999999999999999999999999999999999999988877766655432 334566889999999999999999
Q ss_pred CCCCCHHHHHH
Q 020016 269 DRRPHFDQIVS 279 (332)
Q Consensus 269 ~~Rps~~ell~ 279 (332)
.+||++.+.+.
T Consensus 236 ~~R~~~~~~~~ 246 (325)
T cd05602 236 TKRLGAKDDFM 246 (325)
T ss_pred HHCCCCCCCHH
Confidence 99998875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=275.32 Aligned_cols=223 Identities=28% Similarity=0.570 Sum_probs=186.8
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
++.++|++.+.||.|+||.||++.+. ++.+|+|.+...... ...|.+|++++++++|||+++
T Consensus 1 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd05112 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-------EEDFIEEAQVMMKLSHPKLVQLYGVCTERSP 73 (256)
T ss_pred CChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC-------HHHHHHHHHHHHhCCCCCeeeEEEEEccCCc
Confidence 35678999999999999999999886 788999998754332 246889999999999999986
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 74 ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred eEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 2345788999999999999999999999999999999999999999999999988654322
Q ss_pred CC--CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 020016 182 GS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 258 (332)
Q Consensus 182 ~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 258 (332)
.. .....++..|+|||.+.++.++.++||||||+++|+|++ |..||...........+. .......+...+..+.+
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 232 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-AGFRLYKPRLASQSVYE 232 (256)
T ss_pred cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh-CCCCCCCCCCCCHHHHH
Confidence 11 122335678999999998889999999999999999998 999998877766655543 23344445667899999
Q ss_pred HHHHccccCCCCCCCHHHHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVSILE 282 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~~L~ 282 (332)
|+.+||+.+|++||++.++++.|.
T Consensus 233 l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 233 LMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHHHHcccChhhCCCHHHHHHhhC
Confidence 999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=276.80 Aligned_cols=223 Identities=30% Similarity=0.517 Sum_probs=186.1
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhH---HHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDAS---LASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
+|.+++.||.|++|.||+|.+. ++.||+|.+........ ......+.+.+|+.++++++||||++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999985 68999999876543321 12333467899999999999999986
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 182 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 182 (332)
....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 23567889999999999999999999999999999999999999999999999987554211
Q ss_pred -------CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 020016 183 -------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255 (332)
Q Consensus 183 -------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (332)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+. ....+..+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh-ccCCCcCCcccCHH
Confidence 1123457889999999998889999999999999999999999999877655555443 24456677788999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 020016 256 FSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+.++|.+||+.||.+||++.++++
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhh
Confidence 999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=281.23 Aligned_cols=219 Identities=27% Similarity=0.451 Sum_probs=178.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|++.+.||+|+||.||+|.+. ++.||+|++....... ..+.+.+|+.++.+++||||++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE-----LQKQIMSELEILYKCDSPYIIGFYGAFFVENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChH-----HHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEE
Confidence 36888999999999999999985 7889999987643222 1356889999999999999987
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCCCCcc
Q 020016 121 ------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT 188 (332)
Q Consensus 121 ------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 188 (332)
....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... ......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~ 154 (279)
T cd06619 76 ICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYV 154 (279)
T ss_pred EEEecCCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCCC
Confidence 1234678889999999999999999999999999999999999999999999998654332 234467
Q ss_pred cccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcCCCCC-CCCCCcHHHHHHH
Q 020016 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE-------QAAFAVCQKNARPP-VPPTCPKAFSYLI 260 (332)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~l~~li 260 (332)
++..|+|||.+.+..++.++||||||+++|+|++|..||...... .....+. ....+. .....++++.+++
T Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li 233 (279)
T cd06619 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DEDPPVLPVGQFSEKFVHFI 233 (279)
T ss_pred CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-ccCCCCCCCCcCCHHHHHHH
Confidence 899999999999888999999999999999999999999753321 1111111 112222 2345788999999
Q ss_pred HHccccCCCCCCCHHHHHHH
Q 020016 261 SRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 261 ~~cl~~dp~~Rps~~ell~~ 280 (332)
.+||+.+|++||+++++++.
T Consensus 234 ~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 234 TQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHhhCChhhCCCHHHHhcC
Confidence 99999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=293.36 Aligned_cols=221 Identities=21% Similarity=0.305 Sum_probs=181.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||+||++.+. ++.||||++..... ........+.+|+.++..++||||++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~ 77 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM---LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLY 77 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH---hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 47899999999999999999986 78999999975321 11223466888999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC--
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-- 182 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 182 (332)
....+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 34568999999999999999999999999999999999999999999999999976432110
Q ss_pred ----------------------------------CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCC
Q 020016 183 ----------------------------------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 228 (332)
Q Consensus 183 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~ 228 (332)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 0123468999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHccccCCCCCCC---HHHHHH
Q 020016 229 NMTPEQAAFAVCQKNARPPVPP--TCPKAFSYLISRCWSSSPDRRPH---FDQIVS 279 (332)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~~Rps---~~ell~ 279 (332)
..++......+........+|. .+++++.++|.+|+. ||.+|++ +.++++
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 9888777666654433344443 368899999999774 9999985 555554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=282.75 Aligned_cols=215 Identities=20% Similarity=0.276 Sum_probs=170.7
Q ss_pred ecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------------
Q 020016 63 FASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------------- 120 (332)
Q Consensus 63 lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------------- 120 (332)
||+|+||.||++.+. ++.||+|.+....... ......+..|++++.+++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK---KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc---chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCC
Confidence 699999999999886 7899999986532211 111344567999999999999986
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCCCCcccc
Q 020016 121 ----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT 190 (332)
Q Consensus 121 ----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt 190 (332)
....+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.............++
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGT 157 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCC
Confidence 1234778888999999999999999999999999999999999999999999998765543333445689
Q ss_pred cccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcCCCCCCCCCCcHHHHHHHHHcccc
Q 020016 191 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE----QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 266 (332)
Q Consensus 191 ~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 266 (332)
..|+|||++.+..++.++|||||||++|+|++|..||...... +....... .........+++++.+|+.+||+.
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-DEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc-cccccccccCCHHHHHHHHHHhcc
Confidence 9999999999988999999999999999999999999765332 22222111 111122246789999999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 020016 267 SPDRRPHFDQIVSIL 281 (332)
Q Consensus 267 dp~~Rps~~ell~~L 281 (332)
||.+||++.++++.+
T Consensus 237 ~P~~R~~~~~~~~~~ 251 (277)
T cd05607 237 KPEDRLGSREKNDDP 251 (277)
T ss_pred CHhhCCCCccchhhh
Confidence 999999997766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=286.89 Aligned_cols=213 Identities=25% Similarity=0.351 Sum_probs=175.3
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec-----------------
Q 020016 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT----------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----------------- 120 (332)
+.||+|+||.||+|.++ ++.||||++....... ....+.+..|..++..+ +||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI---DDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---cchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECC
Confidence 47999999999999996 6899999997632110 11134566788887754 8999986
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc-CCCCCCcc
Q 020016 121 -----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKGFT 188 (332)
Q Consensus 121 -----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~~~~~~~~ 188 (332)
....+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++..... ........
T Consensus 78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 345688999999999999999999999999999999999999999999999999864321 12234567
Q ss_pred cccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCC
Q 020016 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 268 (332)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 268 (332)
||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+. ...+.++..++.++.+++.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP 235 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR--VDTPHYPRWITKESKDILEKLFERDP 235 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 8999999999999999999999999999999999999999887766655543 33456677789999999999999999
Q ss_pred CCCCCHH-HHH
Q 020016 269 DRRPHFD-QIV 278 (332)
Q Consensus 269 ~~Rps~~-ell 278 (332)
++||++. +++
T Consensus 236 ~~R~~~~~~~~ 246 (316)
T cd05620 236 TRRLGVVGNIR 246 (316)
T ss_pred HHcCCChHHHH
Confidence 9999984 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=301.48 Aligned_cols=232 Identities=17% Similarity=0.289 Sum_probs=175.2
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCc------eec---
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH------IIT--- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~--- 120 (332)
...++|.+.+.||.|+||+||+|.+. ++.||||+++..... ...+..|+.++..+.|.+ ++.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-------~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY-------TRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh-------HHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 34578999999999999999999986 788999999653211 233455666666665443 332
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccccccceeecCCC---------
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDM--------- 165 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~NIll~~~~--------- 165 (332)
....+++..+..++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 199 ~~~~~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 199 YFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred EEEcCCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence 23468899999999999999999998 5999999999999998765
Q ss_pred -------eEEEeecccccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 020016 166 -------CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA 238 (332)
Q Consensus 166 -------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~ 238 (332)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred ccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 499999998754322 23456799999999999999999999999999999999999999988766544332
Q ss_pred HHhcCCC-------------------------CCCC---------------CCCcHHHHHHHHHccccCCCCCCCHHHHH
Q 020016 239 VCQKNAR-------------------------PPVP---------------PTCPKAFSYLISRCWSSSPDRRPHFDQIV 278 (332)
Q Consensus 239 ~~~~~~~-------------------------~~~~---------------~~~~~~l~~li~~cl~~dp~~Rps~~ell 278 (332)
+...... +... ...++.+.+||.+||+.||.+|||+.|++
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 2111100 0000 01135577999999999999999999999
Q ss_pred H--HHHhhhhhhcCCc
Q 020016 279 S--ILEGYSESLEQDP 292 (332)
Q Consensus 279 ~--~L~~~~~~~~~~~ 292 (332)
+ +|.....+...-+
T Consensus 437 ~Hp~~~~~~~~~~~~~ 452 (467)
T PTZ00284 437 THPYVLKYYPECRQHP 452 (467)
T ss_pred cCccccccCCccccCC
Confidence 7 6666555444333
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=289.01 Aligned_cols=215 Identities=22% Similarity=0.380 Sum_probs=174.0
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec-----------------
Q 020016 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT----------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----------------- 120 (332)
+.||+|+||.||++.+. ++.||||++....... ....+.+..|..++..+ +||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~---~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND---DEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence 46999999999999986 7899999997642211 11235678899999998 7999986
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc-ccCCCCCCcc
Q 020016 121 -----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE-SQCGSAKGFT 188 (332)
Q Consensus 121 -----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~-~~~~~~~~~~ 188 (332)
....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++... ..........
T Consensus 78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 3457899999999999999999999999999999999999999999999999998642 2223334567
Q ss_pred cccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 020016 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT--------PEQAAFAVCQKNARPPVPPTCPKAFSYLI 260 (332)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~li 260 (332)
||+.|+|||++.+..++.++|+||||+++|+|++|+.||.... ..+...... ......+|..++..+.+++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~p~~~~~~~~~li 236 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI-LEKQIRIPRSLSVKASSVL 236 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH-HcCCCCCCCCCCHHHHHHH
Confidence 8999999999999999999999999999999999999996321 112222222 2334456778899999999
Q ss_pred HHccccCCCCCCC------HHHHHH
Q 020016 261 SRCWSSSPDRRPH------FDQIVS 279 (332)
Q Consensus 261 ~~cl~~dp~~Rps------~~ell~ 279 (332)
.+||+.||.+|++ +.++++
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 237 KGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHhccCHHHcCCCCCCCCHHHHhc
Confidence 9999999999997 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=294.64 Aligned_cols=218 Identities=29% Similarity=0.430 Sum_probs=191.4
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
-|.-.+.||+|+||.||.|++. ...||||.+..+..... .--+++++|+..|.+++|||+|.
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~---EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWL 103 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN---EKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWL 103 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccH---HHHHHHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence 3566789999999999999996 68999999987544332 12478999999999999999986
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCCC
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK 185 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 185 (332)
..+++.+.++..|+.+.++||+|||+.+.||||||..|||+++.|.|||+|||.+....+ ..
T Consensus 104 VMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---An 180 (948)
T KOG0577|consen 104 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---AN 180 (948)
T ss_pred HHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---hh
Confidence 567899999999999999999999999999999999999999999999999999866544 56
Q ss_pred CcccccccCChhhhh---cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 020016 186 GFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 186 ~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 262 (332)
.++|||.|||||++. .+.|+-++||||||++..|+.-.++|+-.++.....+.+............++..+..|+..
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~ 260 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS 260 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHH
Confidence 789999999999984 57899999999999999999999999999999888888865544444456789999999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~ 279 (332)
||+.-|.+|||.+++++
T Consensus 261 CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 261 CLQKIPQERPTSEELLK 277 (948)
T ss_pred HHhhCcccCCcHHHHhh
Confidence 99999999999998875
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=281.78 Aligned_cols=231 Identities=16% Similarity=0.218 Sum_probs=172.0
Q ss_pred cccCCeeeeeeecccCceEEEEEEECC-----eeEEEEEecCCCchhHHH-----HHHHHHHHHHHHHHHcCCCCceec-
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYKQ-----RDVAIKLVSQPEEDASLA-----SMLEKQFTSEVALLFRLNHPHIIT- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~- 120 (332)
+..++|.+.+.||+|+||+||+|.+.+ ..+|+|+........... .........+...+..++|+|++.
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 334789999999999999999999863 366777654433221111 001122334555667778988754
Q ss_pred ------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEe
Q 020016 121 ------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVA 170 (332)
Q Consensus 121 ------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~ 170 (332)
.....++..+..++.|++.||.|||+++++||||||+|||++.++.++|+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred EEeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence 11235677888999999999999999999999999999999999999999
Q ss_pred ecccccccccCC--------CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCH-HHHHHH---
Q 020016 171 DFGISCLESQCG--------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP-EQAAFA--- 238 (332)
Q Consensus 171 Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~-~~~~~~--- 238 (332)
|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ......
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 999987543211 12234689999999999999999999999999999999999999987632 221111
Q ss_pred -HHhc-CCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 020016 239 -VCQK-NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282 (332)
Q Consensus 239 -~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~ 282 (332)
.... .........+++.+.+++..||..+|++||++.++.+.|+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 249 DFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1011 1111123456899999999999999999999999998763
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=275.76 Aligned_cols=227 Identities=31% Similarity=0.543 Sum_probs=188.3
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC--C---eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK--Q---RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~--~---~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
+..++|+..+.||+|+||.||+|.+. + ..+|||.+....... ..+.+.+|+.+++.++||||++
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK-----QRQDFLSEASIMGQFSHHNIIRLEGVVT 76 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHH-----HHHHHHHHHHHHhcCCCCCeeEEEEEEc
Confidence 34568999999999999999999885 2 369999987643322 1366889999999999999976
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccc
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 77 KFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 235678999999999999999999999999999999999999999999999999865
Q ss_pred cccCCCC----CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 020016 178 ESQCGSA----KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 252 (332)
Q Consensus 178 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (332)
....... .....+..|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+. .....+.+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~ 235 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRLPAPMDC 235 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-cCCCCCCCCCC
Confidence 4322111 11223457999999998889999999999999999998 999998877766665554 33445556678
Q ss_pred cHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 253 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=274.09 Aligned_cols=227 Identities=27% Similarity=0.456 Sum_probs=185.6
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||.|+||.||+|.+. ++.||+|.++....... ...+.+.+|++++++++|+||++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~ 78 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA---KARQDCLKEIDLLKQLDHPNVIKYLASFIENNELN 78 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccch---hhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 58999999999999999999996 78999999875332211 12467889999999999999976
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..+..++.+++.||.|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 124478899999999999999999999999999999999999999999999999865443
Q ss_pred CC-CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcCCCCCCCC-CCcHHH
Q 020016 181 CG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP--EQAAFAVCQKNARPPVPP-TCPKAF 256 (332)
Q Consensus 181 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~l 256 (332)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... .+...... ....++.+. .++..+
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-KCDYPPLPADHYSEEL 237 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh-cCCCCCCChhhcCHHH
Confidence 22 22345688899999999988899999999999999999999999965432 22222222 233334444 678899
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVSILEGYS 285 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~~L~~~~ 285 (332)
.++|.+||..+|++||++.+|++.|+.+.
T Consensus 238 ~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 238 RDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 99999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=280.03 Aligned_cols=222 Identities=24% Similarity=0.412 Sum_probs=179.2
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||.||+|.+. ++.||+|++....... ...+.+|+.++..++||||++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~------~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD------FSLIQQEIFMVKECKHCNIVAYFGSYLSREKL 81 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch------HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence 468999999999999999999985 7889999997653322 245778999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 182 (332)
....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 82 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 23567889999999999999999999999999999999999999999999999987553222
Q ss_pred CCCCcccccccCChhhhh---cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---CCCCCcHHH
Q 020016 183 SAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP---VPPTCPKAF 256 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l 256 (332)
......++..|+|||.+. ...++.++||||||+++|+|++|..||....+......+......++ ....++..+
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence 223456889999999884 34578899999999999999999999976655443332222222221 123568899
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHH
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVSIL 281 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~~L 281 (332)
.+++.+||..+|++||+++++++.|
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCC
Confidence 9999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=304.24 Aligned_cols=236 Identities=23% Similarity=0.328 Sum_probs=195.6
Q ss_pred CCccccccccCCeeeeeeecccCceEEEEEEEC-C-eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCceec-
Q 020016 45 EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-Q-RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIIT- 120 (332)
Q Consensus 45 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~-~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~- 120 (332)
.....+.+...+++|.+.|.+|||+.||+|.+. + ..||+|++-...... .+.+.+|+++|++|. |+|||.
T Consensus 27 ~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~------L~~v~~EI~~MK~L~gh~nIV~y 100 (738)
T KOG1989|consen 27 FVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEA------LNAVKREIDIMKLLSGHKNIVSY 100 (738)
T ss_pred CCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHH------HHHHHHHHHHHHHhcCCCceeeE
Confidence 344567788899999999999999999999997 4 899999988763332 577899999999995 999996
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC--Cccccccccceeec
Q 020016 121 ------------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLG 162 (332)
Q Consensus 121 ------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~NIll~ 162 (332)
....|++.++++|+.|+++|+++||... |||||||-+||||+
T Consensus 101 idss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls 180 (738)
T KOG1989|consen 101 IDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS 180 (738)
T ss_pred eccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc
Confidence 2345999999999999999999999997 99999999999999
Q ss_pred CCCeEEEeecccccccccCCCCC----------CcccccccCChhhh---hcCCCCCccchhHHHHHHHHHHhCCCCCCC
Q 020016 163 EDMCVKVADFGISCLESQCGSAK----------GFTGTYRWMAPEMI---KEKRHTKKVDVYSFGIVLWELLTALTPFDN 229 (332)
Q Consensus 163 ~~~~~kl~Dfg~a~~~~~~~~~~----------~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~il~elltG~~pf~~ 229 (332)
.+|..||||||.+.......... ....|+.|+|||++ .+...+.|+|||+|||+||-|+....||..
T Consensus 181 ~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~ 260 (738)
T KOG1989|consen 181 ADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE 260 (738)
T ss_pred CCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc
Confidence 99999999999986432222111 12369999999987 466789999999999999999999999987
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 020016 230 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 290 (332)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~ 290 (332)
.... +++......+..+.++..+.+||+.||+.||++||++-+++..+-.+...-..
T Consensus 261 sg~l----aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 261 SGKL----AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred Ccce----eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 5332 33444444444568899999999999999999999999999999877655443
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=278.06 Aligned_cols=218 Identities=28% Similarity=0.473 Sum_probs=181.4
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec-----------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT----------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----------- 120 (332)
+.|.+.+.||.|+||.||+|.+. ++.||+|++...... ...+.+|+.++..+ +|+||++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-------EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc-------HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 57889999999999999999886 689999999765432 24578899999998 7999985
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
....+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 1235788999999999999999999999999999999999999999999999998
Q ss_pred cccccC-CCCCCcccccccCChhhhh-----cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 020016 176 CLESQC-GSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP 249 (332)
Q Consensus 176 ~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (332)
...... .......|+..|+|||++. +..++.++|||||||++|+|++|..||.................+...+
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 238 (272)
T ss_pred eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCC
Confidence 754332 2234467899999999986 3457889999999999999999999998777665555444333344445
Q ss_pred CCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 250 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..++..+.+|+.+||..+|.+||++.++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 678899999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=273.90 Aligned_cols=216 Identities=35% Similarity=0.670 Sum_probs=186.9
Q ss_pred eeecccCceEEEEEEEC-----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------------
Q 020016 61 CKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------------- 120 (332)
+.||.|+||.||+|.+. +..||||++....... ..+.+.+|+.++..++|+||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-----ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-----HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEE
Confidence 46999999999999986 6789999998754433 2467899999999999999986
Q ss_pred -------------C---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 -------------E---------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 -------------~---------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccc
Confidence 2 377899999999999999999999999999999999999999999999999998765
Q ss_pred ccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 020016 179 SQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254 (332)
Q Consensus 179 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (332)
.... ......++..|+|||.+....++.++||||||+++|+|++ |..||......+....+.. ......+..++.
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPD 234 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCCh
Confidence 5432 2334557889999999998889999999999999999999 6999999877776665543 556667788899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHH
Q 020016 255 AFSYLISRCWSSSPDRRPHFDQIVSILE 282 (332)
Q Consensus 255 ~l~~li~~cl~~dp~~Rps~~ell~~L~ 282 (332)
++.+++.+||+.+|.+||++.++++.|+
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 235 ELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 9999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=285.78 Aligned_cols=214 Identities=26% Similarity=0.372 Sum_probs=175.5
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHc-CCCCceec-----------------
Q 020016 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR-LNHPHIIT----------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~----------------- 120 (332)
+.||+|+||.||+|.+. ++.||||++....... ....+.+..|..++.. ++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM---DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence 47999999999999986 6789999997642110 1112456677888876 49999986
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc-CCCCCCcc
Q 020016 121 -----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKGFT 188 (332)
Q Consensus 121 -----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~~~~~~~~ 188 (332)
....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... ........
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 235688999999999999999999999999999999999999999999999999864322 12233457
Q ss_pred cccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCC
Q 020016 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 268 (332)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 268 (332)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.. ..+.++..++.++.+++.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~~P 235 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM--DNPCYPRWLTREAKDILVKLFVREP 235 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHHHHhccCH
Confidence 89999999999998999999999999999999999999998887766655532 3345667789999999999999999
Q ss_pred CCCCCHH-HHHH
Q 020016 269 DRRPHFD-QIVS 279 (332)
Q Consensus 269 ~~Rps~~-ell~ 279 (332)
.+||++. ++..
T Consensus 236 ~~R~~~~~~l~~ 247 (316)
T cd05619 236 ERRLGVKGDIRQ 247 (316)
T ss_pred hhcCCChHHHHc
Confidence 9999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=281.87 Aligned_cols=228 Identities=24% Similarity=0.345 Sum_probs=181.9
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||.|+||.||+|.+. ++.||+|.+........ ...+.+|+.+++.++||||++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIIHTEKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc-----hhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence 468999999999999999999886 78999999876433221 245678999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 182 (332)
....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 80 TLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred EEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 23457889999999999999999999999999999999999999999999999986543222
Q ss_pred CCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------------
Q 020016 183 SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR---------------- 245 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~---------------- 245 (332)
......+++.|+|||.+.+. .++.++||||||+++|+|+||+.||...+..+....+......
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 22344678999999998654 4788999999999999999999999887765443332211000
Q ss_pred ----C--------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH--HHHhhhh
Q 020016 246 ----P--------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYSE 286 (332)
Q Consensus 246 ----~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~--~L~~~~~ 286 (332)
+ .....+++.+.+||.+||+.||.+|||+.++++ .+..+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 0 011356888999999999999999999999987 5544443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=288.72 Aligned_cols=213 Identities=25% Similarity=0.338 Sum_probs=174.4
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHH-HHHcCCCCceec-----------------
Q 020016 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVA-LLFRLNHPHIIT----------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~----------------- 120 (332)
+.||+|+||+||+|.+. ++.||||++....... ......+..|.. +++.++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN---RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcC
Confidence 46999999999999986 7899999997632211 111244555554 567899999986
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc-cCCCCCCcc
Q 020016 121 -----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES-QCGSAKGFT 188 (332)
Q Consensus 121 -----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~-~~~~~~~~~ 188 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.... .........
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 34578999999999999999999999999999999999999999999999999986432 222334567
Q ss_pred cccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCC
Q 020016 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 268 (332)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 268 (332)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+... ....++..+..+.+++.+||+.+|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ll~~ll~~~p 235 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK--PLVLRPGASLTAWSILEELLEKDR 235 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC--CccCCCCCCHHHHHHHHHHhccCH
Confidence 899999999999999999999999999999999999999988877766655432 344556788999999999999999
Q ss_pred CCCCCHHHHH
Q 020016 269 DRRPHFDQIV 278 (332)
Q Consensus 269 ~~Rps~~ell 278 (332)
.+||++.+.+
T Consensus 236 ~~R~~~~~~~ 245 (325)
T cd05604 236 QRRLGAKEDF 245 (325)
T ss_pred HhcCCCCCCH
Confidence 9999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=277.89 Aligned_cols=219 Identities=29% Similarity=0.515 Sum_probs=185.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||.|++|.||+|.+. ++.||+|.+........ ...+.+|+.+++.++|+||++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-----IEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchH-----HHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEE
Confidence 36888999999999999999986 78999999976542221 356789999999999999986
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-CCC
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GSA 184 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~~ 184 (332)
....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred EEEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 2237899999999999999999999999999999999999999999999999998765543 233
Q ss_pred CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC-CcHHHHHHHHHc
Q 020016 185 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT-CPKAFSYLISRC 263 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~c 263 (332)
....+++.|+|||.+.+..++.++||||||+++|+|+||..||...++......+.. ...+..+.. ++..+.+++.+|
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK-NNPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh-cCCCCCcccccCHHHHHHHHHH
Confidence 455688899999999988899999999999999999999999988776555544433 333444444 889999999999
Q ss_pred cccCCCCCCCHHHHHH
Q 020016 264 WSSSPDRRPHFDQIVS 279 (332)
Q Consensus 264 l~~dp~~Rps~~ell~ 279 (332)
|..+|++||+++++++
T Consensus 235 l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 235 LNKDPKERPSAKELLK 250 (274)
T ss_pred hhCChhhCcCHHHHhh
Confidence 9999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=284.43 Aligned_cols=214 Identities=22% Similarity=0.320 Sum_probs=177.9
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCC-Cceec------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH-PHIIT------------ 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~------------ 120 (332)
+|.+.+.||+|+||+||+|.++ ++.||||++....... ....+.+..|..++..+.| ++|+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ---DDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLY 77 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEE
Confidence 4778899999999999999986 7899999987532111 1123567789999988876 44543
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-CC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GS 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~ 183 (332)
....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... ..
T Consensus 78 lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 78 FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 2356899999999999999999999999999999999999999999999999998653222 22
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHc
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 263 (332)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.........+.. ....+|..++..+.+++.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~~ 235 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME--HNVSYPKSLSKEAVSICKGL 235 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHHHH
Confidence 3345689999999999998999999999999999999999999999888777666654 33456778899999999999
Q ss_pred cccCCCCCCCH
Q 020016 264 WSSSPDRRPHF 274 (332)
Q Consensus 264 l~~dp~~Rps~ 274 (332)
|+.+|.+|++.
T Consensus 236 l~~~p~~R~~~ 246 (323)
T cd05615 236 MTKHPSKRLGC 246 (323)
T ss_pred cccCHhhCCCC
Confidence 99999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=286.35 Aligned_cols=210 Identities=24% Similarity=0.315 Sum_probs=172.8
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHH-HHHHcCCCCceec-----------------
Q 020016 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEV-ALLFRLNHPHIIT----------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~----------------- 120 (332)
+.||.|+||.||+|.+. ++.||+|++....... ......+..|. .+++.++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK---KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH---hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcC
Confidence 47999999999999996 7899999997632211 11123455555 4678899999987
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc-cCCCCCCcc
Q 020016 121 -----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES-QCGSAKGFT 188 (332)
Q Consensus 121 -----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~-~~~~~~~~~ 188 (332)
....+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.... .........
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 23567889999999999999999999999999999999999999999999999986532 222334567
Q ss_pred cccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCC
Q 020016 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 268 (332)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 268 (332)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.. ....++...+..+.+++.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~~p 235 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH--KPLQLPGGKTVAACDLLVGLLHKDQ 235 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHccCCH
Confidence 89999999999988999999999999999999999999998877666555543 3455677889999999999999999
Q ss_pred CCCCCHH
Q 020016 269 DRRPHFD 275 (332)
Q Consensus 269 ~~Rps~~ 275 (332)
.+||++.
T Consensus 236 ~~R~~~~ 242 (321)
T cd05603 236 RRRLGAK 242 (321)
T ss_pred hhcCCCC
Confidence 9999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=275.29 Aligned_cols=220 Identities=28% Similarity=0.467 Sum_probs=184.6
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||.|+||.||+|.+. ++.+|+|++....... .+.+.+|+.+++.++||||++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 75 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDD------FEIIQQEISMLKECRHPNIVAYFGSYLRRDKL 75 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhh------HHHHHHHHHHHHhCCCCChhceEEEEEeCCEE
Confidence 368999999999999999999985 6789999998754332 467889999999999999986
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 182 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 182 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 76 ~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 76 WIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred EEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 22678999999999999999999999999999999999999999999999999987654322
Q ss_pred -CCCCcccccccCChhhhhcC---CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---CCCCCcHH
Q 020016 183 -SAKGFTGTYRWMAPEMIKEK---RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP---VPPTCPKA 255 (332)
Q Consensus 183 -~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 255 (332)
......++..|+|||.+.+. .++.++|+||||+++|+|+||..||...+..............+. .+..++.+
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 23345688899999999776 789999999999999999999999998876665555443322221 23446788
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 020016 256 FSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+.+++.+||..+|.+||++.+++.
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhc
Confidence 999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=277.68 Aligned_cols=225 Identities=28% Similarity=0.486 Sum_probs=180.5
Q ss_pred cCCeeeeeeecccCceEEEEEEEC------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
...|++.+.||+|+||.||++... +..||||.+....... .+.+.+|+.++..++||||++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 76 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH------LRDFEREIEILKSLQHDNIVKYKGVCYS 76 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHH------HHHHHHHHHHHHhCCCCCeeEEEEEEcc
Confidence 357899999999999999999752 6789999987653322 367889999999999999886
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccc
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 77 AGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred CCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccc
Confidence 23457889999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCC----CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHH---------------HHH
Q 020016 177 LESQCGSA----KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ---------------AAF 237 (332)
Q Consensus 177 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~---------------~~~ 237 (332)
........ ....++..|+|||.+.+..++.++|+||||+++|||++|..++....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 65432211 11223456999999998889999999999999999999877654322110 011
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 238 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
.........+.+..++..+.+|+.+||..+|++|||+.+|++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 22223334455677889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=290.61 Aligned_cols=225 Identities=23% Similarity=0.354 Sum_probs=198.7
Q ss_pred CCeeeeeeecccCceEEEEEEE--CCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIY--KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
.-|.+.+.||+|.|+.|-+|++ .|..||||++.+...+... ...+++|+..|+.++|||||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s----t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS----TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh----hhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 4588899999999999999977 4999999999997765433 356889999999999999997
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC-CeEEEeecccccccccCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGISCLESQCG 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~ 182 (332)
....+.++.+.+++.||+.|+.|||+..++||||||+||.+-+. |-+||.|||++..+.+..
T Consensus 94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 45678999999999999999999999999999999999988654 999999999998887777
Q ss_pred CCCCcccccccCChhhhhcCCC-CCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 020016 183 SAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 261 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 261 (332)
.....+|+..|.|||++.+..| .+++||||||||||-|++|++||+..++.+..-.++.. ....|..++.++++||.
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC--KYtvPshvS~eCrdLI~ 251 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC--KYTVPSHVSKECRDLIQ 251 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc--cccCchhhhHHHHHHHH
Confidence 7788999999999999999988 57899999999999999999999998888877776544 45678899999999999
Q ss_pred HccccCCCCCCCHHHHHH--HHHhhh
Q 020016 262 RCWSSSPDRRPHFDQIVS--ILEGYS 285 (332)
Q Consensus 262 ~cl~~dp~~Rps~~ell~--~L~~~~ 285 (332)
.||..||.+|.+.++|.. +|+...
T Consensus 252 sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 252 SMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred HHHhcCchhhccHHHHhccccccCCC
Confidence 999999999999999975 444443
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=276.69 Aligned_cols=228 Identities=27% Similarity=0.536 Sum_probs=191.0
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--C----eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--Q----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~----~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
...+|.+.+.||+|+||.||+|.+. + ..||+|.+....... ....+.+|+.++..++||||++
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPK-----ANKEILDEAYVMASVDHPHVVRLLGICL 79 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHH-----HHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 3478999999999999999999874 3 268999887654321 2467889999999999999886
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 80 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 80 SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred cCceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 2346889999999999999999999999999999999999999999999999998765
Q ss_pred ccCCCC---CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 020016 179 SQCGSA---KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254 (332)
Q Consensus 179 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (332)
...... ....++..|+|||.+....++.++|+||||+++|++++ |..||......+....+. .......+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTI 238 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCH
Confidence 432211 11223568999999988889999999999999999999 999999888777655554 4445566777889
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 020016 255 AFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 255 ~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 286 (332)
.+.+++.+||..+|.+||++.++++.|+.+..
T Consensus 239 ~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 239 DVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 99999999999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=278.84 Aligned_cols=226 Identities=31% Similarity=0.570 Sum_probs=186.4
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
++.++|.+.+.||.|+||.||++.+. +..||+|++....... ....+.+|+.+++.++||||++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~ei~~l~~l~h~~iv~~~~~ 76 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-----MQADFQREAALMAEFDHPNIVKLLGV 76 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHH-----HHHHHHHHHHHHHhcCCCchheEEEE
Confidence 34678999999999999999999873 4789999987643322 2366889999999999999986
Q ss_pred --------------C--------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccc
Q 020016 121 --------------E--------------------------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 154 (332)
Q Consensus 121 --------------~--------------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dl 154 (332)
. ...+++..++.++.|++.||.|||++|++||||
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl 156 (288)
T cd05050 77 CAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156 (288)
T ss_pred EcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 0 013567788999999999999999999999999
Q ss_pred cccceeecCCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCC
Q 020016 155 KSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 230 (332)
Q Consensus 155 kp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~ 230 (332)
+|+||+++.++.++|+|||++....... .......+..|+|||.+.+..++.++||||||+++|+|++ |..||.+.
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999986433221 1122334678999999998899999999999999999998 88999888
Q ss_pred CHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 020016 231 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 283 (332)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~ 283 (332)
...+....+. .......+..++.++.+++.+||+.+|.+||++.|+++.|+.
T Consensus 237 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 AHEEVIYYVR-DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 7777665554 333344566789999999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=280.32 Aligned_cols=228 Identities=29% Similarity=0.576 Sum_probs=187.4
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--Ce----eEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QR----DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
.++|++.+.||+|+||.||+|.+. +. .||+|.+....... ....+.+|+.+++.++||||++
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPK-----ANVEFMDEALIMASMDHPHLVRLLGVCLS 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHH-----HHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence 467889999999999999999874 33 57999887643322 1346889999999999999987
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++....
T Consensus 81 ~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 81 PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 12357888999999999999999999999999999999999999999999999987644
Q ss_pred cCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 020016 180 QCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255 (332)
Q Consensus 180 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (332)
.... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+........ ........+.+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 239 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LLEKGERLPQPPICTID 239 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCCCCCCCCCCCHH
Confidence 3221 122345678999999998889999999999999999998 999998876555433 33445555566778899
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 256 FSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
+.+++.+||..+|++||++.++++.|+.+...
T Consensus 240 ~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 240 VYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=287.32 Aligned_cols=210 Identities=22% Similarity=0.373 Sum_probs=170.0
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec-----------------
Q 020016 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT----------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----------------- 120 (332)
+.||+|+||.||++.+. ++.||+|++....... ....+.+.+|+.++.++ +||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND---DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc---hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence 47999999999999986 6789999998643211 11235577899888877 8999986
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc-cCCCCCCcc
Q 020016 121 -----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES-QCGSAKGFT 188 (332)
Q Consensus 121 -----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~-~~~~~~~~~ 188 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.... .........
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 34578999999999999999999999999999999999999999999999999986432 222334567
Q ss_pred cccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 020016 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT--------PEQAAFAVCQKNARPPVPPTCPKAFSYLI 260 (332)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~li 260 (332)
||+.|+|||++.+..++.++||||||+++|+|++|..||.... ......... ......+|..++..+.+++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i-~~~~~~~p~~~~~~~~~ll 236 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-LEKQIRIPRSLSVKAASVL 236 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH-hcCCCCCCCCCCHHHHHHH
Confidence 8999999999999999999999999999999999999995311 111122221 2334567788999999999
Q ss_pred HHccccCCCCCCCH
Q 020016 261 SRCWSSSPDRRPHF 274 (332)
Q Consensus 261 ~~cl~~dp~~Rps~ 274 (332)
.+||..||.+||++
T Consensus 237 ~~~L~~dP~~R~~~ 250 (329)
T cd05618 237 KSFLNKDPKERLGC 250 (329)
T ss_pred HHHhcCCHHHcCCC
Confidence 99999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=272.01 Aligned_cols=220 Identities=26% Similarity=0.419 Sum_probs=185.4
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
.|.+.+.||.|++|.||++.+. ++.||+|.+........ ..+.+.+|+.+++.++|+|+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRR----ERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHH----HHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEE
Confidence 4899999999999999999986 67899999876433221 2456889999999999999986
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 181 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 181 (332)
....+++..+..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 1345788999999999999999999999999999999999999999999999998655332
Q ss_pred CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 261 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 261 (332)
.......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.. ...+..+..+++.+.+++.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 235 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-GKLPPMPKDYSPELGELIA 235 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-cCCCCCccccCHHHHHHHH
Confidence 223345688999999999999999999999999999999999999988777665555443 3334566778999999999
Q ss_pred HccccCCCCCCCHHHHHHH
Q 020016 262 RCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 262 ~cl~~dp~~Rps~~ell~~ 280 (332)
+||+.+|++||++.++++.
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 236 TMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHhccCcccCCCHHHHhcC
Confidence 9999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=279.41 Aligned_cols=219 Identities=31% Similarity=0.534 Sum_probs=178.5
Q ss_pred eeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------
Q 020016 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------- 120 (332)
Q Consensus 57 y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 120 (332)
|++++.||+|+||+||++.+. ++.||+|++......... .....+|+.++.+++||||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE----REENIREIKILRRLRHPNIVQILDVFQDDNYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH----HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc----cchhhhhhhcccccccccccccccccccccccccc
Confidence 789999999999999999997 578999999987654432 223456999999999999986
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc-ccCCCCC
Q 020016 121 --------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE-SQCGSAK 185 (332)
Q Consensus 121 --------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~-~~~~~~~ 185 (332)
....+++..+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+... .......
T Consensus 77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2567899999999999999999999999999999999999999999999999998653 2223345
Q ss_pred CcccccccCChhhhh-cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhcCCCC--CCCCCCcHHHHHH
Q 020016 186 GFTGTYRWMAPEMIK-EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV---CQKNARP--PVPPTCPKAFSYL 259 (332)
Q Consensus 186 ~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~---~~~~~~~--~~~~~~~~~l~~l 259 (332)
...++..|+|||++. +..++.++||||||+++|+|++|..||......+..... ....... ......+..+.++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDL 236 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHH
Confidence 667899999999998 788899999999999999999999999987433322222 1111111 1112234899999
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 020016 260 ISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~ 279 (332)
+.+||+.||++||++.++++
T Consensus 237 i~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 237 IKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHccCChhHCcCHHHHhc
Confidence 99999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=288.36 Aligned_cols=222 Identities=25% Similarity=0.378 Sum_probs=195.2
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCceec----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIIT---------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~---------- 120 (332)
...|.+++.||.|.||.||+++.+ |+.+|+|++.+....... ....+.+|+.+|+++. |||||.
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~---~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE---DREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc---cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 468999999999999999999997 789999999886543221 2367899999999998 999987
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC----CeEEEeeccccccc
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED----MCVKVADFGISCLE 178 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~----~~~kl~Dfg~a~~~ 178 (332)
.. .+++..+..++.|++.++.|||+.|++||||||+|+|+... +.++++|||++...
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 12 39999999999999999999999999999999999999543 57999999999888
Q ss_pred ccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHH
Q 020016 179 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCPKAF 256 (332)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 256 (332)
.........+||+.|+|||++....|+..+||||+|+++|.|++|..||.+.+.......+....... ...+.++..+
T Consensus 190 ~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~a 269 (382)
T KOG0032|consen 190 KPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESA 269 (382)
T ss_pred cCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHH
Confidence 77666778899999999999999999999999999999999999999999999888888776654432 3346679999
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+++..|+..||..|+++.++++
T Consensus 270 kd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 270 KDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HHHHHHhcccCcccCCCHHHHhc
Confidence 99999999999999999999998
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=280.12 Aligned_cols=225 Identities=31% Similarity=0.498 Sum_probs=181.0
Q ss_pred ccCCeeeeeeecccCceEEEEEEECC----------------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCC
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYKQ----------------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~~----------------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 116 (332)
...+|.+.+.||+|+||.||++.+.+ ..||||.+....... ..+.|.+|++++++++|+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~ei~~l~~l~h~ 77 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKT-----ARNDFLKEIKIMSRLKNP 77 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHH-----HHHHHHHHHHHHHhCCCC
Confidence 34689999999999999999997742 258999987643322 246789999999999999
Q ss_pred ceec------------------CC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccccc
Q 020016 117 HIIT------------------EP----------------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKS 156 (332)
Q Consensus 117 niv~------------------~~----------------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp 156 (332)
||++ .. ..+++..+..++.|++.||.|||+.|++|+||||
T Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp 157 (295)
T cd05097 78 NIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT 157 (295)
T ss_pred CcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccCh
Confidence 9976 00 1357788899999999999999999999999999
Q ss_pred cceeecCCCeEEEeecccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh--CCCCCCCCC
Q 020016 157 ENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT--ALTPFDNMT 231 (332)
Q Consensus 157 ~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--G~~pf~~~~ 231 (332)
+||+++.++.+||+|||++........ .....++..|+|||.+.++.++.++||||||+++|+|++ |..||...+
T Consensus 158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 999999999999999999865432211 122345678999999998899999999999999999998 678888877
Q ss_pred HHHHHHHHHh------cCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 020016 232 PEQAAFAVCQ------KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282 (332)
Q Consensus 232 ~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~ 282 (332)
..+....... .......+..+++.+.+|+.+||+.+|++||++++|++.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 6655443321 11122345567899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=279.21 Aligned_cols=214 Identities=22% Similarity=0.334 Sum_probs=172.5
Q ss_pred ecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------------
Q 020016 63 FASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------------- 120 (332)
Q Consensus 63 lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------------- 120 (332)
||+|+||+||++.+. ++.||||.+....... ....+.+..|+.+++.++|+||+.
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK---RKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhh---hHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCC
Confidence 699999999999886 7899999987543221 112356788999999999999986
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-CCCCc
Q 020016 121 ------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-SAKGF 187 (332)
Q Consensus 121 ------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 187 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... .....
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 12457899999999999999999999999999999999999999999999999986543322 22345
Q ss_pred ccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCCCCCCCCCcHHHHHHHHHccc
Q 020016 188 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ--KNARPPVPPTCPKAFSYLISRCWS 265 (332)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~ 265 (332)
.||+.|+|||.+.+..++.++||||||+++|+|++|+.||.............. ......++..+++.+.+++.+||+
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 789999999999999999999999999999999999999986543211111111 122335567789999999999999
Q ss_pred cCCCCCC-----CHHHHHH
Q 020016 266 SSPDRRP-----HFDQIVS 279 (332)
Q Consensus 266 ~dp~~Rp-----s~~ell~ 279 (332)
.||++|| +++++++
T Consensus 238 ~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHhcCCCCCCHHHHhc
Confidence 9999999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=279.21 Aligned_cols=226 Identities=28% Similarity=0.501 Sum_probs=180.5
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC------------------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK------------------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN 114 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~------------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 114 (332)
+.++|++.+.||+|+||.||++.+. +..||+|++....... ..+.|.+|+.+++.++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~E~~~l~~l~ 77 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKN-----ARNDFLKEIKIMSRLK 77 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHH-----HHHHHHHHHHHHHhCC
Confidence 3568999999999999999998643 2368999987643221 2467899999999999
Q ss_pred CCceec----------------------------C-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Q 020016 115 HPHIIT----------------------------E-----------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 155 (332)
Q Consensus 115 h~niv~----------------------------~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlk 155 (332)
|+||++ . ...+++..+..++.|++.||.|||+.|++|+|||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk 157 (296)
T cd05095 78 DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157 (296)
T ss_pred CCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 999975 0 1235667899999999999999999999999999
Q ss_pred ccceeecCCCeEEEeecccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh--CCCCCCCC
Q 020016 156 SENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT--ALTPFDNM 230 (332)
Q Consensus 156 p~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--G~~pf~~~ 230 (332)
|+||+++.++.++|+|||++........ .....++..|++||...++.++.++||||||+++|||++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999999865432211 122334678999999988889999999999999999998 78899877
Q ss_pred CHHHHHHHHHh------cCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 020016 231 TPEQAAFAVCQ------KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 283 (332)
Q Consensus 231 ~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~ 283 (332)
+..+....... .....+.+..+++.+.+++.+||+.||.+||++.+|.+.|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 66554433211 111223456688999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=275.21 Aligned_cols=223 Identities=27% Similarity=0.408 Sum_probs=183.8
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
.+|.+.+.||+|+||.||+|.+. +..||+|.+......... ......+.+|+.+++.++||||++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPET-SKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchh-HHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCE
Confidence 46889999999999999999885 789999998764332211 122456889999999999999976
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 181 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 181 (332)
....+++...+.++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 2345788889999999999999999999999999999999999999999999998654321
Q ss_pred ---CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 020016 182 ---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 258 (332)
Q Consensus 182 ---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 258 (332)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||..................+.++..+++.+.+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence 11123457889999999998889999999999999999999999998877666555554444456667778899999
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~ 279 (332)
++ .||..+|++||++.+++.
T Consensus 241 li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhc
Confidence 99 677789999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=271.11 Aligned_cols=216 Identities=32% Similarity=0.596 Sum_probs=180.7
Q ss_pred eeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------------
Q 020016 61 CKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 120 (332)
+.||+|+||.||+|... ++.||+|++....... ....+.+|++++..++||||++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQE-----LKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP 75 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHH-----HHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence 36899999999999876 6789999987654322 2356889999999999999986
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC--CCCcc
Q 020016 121 ----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS--AKGFT 188 (332)
Q Consensus 121 ----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~ 188 (332)
....+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 76 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 76 GGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 234578999999999999999999999999999999999999999999999999865332211 11223
Q ss_pred cccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccC
Q 020016 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 267 (332)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 267 (332)
++..|+|||++.++.++.++||||||+++|++++ |..||...........+. ...+...+..++..+.+++.+||..+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYK 234 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccC
Confidence 4567999999998889999999999999999999 999999887766655543 34455666778999999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 020016 268 PDRRPHFDQIVSILE 282 (332)
Q Consensus 268 p~~Rps~~ell~~L~ 282 (332)
|++||++.++++.|.
T Consensus 235 p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 235 PENRPKFSELQKELA 249 (250)
T ss_pred cccCCCHHHHHHHhc
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=275.43 Aligned_cols=223 Identities=30% Similarity=0.568 Sum_probs=182.7
Q ss_pred eeeeeeecccCceEEEEEEEC-----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 57 LFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 57 y~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
|.+.+.||+|+||.||+|.+. +..||||++........ ..+++.+|+.+++.++||||++
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSS----DIEEFLREAACMKEFDHPNVIKLIGVSLRSRAK 76 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChH----HHHHHHHHHHHHhcCCCCCcceEEEEEccCCCC
Confidence 567889999999999999864 57899999976433221 1366889999999999999875
Q ss_pred -----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEee
Q 020016 121 -----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVAD 171 (332)
Q Consensus 121 -----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~D 171 (332)
....+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|
T Consensus 77 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 77 GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred CcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECc
Confidence 001356778899999999999999999999999999999999999999999
Q ss_pred cccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCC
Q 020016 172 FGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPP 247 (332)
Q Consensus 172 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 247 (332)
||++....... ......+++.|++||.+....++.++||||||+++|+|++ |..||...+..+....+. ......
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~ 235 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-KGNRLK 235 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-cCCcCC
Confidence 99987543221 1123345678999999998889999999999999999999 999998877665544443 333444
Q ss_pred CCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 248 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 248 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
.+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 5567889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=278.99 Aligned_cols=220 Identities=23% Similarity=0.437 Sum_probs=183.7
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
..+|.+.+.||+|+||.||+|.+. ++.||+|.+....... .+.+.+|+.+++.+.|+||++
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~------~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch------HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence 368999999999999999999975 7899999987654432 256889999999999999987
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-C
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-S 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~ 183 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred EEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 23457888999999999999999999999999999999999999999999999886543322 2
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHH
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~ 262 (332)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||....+............ ....+..++..+.+++.+
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHH
Confidence 2345688999999999988889999999999999999999999988776544433332221 223456688999999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~ 279 (332)
||..+|++||++.+++.
T Consensus 253 ~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 253 CLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HCcCCcccCcCHHHHhh
Confidence 99999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=282.75 Aligned_cols=212 Identities=28% Similarity=0.422 Sum_probs=163.5
Q ss_pred eeeecccCceEEEEEEEC----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------------
Q 020016 60 GCKFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------------- 120 (332)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------------- 120 (332)
+++||+|+||+||+|.+. ++.||+|.+...... ..+.+|+.+++.++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--------MSACREIALLRELKHPNVISLQKVFLSHADRKVWL 77 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc--------HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEE
Confidence 578999999999999864 478999998764322 34678999999999999986
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee----cCCCeEEEeecc
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL----GEDMCVKVADFG 173 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll----~~~~~~kl~Dfg 173 (332)
....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 78 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 01247888899999999999999999999999999999999 456789999999
Q ss_pred cccccccCC----CCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHH---------HHHHHH
Q 020016 174 ISCLESQCG----SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPE---------QAAFAV 239 (332)
Q Consensus 174 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~---------~~~~~~ 239 (332)
++....... ......+|+.|+|||++.+. .++.++||||+||++|+|++|+.||...... .....+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 997654321 22345789999999999764 5799999999999999999999999643211 111111
Q ss_pred HhcCC------------------------CC------------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 240 CQKNA------------------------RP------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 240 ~~~~~------------------------~~------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..... .. ......+..+.+||.+||+.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 00 000123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=272.32 Aligned_cols=217 Identities=28% Similarity=0.551 Sum_probs=184.3
Q ss_pred eeecccCceEEEEEEEC---C--eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------------
Q 020016 61 CKFASGRHSRIYRGIYK---Q--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~---~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------------- 120 (332)
+.||+|++|.||+|.+. + ..||||.+...... ...+.+.+|+.++++++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-----DIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTE 75 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-----HHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEE
Confidence 46899999999999874 2 36999999876543 23578999999999999999986
Q ss_pred -------------CC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC----
Q 020016 121 -------------EP-YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG---- 182 (332)
Q Consensus 121 -------------~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---- 182 (332)
.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 11 457899999999999999999999999999999999999999999999999987654321
Q ss_pred CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 020016 183 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 261 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 261 (332)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.........+..++..+.+++.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVML 235 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHH
Confidence 1123456788999999998899999999999999999999 999999888877766665545555566678899999999
Q ss_pred HccccCCCCCCCHHHHHHHHH
Q 020016 262 RCWSSSPDRRPHFDQIVSILE 282 (332)
Q Consensus 262 ~cl~~dp~~Rps~~ell~~L~ 282 (332)
+||+.+|.+||++.++++.|.
T Consensus 236 ~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 236 QCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHCCCCcccCCCHHHHHHHhc
Confidence 999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=277.26 Aligned_cols=220 Identities=24% Similarity=0.315 Sum_probs=176.3
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|.+.+.||+|++|.||+|.+. +..||||++........ ....+.+|+.+++.++||||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEG----VPSTAIREISLLKELQHPNIVCLQDVLMQESRLYL 76 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCC----chHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEE
Confidence 5889999999999999999985 78999999876433221 1356788999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 182 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 77 IFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred EEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 12568899999999999999999999999999999999999999999999999986543221
Q ss_pred CCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------------
Q 020016 183 SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR---------------- 245 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~---------------- 245 (332)
......+++.|+|||.+.+. .++.++||||||+++|+|+||+.||.+................
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 22234568899999988754 4688999999999999999999999876654433322111000
Q ss_pred -----------CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 246 -----------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 246 -----------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
......+++++.++|.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0112347889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=272.44 Aligned_cols=223 Identities=29% Similarity=0.500 Sum_probs=187.5
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|+..+.||+|++|.||+|.+. +..|++|.+........ .....+.+.+|+.+++.++|+||++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQT-GQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccccc-chHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEE
Confidence 4777899999999999999986 78999999876443211 1222467899999999999999986
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCCC
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK 185 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 185 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 159 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK 159 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence 23457899999999999999999999999999999999999999999999999987654433344
Q ss_pred CcccccccCChhhhhcCC-CCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHcc
Q 020016 186 GFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 264 (332)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 264 (332)
...++..|++||.+.... ++.++|+||||+++|+|++|..||..................+.++..+++.+.+++.+||
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 239 (258)
T cd06632 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL 239 (258)
T ss_pred ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHh
Confidence 566889999999997766 8999999999999999999999998877655555554434556677788999999999999
Q ss_pred ccCCCCCCCHHHHHH
Q 020016 265 SSSPDRRPHFDQIVS 279 (332)
Q Consensus 265 ~~dp~~Rps~~ell~ 279 (332)
+.+|++||++.+++.
T Consensus 240 ~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 240 QRDPSLRPTAAELLE 254 (258)
T ss_pred hcCcccCcCHHHHhc
Confidence 999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=278.16 Aligned_cols=220 Identities=24% Similarity=0.446 Sum_probs=185.1
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
..+|++.+.||.|++|.||+|.+. ++.||||.+....... .+.+.+|+.+++.++||||+.
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK------KELIINEILVMKELKNPNIVNFLDSFLVGDEL 91 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch------HHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence 357999999999999999999875 7899999987643332 356789999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC-
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS- 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 183 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 92 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred EEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 234689999999999999999999999999999999999999999999999998865433222
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHH
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~ 262 (332)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..... ....+..+++.+.++|.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR 251 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence 2335688899999999988899999999999999999999999998777655544433222 223456788999999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~ 279 (332)
||..||.+||++.++++
T Consensus 252 ~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 252 CLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HhhcChhhCCCHHHHhh
Confidence 99999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=281.91 Aligned_cols=223 Identities=20% Similarity=0.274 Sum_probs=181.1
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||.||++.++ ++.||+|++..... ........+.+|+.++..++|+||+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 77 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM---LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLY 77 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH---HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEE
Confidence 47999999999999999999987 67899999865221 11222355888999999999999875
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 182 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 23568899999999999999999999999999999999999999999999999986543222
Q ss_pred -CCCCcccccccCChhhhh-----cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC---CCCc
Q 020016 183 -SAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP---PTCP 253 (332)
Q Consensus 183 -~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~ 253 (332)
......||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..+....+.....+..++ ..++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s 237 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVS 237 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCC
Confidence 123457899999999986 3457899999999999999999999999888777776665544333333 4579
Q ss_pred HHHHHHHHHccccCCCC--CCCHHHHHHH
Q 020016 254 KAFSYLISRCWSSSPDR--RPHFDQIVSI 280 (332)
Q Consensus 254 ~~l~~li~~cl~~dp~~--Rps~~ell~~ 280 (332)
+++.+|+.+|+..++.+ |+++.++++.
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 238 EDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 99999999999765544 6889988876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=272.77 Aligned_cols=220 Identities=29% Similarity=0.544 Sum_probs=178.3
Q ss_pred eeecccCceEEEEEEEC-----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------------
Q 020016 61 CKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------------- 120 (332)
+.||+|+||.||+|.+. ...||||.+....... ..+.+.+|+.+++.++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE-----EVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHH-----HHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEE
Confidence 46899999999999863 2579999986432221 1367889999999999999986
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC---
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG--- 182 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 182 (332)
....+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++.......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 12345677788999999999999999999999999999999999999999999986443211
Q ss_pred --CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 020016 183 --SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 259 (332)
Q Consensus 183 --~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 259 (332)
......++..|+|||.+.+..++.++||||||+++|||++ |.+||...+..+....+. ....+..+..+++.+.++
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 234 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGRRLLQPEYCPDPLYEV 234 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHHH
Confidence 1123345778999999988889999999999999999999 577888777666555443 344455566778999999
Q ss_pred HHHccccCCCCCCCHHHHHHHHHhhhh
Q 020016 260 ISRCWSSSPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~~L~~~~~ 286 (332)
+.+||..+|++||++.++++.|+.+..
T Consensus 235 i~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 235 MLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=271.68 Aligned_cols=220 Identities=23% Similarity=0.387 Sum_probs=186.9
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|.+.+.||.|+||.||++.+. ++.||+|.+........ ..+.+.+|+.+++.++||||++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK----EKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTL 76 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHH----HHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEE
Confidence 5889999999999999999885 68899999876433221 1366889999999999999986
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHH-----HCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLH-----SQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH-----~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 77 ~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 77 YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred EEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccc
Confidence 1356788999999999999999999 88999999999999999999999999999
Q ss_pred ccccccCCC-CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 020016 175 SCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 253 (332)
Q Consensus 175 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (332)
+........ .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+ .....+.++..++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI-KEGKFRRIPYRYS 235 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHH-hcCCCCCCccccC
Confidence 876554332 33456899999999999888999999999999999999999999987755554444 3444456777889
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 254 KAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 254 ~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
..+.+++.+||+.+|++||++.+|++.
T Consensus 236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 236 SELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=273.27 Aligned_cols=223 Identities=28% Similarity=0.434 Sum_probs=183.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
.+|.+++.||+|+||.||+|.+. ++.||||.+......... ....+.+.+|+.+++.+.||||++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPET-SKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCccc-HHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 57999999999999999999986 789999998653222111 112467889999999999999986
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 181 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 181 (332)
....+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 2245788889999999999999999999999999999999999999999999998654321
Q ss_pred ---CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 020016 182 ---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 258 (332)
Q Consensus 182 ---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 258 (332)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||..................+..+..++..+.+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 11233468889999999988889999999999999999999999998876655555544444455567778889999
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~ 279 (332)
++.+||. +|.+||+++++++
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhc
Confidence 9999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=277.20 Aligned_cols=218 Identities=25% Similarity=0.441 Sum_probs=180.8
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
.|++.+.||.|+||.||+|.+. +..+++|.+....... .+.+.+|+.+++.++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~ 79 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE------LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 79 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHH------HHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEE
Confidence 4678899999999999999996 6788999987643322 356889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-CC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GS 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~ 183 (332)
....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...... ..
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~ 159 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 159 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccc
Confidence 2356889999999999999999999999999999999999999999999999998654322 22
Q ss_pred CCCcccccccCChhhhh-----cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCcHHHH
Q 020016 184 AKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-ARPPVPPTCPKAFS 257 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~ 257 (332)
.....++..|+|||++. +..++.++|||||||++|+|++|..||...+............ .....+..++..+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHH
Confidence 33456899999999984 3456789999999999999999999999877766555543322 22344567889999
Q ss_pred HHHHHccccCCCCCCCHHHHHH
Q 020016 258 YLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 258 ~li~~cl~~dp~~Rps~~ell~ 279 (332)
++|.+||+.+|.+||++.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 240 DFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999998874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=307.26 Aligned_cols=230 Identities=23% Similarity=0.364 Sum_probs=182.7
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.++||+|+||.||+|.+. ++.||||++....... ....+.|.+|+.+++.++||||++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~---e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~ly 78 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSEN---PLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVY 78 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccC---HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEE
Confidence 68999999999999999999986 7899999997643221 223467999999999999999986
Q ss_pred ------CC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecc
Q 020016 121 ------EP---------------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 121 ------~~---------------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
.+ ..++...+..++.||+.||.|||++||+||||||+||+++.++.++|+|||
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecC
Confidence 01 123455678899999999999999999999999999999999999999999
Q ss_pred cccccccC-------------------CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHH
Q 020016 174 ISCLESQC-------------------GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 234 (332)
Q Consensus 174 ~a~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~ 234 (332)
++...... .......||+.|+|||.+.+..++.++|||||||++|+|+||..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 98754110 01123468999999999999999999999999999999999999998765544
Q ss_pred HHHHHHhcCC-CCCCCCCCcHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhhhh
Q 020016 235 AAFAVCQKNA-RPPVPPTCPKAFSYLISRCWSSSPDRRP-HFDQIVSILEGYSES 287 (332)
Q Consensus 235 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~ell~~L~~~~~~ 287 (332)
.......... .......+++.+.+++.+||..||++|| +++++.+.|+.....
T Consensus 239 i~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 3332111111 1111246789999999999999999996 677888888877654
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=275.93 Aligned_cols=221 Identities=23% Similarity=0.398 Sum_probs=179.3
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|++.+.||+|+||.||+|.+. ++.||+|++........ ..+.+.+|+.++++++||||++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 76 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV----IKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLH 76 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCcc----ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEE
Confidence 47999999999999999999986 78999999875432211 1356789999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-C
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-S 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~ 183 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 77 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 77 LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred EEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 33468999999999999999999999999999999999999999999999999987654432 2
Q ss_pred CCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------------------
Q 020016 184 AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA------------------ 244 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~------------------ 244 (332)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+....+....+.....
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 234557889999999876 4578999999999999999999999998776555443321100
Q ss_pred --CCC---------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 245 --RPP---------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 245 --~~~---------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+. ....++..+.+|+.+||+.+|++||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000 01346788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=281.99 Aligned_cols=223 Identities=21% Similarity=0.279 Sum_probs=179.1
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||+||++.+. ++.||||++..... ......+.+.+|+.++..++|+||+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 77 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM---LKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLY 77 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH---hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEE
Confidence 47999999999999999999986 78999999975211 11222456889999999999999975
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 235688999999999999999999999999999999999999999999999999865433222
Q ss_pred --CCCcccccccCChhhhhc-----CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC---CCCc
Q 020016 184 --AKGFTGTYRWMAPEMIKE-----KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP---PTCP 253 (332)
Q Consensus 184 --~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~ 253 (332)
.....||+.|+|||++.. ..++.++|||||||++|+|++|+.||...+..+....+........++ ..++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 237 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVS 237 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCC
Confidence 223468999999999873 456889999999999999999999999877766655554433333333 3478
Q ss_pred HHHHHHHHHccccCCCC--CCCHHHHHHH
Q 020016 254 KAFSYLISRCWSSSPDR--RPHFDQIVSI 280 (332)
Q Consensus 254 ~~l~~li~~cl~~dp~~--Rps~~ell~~ 280 (332)
..+.+++++||..++.+ |+++.++++.
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 238 EEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999988654443 7888888875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=288.34 Aligned_cols=214 Identities=24% Similarity=0.415 Sum_probs=168.7
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
...|.+.+.||+|+||.||+|.+. ++.||+|+.... ....|+.++++++||||++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 132 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------------TTLIEAMLLQNVNHPSVIRMKDTLVSGAIT 132 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------------ccHHHHHHHHhCCCCCCcChhheEEeCCee
Confidence 356999999999999999999997 578999985432 2346999999999999987
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 133 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 133 CMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred EEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcc
Confidence 345689999999999999999999999999999999999999999999999999875443333
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCC-CCCCCCCHH---------HHHHHHHhc-CC-CCCCC--
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTAL-TPFDNMTPE---------QAAFAVCQK-NA-RPPVP-- 249 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~-~pf~~~~~~---------~~~~~~~~~-~~-~~~~~-- 249 (332)
.....||+.|+|||++.+..++.++|||||||++|||+++. .+|...... .....+... .. ...++
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 292 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD 292 (357)
T ss_pred cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence 44567899999999999999999999999999999999954 444432110 001111110 00 00011
Q ss_pred ----------------------------CCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 250 ----------------------------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 250 ----------------------------~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..++.++.+||.+||+.||.+|||+.|+++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 134566778999999999999999999985
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=308.78 Aligned_cols=225 Identities=22% Similarity=0.303 Sum_probs=182.0
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
.....++|.+.+.||.|+||+||++.+. +..||+|++........ ....|..|+.++..|+|||||+
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~----~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKER----EKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHH----HHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 3445689999999999999999999997 67899999876533221 2467889999999999999986
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC-------CCccccccccceeecC---
Q 020016 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQ-------GILHRDLKSENLLLGE--- 163 (332)
Q Consensus 121 ---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~-------~iiH~dlkp~NIll~~--- 163 (332)
....+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 124689999999999999999999984 4999999999999964
Q ss_pred --------------CCeEEEeecccccccccCCCCCCcccccccCChhhhhc--CCCCCccchhHHHHHHHHHHhCCCCC
Q 020016 164 --------------DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPF 227 (332)
Q Consensus 164 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~pf 227 (332)
.+.+||+|||++.............||+.|+|||++.+ ..++.++|||||||+||+|+||..||
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 24589999999876554444445679999999999864 45789999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 228 DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.................. ......+.++.+||..||..+|.+||++.+++.
T Consensus 244 ~~~~~~~qli~~lk~~p~-lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 244 HKANNFSQLISELKRGPD-LPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcCCcHHHHHHHHhcCCC-CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 876554444333322222 122457899999999999999999999999984
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=278.09 Aligned_cols=224 Identities=25% Similarity=0.424 Sum_probs=183.3
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
|..+.+.|++.+.||.|+||.||+|.+. +..||+|.+....... .+.+.+|+.+++.++||||++
T Consensus 7 ~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (292)
T cd06644 7 DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE------LEDYMVEIEILATCNHPYIVKLLGAFYW 80 (292)
T ss_pred ccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHH------HHHHHHHHHHHHhCCCCcEeeeEEEEEe
Confidence 3444578999999999999999999986 6899999997654322 467889999999999999986
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..+..++.|++.+|.|||+.|++||||+|+||+++.++.++|+|||++...
T Consensus 81 ~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 81 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceec
Confidence 2346789999999999999999999999999999999999999999999999987643
Q ss_pred ccC-CCCCCcccccccCChhhhh-----cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCC
Q 020016 179 SQC-GSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPT 251 (332)
Q Consensus 179 ~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~-~~~~~~~ 251 (332)
... .......+++.|+|||.+. ...++.++||||||+++|+|++|..||...+............. ....+..
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T cd06644 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK 240 (292)
T ss_pred cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcc
Confidence 222 2223456788999999884 34467899999999999999999999988776555444432211 2234567
Q ss_pred CcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 252 CPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 252 ~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
++.++.+++.+||..+|++||++.++++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 241 WSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 8899999999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=278.77 Aligned_cols=220 Identities=23% Similarity=0.393 Sum_probs=177.8
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCceec----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIIT---------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~---------- 120 (332)
.++|...+.||+|+||.||++.+. ++.||||.+....... ....+.+|+.++.++. |+||++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~ 77 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEK-----EQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD 77 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChH-----HHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc
Confidence 457778899999999999999986 7899999987644331 2456889999999996 999986
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccccccceeecCCCeEEEeecccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++..
T Consensus 78 ~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 78 CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 124578889999999999999999975 999999999999999999999999999876
Q ss_pred cccCCCCCCcccccccCChhhhhcC---CCCCccchhHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCC----C
Q 020016 178 ESQCGSAKGFTGTYRWMAPEMIKEK---RHTKKVDVYSFGIVLWELLTALTPFDNMTPE-QAAFAVCQKNARPPV----P 249 (332)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~elltG~~pf~~~~~~-~~~~~~~~~~~~~~~----~ 249 (332)
...........++..|+|||.+.+. .++.++||||||+++|+|++|+.||...... +...... ....+.. +
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 236 (288)
T cd06616 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV-KGDPPILSNSEE 236 (288)
T ss_pred hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc-CCCCCcCCCcCC
Confidence 5443333445688999999999776 6899999999999999999999999875522 1111111 1112222 2
Q ss_pred CCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 250 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..++..+.+|+.+||+.+|++||++.+|++
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 347889999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=275.42 Aligned_cols=218 Identities=25% Similarity=0.346 Sum_probs=185.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|++.+.||+|+||.||++.+. ++.||+|++...... .....+.+.+|++++++++||||++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV---KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLY 77 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEE
Confidence 47999999999999999999986 789999998753221 1222467889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 184 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 184 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~ 155 (290)
T cd05580 78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--T 155 (290)
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--C
Confidence 3456899999999999999999999999999999999999999999999999998765443 3
Q ss_pred CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHcc
Q 020016 185 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 264 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 264 (332)
....+++.|+|||.+.+...+.++|+||||+++|+|++|..||...........+. .....++..++..+.+++.+||
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l 233 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIRNLL 233 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHHHHc
Confidence 34568899999999988888999999999999999999999998877655555443 3445677788999999999999
Q ss_pred ccCCCCCC-----CHHHHHH
Q 020016 265 SSSPDRRP-----HFDQIVS 279 (332)
Q Consensus 265 ~~dp~~Rp-----s~~ell~ 279 (332)
..||.+|+ ++.+++.
T Consensus 234 ~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 234 QVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred cCCHHHccCcccCCHHHHHc
Confidence 99999998 6677664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=275.85 Aligned_cols=226 Identities=27% Similarity=0.463 Sum_probs=180.7
Q ss_pred cCCeeeeeeecccCceEEEEEEEC------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
...|++.+.||+|+||.||++.+. +..||+|.+....... ....+.+|+.+++.++||||++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN-----HIADLKKEIEILRNLYHENIVKYKGICTE 77 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHH-----HHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 346789999999999999999752 6789999987543322 1357899999999999999975
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccc
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 78 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 78 DGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred CCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccc
Confidence 12357889999999999999999999999999999999999999999999999987
Q ss_pred ccccCCC----CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCC--------------HHHHHHH
Q 020016 177 LESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT--------------PEQAAFA 238 (332)
Q Consensus 177 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~--------------~~~~~~~ 238 (332)
....... .....++..|+|||++.+..++.++||||||+++|+|+|+..|+.... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 5433221 123456778999999988889999999999999999999876543210 0111112
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 239 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
........+.+..++..+.+|+.+||+.+|++||++.++++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 2223344455677899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=282.83 Aligned_cols=210 Identities=21% Similarity=0.347 Sum_probs=171.4
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec-----------------
Q 020016 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT----------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----------------- 120 (332)
+.||+|+||+||++.+. ++.||||++....... ....+.+.+|+.++.++ +||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD---DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC
Confidence 47999999999999986 6889999998643211 12245688899999888 6999876
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc-cCCCCCCcc
Q 020016 121 -----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES-QCGSAKGFT 188 (332)
Q Consensus 121 -----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~-~~~~~~~~~ 188 (332)
....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.... .........
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence 24578999999999999999999999999999999999999999999999999986432 222334567
Q ss_pred cccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 020016 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM------TPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 262 (332)
||+.|+|||++.+..++.++||||||+++|+|++|..||... ...+...... ......+|..++..+.+++.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI-LEKPIRIPRFLSVKASHVLKG 236 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH-HhCCCCCCCCCCHHHHHHHHH
Confidence 999999999999999999999999999999999999999632 2222233322 223445677889999999999
Q ss_pred ccccCCCCCCCH
Q 020016 263 CWSSSPDRRPHF 274 (332)
Q Consensus 263 cl~~dp~~Rps~ 274 (332)
||..||.+|+++
T Consensus 237 ~L~~dP~~R~~~ 248 (327)
T cd05617 237 FLNKDPKERLGC 248 (327)
T ss_pred HhccCHHHcCCC
Confidence 999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=289.99 Aligned_cols=216 Identities=25% Similarity=0.418 Sum_probs=173.6
Q ss_pred cCCeeeeeeecccCceEEEEEEEC----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
..+|.+.+.||.|+||.||++... +..||||.+... ..+.+|+.+++.++||||++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----------~~~~~E~~il~~l~h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----------KTPGREIDILKTISHRAIINLIHAYRWKS 159 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----------ccHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence 356999999999999999999764 468999988653 23457999999999999986
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 182 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 182 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 160 ~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 160 TVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 34568999999999999999999999999999999999999999999999999986544322
Q ss_pred C---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh---------------
Q 020016 183 S---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE---QAAFAVCQ--------------- 241 (332)
Q Consensus 183 ~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~---~~~~~~~~--------------- 241 (332)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... .....+..
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 1 23457899999999999999999999999999999999999999764321 11111110
Q ss_pred ----------cCCCCCC--C-----CCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 242 ----------KNARPPV--P-----PTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 242 ----------~~~~~~~--~-----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
...++.. + ..++.++.++|.+||..||++||++.+++..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0001111 1 2346778899999999999999999999864
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=276.72 Aligned_cols=220 Identities=21% Similarity=0.304 Sum_probs=173.9
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|.+.+.||.|+||.||+|.+. |+.||+|.+........ ....+.+|+.++++++||||++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~----~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALREICLLKELKHKNIVRLYDVLHSDKKLTL 76 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccccc----CccchhHHHHHHHhcCCCCeeeHHHHhccCCceEE
Confidence 5889999999999999999996 78999999976432221 1245778999999999999986
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-CC
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-SA 184 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~ 184 (332)
....+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++....... ..
T Consensus 77 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 77 VFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence 24568999999999999999999999999999999999999999999999999987543321 22
Q ss_pred CCcccccccCChhhhhcCC-CCCccchhHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhcC------------------C
Q 020016 185 KGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPF-DNMTPEQAAFAVCQKN------------------A 244 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~pf-~~~~~~~~~~~~~~~~------------------~ 244 (332)
....++..|+|||.+.+.. ++.++||||||+++|+|+||..|+ .+.+.......+.... .
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 3345788999999987654 689999999999999999988875 4443333222221100 0
Q ss_pred CC---------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 245 RP---------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 245 ~~---------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+ ...+.+++++.+++.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 112346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=269.12 Aligned_cols=219 Identities=26% Similarity=0.369 Sum_probs=185.2
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|.+.+.||+|+||.||++.+. ++.+|||.+........ ..+.+.+|+.+++.++||||++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD----ERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMI 76 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccH----HHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEE
Confidence 5889999999999999999885 78999999976533221 2467889999999999999876
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC-CeEEEeecccccccccCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGISCLESQCG 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~ 182 (332)
....+++..+..++.+++.+|.|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 12347899999999999999999999999999999999999865 568999999987665544
Q ss_pred CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 020016 183 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 262 (332)
......++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.. ......+..++..+.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-GTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh-cCCCCCCCCcCHHHHHHHHH
Confidence 44456788999999999988889999999999999999999999988776665555443 33445667789999999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~ 279 (332)
||+.+|++||++.+++.
T Consensus 236 ~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 236 MLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HccCChhhCCCHHHHhh
Confidence 99999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=275.07 Aligned_cols=220 Identities=25% Similarity=0.437 Sum_probs=179.1
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||.||+|.+. ++.||+|++....... ...+.+|+.+++.++||||++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED------FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKL 81 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhH------HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Confidence 368999999999999999999885 7899999987653322 245778999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-C
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-G 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~ 182 (332)
..+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... .
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 3456889999999999999999999999999999999999999999999999998654322 2
Q ss_pred CCCCcccccccCChhhhh---cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC---CCCCcHHH
Q 020016 183 SAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV---PPTCPKAF 256 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l 256 (332)
......|+..|+|||++. ...++.++|+|||||++|+|++|..||....+.............+.. ...++..+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence 223457899999999974 455789999999999999999999999766554444333222222221 12467889
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+++.+||+.+|++||+++++++
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhc
Confidence 99999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=263.45 Aligned_cols=227 Identities=23% Similarity=0.447 Sum_probs=190.7
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec---
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT--- 120 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--- 120 (332)
...+..|.+++.+...||+|+.|.||+++++ |...|||.+........ .+.++..++++... +.|.||+
T Consensus 84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee-----~kRILmDldvv~~s~dcpyIV~c~G 158 (391)
T KOG0983|consen 84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE-----NKRILMDLDVVLKSHDCPYIVQCFG 158 (391)
T ss_pred CcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH-----HHHHHHhhhHHhhccCCCeeeeeee
Confidence 3455677888999999999999999999997 68999999998765543 35567777777666 4899997
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccccccceeecCCCeEEEeeccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
-.+++++..+-++...++.||.||-.+ ||+|||+||+|||+|+.|++||||||.
T Consensus 159 yFi~n~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGI 238 (391)
T KOG0983|consen 159 YFITNTDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGI 238 (391)
T ss_pred EEeeCchHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccc
Confidence 456789999999999999999999875 899999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCChhhhhc---CCCCCccchhHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCCCC
Q 020016 175 SCLESQCGSAKGFTGTYRWMAPEMIKE---KRHTKKVDVYSFGIVLWELLTALTPFDNMTP-EQAAFAVCQKNARPPVPP 250 (332)
Q Consensus 175 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~pf~~~~~-~~~~~~~~~~~~~~~~~~ 250 (332)
+.............|.+.|||||.+.- ..|+.++||||||++++||.||+.||.+.+. .+..-.+.. ...+.++.
T Consensus 239 sGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~ 317 (391)
T KOG0983|consen 239 SGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPG 317 (391)
T ss_pred cceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCc
Confidence 988777666677789999999999864 4689999999999999999999999998544 334444443 44454443
Q ss_pred --CCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 251 --TCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 251 --~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+++.+.+++..||..|+.+||.+.++++
T Consensus 318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 37999999999999999999999999886
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=269.65 Aligned_cols=220 Identities=25% Similarity=0.501 Sum_probs=181.0
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|.+.+.||+|+||.||+|.+. ++.||+|.+...... ....+.+.+|+.+++.++|+||++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND----PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYI 76 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc----hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEE
Confidence 5889999999999999999885 789999999876543 223577899999999999999876
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC--
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-- 183 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-- 183 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 77 FMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred EEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 234588999999999999999999999999999999999999999999999999876543222
Q ss_pred ---CCCcccccccCChhhhhcCC---CCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC--CcHH
Q 020016 184 ---AKGFTGTYRWMAPEMIKEKR---HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT--CPKA 255 (332)
Q Consensus 184 ---~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 255 (332)
.....++..|+|||.+.+.. ++.++||||||+++|++++|..||..................+.++.. +++.
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPE 236 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHH
Confidence 12346788999999998766 789999999999999999999999876433322222223444445544 4899
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 020016 256 FSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+.+++.+||+.+|.+||++.+++.
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 237 GKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHHccCCcccCCCHHHHhc
Confidence 999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=273.33 Aligned_cols=219 Identities=25% Similarity=0.423 Sum_probs=174.4
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHH-HHcCCCCceec-----------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVAL-LFRLNHPHIIT----------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~----------- 120 (332)
++|.+.+.||+|+||.||++.+. ++.||||.+........ ...+..|+.+ ++.++||||++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-----QKRLLMDLDISMRSVDCPYTVTFYGALFREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-----HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcE
Confidence 47899999999999999999996 78999999876543222 2345556654 66679999986
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 76 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 76 WICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred EEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 224678999999999999999999997 99999999999999999999999999987654
Q ss_pred cCCCCCCcccccccCChhhhhc----CCCCCccchhHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCCC-CCCc
Q 020016 180 QCGSAKGFTGTYRWMAPEMIKE----KRHTKKVDVYSFGIVLWELLTALTPFDNMTP-EQAAFAVCQKNARPPVP-PTCP 253 (332)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlG~il~elltG~~pf~~~~~-~~~~~~~~~~~~~~~~~-~~~~ 253 (332)
.........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... .+...... ....+.++ ..++
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (283)
T cd06617 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKFS 234 (283)
T ss_pred cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCCCCccccC
Confidence 4333334567889999998865 4468899999999999999999999975332 22222332 22233333 4578
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 254 KAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 254 ~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.++.+++.+||..+|++||++.++++
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=271.12 Aligned_cols=217 Identities=29% Similarity=0.488 Sum_probs=183.1
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||.|+||.||+|.+. ++.||+|.+..... .+.+.+|+++++.++||||++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 74 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--------LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLW 74 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--------HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEE
Confidence 68999999999999999999986 68999999876322 367899999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 182 (332)
....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 75 l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred EEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 24567899999999999999999999999999999999999999999999999987654433
Q ss_pred CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCcHHHHHHHH
Q 020016 183 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-ARPPVPPTCPKAFSYLIS 261 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~ 261 (332)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+.... .....+..++..+.+++.
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence 2334557889999999998889999999999999999999999998876655444332211 112234567889999999
Q ss_pred HccccCCCCCCCHHHHHH
Q 020016 262 RCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 262 ~cl~~dp~~Rps~~ell~ 279 (332)
+||+.+|++||++.++++
T Consensus 235 ~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHhcChhhCcCHHHHhc
Confidence 999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=283.49 Aligned_cols=222 Identities=23% Similarity=0.311 Sum_probs=178.8
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceecC----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITE---------- 121 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~---------- 121 (332)
.++|++.+.||+|+||.||+|.+. ++.||||.+......... ...+.+|+.+++.++||||++.
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTH----AKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhH----HHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence 378999999999999999999986 789999998754322211 3457789999999999999750
Q ss_pred ---------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 122 ---------------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 122 ---------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 91 ~~~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 91 EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred cccCcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 11367888899999999999999999999999999999999999999999999976554
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------------
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP-------------- 246 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~-------------- 246 (332)
........++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+......+
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (353)
T cd07850 171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN 250 (353)
T ss_pred CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence 433445568899999999999999999999999999999999999998766443322221100000
Q ss_pred ------C--------------C-------CCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 ------P--------------V-------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 ------~--------------~-------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
. + +...+..+.++|.+||+.||.+||++.+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 0 1134567899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=274.77 Aligned_cols=220 Identities=27% Similarity=0.455 Sum_probs=180.1
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec---------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT--------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------- 120 (332)
..+.|++.+.||.|+||.||+|.+. ++.||+|++...... ...+..|+.++..+ +|+||++
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~-------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-------EEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHH-------HHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 3478999999999999999999995 789999998764321 24578899999998 7999885
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecc
Q 020016 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 121 ---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg 166 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG 166 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCc
Confidence 12347788889999999999999999999999999999999999999999999
Q ss_pred cccccccC-CCCCCcccccccCChhhhh-----cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Q 020016 174 ISCLESQC-GSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 247 (332)
Q Consensus 174 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 247 (332)
++...... .......++..|+|||.+. ...++.++||||||+++|+|++|..||....+...............
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 246 (282)
T cd06636 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246 (282)
T ss_pred chhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence 98654322 2233456899999999875 34578899999999999999999999987776555544433333333
Q ss_pred CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 248 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 248 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
....++..+.++|.+||+.||.+||++.++++
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 44568899999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=272.44 Aligned_cols=225 Identities=27% Similarity=0.498 Sum_probs=187.2
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
+.++|.+.+.||.|+||.||+|..+ .+.||+|.+....... ..+.+.+|+.++.+++|+||++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~ 77 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDEN-----LQSEFRRELDMFRKLSHKNVVRLLGLC 77 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchH-----HHHHHHHHHHHHHhcCCcceeeeEEEE
Confidence 3578999999999999999999974 3579999987643321 2467889999999999999986
Q ss_pred -----------------------CCC---------CCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEE
Q 020016 121 -----------------------EPY---------SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 168 (332)
Q Consensus 121 -----------------------~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~k 168 (332)
... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 78 REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred CCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEE
Confidence 112 589999999999999999999999999999999999999999999
Q ss_pred EeecccccccccC--CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCC
Q 020016 169 VADFGISCLESQC--GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 245 (332)
Q Consensus 169 l~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 245 (332)
++|||++...... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||..................
T Consensus 158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd05046 158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE 237 (275)
T ss_pred EcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcC
Confidence 9999987543221 12233456778999999988888999999999999999999 88999887776666555444444
Q ss_pred CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 020016 246 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282 (332)
Q Consensus 246 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~ 282 (332)
...+..++..+.+++.+||+.+|.+||++.++++.|.
T Consensus 238 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 4556678999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=281.40 Aligned_cols=223 Identities=21% Similarity=0.280 Sum_probs=180.5
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||+||++.+. ++.||||++..... ........+.+|..++..++|+||+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~ 77 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM---LKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLY 77 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH---HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 47999999999999999999986 67899999875321 11222456888999999999999875
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 245688999999999999999999999999999999999999999999999999865543222
Q ss_pred --CCCcccccccCChhhhhc-----CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC---CCCc
Q 020016 184 --AKGFTGTYRWMAPEMIKE-----KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP---PTCP 253 (332)
Q Consensus 184 --~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~ 253 (332)
.....||+.|+|||++.+ +.++.++||||||+++|+|++|+.||...+..+....+.....+..++ ..++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~ 237 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVS 237 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCC
Confidence 223568999999999875 467889999999999999999999999888777666665444444444 3468
Q ss_pred HHHHHHHHHccccCCCC--CCCHHHHHHH
Q 020016 254 KAFSYLISRCWSSSPDR--RPHFDQIVSI 280 (332)
Q Consensus 254 ~~l~~li~~cl~~dp~~--Rps~~ell~~ 280 (332)
.++.+++.+||..++.+ |++++++++.
T Consensus 238 ~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 238 EEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 99999999999876554 4678877753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=271.70 Aligned_cols=219 Identities=31% Similarity=0.520 Sum_probs=177.5
Q ss_pred eeecccCceEEEEEEEC--C--eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec---------------
Q 020016 61 CKFASGRHSRIYRGIYK--Q--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT--------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------------- 120 (332)
+.||.|+||.||+|.+. + ..+|+|.+....... ..+.+.+|+.++.++ +||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-----DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHH-----HHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEE
Confidence 36899999999999986 3 357888887533222 135688999999999 8999986
Q ss_pred ---C----------C----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEee
Q 020016 121 ---E----------P----------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVAD 171 (332)
Q Consensus 121 ---~----------~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~D 171 (332)
. . ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECC
Confidence 0 0 1367889999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 020016 172 FGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 250 (332)
Q Consensus 172 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (332)
||++..............+..|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+. .......+.
T Consensus 156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~ 234 (270)
T cd05047 156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPL 234 (270)
T ss_pred CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh-CCCCCCCCC
Confidence 999753322111222234567999999988889999999999999999997 999998877666554442 334445666
Q ss_pred CCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 020016 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 285 (332)
Q Consensus 251 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~ 285 (332)
.++.++.+++.+||..+|.+||++.+++..|+.+.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 78899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=271.02 Aligned_cols=219 Identities=22% Similarity=0.321 Sum_probs=183.7
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|.+.+.||.|+||.||+|.+. +..||+|++....... ....+.+.+|+.++++++||||++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE---KGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYL 77 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcc---hhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEE
Confidence 5889999999999999999997 7899999997643221 122467899999999999999986
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCCC
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK 185 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 185 (332)
....+++..+..++.|++.||.|||..|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 78 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 157 (258)
T cd05578 78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT 157 (258)
T ss_pred EEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccc
Confidence 23478999999999999999999999999999999999999999999999999987655443344
Q ss_pred CcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHc
Q 020016 186 GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP--EQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263 (332)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 263 (332)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||...+. ........ .......+..++..+.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ-ETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh-ccccccCcccCcHHHHHHHHHH
Confidence 56688899999999988899999999999999999999999987764 22222222 2255667778899999999999
Q ss_pred cccCCCCCCCH--HHHH
Q 020016 264 WSSSPDRRPHF--DQIV 278 (332)
Q Consensus 264 l~~dp~~Rps~--~ell 278 (332)
|..||.+||++ ++++
T Consensus 237 l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 237 LERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCChhHcCCccHHHHh
Confidence 99999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=275.49 Aligned_cols=221 Identities=26% Similarity=0.449 Sum_probs=182.8
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||.|+||.||++.+. +..||+|++....... .+.|.+|+.++++++||||++
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEE------LEDFMVEIDILSECKHPNIVGLYEAYFYENKL 77 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHH------HHHHHHHHHHHHhCCCCceeEEEEEEecCCeE
Confidence 467999999999999999999985 7899999997643322 367889999999999999987
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 181 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 181 (332)
....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 78 WILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred EEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 2346899999999999999999999999999999999999999999999999987654322
Q ss_pred CCCCCcccccccCChhhhh-----cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHH
Q 020016 182 GSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKA 255 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 255 (332)
.......+++.|+|||.+. ...++.++|+||||+++|+|++|..||...+.......+..... ....+..++.+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSS 237 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHH
Confidence 2223456889999999985 34467899999999999999999999998877665554432211 12335578899
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 020016 256 FSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
+.+++.+||+.+|.+||++.++++.
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 238 FNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHHhccChhhCcCHHHHhcC
Confidence 9999999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=267.99 Aligned_cols=220 Identities=26% Similarity=0.375 Sum_probs=186.1
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|++.+.||.|+||.||.+... ++.+++|.+........ ..+.+.+|++++++++|+||++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 76 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK----ERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLI 76 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchh----HHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEE
Confidence 5889999999999999988875 78899999876543221 1356889999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 182 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 13458899999999999999999999999999999999999999999999999987654332
Q ss_pred CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 020016 183 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 262 (332)
......+++.|+|||.+.+..++.++||||||+++|+|++|..||......+....+... .....+..++..+.+++.+
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG-NYTPVVSVYSSELISLVHS 235 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-CCCCCccccCHHHHHHHHH
Confidence 233456899999999998888899999999999999999999999987777766665433 3344556788999999999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~~ 280 (332)
||..+|++||++.++++.
T Consensus 236 ~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 236 LLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HcccCcccCCCHHHHhhC
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=268.15 Aligned_cols=217 Identities=32% Similarity=0.609 Sum_probs=181.0
Q ss_pred eeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------------
Q 020016 61 CKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 120 (332)
++||.|+||.||++.+. ++.||+|.+....... ....+.+|++++++++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPD-----LKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHH-----HHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence 47999999999999987 8999999987754431 2467899999999999999986
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC---CCCc
Q 020016 121 ----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGF 187 (332)
Q Consensus 121 ----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~ 187 (332)
....+++..+..++.+++.+|.|||+++++||||+|+||+++.++.++|+|||++........ ....
T Consensus 76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 234578889999999999999999999999999999999999999999999999865432111 1122
Q ss_pred ccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHcccc
Q 020016 188 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 266 (332)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 266 (332)
..+..|+|||.+.++.++.++|+||||+++|+|+| |..||...........+. .......+..++..+.+++.+||..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~ 234 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAY 234 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHhcc
Confidence 33567999999998889999999999999999999 899998877665554443 3345556678899999999999999
Q ss_pred CCCCCCCHHHHHHHHHh
Q 020016 267 SPDRRPHFDQIVSILEG 283 (332)
Q Consensus 267 dp~~Rps~~ell~~L~~ 283 (332)
+|.+||++.++++.|+.
T Consensus 235 ~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 235 DPENRPSFSEIYNELQI 251 (251)
T ss_pred ChhhCcCHHHHHHHhhC
Confidence 99999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=281.35 Aligned_cols=227 Identities=25% Similarity=0.369 Sum_probs=179.3
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||.||+|.+. ++.||||++....... ....+.+|+.+++.++||||++
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT-----FCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccch-----hHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 68999999999999999999886 7899999986532221 1356788999999999999986
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 80 FNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred cceEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 2346889999999999999999999999999999999999999999999999998654322
Q ss_pred C----CCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------------
Q 020016 182 G----SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA------------ 244 (332)
Q Consensus 182 ~----~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~------------ 244 (332)
. ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+.......+.....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 1 1123467899999998754 4678999999999999999999999987554332221111000
Q ss_pred ------------CCC-----CCCCCcHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhhh
Q 020016 245 ------------RPP-----VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI--LEGYSE 286 (332)
Q Consensus 245 ------------~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~--L~~~~~ 286 (332)
... ..+..++.+.+++.+||+.+|.+||++.++++. |+...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 000 113457889999999999999999999999985 555443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=292.04 Aligned_cols=214 Identities=24% Similarity=0.383 Sum_probs=169.5
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
..|.+.+.||.|+||.||+|.+. ++.||||.... ..+.+|+.+|++++|+|||+
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 47999999999999999999997 68899996432 23568999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC-
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS- 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 183 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 237 lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 237 LVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 234689999999999999999999999999999999999999999999999999876433221
Q ss_pred --CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcCCC-CCCC---
Q 020016 184 --AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT--------PEQAAFAVCQKNAR-PPVP--- 249 (332)
Q Consensus 184 --~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~--------~~~~~~~~~~~~~~-~~~~--- 249 (332)
.....||..|+|||++.+..++.++|||||||++|||++|..|+.... ..++...+...... ..++
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 224568999999999999999999999999999999999776543211 12222111111100 0000
Q ss_pred ----------------------------CCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 250 ----------------------------PTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 250 ----------------------------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
..++..+.+||.+||+.||.+|||+.|+++.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1245678999999999999999999999863
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=274.28 Aligned_cols=221 Identities=24% Similarity=0.356 Sum_probs=181.1
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||.||+|.+. ++.||||++....... ...+.+.+|+++++.++|+||++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE----DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLY 76 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccc----cchhHHHHHHHHHHhcCCCCeeehhheEEECCEEE
Confidence 37999999999999999999986 6899999987643322 12467889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC--
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-- 182 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 182 (332)
....+++..+..++.|++.||.|||..|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 77 LVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 33558899999999999999999999999999999999999999999999999987654433
Q ss_pred CCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-----------------
Q 020016 183 SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA----------------- 244 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~----------------- 244 (332)
......++..|+|||++.+. .++.++||||||+++|+|++|..||......+..........
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 23345678899999999888 789999999999999999999999987665544333221000
Q ss_pred --C-----------CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 245 --R-----------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 245 --~-----------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
. ..++..++..+.++|.+||..+|++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 0123345888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=277.06 Aligned_cols=222 Identities=26% Similarity=0.370 Sum_probs=183.5
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|++|+||+|.+. ++.||||.+....... ....+.+.+|+.++..++||||++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK---RNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLC 77 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch---HHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEE
Confidence 37899999999999999999986 6899999998754332 112466889999999999999986
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 182 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 182 (332)
....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 12568899999999999999999999999999999999999999999999999875432211
Q ss_pred ------------------------------CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCH
Q 020016 183 ------------------------------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP 232 (332)
Q Consensus 183 ------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~ 232 (332)
......|+..|+|||++.+..++.++||||||+++|+|++|..||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 11134678899999999988899999999999999999999999998877
Q ss_pred HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCC----HHHHHH
Q 020016 233 EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPH----FDQIVS 279 (332)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~ell~ 279 (332)
......+.......+....++..+.+++.+||..||++||+ +.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 76665554333333333347899999999999999999999 777766
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=274.78 Aligned_cols=235 Identities=26% Similarity=0.378 Sum_probs=197.9
Q ss_pred ccccCCeeeeeeecccCceEEEEEEECC--eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
.+..+.|++.+.||.|.-|+||++...+ ..+|+|++.+..... ..-..+...|-+||..++||.+..
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~---rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS---RKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh---hhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 3456789999999999999999999985 789999998854332 222456788999999999999875
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
..+.+++..++-++.+++-||.|||..|||+|||||+||||.++|++.|+||.++...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 5677999999999999999999999999999999999999999999999999986310
Q ss_pred -------c---------------------------c-C----------------------CCCCCcccccccCChhhhhc
Q 020016 179 -------S---------------------------Q-C----------------------GSAKGFTGTYRWMAPEMIKE 201 (332)
Q Consensus 179 -------~---------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~ 201 (332)
. . . .....++||-.|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 0 0 0 01123569999999999999
Q ss_pred CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCC----HHHH
Q 020016 202 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPH----FDQI 277 (332)
Q Consensus 202 ~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~el 277 (332)
...+.++|+|+||+++|||+.|..||.+.+..+...++.......+-.+.++..+++||+++|.+||.+|.. +.||
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI 389 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHh
Confidence 999999999999999999999999999999999999998766666655678899999999999999999998 7777
Q ss_pred HH--HHHhhhhhh
Q 020016 278 VS--ILEGYSESL 288 (332)
Q Consensus 278 l~--~L~~~~~~~ 288 (332)
-+ +++.+..++
T Consensus 390 K~HpFF~gVnWaL 402 (459)
T KOG0610|consen 390 KRHPFFEGVNWAL 402 (459)
T ss_pred hcCccccCCChhh
Confidence 65 445544443
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=288.17 Aligned_cols=216 Identities=29% Similarity=0.385 Sum_probs=179.0
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CC-----ceec------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HP-----HIIT------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~------ 120 (332)
.+|.+.+.||+|+||.|.+|.+. ++.||||+++....- ..+-..|+.+|..|+ |. |+|+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-------~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-------LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-------HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 37899999999999999999996 789999999875432 355677999999997 43 5654
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC--CeEEEeecccc
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED--MCVKVADFGIS 175 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~--~~~kl~Dfg~a 175 (332)
.-..++...++.|+.||+.||.+||..||||+||||+|||+... ..+||+|||.+
T Consensus 259 fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 259 FRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred cccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 44568999999999999999999999999999999999999654 47999999999
Q ss_pred cccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--------
Q 020016 176 CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-------- 247 (332)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~-------- 247 (332)
+...+... .+.-+..|.|||++.+.+|+.+.|+||||||++||++|.+.|++.+..+....+......++
T Consensus 339 c~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 339 CFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred cccCCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 88776443 67788999999999999999999999999999999999999999887776655543111110
Q ss_pred ------------------------------------------CC-----------CCCcHHHHHHHHHccccCCCCCCCH
Q 020016 248 ------------------------------------------VP-----------PTCPKAFSYLISRCWSSSPDRRPHF 274 (332)
Q Consensus 248 ------------------------------------------~~-----------~~~~~~l~~li~~cl~~dp~~Rps~ 274 (332)
.| ......+.+++.+||+.||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 11 0112457899999999999999999
Q ss_pred HHHHH
Q 020016 275 DQIVS 279 (332)
Q Consensus 275 ~ell~ 279 (332)
.+.++
T Consensus 497 ~qal~ 501 (586)
T KOG0667|consen 497 AQALN 501 (586)
T ss_pred HHHhc
Confidence 99887
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=269.05 Aligned_cols=219 Identities=30% Similarity=0.539 Sum_probs=181.5
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|++.+.||.|+||+||+|.+. +..+|+|++....... ..+.+.+|+.+++.++|+||++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-----SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-----HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEE
Confidence 47999999999999999999985 6789999997644332 1467899999999999999986
Q ss_pred ----------------C---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 ----------------E---PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 ----------------~---~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
. ...+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++......
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 1 245789999999999999999999999999999999999999999999999998654432
Q ss_pred CC-----CCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-----C
Q 020016 182 GS-----AKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP-----P 250 (332)
Q Consensus 182 ~~-----~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~-----~ 250 (332)
.. .....++..|+|||.+... .++.++|+||||+++|+|++|+.||...+........... ..+..+ .
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN-DPPSLETGADYK 234 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC-CCCCcCCccccc
Confidence 21 2344688999999998877 7899999999999999999999999887766555444332 122222 3
Q ss_pred CCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 251 ~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+++.+.+++.+||..||++||++.++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 235 KYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 56789999999999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=271.47 Aligned_cols=227 Identities=23% Similarity=0.397 Sum_probs=185.8
Q ss_pred CeeeeeeecccCceEEEEEEEC---CeeEEEEEecCCCchhH----HHHHHHHHHHHHHHHHHc-CCCCceec-------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDAS----LASMLEKQFTSEVALLFR-LNHPHIIT------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~---~~~vAvK~~~~~~~~~~----~~~~~~~~~~~E~~~l~~-l~h~niv~------- 120 (332)
.|++.+.||.|+||.||+|.+. ++.+|+|.+........ ........+.+|+.++.+ ++||||++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4788899999999999999986 47899998865322110 112224567889998875 79999986
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccccccceeecCCCeEEEeeccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 23457888999999999999999996 7899999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 020016 175 SCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254 (332)
Q Consensus 175 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (332)
+.............++..|++||.+.+..++.++||||||+++|+|++|..||...........+......+.....+++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE 240 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCH
Confidence 87655443444567899999999999888999999999999999999999999887766655555444433333346789
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHH
Q 020016 255 AFSYLISRCWSSSPDRRPHFDQIVSILE 282 (332)
Q Consensus 255 ~l~~li~~cl~~dp~~Rps~~ell~~L~ 282 (332)
.+.+++.+||+.||++||++.++..+|+
T Consensus 241 ~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 241 DVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 9999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=269.31 Aligned_cols=224 Identities=26% Similarity=0.470 Sum_probs=183.1
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|+.++.||+|++|.||++.+. ++.||+|++..............+.+.+|+.+++.++|+||++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999885 7899999997654332222234578999999999999999987
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC-eEEEeecccccccccCCC-
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVADFGISCLESQCGS- 183 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~- 183 (332)
....+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 235678899999999999999999999999999999999998775 699999999865543211
Q ss_pred ----CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCCCCCCCCcHHH
Q 020016 184 ----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP---EQAAFAVCQKNARPPVPPTCPKAF 256 (332)
Q Consensus 184 ----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l 256 (332)
.....++..|+|||.+.+..++.++|+||+|+++|+|++|..||..... .............+..+..+++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL 240 (268)
T ss_pred CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHH
Confidence 1234678899999999888899999999999999999999999975432 222233333344566777889999
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+++.+||..+|++||++.++++
T Consensus 241 ~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 241 RDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHHcCCCcccCcCHHHHhc
Confidence 99999999999999999999884
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=267.39 Aligned_cols=219 Identities=24% Similarity=0.423 Sum_probs=185.0
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|++.+.||+|+||.||++.+. ++.||+|.+........ ..+.+.+|+.+++.++||||++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK----EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYI 76 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChH----HHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEE
Confidence 5889999999999999999885 78999999876432211 1357889999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 122568889999999999999999999999999999999999999999999999865433221
Q ss_pred -CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 020016 184 -AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 184 -~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 262 (332)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+....+. ....+..+..++.++.++|.+
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQ 235 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHH
Confidence 223457889999999998889999999999999999999999998877777666554 344455677889999999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~ 279 (332)
||+.+|++||++.++++
T Consensus 236 ~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 236 LFKRNPRDRPSVNSILE 252 (256)
T ss_pred HhhCChhhCcCHHHHhh
Confidence 99999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=268.32 Aligned_cols=223 Identities=26% Similarity=0.411 Sum_probs=186.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
.+|.+.+.||+|+||.||+|.+. +..||+|.+........ .......+.+|+.++++++|+||++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQE-TSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccch-hhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 57999999999999999999985 78999999865322211 1222467889999999999999986
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 181 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 181 (332)
..+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 2345788899999999999999999999999999999999999999999999998654321
Q ss_pred ---CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 020016 182 ---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 258 (332)
Q Consensus 182 ---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 258 (332)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||..........+.......+.+|..+++.+.+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 11223568899999999998889999999999999999999999999877666666655455566778889999999
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~ 279 (332)
++.+||. +|..||++.+++.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHhc-CcccCccHHHHhc
Confidence 9999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=283.82 Aligned_cols=212 Identities=23% Similarity=0.336 Sum_probs=169.3
Q ss_pred ecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC---CCCceec-----------------
Q 020016 63 FASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL---NHPHIIT----------------- 120 (332)
Q Consensus 63 lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~----------------- 120 (332)
||+|+||+||+|.+. ++.||||++....... ......+..|..++..+ +||||+.
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA---KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh---hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence 799999999999986 7899999987532111 11123455677777665 6999875
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc-CCCCCCcc
Q 020016 121 -----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKGFT 188 (332)
Q Consensus 121 -----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~~~~~~~~ 188 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..... ........
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 345689999999999999999999999999999999999999999999999999865322 22334567
Q ss_pred cccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-CCCcHHHHHHHHHcccc
Q 020016 189 GTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP-PTCPKAFSYLISRCWSS 266 (332)
Q Consensus 189 gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~ 266 (332)
||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+..... .++ ..+++++.+++.+||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~~L~~ 235 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV--RFPKNVLSDEGRQFVKGLLNR 235 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcCC
Confidence 99999999998765 479999999999999999999999998877666555543322 233 35789999999999999
Q ss_pred CCCCCC----CHHHHHH
Q 020016 267 SPDRRP----HFDQIVS 279 (332)
Q Consensus 267 dp~~Rp----s~~ell~ 279 (332)
||.+|| ++.++++
T Consensus 236 ~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 236 NPQHRLGAHRDAVELKE 252 (330)
T ss_pred CHHHCCCCCCCHHHHhc
Confidence 999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=276.80 Aligned_cols=219 Identities=25% Similarity=0.447 Sum_probs=182.1
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
.+|.+.+.||+|+||.||+|.+. ++.||+|.+....... .+.+.+|+.+++.++|+||++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDELW 92 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence 68999999999999999999975 7899999997644332 356789999999999999987
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-CC
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-SA 184 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~ 184 (332)
....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++....... ..
T Consensus 93 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 172 (297)
T cd06656 93 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (297)
T ss_pred EeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence 23457888999999999999999999999999999999999999999999999986543322 22
Q ss_pred CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCcHHHHHHHHHc
Q 020016 185 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-ARPPVPPTCPKAFSYLISRC 263 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~c 263 (332)
....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+............ .....+..++..+.+++.+|
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 252 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHH
Confidence 34568889999999998889999999999999999999999998766544333222211 12234566788999999999
Q ss_pred cccCCCCCCCHHHHHH
Q 020016 264 WSSSPDRRPHFDQIVS 279 (332)
Q Consensus 264 l~~dp~~Rps~~ell~ 279 (332)
|..+|++||++.++++
T Consensus 253 l~~~p~~Rps~~~il~ 268 (297)
T cd06656 253 LEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccCChhhCcCHHHHhc
Confidence 9999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=273.40 Aligned_cols=228 Identities=25% Similarity=0.465 Sum_probs=181.7
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec---
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT--- 120 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--- 120 (332)
...|.++.++|.+.+.||+|+||.||+|.+. ++.||||.+........ ...+..|+.++... .||||++
T Consensus 7 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~e~~~~~~~~~~~~i~~~~~ 81 (296)
T cd06618 7 GQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE-----NKRILMDLDVVLKSHDCPYIVKCYG 81 (296)
T ss_pred ceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHH-----HHHHHHHHHHHHhccCCCchHhhhe
Confidence 4567888999999999999999999999997 88999999976433221 24566677766666 5999986
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccccccceeecCCCeEEEeeccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..+..++.|++.||+|||+ .|++||||+|+||+++.++.++|+|||+
T Consensus 82 ~~~~~~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~ 161 (296)
T cd06618 82 YFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGI 161 (296)
T ss_pred eeecCCeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECcccc
Confidence 13468889999999999999999997 5999999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCChhhhhcCC----CCCccchhHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCCC
Q 020016 175 SCLESQCGSAKGFTGTYRWMAPEMIKEKR----HTKKVDVYSFGIVLWELLTALTPFDNMTPE-QAAFAVCQKNARPPVP 249 (332)
Q Consensus 175 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~elltG~~pf~~~~~~-~~~~~~~~~~~~~~~~ 249 (332)
+.............++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...... +....+... ..+..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~ 240 (296)
T cd06618 162 SGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE-EPPSLP 240 (296)
T ss_pred chhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC-CCCCCC
Confidence 87654433333445788999999987554 788999999999999999999999764432 222222222 222222
Q ss_pred --CCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 250 --PTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 250 --~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
..++.++.+++.+||..||.+||++.+++..
T Consensus 241 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 241 PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 3478999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=268.79 Aligned_cols=225 Identities=26% Similarity=0.422 Sum_probs=180.4
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
+++++.+++.....||+|+||.||+|.+. +..||+|.+....... .+.+.+|+.+++.++|+||++
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~ 75 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRY------VQPLHEEIALHSYLKHRNIVQYLGSDS 75 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHH------HHHHHHHHHHHHhcCCCCeeeeeeeec
Confidence 34556677777789999999999999876 6789999987654332 357889999999999999987
Q ss_pred -----------------------CCCCC--CHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC-CCeEEEeeccc
Q 020016 121 -----------------------EPYSV--PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMCVKVADFGI 174 (332)
Q Consensus 121 -----------------------~~~~l--~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~-~~~~kl~Dfg~ 174 (332)
....+ ++..+..++.||+.||+|||++|++||||+|+||+++. ++.++|+|||+
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred cCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchh
Confidence 12334 77888899999999999999999999999999999986 67999999999
Q ss_pred ccccccCC-CCCCcccccccCChhhhhcCC--CCCccchhHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCCCC
Q 020016 175 SCLESQCG-SAKGFTGTYRWMAPEMIKEKR--HTKKVDVYSFGIVLWELLTALTPFDNMTPE-QAAFAVCQKNARPPVPP 250 (332)
Q Consensus 175 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltG~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 250 (332)
+....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...... ............+.++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd06624 156 SKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPE 235 (268)
T ss_pred heecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCc
Confidence 86543222 223345789999999986644 788999999999999999999999765432 22222222234456677
Q ss_pred CCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 251 ~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+++++.+++.+||+.+|.+||++.+++.
T Consensus 236 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 236 SLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 88999999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=267.23 Aligned_cols=219 Identities=37% Similarity=0.703 Sum_probs=183.9
Q ss_pred eeeeeeecccCceEEEEEEECC------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 57 LFIGCKFASGRHSRIYRGIYKQ------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 57 y~i~~~lg~G~~g~Vy~~~~~~------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
+++.+.||.|+||.||++.+.+ ..||+|.+....... ..+.+..|+.++..++|+||++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-----QIEEFLREARIMRKLDHPNIVKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-----HHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence 4577899999999999999974 789999997654332 2467889999999999999986
Q ss_pred ------------------CCC-C-CCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 ------------------EPY-S-VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 ------------------~~~-~-l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
... . +++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 111 2 89999999999999999999999999999999999999999999999999876544
Q ss_pred CCCCC--CcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 020016 181 CGSAK--GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 257 (332)
Q Consensus 181 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 257 (332)
..... ...+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+.......+. .......+..++..+.
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK-KGYRLPKPENCPPEIY 234 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHH
Confidence 32111 2336789999999988889999999999999999999 899998877766665554 3445566677899999
Q ss_pred HHHHHccccCCCCCCCHHHHHHHH
Q 020016 258 YLISRCWSSSPDRRPHFDQIVSIL 281 (332)
Q Consensus 258 ~li~~cl~~dp~~Rps~~ell~~L 281 (332)
+++.+||..+|.+|||+.++++.|
T Consensus 235 ~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 235 KLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHCcCChhhCcCHHHHHhhC
Confidence 999999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=272.37 Aligned_cols=224 Identities=23% Similarity=0.409 Sum_probs=179.5
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT------ 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~------ 120 (332)
+....++|.+.+.||+|+||.||++.+. ++.+|+|++...... ...+.+|+.+++.+ +||||++
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI-------DEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch-------HHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 3444689999999999999999999886 789999998653221 24577899999999 7999986
Q ss_pred -------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEE
Q 020016 121 -------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 169 (332)
Q Consensus 121 -------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl 169 (332)
....+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEE
Confidence 1134677788889999999999999999999999999999999999999
Q ss_pred eecccccccccCC-CCCCcccccccCChhhhhc-----CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Q 020016 170 ADFGISCLESQCG-SAKGFTGTYRWMAPEMIKE-----KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 243 (332)
Q Consensus 170 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~ 243 (332)
+|||++....... ......+++.|+|||++.. ..++.++||||||+++|+|++|..||................
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (286)
T cd06638 166 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP 245 (286)
T ss_pred ccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence 9999986544322 2234568999999999853 447889999999999999999999998776544433332211
Q ss_pred -CCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 244 -ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 244 -~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
.....+..++..+.+++.+||+.||++||++.++++.
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1122345568899999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=274.87 Aligned_cols=220 Identities=30% Similarity=0.430 Sum_probs=181.8
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
..|.+.+.||+|+||.||+|.+. ++.||+|++........ ...+.+.+|+.+++.++||||++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcH---HHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 56999999999999999999985 78999999865432211 12356889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 184 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 184 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .
T Consensus 92 lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~---~ 168 (307)
T cd06607 92 LVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---A 168 (307)
T ss_pred EEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC---C
Confidence 245689999999999999999999999999999999999999999999999998865432 2
Q ss_pred CCcccccccCChhhhh---cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 020016 185 KGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 261 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 261 (332)
....+++.|+|||.+. ...++.++||||||+++|+|+||..||...+.......+.........+..++..+.+++.
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 248 (307)
T cd06607 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVD 248 (307)
T ss_pred CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHH
Confidence 3456788999999874 3567899999999999999999999998877766555543332222233457889999999
Q ss_pred HccccCCCCCCCHHHHHHH
Q 020016 262 RCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 262 ~cl~~dp~~Rps~~ell~~ 280 (332)
+||..+|++||++.+++..
T Consensus 249 ~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 249 SCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHhcCChhhCcCHHHHhcC
Confidence 9999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=273.30 Aligned_cols=220 Identities=29% Similarity=0.497 Sum_probs=183.7
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
+.|...+.||+|+||.||+|.+. +..||+|.+....... ..+.+.+|+.+++.++||||++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-----EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLW 78 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH-----HHHHHHHHHHHHHcCCCCccHhhhcccccCCceE
Confidence 35777889999999999999885 6889999987654322 2467889999999999999986
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-CC
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-SA 184 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~ 184 (332)
....+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 79 IIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred EEEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 23457899999999999999999999999999999999999999999999999986544322 12
Q ss_pred CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHcc
Q 020016 185 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 264 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 264 (332)
....++..|+|||.+.+..++.++||||||+++|+|++|..||....+......+. ....+..+..++..+.+++.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYSKPFKEFVEACL 237 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCCCCcccCHHHHHHHHHHc
Confidence 23457889999999998889999999999999999999999998766655444332 33344555678899999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 020016 265 SSSPDRRPHFDQIVSI 280 (332)
Q Consensus 265 ~~dp~~Rps~~ell~~ 280 (332)
+.+|++||++.++++.
T Consensus 238 ~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 238 NKDPRFRPTAKELLKH 253 (277)
T ss_pred cCCcccCcCHHHHHHh
Confidence 9999999999999983
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=268.95 Aligned_cols=224 Identities=30% Similarity=0.492 Sum_probs=180.7
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhH----HHHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDAS----LASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
+|.+.+.||.|+||.||+|.+. ++.||||.+........ ......+.+.+|+.+++.++||||++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5888999999999999999875 78999999865322111 11223467889999999999999976
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 2356888999999999999999999999999999999999999999999999998654322
Q ss_pred C---CCCCcccccccCChhhhhcCC--CCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC----CCC
Q 020016 182 G---SAKGFTGTYRWMAPEMIKEKR--HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP----PTC 252 (332)
Q Consensus 182 ~---~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~ 252 (332)
. ......++..|+|||.+.... ++.++|+||||+++|++++|..||....................++ ..+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 1 123346788999999987655 7899999999999999999999998766655544443333333333 346
Q ss_pred cHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 253 PKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+..+.+++.+||..+|++||++.++++
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 889999999999999999999999885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=279.69 Aligned_cols=212 Identities=27% Similarity=0.431 Sum_probs=163.0
Q ss_pred eeeecccCceEEEEEEEC----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------------
Q 020016 60 GCKFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------------- 120 (332)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------------- 120 (332)
+++||+|+||.||+|.+. +..||+|.+...... ..+.+|+.+++.++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--------MSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc--------HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 468999999999999975 368999998764322 34678999999999999986
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee----cCCCeEEEeecc
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL----GEDMCVKVADFG 173 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll----~~~~~~kl~Dfg 173 (332)
....+++..+..++.||+.||.|||+.|++||||||+||++ +.++.+||+|||
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 78 LFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 01247788899999999999999999999999999999999 456799999999
Q ss_pred cccccccCC----CCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHH---------HHHHHH
Q 020016 174 ISCLESQCG----SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPE---------QAAFAV 239 (332)
Q Consensus 174 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~---------~~~~~~ 239 (332)
++....... ......+|+.|+|||++.+. .++.++||||||+++|+|+||..||...... .....+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 997654322 12345689999999998764 5789999999999999999999999753221 000000
Q ss_pred HhcCC------------------------C------------CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 240 CQKNA------------------------R------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 240 ~~~~~------------------------~------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..... . .......+..+.+|+.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 0 0001123566889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=271.60 Aligned_cols=220 Identities=28% Similarity=0.483 Sum_probs=185.1
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
..|+..+.||.|+||.||+|.+. +..||||++....... ....+.+|+.+++.++||||++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-----EIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 46788899999999999999985 7899999987643322 1467889999999999999986
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-CC
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-SA 184 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~ 184 (332)
....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 79 lv~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 79 IIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred EEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 33457888899999999999999999999999999999999999999999999986544322 22
Q ss_pred CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHcc
Q 020016 185 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 264 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 264 (332)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||....+......+ .....+.++..++..+.+++.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-PKNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-hcCCCCCCchhhhHHHHHHHHHHc
Confidence 3345788999999999888999999999999999999999999987766555443 233345566678899999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 020016 265 SSSPDRRPHFDQIVSI 280 (332)
Q Consensus 265 ~~dp~~Rps~~ell~~ 280 (332)
+.+|.+||++.+++..
T Consensus 238 ~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 238 NKDPSFRPTAKELLKH 253 (277)
T ss_pred ccCcccCcCHHHHHhC
Confidence 9999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=271.50 Aligned_cols=221 Identities=25% Similarity=0.384 Sum_probs=177.9
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||.||+|.++ ++.||+|++....... ...+.+.+|++++..++||||++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 76 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK----MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLY 76 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc----hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEE
Confidence 47899999999999999999996 7899999987643322 12456889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-C
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-S 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~ 183 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 77 LVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence 23458899999999999999999999999999999999999999999999999987543322 2
Q ss_pred CCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------------------
Q 020016 184 AKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA------------------ 244 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~------------------ 244 (332)
.....++..|+|||++.+. .++.++||||||+++|+|++|..||......+....+.....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 2345678899999998753 468899999999999999999999987665443322221000
Q ss_pred --CC---------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 245 --RP---------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 245 --~~---------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+ ...+.++..+.+++.+||..+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 012456888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=271.66 Aligned_cols=226 Identities=27% Similarity=0.527 Sum_probs=184.3
Q ss_pred cCCeeeeeeecccCceEEEEEEEC------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
...|++.+.||+|+||.||++.+. +..||||++...... ...+.|.+|+.+++.++|+||++
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~ 77 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-----QHRSDFEREIEILRTLDHENIVKYKGVCEK 77 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-----HHHHHHHHHHHHHHhCCCCChheEEeeeec
Confidence 357888999999999999999864 578999999875443 12467999999999999999976
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccc
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 78 PGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred CCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 12247888999999999999999999999999999999999999999999999987
Q ss_pred ccccCCC----CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHH--------------HHHH
Q 020016 177 LESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ--------------AAFA 238 (332)
Q Consensus 177 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~--------------~~~~ 238 (332)
....... .....++..|++||.+.+..++.++||||||+++|+|+||..|+....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 6542211 112334567999999988889999999999999999999999986532211 1122
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 239 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
........+.+..++.++.+++.+||+.+|.+||++.+|+++|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 2233444455667889999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=271.70 Aligned_cols=219 Identities=23% Similarity=0.421 Sum_probs=179.8
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|++.+.||+|+||.||++.+. +..||+|.+....... ....+.+|+.++++++||||++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES-----KFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHH-----HHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEE
Confidence 47889999999999999999996 7899999987543222 1356889999999999999976
Q ss_pred ----------------C---CCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 ----------------E---PYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 ----------------~---~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
. ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 1 2378999999999999999999997 5999999999999999999999999999865433
Q ss_pred CCCCCCcccccccCChhhhhcCC------CCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hcCCCCCCCCCC
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKR------HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC--QKNARPPVPPTC 252 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~ 252 (332)
. ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+. .....+..+..+
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 156 S-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred C-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 2 223446788999999986543 4789999999999999999999997755444332221 233445667779
Q ss_pred cHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 253 PKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+.++.++|.+||..+|++||++.+++.
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 999999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=274.41 Aligned_cols=220 Identities=23% Similarity=0.415 Sum_probs=177.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||.||++.+. +..+|+|.+....... ....+.+|++++.+++||||++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPA-----IRNQIIRELKVLHECNSPYIVGFYGAFYSDGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHH-----HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEE
Confidence 36899999999999999999986 6789999987643221 2456889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++...... .
T Consensus 76 lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~ 154 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M 154 (308)
T ss_pred EEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-c
Confidence 23567889999999999999999997 58999999999999999999999999988654332 2
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------------------
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ---------------------- 241 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~---------------------- 241 (332)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 3345789999999999888899999999999999999999999976543332211110
Q ss_pred -------------cCCCCCCC-CCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 242 -------------KNARPPVP-PTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 242 -------------~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
....+..+ ..++.++.+++.+||..+|++||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111111 1367889999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=271.26 Aligned_cols=220 Identities=25% Similarity=0.378 Sum_probs=176.9
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|.+.+.||.|++|.||+|.+. ++.||||.+........ ....+.+|++++++++||||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG----VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL 76 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccc----cchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEE
Confidence 4889999999999999999986 78999999876432221 1356889999999999999987
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-C
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-S 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~ 183 (332)
....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 77 v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 77 VFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred EeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 23567899999999999999999999999999999999999999999999999986543321 2
Q ss_pred CCCcccccccCChhhhhcCC-CCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----------------
Q 020016 184 AKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP---------------- 246 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~---------------- 246 (332)
.....++..|+|||.+.+.. ++.++||||||+++|+|+||+.||...+..............+
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 23345688999999887654 5889999999999999999999998776654444332211111
Q ss_pred -----------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 -----------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 -----------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...+.+++++.++|.+||+.||.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 012346788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=270.28 Aligned_cols=218 Identities=25% Similarity=0.447 Sum_probs=180.3
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||.|++|.||++.++ ++.||+|.+....... ..+.+.+|+++++.++||||++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEA-----IQKQILRELDILHKCNSPYIVGFYGAFYNNGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChH-----HHHHHHHHHHHHHHCCCCchhhhheeeecCCEEE
Confidence 36788899999999999999997 7899999988754332 2467889999999999999976
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccccccceeecCCCeEEEeecccccccccCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 182 (332)
....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 12678889999999999999999999 999999999999999999999999999986544322
Q ss_pred CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcCCCCCCCCC-CcHHH
Q 020016 183 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT-----PEQAAFAVCQKNARPPVPPT-CPKAF 256 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~-~~~~l 256 (332)
.. ...++..|+|||.+.+..++.++||||||+++|+|++|..||.... ..+..... .....+..+.. ++..+
T Consensus 156 ~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 156 AK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI-VNEPPPRLPSGKFSPDF 233 (265)
T ss_pred hh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH-hcCCCCCCChhhcCHHH
Confidence 22 2678889999999998899999999999999999999999997642 22222222 22333444444 88999
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.++|.+||..+|++||++.+++.
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhh
Confidence 99999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=275.52 Aligned_cols=222 Identities=27% Similarity=0.356 Sum_probs=179.4
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||.|+||.||+|.+. ++.||+|++......... ...+.+|+.++++++|+||++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGI----PISSLREITLLLNLRHPNIVELKEVVVGKHLD 81 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCC----cchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence 578999999999999999999986 789999998764332211 134567999999999999875
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 82 SIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred eEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 1245788999999999999999999999999999999999999999999999998765432
Q ss_pred C-CCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------------
Q 020016 182 G-SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------------- 246 (332)
Q Consensus 182 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~------------- 246 (332)
. ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+......+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 2 2223345788999999865 457899999999999999999999999887766655444321110
Q ss_pred ----CC-----------CCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 ----PV-----------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 ----~~-----------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.. ....++.+.++|.+||+.||.+||++.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 0125788899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=290.88 Aligned_cols=217 Identities=27% Similarity=0.437 Sum_probs=177.8
Q ss_pred eeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------------
Q 020016 58 FIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------------- 120 (332)
Q Consensus 58 ~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------------- 120 (332)
++..+||+|+|-+||+|.+. |-.||--.++.... .......+.|..|+.+|+.|+|||||+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~--~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~ 120 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDV--TQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF 120 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHh--hcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence 46779999999999999997 55665433322111 111223578999999999999999997
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccccccceeecCC-CeEEEeecccccccccCC
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGED-MCVKVADFGISCLESQCG 182 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~ 182 (332)
..+.++...+..|++||+.||.|||++. |||||||.+||||+.+ |.|||+|+|+|.......
T Consensus 121 iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred eeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 4467888999999999999999999985 9999999999999876 999999999998876644
Q ss_pred CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 020016 183 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQKNARPPVPPTCPKAFSYLIS 261 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 261 (332)
. ....|||.|||||++. ..|+..+||||||++|+||+|+.+||.... +.+++.++..+.....+..--.+++++||.
T Consensus 201 a-ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIe 278 (632)
T KOG0584|consen 201 A-KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIE 278 (632)
T ss_pred c-ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHH
Confidence 3 4489999999999998 789999999999999999999999999865 455555555444333444445789999999
Q ss_pred HccccCCCCCCCHHHHHH
Q 020016 262 RCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 262 ~cl~~dp~~Rps~~ell~ 279 (332)
+||.. ..+|||+.|+|+
T Consensus 279 kCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 279 KCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHhcC-chhccCHHHHhh
Confidence 99999 999999999986
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=268.77 Aligned_cols=217 Identities=32% Similarity=0.612 Sum_probs=177.8
Q ss_pred eeecccCceEEEEEEECC--------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 61 CKFASGRHSRIYRGIYKQ--------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~--------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
+.||+|+||.||+|.+.+ ..+|||.+....... ....+.+|+.+++.++||||++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ-----EKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchh-----hHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeE
Confidence 368999999999998752 579999886543221 1356889999999999999986
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC-----eEEEeec
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-----CVKVADF 172 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~-----~~kl~Df 172 (332)
....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+||
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCc
Confidence 012367788899999999999999999999999999999999877 8999999
Q ss_pred ccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 020016 173 GISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 248 (332)
Q Consensus 173 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (332)
|++....... ......++..|+|||.+.++.++.++||||||+++|+|++ |..||...+..+....+. .......
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~ 234 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQK 234 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-cCCccCC
Confidence 9986543221 1122345788999999999999999999999999999998 999998877766555443 3344556
Q ss_pred CCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 020016 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 283 (332)
Q Consensus 249 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~ 283 (332)
+..++..+.+++.+||..+|.+||++.++++.|++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 67789999999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=272.50 Aligned_cols=222 Identities=25% Similarity=0.418 Sum_probs=181.2
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
..++|++.+.||+|+||+||++.+. ++.||+|++....... ..+.+.+|+++++.++||||++
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSS-----VRKQILRELQIMHECRSPYIVSFYGAFLNENN 77 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcch-----HHHHHHHHHHHHHHcCCCCcceEeeeEecCCE
Confidence 3578999999999999999999987 7899999987643222 2467899999999999999986
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
..+.+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 23567889999999999999999997 58999999999999999999999999987644322
Q ss_pred CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhcCCCCCCCC
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE-----------QAAFAVCQKNARPPVPP 250 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~ 250 (332)
......++..|+|||++.+..++.++|+|||||++|+|++|..||...... +....+. ....+.++.
T Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 235 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QEPPPRLPS 235 (284)
T ss_pred -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-hccCCCCCc
Confidence 223457899999999998888999999999999999999999999865442 1112221 122223333
Q ss_pred -CCcHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 020016 251 -TCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 281 (332)
Q Consensus 251 -~~~~~l~~li~~cl~~dp~~Rps~~ell~~L 281 (332)
.++..+.+|+.+||+.||++||++.++++..
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 3788999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=266.38 Aligned_cols=214 Identities=29% Similarity=0.380 Sum_probs=181.2
Q ss_pred ecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------------
Q 020016 63 FASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------------- 120 (332)
Q Consensus 63 lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------------- 120 (332)
||.|++|.||++.+. ++.||+|++....... ....+.+.+|+.+++.++||||++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE---TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchh---hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCC
Confidence 689999999999997 7899999997643221 122467899999999999999986
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCCCCcccccc
Q 020016 121 --------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYR 192 (332)
Q Consensus 121 --------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~ 192 (332)
....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.............++..
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 157 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE 157 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcC
Confidence 234678999999999999999999999999999999999999999999999999876654433344568899
Q ss_pred cCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCC
Q 020016 193 WMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT--PEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDR 270 (332)
Q Consensus 193 y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 270 (332)
|++||.+.+..++.++|+||||+++|+|++|..||.... .......+........+|...++++.++|.+||+.+|++
T Consensus 158 ~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 237 (262)
T cd05572 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEE 237 (262)
T ss_pred ccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhh
Confidence 999999988889999999999999999999999998776 555555554445566777778999999999999999999
Q ss_pred CCC-----HHHHHH
Q 020016 271 RPH-----FDQIVS 279 (332)
Q Consensus 271 Rps-----~~ell~ 279 (332)
||+ +.|+++
T Consensus 238 R~~~~~~~~~~l~~ 251 (262)
T cd05572 238 RLGNLKGGIKDIKK 251 (262)
T ss_pred CcCCcccCHHHHhc
Confidence 999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=269.83 Aligned_cols=220 Identities=24% Similarity=0.355 Sum_probs=178.7
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|.+.+.||.|+||.||+|.+. ++.||||++........ ....+.+|+.++++++||||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 76 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGG----IPNQALREIKALQACQHPYVVKLLDVFPHGSGFVL 76 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccch----hhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEE
Confidence 5899999999999999999985 78999999987543221 2367889999999999999986
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC--C
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG--S 183 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--~ 183 (332)
....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 77 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 77 VMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred EecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 23568899999999999999999999999999999999999999999999999987654432 1
Q ss_pred CCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----------------
Q 020016 184 AKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP---------------- 246 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~---------------- 246 (332)
.....++..|+|||.+.+. .++.++||||+|+++|+|++|.+||.+.........+......+
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 2345688999999998654 45899999999999999999988888766544433332211110
Q ss_pred ------------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 ------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 ------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...+..+..+.+++.+||..+|.+||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 011345788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=271.30 Aligned_cols=226 Identities=25% Similarity=0.333 Sum_probs=183.9
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||.||++.+. ++.||||.+...... .....+.+.+|+.+++.++||||++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 77 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI---LRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLC 77 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhh---hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEE
Confidence 36899999999999999999987 678999998764221 1122457889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC---
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC--- 181 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--- 181 (332)
....+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 2356788999999999999999999999999999999999999999999999987531100
Q ss_pred -------------CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CC
Q 020016 182 -------------GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR-PP 247 (332)
Q Consensus 182 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~-~~ 247 (332)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+....+........... +.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 0111245788999999998888999999999999999999999999988777666655443322 23
Q ss_pred CCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 020016 248 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 283 (332)
Q Consensus 248 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~ 283 (332)
.+..++..+.+++.+||+.+|++||+..++.+.|+.
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 334678999999999999999999997777776665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=268.46 Aligned_cols=220 Identities=25% Similarity=0.405 Sum_probs=179.4
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec---------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT--------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------- 120 (332)
..++|.+.+.||+|+||.||++.+. ++.+|+|++...... ...+.+|+.++.++ +|||+++
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~-------~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-------DEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH-------HHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 3578999999999999999999985 789999998754221 24567899999998 8999986
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeec
Q 020016 121 ----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 172 (332)
Q Consensus 121 ----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Df 172 (332)
....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~df 172 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDF 172 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeec
Confidence 1245788899999999999999999999999999999999999999999999
Q ss_pred ccccccccCC-CCCCcccccccCChhhhhcCC-----CCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-C
Q 020016 173 GISCLESQCG-SAKGFTGTYRWMAPEMIKEKR-----HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-R 245 (332)
Q Consensus 173 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-----~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~-~ 245 (332)
|++....... ......++..|+|||.+.... ++.++||||||+++|+|++|+.||...........+..... .
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 252 (291)
T cd06639 173 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPT 252 (291)
T ss_pred ccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCC
Confidence 9986543322 223456889999999986433 58899999999999999999999998776555554432221 1
Q ss_pred CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 246 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 246 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...+..++..+.++|.+||+.+|++||++.++++
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 253 LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1234567788999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=290.98 Aligned_cols=219 Identities=26% Similarity=0.489 Sum_probs=187.7
Q ss_pred CCeeeeeeecccCceEEEEEEECC--eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
+-|.|+..||.|+||.||+|..+. -..|-|++....... .++|+-|++||...+||+||+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEE------LEDylVEIeILa~CdHP~ivkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEE------LEDYLVEIEILAECDHPVIVKLLSAYYFENKLW 105 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhH------HhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence 345578899999999999999874 345788887655443 578999999999999999987
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc-cCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES-QCG 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~-~~~ 182 (332)
....+++.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+.... ...
T Consensus 106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 45679999999999999999999999999999999999999999999999999874322 223
Q ss_pred CCCCcccccccCChhhhh-----cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHH
Q 020016 183 SAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAF 256 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 256 (332)
....+.|||.|||||+.. ..+|+.++||||||++|.||..+.+|-...++..+...+..... ....|..++..+
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence 345789999999999885 46789999999999999999999999999999888777754332 234578899999
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+++.+||..||..||++.++++
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhh
Confidence 99999999999999999999885
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=264.42 Aligned_cols=219 Identities=27% Similarity=0.441 Sum_probs=185.5
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||.|++|.||+|.+. ++.||||++...... ...+.+.+|+..+..++|+||++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-----EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEE
Confidence 36889999999999999999997 789999999875442 12467899999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+........
T Consensus 76 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 76 IVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 23678999999999999999999999 9999999999999999999999999999876544332
Q ss_pred C-CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCCCCCCC-CcHHHHH
Q 020016 184 A-KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT---PEQAAFAVCQKNARPPVPPT-CPKAFSY 258 (332)
Q Consensus 184 ~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~---~~~~~~~~~~~~~~~~~~~~-~~~~l~~ 258 (332)
. ....++..|+|||.+.+..++.++|+||||+++|+|+||..||.... ..+....+. ....+..+.. ++..+.+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~ 234 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFRD 234 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHHH
Confidence 2 24568899999999998889999999999999999999999998764 333333333 3444555566 8999999
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~ 279 (332)
++.+||..+|++||++.++++
T Consensus 235 li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 235 FISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred HHHHHccCChhhCCCHHHHHh
Confidence 999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=268.02 Aligned_cols=217 Identities=22% Similarity=0.307 Sum_probs=174.0
Q ss_pred eeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCceec-------------
Q 020016 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIIT------------- 120 (332)
Q Consensus 57 y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~------------- 120 (332)
|.+.+.||+|+||.||+|.+. ++.||+|++........ .....+|+.++.++. |+||++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-----QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-----hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcE
Confidence 678899999999999999985 78999999876432221 123457888999885 999886
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
....+++..+..++.|++.||.|||+.|++||||+|+||+++. +.++|+|||++........
T Consensus 76 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 76 ALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 1346899999999999999999999999999999999999999 9999999999876554444
Q ss_pred CCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------------C
Q 020016 184 AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR----------------P 246 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~----------------~ 246 (332)
.....++..|+|||.+.. ..++.++|||||||++|+|++|..||.+.+..+....+...... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 344567899999997654 55688999999999999999999999887765544333221100 0
Q ss_pred CC-----------CCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 PV-----------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 ~~-----------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+ ...++..+.++|.+||..+|++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 11 1346789999999999999999999999885
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=266.03 Aligned_cols=216 Identities=24% Similarity=0.471 Sum_probs=168.1
Q ss_pred eeecccCceEEEEEEEC----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------------
Q 020016 61 CKFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------------- 120 (332)
+.||+|+||.||+|.+. +..+|+|.+........ ...+.+|+.++++++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE-----QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEE
Confidence 36899999999999875 35799998876543221 346889999999999999987
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 182 (332)
.....++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 01134556777899999999999999999999999999999999999999999986433221
Q ss_pred --CCCCcccccccCChhhhhcC-------CCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC-C---CCCC
Q 020016 183 --SAKGFTGTYRWMAPEMIKEK-------RHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN-A---RPPV 248 (332)
Q Consensus 183 --~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~-~---~~~~ 248 (332)
......++..|+|||++.+. .++.++|+||||+++|+|++ |..||......+......... . .+..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL 235 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCcc
Confidence 12234567889999998642 35789999999999999997 999998877665543322221 1 1222
Q ss_pred CCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 020016 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282 (332)
Q Consensus 249 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~ 282 (332)
....+..+.+++.+|| .+|++||++++|+..|+
T Consensus 236 ~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 236 KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 3356788999999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=267.40 Aligned_cols=219 Identities=29% Similarity=0.507 Sum_probs=179.0
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT---------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~---------- 120 (332)
.++|.+.+.||.|++|.||+|.+. ++.+++|++...... .+.+.+|+.+++++ +|+||++
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-------EEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh-------HHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 478999999999999999999996 678999998765432 35688999999999 7999865
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeec
Q 020016 121 ----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 172 (332)
Q Consensus 121 ----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Df 172 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCC
Confidence 1346788899999999999999999999999999999999999999999999
Q ss_pred ccccccccC-CCCCCcccccccCChhhhhc-----CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Q 020016 173 GISCLESQC-GSAKGFTGTYRWMAPEMIKE-----KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 246 (332)
Q Consensus 173 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~ 246 (332)
|++...... .......++..|+|||.+.. ..++.++||||||+++|+|++|..||...........+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence 998654332 22234568899999998854 346789999999999999999999998766655555443322211
Q ss_pred -CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 -PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 -~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..+..++..+.+++.+||..||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 122347789999999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=280.23 Aligned_cols=229 Identities=29% Similarity=0.478 Sum_probs=195.1
Q ss_pred ccccCCeeeeeeecccCceEEEEEEECC-eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYKQ-RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
+++.+.+.++++||+|.||.|.++.-.+ ..||||.++...... .+.+|.+|+++|.+|+|||||.
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~-----~r~~F~kEIkiLsqLkhPNIveLvGVC~~De 608 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKN-----ARNDFLKEIKILSRLKHPNIVELLGVCVQDD 608 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchh-----HHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence 4667899999999999999999999985 999999998865543 2588999999999999999986
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+.-.....|+.||+.||+||.+.+++||||.++|+|++.++++||+|||+++...
T Consensus 609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccc
Confidence 11223456677899999999999999999999999999999999999999999998544
Q ss_pred cCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHhc------CCCCCC
Q 020016 180 QCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT--ALTPFDNMTPEQAAFAVCQK------NARPPV 248 (332)
Q Consensus 180 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--G~~pf~~~~~~~~~~~~~~~------~~~~~~ 248 (332)
.... ....+-+.+|||||.+..++++.++|||+||+++||+++ ...||...++++.......- ...+..
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~ 768 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSR 768 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccC
Confidence 3322 233456789999999999999999999999999999876 78999999988877665432 222356
Q ss_pred CCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 249 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
|.-++..+.++|.+||..+..+||+++++...|...
T Consensus 769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 769 PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 788999999999999999999999999999998764
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=267.99 Aligned_cols=209 Identities=22% Similarity=0.448 Sum_probs=166.0
Q ss_pred eeecccCceEEEEEEEC--------------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 61 CKFASGRHSRIYRGIYK--------------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
+.||.|+||.||+|... ...||+|++...... ....|.+|+.++..++||||++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~------~~~~~~~~~~~l~~l~hp~iv~~~~~~~ 74 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRD------ISLAFFETASMMRQVSHKHIVLLYGVCV 74 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhh------HHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 46899999999999853 235899987664322 2356888999999999999987
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCe-------EEEe
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC-------VKVA 170 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~-------~kl~ 170 (332)
....+++..+..++.||+.||.|||++|++||||||+||+++.++. ++++
T Consensus 75 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 75 RDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred cCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 2346899999999999999999999999999999999999986654 8999
Q ss_pred ecccccccccCCCCCCcccccccCChhhhh-cCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 020016 171 DFGISCLESQCGSAKGFTGTYRWMAPEMIK-EKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 248 (332)
Q Consensus 171 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (332)
|||++..... .....++..|+|||.+. +..++.++||||||+++|+|++ |..||......+... .... ....
T Consensus 155 d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~--~~~~ 228 (262)
T cd05077 155 DPGIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEG--QCML 228 (262)
T ss_pred CCCCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhc--CccC
Confidence 9998754432 23345788999999886 4668999999999999999985 899988765443322 1111 1222
Q ss_pred CCCCcHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 020016 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 281 (332)
Q Consensus 249 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L 281 (332)
....+.++.+||.+||+.||.+||++.+|+..|
T Consensus 229 ~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 334567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=272.44 Aligned_cols=220 Identities=24% Similarity=0.387 Sum_probs=179.9
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
+.|.....||+|+||.||++.+. +..||||.+...... ..+.+.+|+.+++.++|+||++
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQ------RRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW 95 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHH------HHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence 44555678999999999999885 789999998654322 1456889999999999999986
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-CC
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-SA 184 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~ 184 (332)
....+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++....... ..
T Consensus 96 lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 96 VVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred EEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 23467899999999999999999999999999999999999999999999999986543222 22
Q ss_pred CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCcHHHHHHHHHc
Q 020016 185 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-ARPPVPPTCPKAFSYLISRC 263 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~c 263 (332)
....++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.... ........++..+.+++.+|
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence 34568899999999988889999999999999999999999998877665544433211 11122235788999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 020016 264 WSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 264 l~~dp~~Rps~~ell~~ 280 (332)
|..||.+||++.++++.
T Consensus 256 l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 256 LVREPSQRATAQELLQH 272 (292)
T ss_pred ccCChhHCcCHHHHhhC
Confidence 99999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=276.27 Aligned_cols=217 Identities=20% Similarity=0.342 Sum_probs=169.4
Q ss_pred eeeeeccc--CceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------
Q 020016 59 IGCKFASG--RHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------- 120 (332)
Q Consensus 59 i~~~lg~G--~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 120 (332)
+.++||+| +|++||++.++ ++.||||.+........ ..+.+.+|+.+++.++||||++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNE----MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHH----HHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEE
Confidence 56789999 78999999986 78999999976543222 2356778999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC--
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-- 182 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 182 (332)
....+++..+..++.|++.||.|||++|++||||||+||+++.++.++++||+.........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 13458899999999999999999999999999999999999999999999998653321111
Q ss_pred ------CCCCcccccccCChhhhhc--CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------
Q 020016 183 ------SAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR--------- 245 (332)
Q Consensus 183 ------~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~--------- 245 (332)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||..................
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 1122346778999999976 45889999999999999999999999876554433222111100
Q ss_pred -----------------------------------CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 246 -----------------------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 246 -----------------------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+....+++.+.+|+.+||+.||++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0011235678999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=291.93 Aligned_cols=213 Identities=28% Similarity=0.472 Sum_probs=184.0
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------------
Q 020016 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------------ 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 120 (332)
=.||.|.||+||.|++. +..+|||-+....... .+.+..|+.+.++|+|.|||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~------~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqV 654 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSRE------VQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQV 654 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchh------hccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecC
Confidence 37999999999999997 5678999988765543 367889999999999999997
Q ss_pred -----------CCCCC--CHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC-CCeEEEeecccccccccCC-CCC
Q 020016 121 -----------EPYSV--PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMCVKVADFGISCLESQCG-SAK 185 (332)
Q Consensus 121 -----------~~~~l--~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~-~~~ 185 (332)
.-+++ .+...-.+.+||++||.|||...|+|||||.+||||+. .|.+||+|||.+....... -+.
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE 734 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE 734 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence 34556 78888899999999999999999999999999999976 5999999999987765433 456
Q ss_pred CcccccccCChhhhhcC--CCCCccchhHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 020016 186 GFTGTYRWMAPEMIKEK--RHTKKVDVYSFGIVLWELLTALTPFDNMTP-EQAAFAVCQKNARPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 186 ~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltG~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 262 (332)
++.||..|||||++..+ .|+.++|||||||++.||.||++||..... ....+++.--+.-|++|..++.+.+.+|.+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filr 814 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILR 814 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHH
Confidence 78899999999999765 478999999999999999999999987654 444556655666788999999999999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~ 279 (332)
|+.++|.+||++.+++.
T Consensus 815 cFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 815 CFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HcCCCcccCccHHHhcc
Confidence 99999999999999986
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=271.48 Aligned_cols=222 Identities=24% Similarity=0.317 Sum_probs=179.1
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||.|+||.||+|.+. ++.+|||.+........ ....+.+|+.++.+++||||++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 79 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG----FPITSLREINILLKLQHPNIVTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccccc----chhhHHHHHHHHHhcCCCCEEEEEEEEEecCCC
Confidence 468999999999999999999996 78899999976543221 1345778999999999999986
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 80 KIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred cEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 1235889999999999999999999999999999999999999999999999998765443
Q ss_pred -CCCCCcccccccCChhhhhcCC-CCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------------
Q 020016 182 -GSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN---------------- 243 (332)
Q Consensus 182 -~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~---------------- 243 (332)
.......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||......+....+....
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 2223455788999999987654 5899999999999999999999998776554433322110
Q ss_pred -------------CCCCCCCC-CcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 244 -------------ARPPVPPT-CPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 244 -------------~~~~~~~~-~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
....++.. +++.+.++|.+||+.+|++||++.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 01112222 5788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=261.44 Aligned_cols=220 Identities=27% Similarity=0.497 Sum_probs=187.1
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|.+.+.||+|++|.||+|.+. ++.|++|++...... ....+.+.+|+.++++++||||++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS----EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTL 76 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc----hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeE
Confidence 4788899999999999999997 789999999876532 122467899999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 77 NIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 223678899999999999999999999999999999999999999999999999876655432
Q ss_pred ---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 020016 184 ---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQKNARPPVPPTCPKAFSYL 259 (332)
Q Consensus 184 ---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l 259 (332)
.....++..|+|||.+.+...+.++||||||+++|+|++|..||.... .......+.........+..++..+.++
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHH
Confidence 345678899999999998889999999999999999999999998766 3333333333345566777889999999
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 020016 260 ISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~ 279 (332)
+.+||..+|++||++.+++.
T Consensus 237 i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 237 LRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHhCcCChhhCCCHHHHhh
Confidence 99999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=265.81 Aligned_cols=216 Identities=25% Similarity=0.504 Sum_probs=168.7
Q ss_pred eeecccCceEEEEEEEC----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------------
Q 020016 61 CKFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------------- 120 (332)
+.||+|+||.||+|... ...+|+|.+....... ....|.+|+.+++.++||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPD-----EQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChH-----HHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEE
Confidence 36899999999999753 3578888876543222 1356889999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 182 (332)
.....++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 01223567788999999999999999999999999999999999999999999985432211
Q ss_pred --CCCCcccccccCChhhhhc-------CCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCC----CCCC
Q 020016 183 --SAKGFTGTYRWMAPEMIKE-------KRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA----RPPV 248 (332)
Q Consensus 183 --~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~----~~~~ 248 (332)
......++..|+|||++.. ..++.++||||||+++|+|++ |..||....+.+.......... .+..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQL 235 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcc
Confidence 1223345678999999753 346889999999999999999 8899988877665554433222 2233
Q ss_pred CCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 020016 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282 (332)
Q Consensus 249 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~ 282 (332)
+..++..+.+++..|| .||++||++++|++.|.
T Consensus 236 ~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 236 DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 4567889999999999 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=271.42 Aligned_cols=224 Identities=29% Similarity=0.422 Sum_probs=186.5
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
..|...+.||+|+||.||++.+. +..||+|.+....... ......+.+|+.+++.++|||+++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS---NEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW 101 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCc---hHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence 45888999999999999999985 7899999987543221 112356889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 184 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 184 (332)
....+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..... .
T Consensus 102 lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~ 178 (317)
T cd06635 102 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---A 178 (317)
T ss_pred EEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---c
Confidence 245578899999999999999999999999999999999999999999999998764432 2
Q ss_pred CCcccccccCChhhhh---cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 020016 185 KGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 261 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 261 (332)
....+++.|+|||.+. .+.++.++||||||+++|+|++|..||...........+............+++.+.+++.
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 258 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 258 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHH
Confidence 3456888999999974 4567899999999999999999999998877766666665444444445567889999999
Q ss_pred HccccCCCCCCCHHHHHHHHHhh
Q 020016 262 RCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 262 ~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
+||+.+|.+||++.++++.+-.+
T Consensus 259 ~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 259 SCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred HHccCCcccCcCHHHHHhChhhh
Confidence 99999999999999999865544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=276.17 Aligned_cols=231 Identities=25% Similarity=0.379 Sum_probs=183.5
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
.|++ ..+|.+.+.||.|+||.||+|.+. ++.||||++........ ....+.+|+.+++.++||||++
T Consensus 10 ~~~~-~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 10 VWEL-PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI----FAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred hhcc-ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccccc----chhHHHHHHHHHHhcCCCCccchhheec
Confidence 4555 368999999999999999999985 78999999876432221 1356789999999999999986
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred ccccCCCCceEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 1125788899999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------
Q 020016 176 CLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA---------- 244 (332)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~---------- 244 (332)
..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+.......+.....
T Consensus 165 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 165 RHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred cCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 65432 2234567889999999876 4578999999999999999999999988765444333222100
Q ss_pred -----------CCC--------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH--HHHhhhh
Q 020016 245 -----------RPP--------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYSE 286 (332)
Q Consensus 245 -----------~~~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~--~L~~~~~ 286 (332)
.+. ..+..++.+.++|.+||+.||.+||++.+++. .++.+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000 01346778999999999999999999999995 4666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=266.84 Aligned_cols=220 Identities=29% Similarity=0.498 Sum_probs=185.1
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
+-|.+.+.||.|+||.||+|.+. +..||||++....... ....+.+|+.++..++||||++
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 78 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-----EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 78 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchH-----HHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEE
Confidence 34778899999999999999885 6899999987543322 1367889999999999999986
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-CC
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-SA 184 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~ 184 (332)
....+++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 79 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 79 IIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred EEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence 34568899999999999999999999999999999999999999999999999886543322 12
Q ss_pred CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHcc
Q 020016 185 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 264 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 264 (332)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+. ....+.++..++.++.+++.+||
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l 237 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACL 237 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHc
Confidence 23467889999999988888999999999999999999999998877655555442 34455566778999999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 020016 265 SSSPDRRPHFDQIVSI 280 (332)
Q Consensus 265 ~~dp~~Rps~~ell~~ 280 (332)
+.+|.+||++.+++..
T Consensus 238 ~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 238 NKEPSFRPTAKELLKH 253 (277)
T ss_pred cCChhhCcCHHHHHhC
Confidence 9999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=274.68 Aligned_cols=221 Identities=24% Similarity=0.354 Sum_probs=177.9
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||.|+||.||+|.+. ++.||+|++........ ..+.+.+|+.+++.++||||++
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPT----LAKRTLRELKILRHFKHDNIIAIRDILRPPGADF 80 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccccc----chHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence 68999999999999999999986 78999999876432211 1356778999999999999986
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 81 KDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred ceEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 2456899999999999999999999999999999999999999999999999998654322
Q ss_pred CC-----CCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------
Q 020016 182 GS-----AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK------------- 242 (332)
Q Consensus 182 ~~-----~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~------------- 242 (332)
.. .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 11 123468889999999865 45789999999999999999999999876544322221111
Q ss_pred -----------CCCCCC-----CCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 243 -----------NARPPV-----PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 243 -----------~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...... .+..+.++.++|.+||+.+|++||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 001111 1446889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=260.81 Aligned_cols=218 Identities=30% Similarity=0.484 Sum_probs=185.5
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|.+.+.||.|+||.||++.+. ++.+|+|.+........ ....+.+|+.+++.++|+||++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK----EREDAVNEIRILASVNHPNIISYKEAFLDGNKLCI 76 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHH----HHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEE
Confidence 4889999999999999999886 67899999876433221 2356788999999999999986
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 1256788899999999999999999999999999999999999999999999998766544
Q ss_pred CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 261 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 261 (332)
......+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+. ....+..+..++.++.+++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCchhhCHHHHHHHH
Confidence 3334568899999999998889999999999999999999999999888766555543 33444556678899999999
Q ss_pred HccccCCCCCCCHHHHHH
Q 020016 262 RCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 262 ~cl~~dp~~Rps~~ell~ 279 (332)
+||..+|++||++.++++
T Consensus 235 ~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 235 SMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHcCCCcccCCCHHHHhc
Confidence 999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=268.35 Aligned_cols=221 Identities=24% Similarity=0.323 Sum_probs=172.4
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
..+|.+.+.||+|+||.||+|.+. +..||||++........ ...+.+|+.+++.++|+||++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 78 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-----PFTAIREASLLKGLKHANIVLLHDIIHTKETL 78 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC-----cHHHHHHHHHHHhcCCCCEeEEEEEEecCCeE
Confidence 368999999999999999999885 78999999876433221 235678999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 182 (332)
....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred EEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 23457788899999999999999999999999999999999999999999999886543221
Q ss_pred CCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcCC----------------
Q 020016 183 SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA-AFAVCQKNA---------------- 244 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~-~~~~~~~~~---------------- 244 (332)
......+++.|+|||.+.+. .++.++||||||+++|+|++|..||........ .........
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 22334578999999998754 478899999999999999999999986554211 111110000
Q ss_pred -----CCCCC---------CCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 245 -----RPPVP---------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 245 -----~~~~~---------~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
....+ -..+..+.+++.+|+..||.+|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000 012567899999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=274.56 Aligned_cols=229 Identities=22% Similarity=0.323 Sum_probs=181.5
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
.+|.+.+.||.|+||+||+|.+. ++.||||.+........ ....+.+|+.+++.++|+||++
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI----DAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccc----hhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 57999999999999999999986 78999999876432211 1245678999999999999975
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 81 FNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred cCcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 235688999999999999999999999999999999999999999999999999876543
Q ss_pred C-CCCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------------
Q 020016 181 C-GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK---------------- 242 (332)
Q Consensus 181 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~---------------- 242 (332)
. .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+.......+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence 2 22334567889999998865 46889999999999999999999999875533222111100
Q ss_pred --------C--CCC---CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhhhh
Q 020016 243 --------N--ARP---PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI--LEGYSES 287 (332)
Q Consensus 243 --------~--~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~--L~~~~~~ 287 (332)
. ... ...+.+++.+.+++.+||+.+|.+||++.++++. +..+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 0 000 1124678899999999999999999999999976 6655333
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=270.85 Aligned_cols=220 Identities=25% Similarity=0.389 Sum_probs=181.0
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
..|.....||.|+||.||++.+. ++.||||++....... .+.+.+|+.++..++||||++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 94 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR------RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELW 94 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch------HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEE
Confidence 34555668999999999999885 7899999987643322 356889999999999999986
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-CC
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-SA 184 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~ 184 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 95 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 174 (297)
T cd06659 95 VLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 174 (297)
T ss_pred EEEecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence 23467899999999999999999999999999999999999999999999999886443222 22
Q ss_pred CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHc
Q 020016 185 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYLISRC 263 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~c 263 (332)
....++..|+|||++.+..++.++||||||+++|+|++|..||......+....+..... ....+..++..+.+++.+|
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence 345689999999999988899999999999999999999999987776655544432211 1223346788999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 020016 264 WSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 264 l~~dp~~Rps~~ell~~ 280 (332)
|+.+|.+||++.++++.
T Consensus 255 l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 255 LTREPQERATAQELLDH 271 (297)
T ss_pred hcCCcccCcCHHHHhhC
Confidence 99999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=301.21 Aligned_cols=217 Identities=29% Similarity=0.446 Sum_probs=168.6
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
.+|...+.||+||||.||+++++ |+.||||++....... ....+.+|+.+|.+|+|||||+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~-----~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDK-----LYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHH-----HHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 56777889999999999999997 9999999999875322 2356789999999999999996
Q ss_pred --------------------------------------------------------------------------------
Q 020016 121 -------------------------------------------------------------------------------- 120 (332)
Q Consensus 121 -------------------------------------------------------------------------------- 120 (332)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred ------------------------------------------------------CCCCC--CHHHHHHHHHHHHHHHHHH
Q 020016 121 ------------------------------------------------------EPYSV--PLNLVLKLALDIARGMQYL 144 (332)
Q Consensus 121 ------------------------------------------------------~~~~l--~~~~~~~i~~qi~~~L~~L 144 (332)
....+ .....+.++++|+.||+|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 11122 3677899999999999999
Q ss_pred HHCCCccccccccceeecCCCeEEEeecccccccc-------------------cCCCCCCcccccccCChhhhhcCC--
Q 020016 145 HSQGILHRDLKSENLLLGEDMCVKVADFGISCLES-------------------QCGSAKGFTGTYRWMAPEMIKEKR-- 203 (332)
Q Consensus 145 H~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~-- 203 (332)
|+.|+|||||||.|||+++++.|||+|||++.... .....+..+||.-|+|||++.+..
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999999999999999999987511 111234578999999999997655
Q ss_pred -CCCccchhHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCC--CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 204 -HTKKVDVYSFGIVLWELLTALTPFDNM-TPEQAAFAVCQKNARPP--VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 204 -~~~~sDvwSlG~il~elltG~~pf~~~-~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
|+.|+|+||||+|++||+ .||... ....+...+.......+ +...--+.-..+|++|++.||++|||+.|++.
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 899999999999999998 667642 22333333321111111 01111233478999999999999999999985
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=258.71 Aligned_cols=217 Identities=29% Similarity=0.562 Sum_probs=183.0
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|.+.+.||+|++|.||++.+. +..+++|++...... ....+.+|+.+++.++|+||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 74 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKE------KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWI 74 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchh------HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 4788899999999999999996 788999999875441 1467889999999999999976
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 184 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 184 (332)
....+++..+..++.|++.||.+||..|++||||+|+||+++.++.++|+|||.+.........
T Consensus 75 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 154 (253)
T cd05122 75 VMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR 154 (253)
T ss_pred EEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccc
Confidence 1247899999999999999999999999999999999999999999999999998765543323
Q ss_pred CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC--CCcHHHHHHHHH
Q 020016 185 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP--TCPKAFSYLISR 262 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~ 262 (332)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......... ...+..+. .++..+.+++.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHH
Confidence 456788999999999988899999999999999999999999988765555444433 22223332 348899999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~ 279 (332)
||+.||.+||++.++++
T Consensus 234 ~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 234 CLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HccCChhhCCCHHHHhc
Confidence 99999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=267.77 Aligned_cols=221 Identities=23% Similarity=0.317 Sum_probs=172.5
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||.|++|.||+|.++ ++.||||.+........ ...+.+|++++++++|+||++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-----PFTAIREASLLKDLKHANIVTLHDIIHTKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC-----chhHHHHHHHHhhCCCcceeeEEEEEecCCeE
Confidence 368999999999999999999986 78999999876432211 234678999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 182 (332)
....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 79 TLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 23467899999999999999999999999999999999999999999999999986533211
Q ss_pred CCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCC---------------
Q 020016 183 SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQKNAR--------------- 245 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~-~~~~~~~~~~~~~~--------------- 245 (332)
......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||.... ..+....+......
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 1222346889999999875 457899999999999999999999997655 22222111110000
Q ss_pred ----------C---CCCCCCc--HHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 246 ----------P---PVPPTCP--KAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 246 ----------~---~~~~~~~--~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
. .....++ ..+.+++.+||+.+|++||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0001233 77889999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=261.47 Aligned_cols=219 Identities=29% Similarity=0.477 Sum_probs=181.6
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|.+.+.||.|+||.||++.++ +..||+|.+........ ..+.+.+|+.+++.++|+||++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~l 76 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK----EKEASKKEVILLAKMKHPNIVTFFASFQENGRLFI 76 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccch----hhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEE
Confidence 5889999999999999999996 68899999876422111 1356789999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC-eEEEeecccccccccCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVADFGISCLESQCG 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~ 182 (332)
....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 122478999999999999999999999999999999999998885 57999999886654322
Q ss_pred C-CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 020016 183 S-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 261 (332)
Q Consensus 183 ~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 261 (332)
. .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....... ......++.++..+.+++.
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~ 235 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-GYFAPISPNFSRDLRSLIS 235 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-ccCCCCCCCCCHHHHHHHH
Confidence 1 2234688899999999888899999999999999999999999988776665554432 3334455678899999999
Q ss_pred HccccCCCCCCCHHHHHH
Q 020016 262 RCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 262 ~cl~~dp~~Rps~~ell~ 279 (332)
+||..+|++||++.++++
T Consensus 236 ~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 236 QLFKVSPRDRPSITSILK 253 (257)
T ss_pred HHhccChhhCcCHHHHhh
Confidence 999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=264.80 Aligned_cols=218 Identities=27% Similarity=0.396 Sum_probs=176.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|...+.||.|++|.||++.+. ++.||+|.+....... ....+.+|+++++.++||||++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 75 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPD-----LQKQILRELEINKSCKSPYIVKYYGAFLDESSSS 75 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchH-----HHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCe
Confidence 46889999999999999999995 7899999998653321 2467899999999999999986
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 76 IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 1234677788899999999999999999999999999999999999999999998654
Q ss_pred ccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcCCCCCCC----
Q 020016 179 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT-----PEQAAFAVCQKNARPPVP---- 249 (332)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~-----~~~~~~~~~~~~~~~~~~---- 249 (332)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|..||.... ..+....+. ....+..+
T Consensus 156 ~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 233 (287)
T cd06621 156 VNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMPNPELKDEPG 233 (287)
T ss_pred cccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-cCCchhhccCCC
Confidence 3322 224457889999999998899999999999999999999999998652 222222222 11122211
Q ss_pred --CCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 250 --PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 250 --~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..+++.+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 234678999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=269.51 Aligned_cols=222 Identities=23% Similarity=0.334 Sum_probs=175.9
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||.|+||.||+|.+. ++.||||++......... ...+.+|+++++.++||||++
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF----PITALREIKILKKLKHPNVVPLIDMAVERPDK 82 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc----chhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence 479999999999999999999986 788999998754322211 235678999999999999986
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
....+++..+..++.|+++||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 83 ~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 83 SKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred ccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 1246889999999999999999999999999999999999999999999999998
Q ss_pred cccccCCC------------CCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 020016 176 CLESQCGS------------AKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 242 (332)
Q Consensus 176 ~~~~~~~~------------~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~ 242 (332)
........ .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+.......+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 65432211 1123567889999988654 4789999999999999999999999887765544333221
Q ss_pred CCCC---------------------CCC-------CCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 243 NARP---------------------PVP-------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 243 ~~~~---------------------~~~-------~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...+ ..+ ..+++.+.+++.+||..||.+|||+.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1100 000 234467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=260.28 Aligned_cols=219 Identities=30% Similarity=0.477 Sum_probs=187.6
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|.+.+.||.|+||.||++.+. +..||+|++........ ..+.+.+|+++++.++|||+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~l 76 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK----EREDALNEVKILKKLNHPNIIKYYESFEEKGKLCI 76 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChH----HHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEE
Confidence 5889999999999999999997 78999999987544321 2466889999999999999876
Q ss_pred ----------------C---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 ----------------E---PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 ----------------~---~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
. ...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 1 366889999999999999999999999999999999999999999999999998765443
Q ss_pred C-CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 020016 182 G-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 260 (332)
Q Consensus 182 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 260 (332)
. ......+++.|+|||...+..++.++|+||+|+++|+|++|..||...+..+...... ......++..++..+.+++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i 235 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-KGQYPPIPSQYSSELRNLV 235 (258)
T ss_pred cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh-cCCCCCCCCCCCHHHHHHH
Confidence 2 2334568889999999998889999999999999999999999998887766655554 3345566678899999999
Q ss_pred HHccccCCCCCCCHHHHHH
Q 020016 261 SRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 261 ~~cl~~dp~~Rps~~ell~ 279 (332)
.+||..+|++||++.++++
T Consensus 236 ~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 236 SSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHcCCChhhCcCHHHHhc
Confidence 9999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=266.86 Aligned_cols=221 Identities=24% Similarity=0.353 Sum_probs=176.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||.|++|.||+|.++ ++.||||.+........ ..+.+.+|+.++++++||||++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEG----VPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLY 77 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccccc----chHHHHHHHHHHHhccCCCEeeEEEEEecCCeEE
Confidence 57999999999999999999986 68899999876433211 2356888999999999999987
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC-CCeEEEeecccccccccC-
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMCVKVADFGISCLESQC- 181 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~- 181 (332)
....+++..+..++.||+.||.|||++|++|+||+|+||+++. ++.+||+|||++......
T Consensus 78 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 78 LVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred EEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 1223577888899999999999999999999999999999985 467999999998654322
Q ss_pred CCCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------------
Q 020016 182 GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP-------------- 246 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~-------------- 246 (332)
.......+++.|+|||.+.+. .++.++||||||+++|+|+||..||...+..+....+......+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 122334678899999998764 56899999999999999999999998876655544432211100
Q ss_pred -----C--------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 -----P--------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 -----~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
. ..+.+++.+.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 12356788999999999999999999999986
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=265.91 Aligned_cols=218 Identities=27% Similarity=0.469 Sum_probs=178.3
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC---CCceec----------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN---HPHIIT---------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~---------- 120 (332)
.|.+.+.||.|+||.||+|.+. ++.||||.+........ ...+.+|+.+++.+. |||+++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-----VSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchh-----HHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE
Confidence 5778899999999999999985 78999999876533221 356788999999996 999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 182 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EEEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 23468899999999999999999999999999999999999999999999999987654332
Q ss_pred CCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC-CCcHHHHHHH
Q 020016 183 SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP-TCPKAFSYLI 260 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li 260 (332)
......++..|+|||.+.++ .++.++|+||||+++|+|++|..||...........+. ....+.++. .++.++.+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i 235 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP-KSKPPRLEDNGYSKLLREFV 235 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc-cCCCCCCCcccCCHHHHHHH
Confidence 22344688899999998754 46899999999999999999999998876654433322 222233333 3788999999
Q ss_pred HHccccCCCCCCCHHHHHH
Q 020016 261 SRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 261 ~~cl~~dp~~Rps~~ell~ 279 (332)
.+||..||++||++.+++.
T Consensus 236 ~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 236 AACLDEEPKERLSAEELLK 254 (277)
T ss_pred HHHcCCCcccCcCHHHHhh
Confidence 9999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=268.47 Aligned_cols=225 Identities=22% Similarity=0.317 Sum_probs=175.6
Q ss_pred ccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
.-+.++|.+.+.||+|+||.||+|.+. ++.||||.+......... ...+.+|+.++++++||||++
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF----PITALREIKILQLLKHENVVNLIEICRTK 83 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCc----hhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence 344678999999999999999999986 789999998754322211 234678999999999999875
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeec
Q 020016 121 ----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 172 (332)
Q Consensus 121 ----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Df 172 (332)
....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 84 ATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred cccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcC
Confidence 1225789999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCC-----CCCcccccccCChhhhhcCC-CCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--
Q 020016 173 GISCLESQCGS-----AKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-- 244 (332)
Q Consensus 173 g~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~-- 244 (332)
|++........ .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+.....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99865433221 12345788999999886644 68899999999999999999999987765443322211000
Q ss_pred CC---------------CC-------------CCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 245 RP---------------PV-------------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 245 ~~---------------~~-------------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+ .+ +...+..+.++|.+||..||.+||+++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 00 1112567789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=283.37 Aligned_cols=220 Identities=28% Similarity=0.425 Sum_probs=195.3
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
...|.+.+.||.|.|++|.+|.+. +..||||+++++...... .+.+.+|+++|+.++|||||+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~----~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK----RQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH----HHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 578999999999999999999986 899999999987665432 355899999999999999987
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
..+.+.+..+..++.|+++|++|||+++|+|||||++|||++.+.++||+|||++..+.....
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~ 210 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM 210 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccc
Confidence 566778899999999999999999999999999999999999999999999999999888778
Q ss_pred CCCcccccccCChhhhhcCCC-CCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 020016 184 AKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 262 (332)
....+|++.|.|||++.+..| ++.+|+||+|+++|-|+.|..||++.+-......+.....+ +|-.++.++.++|++
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r--Ip~~ms~dce~lLrk 288 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR--IPFYMSCDCEDLLRK 288 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec--ccceeechhHHHHHH
Confidence 889999999999999999887 78999999999999999999999987765555555444433 444577889999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~ 279 (332)
+|..+|.+|++++++.+
T Consensus 289 ~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 289 FLVLNPSKRGPCDQIMK 305 (596)
T ss_pred hhccCccccCCHHHhhh
Confidence 99999999999999987
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=270.74 Aligned_cols=220 Identities=26% Similarity=0.367 Sum_probs=178.7
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|++|.||+|.+. ++.||||++........ ..+.+.+|+.+++.++||||++
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI----HAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhh----HHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 368999999999999999999996 68899999876432221 1355778999999999999975
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++....
T Consensus 90 ~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 90 EDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cccccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 12357899999999999999999999999999999999999999999999999987554
Q ss_pred cCCCCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------------
Q 020016 180 QCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------------ 246 (332)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~------------ 246 (332)
.. .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...........+......+
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 170 DE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred cc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 32 3345678899999998653 67899999999999999999999998776655444332211110
Q ss_pred -----------------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 -----------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 -----------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.....+++.+.+++.+||..+|.+|||+.+|+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 011245889999999999999999999999885
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=265.92 Aligned_cols=219 Identities=24% Similarity=0.338 Sum_probs=175.9
Q ss_pred eeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------
Q 020016 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------- 120 (332)
Q Consensus 57 y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 120 (332)
|++.+.||.|++|.||+|.++ +..||||++........ ....+.+|+++++.++|||+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv 76 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG----VPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLV 76 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccccc----chhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEE
Confidence 677899999999999999985 88999999876532221 1245788999999999999986
Q ss_pred -------------CC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-CC
Q 020016 121 -------------EP--YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-SA 184 (332)
Q Consensus 121 -------------~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~ 184 (332)
.. ..+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++....... ..
T Consensus 77 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 77 FEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred EeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 12 268999999999999999999999999999999999999999999999999986543221 22
Q ss_pred CCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------------------
Q 020016 185 KGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR------------------ 245 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~------------------ 245 (332)
....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+......
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 234568899999987654 4688999999999999999999999887665544333221100
Q ss_pred ---------CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 246 ---------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 246 ---------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
......++..+.+++.+||+.+|.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0123456788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=271.17 Aligned_cols=227 Identities=26% Similarity=0.366 Sum_probs=184.6
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|.+.+.||.|++|.||+|.+. ++.||||++....... ...+.+.+|+.+++.++|+||++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL----IDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDF 76 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccc----hhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccc
Confidence 5889999999999999999986 6899999987653211 12367889999999999999875
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 77 ~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 77 NDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred cceEEEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 2346788999999999999999999999999999999999999999999999998765543
Q ss_pred C----CCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---------
Q 020016 182 G----SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--------- 247 (332)
Q Consensus 182 ~----~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~--------- 247 (332)
. ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+......+.
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 2 23345678899999999887 789999999999999999999999988776554443332111100
Q ss_pred --------------------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH--HHHhhhh
Q 020016 248 --------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYSE 286 (332)
Q Consensus 248 --------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~--~L~~~~~ 286 (332)
..+.++..+.+++.+||+.+|.+||++.+++. .++.+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 12346788999999999999999999999997 3555444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=258.52 Aligned_cols=219 Identities=30% Similarity=0.550 Sum_probs=186.4
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|.+.+.||+|++|.||++.+. ++.||+|.+....... ...+.+.+|++++.+++|||+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE----EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYI 76 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH----HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Confidence 5888999999999999999886 6889999998764321 12467899999999999999876
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC-C
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-A 184 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~ 184 (332)
....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........ .
T Consensus 77 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (254)
T cd06627 77 ILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD 156 (254)
T ss_pred EEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccc
Confidence 235689999999999999999999999999999999999999999999999999876544322 2
Q ss_pred CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHcc
Q 020016 185 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 264 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 264 (332)
....++..|+|||...+..++.++||||+|+++|+|++|..||............. ....+.++..++..+.+++.+||
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l 235 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCF 235 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHH
Confidence 34568899999999988888999999999999999999999998877655554443 34455677788999999999999
Q ss_pred ccCCCCCCCHHHHHH
Q 020016 265 SSSPDRRPHFDQIVS 279 (332)
Q Consensus 265 ~~dp~~Rps~~ell~ 279 (332)
..+|++||++.+++.
T Consensus 236 ~~~p~~R~~~~~~l~ 250 (254)
T cd06627 236 QKDPNLRPTAKQLLK 250 (254)
T ss_pred hCChhhCcCHHHHhc
Confidence 999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=267.64 Aligned_cols=210 Identities=23% Similarity=0.465 Sum_probs=168.7
Q ss_pred eeecccCceEEEEEEEC--C-------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 61 CKFASGRHSRIYRGIYK--Q-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
+.||.|+||.||+|.+. + ..||+|.+..... ...+.+.+|+.+++.++||||++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR------NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhH------HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCc
Confidence 46899999999999874 2 3488888764322 12467889999999999999986
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCe--------EEEeeccc
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC--------VKVADFGI 174 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~--------~kl~Dfg~ 174 (332)
....+++..+..++.||+.||.|||++|++||||||+||+++.++. ++++|||+
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred EEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 2335789999999999999999999999999999999999987654 69999998
Q ss_pred ccccccCCCCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 020016 175 SCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNARPPVPPTC 252 (332)
Q Consensus 175 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (332)
+..... .....++..|+|||.+.+. .++.++||||||+++|+|++| ..||...+....... . .....++...
T Consensus 155 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~--~~~~~~~~~~ 228 (258)
T cd05078 155 SITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-Y--EDRHQLPAPK 228 (258)
T ss_pred ccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-H--HccccCCCCC
Confidence 754432 2335678899999999864 578999999999999999998 567766555443222 2 2244566677
Q ss_pred cHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 020016 253 PKAFSYLISRCWSSSPDRRPHFDQIVSILE 282 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~Rps~~ell~~L~ 282 (332)
+.++.+++.+||+.+|++||+++++++.|+
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 789999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=266.50 Aligned_cols=221 Identities=21% Similarity=0.272 Sum_probs=175.6
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCceec-----------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIIT----------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~----------- 120 (332)
++|.+.+.||+|+||.||+|.+. ++.||||.+........ ....+.+|+.+++.+. ||||++
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 76 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG----IPPTALREISLLQMLSESIYIVRLLDVEHVEEKN 76 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccC----CchHHHHHHHHHHHccCCCCccceeeeEeecCCC
Confidence 47899999999999999999986 78999999876433221 1256788999999995 599875
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC-CCeEEEeecc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMCVKVADFG 173 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~-~~~~kl~Dfg 173 (332)
....+++..++.++.||+.||.|||++|++||||+|+||+++. ++.++|+|||
T Consensus 77 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 77 GKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred CCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 0234788999999999999999999999999999999999998 8999999999
Q ss_pred cccccccC-CCCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----
Q 020016 174 ISCLESQC-GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP----- 246 (332)
Q Consensus 174 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~----- 246 (332)
++...... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+......+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98654321 22223456888999998865 456899999999999999999999998877655444332211100
Q ss_pred ---------------------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 ---------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 ---------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...+.++..+.++|.+||..||.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 011357888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=268.63 Aligned_cols=221 Identities=24% Similarity=0.440 Sum_probs=180.7
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||.||++.+. ++.||+|.+....... .+.+.+|+.+++.++||||++
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 91 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK------KELIINEILVMRENKHPNIVNYLDSYLVGDEL 91 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH------HHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence 368999999999999999999875 6889999986543222 356889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-C
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-S 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~ 183 (332)
....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 92 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred EEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 22357888999999999999999999999999999999999999999999999876543322 2
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHH
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~ 262 (332)
.....+++.|++||.+.+..++.++|+||||+++|++++|..||...+.......+..... ....+..++..+.+++.+
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence 2334688899999999888899999999999999999999999987665444333221111 112334567889999999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~~ 280 (332)
||..+|++||++.+++..
T Consensus 252 ~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 252 CLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HccCChhhCcCHHHHhcC
Confidence 999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=265.24 Aligned_cols=217 Identities=26% Similarity=0.419 Sum_probs=178.4
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
.|.-.+.||.|++|.||++.+. ++.|++|++....... .+.+.+|+.+++.++||||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~ 93 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR------RELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWV 93 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhH------HHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEE
Confidence 4555679999999999999885 6889999986543222 356889999999999999886
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-CCC
Q 020016 121 --------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-SAK 185 (332)
Q Consensus 121 --------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~ 185 (332)
....+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+....... ...
T Consensus 94 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 94 VMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred EEeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 22467889999999999999999999999999999999999999999999999876543321 223
Q ss_pred CcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHHHHHHc
Q 020016 186 GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLISRC 263 (332)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~c 263 (332)
...++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+... ..+. .+..++..+.+++.+|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCCcccccCCHHHHHHHHHH
Confidence 356889999999999888999999999999999999999999887765555444332 2222 2334788999999999
Q ss_pred cccCCCCCCCHHHHHH
Q 020016 264 WSSSPDRRPHFDQIVS 279 (332)
Q Consensus 264 l~~dp~~Rps~~ell~ 279 (332)
|+.+|++||++.++++
T Consensus 253 l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 253 LVRDPAQRATAAELLN 268 (285)
T ss_pred cccChhhCcCHHHHcc
Confidence 9999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=272.24 Aligned_cols=221 Identities=25% Similarity=0.325 Sum_probs=177.3
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.++.+++||||++
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII----HAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhH----HHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 478999999999999999999875 78999999976432211 1356788999999999999986
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++....
T Consensus 92 ~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 92 EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred cccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 11357889999999999999999999999999999999999999999999999986543
Q ss_pred cCCCCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------------
Q 020016 180 QCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR------------- 245 (332)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~------------- 245 (332)
. ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+......
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (345)
T cd07877 172 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249 (345)
T ss_pred c--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHh
Confidence 2 2234567889999999866 46788999999999999999999999876654433222111100
Q ss_pred -----------CC-----CCCCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 246 -----------PP-----VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 246 -----------~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
+. .....++.+.++|.+||+.||.+||++.+++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 012357789999999999999999999998864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=262.89 Aligned_cols=209 Identities=24% Similarity=0.475 Sum_probs=167.8
Q ss_pred eeecccCceEEEEEEECCe------------eEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 61 CKFASGRHSRIYRGIYKQR------------DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~------------~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
+.||+|+||.||+|.+.+. .|++|++...... ...|.+|+.+++.++||||++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-------SLAFFETASLMSQLSHKHLVKLYGVCVRD 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-------HHHHHHHHHHHHcCCCcchhheeeEEecC
Confidence 4689999999999999732 3788887654321 367889999999999999986
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC-------eEEEeecc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-------CVKVADFG 173 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~-------~~kl~Dfg 173 (332)
....+++..+..++.||+.||.|||++|++|+||||+||+++.++ .++|+|||
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 122688899999999999999999999999999999999999887 79999999
Q ss_pred cccccccCCCCCCcccccccCChhhhhcC--CCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 020016 174 ISCLESQCGSAKGFTGTYRWMAPEMIKEK--RHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 250 (332)
Q Consensus 174 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (332)
++..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||...+......... ... ..+.
T Consensus 154 ~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~--~~~~ 227 (259)
T cd05037 154 IPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQH--RLPM 227 (259)
T ss_pred ccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCC--CCCC
Confidence 9865433 2234567789999999876 78999999999999999999 688887765433322221 121 2222
Q ss_pred CCcHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 020016 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282 (332)
Q Consensus 251 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~ 282 (332)
.....+.+++.+||..+|++||++.++++.|+
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 228 PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 23478999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=264.26 Aligned_cols=219 Identities=28% Similarity=0.395 Sum_probs=178.8
Q ss_pred eeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------
Q 020016 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------- 120 (332)
Q Consensus 57 y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 120 (332)
|.+.+.||.|++|.||+|.+. ++.+|+|.+........ ....+.+|+.+++.++|+||++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 76 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEG----IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLV 76 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccch----hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEE
Confidence 567889999999999999985 78899999877544321 2356888999999999999986
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-CCC
Q 020016 121 --------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-SAK 185 (332)
Q Consensus 121 --------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~ 185 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 77 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 77 FEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred EeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence 23578999999999999999999999999999999999999999999999999986654433 223
Q ss_pred CcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------------------
Q 020016 186 GFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------------------ 246 (332)
Q Consensus 186 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~------------------ 246 (332)
...++..|+|||.+.+. .++.++|+||||+++|+|+||+.||...+..+....+......+
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 34578899999998876 68999999999999999999999998877655443332211110
Q ss_pred ----------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 ----------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 ----------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...+.++..+.++|.+||+.||.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 112346788999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=267.84 Aligned_cols=221 Identities=28% Similarity=0.416 Sum_probs=181.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
..|...+.||.|+||.||+|.+. +..||||.+........ ...+.+.+|+.+++.++|+|+++
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccCh---HHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 45778899999999999999985 67899999875322111 12356888999999999999876
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 184 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 184 (332)
....+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++..... .
T Consensus 92 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---~ 168 (308)
T cd06634 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---A 168 (308)
T ss_pred EEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC---c
Confidence 244578899999999999999999999999999999999999999999999998865433 2
Q ss_pred CCcccccccCChhhhh---cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 020016 185 KGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 261 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 261 (332)
....+++.|+|||.+. ...++.++||||||+++|+|++|..||...+.......+.........+..++..+.++|.
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 248 (308)
T cd06634 169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248 (308)
T ss_pred ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHH
Confidence 3456788999999985 3457889999999999999999999998877665555544333333334568889999999
Q ss_pred HccccCCCCCCCHHHHHHHH
Q 020016 262 RCWSSSPDRRPHFDQIVSIL 281 (332)
Q Consensus 262 ~cl~~dp~~Rps~~ell~~L 281 (332)
+||..+|.+||++.+++...
T Consensus 249 ~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 249 SCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred HHhhCCcccCCCHHHHhhCc
Confidence 99999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=270.82 Aligned_cols=219 Identities=20% Similarity=0.340 Sum_probs=175.7
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
.+|.+.+.||.|+||.||+|.+. +..||+|.+....... .+.+.+|+++++.++||||++
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~------~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS------VKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCch------HHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 78999999999999999999986 7899999987654422 356888999999999999885
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC-CCeEEEee
Q 020016 121 ----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMCVKVAD 171 (332)
Q Consensus 121 ----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~-~~~~kl~D 171 (332)
....+++..+..++.||+.||.|||+.|++||||||+||+++. ++.++|+|
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 1235788999999999999999999999999999999999974 56789999
Q ss_pred cccccccccCCC----CCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---
Q 020016 172 FGISCLESQCGS----AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN--- 243 (332)
Q Consensus 172 fg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~--- 243 (332)
||++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||................
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999865432211 123357889999998754 457889999999999999999999998776544433322110
Q ss_pred --------------------CCC-----CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 244 --------------------ARP-----PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 244 --------------------~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
... ...+.++.++.+++.+||..||.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 012357788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=266.57 Aligned_cols=219 Identities=29% Similarity=0.435 Sum_probs=180.1
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
-|...++||+|+||.||+|.+. ++.||+|++........ ...+.+.+|+.+++.++|||+++
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 98 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTN---EKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL 98 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCch---HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3666788999999999999985 78999999876433221 12356888999999999999986
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCCC
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK 185 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 185 (332)
....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.... ...
T Consensus 99 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~~ 175 (313)
T cd06633 99 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PAN 175 (313)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CCC
Confidence 24568899999999999999999999999999999999999999999999999875432 223
Q ss_pred CcccccccCChhhhh---cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 020016 186 GFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 186 ~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 262 (332)
...++..|+|||++. ...++.++||||||+++|+|++|..||...+....................++..+.+++.+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 255 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY 255 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 456889999999984 45678899999999999999999999988776666655543333333345677889999999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~~ 280 (332)
||+.+|.+||++.+++..
T Consensus 256 ~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 256 CLQKIPQERPASAELLRH 273 (313)
T ss_pred HccCChhhCcCHHHHhcC
Confidence 999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=263.55 Aligned_cols=219 Identities=21% Similarity=0.325 Sum_probs=176.1
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|++.+.||.|++|.||+|.+. +..||||++........ ...+.+|+.++++++|+||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT-----PSTAIREISLMKELKHENIVRLHDVIHTENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccc-----hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEE
Confidence 5889999999999999999996 78999999986543221 245678999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 182 (332)
....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 76 VFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred EEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 12458999999999999999999999999999999999999999999999999986543221
Q ss_pred CCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------------
Q 020016 183 SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR---------------- 245 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~---------------- 245 (332)
......++..|++||.+.+. .++.++||||||+++|+|++|..||.+.+..+....+......
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 22334578899999998664 4688999999999999999999999877655443333211100
Q ss_pred CC-----------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 246 PP-----------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 246 ~~-----------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.. +.+.+++.+.+++.+||+.||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 11345778899999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=265.52 Aligned_cols=223 Identities=27% Similarity=0.342 Sum_probs=176.6
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|.+.+.||.|++|.||+|.+. ++.||||.+........ .......+..|+++++.++|+||++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA-KDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccc-cchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence 4888999999999999999986 78999999987543311 1112456778999999999999986
Q ss_pred --------------CCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-CC
Q 020016 121 --------------EPY-SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-SA 184 (332)
Q Consensus 121 --------------~~~-~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~ 184 (332)
... .+++..+..++.||++||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 v~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 80 VFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred EEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 222 68999999999999999999999999999999999999999999999999987654332 22
Q ss_pred CCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------------------
Q 020016 185 KGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR------------------ 245 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~------------------ 245 (332)
....+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||......+....+......
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence 33456788999999865 45689999999999999999998888876654433332211000
Q ss_pred ---C-----CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 246 ---P-----PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 246 ---~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
. ......+..+.+++.+||..+|++||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0 011345678999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=265.75 Aligned_cols=209 Identities=25% Similarity=0.462 Sum_probs=166.1
Q ss_pred eecccCceEEEEEEEC--------------------------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCC
Q 020016 62 KFASGRHSRIYRGIYK--------------------------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH 115 (332)
Q Consensus 62 ~lg~G~~g~Vy~~~~~--------------------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 115 (332)
.||+|+||.||+|... ...||+|++...... ....|.+|+.+++.++|
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~------~~~~~~~~~~~~~~l~h 75 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRD------IALAFFETASLMSQVSH 75 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHH------HHHHHHHHHHHHhcCCC
Confidence 6999999999999752 135899998653221 23568899999999999
Q ss_pred Cceec-----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC-
Q 020016 116 PHIIT-----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM- 165 (332)
Q Consensus 116 ~niv~-----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~- 165 (332)
|||++ ..+.+++..+..++.||+.||.|||++|++||||||+||+++..+
T Consensus 76 ~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 76 IHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred CCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCc
Confidence 99986 245688999999999999999999999999999999999997543
Q ss_pred ------eEEEeecccccccccCCCCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHH-hCCCCCCCCCHHHHHH
Q 020016 166 ------CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELL-TALTPFDNMTPEQAAF 237 (332)
Q Consensus 166 ------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell-tG~~pf~~~~~~~~~~ 237 (332)
.++++|||++..... .....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||....+.+...
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccCccceeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 489999998754322 123456788999998865 56799999999999999995 5999998776554432
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 020016 238 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282 (332)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~ 282 (332)
.. .. ....+...++.+.++|.+||+.+|++||++.++++.|.
T Consensus 233 ~~-~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 233 FY-EK--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH-Hh--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 22 11 22344456678999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=263.17 Aligned_cols=219 Identities=25% Similarity=0.344 Sum_probs=176.1
Q ss_pred eeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC---CCCceec-----------
Q 020016 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL---NHPHIIT----------- 120 (332)
Q Consensus 57 y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~----------- 120 (332)
|.+.+.||.|+||.||+|.++ ++.||||.+......... ...+.+|+.++.++ +||||++
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 76 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI----PLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD 76 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchh----hhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC
Confidence 678999999999999999996 789999999865432221 24466777777665 6999876
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccc
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
....+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus 77 ~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 77 RELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred CCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 123478999999999999999999999999999999999999999999999999876
Q ss_pred cccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----------
Q 020016 178 ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP----------- 246 (332)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~----------- 246 (332)
...........++..|+|||.+.+..++.++|+||||+++|+|++|..||......+....+......+
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred ccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 554433344567889999999999899999999999999999999999998877665544443211100
Q ss_pred --------------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 --------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 --------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...+.+++.+.+++.+||+.||.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 001234577889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=270.25 Aligned_cols=229 Identities=23% Similarity=0.385 Sum_probs=182.6
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
.|.+ .++|++.+.||.|+||.||++.+. +..||||++....... .....+.+|+.+++.++||||++
T Consensus 10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07880 10 IWEV-PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSE----LFAKRAYRELRLLKHMKHENVIGLLDVFT 84 (343)
T ss_pred hhcc-ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccch----HHHHHHHHHHHHHHhcCCCCccceeeeec
Confidence 3544 468999999999999999999886 7899999986543222 12356789999999999999975
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 85 PDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred CCccccccceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 124678999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------
Q 020016 175 SCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------- 246 (332)
Q Consensus 175 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~------- 246 (332)
+..... ......+++.|+|||.+.+ ..++.++|+||||+++|++++|..||...+.......+.......
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 165 ARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred cccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 875433 2234567889999999876 457899999999999999999999998776544433322211100
Q ss_pred ----------------------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH--HHHhh
Q 020016 247 ----------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGY 284 (332)
Q Consensus 247 ----------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~--~L~~~ 284 (332)
.....+++.+.++|.+||..||.+||++.+++. .++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 112456788999999999999999999999984 44444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=271.89 Aligned_cols=222 Identities=23% Similarity=0.342 Sum_probs=176.0
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec-----------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT----------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----------- 120 (332)
++|.+.+.||+|+||.||+|.+. ++.||||.+......... ...+.+|+.++.++ +||||++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~----~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD----AQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchh----hhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 67999999999999999999985 789999988653222111 24577899999999 9999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 182 (332)
....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 83 DIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred eEEEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 11257888889999999999999999999999999999999999999999999986543321
Q ss_pred -----CCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----------
Q 020016 183 -----SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR----------- 245 (332)
Q Consensus 183 -----~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~----------- 245 (332)
......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.........+......
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence 1223468899999998755 45788999999999999999999999876554433222111100
Q ss_pred ------------------CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 246 ------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 246 ------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
....+.++.++.+++.+||+.+|++||++.+++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 01123468899999999999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=260.04 Aligned_cols=216 Identities=24% Similarity=0.467 Sum_probs=167.3
Q ss_pred eeecccCceEEEEEEEC-C---eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------------
Q 020016 61 CKFASGRHSRIYRGIYK-Q---RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~-~---~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------------- 120 (332)
++||+|+||.||+|... + ..+++|.+....... ..+.|.+|+.+++.++||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSK-----EQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChH-----HHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEe
Confidence 36999999999999764 2 346677766543221 1467999999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC---
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC--- 181 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--- 181 (332)
.....++..+..++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 1123455667889999999999999999999999999999999999999999987532211
Q ss_pred CCCCCcccccccCChhhhhc-------CCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC----CCCCCC
Q 020016 182 GSAKGFTGTYRWMAPEMIKE-------KRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN----ARPPVP 249 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~----~~~~~~ 249 (332)
.......++..|+|||++.. ..++.++||||||+++|||++ |..||......+....+.... .++..+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE 235 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence 12234567889999998753 235789999999999999997 678998877766555443322 223444
Q ss_pred CCCcHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 020016 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282 (332)
Q Consensus 250 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~ 282 (332)
..+++.+.+++..|| .+|++||++.+|++.|.
T Consensus 236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 236 LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 567889999999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=263.27 Aligned_cols=214 Identities=21% Similarity=0.301 Sum_probs=172.4
Q ss_pred ecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------------
Q 020016 63 FASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------------- 120 (332)
Q Consensus 63 lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------------- 120 (332)
||+|+||+||++.+. ++.||+|.+....... ......+..|+.+++.++||||++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK---RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh---hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCC
Confidence 689999999999886 7899999987642211 112356778999999999999986
Q ss_pred --------CC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCCCCcccc
Q 020016 121 --------EP--YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT 190 (332)
Q Consensus 121 --------~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt 190 (332)
.. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+.............++
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGT 157 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCC
Confidence 11 26889999999999999999999999999999999999999999999999998765443333445678
Q ss_pred cccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCCCCCCCCCcHHHHHHHHHccccCC
Q 020016 191 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ--KNARPPVPPTCPKAFSYLISRCWSSSP 268 (332)
Q Consensus 191 ~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dp 268 (332)
..|+|||.+.+..++.++||||||+++|+|++|+.||...........+.. .......+..+++.+.++|.+||+.+|
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDP 237 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCCh
Confidence 899999999888899999999999999999999999977543211111111 223445667789999999999999999
Q ss_pred CCCC-----CHHHHHH
Q 020016 269 DRRP-----HFDQIVS 279 (332)
Q Consensus 269 ~~Rp-----s~~ell~ 279 (332)
.+|| ++.+++.
T Consensus 238 ~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 238 EKRLGCRGGSADEVRE 253 (277)
T ss_pred hHccCCCcccHHHHHh
Confidence 9999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=267.86 Aligned_cols=221 Identities=25% Similarity=0.345 Sum_probs=172.1
Q ss_pred CeeeeeeecccCceEEEEEEEC----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
+|.+.+.||+|+||.||+|.+. +..||||.+....... ....+.+.+|+.++..++||||++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQY---TGISQSACREIALLRELKHENVVSLVEVFLEHADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccc---cCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCc
Confidence 4889999999999999999984 5899999998743110 011255788999999999999986
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC----CCeEEEeecc
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE----DMCVKVADFG 173 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~----~~~~kl~Dfg 173 (332)
....+++..++.++.|++.||.|||+.+++||||||+||+++. ++.+||+|||
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 1136788899999999999999999999999999999999999 8999999999
Q ss_pred cccccccCC----CCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHH---------HHHHH
Q 020016 174 ISCLESQCG----SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ---------AAFAV 239 (332)
Q Consensus 174 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~---------~~~~~ 239 (332)
++....... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||....... ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 987543322 12345678899999988764 57899999999999999999999997654321 00000
Q ss_pred Hh------------------------cCCCCCCC-----------CCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 240 CQ------------------------KNARPPVP-----------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 240 ~~------------------------~~~~~~~~-----------~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.. ......++ ...+..+.+++.+||+.||.+|||+.+++.
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 01111111 145678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=259.58 Aligned_cols=215 Identities=27% Similarity=0.419 Sum_probs=178.0
Q ss_pred ecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------------
Q 020016 63 FASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------------- 120 (332)
Q Consensus 63 lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------------- 120 (332)
||.|+||.||++.+. ++.||+|++....... ....+.+.+|++++++++||||++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR---KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhh---hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCC
Confidence 689999999999996 7899999987643321 223567899999999999999986
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC---------C
Q 020016 121 --------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG---------S 183 (332)
Q Consensus 121 --------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---------~ 183 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 22468999999999999999999999999999999999999999999999999886533221 1
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC--CcHHHHHHHH
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT--CPKAFSYLIS 261 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~ 261 (332)
.....++..|++||...+...+.++||||||+++|++++|..||......+....+.... ...+.. ++..+.+++.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~ 235 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK--IEWPEDVEVSDEAIDLIS 235 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--cCCCccccCCHHHHHHHH
Confidence 233457889999999988889999999999999999999999999888777666654422 333333 4899999999
Q ss_pred HccccCCCCCCCHHHHHHHHH
Q 020016 262 RCWSSSPDRRPHFDQIVSILE 282 (332)
Q Consensus 262 ~cl~~dp~~Rps~~ell~~L~ 282 (332)
+||+.+|.+||++.++.+.|+
T Consensus 236 ~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 236 KLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHhcCCHhhcCCCccHHHHhc
Confidence 999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=288.31 Aligned_cols=226 Identities=19% Similarity=0.304 Sum_probs=163.5
Q ss_pred cCCeeeeeeecccCceEEEEEEEC---CeeEEEEEecCCCchh-----------HHHHHHHHHHHHHHHHHHcCCCCcee
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDA-----------SLASMLEKQFTSEVALLFRLNHPHII 119 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~---~~~vAvK~~~~~~~~~-----------~~~~~~~~~~~~E~~~l~~l~h~niv 119 (332)
.++|.+.+.||+|+||+||++..+ +..+++|.+....... .........+.+|+.+|.+++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 368999999999999999998764 2222322111100000 00112245688999999999999998
Q ss_pred cC--------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeE
Q 020016 120 TE--------------------------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 167 (332)
Q Consensus 120 ~~--------------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~ 167 (332)
+. ........+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~v 306 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKI 306 (501)
T ss_pred cEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE
Confidence 60 1122355678899999999999999999999999999999999999
Q ss_pred EEeecccccccccCC--CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCC-CCCCCC--HHHHHHHHHhc
Q 020016 168 KVADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALT-PFDNMT--PEQAAFAVCQK 242 (332)
Q Consensus 168 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~-pf~~~~--~~~~~~~~~~~ 242 (332)
||+|||++....... ......||..|+|||++.+..++.++|||||||++|||++|.. |+.... .......+...
T Consensus 307 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~ 386 (501)
T PHA03210 307 VLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDS 386 (501)
T ss_pred EEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHh
Confidence 999999997654322 2234679999999999999999999999999999999999775 443321 22222111110
Q ss_pred CC---------------------CC----C-----CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 243 NA---------------------RP----P-----VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 243 ~~---------------------~~----~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.. .. . ....++.++.++|.+||+.||.+||++.|++.
T Consensus 387 ~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 387 LSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred cccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 00 0 01134667888999999999999999999986
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=263.47 Aligned_cols=219 Identities=28% Similarity=0.510 Sum_probs=183.2
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.+.|.+.+.||+|++|.||+|.+. +..||+|++..... ..+.+.+|+++++.++|+||++
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-------NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL 90 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence 367899999999999999999997 78999999986543 1356889999999999999986
Q ss_pred -----------------CC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC
Q 020016 121 -----------------EP-YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 182 (332)
Q Consensus 121 -----------------~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 182 (332)
.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 12 278999999999999999999999999999999999999999999999999876443221
Q ss_pred -CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CCCCCCcHHHHHHH
Q 020016 183 -SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP-PVPPTCPKAFSYLI 260 (332)
Q Consensus 183 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 260 (332)
......++..|++||.+.+..++.++|+||||+++|+|++|..||....+......+....... ..+..++..+.+++
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 250 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL 250 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHH
Confidence 2233457889999999988889999999999999999999999999877766555443332222 22234789999999
Q ss_pred HHccccCCCCCCCHHHHHH
Q 020016 261 SRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 261 ~~cl~~dp~~Rps~~ell~ 279 (332)
.+||+.+|.+||++.+++.
T Consensus 251 ~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 251 NKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHHhccChhhCcCHHHHhh
Confidence 9999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=264.94 Aligned_cols=222 Identities=23% Similarity=0.315 Sum_probs=177.5
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||.|+||.||+|.++ ++.||||++........ ....+.+|+.+++.++||||++
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~----~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG----FPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC----chHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 478999999999999999999996 78999999976432211 1245778999999999999986
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecc
Q 020016 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 121 ---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 11357899999999999999999999999999999999999999999999999
Q ss_pred cccccccCC--CCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----
Q 020016 174 ISCLESQCG--SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP---- 246 (332)
Q Consensus 174 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~---- 246 (332)
++....... ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+......+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 987654322 12233467889999988654 46889999999999999999999998766554443332211110
Q ss_pred ------------------------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 ------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 ------------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.....++..+.+++.+||+.+|.+||++.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011246889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=267.56 Aligned_cols=220 Identities=24% Similarity=0.310 Sum_probs=173.8
Q ss_pred CeeeeeeecccCceEEEEEEEC----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec----------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT---------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~---------- 120 (332)
+|.+.+.||+|+||.||++.+. +..||||.+........ ..+.+.+|+.++.++ +||||++
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 76 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKI----LAKRALRELKLLRHFRGHKNITCLYDMDIVFPG 76 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccch----hHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence 4889999999999999999986 45899999875332211 235678899999999 5999886
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++....
T Consensus 77 ~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 77 NFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred cCCcEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 23457889999999999999999999999999999999999999999999999987543
Q ss_pred cCC-----CCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------
Q 020016 180 QCG-----SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN---------- 243 (332)
Q Consensus 180 ~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~---------- 243 (332)
... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+....
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 221 1233568999999998765 467899999999999999999999998765433322211110
Q ss_pred ----------------CCC---CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 244 ----------------ARP---PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 244 ----------------~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
... ...+.++..+.+++.+||+.||.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 112345788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=289.00 Aligned_cols=232 Identities=29% Similarity=0.565 Sum_probs=200.0
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC---------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCce
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK---------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHI 118 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 118 (332)
.|+++.+++.+.+.||+|.||.|++|... ...||||.+........ .+.+..|+++|+.+ .|+||
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~-----~~~~~~El~~m~~~g~H~ni 364 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSE-----KKDLMSELNVLKELGKHPNI 364 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHH-----HHHHHHHHHHHHHhcCCcch
Confidence 79999999999999999999999999764 24799999987655422 47899999999999 69999
Q ss_pred ec-----------------------------CC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccc
Q 020016 119 IT-----------------------------EP---------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDL 154 (332)
Q Consensus 119 v~-----------------------------~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dl 154 (332)
+. .. ..++....+.++.||+.|+.||+++.++||||
T Consensus 365 v~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDL 444 (609)
T KOG0200|consen 365 VNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDL 444 (609)
T ss_pred hhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhh
Confidence 86 11 23899999999999999999999999999999
Q ss_pred cccceeecCCCeEEEeecccccccccCCCC--CCcc--cccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCC
Q 020016 155 KSENLLLGEDMCVKVADFGISCLESQCGSA--KGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 229 (332)
Q Consensus 155 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~--gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~ 229 (332)
..+|||+..+..+||+|||+++........ .... -...|||||.+....|+.++||||||++|||++| |..||.+
T Consensus 445 AaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 445 AARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999999754332221 1111 3556999999999999999999999999999999 9999999
Q ss_pred CC-HHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 020016 230 MT-PEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 230 ~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 286 (332)
.. ..+. ......+.+...|..+++++.++|+.||+.+|++||++.++.+.|+....
T Consensus 525 ~~~~~~l-~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 525 IPPTEEL-LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCcHHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 76 4444 55677888999999999999999999999999999999999999998544
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=260.34 Aligned_cols=220 Identities=29% Similarity=0.443 Sum_probs=183.5
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCceec-----------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIIT----------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~----------- 120 (332)
++|.+.+.||+|+||.||++.+. +..||+|++....... ....+.+.+|+.++.+++ ||||++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 77 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK---EKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENL 77 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccc---hHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceE
Confidence 47999999999999999999985 7899999987632211 112366889999999998 999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 182 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 78 YFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 33478999999999999999999999999999999999999999999999999986543322
Q ss_pred --------------------CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 020016 183 --------------------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 242 (332)
Q Consensus 183 --------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~ 242 (332)
......++..|+|||.+.+..++.++|+||||++++++++|..||...+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-- 235 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL-- 235 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--
Confidence 1123457889999999988889999999999999999999999999877555444443
Q ss_pred CCCCCCCCCCcHHHHHHHHHccccCCCCCCCH----HHHHH
Q 020016 243 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHF----DQIVS 279 (332)
Q Consensus 243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~----~ell~ 279 (332)
.....++..+++.+.+++.+||+.+|.+||++ .++++
T Consensus 236 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 34456677889999999999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=261.85 Aligned_cols=216 Identities=25% Similarity=0.333 Sum_probs=187.4
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
+.+++|.+.+.||.|.||+|.+++-+ ++.+|||++++...-. ......-..|-.+|+..+||.+..
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviia---kdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIA---KDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheee---hHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 45788999999999999999999887 8999999998753221 112344577999999999998754
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc-cc
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE-SQ 180 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~-~~ 180 (332)
....+++...+-+-.+|+.||.|||+++|++||||.+|.|+|.+|.+||+|||++... ..
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 4456889999999999999999999999999999999999999999999999999753 34
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 260 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 260 (332)
......++|||.|+|||++....|+.++|.|.+||+||||++|+.||...+......-+. .....+|..++++.+.|+
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl--~ed~kFPr~ls~eAktLL 399 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL--MEDLKFPRTLSPEAKTLL 399 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH--hhhccCCccCCHHHHHHH
Confidence 456788999999999999999999999999999999999999999999988877666554 334567889999999999
Q ss_pred HHccccCCCCCC
Q 020016 261 SRCWSSSPDRRP 272 (332)
Q Consensus 261 ~~cl~~dp~~Rp 272 (332)
..+|..||.+|.
T Consensus 400 sGLL~kdP~kRL 411 (516)
T KOG0690|consen 400 SGLLKKDPKKRL 411 (516)
T ss_pred HHHhhcChHhhc
Confidence 999999999995
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=260.88 Aligned_cols=219 Identities=25% Similarity=0.346 Sum_probs=176.2
Q ss_pred eeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------
Q 020016 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------- 120 (332)
Q Consensus 57 y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 120 (332)
|.+.+.||.|++|.||+|.+. ++.||+|++........ ....+.+|+.+++.++|+|+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 76 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEG----FPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIY 76 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccccccc----chHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEE
Confidence 678899999999999999986 68999999987642111 1356889999999999999886
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC--
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-- 182 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 182 (332)
....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 77 MVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred EEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 12468899999999999999999999999999999999999999999999999987654432
Q ss_pred CCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------------
Q 020016 183 SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--------------- 246 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~--------------- 246 (332)
......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+......+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 1233456888999998765 457899999999999999999999998877655444332211100
Q ss_pred --------------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 --------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 --------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+...++..+.+++.+||..+|.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 011113788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=266.63 Aligned_cols=221 Identities=23% Similarity=0.368 Sum_probs=176.8
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||.|+||.||++.+. ++.||||.+........ ..+.+.+|+.++..++||||++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV----LAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccc----hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 367999999999999999999886 78999998865432211 1356788999999999999987
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 184 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 184 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..... ..
T Consensus 85 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--~~ 162 (328)
T cd07856 85 IYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QM 162 (328)
T ss_pred EEEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--Cc
Confidence 234678888899999999999999999999999999999999999999999999865432 22
Q ss_pred CCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------------------
Q 020016 185 KGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK--------------------- 242 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~--------------------- 242 (332)
....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+...
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd07856 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242 (328)
T ss_pred CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence 34567889999998765 56799999999999999999999999876653322111110
Q ss_pred ---CCCCC-----CCCCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 243 ---NARPP-----VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 243 ---~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
..... ..+.+++.+.++|.+||+.+|++||++.+++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00011 113567899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=273.99 Aligned_cols=227 Identities=24% Similarity=0.356 Sum_probs=177.9
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec-----
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT----- 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----- 120 (332)
.-+.+.-..|++.++||+||.+.||++... .+.||+|.+.....+. ...+.|.+|+..|.+| .|.+||.
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~----qtl~gy~nEI~lL~KLkg~~~IIqL~DYE 429 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADN----QTLDGYRNEIALLNKLKGHDKIIQLYDYE 429 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCH----HHHHHHHHHHHHHHHhcCCceEEEEeeee
Confidence 345567789999999999999999999987 4778888776544333 2357899999999999 5888886
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccc
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
....++.-.++.+..||+.++.++|..||||.||||.|+|+- .|.+||+|||.|..
T Consensus 430 v~d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 430 VTDGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANA 508 (677)
T ss_pred ccCceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcc
Confidence 222233237888999999999999999999999999999984 57999999999976
Q ss_pred cccCCC---CCCcccccccCChhhhhcCC-----------CCCccchhHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhc
Q 020016 178 ESQCGS---AKGFTGTYRWMAPEMIKEKR-----------HTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-AAFAVCQK 242 (332)
Q Consensus 178 ~~~~~~---~~~~~gt~~y~aPE~~~~~~-----------~~~~sDvwSlG~il~elltG~~pf~~~~~~~-~~~~~~~~ 242 (332)
...... ....+||+.||+||.+.... .++++||||||||||+|+.|+.||....... ...++..-
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P 588 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDP 588 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCC
Confidence 654332 23568999999999996432 4689999999999999999999998765332 23333333
Q ss_pred CCCCCCCCCCcHH-HHHHHHHccccCCCCCCCHHHHHH
Q 020016 243 NARPPVPPTCPKA-FSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 243 ~~~~~~~~~~~~~-l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...-++|..-+.. +.++++.||..||.+||++.++++
T Consensus 589 ~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 589 NHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred CccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 2333455444443 999999999999999999999985
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=258.03 Aligned_cols=218 Identities=25% Similarity=0.377 Sum_probs=174.6
Q ss_pred eeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCceec-------------
Q 020016 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIIT------------- 120 (332)
Q Consensus 57 y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~------------- 120 (332)
|.+.+.||+|++|+||+|.+. ++.||||.+........ .....+|+..+.+++ |+||++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-----ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-----HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEE
Confidence 678899999999999999985 68899999876533211 233567999999999 999986
Q ss_pred --------------C--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCC
Q 020016 121 --------------E--PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 184 (332)
Q Consensus 121 --------------~--~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 184 (332)
. ...+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 76 VFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred EEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 1 236799999999999999999999999999999999999999999999999998765544344
Q ss_pred CCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----------------
Q 020016 185 KGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP----------------- 246 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~----------------- 246 (332)
....++..|+|||++.. ..++.++|+||||+++|+|++|..||......+...........+
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 45668889999998754 457899999999999999999999998776554443322111100
Q ss_pred -----------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 -----------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 -----------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...+..+..+.+++.+||+.+|++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 001223678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=256.12 Aligned_cols=216 Identities=25% Similarity=0.387 Sum_probs=171.5
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHH-HHcCCCCceec-----------------
Q 020016 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVAL-LFRLNHPHIIT----------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~----------------- 120 (332)
+.||.|+||.||+|.+. ++.||||++........ . ....+..|..+ ....+|+|+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~--~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK--N-QVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHH--H-HHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEec
Confidence 57899999999999985 78999999876432111 1 12334455444 45568999986
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCCCCccc
Q 020016 121 -----------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG 189 (332)
Q Consensus 121 -----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~g 189 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .....+
T Consensus 79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCC
Confidence 235689999999999999999999999999999999999999999999999998865433 234567
Q ss_pred ccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--CCCCCCCCcHHHHHHHHHccccC
Q 020016 190 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA--RPPVPPTCPKAFSYLISRCWSSS 267 (332)
Q Consensus 190 t~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~d 267 (332)
+..|++||.+.+..++.++||||||+++|+|++|..||...+.......+..... .......+++.+.+++.+||+.+
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 8899999999888889999999999999999999999998877666555443322 22234467899999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 020016 268 PDRRPHFDQIVSILE 282 (332)
Q Consensus 268 p~~Rps~~ell~~L~ 282 (332)
|++||++.++.+.|.
T Consensus 236 p~~R~~~~~~~~~l~ 250 (260)
T cd05611 236 PAKRLGANGYQEIKS 250 (260)
T ss_pred HHHccCCCcHHHHHc
Confidence 999997766655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=259.44 Aligned_cols=215 Identities=20% Similarity=0.297 Sum_probs=165.8
Q ss_pred eecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHH---HHHcCCCCceec----------------
Q 020016 62 KFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVA---LLFRLNHPHIIT---------------- 120 (332)
Q Consensus 62 ~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~niv~---------------- 120 (332)
.||+|+||.||++.+. ++.||||.+.......... ...+.+|.. ++...+||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG---ETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH---HHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence 4899999999999986 7899999987643221111 122334443 344457899875
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCCCCcc
Q 020016 121 ------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT 188 (332)
Q Consensus 121 ------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 188 (332)
....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... ......
T Consensus 78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~ 156 (279)
T cd05633 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASV 156 (279)
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccCcC
Confidence 3456899999999999999999999999999999999999999999999999998654332 223456
Q ss_pred cccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcCCCCCCCCCCcHHHHHHHHHcccc
Q 020016 189 GTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA-AFAVCQKNARPPVPPTCPKAFSYLISRCWSS 266 (332)
Q Consensus 189 gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 266 (332)
++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||........ ............++..+++++.+++.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 8999999999864 5578999999999999999999999975432111 1111112334456778899999999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 020016 267 SPDRRP-----HFDQIVSI 280 (332)
Q Consensus 267 dp~~Rp-----s~~ell~~ 280 (332)
||.+|| ++.++++.
T Consensus 237 ~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CHHHhcCCCCCCHHHHHhC
Confidence 999999 58888873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=301.42 Aligned_cols=221 Identities=24% Similarity=0.391 Sum_probs=188.9
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+++-+..||.|.||.||-|.+. |...|+|-+....... .......+|..++..++|||+|+
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~----k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDH----KTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCcccc----ccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 4666889999999999999885 8889999887754432 22356788999999999999997
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC---
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG--- 182 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 182 (332)
.+...++.....+..|++.|++|||+.||+||||||.||+++.+|.+|++|||.|.......
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 33446777788889999999999999999999999999999999999999999997655432
Q ss_pred --CCCCcccccccCChhhhhcCC---CCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 020016 183 --SAKGFTGTYRWMAPEMIKEKR---HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 257 (332)
Q Consensus 183 --~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 257 (332)
......||+.|||||++.+.. ...++|||||||++.||+||+.||...+...........+..|.+|..++++-.
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~ 1471 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGR 1471 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHH
Confidence 123577999999999997643 578999999999999999999999998887766666667888999999999999
Q ss_pred HHHHHccccCCCCCCCHHHHHHH
Q 020016 258 YLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 258 ~li~~cl~~dp~~Rps~~ell~~ 280 (332)
++|..||..||..|.++.|+++.
T Consensus 1472 dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1472 DFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHHHHHhcCchhhhHHHHHHHh
Confidence 99999999999999999877753
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=261.47 Aligned_cols=217 Identities=24% Similarity=0.370 Sum_probs=177.2
Q ss_pred eeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------
Q 020016 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------- 120 (332)
Q Consensus 57 y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 120 (332)
|....+||.|+||.||++... ++.||||++...... ....+.+|+.+++.++|+||++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQ------RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 95 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchh------HHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEE
Confidence 334568999999999999885 789999998654322 1456889999999999999886
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-CCCC
Q 020016 121 -------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-SAKG 186 (332)
Q Consensus 121 -------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~~ 186 (332)
....+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 96 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 23467899999999999999999999999999999999999999999999999876543321 2234
Q ss_pred cccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHccc
Q 020016 187 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYLISRCWS 265 (332)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~ 265 (332)
..++..|+|||.+.+..++.++|+||+|+++|+|++|..||...........+..... .......+++.+.+++.+||+
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 5688999999999888889999999999999999999999987766554443322111 112234578999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 020016 266 SSPDRRPHFDQIVS 279 (332)
Q Consensus 266 ~dp~~Rps~~ell~ 279 (332)
.+|.+||++.+++.
T Consensus 256 ~~P~~R~~~~~ll~ 269 (292)
T cd06657 256 RDPAQRATAAELLK 269 (292)
T ss_pred CCcccCcCHHHHhc
Confidence 99999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=258.30 Aligned_cols=212 Identities=21% Similarity=0.308 Sum_probs=167.0
Q ss_pred eecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHH---HHHHHcCCCCceec----------------
Q 020016 62 KFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSE---VALLFRLNHPHIIT---------------- 120 (332)
Q Consensus 62 ~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E---~~~l~~l~h~niv~---------------- 120 (332)
.||+|+||.||++.+. ++.||||.+.......... ...+..| +.++....||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG---ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchh---HHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEe
Confidence 4899999999999885 7899999987643221111 1122333 34455568999985
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCCCCcc
Q 020016 121 ------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT 188 (332)
Q Consensus 121 ------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 188 (332)
....+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++...... ......
T Consensus 78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~ 156 (278)
T cd05606 78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASV 156 (278)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcC
Confidence 3356899999999999999999999999999999999999999999999999998654332 223457
Q ss_pred cccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHcc
Q 020016 189 GTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMT---PEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 264 (332)
Q Consensus 189 gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 264 (332)
|+..|+|||.+.++ .++.++|+||+|+++|+|++|..||.... ....... ........+..++..+.+++.+||
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~~li~~~l 234 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--TLTMAVELPDSFSPELRSLLEGLL 234 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH--hhccCCCCCCcCCHHHHHHHHHHh
Confidence 89999999999754 57999999999999999999999998753 2222111 233445667778999999999999
Q ss_pred ccCCCCCC-----CHHHHHH
Q 020016 265 SSSPDRRP-----HFDQIVS 279 (332)
Q Consensus 265 ~~dp~~Rp-----s~~ell~ 279 (332)
..+|.+|| ++.++++
T Consensus 235 ~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 235 QRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred hcCHHhccCCCCCCHHHHHh
Confidence 99999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=265.94 Aligned_cols=225 Identities=20% Similarity=0.252 Sum_probs=175.3
Q ss_pred CCee-eeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHH--------HHHHHHHHHHHHHHHcCCCCceec---
Q 020016 55 SQLF-IGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLA--------SMLEKQFTSEVALLFRLNHPHIIT--- 120 (332)
Q Consensus 55 ~~y~-i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~--- 120 (332)
++|. +.+.||.|+||.||+|.+. ++.||||++.......... ......+.+|+.+++.++|+||++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 5678999999999999986 7899999987643322100 001124778999999999999986
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccc
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 88 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 88 VYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred EEecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcccee
Confidence 23468899999999999999999999999999999999999999999999999986
Q ss_pred ccccC---------------CCCCCcccccccCChhhhhcCC-CCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 020016 177 LESQC---------------GSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC 240 (332)
Q Consensus 177 ~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~ 240 (332)
..... .......++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+..+....+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~ 247 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 54311 1112234678899999987644 6899999999999999999999999877665544333
Q ss_pred hcCCCCC--------------------------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 241 QKNARPP--------------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 241 ~~~~~~~--------------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.....+. .....+..+.+++.+||+.+|++||++++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 2111000 11345788999999999999999999999986
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=253.83 Aligned_cols=221 Identities=25% Similarity=0.434 Sum_probs=177.2
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|.+.+.||+|+||.||++.+. +..+++|++........ .......+..|+.+++.++||||++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGEL-NPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEecccccccc-CcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence 5889999999999999999886 45566776654221110 0011245678999999999999986
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 1345788999999999999999999999999999999999975 56999999988654332
Q ss_pred -CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 020016 182 -GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 260 (332)
Q Consensus 182 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 260 (332)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|..||............. ....+..+..++.++.++|
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 237 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSIM 237 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHHHH
Confidence 22334567889999999988888999999999999999999999998766655544443 3445556677889999999
Q ss_pred HHccccCCCCCCCHHHHHH
Q 020016 261 SRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 261 ~~cl~~dp~~Rps~~ell~ 279 (332)
.+||..+|++||++.++++
T Consensus 238 ~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 238 QSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHhcCChhhCcCHHHHhh
Confidence 9999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=273.53 Aligned_cols=215 Identities=27% Similarity=0.404 Sum_probs=183.5
Q ss_pred eeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------------
Q 020016 59 IGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------------- 120 (332)
Q Consensus 59 i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------------- 120 (332)
-.+.||+|.||+||-|.++ |+.||||++.+-.-.... +.++.+|+.||.++.||.||.
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq----esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME 643 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ----ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME 643 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCCch----HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence 3679999999999999886 899999999874332211 367889999999999999986
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC---CeEEEeecccccccccCCCC
Q 020016 121 -------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED---MCVKVADFGISCLESQCGSA 184 (332)
Q Consensus 121 -------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~ 184 (332)
..+.+++.....++.||+.||.|||-+||+|.||||+|||+... .++||||||+|+........
T Consensus 644 Kl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 644 KLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 67889999999999999999999999999999999999999654 58999999999998887777
Q ss_pred CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCCCCCCCCCcHHHHHHHHH
Q 020016 185 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ--KNARPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~ 262 (332)
...+|||.|+|||+++...|...-|+||.|||+|--++|..||....+ +..++.. -...+.....+++...+||..
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPNPWSEISPEAIDLINN 801 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence 889999999999999999999999999999999999999999986443 2223322 222333346789999999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~ 279 (332)
+|+..-.+|.|.+..+.
T Consensus 802 LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDKSLS 818 (888)
T ss_pred HHHHHHHHhcchHhhcc
Confidence 99999999999887664
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=254.94 Aligned_cols=219 Identities=26% Similarity=0.377 Sum_probs=175.8
Q ss_pred eeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------
Q 020016 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------- 120 (332)
Q Consensus 57 y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 120 (332)
|.+.+.||+|++|.||+|.+. ++.||+|++........ ..+.+.+|+.+++.++|+||++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 76 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG----IPSTALREISLLKELKHPNIVKLLDVIHTERKLYLV 76 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccccccc----ccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEE
Confidence 567789999999999999996 78999999987542221 1356788999999999999986
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-CCC
Q 020016 121 --------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-SAK 185 (332)
Q Consensus 121 --------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~ 185 (332)
....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++....... ...
T Consensus 77 ~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (282)
T cd07829 77 FEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT 156 (282)
T ss_pred ecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence 12478999999999999999999999999999999999999999999999999987654322 223
Q ss_pred CcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------------C---
Q 020016 186 GFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA----------------R--- 245 (332)
Q Consensus 186 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~----------------~--- 245 (332)
...++..|+|||.+.+. .++.++||||||+++|+|++|..||......+....+..... .
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 34567789999998776 789999999999999999999999988765444333221100 0
Q ss_pred C--------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 246 P--------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 246 ~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+ ...+.++..+.+++.+||..+|++||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 011234778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=233.42 Aligned_cols=221 Identities=21% Similarity=0.316 Sum_probs=183.4
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
.+|.-.++||+|.||+||+|+.. ++.||+|.++....++.. .....+|+-+|+.+.|.|||+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv----pssalreicllkelkhknivrl~dvlhsdkklt 77 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV----PSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC----cHHHHHHHHHHHHhhhcceeehhhhhccCceeE
Confidence 35677789999999999999886 689999999887665543 356788999999999999997
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-C
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-S 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~ 183 (332)
.++.++.+.++.++.|++.||.++|++++.||||||.|.+|+.+|.+|++|||+++.++-.. -
T Consensus 78 lvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred EeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 56789999999999999999999999999999999999999999999999999998665432 2
Q ss_pred CCCcccccccCChhhhhcCC-CCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCC--------------
Q 020016 184 AKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPP-------------- 247 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~-------------- 247 (332)
....+.|..|.+|.++-+.. |+...|+||.||++.|+.. |++.|++.+..+....+......+.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 34456799999999987765 6889999999999999998 9999999888887776654322221
Q ss_pred ----CC---------CCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 248 ----VP---------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 248 ----~~---------~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+| +.+...=++++++.|.-+|..|.++++.++
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11 122334578999999999999999998763
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=264.32 Aligned_cols=222 Identities=19% Similarity=0.266 Sum_probs=186.9
Q ss_pred ccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
.+..+.|..-++||.||||.||-+.-+ |+-+|.|.+.+.... ...-+.-.++|-.+|.+++.+.||.
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiK---kr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk 257 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIK---KRKGETMALNEKQILEKVSSPFIVSLAYAFETK 257 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHH---HhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence 355678899999999999999988765 889999988764222 1222355688999999999999986
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
.+..+++..++-++.+|+.||.+||+++|++|||||+|||+|+.|+++|+|+|+|...
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec
Confidence 3457999999999999999999999999999999999999999999999999999988
Q ss_pred ccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hcCCCCCCCCCCcHHH
Q 020016 179 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC--QKNARPPVPPTCPKAF 256 (332)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l 256 (332)
.........+||.+|||||++.++.|+...|+|||||++|||+.|+.||...........+. .......++..++++.
T Consensus 338 ~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ea 417 (591)
T KOG0986|consen 338 PEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEA 417 (591)
T ss_pred CCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHH
Confidence 88777777899999999999999999999999999999999999999998654332221211 1234456778899999
Q ss_pred HHHHHHccccCCCCCCCHH
Q 020016 257 SYLISRCWSSSPDRRPHFD 275 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ 275 (332)
++|.+.+|+.||.+|....
T Consensus 418 kslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 418 KSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHHHHccCHHHhccCC
Confidence 9999999999999996543
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=257.22 Aligned_cols=224 Identities=24% Similarity=0.335 Sum_probs=178.7
Q ss_pred CeeeeeeecccCceEEEEEEEC-----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec---------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT--------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------- 120 (332)
+|.+.+.||.|++|.||++.+. ++.||||++...... ......+.+.+|+.++.++ +||||++
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~--~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV--QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH--hhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC
Confidence 4889999999999999999863 578999998753221 1122346688999999999 5899875
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 2356788999999999999999999999999999999999999999999999998654332
Q ss_pred CC--CCCcccccccCChhhhhcCC--CCCccchhHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCCCCCCCCc
Q 020016 182 GS--AKGFTGTYRWMAPEMIKEKR--HTKKVDVYSFGIVLWELLTALTPFDNMT----PEQAAFAVCQKNARPPVPPTCP 253 (332)
Q Consensus 182 ~~--~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltG~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~ 253 (332)
.. .....++..|+|||.+.+.. .+.++||||||+++|+|++|..||.... ......... ......+..++
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 236 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL--KSKPPFPKTMS 236 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH--ccCCCCCcccC
Confidence 21 22346789999999987665 6889999999999999999999996432 122222222 23345667789
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 020016 254 KAFSYLISRCWSSSPDRRPHFDQIVSILEG 283 (332)
Q Consensus 254 ~~l~~li~~cl~~dp~~Rps~~ell~~L~~ 283 (332)
..+.+++.+||+.||++|||+.++.+.|+.
T Consensus 237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 237 AEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 999999999999999999999888877764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=261.25 Aligned_cols=219 Identities=24% Similarity=0.391 Sum_probs=170.0
Q ss_pred eeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------------
Q 020016 57 LFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------------- 120 (332)
Q Consensus 57 y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------------- 120 (332)
+.+++.+|.|+++.||++...++.||||++........ ..+.+.+|+.+++.++|+||++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e 79 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKE----DLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSP 79 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchh----HHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEe
Confidence 45677777778888888877799999999986522211 2467899999999999999986
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC----
Q 020016 121 --------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG---- 182 (332)
Q Consensus 121 --------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---- 182 (332)
....+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 23457889999999999999999999999999999999999999999999999875432211
Q ss_pred ----CCCCcccccccCChhhhhcC--CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----------
Q 020016 183 ----SAKGFTGTYRWMAPEMIKEK--RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR----------- 245 (332)
Q Consensus 183 ----~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~----------- 245 (332)
......++..|+|||++.+. .++.++|+||||+++|+|++|..||..................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 12234567889999998763 5789999999999999999999999876654433222111100
Q ss_pred ---------------------CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 246 ---------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 246 ---------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
......++.++.+++.+||..||++||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0011223567889999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=276.89 Aligned_cols=226 Identities=27% Similarity=0.467 Sum_probs=181.1
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
.+...+.||+|+||.||+|+++ |+.||||.++....... .+...+|+++|++++|+|||+
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~-----~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRP-----RERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccch-----HHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 3445678999999999999986 99999999988553332 467789999999999999997
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeec--CCC--eEEEeec
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG--EDM--CVKVADF 172 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~--~~~--~~kl~Df 172 (332)
....+++.+++.++.++..||.|||.+||+||||||.||++- ++| ..||+||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 446799999999999999999999999999999999999983 333 5899999
Q ss_pred ccccccccCCCCCCcccccccCChhhhh-cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcC----
Q 020016 173 GISCLESQCGSAKGFTGTYRWMAPEMIK-EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE----QAAFAVCQKN---- 243 (332)
Q Consensus 173 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~----~~~~~~~~~~---- 243 (332)
|.|+...+........||..|++||++. .+.|+..+|.|||||++|+.+||..||-..... +..+.+..+.
T Consensus 169 G~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 169 GAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred cccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 9999988888788899999999999998 488999999999999999999999999654322 2333332211
Q ss_pred ---------------CCCCCCCCCcHHH----HHHHHHccccCCCCCC--CHHHHHHHHHhhhh
Q 020016 244 ---------------ARPPVPPTCPKAF----SYLISRCWSSSPDRRP--HFDQIVSILEGYSE 286 (332)
Q Consensus 244 ---------------~~~~~~~~~~~~l----~~li~~cl~~dp~~Rp--s~~ell~~L~~~~~ 286 (332)
...++|..+++.+ -.++..+|..+|.+|. .+.+....+.++..
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1123444555543 4577788899999998 77777666665543
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=249.48 Aligned_cols=209 Identities=27% Similarity=0.363 Sum_probs=176.7
Q ss_pred ecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------------
Q 020016 63 FASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------------- 120 (332)
Q Consensus 63 lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------------- 120 (332)
||.|+||.||++.+. ++.||+|++........ .....+..|+.+++.++||||++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR---KEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcch---HHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCC
Confidence 689999999999986 78999999877533221 12467889999999999999976
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-CCCCCccccc
Q 020016 121 --------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GSAKGFTGTY 191 (332)
Q Consensus 121 --------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~ 191 (332)
....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... .......++.
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 2346899999999999999999999999999999999999999999999999998765443 2334556888
Q ss_pred ccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCC
Q 020016 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 271 (332)
Q Consensus 192 ~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 271 (332)
.|++||...+...+.++|+||||+++|++++|..||...+.......+.. ....++..++..+.+++.+||..||++|
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R 235 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKR 235 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence 99999999888889999999999999999999999988776555444433 4566777889999999999999999999
Q ss_pred CCHHH
Q 020016 272 PHFDQ 276 (332)
Q Consensus 272 ps~~e 276 (332)
|++.+
T Consensus 236 ~~~~~ 240 (250)
T cd05123 236 LGSGG 240 (250)
T ss_pred CCccc
Confidence 99944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=262.59 Aligned_cols=222 Identities=25% Similarity=0.440 Sum_probs=168.8
Q ss_pred eeeccc--CceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------------
Q 020016 61 CKFASG--RHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------------- 120 (332)
Q Consensus 61 ~~lg~G--~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------------- 120 (332)
..||.| +||+||++.+. ++.||||++........ ..+.+.+|+.+++.++||||++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEE----HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHH----HHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEe
Confidence 456666 99999999985 89999999976543221 1367889999999999999986
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC---
Q 020016 121 --------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS--- 183 (332)
Q Consensus 121 --------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--- 183 (332)
....+++..+..++.|++.||.|||++|++||||||+||+++.++.++++||+.+........
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 123578888999999999999999999999999999999999999999999986432211111
Q ss_pred -----CCCcccccccCChhhhhcC--CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------------
Q 020016 184 -----AKGFTGTYRWMAPEMIKEK--RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA------------ 244 (332)
Q Consensus 184 -----~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~------------ 244 (332)
.....++..|+|||++.+. .++.++||||||+++|+|++|..||.................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 1112345679999999764 468999999999999999999999987665443322211100
Q ss_pred ---------------------------------CCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH--HHHhhhh
Q 020016 245 ---------------------------------RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYSE 286 (332)
Q Consensus 245 ---------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~--~L~~~~~ 286 (332)
..+.+..+++.+.+|+++||+.||++|||+.++++ .++.+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 01112335678999999999999999999999975 4555444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=253.06 Aligned_cols=225 Identities=27% Similarity=0.375 Sum_probs=177.0
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
+...|.+...||+|+||.||+|..+ ...+|||.+..+...... .....+|+.+++.+.|||||.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi----S~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI----SMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc----CHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 3468999999999999999999664 137999999876544333 245789999999999999986
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC----CeEEE
Q 020016 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED----MCVKV 169 (332)
Q Consensus 121 ---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~----~~~kl 169 (332)
....++...+.+|+.||+.|++|||++-|+||||||.|||+..+ |.|||
T Consensus 98 ~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred ccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEe
Confidence 44678999999999999999999999999999999999999877 89999
Q ss_pred eecccccccccCC----CCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCH---------HHH
Q 020016 170 ADFGISCLESQCG----SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTP---------EQA 235 (332)
Q Consensus 170 ~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~---------~~~ 235 (332)
+|||+++...+.- .....+.|..|.|||.+.+. .|+.+.|||+.|||+.||+|-.+.|.+... .+.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 9999998765432 34567789999999999875 579999999999999999999888865321 112
Q ss_pred HHHHHhcCCCCC---------CC--------------------------CCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 236 AFAVCQKNARPP---------VP--------------------------PTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 236 ~~~~~~~~~~~~---------~~--------------------------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
...+..-...+. +| ..-++...+|+.++|..||-+|.|+++.++.
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 222222111111 00 0113446789999999999999999988764
Q ss_pred H
Q 020016 281 L 281 (332)
Q Consensus 281 L 281 (332)
.
T Consensus 338 ~ 338 (438)
T KOG0666|consen 338 P 338 (438)
T ss_pred c
Confidence 3
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=262.00 Aligned_cols=216 Identities=25% Similarity=0.430 Sum_probs=187.8
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
+-|.+.++||+|+||.||+|.++ |..||||.+..... .+++.+|+.++.+.+.|++|+
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD--------LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLW 104 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD--------LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLW 104 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch--------HHHHHHHHHHHHHcCCchhhhhhhhhccCCceE
Confidence 34778999999999999999997 89999999987543 467899999999999999997
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-C
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-G 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~ 182 (332)
.++++++.++..+++..+.||.|||...-+|||||..|||++.+|.+||+|||.+..+... .
T Consensus 105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 6789999999999999999999999999999999999999999999999999998665443 2
Q ss_pred CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHHHH
Q 020016 183 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLI 260 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li 260 (332)
..++..|||.|||||++..-.|+.++||||||++..||..|++||.+..+....+-+- ....+. -|..++.++-+++
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP-T~PPPTF~KPE~WS~~F~DFi 263 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP-TKPPPTFKKPEEWSSEFNDFI 263 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc-CCCCCCCCChHhhhhHHHHHH
Confidence 3456789999999999999999999999999999999999999999887765544432 222222 2456789999999
Q ss_pred HHccccCCCCCCCHHHHHH
Q 020016 261 SRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 261 ~~cl~~dp~~Rps~~ell~ 279 (332)
+.||-.+|++|-++.++++
T Consensus 264 ~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 264 RSCLIKKPEERKTALRLCE 282 (502)
T ss_pred HHHhcCCHHHHHHHHHHhh
Confidence 9999999999999988876
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=253.08 Aligned_cols=229 Identities=22% Similarity=0.342 Sum_probs=186.2
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec--
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT-- 120 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~-- 120 (332)
...-|.+..++++-...||.|.||+|++-.++ |+..|||.++....... .+++..|.+...+- +.||||+
T Consensus 55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke-----q~rll~e~d~~mks~~cp~IVkfy 129 (361)
T KOG1006|consen 55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE-----QKRLLMEHDTVMKSSNCPNIVKFY 129 (361)
T ss_pred cccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH-----HHHHHHHHHHHHhhcCCcHHHHHh
Confidence 34567788888998999999999999999997 89999999988665332 36678888766555 7899997
Q ss_pred ------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccccccceeecCCCeEEE
Q 020016 121 ------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKV 169 (332)
Q Consensus 121 ------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~NIll~~~~~~kl 169 (332)
....+++...-.|..-++.||.||-.. .|||||+||+|||++..|.+||
T Consensus 130 Ga~F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKL 209 (361)
T KOG1006|consen 130 GALFSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKL 209 (361)
T ss_pred hhhhcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEee
Confidence 456788888888888899999999875 8999999999999999999999
Q ss_pred eecccccccccCCCCCCcccccccCChhhhhc--CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCCC
Q 020016 170 ADFGISCLESQCGSAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-AAFAVCQKNARP 246 (332)
Q Consensus 170 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~-~~~~~~~~~~~~ 246 (332)
||||.+..+...-......|...|||||.+.. ..|+.++||||||++|||+.||..||.+.+..- ..-.+. .+..+
T Consensus 210 CDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv-~gdpp 288 (361)
T KOG1006|consen 210 CDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV-IGDPP 288 (361)
T ss_pred ecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH-cCCCC
Confidence 99999877665555556678899999999853 358999999999999999999999999866522 222222 22222
Q ss_pred C--CCC---CCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 247 P--VPP---TCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 247 ~--~~~---~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
. .+. +++..+..+|..||.+|-+.||.+.++.++
T Consensus 289 ~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 289 ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2 222 378899999999999999999999998863
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=256.35 Aligned_cols=220 Identities=24% Similarity=0.364 Sum_probs=174.3
Q ss_pred CeeeeeeecccCceEEEEEEE-----CCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec---------
Q 020016 56 QLFIGCKFASGRHSRIYRGIY-----KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT--------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------- 120 (332)
+|++.+.||.|+||.||++.+ .+..||+|++....... .....+.+.+|+.++..+ +|+||+.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ--KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhh--cchHHHHHHHHHHHHHhcccCCChhceeeEeecCC
Confidence 488999999999999999987 36889999987532211 112246678899999999 5899875
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 2345788999999999999999999999999999999999999999999999998654332
Q ss_pred C--CCCCcccccccCChhhhhcC--CCCCccchhHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCCCCCCCCCCc
Q 020016 182 G--SAKGFTGTYRWMAPEMIKEK--RHTKKVDVYSFGIVLWELLTALTPFDNMTP----EQAAFAVCQKNARPPVPPTCP 253 (332)
Q Consensus 182 ~--~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltG~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~ 253 (332)
. ......++..|+|||.+.+. .++.++||||||+++|+|++|..||..... ......+ ....++.+..++
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 236 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYPQEMS 236 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh--hccCCCCCccCC
Confidence 1 22245688999999998753 467899999999999999999999974322 2222222 223455677889
Q ss_pred HHHHHHHHHccccCCCCCC-----CHHHHHH
Q 020016 254 KAFSYLISRCWSSSPDRRP-----HFDQIVS 279 (332)
Q Consensus 254 ~~l~~li~~cl~~dp~~Rp-----s~~ell~ 279 (332)
+.+.+++.+||+.||++|| ++.+++.
T Consensus 237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 9999999999999999997 6666665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=268.39 Aligned_cols=226 Identities=24% Similarity=0.356 Sum_probs=202.5
Q ss_pred ccccCCeeeeeeecccCceEEEEEEECCee--EEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~--vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
....+++++...||-||||.|=+...+++. +|+|++++..--. ....+.+..|-.+|...+.|.||+
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd---tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ 492 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD---TKQQEHVFSERNIMMECRSDFIVRLYRTFRDS 492 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc---hhHHHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence 345788999999999999999999888654 8999887642211 122467888999999999999987
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
..+.++...+.-++.-+++|+.|||++|||+|||||+|.+++.+|.+||.|||+|.....
T Consensus 493 kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 493 KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 678899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 260 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 260 (332)
...+.+++|||.|.|||++.+...+.++|.||||+++|||++|.+||.+.++......+..+.....+|..++....+||
T Consensus 573 g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence 88999999999999999999999999999999999999999999999999999998888887778889999999999999
Q ss_pred HHccccCCCCCCC-----HHHHHH
Q 020016 261 SRCWSSSPDRRPH-----FDQIVS 279 (332)
Q Consensus 261 ~~cl~~dp~~Rps-----~~ell~ 279 (332)
+++...+|.+|.. +.+|.+
T Consensus 653 k~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 653 KKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred HHHHhcCcHhhhccccCChHHHHh
Confidence 9999999999975 555554
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=271.36 Aligned_cols=226 Identities=28% Similarity=0.546 Sum_probs=196.4
Q ss_pred CeeeeeeecccCceEEEEEEEC--C----eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--Q----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~----~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
+.+..++||+|+||+||+|.|- + -+||||++........ .+++..|+.+|.+++|||+++
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~-----s~e~LdeAl~masldHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKA-----SIELLDEALRMASLDHPNLLRLLGVCMLST 771 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchh-----hHHHHHHHHHHhcCCCchHHHHhhhcccch
Confidence 4556789999999999999983 3 4799999977554432 367899999999999999987
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+.....+.|..||++||.|||.+.++||||..+|||+.+-..+||.|||+++.....
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 5677888999999999999999999999999999999999999999999999999877654
Q ss_pred CCC---CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 020016 182 GSA---KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 257 (332)
Q Consensus 182 ~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 257 (332)
... ....-.+.|||-|.+....|+.++|||||||++||++| |..|+.+...+++- .....+.+...|+.++-++.
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-dlle~geRLsqPpiCtiDVy 930 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-DLLEKGERLSQPPICTIDVY 930 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-HHHhccccCCCCCCccHHHH
Confidence 432 23345678999999999999999999999999999999 99999998877665 44567778999999999999
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 258 YLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 258 ~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
.++.+||..|+..||+++++...+..+...
T Consensus 931 ~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 931 MVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred HHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 999999999999999999999988776543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=257.49 Aligned_cols=224 Identities=32% Similarity=0.563 Sum_probs=184.0
Q ss_pred CCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHc--CCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR--LNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~------------ 120 (332)
.+..+.+.||+|.||.||+|.|+|..||||+|....+ +.+.+|.+|... |+|+||+.
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE---------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE---------RSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccch---------hhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 6789999999999999999999999999999987543 456777777765 59999985
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCccccccccceeecCCCeEEEeecc
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQ--------GILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
....++.+..++++..++.||++||.. .|.|||||+.|||+..+|.+.|+|+|
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 456789999999999999999999964 49999999999999999999999999
Q ss_pred cccccccCC-----CCCCcccccccCChhhhhcCC----C--CCccchhHHHHHHHHHHhC----------CCCCCCCC-
Q 020016 174 ISCLESQCG-----SAKGFTGTYRWMAPEMIKEKR----H--TKKVDVYSFGIVLWELLTA----------LTPFDNMT- 231 (332)
Q Consensus 174 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~----~--~~~sDvwSlG~il~elltG----------~~pf~~~~- 231 (332)
+|....... ..+..+||.+|||||++...- + -..+||||||+++||++.. +.||.+..
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 996544332 245678999999999996432 2 3479999999999999752 56886543
Q ss_pred ----HHHHHHHHHhcCCCCCCCCCCc-----HHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 232 ----PEQAAFAVCQKNARPPVPPTCP-----KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 232 ----~~~~~~~~~~~~~~~~~~~~~~-----~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
.++....+.....+|.+|..+. ..+..+|+.||..||.-|.|+-.+-+.|.++..+
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 3455555666788888886653 3467899999999999999999999999888653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=268.87 Aligned_cols=211 Identities=22% Similarity=0.356 Sum_probs=175.7
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT---------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~---------- 120 (332)
.++|.+...+|.|+|+.|-.+.+. ++..+||++.....+ -.+|+.++... +||||++
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----------~~~e~~~~~~~~~h~niv~~~~v~~~~~~ 390 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----------NQDEIPISLLVRDHPNIVKSHDVYEDGKE 390 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc----------cccccchhhhhcCCCcceeecceecCCce
Confidence 678999999999999999999886 788999999886332 23466555544 8999987
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee-cCCCeEEEeecccccccccCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL-GEDMCVKVADFGISCLESQCG 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll-~~~~~~kl~Dfg~a~~~~~~~ 182 (332)
...+....++..|+.+|+.|+.|||++|++||||||+|||+ +..|+++|+|||.+......
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 11222336788899999999999999999999999999999 68899999999999776654
Q ss_pred CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 020016 183 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 262 (332)
....+-|..|.|||+.....|+.++|+||||++||+||+|+.||..-... ..+......+.+...+|...++|+++
T Consensus 470 -~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s~~vS~~AKdLl~~ 545 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFSECVSDEAKDLLQQ 545 (612)
T ss_pred -hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccccccCHHHHHHHHH
Confidence 33456789999999999999999999999999999999999999875554 23333445555668899999999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~ 279 (332)
||+.||.+||++.++..
T Consensus 546 LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 546 LLQVDPALRLGADEIGA 562 (612)
T ss_pred hccCChhhCcChhhhcc
Confidence 99999999999999875
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=249.92 Aligned_cols=211 Identities=20% Similarity=0.315 Sum_probs=166.0
Q ss_pred CCeeeeeee--cccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHc-CCCCceec---------
Q 020016 55 SQLFIGCKF--ASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR-LNHPHIIT--------- 120 (332)
Q Consensus 55 ~~y~i~~~l--g~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~--------- 120 (332)
++|.+.+.+ |+|+||.||++..+ +..+|+|.+....... .|+..... .+||||++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----------~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----------IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 466666666 99999999999986 7889999987643221 02222221 27999986
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC-eEEEeeccccccccc
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVADFGISCLESQ 180 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~ 180 (332)
....+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++.....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 234789999999999999999999999999999999999999988 999999998865433
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hcCCCCCCCCCCcHHHHH
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC--QKNARPPVPPTCPKAFSY 258 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~ 258 (332)
.....++..|+|||++.+..++.++||||||+++|+|++|..||............. ........+..+++.+.+
T Consensus 163 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T PHA03390 163 ---PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAND 239 (267)
T ss_pred ---CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHH
Confidence 233468899999999998889999999999999999999999998654433211111 112233455678999999
Q ss_pred HHHHccccCCCCCCC-HHHHHH
Q 020016 259 LISRCWSSSPDRRPH-FDQIVS 279 (332)
Q Consensus 259 li~~cl~~dp~~Rps-~~ell~ 279 (332)
+|.+||+.+|.+||+ ++++++
T Consensus 240 li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 240 FVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHhccChhhCCchHHHHhc
Confidence 999999999999995 688874
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=279.59 Aligned_cols=226 Identities=21% Similarity=0.273 Sum_probs=190.0
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
.....++|.|.+.||+|+||.|.+++++ ++.||+|++++-.- .......-|..|-++|..-+.+-|+.
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eM---lKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEM---LKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHH---hhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3455789999999999999999999997 78899999987211 11111245788889998888777764
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
.-..++++.++.++.+|+.||.-||+.|+|||||||+|||+|..|++||+|||.+....
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 23369999999999999999999999999999999999999999999999999986655
Q ss_pred cCC--CCCCcccccccCChhhhh----c-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--C
Q 020016 180 QCG--SAKGFTGTYRWMAPEMIK----E-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--P 250 (332)
Q Consensus 180 ~~~--~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~ 250 (332)
..+ .....+|||.|++||++. + +.|+..+|+||+||++|||+.|..||...+-.+.+-.++.......+| .
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~ 306 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDET 306 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccc
Confidence 433 345678999999999995 3 568999999999999999999999999988888888888776677777 5
Q ss_pred CCcHHHHHHHHHccccCCCCCCC---HHHHHH
Q 020016 251 TCPKAFSYLISRCWSSSPDRRPH---FDQIVS 279 (332)
Q Consensus 251 ~~~~~l~~li~~cl~~dp~~Rps---~~ell~ 279 (332)
.+|.+.++||++.+. +|+.|.. ++++..
T Consensus 307 ~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 307 DVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred ccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 689999999999886 7788887 888876
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=253.68 Aligned_cols=227 Identities=29% Similarity=0.507 Sum_probs=183.1
Q ss_pred cCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHc--CCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR--LNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~----------- 120 (332)
....++.+.||+|+||.||+|..+++.||||+|+... .+.|.+|-+|.+. +.|+||++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~---------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQE---------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCHHH---------HHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 4667888999999999999999999999999998643 3567777777665 48999986
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCccccccccceeecCCCeEEEee
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQ---------GILHRDLKSENLLLGEDMCVKVAD 171 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~---------~iiH~dlkp~NIll~~~~~~kl~D 171 (332)
....++|.....|+..+++||+|||.. .|+|||||..||||..++++.|+|
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 456789999999999999999999963 599999999999999999999999
Q ss_pred cccccccccCC---CCCCcccccccCChhhhhcCCC------CCccchhHHHHHHHHHHhCCC------------CCC--
Q 020016 172 FGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRH------TKKVDVYSFGIVLWELLTALT------------PFD-- 228 (332)
Q Consensus 172 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~------~~~sDvwSlG~il~elltG~~------------pf~-- 228 (332)
||+|..+.... .....+||.+|||||++.+.-. -.+.||||+|.++|||++... ||.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 99998765432 2335789999999999976432 247899999999999998532 332
Q ss_pred ---CCCHHHHHHHHHhcCCCCCCCCCC-----cHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 229 ---NMTPEQAAFAVCQKNARPPVPPTC-----PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 229 ---~~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
..+-++....+..++.||.+|..+ ...+.+.+..||+.||+-|.|+.=+.+++..+...-+
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 123345555666678888877543 3568899999999999999999999888887654443
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=272.90 Aligned_cols=120 Identities=27% Similarity=0.432 Sum_probs=104.5
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
+++|.+.++||.|+||+||+|.+. ++.||||++....... ......+.+|+.++..++||||++
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~---~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 79 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMIN---KNMVHQVQAERDALALSKSPFIVHLYYSLQSANNV 79 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccC---HHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEE
Confidence 578999999999999999999997 7899999997643211 122467889999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccc
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
....+++..++.++.||+.||.|||.+||+||||||+|||++.++.++|+|||++.
T Consensus 80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 23457888999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=243.59 Aligned_cols=214 Identities=24% Similarity=0.359 Sum_probs=176.4
Q ss_pred CCeeee-eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec----------
Q 020016 55 SQLFIG-CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT---------- 120 (332)
Q Consensus 55 ~~y~i~-~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~---------- 120 (332)
++|.+. ++||-|-.|.|-.+.++ ++.+|+|++... ....+|+++.-.. .|||||.
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----------PKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 556653 57999999999999887 889999998763 2345788776555 7999986
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC---CCeEEEeecc
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DMCVKVADFG 173 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~---~~~~kl~Dfg 173 (332)
....+++.++..|+.||..|+.|||+.+|.||||||+|+|... +..+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 3456999999999999999999999999999999999999965 4579999999
Q ss_pred cccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcCCCCCC-
Q 020016 174 ISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ----AAFAVCQKNARPPV- 248 (332)
Q Consensus 174 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~----~~~~~~~~~~~~~~- 248 (332)
+|..........+.+.||.|.|||++....|+...|+||+||+||-|++|.+||....... ....+.......+-
T Consensus 210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p 289 (400)
T KOG0604|consen 210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP 289 (400)
T ss_pred cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence 9988776667778899999999999999999999999999999999999999997654322 22233222222221
Q ss_pred -CCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 249 -PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 249 -~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...+|...+++|+.+|..+|++|.|+.++++
T Consensus 290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 2457889999999999999999999999875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=239.31 Aligned_cols=228 Identities=22% Similarity=0.336 Sum_probs=180.8
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
.+-.+.+.|.-..+||+|.||.||+|+.+ ++.||+|+.-....... ......+|+++|..|.|+|++.
T Consensus 11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeG----fpitalreikiL~~lkHenv~nliEic~ 86 (376)
T KOG0669|consen 11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEG----FPITALREIKILQLLKHENVVNLIEICR 86 (376)
T ss_pred CceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccC----CcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence 34455678888999999999999999886 67899987765333222 1345688999999999999875
Q ss_pred ------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEe
Q 020016 121 ------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVA 170 (332)
Q Consensus 121 ------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~ 170 (332)
....++..++..++.+++.||.|+|+..|+|||+|+.|+||+.+|.+||+
T Consensus 87 tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklA 166 (376)
T KOG0669|consen 87 TKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLA 166 (376)
T ss_pred hccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEee
Confidence 33578999999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCC-----CCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--c
Q 020016 171 DFGISCLESQCGS-----AKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ--K 242 (332)
Q Consensus 171 Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~--~ 242 (332)
|||+++.++.... ....+.|..|.+||.+.+. .|+.+.|+|..||++.||+||.+.+++.+..+....+.. +
T Consensus 167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG 246 (376)
T ss_pred ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence 9999976543321 2334569999999998764 689999999999999999999999998877665544322 1
Q ss_pred CCC------------------CCCCCC-------------CcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 243 NAR------------------PPVPPT-------------CPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 243 ~~~------------------~~~~~~-------------~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
... ++++.. -+++..+|+.++|..||.+|+++++++..
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111 111110 13467899999999999999999998864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=246.11 Aligned_cols=235 Identities=26% Similarity=0.541 Sum_probs=198.2
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEECC-------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT- 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~- 120 (332)
+..+...++++...+-+|.||.||+|+|.. +.|-+|.+.....+ .....+..|.-++..+.|||+..
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~-----iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQ-----IQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccH-----HHHHHHHHHHHHHhcCcCCCccce
Confidence 444556778889999999999999998752 45677776553322 22467899999999999999975
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC
Q 020016 121 ------------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED 164 (332)
Q Consensus 121 ------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~ 164 (332)
....++..+...++.|++.|+.|||+.|++|.||..+|.+||+.
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh
Confidence 23457778899999999999999999999999999999999999
Q ss_pred CeEEEeecccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 020016 165 MCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVC 240 (332)
Q Consensus 165 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~ 240 (332)
.++||+|=.+++..-+... ......+..||+||.+.+..|+.++|||||||+||||+| |+.||...++.+....+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl- 511 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL- 511 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH-
Confidence 9999999998875433221 122335678999999999999999999999999999999 99999999998876655
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 241 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
..+.+...|-+||+++..+|.-||...|++||++++++.-|.++..++.
T Consensus 512 kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 512 KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 4678889999999999999999999999999999999999999877664
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=248.59 Aligned_cols=217 Identities=24% Similarity=0.345 Sum_probs=180.8
Q ss_pred ccccCCeeeeeeecccCceEEEEEEECC--eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCC-Cceec-------
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH-PHIIT------- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~------- 120 (332)
.+...+|.++..||.|+||.|.+|..+| +.+|||++++.-.-+... .+--+.|-.+|..... |.++.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDD---vectm~EKrvLAL~~kppFL~qlHScFQT 421 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDD---VECTMVEKRVLALPGKPPFLVQLHSCFQT 421 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCc---ccceehhhhheecCCCCchHHHHHHHhhh
Confidence 4567889999999999999999999985 679999998742211100 1112345555554433 33322
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
..+.+.+..+.-++.+|+-||-+||++||++||||.+||++|.+|.+||+|||++...-
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 56778899999999999999999999999999999999999999999999999986533
Q ss_pred -cCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 020016 180 -QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 258 (332)
Q Consensus 180 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 258 (332)
...++.+++|||.|+|||++...+|+..+|+||+||+||||+.|++||++.+.++....+... ...+|..+|.+..+
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh--nvsyPKslSkEAv~ 579 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH--NVSYPKSLSKEAVA 579 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc--cCcCcccccHHHHH
Confidence 334567899999999999999999999999999999999999999999999999998888644 46788999999999
Q ss_pred HHHHccccCCCCCC
Q 020016 259 LISRCWSSSPDRRP 272 (332)
Q Consensus 259 li~~cl~~dp~~Rp 272 (332)
+....|...|.+|.
T Consensus 580 ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 580 ICKGLLTKHPGKRL 593 (683)
T ss_pred HHHHHhhcCCcccc
Confidence 99999999999995
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-31 Score=231.05 Aligned_cols=208 Identities=33% Similarity=0.499 Sum_probs=171.8
Q ss_pred CceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------------------
Q 020016 67 RHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------------------ 120 (332)
Q Consensus 67 ~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------------ 120 (332)
+||.||+|.+. ++.+|+|++........ .+.+.+|+..+++++|+||++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-----RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-----HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHH
Confidence 58999999996 58999999987544321 367889999999999999985
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCCCCcccccccCCh
Q 020016 121 ----EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAP 196 (332)
Q Consensus 121 ----~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aP 196 (332)
....+++..+..++.+++.++.+||+.+++|+||+|+||+++.++.++|+|||.+.............++..|++|
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~p 155 (244)
T smart00220 76 DLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAP 155 (244)
T ss_pred HHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCH
Confidence 1122788999999999999999999999999999999999999999999999998776654445566788999999
Q ss_pred hhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC--CcHHHHHHHHHccccCCCCCCCH
Q 020016 197 EMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT--CPKAFSYLISRCWSSSPDRRPHF 274 (332)
Q Consensus 197 E~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~dp~~Rps~ 274 (332)
|.+.+..++.++||||||+++|++++|..||........................ ++..+.+++.+||..+|++||++
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~ 235 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTA 235 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCH
Confidence 9998888899999999999999999999999874433333333333322222222 88999999999999999999999
Q ss_pred HHHHH
Q 020016 275 DQIVS 279 (332)
Q Consensus 275 ~ell~ 279 (332)
.++++
T Consensus 236 ~~~~~ 240 (244)
T smart00220 236 EEALQ 240 (244)
T ss_pred HHHhh
Confidence 99986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=234.00 Aligned_cols=222 Identities=23% Similarity=0.326 Sum_probs=177.8
Q ss_pred eeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------
Q 020016 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------- 120 (332)
Q Consensus 57 y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 120 (332)
.+-.+.||-|+||.||...+. |+.||+|++..-...-. .-+.+.+|+.+|..++|.|++.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~----s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLA----SCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHH----HHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence 344579999999999999885 89999999876433221 1367899999999999999875
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 182 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 182 (332)
.+..++.+.+.-+++||+.||.|||+.||.||||||.|.|++.+..+||+|||+++......
T Consensus 131 EiYV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 131 ELYVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 67889999999999999999999999999999999999999999999999999998755432
Q ss_pred --CCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------------
Q 020016 183 --SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------------- 246 (332)
Q Consensus 183 --~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~------------- 246 (332)
.....+.|-.|.|||++++. .|+.+.||||.|||+.|++..+..|...++.+...-+..-...+
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 23445678899999999875 57999999999999999999999998877765544433211111
Q ss_pred -----------CCC--------CCCcHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 020016 247 -----------PVP--------PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282 (332)
Q Consensus 247 -----------~~~--------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~ 282 (332)
.++ ..-..+...++..++.+||++|.+..+.+..+.
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 111 112235677889999999999999988876543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=235.04 Aligned_cols=190 Identities=19% Similarity=0.287 Sum_probs=153.9
Q ss_pred cCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------------------
Q 020016 66 GRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------------------- 120 (332)
Q Consensus 66 G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------------- 120 (332)
|.+|.||++.+. ++.||+|.+.... .+.+|...+....||||++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCH
Confidence 899999999996 7899999997642 1234555556667999986
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCCCCcccccccCC
Q 020016 121 -----EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMA 195 (332)
Q Consensus 121 -----~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~a 195 (332)
....+++..+..++.|++.||.|||++|++||||||+||+++.++.++++|||.+...... .....++..|+|
T Consensus 73 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~a 150 (237)
T cd05576 73 WSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCA 150 (237)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccC
Confidence 2235789999999999999999999999999999999999999999999999987544332 223445778999
Q ss_pred hhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCH
Q 020016 196 PEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHF 274 (332)
Q Consensus 196 PE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 274 (332)
||.+.+..++.++|+||+|+++|+|++|..|+...... ........++..+++.+.+++.+||+.||++||++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 99998888899999999999999999999887643211 11122334567789999999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=246.10 Aligned_cols=226 Identities=23% Similarity=0.350 Sum_probs=181.0
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchh-HHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDA-SLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
.++|.++..||.|||+.||+|.+- ++.||||+-....... ...+...+...+|.+|.+.|+||.||+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 478999999999999999999885 7899999987654433 333555677889999999999999997
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC--CCccccccccceeecC---CCeEEEeeccccc
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQ--GILHRDLKSENLLLGE---DMCVKVADFGISC 176 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~--~iiH~dlkp~NIll~~---~~~~kl~Dfg~a~ 176 (332)
....+++.+++.|+.||+.||.||... .|||-||||.|||+-. -|.+||.|||++.
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 456789999999999999999999987 4999999999999943 4899999999998
Q ss_pred ccccCCC--------CCCcccccccCChhhhhcC----CCCCccchhHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-Hhc
Q 020016 177 LESQCGS--------AKGFTGTYRWMAPEMIKEK----RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-AAFAV-CQK 242 (332)
Q Consensus 177 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~il~elltG~~pf~~~~~~~-~~~~~-~~~ 242 (332)
....... +....||.+|++||.+.-+ ..+.++||||+|||+|..+.|+.||......+ ++... ..+
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk 701 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK 701 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc
Confidence 7543322 2346799999999998544 35889999999999999999999998754333 32221 112
Q ss_pred CCCCCC--CCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 243 NARPPV--PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 243 ~~~~~~--~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.....+ .+.++.+..++|++||++.-++|.+..++..
T Consensus 702 AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 702 ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 222233 3568999999999999999999988877654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=279.31 Aligned_cols=223 Identities=23% Similarity=0.315 Sum_probs=167.3
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
..|...+.||+|+||.||+|.+. +..||||.+...... ...|++++++++|||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~ 759 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----------PSSEIADMGKLQHPNIVKLIGLCRSEKGAY 759 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----------cHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence 34666789999999999999975 789999998753321 124688999999999997
Q ss_pred ------CC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccccccceeecCCCeEEEeecccccccccCCCC
Q 020016 121 ------EP-------YSVPLNLVLKLALDIARGMQYLH---SQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 184 (332)
Q Consensus 121 ------~~-------~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 184 (332)
.. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++..++. ||....... .
T Consensus 760 lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~ 835 (968)
T PLN00113 760 LIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---D 835 (968)
T ss_pred EEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---C
Confidence 11 23788999999999999999999 6699999999999999998887775 555432221 2
Q ss_pred CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHh-----cCCCCCC------
Q 020016 185 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP-----EQAAFAVCQ-----KNARPPV------ 248 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~-----~~~~~~~~~-----~~~~~~~------ 248 (332)
....+|+.|+|||++.+..++.++|||||||++|||+||+.||..... .+....... ....+..
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 234678999999999999999999999999999999999999854211 111100000 0001111
Q ss_pred CCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 020016 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 291 (332)
Q Consensus 249 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~ 291 (332)
+.....++.+++.+||+.||++||++.++++.|+.+....+..
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~~ 958 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSC 958 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccccc
Confidence 1112235678999999999999999999999999886655433
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=233.72 Aligned_cols=222 Identities=20% Similarity=0.338 Sum_probs=183.3
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec---
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT--- 120 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--- 120 (332)
...|..-..+|.+.+.||+|+|++|..++.+ .+.+|+|++++....... -.+-...|-.+..+. +||.+|.
T Consensus 242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndde---didwvqtek~vfe~asn~pflvglhs 318 (593)
T KOG0695|consen 242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDE---DIDWVQTEKHVFEQASNNPFLVGLHS 318 (593)
T ss_pred ccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcc---cchhHHhhHHHHHhccCCCeEEehhh
Confidence 4678888899999999999999999999886 688999999875322211 123455666666665 7898875
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
....++++.++.+..+|..||.|||++||++||||.+|||+|..|.+||.|+|++
T Consensus 319 cfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmc 398 (593)
T KOG0695|consen 319 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMC 398 (593)
T ss_pred hhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchh
Confidence 5678999999999999999999999999999999999999999999999999998
Q ss_pred cc-cccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHhcCCCCC
Q 020016 176 CL-ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN-------MTPEQAAFAVCQKNARPP 247 (332)
Q Consensus 176 ~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~-------~~~~~~~~~~~~~~~~~~ 247 (332)
.. ......+.+++|||.|.|||++++..|...+|+|+|||+|+||+.|+.||+- .+.++..+++.. .....
T Consensus 399 ke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil-ekqir 477 (593)
T KOG0695|consen 399 KEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL-EKQIR 477 (593)
T ss_pred hcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh-hhccc
Confidence 75 3445567889999999999999999999999999999999999999999962 233444444432 22344
Q ss_pred CCCCCcHHHHHHHHHccccCCCCCC
Q 020016 248 VPPTCPKAFSYLISRCWSSSPDRRP 272 (332)
Q Consensus 248 ~~~~~~~~l~~li~~cl~~dp~~Rp 272 (332)
+|..++-....+++.-|.+||.+|.
T Consensus 478 iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ccceeehhhHHHHHHhhcCCcHHhc
Confidence 6777888888999999999999994
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=240.44 Aligned_cols=216 Identities=22% Similarity=0.350 Sum_probs=170.1
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCC--Cc----eec-----
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH--PH----IIT----- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~n----iv~----- 120 (332)
..+|.+...+|+|+||.|-.+.+. +..||||+++.-. ...+..+-|+++|.++++ |+ +|.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-------kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-------KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-------HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 589999999999999999999997 6789999997632 234667789999999943 22 111
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC-------------
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE------------- 163 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~------------- 163 (332)
.-.+++...++.|++|+++++++||+.+++|.||||+|||+-.
T Consensus 161 dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 161 DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence 3346889999999999999999999999999999999999931
Q ss_pred -------CCeEEEeecccccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 020016 164 -------DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA 236 (332)
Q Consensus 164 -------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~ 236 (332)
+..++|+|||.|+...+.. ...+.|..|.|||++.+-.++..+||||+||||+|+.||...|+.-++.+-.
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 2358999999998766533 5678899999999999999999999999999999999999999876544422
Q ss_pred HHHHhcCC--------------------CCCCC-------------------------CCCcHHHHHHHHHccccCCCCC
Q 020016 237 FAVCQKNA--------------------RPPVP-------------------------PTCPKAFSYLISRCWSSSPDRR 271 (332)
Q Consensus 237 ~~~~~~~~--------------------~~~~~-------------------------~~~~~~l~~li~~cl~~dp~~R 271 (332)
+.++.-. +...+ ...-..+.+|+++||.+||.+|
T Consensus 319 -aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 319 -AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred -HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 1111000 00000 0011357899999999999999
Q ss_pred CCHHHHHH
Q 020016 272 PHFDQIVS 279 (332)
Q Consensus 272 ps~~ell~ 279 (332)
+|+.|++.
T Consensus 398 iTl~EAL~ 405 (415)
T KOG0671|consen 398 ITLREALS 405 (415)
T ss_pred ccHHHHhc
Confidence 99999885
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=217.48 Aligned_cols=189 Identities=24% Similarity=0.376 Sum_probs=158.5
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec---
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT--- 120 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--- 120 (332)
...++++-+.+..+..||+|++|.|-+-++. |+..|+|.+..+-.... ..+...|+++..+. ..|.+|.
T Consensus 38 ~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~-----q~r~L~dldi~~r~~~CPf~V~FyG 112 (282)
T KOG0984|consen 38 DRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQE-----QKRLLMDLDIIMRTVDCPFTVHFYG 112 (282)
T ss_pred cCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHH-----HHHHHHhhhhhccCCCCCeEEEeeh
Confidence 3447888888999999999999998777664 89999999987655443 35677788877665 7888886
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccccccceeecCCCeEEEee
Q 020016 121 ----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVAD 171 (332)
Q Consensus 121 ----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~NIll~~~~~~kl~D 171 (332)
.++.+++..+-+|+..+++||.|||++ .++|||+||.||||+.+|++|+||
T Consensus 113 a~~regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCD 192 (282)
T KOG0984|consen 113 ALFREGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICD 192 (282)
T ss_pred hhhccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcc
Confidence 678899999999999999999999987 899999999999999999999999
Q ss_pred cccccccccCCCCCCcccccccCChhhhhc----CCCCCccchhHHHHHHHHHHhCCCCCCC-CCHHHHHHHHH
Q 020016 172 FGISCLESQCGSAKGFTGTYRWMAPEMIKE----KRHTKKVDVYSFGIVLWELLTALTPFDN-MTPEQAAFAVC 240 (332)
Q Consensus 172 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlG~il~elltG~~pf~~-~~~~~~~~~~~ 240 (332)
||.+..+.+.-..+...|...|+|||.+.. ..|+.++||||||+++.||.+++.||+. .++.+...++.
T Consensus 193 FGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 193 FGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred cccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 999977766554445678889999999853 4689999999999999999999999986 45666666654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=251.16 Aligned_cols=226 Identities=16% Similarity=0.184 Sum_probs=147.1
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC------CeeEEEEEecCCCchhHHHHHHHHHHHHH-----HHHHHcCCC--
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSE-----VALLFRLNH-- 115 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E-----~~~l~~l~h-- 115 (332)
.+....++|.+.+.||+|+||.||+|.+. +..||||.+.......... .+.+.+. ...+..+.+
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~---~e~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWM---NERVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHH---HHHHHhhchhhHHHHHHhhhccc
Confidence 34456789999999999999999999985 4689999886533221110 0111100 000111000
Q ss_pred -------Cceec---------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Q 020016 116 -------PHIIT---------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 155 (332)
Q Consensus 116 -------~niv~---------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlk 155 (332)
-.++. .........+..++.||+.||.|||++||+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 01110 00111234466899999999999999999999999
Q ss_pred ccceeecC-CCeEEEeecccccccccC--CCCCCcccccccCChhhhhcCC----------------------CCCccch
Q 020016 156 SENLLLGE-DMCVKVADFGISCLESQC--GSAKGFTGTYRWMAPEMIKEKR----------------------HTKKVDV 210 (332)
Q Consensus 156 p~NIll~~-~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----------------------~~~~sDv 210 (332)
|+|||++. ++.+||+|||++...... .......+++.|+|||.+.... ++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 589999999999754322 2234567899999999764322 3346699
Q ss_pred hHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-C---------CCCCC----------CCCCcHHHHHHHHHccccCCCC
Q 020016 211 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQK-N---------ARPPV----------PPTCPKAFSYLISRCWSSSPDR 270 (332)
Q Consensus 211 wSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~---------~~~~~----------~~~~~~~l~~li~~cl~~dp~~ 270 (332)
|||||++|||+++..++... .......... . ..... ....+....+||.+||+.||.+
T Consensus 363 wSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 99999999999977665431 1111111000 0 00000 0112334568999999999999
Q ss_pred CCCHHHHHH
Q 020016 271 RPHFDQIVS 279 (332)
Q Consensus 271 Rps~~ell~ 279 (332)
|||+.++++
T Consensus 441 R~ta~e~L~ 449 (566)
T PLN03225 441 RISAKAALA 449 (566)
T ss_pred CCCHHHHhC
Confidence 999999986
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=229.10 Aligned_cols=215 Identities=21% Similarity=0.345 Sum_probs=171.6
Q ss_pred eee-eeeecccCceEEEEEEE--CCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec------------
Q 020016 57 LFI-GCKFASGRHSRIYRGIY--KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT------------ 120 (332)
Q Consensus 57 y~i-~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~------------ 120 (332)
|++ .+.||+|+|+.|--+.. .+..+|||++.+..... +..+.+|++++.+. .|+||+.
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHs------R~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FY 152 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHS------RSRVFREVETFYQCQGHKNILQLIEFFEDDTRFY 152 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchH------HHHHHHHHHHHHHhcCCccHHHHHHHhcccceEE
Confidence 443 56899999999998866 48999999998864332 57789999999999 6999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC---CeEEEeecccccccccC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED---MCVKVADFGISCLESQC 181 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~ 181 (332)
....+++.++..+..+|+.||.|||.+||.||||||+|||-... .-+||+||.++.-....
T Consensus 153 LVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~ 232 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN 232 (463)
T ss_pred EEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence 45568999999999999999999999999999999999999544 45899999987542211
Q ss_pred C--------CCCCcccccccCChhhhh-----cCCCCCccchhHHHHHHHHHHhCCCCCCCCCH---------------H
Q 020016 182 G--------SAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTP---------------E 233 (332)
Q Consensus 182 ~--------~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~pf~~~~~---------------~ 233 (332)
. ...+.+|+..|||||+.. ...|+.+.|.||||+|+|-||+|.+||.+.-. .
T Consensus 233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~ 312 (463)
T KOG0607|consen 233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN 312 (463)
T ss_pred CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH
Confidence 1 123567899999999873 34579999999999999999999999986432 1
Q ss_pred HHHHHHHhcCCCCCCC----CCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 234 QAAFAVCQKNARPPVP----PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 234 ~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.....+..+ ...+| ..++.+..+++..+|..|+.+|.++.+++.
T Consensus 313 ~LFesIQEG--kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 313 KLFESIQEG--KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHhcc--CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 222333322 23344 457899999999999999999999998887
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-30 Score=243.62 Aligned_cols=228 Identities=20% Similarity=0.215 Sum_probs=159.4
Q ss_pred cccCCeeeeeeecccCceEEEEEEE------------------CCeeEEEEEecCCCchhHH--------HHHHHHHHHH
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIY------------------KQRDVAIKLVSQPEEDASL--------ASMLEKQFTS 105 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~------------------~~~~vAvK~~~~~~~~~~~--------~~~~~~~~~~ 105 (332)
...++|.+.++||+|+||+||+|.+ .++.||||.+......... .....+.+..
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4578999999999999999999974 1467999998754321100 0011233455
Q ss_pred HHHHHHcCCCCceec-----------------------------------------------------------------
Q 020016 106 EVALLFRLNHPHIIT----------------------------------------------------------------- 120 (332)
Q Consensus 106 E~~~l~~l~h~niv~----------------------------------------------------------------- 120 (332)
|+.++.+++|.+++.
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 777777776665411
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCCC--CcccccccCChhh
Q 020016 121 EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK--GFTGTYRWMAPEM 198 (332)
Q Consensus 121 ~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~ 198 (332)
....+++..+..++.|++.+|.|||+.+|+||||||+||+++.++.++|+|||++.......... ...+|+.|+|||.
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 00123566788899999999999999999999999999999999999999999986543322212 2335789999998
Q ss_pred hhcCC----------------------CCCccchhHHHHHHHHHHhCCC-CCCCCCHHHHH----------H-HHHhcCC
Q 020016 199 IKEKR----------------------HTKKVDVYSFGIVLWELLTALT-PFDNMTPEQAA----------F-AVCQKNA 244 (332)
Q Consensus 199 ~~~~~----------------------~~~~sDvwSlG~il~elltG~~-pf~~~~~~~~~----------~-~~~~~~~ 244 (332)
+.... ...+.||||+||++|+|++|.. ||......... + .......
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~ 461 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY 461 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence 75322 1234799999999999999875 77542211100 0 0111111
Q ss_pred CCCCCCCCcHHHHHHHHHccccCC---CCCCCHHHHHH
Q 020016 245 RPPVPPTCPKAFSYLISRCWSSSP---DRRPHFDQIVS 279 (332)
Q Consensus 245 ~~~~~~~~~~~l~~li~~cl~~dp---~~Rps~~ell~ 279 (332)
........++...+|+.+||..+| .+|+|++|+++
T Consensus 462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 222335678899999999999866 68999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=257.77 Aligned_cols=222 Identities=31% Similarity=0.474 Sum_probs=170.8
Q ss_pred eeeeecccCceE-EEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec----------------
Q 020016 59 IGCKFASGRHSR-IYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT---------------- 120 (332)
Q Consensus 59 i~~~lg~G~~g~-Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~---------------- 120 (332)
-.+.+|.|+.|+ ||+|.+.++.||||.+-.... ....+|+..|+.- +|||||+
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~---------~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFF---------DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred cHHHcccCCCCcEEEEEeeCCceehHHHHhhHhH---------HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 356789999997 899999999999999865322 3457899999988 7999997
Q ss_pred ----------CC--CC---CCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC---C--CeEEEeeccccccccc
Q 020016 121 ----------EP--YS---VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---D--MCVKVADFGISCLESQ 180 (332)
Q Consensus 121 ----------~~--~~---l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~---~--~~~kl~Dfg~a~~~~~ 180 (332)
.. .. ......+.++.|++.||++||+.+|+||||||.||||+. + ..++|+|||++.....
T Consensus 584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 11 00 111345788999999999999999999999999999975 2 5799999999976554
Q ss_pred CC----CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC-CCCCCCcH
Q 020016 181 CG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP-PVPPTCPK 254 (332)
Q Consensus 181 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 254 (332)
.. ...+..||.+|+|||++.....+.++|+|||||++|+.++ |.+||...-..+. .+....... .+.+....
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d~ 741 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPDC 741 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCchH
Confidence 32 2345679999999999999988999999999999999999 6999987544332 222222211 11112222
Q ss_pred HHHHHHHHccccCCCCCCCHHHHH------------HHHHhhhhhhcCC
Q 020016 255 AFSYLISRCWSSSPDRRPHFDQIV------------SILEGYSESLEQD 291 (332)
Q Consensus 255 ~l~~li~~cl~~dp~~Rps~~ell------------~~L~~~~~~~~~~ 291 (332)
+..+||.+|+.++|..||++.+|+ +.|.++.+.++..
T Consensus 742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e 790 (903)
T KOG1027|consen 742 EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKE 790 (903)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhh
Confidence 789999999999999999999996 4566666666644
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=215.62 Aligned_cols=218 Identities=18% Similarity=0.315 Sum_probs=175.8
Q ss_pred ccCCeeeeeeecccCceEEEEEEE--CCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCceec---------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIY--KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIIT--------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~--------- 120 (332)
..++|++.+++|+|.++.||.|.. +++.++||++++-. .+.+.+|+.+|..|. ||||++
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~ 106 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---------KKKIKREIKILQNLRGGPNIIKLLDIVKDPE 106 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---------HHHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence 468899999999999999999986 47899999998733 356889999999996 999987
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC-CeEEEeecccccccccC
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGISCLESQC 181 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~ 181 (332)
.-..++...++..+.+++.||.|||+.||.|||+||.|++||.. ..++|+|+|+|.+....
T Consensus 107 SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 107 SKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred ccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 22457778899999999999999999999999999999999865 67999999999888776
Q ss_pred CCCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHh------------------
Q 020016 182 GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFD-NMTPEQAAFAVCQ------------------ 241 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~-~~~~~~~~~~~~~------------------ 241 (332)
...+..+.+..|..||.+.. ..|+..-|+|||||++..|+..+.||- +.++.+..-.+..
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 66666777888999999865 457889999999999999999888874 3333222221111
Q ss_pred ---------cCCCCC--------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 242 ---------KNARPP--------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 242 ---------~~~~~~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...+.. -...++++..+|+.++|..|-.+|+|+.|.+.
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 011100 11234689999999999999999999999875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=248.93 Aligned_cols=219 Identities=28% Similarity=0.496 Sum_probs=186.3
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec---------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT--------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------- 120 (332)
+.+.|.|.+.||.|.+|.||++... ++.+|||+.......+ ++...|..+|+.+ .|||++.
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-------eEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-------EEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-------HHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 3577899999999999999999875 8899999998865543 4567788999888 7899875
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
.+..+.|..+..|++.++.||.+||...++|||||-.|||++.++.|||+|||.
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence 567899999999999999999999999999999999999999999999999999
Q ss_pred cccccc-CCCCCCcccccccCChhhhhcC-----CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--
Q 020016 175 SCLESQ-CGSAKGFTGTYRWMAPEMIKEK-----RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP-- 246 (332)
Q Consensus 175 a~~~~~-~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~-- 246 (332)
+..... .....+..|||.|||||++... .|+..+|+||||++..||.-|.+|+.++.+...++.+-. ..++
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR-NPPPkL 248 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-NPPPKL 248 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC-CCCccc
Confidence 865443 3455678899999999999643 468899999999999999999999999998877766532 1112
Q ss_pred CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.-|..++.++-++|..||..|-.+||++.++++
T Consensus 249 krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 249 KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 124667899999999999999999999998875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=220.69 Aligned_cols=220 Identities=24% Similarity=0.325 Sum_probs=177.4
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
.+|.-.+.+|.|.- .|-.+.+. +++||+|.+..+...... .+...+|..++..++|+||++
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~----akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTH----AKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCcc----chhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 57777888999998 77777776 899999998776333221 355678999999999999997
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
..-.++-..+..+++|++.|+.|||+.||+||||||+||++..+..+||.|||+++.....
T Consensus 92 ~~~e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 92 EFQEVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred HHHhHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 1234566778999999999999999999999999999999999999999999999876665
Q ss_pred CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--------------
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-------------- 247 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~-------------- 247 (332)
-..+..+.|..|.|||++.+..+...+||||+||++.||++|...|++.+.-+...++......+.
T Consensus 172 ~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~y 251 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNY 251 (369)
T ss_pred cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHH
Confidence 566778899999999999999999999999999999999999999988665444333322111110
Q ss_pred ---------------CC-----------CCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 248 ---------------VP-----------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 248 ---------------~~-----------~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+| +.-...+++++.+||..||++|.++++++.
T Consensus 252 v~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 252 VENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 11 111345789999999999999999999986
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=236.38 Aligned_cols=217 Identities=21% Similarity=0.286 Sum_probs=175.4
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
.|-+-|..++.||-|+||.|.++.-. ...+|+|.+++... +.......++.|-+||...+++-||+
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV---l~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd 702 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV---LMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD 702 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHH---HhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC
Confidence 45577899999999999999999664 56899999877422 22233456788999999999999997
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc--
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES-- 179 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~-- 179 (332)
.-+-+.++.++.++.++..|+.+.|..|+|||||||+|||||.+|.+||.|||++.-+.
T Consensus 703 nLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence 44668899999999999999999999999999999999999999999999999985210
Q ss_pred -------cCCC----------------------------------CCCcccccccCChhhhhcCCCCCccchhHHHHHHH
Q 020016 180 -------QCGS----------------------------------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 218 (332)
Q Consensus 180 -------~~~~----------------------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ 218 (332)
.... ....+||+.|+|||++....++..+|+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 0000 01245999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHHHHHHccccCCCCCC
Q 020016 219 ELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLISRCWSSSPDRRP 272 (332)
Q Consensus 219 elltG~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rp 272 (332)
||+.|+.||...++.+..+.+........ ....++.+..++|.+++. +++.|.
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence 99999999999888777666655444443 446789999999987543 556664
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-30 Score=233.54 Aligned_cols=217 Identities=24% Similarity=0.331 Sum_probs=173.7
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC------------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN------------------ 114 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------------------ 114 (332)
++|.+....|.|-|++|.+|.+. |..||||++.....- .+.=+.|+++|++|+
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-------~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-------HKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-------hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 67999999999999999999997 789999999874322 244467888888874
Q ss_pred CCc-eec-----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC-CeEEEeecccc
Q 020016 115 HPH-IIT-----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGIS 175 (332)
Q Consensus 115 h~n-iv~-----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~a 175 (332)
|.| ++. .+-.|....+..++.|+.-||..|-..||+|.||||+|||+++. ..+||||||.|
T Consensus 505 hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 505 HKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred hcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence 222 111 55678889999999999999999999999999999999999986 67899999999
Q ss_pred cccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--------
Q 020016 176 CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-------- 247 (332)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~-------- 247 (332)
...+.+.. ..+..+..|.|||++.+.+|+...|+||+||+|||+.||+..|++.++.+.+...+......+
T Consensus 585 ~~~~enei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgq 663 (752)
T KOG0670|consen 585 SFASENEI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQ 663 (752)
T ss_pred cccccccc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcc
Confidence 87766443 345567899999999999999999999999999999999999999887776654433211111
Q ss_pred -----C---------------------------C-----------CCC-------cHHHHHHHHHccccCCCCCCCHHHH
Q 020016 248 -----V---------------------------P-----------PTC-------PKAFSYLISRCWSSSPDRRPHFDQI 277 (332)
Q Consensus 248 -----~---------------------------~-----------~~~-------~~~l~~li~~cl~~dp~~Rps~~el 277 (332)
+ | +.+ -..+.+|+.+||..||++|.+..+.
T Consensus 664 F~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqA 743 (752)
T KOG0670|consen 664 FKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQA 743 (752)
T ss_pred hhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHH
Confidence 0 0 001 1357889999999999999999988
Q ss_pred HH
Q 020016 278 VS 279 (332)
Q Consensus 278 l~ 279 (332)
|+
T Consensus 744 L~ 745 (752)
T KOG0670|consen 744 LK 745 (752)
T ss_pred hc
Confidence 75
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-28 Score=219.66 Aligned_cols=103 Identities=28% Similarity=0.488 Sum_probs=87.2
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-----CC---ceec--
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-----HP---HIIT-- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~---niv~-- 120 (332)
...+|.+.++||-|.|++||+|.+. .+.||+|+.+.. +...+..+.|+.+|++++ |+ .||+
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-------qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-------QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-------hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 3578999999999999999999997 689999998763 233567788999999983 32 3443
Q ss_pred -------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccccccceeec
Q 020016 121 -------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLG 162 (332)
Q Consensus 121 -------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~NIll~ 162 (332)
.-..++...+..|++||+.||.|||.+ ||||-||||+|||+.
T Consensus 149 D~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 149 DHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred ccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 456789999999999999999999986 999999999999993
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-27 Score=199.10 Aligned_cols=180 Identities=35% Similarity=0.615 Sum_probs=156.0
Q ss_pred ecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------------
Q 020016 63 FASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------------- 120 (332)
Q Consensus 63 lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------------- 120 (332)
||+|++|.||++... ++.+++|++....... ..+.+.+|+..++.+.|++|++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCC
Confidence 689999999999997 8999999998765432 2367899999999999999876
Q ss_pred -------CC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC-CCeEEEeecccccccccCC-CCCCccc
Q 020016 121 -------EP--YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMCVKVADFGISCLESQCG-SAKGFTG 189 (332)
Q Consensus 121 -------~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~-~~~~~~g 189 (332)
.. ..+++..+..++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+....... ......+
T Consensus 76 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccC
Confidence 11 35888999999999999999999999999999999999999 8999999999987654432 1334567
Q ss_pred ccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCC
Q 020016 190 TYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 268 (332)
Q Consensus 190 t~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 268 (332)
...|++||..... .++.++|+|++|++++++ ..+.+++..|++.+|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p 202 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDP 202 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCc
Confidence 8899999999877 788999999999999998 678999999999999
Q ss_pred CCCCCHHHHHHH
Q 020016 269 DRRPHFDQIVSI 280 (332)
Q Consensus 269 ~~Rps~~ell~~ 280 (332)
++||++.++++.
T Consensus 203 ~~R~~~~~l~~~ 214 (215)
T cd00180 203 EKRPSAKEILEH 214 (215)
T ss_pred ccCcCHHHHhhC
Confidence 999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=200.00 Aligned_cols=153 Identities=24% Similarity=0.292 Sum_probs=122.1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCCCCcccccccCChhhhhc
Q 020016 122 PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE 201 (332)
Q Consensus 122 ~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 201 (332)
...+++..++.++.|++.||.|||+++ ||+||+++.++.+++ ||++...... ...||+.|+|||++.+
T Consensus 11 ~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~~y~aPE~~~~ 78 (176)
T smart00750 11 GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDPYFMAPEVIQG 78 (176)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcccccChHHhcC
Confidence 456899999999999999999999998 999999999999999 9998765432 2267899999999999
Q ss_pred CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcCCCC-----CCCCCCcH--HHHHHHHHccccCCCCCCC
Q 020016 202 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA-AFAVCQKNARP-----PVPPTCPK--AFSYLISRCWSSSPDRRPH 273 (332)
Q Consensus 202 ~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~--~l~~li~~cl~~dp~~Rps 273 (332)
..++.++||||||+++|||+||..||........ ...+....... ..+..++. .+.+++.+||..+|.+||+
T Consensus 79 ~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~ 158 (176)
T smart00750 79 QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREA 158 (176)
T ss_pred CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccC
Confidence 9999999999999999999999999976543222 22222111111 11122333 6899999999999999999
Q ss_pred HHHHHHHHHhhhh
Q 020016 274 FDQIVSILEGYSE 286 (332)
Q Consensus 274 ~~ell~~L~~~~~ 286 (332)
+.++++.+.....
T Consensus 159 ~~~ll~~~~~~~~ 171 (176)
T smart00750 159 ANHYLAHCRALFA 171 (176)
T ss_pred HHHHHHHHHHHHH
Confidence 9999998876643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=227.66 Aligned_cols=175 Identities=26% Similarity=0.401 Sum_probs=148.3
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchh--HHHHHHHHHHHHHHHHHHcCC---CCceec------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDA--SLASMLEKQFTSEVALLFRLN---HPHIIT------ 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~---h~niv~------ 120 (332)
+.+|...+.+|.|+||.|++|.++ ...|+||.+.+..--. +....-.-.+--|+.||..++ |+||++
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 566899999999999999999998 5789999987742211 010111123557999999997 999997
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccc
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
....+++.++..|++|++.|+++||+.||+|||||-+||.++.+|-+||+|||.+..
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 456799999999999999999999999999999999999999999999999999866
Q ss_pred cccCCCCCCcccccccCChhhhhcCCC-CCccchhHHHHHHHHHHhCCCCCCC
Q 020016 178 ESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDN 229 (332)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~pf~~ 229 (332)
... +....++||..|.|||++.+.+| +..-|||++|++||.++....||..
T Consensus 720 ~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 720 TKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 544 55678899999999999999888 7789999999999999998888853
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=202.90 Aligned_cols=224 Identities=21% Similarity=0.349 Sum_probs=172.3
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec-----------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT----------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----------- 120 (332)
+.|.|.+.||+|.||.+-++.++ ++.+++|.++.+... ..+|.+|..--..| .|.||+.
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt-------~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT-------QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh-------HHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 78999999999999999999998 588999999887654 36788998766666 5788886
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC--CCeEEEeecccccccccC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE--DMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~ 181 (332)
....+.+.....++.|+++|+.|+|+++++|||||.+||||-. ...+||||||..+..+.
T Consensus 97 YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~- 175 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT- 175 (378)
T ss_pred EEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc-
Confidence 4456788999999999999999999999999999999999943 35899999998754332
Q ss_pred CCCCCcccccccCChhhhhc---CC--CCCccchhHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhcCCCCCCC---C
Q 020016 182 GSAKGFTGTYRWMAPEMIKE---KR--HTKKVDVYSFGIVLWELLTALTPFDNMTPEQ---AAFAVCQKNARPPVP---P 250 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~---~~--~~~~sDvwSlG~il~elltG~~pf~~~~~~~---~~~~~~~~~~~~~~~---~ 250 (332)
......-+..|.+||.... +. ..+.+|+|.||+++|.++||..||+.....+ ..+....+...+..| .
T Consensus 176 -tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~ 254 (378)
T KOG1345|consen 176 -TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFN 254 (378)
T ss_pred -eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhc
Confidence 1122334667899998743 22 3788999999999999999999998543322 222222333334444 3
Q ss_pred CCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 251 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
.+++.+..+.++-|..++.+|-...++.++-...+.+
T Consensus 255 ~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 255 PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 4688899999999999999996666666655544433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-26 Score=198.06 Aligned_cols=182 Identities=31% Similarity=0.466 Sum_probs=150.9
Q ss_pred eeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------
Q 020016 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------- 120 (332)
Q Consensus 57 y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 120 (332)
|.+.+.||.|++|.||++... ++.+|+|.+...... ...+.+.+|++.+..++|+|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEE
Confidence 567889999999999999996 589999999875443 12467889999999999999876
Q ss_pred --------------CCCC-CCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC--C
Q 020016 121 --------------EPYS-VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG--S 183 (332)
Q Consensus 121 --------------~~~~-l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--~ 183 (332)
.... +++..+..++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+....... .
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred EeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 1223 7889999999999999999999999999999999999999999999999987655432 3
Q ss_pred CCCcccccccCChhhh-hcCCCCCccchhHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcC
Q 020016 184 AKGFTGTYRWMAPEMI-KEKRHTKKVDVYSFGIVLWELLTALTPFDN-MTPEQAAFAVCQKN 243 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~elltG~~pf~~-~~~~~~~~~~~~~~ 243 (332)
.....++..|++||.+ ....++.++|+|+||+++++|++|+.||.. ..+.....+.....
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG 217 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence 3455678899999998 666778899999999999999999999977 55554444444333
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-28 Score=226.32 Aligned_cols=220 Identities=26% Similarity=0.458 Sum_probs=188.8
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+...+|+|+||.||++++. ++..|||+++....+.. .-..+|+-+++..+|||||.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~------~~iqqei~~~~dc~h~nivay~gsylr~dkl 87 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDF------SGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL 87 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccc------cccccceeeeecCCCcChHHHHhhhhhhcCc
Confidence 368999999999999999999997 78999999998766552 45678999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc-CC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CG 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~~ 182 (332)
..+++++.++..++++.++||+|||+.|=+|||||-.||+++..|.+|++|||.+..... ..
T Consensus 88 wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhh
Confidence 457899999999999999999999999999999999999999999999999998754432 23
Q ss_pred CCCCcccccccCChhhh---hcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC---CCCCcHHH
Q 020016 183 SAKGFTGTYRWMAPEMI---KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV---PPTCPKAF 256 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l 256 (332)
....+.||+.|||||+. +.+.|...+|+|++|+...|+---++|.....+....+-.......++- +...++.+
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence 45678899999999986 4677899999999999999998888888777777777666555555543 34578999
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+|++.||..+|.+||+++.++.
T Consensus 248 h~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHHhcCCCccCCChhhhee
Confidence 99999999999999999988764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=229.47 Aligned_cols=155 Identities=17% Similarity=0.191 Sum_probs=114.3
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC-------------------CeEEEeecccccccccCC
Q 020016 122 PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-------------------MCVKVADFGISCLESQCG 182 (332)
Q Consensus 122 ~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~-------------------~~~kl~Dfg~a~~~~~~~ 182 (332)
...+++..+..++.||+.||.|||++||+||||||+||||+.. +.+|++|||+++......
T Consensus 74 ~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~ 153 (793)
T PLN00181 74 DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILS 153 (793)
T ss_pred cccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCccccccccccccccccc
Confidence 3458999999999999999999999999999999999999654 445566666654321100
Q ss_pred -----------------CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Q 020016 183 -----------------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 245 (332)
Q Consensus 183 -----------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~ 245 (332)
......||+.|+|||++.+..++.++|||||||+||||++|..|+..... ....+.... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~-~ 230 (793)
T PLN00181 154 ERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV-L 230 (793)
T ss_pred ccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh-c
Confidence 00113578889999999999999999999999999999999888764221 111221111 1
Q ss_pred CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 246 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 246 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
++......+....++.+||+.+|.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 231 PPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred ChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 1111122455678999999999999999999975
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.8e-26 Score=203.17 Aligned_cols=217 Identities=23% Similarity=0.369 Sum_probs=163.6
Q ss_pred CCeeeeeeecccCceEEEEEEEC-----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec--------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT-------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~-------- 120 (332)
..|.+.++||.|.|++||++.+. ++.||+|.+...... ..+.+|+++|..+ .+.||++
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--------~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--------SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--------hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 67899999999999999999774 478999999887654 4578899999999 5677765
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC-CeEEEeeccccccc----
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGISCLE---- 178 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~a~~~---- 178 (332)
-...++...+..+++.++.||.++|..||+||||||.|++.+.. +.-.|+|||++...
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred CeeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 12356788999999999999999999999999999999999865 78899999998610
Q ss_pred -------------cc-CCC---------------------------CCCcccccccCChhhhhc-CCCCCccchhHHHHH
Q 020016 179 -------------SQ-CGS---------------------------AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIV 216 (332)
Q Consensus 179 -------------~~-~~~---------------------------~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~i 216 (332)
.. .+. .....||++|.|||++.. ...+.++||||.|+|
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 00 000 001348999999999854 456899999999999
Q ss_pred HHHHHhCCCCCCCCCHH--------------HHHHHHHh-cC-------CC----------------------------C
Q 020016 217 LWELLTALTPFDNMTPE--------------QAAFAVCQ-KN-------AR----------------------------P 246 (332)
Q Consensus 217 l~elltG~~pf~~~~~~--------------~~~~~~~~-~~-------~~----------------------------~ 246 (332)
++.++++..||-....+ ++...... +. .. .
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 99999999998532211 00000000 00 00 0
Q ss_pred CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
......+..+.+|+.+||+.||.+|.|+++.++
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 001123457889999999999999999999986
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-24 Score=196.02 Aligned_cols=228 Identities=21% Similarity=0.344 Sum_probs=175.8
Q ss_pred CeeeeeeecccCceEEEEEEECC---eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCC-------Cceec-----
Q 020016 56 QLFIGCKFASGRHSRIYRGIYKQ---RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH-------PHIIT----- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~~---~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-------~niv~----- 120 (332)
+|.+.++||+|+||.||.+.+.. ..+|+|+......... ..+..|..++..+.. |.++.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP------SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC------ccchhHHHHHHHHhhhcCCCCCCEEEEeccCC
Confidence 89999999999999999999874 4699998877533321 135667777777752 12211
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC-----CeEEEeecc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-----MCVKVADFG 173 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~-----~~~kl~Dfg 173 (332)
....++...+..++.|++.+|.+||+.|++||||||.|+++... ..+.|.|||
T Consensus 93 ~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 93 EDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred CceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 23689999999999999999999999999999999999999764 469999999
Q ss_pred cccccc---cCC-------C-CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-
Q 020016 174 ISCLES---QCG-------S-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ- 241 (332)
Q Consensus 174 ~a~~~~---~~~-------~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~- 241 (332)
+++... ... . .....||..|+++.++.+...+++.|+||++.++.+++.|..||..............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998221 110 1 2245599999999999999999999999999999999999999987664322222211
Q ss_pred --cCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 242 --KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 242 --~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
...........+..+..+...+-..+...+|....+...|........
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~ 302 (322)
T KOG1164|consen 253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEG 302 (322)
T ss_pred hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcC
Confidence 111111334456788888888888999999999999999988776653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-25 Score=188.77 Aligned_cols=224 Identities=31% Similarity=0.572 Sum_probs=188.9
Q ss_pred cccCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
+|.+++.+.-+|.....|..|+|+|+|.++++|++....... ...++|..|.-.|+-+.||||+.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~----risrdfneefp~lrifshpnilpvlgacnsppnl 262 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTA----RISRDFNEEFPALRIFSHPNILPVLGACNSPPNL 262 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcch----hhcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence 667888889999999999999999999999999998754433 33578999999999999999975
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccccccceeecCCCeEEEe--ecccccc
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGEDMCVKVA--DFGISCL 177 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~NIll~~~~~~kl~--Dfg~a~~ 177 (332)
.....+..++.+++.+++.|++|||+.. |.---|+...|+||++.+++|+ |--++.
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf- 341 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF- 341 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-
Confidence 2234567889999999999999999975 4445688999999999877664 322221
Q ss_pred cccCCCCCCcccccccCChhhhhcCCC---CCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 020016 178 ESQCGSAKGFTGTYRWMAPEMIKEKRH---TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254 (332)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (332)
...+..-.|.|++||.+...+. -.++|+|||++++||+.|...||....+.+.-..+...+.+..+|+.++.
T Consensus 342 -----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~ 416 (448)
T KOG0195|consen 342 -----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISR 416 (448)
T ss_pred -----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccH
Confidence 1123345789999999987654 46899999999999999999999999999999999889999999999999
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 020016 255 AFSYLISRCWSSSPDRRPHFDQIVSILEGYS 285 (332)
Q Consensus 255 ~l~~li~~cl~~dp~~Rps~~ell~~L~~~~ 285 (332)
.+..|+.-|+..||.+||.++.++-.|+++.
T Consensus 417 hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 417 HMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 9999999999999999999999999999864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=177.01 Aligned_cols=235 Identities=22% Similarity=0.340 Sum_probs=187.6
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCC----Cceec-----
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH----PHIIT----- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~----- 120 (332)
+-..+|.+.++||+|+||.+|.|..- |..||||+-...... -++.-|..+...|++ |+|-.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--------pqL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--------PQLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--------cchhHHHHHHHHhccCCCCchhhhhcccc
Confidence 34589999999999999999999884 899999998765443 235667778777754 33321
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC---CeEEEeecccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED---MCVKVADFGISCL 177 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~---~~~kl~Dfg~a~~ 177 (332)
-...++...++.++-|++.-++|+|.++++||||||+|+|..-+ ..+.|+|||++..
T Consensus 84 ~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 84 DYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence 23467888999999999999999999999999999999999643 5799999999975
Q ss_pred cccCC--------CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhcCCCC
Q 020016 178 ESQCG--------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA---FAVCQKNARP 246 (332)
Q Consensus 178 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~---~~~~~~~~~~ 246 (332)
..+.. ......||.+|.+-..+.+...+...|+-|+|.++.+..-|..||++....... ..+.+.....
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 43322 234567999999999998888999999999999999999999999997654433 3343333332
Q ss_pred C---CCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCccc
Q 020016 247 P---VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEF 294 (332)
Q Consensus 247 ~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 294 (332)
+ +-..+|.++.-.+..|-...-++-|+..-+.+.+.-+..++.-...+
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~ 294 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDY 294 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCe
Confidence 2 23567899999999999999999999999999999888888866554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=182.45 Aligned_cols=228 Identities=18% Similarity=0.316 Sum_probs=184.3
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCC-Cceec-----------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH-PHIIT----------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~----------- 120 (332)
-.|.++++||+|.||.++.|..- ++.||||.-...... -++..|....+.|.+ ++|-.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--------PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--------PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCc--------chHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 47999999999999999999874 899999998765443 235567777777743 33322
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC-----CeEEEeeccccccc
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-----MCVKVADFGISCLE 178 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~-----~~~kl~Dfg~a~~~ 178 (332)
-+..++...+..++.|++.-+.|+|++.+|.|||||+|+||... ..+.|+|||+|...
T Consensus 100 iLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 100 ILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 45678999999999999999999999999999999999999754 46999999999876
Q ss_pred ccCCC--------CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCCC
Q 020016 179 SQCGS--------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT---PEQAAFAVCQKNARPP 247 (332)
Q Consensus 179 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~---~~~~~~~~~~~~~~~~ 247 (332)
.+..+ .....||.+||+-..+.+...+.+.|+-|||-++.+.|-|..||++.. ..+....+.......+
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP 259 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence 54433 245679999999999999999999999999999999999999999854 3444445544333322
Q ss_pred ---CCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 020016 248 ---VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 290 (332)
Q Consensus 248 ---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~ 290 (332)
+-..+|.++...+...-..+-.+-|+.+-+...+.++.+.+..
T Consensus 260 i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 260 IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 2255788999988888888999999999999999988887763
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-23 Score=184.78 Aligned_cols=206 Identities=22% Similarity=0.299 Sum_probs=139.4
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCC---C-------c-ee--
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH---P-------H-II-- 119 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~-------n-iv-- 119 (332)
..+..++.||.|+++.||.+.+. ++.+|||++....... ....+++.+|.-....+.+ | . ++
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~---~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~ 88 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADAS---ANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL 88 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTH---TTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccc---hHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee
Confidence 46788999999999999999997 6999999998765321 2224566666655544332 1 0 00
Q ss_pred ---c---------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 020016 120 ---T---------------------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILH 151 (332)
Q Consensus 120 ---~---------------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH 151 (332)
. ....+.......+..|+++.+++||..|++|
T Consensus 89 d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVH 168 (288)
T PF14531_consen 89 DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVH 168 (288)
T ss_dssp EEEEETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEEEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEe
Confidence 0 1112334445667789999999999999999
Q ss_pred ccccccceeecCCCeEEEeecccccccccCCCCCCcccccccCChhhhhcC--------CCCCccchhHHHHHHHHHHhC
Q 020016 152 RDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK--------RHTKKVDVYSFGIVLWELLTA 223 (332)
Q Consensus 152 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~sDvwSlG~il~elltG 223 (332)
+||+|+|++++.+|.+.|+||+.....+..... ...+..|.+||..... .++.+.|.|+||+++|.|++|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999999876544432221 3456789999987543 468899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCC
Q 020016 224 LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 271 (332)
Q Consensus 224 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 271 (332)
..||....+...... .-.... ++|+.++.||..+|+.||.+|
T Consensus 247 ~lPf~~~~~~~~~~~-----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW-----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG-----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc-----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999987544221110 111233 788999999999999999987
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-21 Score=174.34 Aligned_cols=220 Identities=31% Similarity=0.472 Sum_probs=176.0
Q ss_pred eeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCC-ceec---------------
Q 020016 57 LFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP-HIIT--------------- 120 (332)
Q Consensus 57 y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~--------------- 120 (332)
|.+.+.||.|+||.||++.+. ..+++|.+........ .....+.+|+.++..+.|+ +++.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS---KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch---hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence 778899999999999999998 8899999987654432 1246789999999999988 5765
Q ss_pred -------------CC---CCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC-eEEEeecccccccccCC-
Q 020016 121 -------------EP---YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVADFGISCLESQCG- 182 (332)
Q Consensus 121 -------------~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~- 182 (332)
.. ..+.......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.+.......
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 22 2789999999999999999999999999999999999999988 79999999987544332
Q ss_pred ------CCCCcccccccCChhhhhc---CCCCCccchhHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCCC---C
Q 020016 183 ------SAKGFTGTYRWMAPEMIKE---KRHTKKVDVYSFGIVLWELLTALTPFDNMTP----EQAAFAVCQKNAR---P 246 (332)
Q Consensus 183 ------~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~pf~~~~~----~~~~~~~~~~~~~---~ 246 (332)
......++..|++||.+.+ ..++...|+||+|++++++++|..||..... ......+...... .
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 2356789999999999987 5789999999999999999999999887663 2333333222211 1
Q ss_pred CCCCCC----cHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 247 PVPPTC----PKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 247 ~~~~~~----~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
...... ...+.+++..|+..+|..|.+..+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 122222 2578999999999999999988877764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=199.51 Aligned_cols=218 Identities=20% Similarity=0.215 Sum_probs=160.1
Q ss_pred CeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------------- 120 (332)
+|...+.||++.|=+|.+|.+....|+||+|-+....-.+..- .+-..|++ ...+++||.+.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~--~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPF--KQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHH--HHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 7888999999999999999998666999999887654443221 22233444 55669999876
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc--cCC--CC
Q 020016 121 ------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES--QCG--SA 184 (332)
Q Consensus 121 ------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~--~~~--~~ 184 (332)
....+...+...|+.|++.||..+|..||+|||||.+||||+.-..+.|+||..-+... ..+ ..
T Consensus 101 qyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf 180 (1431)
T KOG1240|consen 101 QYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF 180 (1431)
T ss_pred HHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence 44567788899999999999999999999999999999999999999999998654321 111 11
Q ss_pred ----CCcccccccCChhhhhcCC-----------CCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCC-CC-
Q 020016 185 ----KGFTGTYRWMAPEMIKEKR-----------HTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA-RP- 246 (332)
Q Consensus 185 ----~~~~gt~~y~aPE~~~~~~-----------~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~-~~- 246 (332)
.+...-.+|+|||.+.... .+++-||||+||+++|+++ |++||.-. + ..+...... .+
T Consensus 181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---Q-L~aYr~~~~~~~e 256 (1431)
T KOG1240|consen 181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---Q-LLAYRSGNADDPE 256 (1431)
T ss_pred eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---H-HHhHhccCccCHH
Confidence 1122345799999986421 4678999999999999999 89999631 1 111111100 00
Q ss_pred -CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 247 -PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 247 -~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
.+..--+..++.|+..|++.||.+|.++++.++.
T Consensus 257 ~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 257 QLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0001123468999999999999999999999986
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=184.86 Aligned_cols=157 Identities=18% Similarity=0.220 Sum_probs=116.6
Q ss_pred cCCeeeeeeecccCceEEEEEEEC---CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
.+.|.+.+.||+|+||+||+|.+. ++.||||+........ ......+.|.+|+++|++++|+|++.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~-~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~~L 95 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWW-SKPLARHLAAREIRALKTVRGIGVVPQLLATGKDGL 95 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEeccccccc-ccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCcEE
Confidence 478999999999999999999874 5778999876331100 01112466899999999999999984
Q ss_pred -----CCCCCCH---HHHHHHHHHHHHHHHHHHHCCCccccc-cccceeecCCCeEEEeecccccccccCCCC-------
Q 020016 121 -----EPYSVPL---NLVLKLALDIARGMQYLHSQGILHRDL-KSENLLLGEDMCVKVADFGISCLESQCGSA------- 184 (332)
Q Consensus 121 -----~~~~l~~---~~~~~i~~qi~~~L~~LH~~~iiH~dl-kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~------- 184 (332)
.+..+.. .....++.+++++|.|||++||+|||| ||+|||++.++.++|+|||+++........
T Consensus 96 VmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~ 175 (365)
T PRK09188 96 VRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYE 175 (365)
T ss_pred EEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhh
Confidence 1222211 112578899999999999999999999 999999999999999999999865443211
Q ss_pred --CCcccccccCChhhhhcCC------CCCccchh
Q 020016 185 --KGFTGTYRWMAPEMIKEKR------HTKKVDVY 211 (332)
Q Consensus 185 --~~~~gt~~y~aPE~~~~~~------~~~~sDvw 211 (332)
....+++.|.|||++.... .+..+|-|
T Consensus 176 d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 176 DLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred hhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 2345788899999886433 23446665
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=179.66 Aligned_cols=159 Identities=23% Similarity=0.367 Sum_probs=123.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee--cCC--CeEEEeeccccccccc-------CCCCCCcccccc
Q 020016 124 SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL--GED--MCVKVADFGISCLESQ-------CGSAKGFTGTYR 192 (332)
Q Consensus 124 ~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll--~~~--~~~kl~Dfg~a~~~~~-------~~~~~~~~gt~~ 192 (332)
..+.....-|+.|+++|+.|||.+||.|||+|.+|||+ |++ ..+.|+|||++--... ........|...
T Consensus 337 ~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~ 416 (598)
T KOG4158|consen 337 HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAK 416 (598)
T ss_pred CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcce
Confidence 45666778899999999999999999999999999999 333 4789999998743222 112223457888
Q ss_pred cCChhhhhcCC--C----CCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHcccc
Q 020016 193 WMAPEMIKEKR--H----TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 266 (332)
Q Consensus 193 y~aPE~~~~~~--~----~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 266 (332)
.||||+....+ . -.++|.|+.|.+.||+++...||.................-+.+|..+++.+++++...|+.
T Consensus 417 lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r 496 (598)
T KOG4158|consen 417 LMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKR 496 (598)
T ss_pred ecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcC
Confidence 99999986432 1 35899999999999999999999874333222223344556788999999999999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 020016 267 SPDRRPHFDQIVSILE 282 (332)
Q Consensus 267 dp~~Rps~~ell~~L~ 282 (332)
||.+|++..-....|.
T Consensus 497 ~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 497 DPSKRVSPNIAANVLN 512 (598)
T ss_pred CccccCCccHHHhHHH
Confidence 9999998876666554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.7e-23 Score=199.39 Aligned_cols=222 Identities=24% Similarity=0.332 Sum_probs=166.6
Q ss_pred eeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------------
Q 020016 58 FIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------------- 120 (332)
Q Consensus 58 ~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------------- 120 (332)
.....+|.|++|.|+..... ...++.|.+................+..|+-+-..+.|+|++.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 46788999999988877664 3445555443210000001111122677888888899999865
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-----C
Q 020016 121 ------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-----S 183 (332)
Q Consensus 121 ------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-----~ 183 (332)
..+.+....+..++.|++.|+.|+|..|+.|||||++|+++..+|.+||+|||.+....... .
T Consensus 401 E~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~ 480 (601)
T KOG0590|consen 401 EYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHE 480 (601)
T ss_pred hcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhh
Confidence 23478888999999999999999999999999999999999999999999999987654322 2
Q ss_pred CCCcccccccCChhhhhcCCCC-CccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhc------CCCCCCCCCCcHH
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHT-KKVDVYSFGIVLWELLTALTPFDNMTPEQAAF-AVCQK------NARPPVPPTCPKA 255 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~elltG~~pf~~~~~~~~~~-~~~~~------~~~~~~~~~~~~~ 255 (332)
....+|+..|+|||.+.+..|+ ...||||.|+++..|++|+.||......+..+ ..... .....+...++..
T Consensus 481 ~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~ 560 (601)
T KOG0590|consen 481 SSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRE 560 (601)
T ss_pred hcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhh
Confidence 3567899999999999999885 57999999999999999999998755443321 11111 1111123456788
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 020016 256 FSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+.+|.+||+.||.+|.++++|++
T Consensus 561 ~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 561 TRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHHHHHHccCChhheecHHHHhh
Confidence 899999999999999999999986
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.4e-21 Score=191.08 Aligned_cols=196 Identities=28% Similarity=0.391 Sum_probs=157.1
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------CCCCC
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------EPYSV 125 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------~~~~l 125 (332)
++|..++.|..|+||.||..+++ .+.+|+|+ ++... +.+- ++.....|.+|. ..+.+
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----------ilRn--ilt~a~npfvvgDc~tllk~~g~l 148 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----------ILRN--ILTFAGNPFVVGDCATLLKNIGPL 148 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----------hhhc--cccccCCcceechhhhhcccCCCC
Confidence 67888999999999999999987 78899954 33111 1111 566667888864 33444
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC----------------CCCCCccc
Q 020016 126 PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC----------------GSAKGFTG 189 (332)
Q Consensus 126 ~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~----------------~~~~~~~g 189 (332)
+... +.+++|||+-||+|||+||+|.+|+.-|.+|+.|||++...-.. -.....+|
T Consensus 149 Pvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcg 220 (1205)
T KOG0606|consen 149 PVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCG 220 (1205)
T ss_pred cchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccC
Confidence 4433 78999999999999999999999999999999999997532110 11245689
Q ss_pred ccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHHHccccCC
Q 020016 190 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK-NARPPVPPTCPKAFSYLISRCWSSSP 268 (332)
Q Consensus 190 t~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp 268 (332)
|+.|.|||++....|+..+|+|++|+|+|+.+.|..||.+.++++.+..+... ...+.-...+++++++++.++|+.+|
T Consensus 221 TPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp 300 (1205)
T KOG0606|consen 221 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNP 300 (1205)
T ss_pred CccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhCh
Confidence 99999999999999999999999999999999999999999999887665442 33444456788999999999999999
Q ss_pred CCCC
Q 020016 269 DRRP 272 (332)
Q Consensus 269 ~~Rp 272 (332)
..|-
T Consensus 301 ~~Rl 304 (1205)
T KOG0606|consen 301 LCRL 304 (1205)
T ss_pred Hhhc
Confidence 9995
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.8e-21 Score=182.11 Aligned_cols=198 Identities=24% Similarity=0.329 Sum_probs=160.4
Q ss_pred eecccCceEEEEEEE-----CCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCceec---------------
Q 020016 62 KFASGRHSRIYRGIY-----KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIIT--------------- 120 (332)
Q Consensus 62 ~lg~G~~g~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~--------------- 120 (332)
.+|.|.||.|+++.- .+..+|+|+..+........ .....|-.++...+ ||.+|+
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~----~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~l 76 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR----THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLIL 76 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccc----cccccHHHHHhhccCCCceeeeeeeeccccchhHhh
Confidence 378999999987533 36788999887754333221 23456777888886 888886
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCCCCc
Q 020016 121 -------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGF 187 (332)
Q Consensus 121 -------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 187 (332)
....+.+.........++-++.++|+.+++|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 77 d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 3345667778888899999999999999999999999999999999999999998765443322
Q ss_pred ccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccC
Q 020016 188 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 267 (332)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 267 (332)
+||..|||||++. ....++|.||||+++++|+||..||.. +....+. ...+.+|..++..+.+++..++..+
T Consensus 154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il--~~~~~~p~~l~~~a~~~~~~l~~r~ 225 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRIL--KAELEMPRELSAEARSLFRQLFKRN 225 (612)
T ss_pred ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHh--hhccCCchhhhHHHHHHHHHHHhhC
Confidence 9999999999998 567899999999999999999999998 4444443 3456778889999999999999999
Q ss_pred CCCCCCH
Q 020016 268 PDRRPHF 274 (332)
Q Consensus 268 p~~Rps~ 274 (332)
|.+|...
T Consensus 226 p~nrLg~ 232 (612)
T KOG0603|consen 226 PENRLGA 232 (612)
T ss_pred HHHHhcc
Confidence 9999755
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.4e-21 Score=176.50 Aligned_cols=144 Identities=31% Similarity=0.528 Sum_probs=108.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-------CCCCcccccccCCh
Q 020016 124 SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-------SAKGFTGTYRWMAP 196 (332)
Q Consensus 124 ~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aP 196 (332)
..+......++.|++.|+.| +|.+|+|+||.||++..+..+||.|||+........ ......||..||+|
T Consensus 355 ~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsP 431 (516)
T KOG1033|consen 355 ERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSP 431 (516)
T ss_pred ccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCH
Confidence 45666778899999999999 999999999999999999999999999986544433 34567899999999
Q ss_pred hhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC-CCCCCCcHHHHHHHHHccccCCCCCCCH
Q 020016 197 EMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP-PVPPTCPKAFSYLISRCWSSSPDRRPHF 274 (332)
Q Consensus 197 E~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~ 274 (332)
|.+.+..|+.++||||||++++|+++ =..++. ..........+..+ .+-.+++ .-..|+.+++.+.|.+||++
T Consensus 432 EQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----r~~t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 432 EQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----RIATLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred HHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----HHHhhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchH
Confidence 99999999999999999999999986 222222 11111111122222 2223333 34689999999999999944
Q ss_pred H
Q 020016 275 D 275 (332)
Q Consensus 275 ~ 275 (332)
.
T Consensus 507 ~ 507 (516)
T KOG1033|consen 507 I 507 (516)
T ss_pred H
Confidence 3
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.8e-20 Score=157.87 Aligned_cols=156 Identities=12% Similarity=0.098 Sum_probs=113.9
Q ss_pred cCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHH---HHHHHHHHHHHHHcCCCCceec--------CC
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASM---LEKQFTSEVALLFRLNHPHIIT--------EP 122 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~--------~~ 122 (332)
..+|.+.+.||.|+||.||+....+..+|||++............ ....+.+|+..+.++.|++|.. ..
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 478999999999999999998777789999999865443321100 0123689999999999998754 00
Q ss_pred ----------------CCCCHHHH----HHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC
Q 020016 123 ----------------YSVPLNLV----LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 182 (332)
Q Consensus 123 ----------------~~l~~~~~----~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 182 (332)
...+.... .....+++.+|..+|..|++|||++|.||+++.+| ++|+|||.........
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~ 188 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRK 188 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccchh
Confidence 00112111 23567999999999999999999999999999988 9999999875432211
Q ss_pred CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHH
Q 020016 183 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 221 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell 221 (332)
. ...++....+..++|+||||+++....
T Consensus 189 a-----------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 189 A-----------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred h-----------HHHHHHHhHhcccccccceeEeehHHH
Confidence 1 011445556778999999999987653
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.9e-19 Score=176.41 Aligned_cols=231 Identities=17% Similarity=0.206 Sum_probs=166.9
Q ss_pred CCccccccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhH-HHHHHHHHHHHHHHHHHcC---------
Q 020016 45 EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDAS-LASMLEKQFTSEVALLFRL--------- 113 (332)
Q Consensus 45 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l--------- 113 (332)
.+..+++.-...|.|.+.||.|+||+||+|... |+.||+|+-..+...+. ....+..++. ..++..+
T Consensus 688 ~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk--~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 688 NPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLK--PQMLPSIMHISSAHVF 765 (974)
T ss_pred CccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhc--hhhhcchHHHHHHHcc
Confidence 345666777889999999999999999999886 89999999888655432 2222222222 1111111
Q ss_pred -CCCcee-------------cCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC-------CCeEEEeec
Q 020016 114 -NHPHII-------------TEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-------DMCVKVADF 172 (332)
Q Consensus 114 -~h~niv-------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~-------~~~~kl~Df 172 (332)
+-..+| ...+.+++..+..+..|++..+..||..+||||||||+|+||.. ...++|+||
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 111112 26678999999999999999999999999999999999999942 346999999
Q ss_pred ccccc---cccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--
Q 020016 173 GISCL---ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-- 247 (332)
Q Consensus 173 g~a~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~-- 247 (332)
|.+.. ..+........+|-.+-.+|+..|.+++..+|.|.|+.+++-||.|+.-= . ..+....
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------~-~~g~~~~~~ 913 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------V-KNGSSWMVK 913 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------h-cCCcceecc
Confidence 99853 33333455677899999999999999999999999999999999996531 1 1111111
Q ss_pred --CCCCCcHH-HHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 248 --VPPTCPKA-FSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 248 --~~~~~~~~-l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
++..+..+ +.+++..+|..|-..=|...++...|+....+..
T Consensus 914 ~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~ 958 (974)
T KOG1166|consen 914 TNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHF 958 (974)
T ss_pred ccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHH
Confidence 22222222 4568888888666666888888888888766544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=152.49 Aligned_cols=118 Identities=21% Similarity=0.204 Sum_probs=91.2
Q ss_pred eeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHH--------------------HHHHHHHHHHHHHHHHcCCCCce
Q 020016 60 GCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASL--------------------ASMLEKQFTSEVALLFRLNHPHI 118 (332)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~--------------------~~~~~~~~~~E~~~l~~l~h~ni 118 (332)
.+.||+|++|.||+|.+. |+.||||+++........ .........+|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 468999999999999986 899999999764321100 01112334569999999865443
Q ss_pred -----ec---------------------CCCCCCHHHHHHHHHHHHHHHHHH-HHCCCccccccccceeecCCCeEEEee
Q 020016 119 -----IT---------------------EPYSVPLNLVLKLALDIARGMQYL-HSQGILHRDLKSENLLLGEDMCVKVAD 171 (332)
Q Consensus 119 -----v~---------------------~~~~l~~~~~~~i~~qi~~~L~~L-H~~~iiH~dlkp~NIll~~~~~~kl~D 171 (332)
+. ....++...+..++.|++.+|.++ |+.||+||||||+||+++ ++.++|+|
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiD 160 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIID 160 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEE
Confidence 11 234678888999999999999999 799999999999999998 47899999
Q ss_pred ccccccc
Q 020016 172 FGISCLE 178 (332)
Q Consensus 172 fg~a~~~ 178 (332)
||++...
T Consensus 161 FG~a~~~ 167 (190)
T cd05147 161 VSQSVEH 167 (190)
T ss_pred ccccccC
Confidence 9998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.8e-19 Score=149.83 Aligned_cols=120 Identities=17% Similarity=0.178 Sum_probs=94.8
Q ss_pred eeeeecccCceEEEEEEEC-CeeEEEEEecCCCchh--------------------HHHHHHHHHHHHHHHHHHcCCCCc
Q 020016 59 IGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDA--------------------SLASMLEKQFTSEVALLFRLNHPH 117 (332)
Q Consensus 59 i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~--------------------~~~~~~~~~~~~E~~~l~~l~h~n 117 (332)
+.+.||+|++|.||+|.+. |+.||||+++...... .........+..|...+.++.|++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 3578999999999999986 8999999998753210 011111234568999999998776
Q ss_pred eec--------------------------CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccccccceeecCCCeEEEe
Q 020016 118 IIT--------------------------EPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVA 170 (332)
Q Consensus 118 iv~--------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~NIll~~~~~~kl~ 170 (332)
+.. ....++...+..++.|++.++.++|. .||+||||||+||+++ ++.++|+
T Consensus 81 i~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~li 159 (190)
T cd05145 81 VPVPEPILLKKNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYII 159 (190)
T ss_pred CCCceEEEecCCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEE
Confidence 521 12346678899999999999999999 9999999999999999 8899999
Q ss_pred ecccccccc
Q 020016 171 DFGISCLES 179 (332)
Q Consensus 171 Dfg~a~~~~ 179 (332)
|||++....
T Consensus 160 DFG~a~~~~ 168 (190)
T cd05145 160 DVSQAVELD 168 (190)
T ss_pred EcccceecC
Confidence 999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.2e-18 Score=145.74 Aligned_cols=170 Identities=18% Similarity=0.084 Sum_probs=123.2
Q ss_pred eeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCC-C---ceec-----------CC
Q 020016 58 FIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH-P---HIIT-----------EP 122 (332)
Q Consensus 58 ~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~---niv~-----------~~ 122 (332)
.+...|++|+||+||.+...+.+++.+.+.....-. .......|.+|+++|++|.| + +++. .+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~--~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G 82 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWL--RGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAG 82 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhh--hhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecC
Confidence 356789999999999888888899988876643321 11112357899999999954 3 3332 12
Q ss_pred CCCCH---HHHHHHHHHHHHHHHHHHHCCCccccc-cccceeecCCCeEEEeecccccccccCCCC--------------
Q 020016 123 YSVPL---NLVLKLALDIARGMQYLHSQGILHRDL-KSENLLLGEDMCVKVADFGISCLESQCGSA-------------- 184 (332)
Q Consensus 123 ~~l~~---~~~~~i~~qi~~~L~~LH~~~iiH~dl-kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-------------- 184 (332)
..+.. .....++.|++.+|.++|+.||+|||| ||.|||++.++.++|+|||++.........
T Consensus 83 ~~L~~~~~~~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk 162 (218)
T PRK12274 83 AAMYQRPPRGDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLK 162 (218)
T ss_pred ccHHhhhhhhhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHH
Confidence 22211 123467889999999999999999999 799999999999999999999754433210
Q ss_pred CCcccccccCChhhhhcC-CCC-CccchhHHHHHHHHHHhCCCCCCC
Q 020016 185 KGFTGTYRWMAPEMIKEK-RHT-KKVDVYSFGIVLWELLTALTPFDN 229 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~-~~~-~~sDvwSlG~il~elltG~~pf~~ 229 (332)
.-...++.|++|+...-- ..+ ...+.++.|.-+|.++|+..+.-+
T Consensus 163 ~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 163 HKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 011257888888865432 333 577889999999999998887654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.1e-17 Score=151.66 Aligned_cols=168 Identities=32% Similarity=0.600 Sum_probs=130.4
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHCCC-ccccccccceeecCCCeEEEeecccccccccC---CCCCCcccccccCCh
Q 020016 121 EPYSVPLNLVLKLALDIARGMQYLHSQGI-LHRDLKSENLLLGEDMCVKVADFGISCLESQC---GSAKGFTGTYRWMAP 196 (332)
Q Consensus 121 ~~~~l~~~~~~~i~~qi~~~L~~LH~~~i-iH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aP 196 (332)
....+++.-...++++|+.||.|||...| .|+.+++.|.++|....+||+|||+....... .......-..-|.||
T Consensus 41 ~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aP 120 (484)
T KOG1023|consen 41 EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAP 120 (484)
T ss_pred cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCH
Confidence 45667888889999999999999999876 99999999999999999999999998665321 111222345679999
Q ss_pred hhhhcCC-------CCCccchhHHHHHHHHHHhCCCCCCC----CCHHHHHHHHHhcCC---CCCCC--CCCcHHHHHHH
Q 020016 197 EMIKEKR-------HTKKVDVYSFGIVLWELLTALTPFDN----MTPEQAAFAVCQKNA---RPPVP--PTCPKAFSYLI 260 (332)
Q Consensus 197 E~~~~~~-------~~~~sDvwSlG~il~elltG~~pf~~----~~~~~~~~~~~~~~~---~~~~~--~~~~~~l~~li 260 (332)
|.++... .+.+.|+||||++++|+++...||+. ..+.++...+..... +|.+. ...++++..++
T Consensus 121 ellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~ 200 (484)
T KOG1023|consen 121 ELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLV 200 (484)
T ss_pred HHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHH
Confidence 9997642 36789999999999999999999976 234455555543122 22222 13456789999
Q ss_pred HHccccCCCCCCCHHHHHHHHHhhhhhh
Q 020016 261 SRCWSSSPDRRPHFDQIVSILEGYSESL 288 (332)
Q Consensus 261 ~~cl~~dp~~Rps~~ell~~L~~~~~~~ 288 (332)
..||..+|.+||+++++...++.+....
T Consensus 201 ~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 201 ARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred HHhcccChhhCccHHHHHhhhhhhcccc
Confidence 9999999999999999999998876644
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.5e-17 Score=140.66 Aligned_cols=122 Identities=20% Similarity=0.245 Sum_probs=93.5
Q ss_pred CeeeeeeecccCceEEEEEE-E--CCeeEEEEEecCCCchh------------------HHHHHHHHHHHHHHHHHHcCC
Q 020016 56 QLFIGCKFASGRHSRIYRGI-Y--KQRDVAIKLVSQPEEDA------------------SLASMLEKQFTSEVALLFRLN 114 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~-~--~~~~vAvK~~~~~~~~~------------------~~~~~~~~~~~~E~~~l~~l~ 114 (332)
-|.+.+.||.|++|.||+|. + .|+.||||+++...... .........+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 3 38999999998643210 011122345678999999996
Q ss_pred CCcee-------------c-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC-CccccccccceeecCCCeE
Q 020016 115 HPHII-------------T-------------EPYSVPLNLVLKLALDIARGMQYLHSQG-ILHRDLKSENLLLGEDMCV 167 (332)
Q Consensus 115 h~niv-------------~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~-iiH~dlkp~NIll~~~~~~ 167 (332)
+..+. . ....+....+..++.|++.++.+||..| ++||||||+||+++ ++.+
T Consensus 109 ~~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i 187 (237)
T smart00090 109 EAGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKV 187 (237)
T ss_pred hcCCCCCeeeEecCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCE
Confidence 53221 0 1233455567899999999999999999 99999999999999 8899
Q ss_pred EEeeccccccc
Q 020016 168 KVADFGISCLE 178 (332)
Q Consensus 168 kl~Dfg~a~~~ 178 (332)
+|+|||.+...
T Consensus 188 ~LiDFg~a~~~ 198 (237)
T smart00090 188 VIIDVSQSVEL 198 (237)
T ss_pred EEEEChhhhcc
Confidence 99999987543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.4e-15 Score=129.92 Aligned_cols=124 Identities=18% Similarity=0.174 Sum_probs=92.7
Q ss_pred CeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHH----------------HHHHHHHHHHHHHHHHcCCCCce
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASL----------------ASMLEKQFTSEVALLFRLNHPHI 118 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~ni 118 (332)
.|.+.+.||+|+||.||++... ++.||||+++........ .......+..|..++..+.|+++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 4778899999999999999885 899999998764311100 01112346788888888877642
Q ss_pred --ec--------------CCCC---CCH-HHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 119 --IT--------------EPYS---VPL-NLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 119 --v~--------------~~~~---l~~-~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
.. .+.. +.. .....++.+++.++.++|..|++||||+|.||+++.++.++|+|||++...
T Consensus 96 ~v~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 96 PVPKPIDWNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCceeecCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 11 1111 111 456678999999999999999999999999999999999999999998544
Q ss_pred c
Q 020016 179 S 179 (332)
Q Consensus 179 ~ 179 (332)
.
T Consensus 176 ~ 176 (198)
T cd05144 176 D 176 (198)
T ss_pred C
Confidence 3
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.6e-15 Score=128.14 Aligned_cols=115 Identities=24% Similarity=0.276 Sum_probs=87.7
Q ss_pred eecccCceEEEEEEECCeeEEEEEecCCCch--hHHHHHHHHHHHHHHHHHHcCCCCceec------------------C
Q 020016 62 KFASGRHSRIYRGIYKQRDVAIKLVSQPEED--ASLASMLEKQFTSEVALLFRLNHPHIIT------------------E 121 (332)
Q Consensus 62 ~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------~ 121 (332)
.||+|+||.||+|.+.+..|++|+....... ..........+.+|+.++..+.|+++.. .
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 3799999999999998999999996643211 1111222366789999999998776432 2
Q ss_pred CCCCCHHHHH---HHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccc
Q 020016 122 PYSVPLNLVL---KLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 122 ~~~l~~~~~~---~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
+..+...... .++.+++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus 81 g~~l~~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGNDELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 2222222222 7899999999999999999999999999999 88999999998755
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=2e-15 Score=129.38 Aligned_cols=105 Identities=19% Similarity=0.250 Sum_probs=78.3
Q ss_pred eeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-----CCCceec-------------
Q 020016 60 GCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-----NHPHIIT------------- 120 (332)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~------------- 120 (332)
.+.||+|+||.||. +. ....+||++....... .+.+.+|+.+++.+ +||||++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~------~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGG------DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccch------HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 46899999999996 43 2334799987643322 35689999999999 6799986
Q ss_pred -------CC-------------CCCCHHHHHHHHHHHHHHH-HHHHHCCCccccccccceeecCC----CeEEEeeccc
Q 020016 121 -------EP-------------YSVPLNLVLKLALDIARGM-QYLHSQGILHRDLKSENLLLGED----MCVKVADFGI 174 (332)
Q Consensus 121 -------~~-------------~~l~~~~~~~i~~qi~~~L-~~LH~~~iiH~dlkp~NIll~~~----~~~kl~Dfg~ 174 (332)
.. ..+++. ..++.+++.++ .|||+.+|+||||||+||+++.. +.++|+||+.
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 10 112233 34577888777 99999999999999999999743 4799999543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.4e-15 Score=127.84 Aligned_cols=116 Identities=22% Similarity=0.273 Sum_probs=89.7
Q ss_pred eeecccCceEEEEEEECCeeEEEEEecCCCch--hHHHHHHHHHHHHHHHHHHcCCCCceec------------------
Q 020016 61 CKFASGRHSRIYRGIYKQRDVAIKLVSQPEED--ASLASMLEKQFTSEVALLFRLNHPHIIT------------------ 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 120 (332)
+.||+|++|.||+|.+.+..|+||+....... ..........+.+|+.++..+.|++|..
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 57999999999999999999999987653321 1111222456889999999998877643
Q ss_pred CCCCCCHH------HHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccc
Q 020016 121 EPYSVPLN------LVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 ~~~~l~~~------~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
.+..+... ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNGMEELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 11111111 4568999999999999999999999999999999 78899999998754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.1e-15 Score=144.94 Aligned_cols=121 Identities=21% Similarity=0.225 Sum_probs=92.0
Q ss_pred CeeeeeeecccCceEEEEEEECCeeEEEEEecCCCch-h-HHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEED-A-SLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~-~-~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
.|...+.||+|+||+||+|.+.+..+++|+....... . .......+.+.+|+.++..++|++++.
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 3456899999999999999998777777654332111 1 111222466889999999999998754
Q ss_pred -----CCCCCCHH--HHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccc
Q 020016 121 -----EPYSVPLN--LVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 -----~~~~l~~~--~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
....+... ....++.+++.+|.+||+.|++||||||+||++ .++.++|+|||++..
T Consensus 414 v~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 414 VMEYIGGKDLKDVLEGNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEecCCCcHHHHHHHHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 22233222 257789999999999999999999999999999 577899999999854
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.5e-14 Score=120.77 Aligned_cols=118 Identities=20% Similarity=0.188 Sum_probs=83.5
Q ss_pred eeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHH------------------HHHHHHHHHHHHcCCCCc---
Q 020016 60 GCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASML------------------EKQFTSEVALLFRLNHPH--- 117 (332)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~------------------~~~~~~E~~~l~~l~h~n--- 117 (332)
++.||+|+||+||+|.+. ++.||||++............. ......|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 568999999999999987 8999999987643221111000 011135556665553332
Q ss_pred ----------eec---CC-----CCC---CH-HHHHHHHHHHHHHHHHHHH-CCCccccccccceeecCCCeEEEeeccc
Q 020016 118 ----------IIT---EP-----YSV---PL-NLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 118 ----------iv~---~~-----~~l---~~-~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
++. .. ..+ .. ..+..++.+++.++.++|. .|++|+||+|+||+++ ++.++|+|||.
T Consensus 82 ~~~~~~~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~ 160 (187)
T cd05119 82 PKPIDLNRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQ 160 (187)
T ss_pred CceEecCCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECcc
Confidence 121 11 111 11 5678899999999999999 9999999999999999 89999999999
Q ss_pred cccc
Q 020016 175 SCLE 178 (332)
Q Consensus 175 a~~~ 178 (332)
+...
T Consensus 161 a~~~ 164 (187)
T cd05119 161 AVEI 164 (187)
T ss_pred cccc
Confidence 8543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.4e-16 Score=152.75 Aligned_cols=222 Identities=23% Similarity=0.345 Sum_probs=171.6
Q ss_pred cCCeeeeeeecccCceEEEEEEEC---CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCceec---------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIIT--------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~--------- 120 (332)
...|.+.+.||+|.|+.|-..... ...+|+|.+......... ......|..+-+.+. |+|++.
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~----~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~ 94 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDS----SEHIDTETDIQKKLSKHSNTVHMIEPSSSPR 94 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccch----hhhcCccccccccccccccccccCCccCCCc
Confidence 467888899999999999988774 356777877765422211 244556788878887 999986
Q ss_pred --------------------CCC-CCCHHHHHHHHHHHHHHHHHHH-HCCCccccccccceeecCCC-eEEEeecccccc
Q 020016 121 --------------------EPY-SVPLNLVLKLALDIARGMQYLH-SQGILHRDLKSENLLLGEDM-CVKVADFGISCL 177 (332)
Q Consensus 121 --------------------~~~-~l~~~~~~~i~~qi~~~L~~LH-~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~a~~ 177 (332)
... ..+...+-..+.|+..++.|+| ..++.|+||||+|.+++..+ .++++|||+|..
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 111 4566778889999999999999 99999999999999999999 999999999976
Q ss_pred ccc-CCC---CCCccc-ccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-C--CCCC
Q 020016 178 ESQ-CGS---AKGFTG-TYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-A--RPPV 248 (332)
Q Consensus 178 ~~~-~~~---~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~-~--~~~~ 248 (332)
... .+. ....+| ++.|.|||...+. ......|+||.|+++.-+++|..|+.........+...... . ....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP 254 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence 655 222 234567 9999999999874 55789999999999999999999998765544332221111 1 2334
Q ss_pred CCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 249 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...++....+++.+++..+|..|.+.+++..
T Consensus 255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 255 WNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccCChhhhhcccccccCCchhccccccccc
Confidence 4667888999999999999999999888764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.1e-13 Score=122.88 Aligned_cols=175 Identities=19% Similarity=0.315 Sum_probs=133.3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCCCCcccccccCChhhhh--
Q 020016 123 YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK-- 200 (332)
Q Consensus 123 ~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-- 200 (332)
....|.-.+..++.++.+.+.||..|..-||++++|+|+++++.+.|.|-..-....+.....+.+|...|++||.-.
T Consensus 112 P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~ 191 (637)
T COG4248 112 PHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLP 191 (637)
T ss_pred CccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeeccCCceEecccCccccCCHHHhccc
Confidence 446788999999999999999999999999999999999999999999865443333334456778999999999875
Q ss_pred ---cCCCCCccchhHHHHHHHHHHh-CCCCCCCCC-------HH--HHHH---HHHhcCCC--CCCC-----CCCcHHHH
Q 020016 201 ---EKRHTKKVDVYSFGIVLWELLT-ALTPFDNMT-------PE--QAAF---AVCQKNAR--PPVP-----PTCPKAFS 257 (332)
Q Consensus 201 ---~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~-------~~--~~~~---~~~~~~~~--~~~~-----~~~~~~l~ 257 (332)
+...+...|.|.||+++++++. |++||.+.. +- .+.. .......+ .+.| ..+++++.
T Consensus 192 sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vq 271 (637)
T COG4248 192 SFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQ 271 (637)
T ss_pred cccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHH
Confidence 3345788999999999999998 599998632 11 1111 00111111 1111 34688999
Q ss_pred HHHHHccccC--CCCCCCHHHHHHHHHhhhhhhcCCcccccc
Q 020016 258 YLISRCWSSS--PDRRPHFDQIVSILEGYSESLEQDPEFFSS 297 (332)
Q Consensus 258 ~li~~cl~~d--p~~Rps~~ell~~L~~~~~~~~~~~~~~~~ 297 (332)
.|..+|+..- +.-||+++..+..|..+.+++........+
T Consensus 272 AlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H 313 (637)
T COG4248 272 ALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMH 313 (637)
T ss_pred HHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccc
Confidence 9999999653 568999999999999999999988765333
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.9e-13 Score=119.98 Aligned_cols=118 Identities=15% Similarity=0.101 Sum_probs=85.7
Q ss_pred eeeec-ccCceEEEEEEECCeeEEEEEecCCCchhH-------HHHHHHHHHHHHHHHHHcCCCCcee--c---------
Q 020016 60 GCKFA-SGRHSRIYRGIYKQRDVAIKLVSQPEEDAS-------LASMLEKQFTSEVALLFRLNHPHII--T--------- 120 (332)
Q Consensus 60 ~~~lg-~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~niv--~--------- 120 (332)
+..|| .||.|+||.+...+..++||.+.....-.. ........+.+|+.++..|.|++|. .
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 34677 899999999988899999999865321000 0011235678899999999887741 0
Q ss_pred ------------CCCCCCHHH-------HHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccc
Q 020016 121 ------------EPYSVPLNL-------VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 ------------~~~~l~~~~-------~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
..+..+... ....+.+++.+|.+||..||+|+||||.|||++.++.++|+|||.+..
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 011111111 123467899999999999999999999999999989999999998754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.40 E-value=2e-12 Score=104.28 Aligned_cols=111 Identities=21% Similarity=0.212 Sum_probs=88.7
Q ss_pred eeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCC--ceec----------------
Q 020016 59 IGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP--HIIT---------------- 120 (332)
Q Consensus 59 i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~---------------- 120 (332)
+.+.||.|.++.||++...+..++||.+..... ...+.+|+.++..+.|. ++.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc--------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEE
Confidence 457899999999999999888999999876543 14577888888888653 3322
Q ss_pred --CCCCC---CHHHHHHHHHHHHHHHHHHHHC---CCccccccccceeecCCCeEEEeecccccc
Q 020016 121 --EPYSV---PLNLVLKLALDIARGMQYLHSQ---GILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 --~~~~l---~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
....+ +......++.+++.+++++|.. +++|+|++|.||+++..+.++++|||.+..
T Consensus 74 ~~~g~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 11222 3477788999999999999985 699999999999999989999999998743
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.6e-11 Score=100.51 Aligned_cols=109 Identities=18% Similarity=0.101 Sum_probs=81.7
Q ss_pred eeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------------CC
Q 020016 60 GCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-----------------EP 122 (332)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-----------------~~ 122 (332)
.+.|+.|.++.||++...+..|++|+....... ...+.+|+.++..+.+.+++. .+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~-------~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL-------LINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCccc-------ccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCC
Confidence 357889999999999999999999998664321 123567888888875544432 12
Q ss_pred CCCCH--HHHHHHHHHHHHHHHHHHHCCC-----ccccccccceeecCCCeEEEeeccccc
Q 020016 123 YSVPL--NLVLKLALDIARGMQYLHSQGI-----LHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 123 ~~l~~--~~~~~i~~qi~~~L~~LH~~~i-----iH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
..+.. .....++.+++.+|+.||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 76 ~~l~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 76 SELLTEDFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CccccccccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 22221 2234567899999999999985 9999999999999 6789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.6e-12 Score=119.94 Aligned_cols=219 Identities=19% Similarity=0.207 Sum_probs=157.0
Q ss_pred CCeeeeeeecc--cCceEEEEEEE--C--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec-------
Q 020016 55 SQLFIGCKFAS--GRHSRIYRGIY--K--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~--G~~g~Vy~~~~--~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~------- 120 (332)
..+.+.+.+|. |.+|.||.+.. . +..+|+|.-+........ ...=.+|+.....+ .|+|.+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~----~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD----SKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc----cccccchhhcccccCccccccccCccccc
Confidence 45778889999 99999999988 3 678999985443321110 11123455555555 4677765
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHH----HHHHHHHCCCccccccccceeecCC-CeEEEeeccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIAR----GMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGI 174 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~----~L~~LH~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~ 174 (332)
....++...++..+.+... ||.++|+.+++|-|++|.||++..+ ...+++|||+
T Consensus 190 ~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 190 SGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred CCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence 2234778888999999999 9999999999999999999999999 8899999999
Q ss_pred ccccccCCCC------CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 020016 175 SCLESQCGSA------KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 248 (332)
Q Consensus 175 a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (332)
.......... ....+...|++||... +-++.++|+|++|.++.+..+|..+....... ....+........+
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS-SWSQLRQGYIPLEF 347 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC-CccccccccCchhh
Confidence 8765544321 2235788999999876 45688999999999999999987665432110 01111112223334
Q ss_pred CCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 249 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
-...+.++...+..+++.+|..|++++.+..
T Consensus 348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred hcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 4455677788999999999999998876553
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.19 E-value=6.4e-11 Score=112.84 Aligned_cols=120 Identities=23% Similarity=0.243 Sum_probs=81.9
Q ss_pred eeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHH----------------------------HHHH------HHHH
Q 020016 60 GCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLA----------------------------SMLE------KQFT 104 (332)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~----------------------------~~~~------~~~~ 104 (332)
.+.||+|++|.||+|... |+.||||+.++........ +... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999986 8999999987643221110 0111 1355
Q ss_pred HHHHHHHcCC-----CCceec------------------CCCCCCHH--------HHHHHHHHHHH-HHHHHHHCCCccc
Q 020016 105 SEVALLFRLN-----HPHIIT------------------EPYSVPLN--------LVLKLALDIAR-GMQYLHSQGILHR 152 (332)
Q Consensus 105 ~E~~~l~~l~-----h~niv~------------------~~~~l~~~--------~~~~i~~qi~~-~L~~LH~~~iiH~ 152 (332)
+|+..+.++. +++|.- .+..+..- ....++..++. .+..+|..|++|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g~~H~ 281 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDGFFHA 281 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCceeC
Confidence 6666666552 344321 22222211 12356666666 4788999999999
Q ss_pred cccccceeecCCCeEEEeecccccccc
Q 020016 153 DLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 153 dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
|++|.||+++.++.++++|||++....
T Consensus 282 D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 282 DLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999986544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.5e-10 Score=94.95 Aligned_cols=118 Identities=17% Similarity=0.170 Sum_probs=83.7
Q ss_pred eeeecccCceEEEEEEEC--------CeeEEEEEecCCCchh--------------------HHHHHHHHHHHHHHHHHH
Q 020016 60 GCKFASGRHSRIYRGIYK--------QRDVAIKLVSQPEEDA--------------------SLASMLEKQFTSEVALLF 111 (332)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~--------~~~vAvK~~~~~~~~~--------------------~~~~~~~~~~~~E~~~l~ 111 (332)
...||.|--+.||.|... +..+|||+++...... ...........+|+..|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 457999999999999865 2689999986532100 011122223348999998
Q ss_pred cCCC-----Cceec-----------C----------CCCCCHHHHHHHHHHHHHHHHHH-HHCCCccccccccceeecCC
Q 020016 112 RLNH-----PHIIT-----------E----------PYSVPLNLVLKLALDIARGMQYL-HSQGILHRDLKSENLLLGED 164 (332)
Q Consensus 112 ~l~h-----~niv~-----------~----------~~~l~~~~~~~i~~qi~~~L~~L-H~~~iiH~dlkp~NIll~~~ 164 (332)
++.. |.++. . ...++......+..+++.+|..| |..|++||||++.||+++ +
T Consensus 82 rl~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~ 160 (197)
T cd05146 82 RMQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-D 160 (197)
T ss_pred HHHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE-C
Confidence 8843 32221 1 11334456678889999999999 899999999999999997 4
Q ss_pred CeEEEeeccccccc
Q 020016 165 MCVKVADFGISCLE 178 (332)
Q Consensus 165 ~~~kl~Dfg~a~~~ 178 (332)
+.+.|+|||.+...
T Consensus 161 ~~v~iIDF~qav~~ 174 (197)
T cd05146 161 GKVWFIDVSQSVEP 174 (197)
T ss_pred CcEEEEECCCceeC
Confidence 67999999987544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.6e-11 Score=118.13 Aligned_cols=147 Identities=15% Similarity=0.247 Sum_probs=108.9
Q ss_pred HHHHHHHHHHHHHHC-CCccccccccceeecCCCeEEEeecccccccccCCC----------CCCcccccccCChhhhhc
Q 020016 133 LALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS----------AKGFTGTYRWMAPEMIKE 201 (332)
Q Consensus 133 i~~qi~~~L~~LH~~-~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~ 201 (332)
=+.+++.|+.|+|.. +++|++|.|++|.++.+|..||+.|+++........ .........|.|||++.+
T Consensus 104 nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 104 NLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 344566999999986 799999999999999999999999998754332111 111234668999999999
Q ss_pred CCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHH--HHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHH
Q 020016 202 KRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAF--AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 278 (332)
Q Consensus 202 ~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell 278 (332)
...+.++|+||+|+++|.+.. |+.-+.......... ..............++.++++=+.+++..++..||++.++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 888999999999999999984 666555433222111 11112223345578899999999999999999999777665
Q ss_pred H
Q 020016 279 S 279 (332)
Q Consensus 279 ~ 279 (332)
.
T Consensus 264 ~ 264 (700)
T KOG2137|consen 264 S 264 (700)
T ss_pred c
Confidence 3
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.6e-10 Score=106.32 Aligned_cols=138 Identities=17% Similarity=0.244 Sum_probs=101.9
Q ss_pred CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------------CCC-------CCCHHHHHHHH
Q 020016 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------------EPY-------SVPLNLVLKLA 134 (332)
Q Consensus 78 ~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------~~~-------~l~~~~~~~i~ 134 (332)
+.+|.|.+++...... .+...+-+..|+.++||||++ ... .+.......-+
T Consensus 37 ~~~vsVF~~~~~~~~~------~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~lk~l~~~~v~~Gl 110 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNGEV------TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLETVLKELGKEEVCLGL 110 (690)
T ss_pred CCceEEEEEeCCCchh------hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHHHHHHHhHHHHHHHHH
Confidence 6788888888765511 245667888999999999987 111 23355677788
Q ss_pred HHHHHHHHHHH-HCCCccccccccceeecCCCeEEEeecccccccccCCC-CCCcccccccCChhhhhcCCCCCccchhH
Q 020016 135 LDIARGMQYLH-SQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYS 212 (332)
Q Consensus 135 ~qi~~~L~~LH-~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 212 (332)
.||+.||.||| ..+++|++|..+.|+++..|..||++|.++........ ......-..|..|+.+.... ...|.|.
T Consensus 111 ~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~ 188 (690)
T KOG1243|consen 111 FQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWG 188 (690)
T ss_pred HHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchhhhh
Confidence 99999999998 56899999999999999999999999998754433221 12222233456666543322 4579999
Q ss_pred HHHHHHHHHhC
Q 020016 213 FGIVLWELLTA 223 (332)
Q Consensus 213 lG~il~elltG 223 (332)
||+++++++.|
T Consensus 189 Lg~li~el~ng 199 (690)
T KOG1243|consen 189 LGCLIEELFNG 199 (690)
T ss_pred HHHHHHHHhCc
Confidence 99999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=9.1e-11 Score=103.69 Aligned_cols=155 Identities=17% Similarity=0.202 Sum_probs=104.8
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccccccceeecCCCeEEEeeccccccccc-----CCCCCCccccccc
Q 020016 121 EPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGEDMCVKVADFGISCLESQ-----CGSAKGFTGTYRW 193 (332)
Q Consensus 121 ~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~gt~~y 193 (332)
....+......+|+.||+.||.|||+.. ++|+++..+.|++..+|-+|+.--........ ........+-++|
T Consensus 169 ~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~ 248 (458)
T KOG1266|consen 169 NQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGF 248 (458)
T ss_pred hhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCcc
Confidence 3456788889999999999999999985 99999999999999999888864322111100 0111223467889
Q ss_pred CChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCC
Q 020016 194 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPH 273 (332)
Q Consensus 194 ~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 273 (332)
.+||.=.....+-++|||+||...++|..|..--............ .... .-..-...-++++.+|++..|..||+
T Consensus 249 ~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~---ia~~-i~~len~lqr~~i~kcl~~eP~~rp~ 324 (458)
T KOG1266|consen 249 SAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEEN---IANV-IIGLENGLQRGSITKCLEGEPNGRPD 324 (458)
T ss_pred ccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhh---hhhh-eeeccCccccCcCcccccCCCCCCcc
Confidence 9999766666678999999999999998876542221111110000 0000 00001122356899999999999999
Q ss_pred HHHHHH
Q 020016 274 FDQIVS 279 (332)
Q Consensus 274 ~~ell~ 279 (332)
+.+++-
T Consensus 325 ar~llf 330 (458)
T KOG1266|consen 325 ARLLLF 330 (458)
T ss_pred hhhhhc
Confidence 998764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=7.7e-11 Score=117.69 Aligned_cols=223 Identities=22% Similarity=0.289 Sum_probs=159.0
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
+.+.++.+.+.+-+-+|.++.++.+.-. +...++|+......-.. ...+....+-.++-...+|-++.
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~---~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~ 875 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT---NDYESIRSKSNILITPRSPAVVRSFPSFPC 875 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhcc---ccccccCCccCccccCCCCceecccCCCCC
Confidence 4456778888889999999999987664 43344444322110000 00011122222222233454443
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
..+..+.+.++.....+.+++.+||...+.|+|++|.|.++..+|..++.|||......
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccc
Confidence 22345666778888899999999999999999999999999999999999998432100
Q ss_pred cC--------------------------------CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCC
Q 020016 180 QC--------------------------------GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227 (332)
Q Consensus 180 ~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf 227 (332)
-. .......+|+.|.+||...+......+|+|++|+++++.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 0012345899999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcCCC-CCCCCCCcHHHHHHHHHccccCCCCCCCHH
Q 020016 228 DNMTPEQAAFAVCQKNAR-PPVPPTCPKAFSYLISRCWSSSPDRRPHFD 275 (332)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 275 (332)
....+.++...+...... +.-+...+.+..+++...+..+|.+|..+.
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999998888766543332 334566788999999999999999997765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.4e-10 Score=108.37 Aligned_cols=228 Identities=19% Similarity=0.265 Sum_probs=151.2
Q ss_pred Ccccc-ccccCCeeeeeeecccCceEEEEEEEC---CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec
Q 020016 46 GEEEW-SADMSQLFIGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT 120 (332)
Q Consensus 46 ~~~~~-~~~~~~y~i~~~lg~G~~g~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 120 (332)
...+| ..-..+|..+..||.|.|+.|+....+ +..|++|-............. -..|+.+...+ .|.+++.
T Consensus 255 ~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~----sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 255 TTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF----SLGEVILEAILGSHLPSVG 330 (524)
T ss_pred cccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc----chhhhhHhhHhhcccccCC
Confidence 34443 333678889999999999999997654 578888877654332221111 12233333333 2444433
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC-CeEEEee
Q 020016 121 ----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVAD 171 (332)
Q Consensus 121 ----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~-~~~kl~D 171 (332)
....+++...+.+..|++.++.++|+..++|+|++|+||++..+ +..++.|
T Consensus 331 ~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~ 410 (524)
T KOG0601|consen 331 KNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGD 410 (524)
T ss_pred CCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccc
Confidence 12345677788899999999999999999999999999999876 7889999
Q ss_pred cccccccccCCCCCCccc-cccc-CChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 020016 172 FGISCLESQCGSAKGFTG-TYRW-MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP 249 (332)
Q Consensus 172 fg~a~~~~~~~~~~~~~g-t~~y-~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (332)
||++...... ...... +..| .++.......+..++|++|||..+.+.++|...-..... ...+ .....+..
T Consensus 411 ~~~~t~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i--~~~~~p~~ 483 (524)
T KOG0601|consen 411 FGCWTRLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTI--RSGDTPNL 483 (524)
T ss_pred ccccccccee--cccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceee--ecccccCC
Confidence 9988542211 111222 3333 355555666778999999999999999998543221111 1111 12222223
Q ss_pred CCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 250 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
+.....+..+...+...++..||.+.++....+-.
T Consensus 484 ~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 484 PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred CchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 34447788899999999999999998887665544
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.2e-10 Score=108.88 Aligned_cols=125 Identities=19% Similarity=0.170 Sum_probs=77.1
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchh----------------------------HHHHHHHHH-
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDA----------------------------SLASMLEKQ- 102 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~----------------------------~~~~~~~~~- 102 (332)
+.+|.. +.||+|++|.||+|+.+ |+.||||+.++..... ....+..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456676 78999999999999985 7999999998653211 011122222
Q ss_pred -----HHHHHHHHHcCC----CC-cee---------------c---CCCCCCHHHH--------HHHHHHHHH-HHHHHH
Q 020016 103 -----FTSEVALLFRLN----HP-HII---------------T---EPYSVPLNLV--------LKLALDIAR-GMQYLH 145 (332)
Q Consensus 103 -----~~~E~~~l~~l~----h~-niv---------------~---~~~~l~~~~~--------~~i~~qi~~-~L~~LH 145 (332)
|.+|+..+.++. +. .|. . .+.+++.-.. ..++...+. -+..+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 444554444442 22 221 0 2223321110 123322222 234455
Q ss_pred HCCCccccccccceeecCCC----eEEEeecccccccc
Q 020016 146 SQGILHRDLKSENLLLGEDM----CVKVADFGISCLES 179 (332)
Q Consensus 146 ~~~iiH~dlkp~NIll~~~~----~~kl~Dfg~a~~~~ 179 (332)
..|++|+|++|.||+++.+| .++++|||++...+
T Consensus 278 ~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 78999999999999999888 99999999986543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.6e-08 Score=81.25 Aligned_cols=116 Identities=20% Similarity=0.259 Sum_probs=80.6
Q ss_pred eeecccCceEEEEEEECCeeEEEEEec-CCCchhHHH-HHHHHHHHHHHHHHHcCC-----CCceec-------------
Q 020016 61 CKFASGRHSRIYRGIYKQRDVAIKLVS-QPEEDASLA-SMLEKQFTSEVALLFRLN-----HPHIIT------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~vAvK~~~-~~~~~~~~~-~~~~~~~~~E~~~l~~l~-----h~niv~------------- 120 (332)
..+++|+-+.+|.+.+.|.++++|.=. +......+. ......-.+|+.++.++. -|-+..
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 357899999999998888777776422 222222222 233466788999998874 333322
Q ss_pred CCCCCCH---HHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccc
Q 020016 121 EPYSVPL---NLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 ~~~~l~~---~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
.+..+.. .....++..+-.-+.-||..||+||||+++||++...+ +.++|||++..
T Consensus 82 ~G~~lkd~l~~~~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEARPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhcchHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 1122211 11246788888899999999999999999999998765 99999999854
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=5.3e-08 Score=80.05 Aligned_cols=119 Identities=26% Similarity=0.291 Sum_probs=85.5
Q ss_pred eeeeecccCceEEEEEEECCeeEEEEEe-cCCCch-hHHHHHHHHHHHHHHHHHHcCC-----CCceec-----------
Q 020016 59 IGCKFASGRHSRIYRGIYKQRDVAIKLV-SQPEED-ASLASMLEKQFTSEVALLFRLN-----HPHIIT----------- 120 (332)
Q Consensus 59 i~~~lg~G~~g~Vy~~~~~~~~vAvK~~-~~~~~~-~~~~~~~~~~~~~E~~~l~~l~-----h~niv~----------- 120 (332)
....|-+|+-+.|+++.+.|+...||.= .+.... ....+-......+|+.+|.++. -|-++-
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 4567889999999999999988777742 222111 1122334577888999998874 343321
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC---eEEEeecccccc
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM---CVKVADFGISCL 177 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~---~~kl~Dfg~a~~ 177 (332)
............++..|-+.+.-||..+++||||..+||++.+++ .+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 112223333478899999999999999999999999999997654 468999999754
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.78 E-value=3.4e-07 Score=86.00 Aligned_cols=191 Identities=13% Similarity=0.207 Sum_probs=133.9
Q ss_pred eeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------------
Q 020016 60 GCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------------- 120 (332)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 120 (332)
.+..+.-...+.|++..+ |..|++|+++....... ..-..-++.++++.|+|||.
T Consensus 281 l~~~~~~~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~------nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~Slvl 354 (655)
T KOG3741|consen 281 LELLNDLFSITTYKATSNVDGNAYVLKRLHGDRDQST------NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVL 354 (655)
T ss_pred cccccccccceeEeeeeccCCceeeeeeeccccccCc------ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEE
Confidence 334433356688999886 88999999954322221 11234678999999999996
Q ss_pred -------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEE
Q 020016 121 -------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 169 (332)
Q Consensus 121 -------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl 169 (332)
.+...++..+|.++.|+..||.++|+.|+..+-|.+.+|+++.+..++|
T Consensus 355 vYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIri 434 (655)
T KOG3741|consen 355 VYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRI 434 (655)
T ss_pred EEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEE
Confidence 3456789999999999999999999999999999999999999888888
Q ss_pred eecccccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhcCCCCCC
Q 020016 170 ADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP-FDNMTPEQAAFAVCQKNARPPV 248 (332)
Q Consensus 170 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p-f~~~~~~~~~~~~~~~~~~~~~ 248 (332)
+..|......... .+| +.+ -.+-|.=.||.+++.|.||..- +......+.. ...+
T Consensus 435 S~C~i~Dvl~~d~-----------~~~--le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~--------~~~I 490 (655)
T KOG3741|consen 435 SGCGIMDVLQEDP-----------TEP--LES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSH--------LTRI 490 (655)
T ss_pred ecccceeeecCCC-----------Ccc--hhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHH--------HHHh
Confidence 8777665443322 011 111 2356888999999999998543 2211111110 1112
Q ss_pred CCCCcHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 020016 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 281 (332)
Q Consensus 249 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L 281 (332)
...++.++++++......++++ -++.+++.++
T Consensus 491 ~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 491 TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 3456788889999888888886 5677776654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1e-07 Score=83.14 Aligned_cols=121 Identities=23% Similarity=0.237 Sum_probs=88.5
Q ss_pred eeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHH----------------HHHHHHHHHHHHHHHcCCCC---
Q 020016 57 LFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLA----------------SMLEKQFTSEVALLFRLNHP--- 116 (332)
Q Consensus 57 y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~--- 116 (332)
+.++.+||-|--|.||.|.+. |.++|||.-+....+.... ...+....+|.++|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 457899999999999999997 9999999765432211100 11234567899999988433
Q ss_pred ---------ceec---------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccc
Q 020016 117 ---------HIIT---------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 117 ---------niv~---------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
|.|- ..-+++.+....++..|+.-+.-+-..|++|||+++-||+++++|.+.++||-.+..
T Consensus 173 VP~P~~~nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 173 VPKPIAWNRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred CCCccccccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCccccc
Confidence 2211 122234666777777788777777799999999999999999999999999987643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.4e-07 Score=79.38 Aligned_cols=108 Identities=23% Similarity=0.308 Sum_probs=71.2
Q ss_pred EEEEEEEC-CeeEEEEEecCCCchh--------------------HHHHHHHHHHHHHHHHHHcCCCCce-ec-------
Q 020016 70 RIYRGIYK-QRDVAIKLVSQPEEDA--------------------SLASMLEKQFTSEVALLFRLNHPHI-IT------- 120 (332)
Q Consensus 70 ~Vy~~~~~-~~~vAvK~~~~~~~~~--------------------~~~~~~~~~~~~E~~~l~~l~h~ni-v~------- 120 (332)
.||.|... +..+|||+.+...... ...........+|...|.++..-++ |+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~ 80 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR 80 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence 48999985 8899999986531111 1112234667899999999976543 11
Q ss_pred --------C--CCC--------CCHHHHHHHHHHHHHHHHH-HHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 --------E--PYS--------VPLNLVLKLALDIARGMQY-LHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 --------~--~~~--------l~~~~~~~i~~qi~~~L~~-LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
. +.+ ++......++.+++..+.. +|..|++||||++.||+++++ .+.|+|||.+...
T Consensus 81 ~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 81 NVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp TEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred CEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence 1 111 1134466788888885555 579999999999999999887 8999999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.61 E-value=5e-07 Score=80.49 Aligned_cols=115 Identities=18% Similarity=0.098 Sum_probs=77.9
Q ss_pred eecccCceEEEEEEECCeeEEEEEecCCCchhHHHHH-----HHHHHHHHHHHHHcCC-----CCceec-----------
Q 020016 62 KFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASM-----LEKQFTSEVALLFRLN-----HPHIIT----------- 120 (332)
Q Consensus 62 ~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~-----~~~~~~~E~~~l~~l~-----h~niv~----------- 120 (332)
.+-......|++....|+.|.||.............- -...+.+|...+..+. -|.+|-
T Consensus 29 ~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 29 VFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 3333444457788888999999988554322111100 0013678888887773 232221
Q ss_pred --------C--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC-------CCeEEEee
Q 020016 121 --------E--------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-------DMCVKVAD 171 (332)
Q Consensus 121 --------~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~-------~~~~kl~D 171 (332)
- ....+......++.+++..+.-||..||+|+|+++.|||++. ++.+.|+|
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 0 122344566789999999999999999999999999999975 46899999
Q ss_pred ccccc
Q 020016 172 FGISC 176 (332)
Q Consensus 172 fg~a~ 176 (332)
|+.+.
T Consensus 189 l~r~~ 193 (268)
T PRK15123 189 LHRAQ 193 (268)
T ss_pred CCccc
Confidence 99774
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.1e-07 Score=79.13 Aligned_cols=113 Identities=12% Similarity=0.035 Sum_probs=82.3
Q ss_pred cccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------------------
Q 020016 64 ASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------------------- 120 (332)
Q Consensus 64 g~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------------- 120 (332)
|.||.+.|++-...|..+-+|.-............-+..|.+|...|.+|..-+|--
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 469999999999888888888764211000000111367899999999985433211
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCe--EEEeeccccc
Q 020016 121 --------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC--VKVADFGISC 176 (332)
Q Consensus 121 --------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~--~kl~Dfg~a~ 176 (332)
...+.+......++.+++..++-||..|+.|+|+.+.||+++.+|. ++++||.-++
T Consensus 107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 1123455666799999999999999999999999999999986666 9999998654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.56 E-value=6e-07 Score=77.34 Aligned_cols=111 Identities=19% Similarity=0.249 Sum_probs=83.4
Q ss_pred eeecccCceEEEEEEECC-eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCC-----Cceec--------------
Q 020016 61 CKFASGRHSRIYRGIYKQ-RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH-----PHIIT-------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-----~niv~-------------- 120 (332)
+.|+.|.++.||++...+ ..+++|+........ ....+.+|+.++..+.+ |.++.
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~-----~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v 78 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLP-----SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYV 78 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCc-----ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEE
Confidence 568999999999998875 899999987643311 12457788888888754 32221
Q ss_pred ----------CC---CCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 020016 121 ----------EP---YSVPLNLVLKLALDIARGMQYLHS----------------------------------------- 146 (332)
Q Consensus 121 ----------~~---~~l~~~~~~~i~~qi~~~L~~LH~----------------------------------------- 146 (332)
.. ..+++.....++.+++.+|..||+
T Consensus 79 ~e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 79 MERVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 00 235667788889999999999984
Q ss_pred ---------------CCCccccccccceeecC--CCeEEEeeccccc
Q 020016 147 ---------------QGILHRDLKSENLLLGE--DMCVKVADFGISC 176 (332)
Q Consensus 147 ---------------~~iiH~dlkp~NIll~~--~~~~kl~Dfg~a~ 176 (332)
..++|+|+.+.||+++. ++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 13589999999999998 6778999999774
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.39 E-value=5.5e-06 Score=71.68 Aligned_cols=119 Identities=18% Similarity=0.193 Sum_probs=84.8
Q ss_pred eeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHH------------------HHHHHHHHHHHHHHHHcCCCC----
Q 020016 60 GCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASL------------------ASMLEKQFTSEVALLFRLNHP---- 116 (332)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~------------------~~~~~~~~~~E~~~l~~l~h~---- 116 (332)
...|.+|.-+.||+|... +..||||++......... ......-..+|+.-|+++..-
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 347888999999999875 889999999764332211 011122245677777776321
Q ss_pred --------ceec--------------CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccccccceeecCCCeEEEeecc
Q 020016 117 --------HIIT--------------EPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 117 --------niv~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
||+- ...++....+..+..++++.+.-|-. .+++|+||+.-|||+. ++.+.|+|||
T Consensus 133 P~Pi~~~~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~ 211 (268)
T COG1718 133 PEPIAFRNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVS 211 (268)
T ss_pred CCceeecCCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECc
Confidence 3321 22334444788888999999988877 8999999999999999 8899999999
Q ss_pred cccccc
Q 020016 174 ISCLES 179 (332)
Q Consensus 174 ~a~~~~ 179 (332)
.+....
T Consensus 212 QaV~~~ 217 (268)
T COG1718 212 QAVTID 217 (268)
T ss_pred cccccC
Confidence 885443
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.5e-06 Score=69.10 Aligned_cols=115 Identities=21% Similarity=0.250 Sum_probs=87.5
Q ss_pred CCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 120 (332)
-.....+.||.|++|.||+|.+.+..+|+|+-+.... +..+..|+++|..+.-.++..
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~--------r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~ 93 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP--------RRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEY 93 (201)
T ss_pred hhhhhhhhhhcccccEEEEeeccCceEEEEEecCCcc--------hhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhh
Confidence 3455678899999999999999999999999776544 356788999999998766654
Q ss_pred -CCCCCCHHHH---HHHHHHHHHHHHHHHHCCCcccccc-ccceeecCCCeEEEeecccccc
Q 020016 121 -EPYSVPLNLV---LKLALDIARGMQYLHSQGILHRDLK-SENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 -~~~~l~~~~~---~~i~~qi~~~L~~LH~~~iiH~dlk-p~NIll~~~~~~kl~Dfg~a~~ 177 (332)
.+.++..... .+-+..+++.-.-|-..||-|+.|+ |...++-.++.+.|+||..|+.
T Consensus 94 i~G~~L~~~~~~~~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIGGDRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhcccHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 3333433333 5566677788777888899999996 5555555556899999998864
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.32 E-value=3e-06 Score=72.74 Aligned_cols=53 Identities=26% Similarity=0.318 Sum_probs=47.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC---eEEEeecccccc
Q 020016 125 VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM---CVKVADFGISCL 177 (332)
Q Consensus 125 l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~---~~kl~Dfg~a~~ 177 (332)
.+......++.+++..++-||..||+|+|+++.|||++.++ .+.++||+-+..
T Consensus 115 ~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 115 LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 45667789999999999999999999999999999999887 899999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.01 E-value=0.00013 Score=62.54 Aligned_cols=122 Identities=13% Similarity=0.125 Sum_probs=77.8
Q ss_pred cCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHH-HHH--HHHHHHHHHHHHcCC-----CC---ceec--
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLA-SML--EKQFTSEVALLFRLN-----HP---HIIT-- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~-~~~--~~~~~~E~~~l~~l~-----h~---niv~-- 120 (332)
-.+|.+.+.+-......|.+-..+++.+++|..+......... ... .....+++..+..+. .+ .++.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 3688999999999999999998899999999987643221100 000 011122333232221 11 1111
Q ss_pred ----------------CCCCCCHHH--HHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccc
Q 020016 121 ----------------EPYSVPLNL--VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 121 ----------------~~~~l~~~~--~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
.+..+..-. --.+...+++++.-+|..|++|||..|.|++++.++ ++++||+...
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~~i~e~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIEDIDEDLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred eeccceeEEEEEEEEecCeecccchhcCHHHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 232332211 113556788899999999999999999999998654 9999998653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.0001 Score=75.89 Aligned_cols=170 Identities=16% Similarity=0.187 Sum_probs=123.2
Q ss_pred HHHHHHHHHHHcCCCCceec--------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 020016 101 KQFTSEVALLFRLNHPHIIT--------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQG 148 (332)
Q Consensus 101 ~~~~~E~~~l~~l~h~niv~--------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 148 (332)
....-|...+.++.|+|++. .....+.+..+.+..++..||.|+|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 33455778888889999875 4567888999999999999999999997
Q ss_pred Ccccccccc---ceeecCCCeEEEe--ecccccccccCCCCCCcccccccCChhhhhcCCC--CCccchhHHHHHHHHHH
Q 020016 149 ILHRDLKSE---NLLLGEDMCVKVA--DFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH--TKKVDVYSFGIVLWELL 221 (332)
Q Consensus 149 iiH~dlkp~---NIll~~~~~~kl~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~sDvwSlG~il~ell 221 (332)
..|.-|... +...+..+.+.++ ||+.+..............+..+-++|......+ +...|+|.+|.....+.
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~ 386 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS 386 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence 777666655 4555666777777 8888877666555555556677788887766555 44579999999999998
Q ss_pred hCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 020016 222 TALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 281 (332)
Q Consensus 222 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L 281 (332)
.|..+-..... ....++......+.+...+|+..++++|+++.+++...
T Consensus 387 ~~~~i~~~~~~-----------~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 387 QGEDISEKSAV-----------PVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hcCcccccccc-----------hhhhhccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 87654321110 01111122222678899999999999999999988754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.81 E-value=1e-05 Score=78.21 Aligned_cols=158 Identities=22% Similarity=0.202 Sum_probs=116.4
Q ss_pred CeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCc-eec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH-IIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~------------- 120 (332)
.+.....++.|+++++|+.+.. .+....+++..+. ...-++++|.+++||| .+.
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l-----------~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTL-----------SRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeeccch-----------hhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 3445566789999999998876 3344466665531 1335788999999999 443
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
....+..-+...+.+.-+.+++++|+.-=+|+| ||+..+ +..+..||+....+.....
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~ 386 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMK 386 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccc
Confidence 111233344555666677889999988778888 766654 6789999998876666555
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCC
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 229 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~ 229 (332)
.....+++.++|||+.....+..+.|+|++|+--.++.-|.+|-..
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 6778899999999999999999999999999877777777776543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.81 E-value=8.7e-05 Score=71.86 Aligned_cols=38 Identities=29% Similarity=0.419 Sum_probs=32.1
Q ss_pred HHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 142 QYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 142 ~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
..+=..|+.|.|..|.||+++.+|.+.+.|||+.....
T Consensus 279 ~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 279 RQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHhcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 33345799999999999999999999999999875443
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00028 Score=59.73 Aligned_cols=116 Identities=22% Similarity=0.285 Sum_probs=78.4
Q ss_pred CCeeeeeeecccCc-eEEEEEEECCeeEEEEEecC---CCchhH---H---------HHHHHHHHHHHHHHHHcC---CC
Q 020016 55 SQLFIGCKFASGRH-SRIYRGIYKQRDVAIKLVSQ---PEEDAS---L---------ASMLEKQFTSEVALLFRL---NH 115 (332)
Q Consensus 55 ~~y~i~~~lg~G~~-g~Vy~~~~~~~~vAvK~~~~---~~~~~~---~---------~~~~~~~~~~E~~~l~~l---~h 115 (332)
.+++..+.||.|.. |.||++...|+.+|+|++.. ...... . .......|..|.....+| .+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 78999999999999 99999999999999999322 111100 0 012234566776666655 33
Q ss_pred Cce--ec---------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccccccee
Q 020016 116 PHI--IT---------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 160 (332)
Q Consensus 116 ~ni--v~---------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIl 160 (332)
+++ |+ .-..........-+.+|.+-|..+|..||+-+|+++.|..
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~ 196 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRDIPQMLRDLKILHKLGIVPRDVKPRNYR 196 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCccccchhHHHHHHHHHHHHHHCCeeeccCcccccc
Confidence 343 22 1111111224445667888899999999999999999987
Q ss_pred ecCCCeEEEeecccc
Q 020016 161 LGEDMCVKVADFGIS 175 (332)
Q Consensus 161 l~~~~~~kl~Dfg~a 175 (332)
.-+|+|||.+
T Consensus 197 -----~G~lvDfs~~ 206 (207)
T PF13095_consen 197 -----GGKLVDFSSS 206 (207)
T ss_pred -----CCEEEecccC
Confidence 3488999864
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00025 Score=61.75 Aligned_cols=105 Identities=20% Similarity=0.154 Sum_probs=67.1
Q ss_pred eeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-----CCceec---------------
Q 020016 61 CKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-----HPHIIT--------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~--------------- 120 (332)
..||+|..+.||+. .+..+++|........ ....+|.+++..+. .|.++.
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~~--------~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFDK--------ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCCCH--------HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence 47899999999984 3567889998764322 23466777776663 343332
Q ss_pred CCC-------CCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------CCCc
Q 020016 121 EPY-------SVPLNLVLKLALDIARGMQYLHS-------------------------------------------QGIL 150 (332)
Q Consensus 121 ~~~-------~l~~~~~~~i~~qi~~~L~~LH~-------------------------------------------~~ii 150 (332)
.+. ..+......++.+++..+.-||+ ..++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 111 11222223344444444444442 1367
Q ss_pred cccccccceeecCCCeEEEeeccccc
Q 020016 151 HRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 151 H~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
|+|+.|.||+++.++ +.++||+.+.
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcC
Confidence 999999999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00039 Score=60.05 Aligned_cols=47 Identities=21% Similarity=0.340 Sum_probs=36.0
Q ss_pred eeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC
Q 020016 60 GCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN 114 (332)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 114 (332)
.+.|+.|..+.||+....+..+++|+.... . ....+.+|..++..+.
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~-~-------~~~~~~~e~~~~~~l~ 48 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP-D-------AAERLRREAAVLRQLA 48 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH-H-------HHHHHHHHHHHHHHHH
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC-C-------CHHHHHHHHHHHHHHH
Confidence 467899999999999998889999998764 1 1245667777777763
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00036 Score=62.93 Aligned_cols=122 Identities=20% Similarity=0.249 Sum_probs=83.3
Q ss_pred CeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHH----------------HHHHHHHHHHHHHHHcCCC---
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLA----------------SMLEKQFTSEVALLFRLNH--- 115 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h--- 115 (332)
-+.+++.||-|.-+.||.+-+. |++.++|+-+......... --.+-...+|+..|+.|..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 4668999999999999999998 8999999664422211110 0012235677777777732
Q ss_pred --C-------ceec----CCCCC----CHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccc
Q 020016 116 --P-------HIIT----EPYSV----PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 116 --~-------niv~----~~~~l----~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
| |+|- ...++ .......+...++.-+.-|-.+|+||+|.+--||++++++.++++||-....
T Consensus 173 pVPkpiD~~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 173 PVPKPIDHNRHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred CCCCcccccceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechHhhc
Confidence 2 2221 11111 1233445666677777788899999999999999999999999999986543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0049 Score=56.14 Aligned_cols=30 Identities=37% Similarity=0.702 Sum_probs=26.9
Q ss_pred CCCccccccccceeecCCCeEEEeeccccc
Q 020016 147 QGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 147 ~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 579999999999999998877999999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0026 Score=56.28 Aligned_cols=29 Identities=24% Similarity=0.334 Sum_probs=25.3
Q ss_pred CCccccccccceeecCCCeEEEeecccccc
Q 020016 148 GILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 148 ~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
.++|+|+.|.||+++.++ +.|+||..+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 479999999999999877 78999998743
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0058 Score=55.91 Aligned_cols=30 Identities=33% Similarity=0.637 Sum_probs=26.1
Q ss_pred CCCccccccccceeecCCCeEEEeeccccc
Q 020016 147 QGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 147 ~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
.+++|+|+.|.||+++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 379999999999999977667899999764
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.00046 Score=73.08 Aligned_cols=148 Identities=14% Similarity=0.016 Sum_probs=101.5
Q ss_pred EEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------------------------------CCCCCC
Q 020016 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------------------------------EPYSVP 126 (332)
Q Consensus 81 vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------------------------~~~~l~ 126 (332)
+-+|+.....- +.+.+..++-...|.+.++...|+++.. ....+.
T Consensus 1255 Fk~~I~ke~d~-e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld 1333 (2724)
T KOG1826|consen 1255 FKFSIYKEYDF-ENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLD 1333 (2724)
T ss_pred eEEEeehhhhH-HHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcch
Confidence 45666654332 2233444555667777777788988865 112222
Q ss_pred HHHHHHHHHHHHHHHHHHHHC-----CCccccccccceeecCCCeEEEeeccccccc-ccCCCCCCcccccccCChhhhh
Q 020016 127 LNLVLKLALDIARGMQYLHSQ-----GILHRDLKSENLLLGEDMCVKVADFGISCLE-SQCGSAKGFTGTYRWMAPEMIK 200 (332)
Q Consensus 127 ~~~~~~i~~qi~~~L~~LH~~-----~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~ 200 (332)
..-+.....+.+.+..-+|+. -.+|++|++.|.+|..+..+++.++|+.+.. ..........+++-|+.|+...
T Consensus 1334 ~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N 1413 (2724)
T KOG1826|consen 1334 RSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN 1413 (2724)
T ss_pred hchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHH
Confidence 222222223335555555554 2689999999999999999999999999833 3333344566788899999999
Q ss_pred cCCCCCccchhHHHHHHHHHHhCCCCCCC
Q 020016 201 EKRHTKKVDVYSFGIVLWELLTALTPFDN 229 (332)
Q Consensus 201 ~~~~~~~sDvwSlG~il~elltG~~pf~~ 229 (332)
.-.++.++|+|..|+.+|....|..+|-.
T Consensus 1414 ~ik~t~rsdilr~s~~ly~rs~~n~~fi~ 1442 (2724)
T KOG1826|consen 1414 EIKFTKRSDILRRSLSLYLRSDGNAYFIF 1442 (2724)
T ss_pred HHhhhhHHHHHHHHHHHHHHhcccHHHHH
Confidence 88899999999999999998888777643
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.013 Score=54.11 Aligned_cols=117 Identities=23% Similarity=0.251 Sum_probs=86.0
Q ss_pred eeeeecccCceEEEEEEEC-CeeEEEEEecCCC--------------------chhHHHHHHHHHHHHHHHHHHcCCCCc
Q 020016 59 IGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPE--------------------EDASLASMLEKQFTSEVALLFRLNHPH 117 (332)
Q Consensus 59 i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~--------------------~~~~~~~~~~~~~~~E~~~l~~l~h~n 117 (332)
|-..|..|.-+.||.+.-. |..+|||+++-+. .......++.--..+|+.-|++|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 4567889999999999886 8889999884321 111122333444567888888885433
Q ss_pred e-------ec-------------------CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccccccceeecCCCeEEEe
Q 020016 118 I-------IT-------------------EPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVA 170 (332)
Q Consensus 118 i-------v~-------------------~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~NIll~~~~~~kl~ 170 (332)
| ++ ....++...+..+-.+++.-+.-|-+ .+++|.||+--|+|+. +|.+.|+
T Consensus 228 IP~PePIlLk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~lyiI 306 (520)
T KOG2270|consen 228 IPCPEPILLKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKLYII 306 (520)
T ss_pred CCCCCceeeecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEEEEE
Confidence 2 11 45567888899999999988887754 5899999999999996 5789999
Q ss_pred eccccc
Q 020016 171 DFGISC 176 (332)
Q Consensus 171 Dfg~a~ 176 (332)
|.+.+.
T Consensus 307 DVSQSV 312 (520)
T KOG2270|consen 307 DVSQSV 312 (520)
T ss_pred Eccccc
Confidence 998764
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0062 Score=53.01 Aligned_cols=29 Identities=31% Similarity=0.410 Sum_probs=25.9
Q ss_pred CCccccccccceeecC-CCeEEEeeccccc
Q 020016 148 GILHRDLKSENLLLGE-DMCVKVADFGISC 176 (332)
Q Consensus 148 ~iiH~dlkp~NIll~~-~~~~kl~Dfg~a~ 176 (332)
+++|+|+.+.||+++. ++.+.|+||..+.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 5899999999999998 5789999998774
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.011 Score=51.83 Aligned_cols=29 Identities=17% Similarity=0.166 Sum_probs=25.7
Q ss_pred CCccccccccceeecCCCeEEEeeccccc
Q 020016 148 GILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 148 ~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
.++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 37999999999999998888999999763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0042 Score=56.10 Aligned_cols=30 Identities=37% Similarity=0.680 Sum_probs=26.6
Q ss_pred CCCccccccccceeecCCCeEEEeeccccc
Q 020016 147 QGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 147 ~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
.+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 369999999999999998878999999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.018 Score=56.06 Aligned_cols=32 Identities=25% Similarity=0.244 Sum_probs=27.6
Q ss_pred eeeecccCceEEEEEEEC-CeeEEEEEecCCCc
Q 020016 60 GCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEE 91 (332)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~ 91 (332)
.+.||.-+.|.||+|+.+ |+.||||+-++.-.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~ 198 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLE 198 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChH
Confidence 468999999999999998 88999999877543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.029 Score=58.23 Aligned_cols=54 Identities=13% Similarity=0.149 Sum_probs=36.5
Q ss_pred eeeecccCceEEEEEEECC----eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCce
Q 020016 60 GCKFASGRHSRIYRGIYKQ----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHI 118 (332)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~----~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni 118 (332)
.+.|+.|.++.+|+....+ ..+++|+......... ...+.+|+.+|+.+. |+++
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~-----~~~~~rE~~~l~~L~~~~~v 101 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS-----AHAVEREYQVLRALGEHTDV 101 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc-----HHHHHHHHHHHHHHhhcCCC
Confidence 5678999999999987763 4678887654321111 135778998888884 5443
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.018 Score=52.17 Aligned_cols=29 Identities=28% Similarity=0.355 Sum_probs=25.9
Q ss_pred CCccccccccceeecCC----CeEEEeeccccc
Q 020016 148 GILHRDLKSENLLLGED----MCVKVADFGISC 176 (332)
Q Consensus 148 ~iiH~dlkp~NIll~~~----~~~kl~Dfg~a~ 176 (332)
+++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 57999999999999874 889999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.029 Score=47.30 Aligned_cols=54 Identities=19% Similarity=0.210 Sum_probs=48.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCCccccccccceeecCCCeEEEeecccccc
Q 020016 124 SVPLNLVLKLALDIARGMQYLHS---QGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 124 ~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
..+|..+.+|+.++++.+.+++. ..+.-.|++++|+-++.+|.+|++|.+.+..
T Consensus 55 ~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 55 QSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred ccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 45799999999999999999998 3477889999999999999999999987644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.04 Score=49.23 Aligned_cols=30 Identities=30% Similarity=0.333 Sum_probs=27.1
Q ss_pred CCccccccccceeecCCCeEEEeecccccc
Q 020016 148 GILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 148 ~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
-++|+|+.|.|++.++.+.++|+||..|..
T Consensus 154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred eeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 489999999999999999999999988743
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.17 Score=43.03 Aligned_cols=113 Identities=18% Similarity=0.224 Sum_probs=66.0
Q ss_pred eeeecccCceEEEEEEECCeeEEEEEecCCCchhH----------HHHHHHHHHHHHHHHHHcCC-CCce-----ec---
Q 020016 60 GCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDAS----------LASMLEKQFTSEVALLFRLN-HPHI-----IT--- 120 (332)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~----------~~~~~~~~~~~E~~~l~~l~-h~ni-----v~--- 120 (332)
...||+|+.-.||.-- .+....||+......... ......+++.+|+.-...+. ..++ .+
T Consensus 6 ~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 3578999999999632 256678999887650000 00011245666776666665 3332 21
Q ss_pred -----------------CCCCC--CHHHHH-------HHHHHHHHHHHHHHHCCCccccccccceeecCC--C--eEEEe
Q 020016 121 -----------------EPYSV--PLNLVL-------KLALDIARGMQYLHSQGILHRDLKSENLLLGED--M--CVKVA 170 (332)
Q Consensus 121 -----------------~~~~l--~~~~~~-------~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~--~--~~kl~ 170 (332)
..+.+ +..... .+...+-+-..||-..+|+.+|++|.||++... + .+.|+
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlI 164 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLI 164 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEE
Confidence 12221 111111 233334445668888999999999999999543 2 57777
Q ss_pred e-cc
Q 020016 171 D-FG 173 (332)
Q Consensus 171 D-fg 173 (332)
| ||
T Consensus 165 DG~G 168 (199)
T PF10707_consen 165 DGLG 168 (199)
T ss_pred eCCC
Confidence 7 44
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.11 Score=47.78 Aligned_cols=29 Identities=34% Similarity=0.447 Sum_probs=25.2
Q ss_pred CccccccccceeecC-CCeEEEeecccccc
Q 020016 149 ILHRDLKSENLLLGE-DMCVKVADFGISCL 177 (332)
Q Consensus 149 iiH~dlkp~NIll~~-~~~~kl~Dfg~a~~ 177 (332)
++|+|+.+.||++++ ++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 699999999999975 47899999998743
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.87 E-value=0.096 Score=48.58 Aligned_cols=29 Identities=24% Similarity=0.571 Sum_probs=25.6
Q ss_pred CCccccccccceeecC-CCeEEEeeccccc
Q 020016 148 GILHRDLKSENLLLGE-DMCVKVADFGISC 176 (332)
Q Consensus 148 ~iiH~dlkp~NIll~~-~~~~kl~Dfg~a~ 176 (332)
.++|+|+++.||+++. ++.+.++||.++.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 5899999999999986 4789999999874
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.84 E-value=0.077 Score=50.09 Aligned_cols=29 Identities=28% Similarity=0.471 Sum_probs=24.8
Q ss_pred CCCccccccccceeecCCCeEEEeeccccc
Q 020016 147 QGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 147 ~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
..++|||+.+.||++..+ .++++||-++.
T Consensus 223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a~ 251 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE-ETKVIDPEFAF 251 (401)
T ss_pred CceeeccCCcccEEeeCC-CcEEEeccccc
Confidence 368999999999999776 58999998764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.05 Score=51.07 Aligned_cols=29 Identities=28% Similarity=0.485 Sum_probs=24.6
Q ss_pred CCCccccccccceeecCCCeEEEeeccccc
Q 020016 147 QGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 147 ~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
..++||||.|.|||++++ .+|++|..++.
T Consensus 227 ~aLlHGDlHtGSI~v~~~-~~kvIDpEFAf 255 (409)
T PRK12396 227 QALIHGDLHTGSVFVKND-STKVIDPEFAF 255 (409)
T ss_pred hhhccCcCCCCCEEecCC-ceEEEcccccc
Confidence 359999999999999976 58999977764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.06 Score=49.67 Aligned_cols=82 Identities=20% Similarity=0.282 Sum_probs=57.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC-CCccccccccceeecCCCeEEEeecccccccccCCCCCCcccccccCChhhhhcCC
Q 020016 125 VPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR 203 (332)
Q Consensus 125 l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 203 (332)
-..+++..++.+.+..+.-+..+ .+-|||+.-+||+|+ +|++.|+||-+++.....+ .......--|-.+.| .
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~~~q~----~isy~rldhp~lF~G-~ 391 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSYSQG----IISYNRLDHPDLFNG-V 391 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecccCCc----eeeccccCchhhhcC-c
Confidence 46788899999988888877766 689999999999999 9999999999997433222 122222334444543 2
Q ss_pred CCCccchhH
Q 020016 204 HTKKVDVYS 212 (332)
Q Consensus 204 ~~~~sDvwS 212 (332)
-+..=|||-
T Consensus 392 dd~QFeIYr 400 (488)
T COG5072 392 DDYQFEIYR 400 (488)
T ss_pred cceeeeHHH
Confidence 255556665
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.51 E-value=0.076 Score=48.20 Aligned_cols=29 Identities=34% Similarity=0.501 Sum_probs=25.2
Q ss_pred CCCccccccccceeecCCCeEEEeeccccc
Q 020016 147 QGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 147 ~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
.+++|||+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 668999999653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=94.44 E-value=0.038 Score=48.20 Aligned_cols=29 Identities=34% Similarity=0.418 Sum_probs=25.4
Q ss_pred CCccccccccceeecCCCeEEEeeccccc
Q 020016 148 GILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 148 ~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
+++|+|+.+.||+++.++..-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 58999999999999877667899999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.42 E-value=0.11 Score=44.71 Aligned_cols=104 Identities=14% Similarity=0.162 Sum_probs=62.5
Q ss_pred cCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC------CCc-----ee-cCCCCCCHHHHHHH
Q 020016 66 GRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN------HPH-----II-TEPYSVPLNLVLKL 133 (332)
Q Consensus 66 G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~n-----iv-~~~~~l~~~~~~~i 133 (332)
|+.++.-.+..+=.+..+|+++.....-. ..-|.++..++.++. ..| |+ ..-.++. .....+
T Consensus 73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~~-----~~~y~nky~v~ArmhGilrL~NDn~~~yGvIlE~Cy~~~-i~~~N~ 146 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGPLFLKKIRSLPCCIN-----DALYFNKYRVFARMHGILRLKNDNNYKYGVILERCYKIK-INFSNF 146 (308)
T ss_pred CCceEEEEeccccchhhhhhccCCCcccc-----hhhhhhhhhHHHHhhheeEeecCCCceeEEEEeeccCcc-cchhHH
Confidence 55666666655533455666554322211 134667777777662 112 22 1222222 222333
Q ss_pred HHHHHHHHHHHHHC--CCccccccccceeecCCCeEEEeecccc
Q 020016 134 ALDIARGMQYLHSQ--GILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 134 ~~qi~~~L~~LH~~--~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
+.--+.+|.-.|+. +.+|||-.|+||+-|..|.+||.|-+..
T Consensus 147 i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 147 ITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 33335678888954 6999999999999999999999998753
|
The function of this family is unknown. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.40 E-value=0.07 Score=49.98 Aligned_cols=40 Identities=28% Similarity=0.275 Sum_probs=27.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHH-HHCCCccccccccceeecC
Q 020016 124 SVPLNLVLKLALDIARGMQYL-HSQGILHRDLKSENLLLGE 163 (332)
Q Consensus 124 ~l~~~~~~~i~~qi~~~L~~L-H~~~iiH~dlkp~NIll~~ 163 (332)
..++.....++.-.+.|+--+ --.+++|.|+.|.||++.-
T Consensus 340 ~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 340 SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 344555666666556654433 3458999999999999953
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.86 E-value=0.59 Score=42.98 Aligned_cols=28 Identities=25% Similarity=0.198 Sum_probs=23.6
Q ss_pred CCCccccccccceeecCCCeEEEeeccccc
Q 020016 147 QGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 147 ~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
.+++|+|+.+.||+++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 3689999999999995 4 57899999764
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.33 E-value=0.063 Score=45.07 Aligned_cols=27 Identities=22% Similarity=0.367 Sum_probs=24.4
Q ss_pred CccccccccceeecCCCeEEEeeccccc
Q 020016 149 ILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 149 iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
.+|+|+.|.||+++++| ++|+||+.+.
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCccc
Confidence 69999999999998877 8899999874
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.03 E-value=0.86 Score=42.93 Aligned_cols=29 Identities=24% Similarity=0.162 Sum_probs=24.0
Q ss_pred CCCccccccccceeecCCCeEEEeeccccc
Q 020016 147 QGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 147 ~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
..++|.|+-+.||+.+. +.+.++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 35799999999999765 459999998774
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.78 E-value=0.18 Score=45.89 Aligned_cols=30 Identities=17% Similarity=0.220 Sum_probs=27.4
Q ss_pred CCccccccccceeecCCCeEEEeecccccc
Q 020016 148 GILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 148 ~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
+++|+|+.++||+++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=92.66 E-value=0.062 Score=41.67 Aligned_cols=30 Identities=23% Similarity=0.241 Sum_probs=26.7
Q ss_pred eeeecccCceEEEEEEEC-CeeEEEEEecCC
Q 020016 60 GCKFASGRHSRIYRGIYK-QRDVAIKLVSQP 89 (332)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~ 89 (332)
.+.||+|+.|.||+|+.+ |+.||||+.++.
T Consensus 16 ~~PlasASiaQVh~a~l~~g~~VaVKV~rP~ 46 (119)
T PF03109_consen 16 PEPLASASIAQVHRARLKDGEEVAVKVQRPG 46 (119)
T ss_pred cchhhheehhhheeeeecccchhhhhhcchH
Confidence 357999999999999986 899999998774
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=92.56 E-value=0.11 Score=48.18 Aligned_cols=29 Identities=31% Similarity=0.463 Sum_probs=24.3
Q ss_pred CCCccccccccceeecCCCeEEEeeccccc
Q 020016 147 QGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 147 ~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
..++|||+.+.||++++++ ++++|+.++.
T Consensus 192 ~~llHGDl~~gNi~~~~~~-~~~iD~e~~~ 220 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEHE-TKVIDPEFAF 220 (370)
T ss_pred ceeeeccCCcccEEEcCCC-CEEEcCcccc
Confidence 3689999999999997764 7799998664
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=92.53 E-value=0.077 Score=45.38 Aligned_cols=30 Identities=33% Similarity=0.464 Sum_probs=21.3
Q ss_pred CCccccccccceee-cCCCeEEEeecccccc
Q 020016 148 GILHRDLKSENLLL-GEDMCVKVADFGISCL 177 (332)
Q Consensus 148 ~iiH~dlkp~NIll-~~~~~~kl~Dfg~a~~ 177 (332)
.++|+|+.+.||++ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58999999999999 7889999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=92.11 E-value=0.082 Score=48.11 Aligned_cols=55 Identities=22% Similarity=0.071 Sum_probs=45.2
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHH-HCCCccccccccceeecCCCeEEEeeccccc
Q 020016 121 EPYSVPLNLVLKLALDIARGMQYLH-SQGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 121 ~~~~l~~~~~~~i~~qi~~~L~~LH-~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
....++..+....-.|+...+.-|- ..-++|.|++--|+|+... .+.++|...+.
T Consensus 376 K~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHADlSEyN~Lw~~g-Kvw~IDVsQsv 431 (531)
T KOG2269|consen 376 KNVELTDDERRNAYDQVQSIMCRLYKECLLVHADLSEYNLLWTPG-KVWVIDVSQSV 431 (531)
T ss_pred cccccChHHHHHHHHHHHHHHHHHHHhhheeecchhhhhheecCC-ceEEEechhcc
Confidence 3456888888888999999888774 5579999999999999876 89999987653
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=91.85 E-value=0.3 Score=41.30 Aligned_cols=30 Identities=30% Similarity=0.378 Sum_probs=25.1
Q ss_pred CCCccccccccceeecCCC-----eEEEeeccccc
Q 020016 147 QGILHRDLKSENLLLGEDM-----CVKVADFGISC 176 (332)
Q Consensus 147 ~~iiH~dlkp~NIll~~~~-----~~kl~Dfg~a~ 176 (332)
..++|||+.+.||++..++ .+.++||..+.
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 4689999999999997543 68999999764
|
subfamily of choline kinases |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.75 E-value=0.22 Score=45.83 Aligned_cols=28 Identities=32% Similarity=0.522 Sum_probs=25.2
Q ss_pred CccccccccceeecCCCe-EEEeeccccc
Q 020016 149 ILHRDLKSENLLLGEDMC-VKVADFGISC 176 (332)
Q Consensus 149 iiH~dlkp~NIll~~~~~-~kl~Dfg~a~ 176 (332)
+||+|+.|+||+++.+.. +.++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999998874 8999999763
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=91.70 E-value=0.13 Score=47.16 Aligned_cols=32 Identities=31% Similarity=0.513 Sum_probs=23.7
Q ss_pred CCCccccccccceeecCC------------------CeEEEeeccccccc
Q 020016 147 QGILHRDLKSENLLLGED------------------MCVKVADFGISCLE 178 (332)
Q Consensus 147 ~~iiH~dlkp~NIll~~~------------------~~~kl~Dfg~a~~~ 178 (332)
.+++|-||||+|||+-+. -.++|.||.++...
T Consensus 298 ~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 298 TNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred ceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 469999999999999422 23677788877543
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.26 E-value=2 Score=41.34 Aligned_cols=28 Identities=25% Similarity=0.424 Sum_probs=23.7
Q ss_pred CCccccccccceeecCCCeEEEeeccccc
Q 020016 148 GILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 148 ~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
.++|.|+.+.||+.+.++ ++|+||..|.
T Consensus 285 VfCHNDl~~~NiL~~~~~-l~LIDfEYAg 312 (442)
T PTZ00296 285 VFCHNDLQENNIINTNKC-LRLIDFEYSG 312 (442)
T ss_pred eEEeCCCCccceeecCCC-EEEEeecccc
Confidence 479999999999886554 9999998774
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=90.23 E-value=0.19 Score=45.03 Aligned_cols=30 Identities=23% Similarity=0.401 Sum_probs=24.9
Q ss_pred CCccccccccceeecCCCe-EEEeecccccc
Q 020016 148 GILHRDLKSENLLLGEDMC-VKVADFGISCL 177 (332)
Q Consensus 148 ~iiH~dlkp~NIll~~~~~-~kl~Dfg~a~~ 177 (332)
.++|+|+.+.||+++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3799999999999997554 57999998744
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 332 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-34 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-33 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-31 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-31 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-31 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-31 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-31 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-31 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-31 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-31 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-31 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-30 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-30 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-30 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-30 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-30 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-29 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-29 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-29 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-29 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-27 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-27 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-27 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-27 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-27 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-26 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-26 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-26 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-26 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-26 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-26 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-26 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-26 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-26 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-26 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-26 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-26 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-26 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-26 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-26 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-26 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-26 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-26 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-26 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-26 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-26 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-26 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-26 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-26 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-26 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-25 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-25 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-25 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-25 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-25 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-25 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-25 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-25 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-25 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-25 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-25 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-25 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-25 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-25 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-25 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-25 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-25 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-25 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-25 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-25 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-25 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-25 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-25 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-25 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-25 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-25 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-25 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-25 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-25 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-25 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-25 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-25 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-25 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-25 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-25 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-25 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-25 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-25 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-25 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-25 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-25 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-25 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-25 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-25 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-25 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-25 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-25 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-25 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-25 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-24 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-24 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-24 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-24 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-24 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-24 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-24 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-24 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-24 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-24 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-24 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-24 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-24 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-24 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-24 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-24 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-24 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-24 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-24 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-24 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-24 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-24 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-23 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-23 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-23 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-23 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-23 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-23 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-23 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-23 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-23 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-23 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-23 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-23 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-23 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-23 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-23 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-23 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-23 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-23 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-23 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-23 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-23 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-23 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-23 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-23 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-23 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-23 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-22 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-22 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-22 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-22 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-22 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-22 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-22 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-22 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-22 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-22 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-22 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-22 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-22 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-22 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-22 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-22 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-22 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-22 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-22 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-22 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-22 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-22 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-22 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-22 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-22 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-22 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-22 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-22 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-22 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-22 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-22 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-22 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-22 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-22 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-22 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-22 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-22 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-22 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-22 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-22 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-22 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-22 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-22 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-22 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-22 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-22 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-22 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-22 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-22 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-22 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-22 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-22 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-22 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-22 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-21 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-21 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-21 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-21 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-21 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-21 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-21 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-21 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-21 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-21 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-21 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-21 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-21 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-21 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-21 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-21 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-21 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-21 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-21 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-21 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-21 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-20 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-20 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-20 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-20 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-20 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-20 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-20 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-20 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-19 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-19 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-19 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-19 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-19 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-19 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-19 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-19 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-19 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-19 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-18 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-18 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-18 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-18 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-18 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-18 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-18 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-18 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-18 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-18 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-18 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-18 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-18 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-18 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-18 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-18 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-18 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-18 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-18 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-18 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-18 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-18 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-18 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-18 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-18 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-18 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-18 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-18 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-18 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-18 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-18 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-18 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-18 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-18 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-18 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-18 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-18 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-18 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-18 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-18 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-18 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-18 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-18 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-18 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-18 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-18 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-18 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-18 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-18 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-18 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-18 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-18 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-18 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-18 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-18 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-18 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-18 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-18 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-18 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-18 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-18 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-18 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-18 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-18 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-18 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-18 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-18 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-18 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-17 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-17 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-17 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-17 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-17 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-17 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-17 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-17 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-17 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-17 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-17 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-17 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-17 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-17 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-17 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-17 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-17 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-17 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-17 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-17 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-17 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-17 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-17 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-16 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-16 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-16 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-16 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-15 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-15 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-15 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-15 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-15 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-15 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-14 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-14 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-14 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-13 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-13 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-13 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-11 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-11 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-09 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-09 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-08 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 326 bits (839), Expect = e-112
Identities = 88/280 (31%), Positives = 137/280 (48%), Gaps = 38/280 (13%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEV 107
++ L I K +G ++R + DVA+K++ + + A +F EV
Sbjct: 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAER----VNEFLREV 85
Query: 108 ALLFRLNHPH---------------IITE----------------PYSVPLNLVLKLALD 136
A++ RL HP+ I+TE + L +A D
Sbjct: 86 AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 145
Query: 137 IARGMQYLHSQG--ILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-SAKGFTGTYRW 193
+A+GM YLH++ I+HR+LKS NLL+ + VKV DFG+S L++ S+K GT W
Sbjct: 146 VAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEW 205
Query: 194 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 253
MAPE+++++ +K DVYSFG++LWEL T P+ N+ P Q AV K R +P
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN 265
Query: 254 KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPE 293
+ +I CW++ P +RP F I+ +L +S P
Sbjct: 266 PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 306 bits (787), Expect = e-104
Identities = 76/271 (28%), Positives = 122/271 (45%), Gaps = 41/271 (15%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVAL 109
D ++L + G ++YR + +VA+K ++ S + E L
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDE--DISQTIENVRQEAKL 59
Query: 110 LFRLNHPH---------------IITE------------PYSVPLNLVLKLALDIARGMQ 142
L HP+ ++ E +P ++++ A+ IARGM
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMN 119
Query: 143 YLHSQG---ILHRDLKSENLLLGE--------DMCVKVADFGISCLESQCGSAKGFTGTY 191
YLH + I+HRDLKS N+L+ + + +K+ DFG++ + G Y
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK-MSAAGAY 178
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 251
WMAPE+I+ +K DV+S+G++LWELLT PF + A+ V P+P T
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238
Query: 252 CPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
CP+ F+ L+ CW+ P RP F I+ L
Sbjct: 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 303 bits (778), Expect = e-103
Identities = 65/276 (23%), Positives = 117/276 (42%), Gaps = 45/276 (16%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEV 107
+ D QL K +++G ++ D+ +K++ + ++ + F E
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRD----WSTRKSRDFNEEC 58
Query: 108 ALLFRLNHPH-----------------IITE---------------PYSVPLNLVLKLAL 135
L +HP+ +IT + V + +K AL
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118
Query: 136 DIARGMQYLHSQG--ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW 193
D+ARGM +LH+ I L S ++++ EDM +++ + G W
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAW 174
Query: 194 MAPEMIKEKR---HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP 250
+APE +++K + + D++SF ++LWEL+T PF +++ + V + RP +PP
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234
Query: 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 286
S L+ C + P +RP FD IV ILE +
Sbjct: 235 GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 301 bits (774), Expect = e-102
Identities = 81/277 (29%), Positives = 130/277 (46%), Gaps = 43/277 (15%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQR--DVAIK-LVSQPEEDASLASMLEKQF 103
+ +++ + G +++G + VAIK L+ E + ++F
Sbjct: 11 SRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEF 70
Query: 104 TSEVALLFRLNHP-------------HIITE--------------PYSVPLNLVLKLALD 136
EV ++ LNHP ++ E + + ++ L+L LD
Sbjct: 71 QREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 137 IARGMQYLHSQG--ILHRDLKSENLLLGE-----DMCVKVADFGISCLESQCGSAKGFTG 189
IA G++Y+ +Q I+HRDL+S N+ L +C KVADFG+S S G G
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLG 188
Query: 190 TYRWMAPEMI--KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF--AVCQKNAR 245
++WMAPE I +E+ +T+K D YSF ++L+ +LT PFD + + F + ++ R
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248
Query: 246 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
P +P CP +I CWS P +RPHF IV L
Sbjct: 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 298 bits (765), Expect = e-101
Identities = 76/276 (27%), Positives = 132/276 (47%), Gaps = 43/276 (15%)
Query: 45 EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFT 104
+ ++W Q+ +G + SG +Y+G + DVA+K+++ + F
Sbjct: 14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ----LQAFK 68
Query: 105 SEVALLFRLNHPH--------------IITE--------------PYSVPLNLVLKLALD 136
+EV +L + H + I+T+ + ++ +A
Sbjct: 69 NEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQ 128
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA---KGFTGTYRW 193
ARGM YLH++ I+HRDLKS N+ L ED VK+ DFG++ +S+ + + +G+ W
Sbjct: 129 TARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
Query: 194 MAPEMIKEKRH---TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--- 247
MAPE+I+ + + + DVY+FGIVL+EL+T P+ N+ + + + P
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS 248
Query: 248 -VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
V CPK L++ C D RP F +I++ +E
Sbjct: 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 5e-99
Identities = 79/313 (25%), Positives = 120/313 (38%), Gaps = 64/313 (20%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTS 105
S L G G + + +++ + +K + + +E ++ F
Sbjct: 3 PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE------ETQRTFLK 56
Query: 106 EVALLFRLNHP---------------HIITE--------------PYSVPLNLVLKLALD 136
EV ++ L HP + ITE P + + A D
Sbjct: 57 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC--------------- 181
IA GM YLHS I+HRDL S N L+ E+ V VADFG++ L
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV-C 240
G WMAPEMI + + +KVDV+SFGIVL E++ + + P F +
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV 236
Query: 241 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE----------- 289
+ PP CP +F + RC P++RP F ++ LE L
Sbjct: 237 RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQ 296
Query: 290 QDPEFFSSFIPSP 302
D F+ ++
Sbjct: 297 LDRGFWETYRRGE 309
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 8e-99
Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 49/293 (16%)
Query: 53 DMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR 112
D ++ + G + + ++ +DVAIK + E K F E+ L R
Sbjct: 6 DYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESE--------RKAFIVELRQLSR 57
Query: 113 LNHPHII------TEPYS-----------------------VPLNLVLKLALDIARGMQY 143
+NHP+I+ P + L ++G+ Y
Sbjct: 58 VNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 144 LHS---QGILHRDLKSENLLLGEDM-CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI 199
LHS + ++HRDLK NLLL +K+ DFG +C G+ WMAPE+
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT--HMTNNKGSAAWMAPEVF 175
Query: 200 KEKRHTKKVDVYSFGIVLWELLTALTPFDNM-TPEQAAFAVCQKNARPPVPPTCPKAFSY 258
+ +++K DV+S+GI+LWE++T PFD + P RPP+ PK
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235
Query: 259 LISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPE-----FFSSFIPSPDHTI 306
L++RCWS P +RP ++IV I+ E S P D +
Sbjct: 236 LMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRV 288
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 4e-97
Identities = 67/280 (23%), Positives = 116/280 (41%), Gaps = 52/280 (18%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEV 107
+EW QL IG GR ++Y G + +VAI+L+ ++ K F EV
Sbjct: 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQ----LKAFKREV 80
Query: 108 ALLFRLNHPH---------------IITE--------------PYSVPLNLVLKLALDIA 138
+ H + IIT + +N ++A +I
Sbjct: 81 MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIV 140
Query: 139 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC------GSAKGFTGTYR 192
+GM YLH++GILH+DLKS+N+ ++ V + DFG+ + + G
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 193 WMAPEMIK---------EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 243
+APE+I+ + +K DV++ G + +EL PF E + +
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM-GTG 258
Query: 244 ARPPVPP-TCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
+P + K S ++ CW+ + RP F +++ +LE
Sbjct: 259 MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 3e-82
Identities = 69/297 (23%), Positives = 119/297 (40%), Gaps = 77/297 (25%)
Query: 56 QLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH 115
+ + GR+ ++RG ++ +VA+K+ S +E +E+ L H
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEK-------SWFRETELYNTVMLRH 61
Query: 116 PHI-------------------ITE------------PYSVPLNLVLKLALDIARGMQYL 144
+I IT ++ L++ L IA G+ +L
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHL 121
Query: 145 HSQ--------GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-----AKGFTGTY 191
H + I HRDLKS+N+L+ ++ +AD G++ + SQ + GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 192 RWMAPEMIKEK------RHTKKVDVYSFGIVLWELLTALT----------PFDNMTPEQA 235
R+MAPE++ E K+VD+++FG+VLWE+ + PF ++ P
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241
Query: 236 AF-----AVCQKNARPPVPPT-----CPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
+F VC RP +P + + L+ CW +P R +I L
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 4e-82
Identities = 67/316 (21%), Positives = 118/316 (37%), Gaps = 77/316 (24%)
Query: 44 GEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQF 103
G Q+ + + GR+ ++ G ++ VA+K+ EE
Sbjct: 26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEA-------SWFR 78
Query: 104 TSEVALLFRLNHPHI-------------------ITE------------PYSVPLNLVLK 132
+E+ + H +I IT+ ++ +LK
Sbjct: 79 ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLK 138
Query: 133 LALDIARGMQYLHSQ--------GILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-- 182
LA G+ +LH++ I HRDLKS+N+L+ ++ +AD G++
Sbjct: 139 LAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE 198
Query: 183 ---SAKGFTGTYRWMAPEMIKEKRH------TKKVDVYSFGIVLWELLTALT-------- 225
GT R+M PE++ E + D+YSFG++LWE+
Sbjct: 199 VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258
Query: 226 --PFDNMTPEQAAF-----AVCQKNARPPVPPT-----CPKAFSYLISRCWSSSPDRRPH 273
P+ ++ P ++ VC K RP P C + L++ CW+ +P R
Sbjct: 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318
Query: 274 FDQIVSILEGYSESLE 289
++ L SES +
Sbjct: 319 ALRVKKTLAKMSESQD 334
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 5e-79
Identities = 64/309 (20%), Positives = 119/309 (38%), Gaps = 77/309 (24%)
Query: 49 EWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVA 108
+ + GR ++RG ++ +VA+K+ S EE + E E+
Sbjct: 36 VQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFR---EA----EIY 88
Query: 109 LLFRLNHPHI-------------------ITE------------PYSVPLNLVLKLALDI 137
L H +I +++ Y+V + ++KLAL
Sbjct: 89 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST 148
Query: 138 ARGMQYLHSQ--------GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-----A 184
A G+ +LH + I HRDLKS+N+L+ ++ +AD G++
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208
Query: 185 KGFTGTYRWMAPEMIKE------KRHTKKVDVYSFGIVLWELLTALT----------PFD 228
GT R+MAPE++ + K+ D+Y+ G+V WE+ + P+
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268
Query: 229 NMTPEQAAF-----AVCQKNARPPVPPT-----CPKAFSYLISRCWSSSPDRRPHFDQIV 278
++ P + VC++ RP +P + + ++ CW ++ R +I
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328
Query: 279 SILEGYSES 287
L S+
Sbjct: 329 KTLSQLSQQ 337
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 230 bits (587), Expect = 1e-73
Identities = 67/333 (20%), Positives = 120/333 (36%), Gaps = 92/333 (27%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSE- 106
E S D+ L + GR+ +Y+G +R VA+K+ S + F +E
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR---------QNFINEK 56
Query: 107 -VALLFRLNHPHI--------------------ITE------------PYSVPLNLVLKL 133
+ + + H +I + E ++ +L
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL 116
Query: 134 ALDIARGMQYLHSQ---------GILHRDLKSENLLLGEDMCVKVADFGISCLES----- 179
A + RG+ YLH++ I HRDL S N+L+ D ++DFG+S +
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 180 ----QCGSAKGFTGTYRWMAPEMIKE-------KRHTKKVDVYSFGIVLWELLTALT--- 225
+ +A GT R+MAPE+++ + K+VD+Y+ G++ WE+ T
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 226 PFDNMTPEQAAFA---------------VCQKNARPPVPPTC------PKAFSYLISRCW 264
P +++ Q AF V ++ RP P ++ I CW
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
Query: 265 SSSPDRRPHFDQIVSILEGYSESLEQDPEFFSS 297
+ R + E++ +
Sbjct: 297 DQDAEARLTAQXAEERMAELMMIWERNKSVSPT 329
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 7e-69
Identities = 72/316 (22%), Positives = 111/316 (35%), Gaps = 80/316 (25%)
Query: 37 SSGAEIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLA 96
SSG ++ G E L + A GR +++ VA+K+ ++
Sbjct: 9 SSGVDL---GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQ---- 61
Query: 97 SMLEKQFTSEVALLFRLNHPHI-------------------ITE------------PYSV 125
Q EV L + H +I IT V
Sbjct: 62 ---SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVV 118
Query: 126 PLNLVLKLALDIARGMQYLHSQ----------GILHRDLKSENLLLGEDMCVKVADFGIS 175
N + +A +ARG+ YLH I HRD+KS+N+LL ++ +ADFG++
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178
Query: 176 CL---ESQCGSAKGFTGTYRWMAPEMI-----KEKRHTKKVDVYSFGIVLWELLTALTPF 227
G G GT R+MAPE++ ++ ++D+Y+ G+VLWEL + T
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
Query: 228 DNMTPE-QAAF---------------AVCQKNARPPVPPTCPK-----AFSYLISRCWSS 266
D E F V K RP + K I CW
Sbjct: 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298
Query: 267 SPDRRPHFDQIVSILE 282
+ R + +
Sbjct: 299 DAEARLSAGCVGERIT 314
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 7e-54
Identities = 73/276 (26%), Positives = 125/276 (45%), Gaps = 41/276 (14%)
Query: 42 IKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASML 99
+ +++W + L +G + G ++ G + VA+K E L
Sbjct: 101 HRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC---RETLP--PDL 155
Query: 100 EKQFTSEVALLFRLNHPH---------------IITE--------------PYSVPLNLV 130
+ +F E +L + +HP+ I+ E + + +
Sbjct: 156 KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTL 215
Query: 131 LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTG 189
L++ D A GM+YL S+ +HRDL + N L+ E +K++DFG+S +A G
Sbjct: 216 LQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLR 275
Query: 190 T--YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 246
+W APE + R++ + DV+SFGI+LWE + +P+ N++ +Q V +K R
Sbjct: 276 QVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV-EKGGRL 334
Query: 247 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
P P CP A L+ +CW+ P +RP F I L+
Sbjct: 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 8e-54
Identities = 75/277 (27%), Positives = 126/277 (45%), Gaps = 41/277 (14%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSE 106
+EW L + + +G+ ++ G Y VA+K + Q SM F +E
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-------GSMSPDAFLAE 58
Query: 107 VALLFRLNHPH--------------IITE---------------PYSVPLNLVLKLALDI 137
L+ +L H IITE + +N +L +A I
Sbjct: 59 ANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 138 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMA 195
A GM ++ + +HRDL++ N+L+ + + K+ADFG++ +++ + +G +W A
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178
Query: 196 PEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254
PE I T K DV+SFGI+L E++T P+ MT + + ++ R P CP+
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-ERGYRMVRPDNCPE 237
Query: 255 AFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 291
L+ CW P+ RP FD + S+LE + + E
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 5e-53
Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 43/280 (15%)
Query: 40 AEIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASML 99
A W+ +M +L + G + G Y+ VA+K + DA+
Sbjct: 178 AAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK---NDAT----- 229
Query: 100 EKQFTSEVALLFRLNHPH----------------IITE---------------PYSVPLN 128
+ F +E +++ +L H + I+TE + +
Sbjct: 230 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 289
Query: 129 LVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT 188
+LK +LD+ M+YL +HRDL + N+L+ ED KV+DFG++ S
Sbjct: 290 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL- 348
Query: 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPP 247
+W APE ++EK+ + K DV+SFGI+LWE+ + P+ + + V +K +
Sbjct: 349 -PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMD 406
Query: 248 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287
P CP A ++ CW RP F Q+ LE
Sbjct: 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 7e-53
Identities = 80/289 (27%), Positives = 129/289 (44%), Gaps = 44/289 (15%)
Query: 43 KGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEK 101
+G ++ W L + K G ++ G + VAIK + +M +
Sbjct: 172 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-------GTMSPE 224
Query: 102 QFTSEVALLFRLNHPH--------------IITEPYS---------------VPLNLVLK 132
F E ++ +L H I+TE S + L ++
Sbjct: 225 AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 284
Query: 133 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGT 190
+A IA GM Y+ +HRDL++ N+L+GE++ KVADFG++ +++ + +G
Sbjct: 285 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 191 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 249
+W APE R T K DV+SFGI+L EL T P+ M + V ++ R P P
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCP 403
Query: 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY---SESLEQDPEFF 295
P CP++ L+ +CW P+ RP F+ + + LE Y +E Q E
Sbjct: 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 452
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 7e-53
Identities = 75/291 (25%), Positives = 131/291 (45%), Gaps = 47/291 (16%)
Query: 43 KGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQR--DVAIKLVSQPEEDASLASMLE 100
++W + + + + K G++ +Y G++K+ VA+K + + +M
Sbjct: 208 VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-------DTMEV 260
Query: 101 KQFTSEVALLFRLNHPH---------------IITE---------------PYSVPLNLV 130
++F E A++ + HP+ IITE V ++
Sbjct: 261 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 320
Query: 131 LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFT 188
L +A I+ M+YL + +HR+L + N L+GE+ VKVADFG+S + G
Sbjct: 321 LYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 380
Query: 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPP 247
+W APE + + + K DV++FG++LWE+ T ++P+ + Q + +K+ R
Sbjct: 381 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRME 439
Query: 248 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY----SESLEQDPEF 294
P CP+ L+ CW +P RP F +I E S S E + E
Sbjct: 440 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 490
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 8e-53
Identities = 72/283 (25%), Positives = 119/283 (42%), Gaps = 43/283 (15%)
Query: 37 SSGAEIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLA 96
S A W+ +M +L + G + G Y+ VA+K + DA+
Sbjct: 3 GSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK---NDAT-- 57
Query: 97 SMLEKQFTSEVALLFRLNHPH----------------IITE---------------PYSV 125
+ F +E +++ +L H + I+TE +
Sbjct: 58 ---AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 114
Query: 126 PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK 185
+ +LK +LD+ M+YL +HRDL + N+L+ ED KV+DFG++ S
Sbjct: 115 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 174
Query: 186 GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 244
+W APE ++EK+ + K DV+SFGI+LWE+ + P+ + + V +K
Sbjct: 175 KL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGY 231
Query: 245 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287
+ P CP A ++ CW RP F Q+ LE
Sbjct: 232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 2e-52
Identities = 74/283 (26%), Positives = 130/283 (45%), Gaps = 47/283 (16%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQR--DVAIKLVSQPEEDASLASMLEKQFTS 105
++W + + + + K G++ +Y G++K+ VA+K + + +M ++F
Sbjct: 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-------DTMEVEEFLK 58
Query: 106 EVALLFRLNHPH---------------IITE---------------PYSVPLNLVLKLAL 135
E A++ + HP+ IITE V ++L +A
Sbjct: 59 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 136 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT---Y 191
I+ M+YL + +HRDL + N L+GE+ VKVADFG+S + +A G
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH--AGAKFPI 176
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 250
+W APE + + + K DV++FG++LWE+ T ++P+ + Q + +K+ R P
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPE 235
Query: 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPE 293
CP+ L+ CW +P RP F +I E + E
Sbjct: 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 278
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 7e-52
Identities = 64/273 (23%), Positives = 102/273 (37%), Gaps = 41/273 (15%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEKQ 102
L + K G + RG + VA+K + D
Sbjct: 11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK---PDVLSQPEAMDD 67
Query: 103 FTSEVALLFRLNHPH--------------IITE--------------PYSVPLNLVLKLA 134
F EV + L+H + ++TE L + + A
Sbjct: 68 FIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 127
Query: 135 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT--- 190
+ +A GM YL S+ +HRDL + NLLL VK+ DFG+ L
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187
Query: 191 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 249
+ W APE +K + + D + FG+ LWE+ T P+ + Q + ++ R P P
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 247
Query: 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
CP+ ++ +CW+ P+ RP F + L
Sbjct: 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-51
Identities = 80/293 (27%), Positives = 131/293 (44%), Gaps = 41/293 (13%)
Query: 32 SKYLVSSGAEIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPE 90
+ +S + +G ++ W L + K G ++ G + VAIK +
Sbjct: 244 TTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-- 301
Query: 91 EDASLASMLEKQFTSEVALLFRLNHPH--------------IITEPYS------------ 124
+M + F E ++ +L H I+TE S
Sbjct: 302 -----GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGET 356
Query: 125 ---VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLES 179
+ L ++ +A IA GM Y+ +HRDL++ N+L+GE++ KVADFG++ ++
Sbjct: 357 GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416
Query: 180 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFA 238
+ + +G +W APE R T K DV+SFGI+L EL T P+ M +
Sbjct: 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 476
Query: 239 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 291
V ++ R P PP CP++ L+ +CW P+ RP F+ + + LE Y S E
Sbjct: 477 V-ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-51
Identities = 71/270 (26%), Positives = 124/270 (45%), Gaps = 41/270 (15%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVA 108
++ + + SG+ + G +K Q DVA+K++ + SM E +F E
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKE-------GSMSEDEFFQEAQ 55
Query: 109 LLFRLNHPH---------------IITE--------------PYSVPLNLVLKLALDIAR 139
+ +L+HP I+TE + + +L++ D+
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCE 115
Query: 140 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPE 197
GM +L S +HRDL + N L+ D+CVKV+DFG++ + Q S+ G +W APE
Sbjct: 116 GMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPE 175
Query: 198 MIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 256
+ +++ K DV++FGI++WE+ + P+D T + V + R P
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV-SQGHRLYRPHLASDTI 234
Query: 257 SYLISRCWSSSPDRRPHFDQIVSILEGYSE 286
++ CW P++RP F Q++S +E E
Sbjct: 235 YQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-51
Identities = 69/272 (25%), Positives = 125/272 (45%), Gaps = 41/272 (15%)
Query: 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEV 107
+W D S+L + SG+ ++ G + + VAIK + + +M E+ F E
Sbjct: 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-------GAMSEEDFIEEA 54
Query: 108 ALLFRLNHPH---------------IITE--------------PYSVPLNLVLKLALDIA 138
++ +L+HP ++TE +L + LD+
Sbjct: 55 EVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 114
Query: 139 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAP 196
GM YL ++HRDL + N L+GE+ +KV+DFG++ L+ Q S+ G +W +P
Sbjct: 115 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 174
Query: 197 EMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255
E+ R++ K DV+SFG+++WE+ + P++N + + + R P
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRLYKPRLASTH 233
Query: 256 FSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287
+++ CW P+ RP F +++ L +ES
Sbjct: 234 VYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 3e-51
Identities = 74/286 (25%), Positives = 117/286 (40%), Gaps = 47/286 (16%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEK 101
+ + G +Y G Y + AIK +S +
Sbjct: 13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITE--MQQVE 67
Query: 102 QFTSEVALLFRLNHPHII--------TEPY----------------------SVPLNLVL 131
F E L+ LNHP+++ E + + ++
Sbjct: 68 AFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI 127
Query: 132 KLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTG 189
L +ARGM+YL Q +HRDL + N +L E VKVADFG++ L+ + S +
Sbjct: 128 SFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRH 187
Query: 190 T---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 245
+W A E ++ R T K DV+SFG++LWELLT P+ ++ P + + R
Sbjct: 188 ARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-AQGRR 246
Query: 246 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 291
P P CP + ++ +CW + P RP F +V +E +L D
Sbjct: 247 LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-51
Identities = 71/278 (25%), Positives = 126/278 (45%), Gaps = 41/278 (14%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTS 105
++ W L + K +G+ ++ Y VA+K + SM + F +
Sbjct: 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-------GSMSVEAFLA 232
Query: 106 EVALLFRLNHPH--------------IITEPYS---------------VPLNLVLKLALD 136
E ++ L H IITE + PL ++ +
Sbjct: 233 EANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 292
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWM 194
IA GM ++ + +HRDL++ N+L+ + K+ADFG++ +++ + +G +W
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT 352
Query: 195 APEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 253
APE I T K DV+SFGI+L E++T P+ M+ + A+ ++ R P P CP
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCP 411
Query: 254 KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 291
+ ++ RCW + P+ RP F+ I S+L+ + + E
Sbjct: 412 EELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 3e-51
Identities = 67/282 (23%), Positives = 120/282 (42%), Gaps = 45/282 (15%)
Query: 41 EIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASML 99
G G W D L + +G+ + G ++ Q DVAIK++ + SM
Sbjct: 10 STAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-------GSMS 62
Query: 100 EKQFTSEVALLFRLNHPH---------------IITE--------------PYSVPLNLV 130
E +F E ++ L+H IITE + +
Sbjct: 63 EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL 122
Query: 131 LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTG 189
L++ D+ M+YL S+ LHRDL + N L+ + VKV+DFG+S + ++ G
Sbjct: 123 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV--G 180
Query: 190 T---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 245
+ RW PE++ + + K D+++FG+++WE+ + P++ T + A + + R
Sbjct: 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLR 239
Query: 246 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287
P + ++ CW D RP F ++S + +
Sbjct: 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 5e-51
Identities = 83/306 (27%), Positives = 130/306 (42%), Gaps = 53/306 (17%)
Query: 32 SKYLVSSGAEIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLV 86
S LV G+E E+ D + L +G G + G KQ D VA+K +
Sbjct: 11 SSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM 70
Query: 87 SQPEEDASLASMLEKQFTSEVALLFRLNHPHII--------TEPYSVPLNLV-------- 130
+++S + E F SE A + +HP++I +P +V
Sbjct: 71 --KLDNSSQREIEE--FLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYG 126
Query: 131 -----------------------LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 167
LK +DIA GM+YL ++ LHRDL + N +L +DM V
Sbjct: 127 DLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV 186
Query: 168 KVADFGIS-CLESQCGSAKGFTGTY--RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-A 223
VADFG+S + S +G +W+A E + ++ +T K DV++FG+ +WE+ T
Sbjct: 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRG 246
Query: 224 LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 283
+TP+ + + + R P C ++ CW + P RP F + LE
Sbjct: 247 MTPYPGVQNHEMYDYL-LHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305
Query: 284 YSESLE 289
ESL
Sbjct: 306 LLESLP 311
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 6e-51
Identities = 78/282 (27%), Positives = 122/282 (43%), Gaps = 45/282 (15%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQR-----DVAIKLVSQPEEDASLASMLEK 101
+ S++ I SG + G + VAIK + + +
Sbjct: 41 SFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYT--ERQRR 95
Query: 102 QFTSEVALLFRLNHPH---------------IITE--------------PYSVPLNLVLK 132
F SE +++ + +HP+ I+TE + ++
Sbjct: 96 DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVG 155
Query: 133 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT- 190
+ + GM+YL G +HRDL + N+L+ ++ KV+DFG+S LE +A TG
Sbjct: 156 MLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGK 215
Query: 191 --YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPP 247
RW APE I + + DV+SFG+V+WE+L P+ NMT +V ++ R P
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV-EEGYRLP 274
Query: 248 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289
P CP A L+ CW +RP F QIVS+L+ S E
Sbjct: 275 APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 7e-51
Identities = 72/285 (25%), Positives = 123/285 (43%), Gaps = 46/285 (16%)
Query: 44 GEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASM 98
G ++ ++ +G G+ +++GIY + VAIK S
Sbjct: 4 GSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTS--DS 58
Query: 99 LEKQFTSEVALLFRLNHPH--------------IITE--------------PYSVPLNLV 130
+ ++F E + + +HPH II E YS+ L +
Sbjct: 59 VREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASL 118
Query: 131 LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTG 189
+ A ++ + YL S+ +HRD+ + N+L+ + CVK+ DFG+S +E
Sbjct: 119 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--K 176
Query: 190 T---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 245
+WMAPE I +R T DV+ FG+ +WE+L + PF + + + R
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGER 235
Query: 246 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 290
P+PP CP L+++CW+ P RRP F ++ + L E +
Sbjct: 236 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 280
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-50
Identities = 64/286 (22%), Positives = 115/286 (40%), Gaps = 47/286 (16%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEK 101
+ G +Y G D A+K ++
Sbjct: 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITD--IGEVS 71
Query: 102 QFTSEVALLFRLNHPHII------------------------------TEPYSVPLNLVL 131
QF +E ++ +HP+++ E ++ + ++
Sbjct: 72 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 131
Query: 132 KLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTG 189
L +A+GM+YL S+ +HRDL + N +L E VKVADFG++ + + S TG
Sbjct: 132 GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 191
Query: 190 T---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 245
+WMA E ++ ++ T K DV+SFG++LWEL+T P+ ++ + + R
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRR 250
Query: 246 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 291
P CP ++ +CW + RP F ++VS + + +
Sbjct: 251 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-50
Identities = 78/306 (25%), Positives = 126/306 (41%), Gaps = 50/306 (16%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLE 100
+ S + +G +Y+G+ K + VAIK + +
Sbjct: 36 KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYT--EKQR 90
Query: 101 KQFTSEVALLFRLNHPH---------------IITE--------------PYSVPLNLVL 131
F E ++ + +H + IITE + ++
Sbjct: 91 VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLV 150
Query: 132 KLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT 190
+ IA GM+YL + +HRDL + N+L+ ++ KV+DFG+S LE + +G
Sbjct: 151 GMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210
Query: 191 ---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 246
RW APE I ++ T DV+SFGIV+WE++T P+ ++ + A+ R
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-NDGFRL 269
Query: 247 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTI 306
P P CP A L+ +CW RRP F IVSIL + L + P+ +
Sbjct: 270 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL----DKLIRAPDSLKTLADFDPRVS 325
Query: 307 LRCLPT 312
+R T
Sbjct: 326 IRLPST 331
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-50
Identities = 66/285 (23%), Positives = 124/285 (43%), Gaps = 42/285 (14%)
Query: 47 EEEWSADMSQLFIGCKF-ASGRHSRIYRGIYKQR----DVAIKLVSQPEEDASLASMLEK 101
+E D L + K SG + +G Y+ + VA+K++ + +A+ ++ ++
Sbjct: 8 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL---KNEANDPALKDE 64
Query: 102 QFTSEVALLFRLNHPHII-------TEPY--------------------SVPLNLVLKLA 134
+E ++ +L++P+I+ E + V +++L
Sbjct: 65 -LLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV 123
Query: 135 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT--- 190
++ GM+YL +HRDL + N+LL K++DFG+S L + K T
Sbjct: 124 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183
Query: 191 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 249
+W APE I + + K DV+SFG+++WE + P+ M + + +K R P
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-EKGERMGCP 242
Query: 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEF 294
CP+ L++ CW+ + RP F + L Y + +
Sbjct: 243 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHH 287
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 5e-50
Identities = 64/260 (24%), Positives = 116/260 (44%), Gaps = 48/260 (18%)
Query: 72 YRGIYKQRD------VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH-------- 117
Y+G++ VAIK + E S + E E ++ +++PH
Sbjct: 32 YKGLWIPEGEKVKIPVAIKEL---REATSPKANKE--ILDEAYVMASVDNPHVCRLLGIC 86
Query: 118 ------IITE--------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 157
+IT+ ++ +L + IA+GM YL + ++HRDL +
Sbjct: 87 LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR 146
Query: 158 NLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY--RWMAPEMIKEKRHTKKVDVYSFG 214
N+L+ VK+ DFG++ L ++ G +WMA E I + +T + DV+S+G
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 206
Query: 215 IVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPH 273
+ +WEL+T P+D + + + + +K R P PP C ++ +CW D RP
Sbjct: 207 VTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVYMIMRKCWMIDADSRPK 265
Query: 274 FDQIVSILEGYSESLEQDPE 293
F +++ + +DP+
Sbjct: 266 FRELIIEF----SKMARDPQ 281
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 5e-50
Identities = 72/280 (25%), Positives = 119/280 (42%), Gaps = 46/280 (16%)
Query: 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLE 100
G ++ + + G +Y G+Y VA+K +D +L + +
Sbjct: 3 GGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDN--K 57
Query: 101 KQFTSEVALLFRLNHPH--------------IITE--------------PYSVPLNLVLK 132
++F SE ++ L+HPH II E S+ + ++
Sbjct: 58 EKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL 117
Query: 133 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT- 190
+L I + M YL S +HRD+ N+L+ CVK+ DFG+S +E + T
Sbjct: 118 YSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS--VTR 175
Query: 191 --YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPP 247
+WM+PE I +R T DV+ F + +WE+L+ PF + + + +K R P
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-EKGDRLP 234
Query: 248 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287
P CP L++RCW P RP F ++V L +
Sbjct: 235 KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-49
Identities = 78/295 (26%), Positives = 125/295 (42%), Gaps = 49/295 (16%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEK 101
E D + + I +G + G K VAIK + + +
Sbjct: 37 EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYT--EKQRR 91
Query: 102 QFTSEVALLFRLNHPH---------------IITE--------------PYSVPLNLVLK 132
F E +++ + +HP+ I+TE + ++
Sbjct: 92 DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 133 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT- 190
+ IA GM+YL G +HRDL + N+L+ ++ KV+DFG+ LE +A G
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 191 --YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPP 247
RW +PE I ++ T DV+S+GIVLWE+++ P+ M+ + AV + R P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV-DEGYRLP 270
Query: 248 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSP 302
P CP A L+ CW + RP F+QIVSIL + L ++P +
Sbjct: 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL----DKLIRNPGSLKIITSAA 321
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-49
Identities = 63/286 (22%), Positives = 115/286 (40%), Gaps = 47/286 (16%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEK 101
+ G +Y G D A+K ++
Sbjct: 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITD--IGEVS 135
Query: 102 QFTSEVALLFRLNHPHII------------------------------TEPYSVPLNLVL 131
QF +E ++ +HP+++ E ++ + ++
Sbjct: 136 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 195
Query: 132 KLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTG 189
L +A+GM++L S+ +HRDL + N +L E VKVADFG++ + + S TG
Sbjct: 196 GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 255
Query: 190 T---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 245
+WMA E ++ ++ T K DV+SFG++LWEL+T P+ ++ + + R
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRR 314
Query: 246 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 291
P CP ++ +CW + RP F ++VS + + +
Sbjct: 315 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-49
Identities = 80/312 (25%), Positives = 131/312 (41%), Gaps = 60/312 (19%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEKQ 102
E+ Q +G G + KQ D VA+K++ D +S +E+
Sbjct: 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK---ADIIASSDIEE- 71
Query: 103 FTSEVALLFRLNHPHII----------------------------------------TEP 122
F E A + +HPH+ P
Sbjct: 72 FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 123 YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQC 181
+++PL +++ +DIA GM+YL S+ +HRDL + N +L EDM V VADFG+S + S
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 182 GSAKGFTGTY--RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFA 238
+G +W+A E + + +T DV++FG+ +WE++T TP+ + +
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251
Query: 239 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE-----QDPE 293
+ R PP C + L+ +CWS+ P +RP F + LE L QDP
Sbjct: 252 L-IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310
Query: 294 FFSSFIPSPDHT 305
+ + + H
Sbjct: 311 YI-NIERAHHHH 321
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-49
Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 44/285 (15%)
Query: 47 EEEWSADMSQLFIG-CKFASGRHSRIYRGIYKQR----DVAIKLVSQPEEDASLASMLEK 101
+++ L I + G + +G+Y+ R DVAIK++ + +
Sbjct: 1 DKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK---QGTE--KADTE 55
Query: 102 QFTSEVALLFRLNHPH--------------IITE--------------PYSVPLNLVLKL 133
+ E ++ +L++P+ ++ E +P++ V +L
Sbjct: 56 EMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 115
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT-- 190
++ GM+YL + +HRDL + N+LL K++DFG+S L + +
Sbjct: 116 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175
Query: 191 -YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 248
+W APE I ++ + + DV+S+G+ +WE L+ P+ M + + ++ R
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMEC 234
Query: 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPE 293
PP CP L+S CW + RP F + + SL E
Sbjct: 235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-48
Identities = 64/301 (21%), Positives = 119/301 (39%), Gaps = 48/301 (15%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRD------VAIKLVSQPEEDASLASMLEKQF 103
++L SG +++G++ V IK++ E+ + +
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI---EDKSG--RQSFQAV 62
Query: 104 TSEVALLFRLNHPH--------------IITE--------------PYSVPLNLVLKLAL 135
T + + L+H H ++T+ ++ L+L +
Sbjct: 63 TDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 122
Query: 136 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT---YR 192
IA+GM YL G++HR+L + N+LL V+VADFG++ L ++ +
Sbjct: 123 QIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 182
Query: 193 WMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 251
WMA E I ++T + DV+S+G+ +WEL+T P+ + + + +K R P
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-EKGERLAQPQI 241
Query: 252 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY----SESLEQDPEFFSSFIPSPDHTIL 307
C ++ +CW + RP F ++ + L E P P+ L
Sbjct: 242 CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGL 301
Query: 308 R 308
Sbjct: 302 T 302
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-48
Identities = 82/307 (26%), Positives = 131/307 (42%), Gaps = 71/307 (23%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASMLE 100
+EW ++ + + G +Y G+ K VAIK V+ E AS+ +E
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIE 74
Query: 101 KQFTSEVALLFRLNHPHI---------------ITE---------------------PYS 124
F +E +++ N H+ I E P
Sbjct: 75 --FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 132
Query: 125 VPLNLV--LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQC 181
P +L +++A +IA GM YL++ +HRDL + N ++ ED VK+ DFG++ +
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-- 190
Query: 182 GSAKGFTGTY----------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 230
T Y RWM+PE +K+ T DV+SFG+VLWE+ T A P+ +
Sbjct: 191 ------TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244
Query: 231 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 290
+ EQ V + P CP L+ CW +P RP F +I+S ++ E +
Sbjct: 245 SNEQVLRFV-MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 303
Query: 291 DPEFFSS 297
+ F+ S
Sbjct: 304 EVSFYYS 310
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-47
Identities = 65/279 (23%), Positives = 117/279 (41%), Gaps = 47/279 (16%)
Query: 72 YRGIYKQRD------VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH-------- 117
Y+G++ VAIK + E S + E E ++ +++PH
Sbjct: 32 YKGLWIPEGEKVKIPVAIKEL---REATSPKANKE--ILDEAYVMASVDNPHVCRLLGIC 86
Query: 118 ------IITE--------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 157
+IT+ ++ +L + IA+GM YL + ++HRDL +
Sbjct: 87 LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR 146
Query: 158 NLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY--RWMAPEMIKEKRHTKKVDVYSFG 214
N+L+ VK+ DFG++ L ++ G +WMA E I + +T + DV+S+G
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 206
Query: 215 IVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPH 273
+ +WEL+T P+D + + + + +K R P PP C ++ +CW D RP
Sbjct: 207 VTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVYMIMVKCWMIDADSRPK 265
Query: 274 FDQIVSILEGY---SESLEQDPEFFSSFIPSPDHTILRC 309
F +++ + +PSP +
Sbjct: 266 FRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYR 304
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-47
Identities = 64/292 (21%), Positives = 105/292 (35%), Gaps = 62/292 (21%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD------VAIKLVSQPEEDASLASMLE 100
+ + L G ++ Y VA+K + + ++
Sbjct: 13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL---KPESG--GNHI 67
Query: 101 KQFTSEVALLFRLNHPHII------TEPYSVPLNLV------------------------ 130
E+ +L L H +I+ TE + L+
Sbjct: 68 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
Query: 131 -LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFT 188
LK A+ I +GM YL S+ +HRDL + N+L+ + VK+ DFG++ +E+
Sbjct: 128 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 187
Query: 189 GT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT---------------ALTPFDNM 230
W APE + + + DV+SFG+ L ELLT M
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM 247
Query: 231 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
T + + ++ R P PP CP L+ +CW P R F ++ E
Sbjct: 248 TVTRLVNTL-KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 5e-47
Identities = 70/314 (22%), Positives = 118/314 (37%), Gaps = 75/314 (23%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASML 99
+ + + G +Y G VA+K + E S L
Sbjct: 63 SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDEL 119
Query: 100 EKQFTSEVALLFRLNHPHII-----------------------------------TEPYS 124
+ F E ++ + NH +I+ ++P S
Sbjct: 120 D--FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 125 VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGIS-CLESQ 180
+ + +L +A DIA G QYL +HRD+ + N LL G K+ DFG++ +
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR- 236
Query: 181 CGSAKGFTGTY----------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 229
G Y +WM PE E T K D +SFG++LWE+ + P+ +
Sbjct: 237 -------AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289
Query: 230 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289
+ ++ V R P CP ++++CW P+ RP+F I+ + E
Sbjct: 290 KSNQEVLEFV-TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI----EYCT 344
Query: 290 QDPEFFSSFIPSPD 303
QDP+ ++ +P
Sbjct: 345 QDPDVINTALPIEY 358
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-47
Identities = 72/296 (24%), Positives = 109/296 (36%), Gaps = 60/296 (20%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD------VAIKLVSQPEEDASLASMLEK 101
+ L G ++ Y + VA+K + DA
Sbjct: 24 DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK---ADAG--PQHRS 78
Query: 102 QFTSEVALLFRLNHPHII------TEPYSVPLNLV-----------------------LK 132
+ E+ +L L H HII + + L LV L
Sbjct: 79 GWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLL 138
Query: 133 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT- 190
A I GM YLH+Q +HRDL + N+LL D VK+ DFG++ + +
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198
Query: 191 --YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT---------------ALTPFDNMTPE 233
W APE +KE + DV+SFG+ L+ELLT MT
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258
Query: 234 QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289
+ + ++ R P P CP +L+ CW + RP F+ ++ IL+ E +
Sbjct: 259 RLTELL-ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 7e-47
Identities = 62/301 (20%), Positives = 110/301 (36%), Gaps = 64/301 (21%)
Query: 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD------VAIKLVSQPEEDASLASML 99
G + + L + G + Y VA+K + E+
Sbjct: 1 GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----- 55
Query: 100 EKQFTSEVALLFRLNHPHII------TEPYSVPLNLV----------------------- 130
+ F E+ +L L H +I+ L L+
Sbjct: 56 -RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 114
Query: 131 --LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGF 187
L+ I +GM+YL ++ +HRDL + N+L+ + VK+ DFG++ L K
Sbjct: 115 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK 174
Query: 188 TGT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT----------------ALTPFD 228
W APE + E + + DV+SFG+VL+EL T
Sbjct: 175 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 234
Query: 229 NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 288
M + + N R P P CP +++ CW+++ ++RP F + ++ +++
Sbjct: 235 QMIVFHLIELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293
Query: 289 E 289
Sbjct: 294 A 294
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 7e-47
Identities = 69/313 (22%), Positives = 117/313 (37%), Gaps = 75/313 (23%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASMLE 100
+ + + G +Y G VA+K + E S L+
Sbjct: 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELD 79
Query: 101 KQFTSEVALLFRLNHPHII-----------------------------------TEPYSV 125
F E ++ + NH +I+ ++P S+
Sbjct: 80 --FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSL 137
Query: 126 PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGIS-CLESQC 181
+ +L +A DIA G QYL +HRD+ + N LL G K+ DFG++ +
Sbjct: 138 AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-- 195
Query: 182 GSAKGFTGTY----------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 230
Y +WM PE E T K D +SFG++LWE+ + P+ +
Sbjct: 196 ------ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249
Query: 231 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 290
+ ++ V R P CP ++++CW P+ RP+F I+ + E Q
Sbjct: 250 SNQEVLEFV-TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI----EYCTQ 304
Query: 291 DPEFFSSFIPSPD 303
DP+ ++ +P
Sbjct: 305 DPDVINTALPIEY 317
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-46
Identities = 67/317 (21%), Positives = 113/317 (35%), Gaps = 64/317 (20%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD------VAIKLVSQPEEDASLASMLE 100
++ + L + G + Y VA+K + +
Sbjct: 15 QDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS------GPDQQ 68
Query: 101 KQFTSEVALLFRLNHPHII------TEPYSVPLNLV------------------------ 130
+ F E+ +L L+ I+ P L LV
Sbjct: 69 RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASR 128
Query: 131 -LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFT 188
L + I +GM+YL S+ +HRDL + N+L+ + VK+ADFG++ L
Sbjct: 129 LLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 188
Query: 189 GT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT---------------ALTPFDNM 230
W APE + + +++ DV+SFG+VL+EL T D
Sbjct: 189 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248
Query: 231 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE- 289
+ + ++ R P PP CP L+ CW+ SP RP F + L+
Sbjct: 249 ALSRLLELL-EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307
Query: 290 QDPEFFSSFIPSPDHTI 306
+ F++ H++
Sbjct: 308 CETHAFTAHPEGKHHSL 324
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-46
Identities = 57/261 (21%), Positives = 96/261 (36%), Gaps = 64/261 (24%)
Query: 65 SGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII--- 119
SG ++++ ++ + IK V E A EV L +L+H +I+
Sbjct: 21 SGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----------EREVKALAKLDHVNIVHYN 70
Query: 120 ---------------TEPYSVPLNL----------------------------VLKLALD 136
S L L+L
Sbjct: 71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAP 196
I +G+ Y+HS+ +++RDLK N+ L + VK+ DFG+ G GT R+M+P
Sbjct: 131 ITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSP 190
Query: 197 EMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 256
E I + + K+VD+Y+ G++L ELL + + K
Sbjct: 191 EQISSQDYGKEVDLYALGLILAELLHVCDTAFETS------KFFTDLRDGIISDIFDKKE 244
Query: 257 SYLISRCWSSSPDRRPHFDQI 277
L+ + S P+ RP+ +I
Sbjct: 245 KTLLQKLLSKKPEDRPNTSEI 265
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-46
Identities = 69/276 (25%), Positives = 119/276 (43%), Gaps = 46/276 (16%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEK 101
++ ++ +G G+ +++GIY + VAIK S + +
Sbjct: 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK---NCTSDSVREK- 437
Query: 102 QFTSEVALLFRLNHPH--------------IITE--------------PYSVPLNLVLKL 133
F E + + +HPH II E +S+ L ++
Sbjct: 438 -FLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILY 496
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT-- 190
A ++ + YL S+ +HRD+ + N+L+ + CVK+ DFG+S +E
Sbjct: 497 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--KGKL 554
Query: 191 -YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 248
+WMAPE I +R T DV+ FG+ +WE+L + PF + + + R P+
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPM 613
Query: 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284
PP CP L+++CW+ P RRP F ++ + L
Sbjct: 614 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-46
Identities = 67/298 (22%), Positives = 110/298 (36%), Gaps = 77/298 (25%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASMLEKQ 102
+S + + R ++Y+G VAIK + + A E
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREE-- 58
Query: 103 FTSEVALLFRLNHPHI---------------ITE-------------------------- 121
F E L RL HP++ I
Sbjct: 59 FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 122 ---PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CL 177
++ + L IA GM+YL S ++H+DL + N+L+ + + VK++D G+ +
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV 178
Query: 178 ESQCGSAKGFTGTY----------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTP 226
+ Y RWMAPE I + + D++S+G+VLWE+ + L P
Sbjct: 179 YA--------ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
Query: 227 FDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284
+ + + + + P P CP L+ CW+ P RRP F I S L +
Sbjct: 231 YCGYSNQDVVEMI-RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 287
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 8e-46
Identities = 69/306 (22%), Positives = 112/306 (36%), Gaps = 79/306 (25%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASML 99
+ + + G +++ VA+K + + AS
Sbjct: 33 ACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-------ASES 85
Query: 100 EKQ-FTSEVALLFRLNHPHII--------TEPYSV------------------------- 125
+Q F E LL L H HI+ P +
Sbjct: 86 ARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLA 145
Query: 126 --------PLNLV--LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175
PL L L +A +A GM YL +HRDL + N L+G+ + VK+ DFG+S
Sbjct: 146 GGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
Query: 176 -CLESQCGSAKGFTGTY----------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-A 223
+ S T Y RWM PE I ++ T + DV+SFG+VLWE+ T
Sbjct: 206 RDIYS--------TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 257
Query: 224 LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 283
P+ ++ +A + + P CP ++ CW P +R + + L+
Sbjct: 258 KQPWYQLSNTEAIDCI-TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316
Query: 284 YSESLE 289
+++
Sbjct: 317 LAQAPP 322
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 1e-45
Identities = 60/259 (23%), Positives = 111/259 (42%), Gaps = 43/259 (16%)
Query: 72 YRGIYKQR----DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH---------- 117
+G+Y+ R DVAIK++ ++ E ++ +L++P+
Sbjct: 353 RQGVYRMRKKQIDVAIKVLK-----QGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 407
Query: 118 ----IITE--------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 159
++ E +P++ V +L ++ GM+YL + +HR+L + N+
Sbjct: 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNV 467
Query: 160 LLGEDMCVKVADFGIS-CLESQCGSAKGFTGT---YRWMAPEMIKEKRHTKKVDVYSFGI 215
LL K++DFG+S L + + +W APE I ++ + + DV+S+G+
Sbjct: 468 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGV 527
Query: 216 VLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHF 274
+WE L+ P+ M + + ++ R PP CP L+S CW + RP F
Sbjct: 528 TMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPPECPPELYALMSDCWIYKWEDRPDF 586
Query: 275 DQIVSILEGYSESLEQDPE 293
+ + SL E
Sbjct: 587 LTVEQRMRACYYSLASKVE 605
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-45
Identities = 61/300 (20%), Positives = 108/300 (36%), Gaps = 64/300 (21%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD------VAIKLVSQPEEDASLASMLE 100
+ + L + G + Y VA+K + E+
Sbjct: 33 RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL------ 86
Query: 101 KQFTSEVALLFRLNHPHII------TEPYSVPLNLV------------------------ 130
+ F E+ +L L H +I+ L L+
Sbjct: 87 RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK 146
Query: 131 -LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFT 188
L+ I +GM+YL ++ +HRDL + N+L+ + VK+ DFG++ L K
Sbjct: 147 LLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE 206
Query: 189 GT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT----------------ALTPFDN 229
W APE + E + + DV+SFG+VL+EL T
Sbjct: 207 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 266
Query: 230 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289
M + + N R P P CP +++ CW+++ ++RP F + ++ + +
Sbjct: 267 MIVFHLIELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-45
Identities = 68/304 (22%), Positives = 113/304 (37%), Gaps = 80/304 (26%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASMLE 100
+ + + G +++ VA+K + ++
Sbjct: 8 HVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-------PTLAA 60
Query: 101 KQ-FTSEVALLFRLNHPHI---------------ITE----------------------- 121
++ F E LL L H HI + E
Sbjct: 61 RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 122 ------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175
+ L+ +L +A IA GM YL SQ +HRDL + N L+G ++ VK+ DFG+S
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
Query: 176 -CLESQCGSAKGFTGTY----------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-A 223
+ S T Y RWM PE I ++ T + DV+SFG++LWE+ T
Sbjct: 181 RDVYS--------TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYG 232
Query: 224 LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 283
P+ ++ + + + P CPK ++ CW P +R + +I IL
Sbjct: 233 KQPWFQLSNTEVIECI-TQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHA 291
Query: 284 YSES 287
++
Sbjct: 292 LGKA 295
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-44
Identities = 78/313 (24%), Positives = 120/313 (38%), Gaps = 85/313 (27%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASMLE 100
+ + G R+++ VA+K++ E+AS +
Sbjct: 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQAD 96
Query: 101 KQFTSEVALLFRLNHPHII--------TEPYSV--------------------------- 125
F E AL+ ++P+I+ +P +
Sbjct: 97 --FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 154
Query: 126 ---------------PLNLV--LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 168
PL+ L +A +A GM YL + +HRDL + N L+GE+M VK
Sbjct: 155 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVK 214
Query: 169 VADFGIS-CLESQCGSAKGFTGTY----------RWMAPEMIKEKRHTKKVDVYSFGIVL 217
+ADFG+S + S Y RWM PE I R+T + DV+++G+VL
Sbjct: 215 IADFGLSRNIYS--------ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 266
Query: 218 WELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQ 276
WE+ + L P+ M E+ + V + P CP L+ CWS P RP F
Sbjct: 267 WEIFSYGLQPYYGMAHEEVIYYV-RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCS 325
Query: 277 IVSILEGYSESLE 289
I IL+ E E
Sbjct: 326 IHRILQRMCERAE 338
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 7e-44
Identities = 57/249 (22%), Positives = 104/249 (41%), Gaps = 44/249 (17%)
Query: 65 SGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEK---QFTSEVALLFRLNHPHII 119
G + R IK ++ ++ M K + EVA+L + HP+I+
Sbjct: 34 EGSFGKAILVKSTEDGRQYVIKEIN-------ISRMSSKEREESRREVAVLANMKHPNIV 86
Query: 120 T------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGI 149
+ + +L + I ++++H + I
Sbjct: 87 QYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKI 146
Query: 150 LHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 208
LHRD+KS+N+ L +D V++ DFGI+ L S A+ GT +++PE+ + K + K
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKS 206
Query: 209 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 268
D+++ G VL+EL T F+ + + + + PPV L+S+ + +P
Sbjct: 207 DIWALGCVLYELCTLKHAFEAGSMKNLVLKII-SGSFPPVSLHYSYDLRSLVSQLFKRNP 265
Query: 269 DRRPHFDQI 277
RP + I
Sbjct: 266 RDRPSVNSI 274
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-43
Identities = 75/338 (22%), Positives = 122/338 (36%), Gaps = 82/338 (24%)
Query: 32 SKYLVSSGAEIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD----VAIKLVS 87
K+ + + D + + G ++ + K+ AIK +
Sbjct: 2 KKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM- 60
Query: 88 QPEEDASLASMLEKQFTSEVALLFRL-NHPHI---------------ITE---------- 121
+E AS + F E+ +L +L +HP+I E
Sbjct: 61 --KEYASKDDHRD--FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 116
Query: 122 -------------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 162
++ +L A D+ARGM YL + +HRDL + N+L+G
Sbjct: 117 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176
Query: 163 EDMCVKVADFGISCLESQCGSAKGFTGTY----------RWMAPEMIKEKRHTKKVDVYS 212
E+ K+ADFG+S Y RWMA E + +T DV+S
Sbjct: 177 ENYVAKIADFGLS----------RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 226
Query: 213 FGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 271
+G++LWE+++ TP+ MT + + + R P C L+ +CW P R
Sbjct: 227 YGVLLWEIVSLGGTPYCGMTCAELYEKL-PQGYRLEKPLNCDDEVYDLMRQCWREKPYER 285
Query: 272 PHFDQIVSILEGYSES------LEQDPEFFSSFIPSPD 303
P F QI+ L E +F + I
Sbjct: 286 PSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCSA 323
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-43
Identities = 75/319 (23%), Positives = 126/319 (39%), Gaps = 85/319 (26%)
Query: 35 LVSSGAEIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVS 87
L S K + +W L +G G ++ + VA+K++
Sbjct: 3 LSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK 62
Query: 88 QPEEDASLASMLEKQFTSEVALLFRLNHPHI---------------ITE----------- 121
E+AS + + + SE +L ++NHPH+ I E
Sbjct: 63 ---ENASPSELRD--LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL 117
Query: 122 ------------------------PYSVPLNLV--LKLALDIARGMQYLHSQGILHRDLK 155
P L + + A I++GMQYL ++HRDL
Sbjct: 118 RESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177
Query: 156 SENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY----------RWMAPEMIKEKRH 204
+ N+L+ E +K++DFG+S + +Y +WMA E + + +
Sbjct: 178 ARNILVAEGRKMKISDFGLSRDVYE--------EDSYVKRSQGRIPVKWMAIESLFDHIY 229
Query: 205 TKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263
T + DV+SFG++LWE++T P+ + PE+ + + R P C + L+ +C
Sbjct: 230 TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL-KTGHRMERPDNCSEEMYRLMLQC 288
Query: 264 WSSSPDRRPHFDQIVSILE 282
W PD+RP F I LE
Sbjct: 289 WKQEPDKRPVFADISKDLE 307
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-42
Identities = 62/300 (20%), Positives = 117/300 (39%), Gaps = 62/300 (20%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASMLE 100
+W +L +G G ++ D VA+K++ E A+ +
Sbjct: 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRA 76
Query: 101 KQFTSEVALLFRL-NHPHI----------------ITE---------------------- 121
SE+ +L + +H ++ I E
Sbjct: 77 --LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 122 -------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174
+ L ++ + +A+GM++L S+ +HRDL + N+LL E VK+ DFG+
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 194
Query: 175 SCLESQCGSAKGFTGT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 230
+ + +WMAPE I ++ +T + DV+SFG++LWE+ + +P+ +
Sbjct: 195 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254
Query: 231 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 290
++ ++ R P + CW P +RP F ++V L ++ Q
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-42
Identities = 64/276 (23%), Positives = 117/276 (42%), Gaps = 60/276 (21%)
Query: 71 IYRGIYKQRD-----VAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHI------ 118
GI K + VA+K++ +DA+ + + SE+ ++ + H +I
Sbjct: 55 EAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSD--LVSEMEMMKMIGKHKNIINLLGA 109
Query: 119 ---------ITE-----------------------------PYSVPLNLVLKLALDIARG 140
I E + ++ +ARG
Sbjct: 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 169
Query: 141 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT---YRWMAPE 197
M+YL SQ +HRDL + N+L+ E+ +K+ADFG++ + K T +WMAPE
Sbjct: 170 MEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE 229
Query: 198 MIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 256
+ ++ +T + DV+SFG+++WE+ T +P+ + E+ + ++ R P C
Sbjct: 230 ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMDKPANCTNEL 288
Query: 257 SYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 292
++ CW + P +RP F Q+V L+ +
Sbjct: 289 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE 324
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-42
Identities = 66/283 (23%), Positives = 121/283 (42%), Gaps = 61/283 (21%)
Query: 71 IYRGIYKQRD-----VAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHI------ 118
G+ K + VA+K++ DA+ + + SE+ ++ + H +I
Sbjct: 89 EAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSD--LISEMEMMKMIGKHKNIINLLGA 143
Query: 119 ---------ITE-----------------------------PYSVPLNLVLKLALDIARG 140
I E + ++ A +ARG
Sbjct: 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARG 203
Query: 141 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT---YRWMAPE 197
M+YL S+ +HRDL + N+L+ ED +K+ADFG++ K T +WMAPE
Sbjct: 204 MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 263
Query: 198 MIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 256
+ ++ +T + DV+SFG++LWE+ T +P+ + E+ + ++ R P C
Sbjct: 264 ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMDKPSNCTNEL 322
Query: 257 SYLISRCWSSSPDRRPHFDQIVSILEGY-SESLEQDPEFFSSF 298
++ CW + P +RP F Q+V L+ + + Q+ ++
Sbjct: 323 YMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHH 365
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-42
Identities = 69/348 (19%), Positives = 137/348 (39%), Gaps = 64/348 (18%)
Query: 2 KNFHWFKQISINAKPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFIGC 61
+ + S + L R + + +++ +E + + +W +L +G
Sbjct: 28 RQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGK 87
Query: 62 KFASGRHSRIYRGIYKQRD---------VAIKLVSQPEEDASLASMLEKQFTSEVALLFR 112
G ++ D VA+K++ +DA+ + + SE+ ++
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSD--LVSEMEMMKM 142
Query: 113 L-NHPHII--------------------------------------------TEPYSVPL 127
+ H +II +
Sbjct: 143 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 128 NLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGF 187
++ +ARGM+YL SQ +HRDL + N+L+ E+ +K+ADFG++ + K
Sbjct: 203 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 188 TGT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 243
T +WMAPE + ++ +T + DV+SFG+++WE+ T +P+ + E+ + ++
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEG 321
Query: 244 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 291
R P C ++ CW + P +RP F Q+V L+ +
Sbjct: 322 HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 369
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-41
Identities = 59/255 (23%), Positives = 105/255 (41%), Gaps = 44/255 (17%)
Query: 65 SGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFT-SEVALLFRLNHPHIIT- 120
G+ S +YR VA+K V L + E+ LL +LNHP++I
Sbjct: 42 RGQFSEVYRAACLLDGVPVALKKVQ----IFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 121 -------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGI 149
+ +P V K + + ++++HS+ +
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRV 157
Query: 150 LHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 208
+HRD+K N+ + VK+ D G+ S+ +A GT +M+PE I E + K
Sbjct: 158 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKS 217
Query: 209 DVYSFGIVLWELLTALTPF--DNMTPEQAAFAVCQKNARPPVPPTC-PKAFSYLISRCWS 265
D++S G +L+E+ +PF D M + Q + PP+P + L++ C +
Sbjct: 218 DIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-YPPLPSDHYSEELRQLVNMCIN 276
Query: 266 SSPDRRPHFDQIVSI 280
P++RP + +
Sbjct: 277 PDPEKRPDVTYVYDV 291
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-41
Identities = 46/244 (18%), Positives = 83/244 (34%), Gaps = 39/244 (15%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT- 120
G + +++ K+ R A+K P + +EV ++ HP +
Sbjct: 67 HGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD----RARKLAEVGSHEKVGQHPCCVRL 122
Query: 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRD 153
S+P V D + +LHSQG++H D
Sbjct: 123 EQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLD 182
Query: 154 LKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSF 213
+K N+ LG K+ DFG+ G+ + G R+MAPE+++ + DV+S
Sbjct: 183 VKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS-YGTAADVFSL 241
Query: 214 GIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPH 273
G+ + E+ + Q + Q P ++ P R
Sbjct: 242 GLTILEVACNMELPHGGEGWQ---QLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRAT 298
Query: 274 FDQI 277
+ +
Sbjct: 299 AEAL 302
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-41
Identities = 66/268 (24%), Positives = 107/268 (39%), Gaps = 59/268 (22%)
Query: 71 IYRGIYKQRD---VAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHI-------- 118
G+ K VA+K++ A L SE+ +L L NH +I
Sbjct: 43 TAYGLIKSDAAMTVAVKMLK---PSAHLTEREA--LMSELKVLSYLGNHMNIVNLLGACT 97
Query: 119 -------ITE-------------------------------PYSVPLNLVLKLALDIARG 140
ITE ++ L +L + +A+G
Sbjct: 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKG 157
Query: 141 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT---YRWMAPE 197
M +L S+ +HRDL + N+LL K+ DFG++ + +WMAPE
Sbjct: 158 MAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE 217
Query: 198 MIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 256
I +T + DV+S+GI LWEL + +P+ M + + + ++ R P P
Sbjct: 218 SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEM 277
Query: 257 SYLISRCWSSSPDRRPHFDQIVSILEGY 284
++ CW + P +RP F QIV ++E
Sbjct: 278 YDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-41
Identities = 58/239 (24%), Positives = 99/239 (41%), Gaps = 44/239 (18%)
Query: 72 YRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI----------- 118
Y+G+ + +VA + D L ++F E +L L HP+I
Sbjct: 43 YKGLDTETTVEVAWCELQ----DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98
Query: 119 --------ITE-------------PYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLK 155
+TE + + ++ I +G+Q+LH++ I+HRDLK
Sbjct: 99 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK 158
Query: 156 SENLLL-GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFG 214
+N+ + G VK+ D G++ L+ AK GT +MAPEM +EK + + VDVY+FG
Sbjct: 159 CDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFG 216
Query: 215 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP-TCPKAFSYLISRCWSSSPDRRP 272
+ + E+ T+ P+ + +P +I C + D R
Sbjct: 217 MCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY 275
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-41
Identities = 61/255 (23%), Positives = 93/255 (36%), Gaps = 64/255 (25%)
Query: 79 RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------------EPYS 124
+ AIK + P + + ++ EV L +L HP I+ +P S
Sbjct: 31 CNYAIKRIRLPNRELA-----REKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85
Query: 125 VPLNL-----------------------------VLKLALDIARGMQYLHSQGILHRDLK 155
+ L L + L IA +++LHS+G++HRDLK
Sbjct: 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLK 145
Query: 156 SENLLLGEDMCVKVADFGISCL-------------ESQCGSAKGFTGTYRWMAPEMIKEK 202
N+ D VKV DFG+ G GT +M+PE I
Sbjct: 146 PSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN 205
Query: 203 RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 262
++ KVD++S G++L+EL L PF + PP+ ++
Sbjct: 206 SYSHKVDIFSLGLILFEL---LYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQD 262
Query: 263 CWSSSPDRRPHFDQI 277
S SP RP I
Sbjct: 263 MLSPSPMERPEAINI 277
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-41
Identities = 54/306 (17%), Positives = 106/306 (34%), Gaps = 75/306 (24%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRD---------VAIKLVSQPEEDASLASMLE 100
L G ++I++G+ ++ V +K++ + +
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY------S 56
Query: 101 KQFTSEVALLFRLNHPH---------------IITE--------------PYSVPLNLVL 131
+ F +++ +L+H H ++ E + + L
Sbjct: 57 ESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL 116
Query: 132 KLALDIARGMQYLHSQGILHRDLKSENLLL--------GEDMCVKVADFGIS--CLESQC 181
++A +A M +L ++H ++ ++N+LL G +K++D GIS L
Sbjct: 117 EVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI 176
Query: 182 GSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAV 239
+ W+ PE I+ ++ D +SFG LWE+ + P + ++
Sbjct: 177 LQER-----IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
Query: 240 CQKNARPPVPPTCPKAFSY-LISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSF 298
+ + P P LI+ C PD RP F I+ L F
Sbjct: 232 -EDRHQLPAPKAAE---LANLINNCMDYEPDHRPSFRAIIRDLNSL---------FTPDL 278
Query: 299 IPSPDH 304
+P H
Sbjct: 279 VPRGSH 284
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-40
Identities = 63/301 (20%), Positives = 114/301 (37%), Gaps = 59/301 (19%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASML 99
E+W + L G +G ++ VA+K++ A
Sbjct: 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKE 94
Query: 100 EKQFTSEVALLFRL-NHPHI---------------ITE---------------------- 121
SE+ ++ L H +I ITE
Sbjct: 95 A--LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 122 -----PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 176
+ +L + +A+GM +L S+ +HRD+ + N+LL K+ DFG++
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 177 LESQCGSAKGFTGT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTP 232
+ +WMAPE I + +T + DV+S+GI+LWE+ + L P+ +
Sbjct: 213 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272
Query: 233 EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 292
+ + + + P PK ++ CW+ P RP F QI S L+ ++ ++
Sbjct: 273 NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRER 332
Query: 293 E 293
+
Sbjct: 333 D 333
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-40
Identities = 57/276 (20%), Positives = 99/276 (35%), Gaps = 58/276 (21%)
Query: 59 IGCKFASGRHSRIY--RGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
K G S + G++ A+K + E+ ++ E + NHP
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD------REEAQREADMHRLFNHP 86
Query: 117 HIIT----------EPYSV--------------------------PLNLVLKLALDIARG 140
+I+ + + +L L L I RG
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 141 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES----------QCGSAKGFTGT 190
++ +H++G HRDLK N+LLG++ + D G T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 191 YRWMAPEMIKEKRH---TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA-VCQKNARP 246
+ APE+ + H ++ DV+S G VL+ ++ P+D + + + A Q
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 247 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
P P A L++ + P +RPH ++S LE
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-39
Identities = 52/241 (21%), Positives = 85/241 (35%), Gaps = 49/241 (20%)
Query: 70 RIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII-------T 120
++R KQ A+K V LE E+ L+ P I+
Sbjct: 73 EVHRMKDKQTGFQCAVKKVR-----------LEVFRVEELVACAGLSSPRIVPLYGAVRE 121
Query: 121 EPY-----------SV----------PLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 159
P+ S+ P + L G++YLH++ ILH D+K++N+
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 181
Query: 160 LLGED-MCVKVADFGIS------CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYS 212
LL D + DFG + L + GT MAPE++ K KVD++S
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWS 241
Query: 213 FGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYLISRCWSSSPDRR 271
++ +L P+ + + +PP+C + I P R
Sbjct: 242 SCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHR 301
Query: 272 P 272
Sbjct: 302 A 302
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-39
Identities = 67/344 (19%), Positives = 123/344 (35%), Gaps = 76/344 (22%)
Query: 5 HWFKQISINAKPERMLSLREYRRAVSWS-KYLVSSGAEIKGEGEEEWSADMSQLFIGCKF 63
H +K+ + L+ + S +Y E E + +W L G
Sbjct: 1 HKYKK-----QFRYESQLQMVQVTGSSDNEYFYVDFREY--EYDLKWEFPRENLEFGKVL 53
Query: 64 ASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NH 115
SG ++ VA+K++ E A + SE+ ++ +L +H
Sbjct: 54 GSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREA--LMSELKMMTQLGSH 108
Query: 116 PHI---------------ITE------------------------------------PYS 124
+I I E
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 125 VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 184
+ +L A +A+GM++L + +HRDL + N+L+ VK+ DFG++ +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 185 KGFTGT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVC 240
+WMAPE + E +T K DV+S+GI+LWE+ + + P+ + + + +
Sbjct: 229 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 288
Query: 241 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284
Q + P + ++ CW+ +RP F + S L
Sbjct: 289 QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-39
Identities = 64/266 (24%), Positives = 111/266 (41%), Gaps = 48/266 (18%)
Query: 45 EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQ 102
E + E+ + ++ +G G + +Y G Q +AIK + + + S +
Sbjct: 16 EYDYEYDENGDRVVLG----KGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS------QP 65
Query: 103 FTSEVALLFRLNHPHII----TEPYSVPLNLVL--------------------------- 131
E+AL L H +I+ + + + + +
Sbjct: 66 LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG 125
Query: 132 KLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVADFGIS-CLESQCGSAKGFTG 189
I G++YLH I+HRD+K +N+L+ +K++DFG S L + FTG
Sbjct: 126 FYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTG 185
Query: 190 TYRWMAPEMIKEKR--HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA-FAVCQKNARP 246
T ++MAPE+I + + K D++S G + E+ T PF + QAA F V P
Sbjct: 186 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP 245
Query: 247 PVPPTCPKAFSYLISRCWSSSPDRRP 272
+P + I +C+ PD+R
Sbjct: 246 EIPESMSAEAKAFILKCFEPDPDKRA 271
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-39
Identities = 58/258 (22%), Positives = 102/258 (39%), Gaps = 53/258 (20%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEK---QFTSEVALLFRLNHPHII 119
+G + R + K + + K + SM E SEV LL L HP+I+
Sbjct: 16 TGSYGRCQKIRRKSDGKILVWKELD-------YGSMTEAEKQMLVSEVNLLRELKHPNIV 68
Query: 120 T------EPYSVPLNLV----------------------------LKLALDIARGMQYLH 145
+ + L +V L++ + ++ H
Sbjct: 69 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 146 SQG-----ILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMI 199
+ +LHRDLK N+ L VK+ DFG++ L AK F GT +M+PE +
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 200 KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 259
+ +K D++S G +L+EL + PF + ++ A + + +P + +
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDELNEI 247
Query: 260 ISRCWSSSPDRRPHFDQI 277
I+R + RP ++I
Sbjct: 248 ITRMLNLKDYHRPSVEEI 265
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 53/262 (20%), Positives = 95/262 (36%), Gaps = 66/262 (25%)
Query: 69 SRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH---------- 117
S++++ + + ++ AIK V+ E D E+A L +L
Sbjct: 23 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN----EIAYLNKLQQHSDKIIRLYDYE 78
Query: 118 -------IITEPY-------------SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 157
++ E S+ ++ + +H GI+H DLK
Sbjct: 79 ITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA 137
Query: 158 NLLLGEDMCVKVADFGIS----------CLESQCGSAKGFTGTYRWMAPEMIKEK----- 202
N L+ + M +K+ DFGI+ +SQ GT +M PE IK+
Sbjct: 138 NFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-------GTVNYMPPEAIKDMSSSRE 189
Query: 203 ------RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA-FAVCQKNARPPVPPTCPKA 255
+ + K DV+S G +L+ + TPF + + + A+ N P K
Sbjct: 190 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKD 249
Query: 256 FSYLISRCWSSSPDRRPHFDQI 277
++ C P +R ++
Sbjct: 250 LQDVLKCCLKRDPKQRISIPEL 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-38
Identities = 53/262 (20%), Positives = 95/262 (36%), Gaps = 66/262 (25%)
Query: 69 SRIYRGIYKQRD-VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH---------- 117
S++++ + +++ AIK V+ E D + +E+A L +L
Sbjct: 42 SKVFQVLNEKKQIYAIKYVNLEEADNQTL----DSYRNEIAYLNKLQQHSDKIIRLYDYE 97
Query: 118 -------IITEPY-------------SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 157
++ E S+ ++ + +H GI+H DLK
Sbjct: 98 ITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA 156
Query: 158 NLLLGEDMCVKVADFGIS----------CLESQCGSAKGFTGTYRWMAPEMIKEK----- 202
N L+ + M +K+ DFGI+ +SQ GT +M PE IK+
Sbjct: 157 NFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-------GTVNYMPPEAIKDMSSSRE 208
Query: 203 ------RHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQKNARPPVPPTCPKA 255
+ + K DV+S G +L+ + TPF + A+ N P K
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKD 268
Query: 256 FSYLISRCWSSSPDRRPHFDQI 277
++ C P +R ++
Sbjct: 269 LQDVLKCCLKRDPKQRISIPEL 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 53/265 (20%), Positives = 93/265 (35%), Gaps = 64/265 (24%)
Query: 65 SGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH------ 117
SG S++++ + + ++ AIK V+ E D +E+A L +L
Sbjct: 66 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYR----NEIAYLNKLQQHSDKIIRL 121
Query: 118 -----------------------IITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 154
+ + S+ ++ + +H GI+H DL
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 181
Query: 155 KSENLLLGEDMCVKVADFGIS----------CLESQCGSAKGFTGTYRWMAPEMIKEK-- 202
K N L+ D +K+ DFGI+ +SQ G +M PE IK+
Sbjct: 182 KPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV-------GAVNYMPPEAIKDMSS 233
Query: 203 ---------RHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQKNARPPVPPTC 252
+ + K DV+S G +L+ + TPF + A+ N P
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 293
Query: 253 PKAFSYLISRCWSSSPDRRPHFDQI 277
K ++ C P +R ++
Sbjct: 294 EKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 55/262 (20%), Positives = 90/262 (34%), Gaps = 73/262 (27%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII------------------ 119
R AIK + EE SEV LL LNH +++
Sbjct: 31 SRYYAIKKIRHTEEK-------LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83
Query: 120 ------------------------TEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 155
+E + + +L I + Y+HSQGI+HRDLK
Sbjct: 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLK 143
Query: 156 SENLLLGEDMCVKVADFGIS---------------CLESQCGSAKGFTGTYRWMAPEMIK 200
N+ + E VK+ DFG++ L + GT ++A E++
Sbjct: 144 PMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD 203
Query: 201 EKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY- 258
H +K+D+YS GI+ +E++ M + ++ PP
Sbjct: 204 GTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKL--RSVSIEFPPDFDDNKMKV 259
Query: 259 ---LISRCWSSSPDRRPHFDQI 277
+I P++RP +
Sbjct: 260 EKKIIRLLIDHDPNKRPGARTL 281
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-37
Identities = 44/156 (28%), Positives = 79/156 (50%), Gaps = 4/156 (2%)
Query: 131 LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT 190
+ + +A+GM++L S+ +HRDL + N+LL E VK+ DFG++ +
Sbjct: 196 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 191 ---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 246
+WMAPE I ++ +T + DV+SFG++LWE+ + +P+ + ++ ++ R
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 315
Query: 247 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
P + CW P +RP F ++V L
Sbjct: 316 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 56/236 (23%), Positives = 90/236 (38%), Gaps = 50/236 (21%)
Query: 78 QRDVAIK-LVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI------------------ 118
VAIK + P E K+F EV +L+H +I
Sbjct: 36 NIKVAIKAIFIPPREKEETL----KRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME 91
Query: 119 ----------ITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 168
I + ++ + I G+++ H I+HRD+K +N+L+ + +K
Sbjct: 92 YIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLK 151
Query: 169 VADFGISCLESQCGSAKGFT------GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT 222
+ DFGI ++ S T GT ++ +PE K + + D+YS GIVL+E+L
Sbjct: 152 IFDFGI----AKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLV 207
Query: 223 ALTPFDNMTPEQAAFAVCQKNARPPVPPT-----CPKAFSYLISRCWSSSPDRRPH 273
PF+ T A P T P++ S +I R R
Sbjct: 208 GEPPFNGETAVSIAIK--HIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYK 261
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-35
Identities = 71/273 (26%), Positives = 120/273 (43%), Gaps = 49/273 (17%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
IG G+ +Y KQ +A+K++ + + + +E Q EV + L HP
Sbjct: 13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ---LEKAGVEHQLRREVEIQSHLRHP 69
Query: 117 HIITEPYSV-----PLNLVLKLA--------------LD----------IARGMQYLHSQ 147
+I+ Y + L+L+ A D +A + Y HS+
Sbjct: 70 NIL-RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 148 GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 207
++HRD+K ENLLLG +K+ADFG S + GT ++ PEMI+ + H +K
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDLCGTLDYLPPEMIEGRMHDEK 187
Query: 208 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY----LISRC 263
VD++S G++ +E L PF+ T ++ ++ +R V T P + LISR
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQE----TYKRISR--VEFTFPDFVTEGARDLISRL 241
Query: 264 WSSSPDRRPHFDQIVS---ILEGYSESLEQDPE 293
+P +RP +++ I S+ +
Sbjct: 242 LKHNPSQRPMLREVLEHPWITANSSKPSNCQNK 274
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-35
Identities = 43/163 (26%), Positives = 71/163 (43%), Gaps = 16/163 (9%)
Query: 128 NLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKG 186
+ L + + IA +++LHS+G++HRDLK N+ D VKV DFG+ ++
Sbjct: 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 187 FT------------GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 234
T GT +M+PE I ++ KVD++S G++L+ELL + +
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--- 280
Query: 235 AAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 277
+ P + ++ S SP RP I
Sbjct: 281 RIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-35
Identities = 49/274 (17%), Positives = 91/274 (33%), Gaps = 66/274 (24%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NH 115
K SG +++ + + AIK +P S+ E+ EV L H
Sbjct: 15 ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG----SVDEQNALREVYAHAVLGQH 70
Query: 116 PH---------------IITE-----------------PYSVPLNLVLKLALDIARGMQY 143
H I E + L L + RG++Y
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 144 LHSQGILHRDLKSENLLLGED-------------------MCVKVADFGISCLESQCGSA 184
+HS ++H D+K N+ + + K+ D G ++ S
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISSP 187
Query: 185 KGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 243
+ G R++A E+++E H K D+++ + + A N + ++
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----WHEIRQG 243
Query: 244 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 277
P +P + F+ L+ P+RRP +
Sbjct: 244 RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 56/240 (23%), Positives = 90/240 (37%), Gaps = 42/240 (17%)
Query: 69 SRIYRG--IYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI-------- 118
+Y ++R VA+KL+ E +S + E RL PH+
Sbjct: 48 GDVYEAEDTVRERIVALKLM--SETLSSDPVFRTR-MQREARTAGRLQEPHVVPIHDFGE 104
Query: 119 --------------------ITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 158
+ + + + I + H+ G HRD+K EN
Sbjct: 105 IDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPEN 164
Query: 159 LLLGEDMCVKVADFGI--SCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIV 216
+L+ D + DFGI + + + GT +MAPE E T + D+Y+ V
Sbjct: 165 ILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCV 224
Query: 217 LWELLTALTPFDNMTPEQAAFAVCQKNARPPVP----PTCPKAFSYLISRCWSSSPDRRP 272
L+E LT P+ +Q + N P P P P AF +I+R + +P+ R
Sbjct: 225 LYECLTGSPPYQG---DQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRY 281
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 75/264 (28%), Positives = 117/264 (44%), Gaps = 47/264 (17%)
Query: 45 EGEEEWSADMSQLF-IGCKFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDASLASMLEK 101
G + AD +LF K G +++GI + VAIK++ E + + + +
Sbjct: 11 PGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ- 69
Query: 102 QFTSEVALLFRLNHPHI--------------ITEPY----SVPLNLVLKLALD---IA-- 138
E+ +L + + P++ I Y S L+L+ LD IA
Sbjct: 70 ----EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDETQIATI 124
Query: 139 -----RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYR 192
+G+ YLHS+ +HRD+K+ N+LL E VK+ADFG++ L F GT
Sbjct: 125 LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF 184
Query: 193 WMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTC 252
WMAPE+IK+ + K D++S GI EL P + P + F + + N PPT
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-----PPTL 239
Query: 253 PKAFSYL----ISRCWSSSPDRRP 272
+S + C + P RP
Sbjct: 240 EGNYSKPLKEFVEACLNKEPSFRP 263
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 60/279 (21%), Positives = 103/279 (36%), Gaps = 78/279 (27%)
Query: 70 RIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP------------- 116
+Y+G VA+K ++ + + L++QF E+ ++ + H
Sbjct: 46 VVYKGYVNNTTVAVKKLAAMVDITTEE--LKQQFDQEIKVMAKCQHENLVELLGFSSDGD 103
Query: 117 ----------------HIITEPYSVPL--NLVLKLALDIARGMQYLHSQGILHRDLKSEN 158
+ + PL ++ K+A A G+ +LH +HRD+KS N
Sbjct: 104 DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSAN 163
Query: 159 LLLGEDMCVKVADFGISCLESQCGSAKGFT-------GTYRWMAPEMIKEKRHTKKVDVY 211
+LL E K++DFG++ T GT +MAPE ++ + T K D+Y
Sbjct: 164 ILLDEAFTAKISDFGLARA----SEKFAQTVMTSRIVGTTAYMAPEALRGEI-TPKSDIY 218
Query: 212 SFGIVLWELLTALTPFDNMTPEQAAFAVCQKN----ARPPVPPTCPKAFSYLI------- 260
SFG+VL E++T L D Q K I
Sbjct: 219 SFGVVLLEIITGLPAVDEHREPQ--------LLLDIKEEIE--DEEKTIEDYIDKKMNDA 268
Query: 261 ------------SRCWSSSPDRRPHFDQIVSILEGYSES 287
S+C ++RP ++ +L+ + S
Sbjct: 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-34
Identities = 63/265 (23%), Positives = 111/265 (41%), Gaps = 57/265 (21%)
Query: 70 RIYRGIYKQ-RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII--------- 119
++Y+G+ + VA+K + ++F +E+ L HPH++
Sbjct: 54 KVYKGVLRDGAKVALKRRTPESSQG------IEEFETEIETLSFCRHPHLVSLIGFCDER 107
Query: 120 ---------------------TEPYSVPL--NLVLKLALDIARGMQYLHSQGILHRDLKS 156
++ ++ + L++ + ARG+ YLH++ I+HRD+KS
Sbjct: 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKS 167
Query: 157 ENLLLGEDMCVKVADFGISCLESQCGSAKGFT---GTYRWMAPEMIKEKRHTKKVDVYSF 213
N+LL E+ K+ DFGIS ++ T GT ++ PE + R T+K DVYSF
Sbjct: 168 INILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF 227
Query: 214 GIVLWELLTALTPFDNMTPEQAAFAV-----CQKNARPP----------VPPTCPKAFSY 258
G+VL+E+L A + P + N + + P + F
Sbjct: 228 GVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGD 287
Query: 259 LISRCWSSSPDRRPHFDQIVSILEG 283
+C + S + RP ++ LE
Sbjct: 288 TAVKCLALSSEDRPSMGDVLWKLEY 312
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-34
Identities = 56/237 (23%), Positives = 95/237 (40%), Gaps = 49/237 (20%)
Query: 78 QRDVAIK-LVSQPEEDASLASMLEKQFTSE---VALLFRLNHPHI--------------- 118
RDVA+K L + D S +F E A LNHP I
Sbjct: 37 HRDVAVKVLRADLARDPSFY----LRFRREAQNAA---ALNHPAIVAVYDTGEAETPAGP 89
Query: 119 -----------------ITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 161
+ + +++ D + + + H GI+HRD+K N+++
Sbjct: 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI 149
Query: 162 GEDMCVKVADFGISCLESQCGSAKGFT----GTYRWMAPEMIKEKRHTKKVDVYSFGIVL 217
VKV DFGI+ + G++ T GT ++++PE + + DVYS G VL
Sbjct: 150 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 209
Query: 218 WELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLISRCWSSSPDRRP 272
+E+LT PF +P A+ +++ PP ++ + + +P+ R
Sbjct: 210 YEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRY 266
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-33
Identities = 67/264 (25%), Positives = 108/264 (40%), Gaps = 51/264 (19%)
Query: 79 RDVAIKLVSQPEEDASLASM-LEKQFTSEVALLFRLNHPHIITEPYSV---PLN--LVL- 131
A K+V + + L ++ + E+++ L H H++ + +VL
Sbjct: 41 EVFAGKIVPK----SLLLKPHQREKMSMEISIHRSLAHQHVV-GFHGFFEDNDFVFVVLE 95
Query: 132 ---------------KLALDIAR--------GMQYLHSQGILHRDLKSENLLLGEDMCVK 168
L AR G QYLH ++HRDLK NL L ED+ VK
Sbjct: 96 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVK 155
Query: 169 VADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP 226
+ DFG++ G K GT ++APE++ +K H+ +VDV+S G +++ LL P
Sbjct: 156 IGDFGLATKVEYDGERK-KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
Query: 227 FDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS---ILEG 283
F+ T + K +P + LI + + P RP +++++ G
Sbjct: 215 FE--TSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272
Query: 284 Y------SESLEQDPEFFSSFIPS 301
Y L P F S PS
Sbjct: 273 YIPARLPITCLTIPPRF--SIAPS 294
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-33
Identities = 61/294 (20%), Positives = 106/294 (36%), Gaps = 69/294 (23%)
Query: 59 IGCKFASGRHSRIY--RGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NH 115
+ A G + +Y + + R+ A+K + EE+ + EV + +L H
Sbjct: 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEK------NRAIIQEVCFMKKLSGH 85
Query: 116 PHIIT----------------------EPYS----------------VPLNLVLKLALDI 137
P+I+ + + VLK+
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 138 ARGMQYLHSQG--ILHRDLKSENLLLGEDMCVKVADFGISCLES----QCGSAKGFT--- 188
R +Q++H Q I+HRDLK ENLLL +K+ DFG + S SA+
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 189 ------GTYRWMAPEMI---KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV 239
T + PE+I +K D+++ G +L+ L PF+ + A +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE----DGAKLRI 261
Query: 240 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPE 293
P T F LI +P+ R ++V L+ + + +P+
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK 315
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-33
Identities = 64/253 (25%), Positives = 105/253 (41%), Gaps = 47/253 (18%)
Query: 79 RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITEPYSV---PLN--LVL-- 131
A K+V + L ++ + E+++ L H H++ + +VL
Sbjct: 67 EVFAGKIVPK---SLLLKPHQREKMSMEISIHRSLAHQHVV-GFHGFFEDNDFVFVVLEL 122
Query: 132 --------------KLALDIAR--------GMQYLHSQGILHRDLKSENLLLGEDMCVKV 169
L AR G QYLH ++HRDLK NL L ED+ VK+
Sbjct: 123 CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKI 182
Query: 170 ADFGISCLESQCGSAKG-FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 228
DFG++ G K GT ++APE++ +K H+ +VDV+S G +++ LL PF+
Sbjct: 183 GDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242
Query: 229 NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 288
T + K +P + LI + + P RP ++++
Sbjct: 243 --TSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL---------- 290
Query: 289 EQDPEFFSSFIPS 301
D F S +IP+
Sbjct: 291 -NDEFFTSGYIPA 302
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 9e-33
Identities = 50/249 (20%), Positives = 79/249 (31%), Gaps = 64/249 (25%)
Query: 64 ASGRHSRIYRG---IYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
A G IY R V +K + DA +E L + HP I+
Sbjct: 89 AHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAEAQ----AMAMAERQFLAEVVHPSIVQ 143
Query: 121 --------------EPYSV-----------------PLNLVLKLALDIARGMQYLHSQGI 149
Y V P+ + L+I + YLHS G+
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGL 203
Query: 150 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT------GTYRWMAPEMIKEKR 203
++ DLK EN++L E+ +K+ D G GT + APE+++
Sbjct: 204 VYNDLKPENIMLTEEQ-LKLIDLGA---------VSRINSFGYLYGTPGFQAPEIVRT-G 252
Query: 204 HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263
T D+Y+ G L L L + + ++ L+ R
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------PEDDPVLKTYDSYGRLLRRA 304
Query: 264 WSSSPDRRP 272
P +R
Sbjct: 305 IDPDPRQRF 313
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 54/230 (23%), Positives = 97/230 (42%), Gaps = 44/230 (19%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITEPYSV-----PLNLVL---- 131
+A+K++ + +E Q E+ + L HP+I+ Y+ + L+L
Sbjct: 42 MALKVLFK---SQLEKEGVEHQLRREIEIQSHLRHPNIL-RMYNYFHDRKRIYLMLEFAP 97
Query: 132 ------------KLALDIAR--------GMQYLHSQGILHRDLKSENLLLGEDMCVKVAD 171
+ + + Y H + ++HRD+K ENLL+G +K+AD
Sbjct: 98 RGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIAD 157
Query: 172 FGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT 231
FG S + + + GT ++ PEMI+ K H +KVD++ G++ +E L + PFD+ +
Sbjct: 158 FGWS-VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216
Query: 232 PEQAAFAVCQKNARPPVPPTCPKAFSY----LISRCWSSSPDRRPHFDQI 277
++ V P S LIS+ P +R +
Sbjct: 217 HT----ETHRRIVN--VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGV 260
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 4e-32
Identities = 63/246 (25%), Positives = 99/246 (40%), Gaps = 42/246 (17%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITEPYSV---PLN--LVLKLA- 134
VAIK++ + A + + ++ +EV + +L HP I+ E Y+ LVL++
Sbjct: 39 VAIKMIDK---KAMYKAGMVQRVQNEVKIHCQLKHPSIL-ELYNYFEDSNYVYLVLEMCH 94
Query: 135 --------------LD----------IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVA 170
I GM YLHS GILHRDL NLLL +M +K+A
Sbjct: 95 NGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIA 154
Query: 171 DFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 228
DFG++ +T GT +++PE+ H + DV+S G + + LL PFD
Sbjct: 155 DFGLATQLKMPHEKH-YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213
Query: 229 NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS---ILEGYS 285
T A +P LI + +P R ++ + S
Sbjct: 214 --TDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS 271
Query: 286 ESLEQD 291
+ +
Sbjct: 272 TKSKDE 277
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-32
Identities = 62/256 (24%), Positives = 113/256 (44%), Gaps = 42/256 (16%)
Query: 51 SADMSQLF-IGCKFASGRHSRIYRGIYKQ--RDVAIKLVS-QPEEDASLASMLEKQFTSE 106
D + + K G +Y + ++VAI+ ++ Q + L +E
Sbjct: 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-------IINE 67
Query: 107 VALLFRLNHPHIIT--EPYSVP---------------LNLVLKLALD---IA-------R 139
+ ++ +P+I+ + Y V ++V + +D IA +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 127
Query: 140 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEM 198
+++LHS ++HRD+KS+N+LLG D VK+ DFG + + GT WMAPE+
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 199 IKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAF 256
+ K + KVD++S GI+ E++ P+ N P +A + + N P + P F
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTPELQNPEKLSAIF 246
Query: 257 SYLISRCWSSSPDRRP 272
++RC ++R
Sbjct: 247 RDFLNRCLEMDVEKRG 262
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 41/229 (17%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII-------TEPYSVPLNLVL-- 131
VAIK++ + L ++ EV ++ LNHP+I+ TE L L++
Sbjct: 43 VAIKII----DKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT---LYLIMEY 95
Query: 132 --------------KLALDIAR--------GMQYLHSQGILHRDLKSENLLLGEDMCVKV 169
++ AR +QY H + I+HRDLK+ENLLL DM +K+
Sbjct: 96 ASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKI 155
Query: 170 ADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT-KKVDVYSFGIVLWELLTALTPFD 228
ADFG S + G F G + APE+ + K++ +VDV+S G++L+ L++ PFD
Sbjct: 156 ADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
Query: 229 NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 277
+ +P L+ R +P +R +QI
Sbjct: 216 GQN--LKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQI 262
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 2e-31
Identities = 27/172 (15%), Positives = 52/172 (30%), Gaps = 11/172 (6%)
Query: 117 HIITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 176
+ + + L + R L S+G++H +NL + D + + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 177 LESQCGSAKGFTGTYRWMAPEMI--KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 234
G A TY E + T ++ + G+ ++ + PF +TP
Sbjct: 243 KVGTRGPASSVPVTY--APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 235 AAFAVCQKNARPPVPPTCPKAFSY-------LISRCWSSSPDRRPHFDQIVS 279
P + + LI R + RR + +
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-31
Identities = 59/250 (23%), Positives = 93/250 (37%), Gaps = 52/250 (20%)
Query: 71 IYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIIT--EPYSVP- 126
+YRG++ RDVA+K + E S A EV LL + HP++I
Sbjct: 41 VYRGMFDNRDVAVKRILP--ECFSFAD-------REVQLLRESDEHPNVIRYFCTEKDRQ 91
Query: 127 -LNLVL------------------------KLALDIARGMQYLHSQGILHRDLKSENLLL 161
+ + L G+ +LHS I+HRDLK N+L+
Sbjct: 92 FQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILI 151
Query: 162 GE-----DMCVKVADFGISCL----ESQCGSAKGFTGTYRWMAPEMIKE---KRHTKKVD 209
+ ++DFG+ G GT W+APEM+ E + T VD
Sbjct: 152 SMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVD 211
Query: 210 VYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNARPPVP-PTCPKAFSYLISRCWSSS 267
++S G V + +++ PF QA + + P LI + +
Sbjct: 212 IFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMD 271
Query: 268 PDRRPHFDQI 277
P +RP +
Sbjct: 272 PQKRPSAKHV 281
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 3e-31
Identities = 26/174 (14%), Positives = 59/174 (33%), Gaps = 20/174 (11%)
Query: 117 HIITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 176
+ S+ + L+L L + R + LH G++H L+ +++L + V + F
Sbjct: 195 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 177 LESQCGSAKGFTGTYRWMAPEMIK-----------EKRHTKKVDVYSFGIVLWELLTALT 225
+ G+ + + + PE+ T D ++ G+V++ + A
Sbjct: 255 RD---GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 226 PFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279
P + + + P+ L+ + R Q +
Sbjct: 312 PITKDAALGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-31
Identities = 57/236 (24%), Positives = 100/236 (42%), Gaps = 45/236 (19%)
Query: 72 YRGIYKQ--RDVAIK---LVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--EPYS 124
K R VA+K L Q + +EV ++ H +++ + Y
Sbjct: 62 CLAREKHSGRQVAVKMMDLRKQQRRE---------LLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 125 VP---------------LNLVLKLALD---IA-------RGMQYLHSQGILHRDLKSENL 159
V ++V ++ L+ IA + + YLH+QG++HRD+KS+++
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSI 172
Query: 160 LLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 218
LL D VK++DFG + K GT WMAPE+I + +VD++S GI++
Sbjct: 173 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVI 232
Query: 219 ELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSYLISRCWSSSPDRRP 272
E++ P+ + +P QA + + + P + + R P R
Sbjct: 233 EMVDGEPPYFSDSPVQAMKRL-RDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERA 287
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-31
Identities = 40/214 (18%), Positives = 78/214 (36%), Gaps = 51/214 (23%)
Query: 66 GRHSRIYRGIYKQRDVAIKLVS-----------QPEEDASLASMLEKQFTSEVALLFRLN 114
G+ ++I + A+K + D F +E+ ++ +
Sbjct: 42 GKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK 101
Query: 115 HPHII------------------------------------TEPYSVPLNLVLKLALDIA 138
+ + + +P+ ++ + +
Sbjct: 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVL 161
Query: 139 RGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE 197
Y+H++ I HRD+K N+L+ ++ VK++DFG S KG GTY +M PE
Sbjct: 162 NSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD-KKIKGSRGTYEFMPPE 220
Query: 198 MIKEKR--HTKKVDVYSFGIVLWELLTALTPFDN 229
+ + KVD++S GI L+ + + PF
Sbjct: 221 FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-31
Identities = 65/262 (24%), Positives = 115/262 (43%), Gaps = 46/262 (17%)
Query: 47 EEEWSADMSQLF-IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQF 103
E+ + ++F + K G + +Y+ I+K+ + VAIK V E D ++
Sbjct: 20 EDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-VESD-------LQEI 71
Query: 104 TSEVALLFRLNHPHIIT--EPYSVPLNL-----------------VLKLALD---IA--- 138
E++++ + + PH++ Y +L + L IA
Sbjct: 72 IKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATIL 131
Query: 139 ----RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRW 193
+G++YLH +HRD+K+ N+LL + K+ADFG++ L GT W
Sbjct: 132 QSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFW 191
Query: 194 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV---PP 250
MAPE+I+E + D++S GI E+ P+ ++ P +A F + PP P
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP--PPTFRKPE 249
Query: 251 TCPKAFSYLISRCWSSSPDRRP 272
F+ + +C SP++R
Sbjct: 250 LWSDNFTDFVKQCLVKSPEQRA 271
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 76/266 (28%), Positives = 101/266 (37%), Gaps = 52/266 (19%)
Query: 47 EEEWSADMSQLF-IGCKFASGRHSRIYRGIYKQ--RDVAIKLVS----QPEEDASLASML 99
E + D +LF + G +Y + VAIK +S Q E
Sbjct: 45 ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD---- 100
Query: 100 EKQFTSEVALLFRLNHPHIIT--EPYSVPLNL----------------VLKLALD---IA 138
EV L +L HP+ I Y V K L IA
Sbjct: 101 ---IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA 157
Query: 139 -------RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY 191
+G+ YLHS ++HRD+K+ N+LL E VK+ DFG + S A F GT
Sbjct: 158 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA---SIMAPANSFVGTP 214
Query: 192 RWMAPEMI---KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 248
WMAPE+I E ++ KVDV+S GI EL P NM A + + Q P
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--SPA 272
Query: 249 --PPTCPKAFSYLISRCWSSSPDRRP 272
+ F + C P RP
Sbjct: 273 LQSGHWSEYFRNFVDSCLQKIPQDRP 298
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 51/277 (18%), Positives = 93/277 (33%), Gaps = 59/277 (21%)
Query: 69 SRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120
+ ++RG +K+ AIK+ + S ++ Q E +L +LNH +I+
Sbjct: 23 ANVFRGRHKKTGDLFAIKVFNN----ISFLRPVDVQM-REFEVLKKLNHKNIVKLFAIEE 77
Query: 121 EPYSVPLNLVLKLA---------------------------LDIARGMQYLHSQGILHRD 153
E + L+++ D+ GM +L GI+HR+
Sbjct: 78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRN 137
Query: 154 LKSENLLLG----EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK--------E 201
+K N++ K+ DFG + GT ++ P+M + +
Sbjct: 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQ 197
Query: 202 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 261
K++ VD++S G+ + T PF + V K P+ +
Sbjct: 198 KKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--GKPSGAISGVQKAE 255
Query: 262 RCWSSSPDRRPHFDQIVSILEGYSES-----LEQDPE 293
P + L+ LE D E
Sbjct: 256 NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-30
Identities = 26/167 (15%), Positives = 57/167 (34%), Gaps = 13/167 (7%)
Query: 119 ITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178
+ S+ + L+L L + R + LH G++H L+ +++L + V + F +
Sbjct: 202 SSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 179 SQCGSAKG--FTGTYRWMAPEMIKEKRH-----TKKVDVYSFGIVLWELLTALTPFDNMT 231
+ A M+ +H T D ++ G+ ++ + A P +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321
Query: 232 PEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 278
+ + + P P L+ + R Q +
Sbjct: 322 ALGGSEWIFRSCKNIPQP------VRALLEGFLRYPKEDRLLPLQAM 362
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 73/278 (26%), Positives = 115/278 (41%), Gaps = 62/278 (22%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDASLASMLEKQFTSEV 107
WS + + SG + + + VAIK ++ + S+ +L+ E+
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLK-----EI 64
Query: 108 ALLFRLNHPHI--------------ITEPY------------SVPLNLVLKLALD---IA 138
+ + +HP+I + V LD IA
Sbjct: 65 QAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA 124
Query: 139 -------RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKG---- 186
G++YLH G +HRD+K+ N+LLGED V++ADFG+S L + +
Sbjct: 125 TILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 187 -FTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 244
F GT WMAPE++++ R + K D++SFGI EL T P+ P + Q +
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND- 243
Query: 245 RPPVPPTCP----------KAFSYLISRCWSSSPDRRP 272
PP T K+F +IS C P++RP
Sbjct: 244 -PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 51/313 (16%), Positives = 99/313 (31%), Gaps = 56/313 (17%)
Query: 45 EGEEEWSADMSQLFIGCKFASGRHS--RIYRGIYKQRD--VAIKLVSQPEEDASLASMLE 100
+G + + + G + YK V ++ ++ + + L+
Sbjct: 15 QGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQ 74
Query: 101 KQFTSEVALLFRLNHPHI----------------------------ITEPYSVPLN---- 128
E+ + NHP+I I + +N
Sbjct: 75 G----ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAI 130
Query: 129 -LVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS---- 183
+L+ L + + Y+H G +HR +K+ ++L+ D V ++ + G
Sbjct: 131 AYILQGVL---KALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRV 187
Query: 184 ----AKGFTGTYRWMAPEMIKEKRH--TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF 237
K W++PE++++ K D+YS GI EL PF +M Q
Sbjct: 188 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 247
Query: 238 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSS 297
P + ++ S S D + + S + +
Sbjct: 248 EKLNGT--VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRT 305
Query: 298 FIPSPDHTILRCL 310
F P H + +CL
Sbjct: 306 FSPHFHHFVEQCL 318
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 56/245 (22%), Positives = 96/245 (39%), Gaps = 56/245 (22%)
Query: 72 YRGIYKQ--RDVAIKLVS-QPEEDASLASMLEKQFTSEVALLFRLNHPHI---------- 118
Y+ K+ A K++ + EE+ + E+ +L +HP+I
Sbjct: 36 YKAKNKETGALAAAKVIETKSEEELED-------YIVEIEILATCDHPYIVKLLGAYYHD 88
Query: 119 -----------------ITEPYSVPLN-----LVLKLALDIARGMQYLHSQGILHRDLKS 156
I L +V + L + +LHS+ I+HRDLK+
Sbjct: 89 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML---EALNFLHSKRIIHRDLKA 145
Query: 157 ENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMI-----KEKRHTKKVDV 210
N+L+ + +++ADFG+S F GT WMAPE++ K+ + K D+
Sbjct: 146 GNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADI 205
Query: 211 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV---PPTCPKAFSYLISRCWSSS 267
+S GI L E+ P + P + + + + PP P F + +
Sbjct: 206 WSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD--PPTLLTPSKWSVEFRDFLKIALDKN 263
Query: 268 PDRRP 272
P+ RP
Sbjct: 264 PETRP 268
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 56/262 (21%), Positives = 106/262 (40%), Gaps = 47/262 (17%)
Query: 79 RDVAIKLV--SQPEEDASLASMLEKQFTSEVALLFRLNHPHII---------------TE 121
++V +K + + ED + + T E+A+L R+ H +II E
Sbjct: 50 KEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVME 109
Query: 122 PYSVPLNL----VLKLALD----------IARGMQYLHSQGILHRDLKSENLLLGEDMCV 167
+ L+L LD + + YL + I+HRD+K EN+++ ED +
Sbjct: 110 KHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTI 169
Query: 168 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT-KKVDVYSFGIVLWELLTALTP 226
K+ DFG + + F GT + APE++ + +++++S G+ L+ L+ P
Sbjct: 170 KLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
Query: 227 FDNMTPEQAAFAVCQK--NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS---IL 281
F + ++ A P K L+S P+RR +++V+ +
Sbjct: 230 FCEL----------EETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVT 279
Query: 282 EGYSESLEQDPEFFSSFIPSPD 303
+ + + E F P
Sbjct: 280 QPVNLADYTWEEVFRVNKPESG 301
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-29
Identities = 66/268 (24%), Positives = 113/268 (42%), Gaps = 57/268 (21%)
Query: 53 DMSQLF-IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVAL 109
D + +F + +G + ++Y+G + + + AIK++ ++ E++ E+ +
Sbjct: 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-------EEEIKQEINM 73
Query: 110 LFRL-NHPHIIT--------EPYSVPLNL--------------VLKLALD-------IA- 138
L + +H +I T P + L ++K IA
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 133
Query: 139 ------RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTY 191
RG+ +LH ++HRD+K +N+LL E+ VK+ DFG+S L+ G F GT
Sbjct: 134 ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 193
Query: 192 RWMAPEMIKEKRHTK-----KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 246
WMAPE+I + K D++S GI E+ P +M P +A F + +
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--A 251
Query: 247 PV--PPTCPKAFSYLISRCWSSSPDRRP 272
P K F I C + +RP
Sbjct: 252 PRLKSKKWSKKFQSFIESCLVKNHSQRP 279
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 7e-29
Identities = 60/242 (24%), Positives = 102/242 (42%), Gaps = 33/242 (13%)
Query: 69 SRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI------ITEP 122
++ R R + +Q E+A+L +L+HP++ + +P
Sbjct: 49 KKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDP 108
Query: 123 YSVPLNLVLKLA-----LDI----------AR--------GMQYLHSQGILHRDLKSENL 159
L +V +L +++ AR G++YLH Q I+HRD+K NL
Sbjct: 109 NEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168
Query: 160 LLGEDMCVKVADFGISCL-ESQCGSAKGFTGTYRWMAPEMIKEKRHT---KKVDVYSFGI 215
L+GED +K+ADFG+S + GT +MAPE + E R K +DV++ G+
Sbjct: 169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
Query: 216 VLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFD 275
L+ + PF + + + P P + LI+R +P+ R
Sbjct: 229 TLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVP 288
Query: 276 QI 277
+I
Sbjct: 289 EI 290
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-29
Identities = 53/277 (19%), Positives = 94/277 (33%), Gaps = 59/277 (21%)
Query: 69 SRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII------- 119
+ ++RG +K+ AIK+ + S ++ Q E +L +LNH +I+
Sbjct: 23 ANVFRGRHKKTGDLFAIKVFNN----ISFLRPVDVQM-REFEVLKKLNHKNIVKLFAIEE 77
Query: 120 ----------TE----------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRD 153
E Y +P + L + D+ GM +L GI+HR+
Sbjct: 78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRN 137
Query: 154 LKSENLLLG----EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK--------E 201
+K N++ K+ DFG + GT ++ P+M + +
Sbjct: 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQ 197
Query: 202 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 261
K++ VD++S G+ + T PF + V K P+ +
Sbjct: 198 KKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG--KPSGAISGVQKAE 255
Query: 262 RCWSSSPDRRPHFDQIVSILEGYSES-----LEQDPE 293
P + L+ LE D E
Sbjct: 256 NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 114 bits (285), Expect = 3e-28
Identities = 55/249 (22%), Positives = 95/249 (38%), Gaps = 50/249 (20%)
Query: 72 YRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII-------TEP 122
R I++ VAIK Q E+ E+ ++ +LNHP+++
Sbjct: 31 LRWIHQDTGEQVAIKQCRQ----ELSPKNRERWC-LEIQIMKKLNHPNVVSAREVPDGLQ 85
Query: 123 YSVPLNL------------------------------VLKLALDIARGMQYLHSQGILHR 152
P +L + L DI+ ++YLH I+HR
Sbjct: 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHR 145
Query: 153 DLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVD 209
DLK EN++L + + K+ D G + Q F GT +++APE++++K++T VD
Sbjct: 146 DLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVD 205
Query: 210 VYSFGIVLWELLTALTPF-DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 268
+SFG + +E +T PF N P Q + + + +P
Sbjct: 206 YWSFGTLAFECITGFRPFLPNWQPVQ--WHGKVREKSNEHIVVYDDLTGAVKFSSVLPTP 263
Query: 269 DRRPHFDQI 277
+
Sbjct: 264 NHLSGILAG 272
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 59/257 (22%), Positives = 100/257 (38%), Gaps = 44/257 (17%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH--PHIIT--EPYSVPLNLVL----- 131
VAIK V + + EV LL +++ +I + + P + VL
Sbjct: 71 VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 130
Query: 132 --------------KLALDIAR--------GMQYLHSQGILHRDLKSENLLL-GEDMCVK 168
L ++AR +++ H+ G+LHRD+K EN+L+ +K
Sbjct: 131 EPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 190
Query: 169 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPF 227
+ DFG L F GT + PE I+ R H + V+S GI+L++++ PF
Sbjct: 191 LIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249
Query: 228 DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI--LEGYS 285
++ E+ + +LI C + P RP F++I + ++
Sbjct: 250 EH--DEEI------IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301
Query: 286 ESLEQDPEFFSSFIPSP 302
E S P P
Sbjct: 302 LPQETAEIHLHSLSPGP 318
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 5e-28
Identities = 54/291 (18%), Positives = 109/291 (37%), Gaps = 44/291 (15%)
Query: 45 EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQ 102
+ ++ + +G +++ +K +A KL+ + A Q
Sbjct: 23 QKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR-----NQ 77
Query: 103 FTSEVALLFRLNHPHIIT----------------------------EPYSVPLNLVLKLA 134
E+ +L N P+I+ + +P ++ K++
Sbjct: 78 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS 137
Query: 135 LDIARGMQYLHSQG-ILHRDLKSENLLLGEDMCVKVADFGISC--LESQCGSAKGFTGTY 191
+ + +G+ YL + I+HRD+K N+L+ +K+ DFG+S ++S A F GT
Sbjct: 138 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTR 194
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF-DNMTPEQAAFAVCQKNARPPVPP 250
+M+PE ++ ++ + D++S G+ L E+ P E CQ P
Sbjct: 195 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254
Query: 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD--PEFFSSFI 299
P+ +++ S F+ + I+ L F F+
Sbjct: 255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 305
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-28
Identities = 55/276 (19%), Positives = 105/276 (38%), Gaps = 83/276 (30%)
Query: 71 IYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTS----EVALLFRL-NHPHIIT--EPY 123
+++G ++ R VA+K + F E+ LL +HP++I
Sbjct: 32 VFQGSFQGRPVAVK-------------RMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE 78
Query: 124 SVPLN--LVLKLA------------------------------LDIARGMQYLHSQGILH 151
+ + L+L IA G+ +LHS I+H
Sbjct: 79 TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIH 138
Query: 152 RDLKSENLLL-------------GEDMCVKVADFGISCL-----ESQCGSAKGFTGTYRW 193
RDLK +N+L+ E++ + ++DFG+ S + +GT W
Sbjct: 139 RDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGW 198
Query: 194 MAPEMIKE-------KRHTKKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNAR 245
APE+++E +R T+ +D++S G V + +L+ PF + ++ +
Sbjct: 199 RAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSL- 257
Query: 246 PPVPPTCPKAFSY----LISRCWSSSPDRRPHFDQI 277
+ ++ LIS+ P +RP ++
Sbjct: 258 DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 67/251 (26%), Positives = 110/251 (43%), Gaps = 44/251 (17%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
K SG + + K + AIK++ + S+++ + EVA+L L+HP
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRK----TSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 117 HIIT--EPYSVPLN--LVLKL--------------------ALDIAR----GMQYLHSQG 148
+I+ + + N LV++ A I + G+ YLH
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 149 ILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT 205
I+HRDLK ENLLL +D +K+ DFG+S + K GT ++APE+++ K++
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYD 215
Query: 206 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY----LIS 261
+K DV+S G++L+ LL PF T ++ V + + K S LI
Sbjct: 216 EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV--EKGKYTFDSPEWKNVSEGAKDLIK 273
Query: 262 RCWSSSPDRRP 272
+ RR
Sbjct: 274 QMLQFDSQRRI 284
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 36/208 (17%)
Query: 100 EKQFTSEVALLFRLNHPHIIT--EPYSVP--LNLVLKLA--------------------- 134
+K +E+ +L RL+HP+II E + P ++LVL+L
Sbjct: 92 KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA 151
Query: 135 ---LDIARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFT 188
I + YLH GI+HRDLK ENLL D +K+ADFG+S + K
Sbjct: 152 DAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC 211
Query: 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA---- 244
GT + APE+++ + +VD++S GI+ + LL PF + +Q F
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI 271
Query: 245 RPPVPPTCPKAFSYLISRCWSSSPDRRP 272
P A L+ + P +R
Sbjct: 272 SPWWDEVSLNAKD-LVRKLIVLDPKKRL 298
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 32/243 (13%), Positives = 54/243 (22%), Gaps = 64/243 (26%)
Query: 64 ASGRHSRIYRG--IYKQRDVAIKLV-SQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
+ ++ R VA+ V Q + + S L R++ P +
Sbjct: 40 GGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQ----ETLSRTLRLSRIDKPGVAR 95
Query: 121 ---------EPYSV-------PLNLVL----------KLALDIARGMQYLHSQGILHRDL 154
V L V + +A H G+
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSID 155
Query: 155 KSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFG 214
+ + D V +A M + D+ G
Sbjct: 156 HPSRVRVSIDGDVVLAYPAT-------------------MPDA-------NPQDDIRGIG 189
Query: 215 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP-----TCPKAFSYLISRCWSSSPD 269
L+ LL P + A P+ P P S + +R
Sbjct: 190 ASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGG 249
Query: 270 RRP 272
R
Sbjct: 250 IRS 252
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 37/197 (18%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120
G S + R ++K + A K+++ L++ ++ E + +L HP+I+
Sbjct: 16 KGAFSVVRRCVHKTTGLEFAAKIINT----KKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 121 EPYSVPLNLVL--------------------------KLALDIARGMQYLHSQGILHRDL 154
+ L I + Y HS GI+HR+L
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNL 131
Query: 155 KSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVY 211
K ENLLL + VK+ADFG++ + + GF GT +++PE++K+ ++K VD++
Sbjct: 132 KPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIW 191
Query: 212 SFGIVLWELLTALTPFD 228
+ G++L+ LL PF
Sbjct: 192 ACGVILYILLVGYPPFW 208
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 64/278 (23%), Positives = 103/278 (37%), Gaps = 78/278 (28%)
Query: 70 RIYRGIYKQ-RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII--------- 119
++Y+G VA+K + E QF +EV ++ H +++
Sbjct: 45 KVYKGRLADGTLVAVKRLK-----EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99
Query: 120 ---------------------TEPYSVPLNLV--LKLALDIARGMQYLHSQG---ILHRD 153
PL+ ++AL ARG+ YLH I+HRD
Sbjct: 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRD 159
Query: 154 LKSENLLLGEDMCVKVADFGISCLESQCGSAK----GFT-------GTYRWMAPEMIKEK 202
+K+ N+LL E+ V DFG+ AK T GT +APE +
Sbjct: 160 VKAANILLDEEFEAVVGDFGL---------AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 210
Query: 203 RHTKKVDVYSFGIVLWELLTALTPFDNMTP---------EQAAFAVCQKNARPPVPPTCP 253
+ ++K DV+ +G++L EL+T FD + + +K V
Sbjct: 211 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQ 270
Query: 254 KAFSY--------LISRCWSSSPDRRPHFDQIVSILEG 283
+ + C SSP RP ++V +LEG
Sbjct: 271 GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 51/197 (25%), Positives = 91/197 (46%), Gaps = 40/197 (20%)
Query: 65 SGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120
SG S ++ + + A+K + + + + +E+A+L ++ H +I+T
Sbjct: 19 SGAFSEVFLVKQRLTGKLFALKCIKK----SPAFR--DSSLENEIAVLKKIKHENIVTLE 72
Query: 121 EPYSVPLN--LVLKLA------------------------LDIARGMQYLHSQGILHRDL 154
+ Y + LV++L + ++YLH GI+HRDL
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDL 132
Query: 155 KSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVY 211
K ENLL E+ + + DFG+S +E G GT ++APE++ +K ++K VD +
Sbjct: 133 KPENLLYLTPEENSKIMITDFGLSKMEQN-GIMSTACGTPGYVAPEVLAQKPYSKAVDCW 191
Query: 212 SFGIVLWELLTALTPFD 228
S G++ + LL PF
Sbjct: 192 SIGVITYILLCGYPPFY 208
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-27
Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 37/207 (17%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVS--QPEEDASLASMLEKQFTSEVALLFRLN 114
+ SG + ++ + VAI+++S + ++ + +E+ +L +LN
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 115 HPHIIT--EPYSVP-LNLVLKLA------------------------LDIARGMQYLHSQ 147
HP II + +VL+L + +QYLH
Sbjct: 199 HPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 258
Query: 148 GILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE--- 201
GI+HRDLK EN+LL ED +K+ DFG S + + + GT ++APE++
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGT 318
Query: 202 KRHTKKVDVYSFGIVLWELLTALTPFD 228
+ + VD +S G++L+ L+ PF
Sbjct: 319 AGYNRAVDCWSLGVILFICLSGYPPFS 345
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-27
Identities = 57/234 (24%), Positives = 90/234 (38%), Gaps = 48/234 (20%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN----HPHIIT--EPYSVPLNLVL--- 131
VAIK++ + EVALL+++ HP +I + + +L
Sbjct: 59 VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLE 118
Query: 132 ----------------KLALDIAR--------GMQYLHSQGILHRDLKSENLLL-GEDMC 166
L +R +Q+ HS+G++HRD+K EN+L+ C
Sbjct: 119 RPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC 178
Query: 167 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALT 225
K+ DFG L F GT + PE I + H V+S GI+L++++
Sbjct: 179 AKLIDFGSGAL-LHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237
Query: 226 PFDNMTPEQAAFAVCQK--NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 277
PF+ Q+ A P LI RC + P RP ++I
Sbjct: 238 PFERD----------QEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEI 281
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-27
Identities = 60/257 (23%), Positives = 107/257 (41%), Gaps = 45/257 (17%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVS-------QPEEDASLASMLEKQFTSEVAL 109
K SG + + K + AIK++ + +D ++ +E++L
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 110 LFRLNHPHIIT--EPYSVPLN--LVLKL--------------------ALDIAR----GM 141
L L+HP+II + + LV + A +I + G+
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGI 159
Query: 142 QYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEM 198
YLH I+HRD+K EN+LL + +K+ DFG+S S+ + GT ++APE+
Sbjct: 160 CYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEV 219
Query: 199 IKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN---ARPPVPPTCPKA 255
+K K++ +K DV+S G++++ LL PF + V + +A
Sbjct: 220 LK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEA 278
Query: 256 FSYLISRCWSSSPDRRP 272
LI + ++R
Sbjct: 279 KE-LIKLMLTYDYNKRC 294
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 53/243 (21%), Positives = 91/243 (37%), Gaps = 60/243 (24%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITEPYSVPLN-------LVL-- 131
A+K++ + + E E+ LL RL H ++I + V N +V+
Sbjct: 33 RAVKILKK--KKLRRIPNGEANVKKEIQLLRRLRHKNVI-QLVDVLYNEEKQKMYMVMEY 89
Query: 132 ---------------KLALDIAR--------GMQYLHSQGILHRDLKSENLLLGEDMCVK 168
+ + A G++YLHSQGI+H+D+K NLLL +K
Sbjct: 90 CVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLK 149
Query: 169 VADFGIS----------CLESQCGSAKGFTGTYRWMAPEMIKEKR--HTKKVDVYSFGIV 216
++ G++ + GS + PE+ KVD++S G+
Sbjct: 150 ISALGVAEALHPFAADDTCRTSQGSP-----AF--QPPEIANGLDTFSGFKVDIWSAGVT 202
Query: 217 LWELLTALTPFDNMTPEQAAFAVCQK--NARPPVPPTCPKAFSYLISRCWSSSPDRRPHF 274
L+ + T L PF+ + + + +P C S L+ P +R
Sbjct: 203 LYNITTGLYPFE----GDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSI 258
Query: 275 DQI 277
QI
Sbjct: 259 RQI 261
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 37/139 (26%), Positives = 65/139 (46%), Gaps = 4/139 (2%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAP 196
+ + YL +Q I+HRD+K +N+LL E V + DF I+ + + GT +MAP
Sbjct: 124 LVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAP 183
Query: 197 EMIKEKR---HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ-KNARPPVPPTC 252
EM ++ ++ VD +S G+ +ELL P+ + + V + P
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAW 243
Query: 253 PKAFSYLISRCWSSSPDRR 271
+ L+ + +PD+R
Sbjct: 244 SQEMVSLLKKLLEPNPDQR 262
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 57/266 (21%), Positives = 107/266 (40%), Gaps = 44/266 (16%)
Query: 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQF 103
G + + A+++ L + SG ++++ +++ +A+K + S K+
Sbjct: 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-----RRSGNKEENKRI 70
Query: 104 TSEVALLFRL-NHPHIIT----------------------------EPYSVPLNLVLKLA 134
++ ++ + + P+I+ +P ++ K+
Sbjct: 71 LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMT 130
Query: 135 LDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW 193
+ I + + YL + G++HRD+K N+LL E +K+ DFGIS + G +
Sbjct: 131 VAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAY 190
Query: 194 MAPEMIKEKRHTK-----KVDVYSFGIVLWELLTALTPFDNMTPE-QAAFAVCQKNA-RP 246
MAPE I TK + DV+S GI L EL T P+ N + + V Q+
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL 250
Query: 247 PVPPTCPKAFSYLISRCWSSSPDRRP 272
P F + C + +RP
Sbjct: 251 PGHMGFSGDFQSFVKDCLTKDHRKRP 276
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 54/229 (23%), Positives = 99/229 (43%), Gaps = 41/229 (17%)
Query: 37 SSGAEIKGEGEEEWSADMSQLF----IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPE 90
+G + G G E ++ + + G S + R ++K + A K+++
Sbjct: 7 MTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-- 64
Query: 91 EDASLASMLEKQFTSEVALLFRLNHPHIIT--EPYSVPLNLVL----------------- 131
L++ ++ E + +L HP+I+ + L
Sbjct: 65 --KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR 122
Query: 132 ---------KLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLES 179
I + Y HS GI+HR+LK ENLLL + VK+ADFG++ +
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182
Query: 180 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 228
+ GF GT +++PE++K+ ++K VD+++ G++L+ LL PF
Sbjct: 183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 231
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 49/211 (23%), Positives = 95/211 (45%), Gaps = 35/211 (16%)
Query: 52 ADMSQLF-IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVA 108
+ + + +G + SG+ + + + K ++ A K + + +S + ++ EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 109 LLFRLNHPHIIT--EPYSVPLNLVL--------------------------KLALDIARG 140
+L + HP+IIT + + ++VL + I G
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 141 MQYLHSQGILHRDLKSENLLL----GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAP 196
+ YLHS+ I H DLK EN++L + +K+ DFGI+ K GT ++AP
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180
Query: 197 EMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
E++ + + D++S G++ + LL+ +PF
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASPF 211
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 61/250 (24%), Positives = 100/250 (40%), Gaps = 41/250 (16%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
G + K ++ A+K++S+ ++ EV LL +L+HP
Sbjct: 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISK---RQVKQKTDKESLLREVQLLKQLDHP 86
Query: 117 HIIT--EPYSVPLN--LVLKL--------------------ALDIAR----GMQYLHSQG 148
+I+ E + LV ++ A I R G+ Y+H
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 149 ILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT 205
I+HRDLK ENLLL +D +++ DFG+S K GT ++APE++ +
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-GTYD 205
Query: 206 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN---ARPPVPPTCPKAFSYLISR 262
+K DV+S G++L+ LL+ PF+ V + P A LI +
Sbjct: 206 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD-LIRK 264
Query: 263 CWSSSPDRRP 272
+ P R
Sbjct: 265 MLTYVPSMRI 274
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 72/262 (27%), Positives = 110/262 (41%), Gaps = 41/262 (15%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITEPYSV-----PLNLVL---- 131
VA+K +S+ S M + E++ L L HPHII + Y V + +V+
Sbjct: 37 VALKFISRQLLKKS--DMHMRVER-EISYLKLLRHPHII-KLYDVITTPTDIVMVIEYAG 92
Query: 132 -----------KLALDIAR--------GMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 172
++ D R ++Y H I+HRDLK ENLLL +++ VK+ADF
Sbjct: 93 GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADF 152
Query: 173 GISCLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMT 231
G+S + + K G+ + APE+I K +VDV+S GIVL+ +L PFD+
Sbjct: 153 GLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212
Query: 232 PEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS---ILEGYSESL 288
V + +P LI R + P +R +I + L
Sbjct: 213 IPNLFKKV--NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYL 270
Query: 289 EQDPEFFSSFIPSPDHTILRCL 310
E S+ D I+ L
Sbjct: 271 RPMEEVQGSYA---DSRIVSKL 289
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 40/210 (19%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEK---QFTSEVALLFRLN-HPHI 118
G S + R I+K ++ A+K++ + A +++ EV +L +++ HP+I
Sbjct: 27 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86
Query: 119 IT--EPYSVPLN--LVLKLA-----LD-------------------IARGMQYLHSQGIL 150
I + Y LV L D + + LH I+
Sbjct: 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIV 146
Query: 151 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK------EKRH 204
HRDLK EN+LL +DM +K+ DFG SC + GT ++APE+I+ +
Sbjct: 147 HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY 206
Query: 205 TKKVDVYSFGIVLWELLTALTPFDNMTPEQ 234
K+VD++S G++++ LL PF +
Sbjct: 207 GKEVDMWSTGVIMYTLLAGSPPFWHRKQML 236
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 63/250 (25%), Positives = 104/250 (41%), Gaps = 42/250 (16%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
I C G + + + ++ A+K++++ AS + EV LL +L+HP
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINK----ASAKNKDTSTILREVELLKKLDHP 81
Query: 117 HIIT--EPYSVPLN--LVLKL--------------------ALDIAR----GMQYLHSQG 148
+I+ E + +V +L A I + G+ Y+H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 149 ILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT 205
I+HRDLK EN+LL +D +K+ DFG+S Q K GT ++APE+++ +
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTYD 200
Query: 206 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN---ARPPVPPTCPKAFSYLISR 262
+K DV+S G++L+ LL+ PF V P A LI +
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD-LIRK 259
Query: 263 CWSSSPDRRP 272
+ P R
Sbjct: 260 MLTFHPSLRI 269
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-26
Identities = 59/262 (22%), Positives = 101/262 (38%), Gaps = 47/262 (17%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITEPYSVPLN-----LVL---- 131
VA+K+V E E+ + LNH +++ + Y L L
Sbjct: 35 VAVKIVDM----KRAVDCPENIKK-EICINKMLNHENVV-KFYGHRREGNIQYLFLEYCS 88
Query: 132 ------------KLALDIAR--------GMQYLHSQGILHRDLKSENLLLGEDMCVKVAD 171
+ A+ G+ YLH GI HRD+K ENLLL E +K++D
Sbjct: 89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISD 148
Query: 172 FGISCLESQCGSAKGF--T--GTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTP 226
FG++ + + + + GT ++APE++K + H + VDV+S GIVL +L P
Sbjct: 149 FGLATV-FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
Query: 227 FDNMTPEQAAFA--VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS---IL 281
+D + ++ +K P + L+ + +P R I
Sbjct: 208 WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA-LLHKILVENPSARITIPDIKKDRWYN 266
Query: 282 EGYSESLEQDPEFFSSFIPSPD 303
+ + ++ SP
Sbjct: 267 KPLKKGAKRPRVTSGGVSESPS 288
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-26
Identities = 49/181 (27%), Positives = 79/181 (43%), Gaps = 34/181 (18%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITEPYSV-----PLNLVL- 131
VA+K++ + + + E+ L HPHII + Y V +V+
Sbjct: 36 GHKVAVKIL---NRQKIRSLDVVGKIKREIQNLKLFRHPHII-KLYQVISTPTDFFMVME 91
Query: 132 ---------------KLALDIAR--------GMQYLHSQGILHRDLKSENLLLGEDMCVK 168
++ AR + Y H ++HRDLK EN+LL M K
Sbjct: 92 YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAK 151
Query: 169 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPF 227
+ADFG+S + S + G+ + APE+I + +VD++S G++L+ LL PF
Sbjct: 152 IADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF 211
Query: 228 D 228
D
Sbjct: 212 D 212
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 38/101 (37%), Positives = 62/101 (61%), Gaps = 3/101 (2%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG---ISCLESQCGSAKGFTGTYRW 193
I ++YLH +GI+HRDLK EN+LL EDM +++ DFG + ES+ A F GT ++
Sbjct: 139 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198
Query: 194 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 234
++PE++ EK K D+++ G ++++L+ L PF
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-26
Identities = 57/233 (24%), Positives = 95/233 (40%), Gaps = 44/233 (18%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITEPYSVPLN-----LVL---- 131
VA+K+V E E+ + LNH +++ + Y L L
Sbjct: 35 VAVKIVDM----KRAVDCPENIKK-EICINKMLNHENVV-KFYGHRREGNIQYLFLEYCS 88
Query: 132 ------------KLALDIAR--------GMQYLHSQGILHRDLKSENLLLGEDMCVKVAD 171
+ A+ G+ YLH GI HRD+K ENLLL E +K++D
Sbjct: 89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISD 148
Query: 172 FGISCLESQCGSAKGF--T--GTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTP 226
FG++ + + + + GT ++APE++K + H + VDV+S GIVL +L P
Sbjct: 149 FGLATV-FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
Query: 227 FDNMTPEQAAFA--VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 277
+D + ++ +K P + L+ + +P R I
Sbjct: 208 WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA-LLHKILVENPSARITIPDI 259
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 53/187 (28%), Positives = 81/187 (43%), Gaps = 43/187 (22%)
Query: 81 VAIK------LVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--EPYSVP-LNLVL 131
VAIK +A A +E E+ +L +LNHP II + +VL
Sbjct: 38 VAIKIISKRKFAIGSAREADPALNVET----EIEILKKLNHPCIIKIKNFFDAEDYYIVL 93
Query: 132 KLA------------------------LDIARGMQYLHSQGILHRDLKSENLLL---GED 164
+L + +QYLH GI+HRDLK EN+LL ED
Sbjct: 94 ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 153
Query: 165 MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE---KRHTKKVDVYSFGIVLWELL 221
+K+ DFG S + + + GT ++APE++ + + VD +S G++L+ L
Sbjct: 154 CLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 213
Query: 222 TALTPFD 228
+ PF
Sbjct: 214 SGYPPFS 220
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 34/203 (16%)
Query: 59 IGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
IG + SG+ + + + K + A K + + + AS + ++ EV++L ++ HP
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 117 HIIT--EPYSVPLNLVL--------------------------KLALDIARGMQYLHSQG 148
+IIT + Y ++VL I G+ YLH++
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 149 ILHRDLKSENLLL----GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH 204
I H DLK EN++L +K+ DFG++ K GT ++APE++ +
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 205 TKKVDVYSFGIVLWELLTALTPF 227
+ D++S G++ + LL+ +PF
Sbjct: 196 GLEADMWSIGVITYILLSGASPF 218
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 52/202 (25%), Positives = 83/202 (41%), Gaps = 39/202 (19%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120
G S + R I ++ + A+K+V + +S E E ++ L HPHI+
Sbjct: 34 KGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED-LKREASICHMLKHPHIVELL 92
Query: 121 EPYSVPLNLVL------------------------------KLALDIARGMQYLHSQGIL 150
E YS L + I ++Y H I+
Sbjct: 93 ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNII 152
Query: 151 HRDLKSENLLL---GEDMCVKVADFGISCLESQCGSA-KGFTGTYRWMAPEMIKEKRHTK 206
HRD+K +LL VK+ FG++ + G G GT +MAPE++K + + K
Sbjct: 153 HRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGK 212
Query: 207 KVDVYSFGIVLWELLTALTPFD 228
VDV+ G++L+ LL+ PF
Sbjct: 213 PVDVWGCGVILFILLSGCLPFY 234
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 34/203 (16%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
IG + SG+ + + + K + A K + + + AS + ++ EV++L ++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 117 HIIT--EPYSVPLNLVL--------------------------KLALDIARGMQYLHSQG 148
++IT + Y ++VL I G+ YLH++
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 149 ILHRDLKSENLLL----GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH 204
I H DLK EN++L +K+ DFG++ K GT ++APE++ +
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 205 TKKVDVYSFGIVLWELLTALTPF 227
+ D++S G++ + LL+ +PF
Sbjct: 196 GLEADMWSIGVITYILLSGASPF 218
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 38/203 (18%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
I C G + + + ++ A+K++++ AS + EV LL +L+HP
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINK----ASAKNKDTSTILREVELLKKLDHP 81
Query: 117 HIIT--EPYSVPLN--LVLKLA-----LD-------------------IARGMQYLHSQG 148
+I+ E + +V +L D + G+ Y+H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 149 ILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT 205
I+HRDLK EN+LL +D +K+ DFG+S Q K GT ++APE+++ +
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTYD 200
Query: 206 KKVDVYSFGIVLWELLTALTPFD 228
+K DV+S G++L+ LL+ PF
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFY 223
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 53/216 (24%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASM--LEKQFTSEVALLFRL-NHPHII 119
G S + R +++ + A+K++ E S + + + E +L ++ HPHII
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163
Query: 120 T--EPYSVPLN--LVLKLA-----LD-------------------IARGMQYLHSQGILH 151
T + Y LV L D + + +LH+ I+H
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVH 223
Query: 152 RDLKSENLLLGEDMCVKVADFGISC-------LESQCGSAKGFTGTYRWMAPEMIK---- 200
RDLK EN+LL ++M ++++DFG SC L CG+ Y +APE++K
Sbjct: 224 RDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTP-----GY--LAPEILKCSMD 276
Query: 201 --EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 234
+ K+VD+++ G++L+ LL PF +
Sbjct: 277 ETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL 312
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 32/193 (16%), Positives = 64/193 (33%), Gaps = 20/193 (10%)
Query: 109 LLFRLNHPHIITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC-- 166
LL +N E +P LV+ A+ + ++ +H I+H D+K +N +LG
Sbjct: 154 LLNAINLYKNTPEK-VMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQ 212
Query: 167 ---------VKVADFGISC---LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFG 214
+ + D G S L + T + EM+ K ++D +
Sbjct: 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVA 272
Query: 215 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHF 274
++ +L + + R P + F +++ P
Sbjct: 273 ATVYCMLFGTYMKVKNEGGECKPEGLFR--RLPHLDMWNEFFHVMLN---IPDCHHLPSL 327
Query: 275 DQIVSILEGYSES 287
D + L+ +
Sbjct: 328 DLLRQKLKKVFQQ 340
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 48/203 (23%), Positives = 87/203 (42%), Gaps = 34/203 (16%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
G + SG+ + + + K A K + + +S + + EV++L + HP
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 117 HIIT--EPYSVPLNLVL--------------------------KLALDIARGMQYLHSQG 148
++IT E Y +++L + I G+ YLHS
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 149 ILHRDLKSENLLL----GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH 204
I H DLK EN++L +K+ DFG++ K GT ++APE++ +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 205 TKKVDVYSFGIVLWELLTALTPF 227
+ D++S G++ + LL+ +PF
Sbjct: 195 GLEADMWSIGVITYILLSGASPF 217
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 58/289 (20%), Positives = 111/289 (38%), Gaps = 57/289 (19%)
Query: 36 VSSGAEIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDA 93
+ S ++K E+ W L + G + + + ++K + +A+K + +
Sbjct: 3 IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-----RS 57
Query: 94 SLASMLEKQFTSEVALLFRL-NHPHIIT-------------------------------- 120
++ +KQ ++ ++ R + P+I+
Sbjct: 58 TVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSV 117
Query: 121 EPYSVPLNLVLKLALDIARGMQYLHSQG-ILHRDLKSENLLLGEDMCVKVADFGIS-CLE 178
+P ++ K+ L + + +L I+HRD+K N+LL +K+ DFGIS L
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177
Query: 179 SQCGSAKGFT-GTYRWMAPEMIKEKRHTK----KVDVYSFGIVLWELLTALTPFDNM-TP 232
AK G +MAPE I + + DV+S GI L+EL T P+ +
Sbjct: 178 DS--IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV 235
Query: 233 EQAAFAVCQKNARPPVPPTCP-----KAFSYLISRCWSSSPDRRPHFDQ 276
V + + PP +F ++ C + +RP + +
Sbjct: 236 FDQLTQVVKGD--PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 60/212 (28%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT- 120
G +S R I+K + A+K++ + + D + E+ +L R HP+IIT
Sbjct: 32 VGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT----------EEIEILLRYGQHPNIITL 81
Query: 121 -EPYSVPLN--LVLKLA------------------------LDIARGMQYLHSQGILHRD 153
+ Y +V +L I + ++YLH+QG++HRD
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRD 141
Query: 154 LKSENLLL----GEDMCVKVADFGIS--------CLESQCGSAKGFTGTYRWMAPEMIKE 201
LK N+L G +++ DFG + L + C +A + +APE+++
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTA-----NF--VAPEVLER 194
Query: 202 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPE 233
+ + D++S G++L+ +LT TPF N +
Sbjct: 195 QGYDAACDIWSLGVLLYTMLTGYTPFANGPDD 226
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-25
Identities = 36/160 (22%), Positives = 69/160 (43%), Gaps = 32/160 (20%)
Query: 100 EKQFTSEVALLFRLNHPHIIT--EPYSVPLN--LVLKLA-----LD-------------- 136
+F E+ ++ L+HP+II E + + LV++L +
Sbjct: 50 VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA 109
Query: 137 -----IARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFT 188
+ + Y H + HRDLK EN L D +K+ DFG++ +
Sbjct: 110 RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV 169
Query: 189 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 228
GT +++P++++ + + D +S G++++ LL PF
Sbjct: 170 GTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFS 208
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 33/94 (35%), Positives = 59/94 (62%), Gaps = 1/94 (1%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-AKGFTGTYRWMA 195
I G+++LH + I++RDLK EN+LL +D V+++D G++ + KG+ GT +MA
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 196 PEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 229
PE++ + + VD ++ G+ L+E++ A PF
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 48/198 (24%), Positives = 93/198 (46%), Gaps = 38/198 (19%)
Query: 65 SGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120
G S + R + ++ A +++ L++ ++ E + L HP+I+
Sbjct: 21 KGAFSVVRRCVKVLAGQEYAAMIINT----KKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 121 EPYSVPLN--LVLKLA-----LD--IARG-----------------MQYLHSQGILHRDL 154
+ S + L+ L + +AR + + H G++HR+L
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNL 136
Query: 155 KSENLLL---GEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 210
K ENLLL + VK+ADFG++ +E + + GF GT +++PE++++ + K VD+
Sbjct: 137 KPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDL 196
Query: 211 YSFGIVLWELLTALTPFD 228
++ G++L+ LL PF
Sbjct: 197 WACGVILYILLVGYPPFW 214
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-24
Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 12/170 (7%)
Query: 113 LNHPHIITEPYSVPLNLVLKLALDIARGMQYLHSQG-ILHRDLKSENLLLGEDMCVKVAD 171
++ I E + K+A+ I + +++LHS+ ++HRD+K N+L+ VK+ D
Sbjct: 100 IDKGQTIPEDI------LGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCD 153
Query: 172 FGISCLESQCGSAKGFTGTYRWMAPEMIK----EKRHTKKVDVYSFGIVLWELLTALTPF 227
FGIS + G +MAPE I +K ++ K D++S GI + EL P+
Sbjct: 154 FGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 213
Query: 228 DNM-TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQ 276
D+ TP Q V ++ + F S+C + RP + +
Sbjct: 214 DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 34/181 (18%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITEPYSV-----PLNLVL- 131
VA+K++++ + + ++ K E+ L HPHII + Y V + +V+
Sbjct: 41 GHKVAVKILNRQKIRSL--DVVGKIRR-EIQNLKLFRHPHII-KLYQVISTPSDIFMVME 96
Query: 132 ---------------KLALDIAR--------GMQYLHSQGILHRDLKSENLLLGEDMCVK 168
+L +R G+ Y H ++HRDLK EN+LL M K
Sbjct: 97 YVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAK 156
Query: 169 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPF 227
+ADFG+S + S + G+ + APE+I + +VD++S G++L+ LL PF
Sbjct: 157 IADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF 216
Query: 228 D 228
D
Sbjct: 217 D 217
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 32/93 (34%), Positives = 59/93 (63%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAP 196
I G++ LH + I++RDLK EN+LL + ++++D G++ + + KG GT +MAP
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAP 354
Query: 197 EMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 229
E++K +R+T D ++ G +L+E++ +PF
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-24
Identities = 45/224 (20%), Positives = 91/224 (40%), Gaps = 64/224 (28%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT- 120
G + ++ +++ + A+KL+ + EV ++ PHI+
Sbjct: 39 LGVNGKVLECFHRRTGQKCALKLLYD-----------SPKARQEVDHHWQASGGPHIVCI 87
Query: 121 -------EPYSVPLNLVL--------------------------KLALDIARGMQYLHSQ 147
L +++ ++ DI +Q+LHS
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH 147
Query: 148 GILHRDLKSENLLL---GEDMCVKVADFGIS------CLESQCGSAKGFTGTYRWMAPEM 198
I HRD+K ENLL +D +K+ DFG + L++ C + Y +APE+
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTP-----YY--VAPEV 200
Query: 199 IKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 242
+ +++ K D++S G++++ LL PF + T + + + ++
Sbjct: 201 LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR 244
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 8e-24
Identities = 39/95 (41%), Positives = 62/95 (65%), Gaps = 3/95 (3%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWM 194
+A + +LHS GI++RDLK EN+LL E+ +K+ DFG+ ES K ++ GT +M
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL-SKESIDHEKKAYSFCGTVEYM 193
Query: 195 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 229
APE++ + HT+ D +SFG++++E+LT PF
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-23
Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 23/171 (13%)
Query: 109 LLFRLNHPHIITEP----YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED 164
L F L+ + TE Y +I ++YLHS+ +++RD+K ENL+L +D
Sbjct: 92 LFFHLSRERVFTEERARFY----------GAEIVSALEYLHSRDVVYRDIKLENLMLDKD 141
Query: 165 MCVKVADFGISCLE--SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT 222
+K+ DFG+ C E S + K F GT ++APE++++ + + VD + G+V++E++
Sbjct: 142 GHIKITDFGL-CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 223 ALTPFDNMTPEQAAFAVCQK--NARPPVPPTCPKAFSYLISRCWSSSPDRR 271
PF N E+ + + P T L++ P +R
Sbjct: 201 GRLPFYNQDHER----LFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-23
Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 47/203 (23%)
Query: 65 SGRHSRIYRGIYK--QRDVAIKLV--SQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
SG ++ + + IK + + + +Q +E+ +L L+HP+II
Sbjct: 32 SGAFGDVHLVEERSSGLERVIKTINKDRSQVP-------MEQIEAEIEVLKSLDHPNIIK 84
Query: 121 --EPYSVPLNLVL------------------------------KLALDIARGMQYLHSQG 148
E + N+ + +L + + Y HSQ
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144
Query: 149 ILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT 205
++H+DLK EN+L +K+ DFG++ L + GT +MAPE+ K + T
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVT 203
Query: 206 KKVDVYSFGIVLWELLTALTPFD 228
K D++S G+V++ LLT PF
Sbjct: 204 FKCDIWSAGVVMYFLLTGCLPFT 226
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-23
Identities = 35/100 (35%), Positives = 59/100 (59%), Gaps = 3/100 (3%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWM 194
I + +LH +GI++RDLK +N+LL + K+ADFG+ C E C T GT ++
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM-CKEGICNGVTTATFCGTPDYI 191
Query: 195 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 234
APE+++E + VD ++ G++L+E+L PF+ +
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD 231
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-23
Identities = 35/202 (17%), Positives = 71/202 (35%), Gaps = 40/202 (19%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
I G ++R + + K V D + E+++L H
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-------QVLVKKEISILNIARHR 61
Query: 117 HIIT--EPYSVPLNLVL---------------------------KLALDIARGMQYLHSQ 147
+I+ E + LV+ + +Q+LHS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 148 GILHRDLKSENLLLG--EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT 205
I H D++ EN++ +K+ +FG + + + + APE+ + +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 206 KKVDVYSFGIVLWELLTALTPF 227
D++S G +++ LL+ + PF
Sbjct: 182 TATDMWSLGTLVYVLLSGINPF 203
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-23
Identities = 42/200 (21%), Positives = 83/200 (41%), Gaps = 46/200 (23%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVS-QPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT 120
G S + ++K+ + A+K++S + E + E+ L HP+I+
Sbjct: 21 EGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ----------KEITALKLCEGHPNIVK 70
Query: 121 --EPYSVPLNLVL--------------------------KLALDIARGMQYLHSQGILHR 152
E + L+ L + + + ++H G++HR
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 153 DLKSENLLL---GEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 208
DLK ENLL +++ +K+ DFG + K T + APE++ + + +
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESC 190
Query: 209 DVYSFGIVLWELLTALTPFD 228
D++S G++L+ +L+ PF
Sbjct: 191 DLWSLGVILYTMLSGQVPFQ 210
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 2e-23
Identities = 36/95 (37%), Positives = 56/95 (58%), Gaps = 3/95 (3%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWM 194
I+ + +LH +GI++RDLK EN++L VK+ DFG+ C ES T GT +M
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL-CKESIHDGTVTHTFCGTIEYM 188
Query: 195 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 229
APE++ H + VD +S G +++++LT PF
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-23
Identities = 36/100 (36%), Positives = 59/100 (59%), Gaps = 3/100 (3%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWM 194
IA + YLHS I++RDLK EN+LL + + DFG+ C E+ ++ T GT ++
Sbjct: 148 IASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL-CKENIEHNSTTSTFCGTPEYL 206
Query: 195 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 234
APE++ ++ + + VD + G VL+E+L L PF + +
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 246
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-23
Identities = 50/142 (35%), Positives = 83/142 (58%), Gaps = 9/142 (6%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTY 191
A +I G+Q+LHS+GI++RDLK +N+LL +D +K+ADFG+ C E+ G AK T GT
Sbjct: 124 AAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGM-CKENMLGDAKTNTFCGTP 182
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK--NARPPVP 249
++APE++ +++ VD +SFG++L+E+L +PF E+ + P P
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE----LFHSIRMDNPFYP 238
Query: 250 PTCPKAFSYLISRCWSSSPDRR 271
K L+ + + P++R
Sbjct: 239 RWLEKEAKDLLVKLFVREPEKR 260
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-23
Identities = 38/98 (38%), Positives = 64/98 (65%), Gaps = 3/98 (3%)
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTY 191
A +IA G+ +L S+GI++RDLK +N++L + +K+ADFG+ C E+ T GT
Sbjct: 127 AAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM-CKENIWDGVTTKTFCGTP 185
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 229
++APE+I + + K VD ++FG++L+E+L PF+
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 4e-23
Identities = 30/92 (32%), Positives = 56/92 (60%), Gaps = 2/92 (2%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAP 196
I G++++H++ +++RDLK N+LL E V+++D G++C + GT+ +MAP
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAP 359
Query: 197 EMI-KEKRHTKKVDVYSFGIVLWELLTALTPF 227
E++ K + D +S G +L++LL +PF
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-23
Identities = 47/180 (26%), Positives = 75/180 (41%), Gaps = 40/180 (22%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITEPYSVPLN-----LVL---- 131
VA+K + + + +++ E+ L HP+I+ V L +++
Sbjct: 48 VAVKYIER-------GAAIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIIMEYAS 99
Query: 132 ------------KLALDIAR--------GMQYLHSQGILHRDLKSENLLLGED--MCVKV 169
+ + D AR G+ Y HS I HRDLK EN LL +K+
Sbjct: 100 GGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKI 159
Query: 170 ADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFD 228
DFG S K GT ++APE++ + K DV+S G+ L+ +L PF+
Sbjct: 160 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-23
Identities = 31/100 (31%), Positives = 60/100 (60%), Gaps = 3/100 (3%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWM 194
I+ + YLH +GI++RDLK +N+LL + +K+ D+G+ C E T GT ++
Sbjct: 119 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM-CKEGLRPGDTTSTFCGTPNYI 177
Query: 195 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 234
APE+++ + + VD ++ G++++E++ +PFD +
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 31/104 (29%), Positives = 60/104 (57%), Gaps = 3/104 (2%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWM 194
I+ + YLH +GI++RDLK +N+LL + +K+ D+G+ C E T GT ++
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM-CKEGLRPGDTTSTFCGTPNYI 220
Query: 195 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA 238
APE+++ + + VD ++ G++++E++ +PFD +
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 41/203 (20%), Positives = 84/203 (41%), Gaps = 41/203 (20%)
Query: 59 IGCKFASGRHSRIYRGIYK--QRDVAIKLVS-QPEEDASLASMLEKQFTSEVALLFRLNH 115
I + SG ++R + K R K ++ D + +E++++ +L+H
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-------KYTVKNEISIMNQLHH 107
Query: 116 PHIIT--EPYSVPLNLVL---------------------------KLALDIARGMQYLHS 146
P +I + + +VL G++++H
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167
Query: 147 QGILHRDLKSENLLLG--EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH 204
I+H D+K EN++ + VK+ DFG++ + K T T + APE++ +
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 227
Query: 205 TKKVDVYSFGIVLWELLTALTPF 227
D+++ G++ + LL+ L+PF
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPF 250
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 42/123 (34%), Positives = 73/123 (59%), Gaps = 9/123 (7%)
Query: 109 LLFRLNHPHIITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 168
L++ + EP++V A +IA G+ +L S+GI++RDLK +N++L + +K
Sbjct: 429 LMYHIQQVGRFKEPHAV------FYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 482
Query: 169 VADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP 226
+ADFG+ C E+ T GT ++APE+I + + K VD ++FG++L+E+L P
Sbjct: 483 IADFGM-CKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
Query: 227 FDN 229
F+
Sbjct: 542 FEG 544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 44/141 (31%), Positives = 74/141 (52%), Gaps = 6/141 (4%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWM 194
I +++LH GI++RD+K EN+LL + V + DFG+S + + A F GT +M
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 195 APEMIKEKR--HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK--NARPPVPP 250
AP++++ H K VD +S G++++ELLT +PF + + + ++ + PP P
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 287
Query: 251 TCPKAFSYLISRCWSSSPDRR 271
LI R P +R
Sbjct: 288 EMSALAKDLIQRLLMKDPKKR 308
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 2e-22
Identities = 34/98 (34%), Positives = 59/98 (60%), Gaps = 2/98 (2%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAP 196
+ ++YLHS+ I++RDLK EN+LL ++ +K+ DFG + GT ++AP
Sbjct: 115 VCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAP 172
Query: 197 EMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 234
E++ K + K +D +SFGI+++E+L TPF + +
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-22
Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 2/98 (2%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAP 196
I +YLHS +++RDLK ENLL+ + ++V DFG + G GT +AP
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF-AKRVK-GRTWTLCGTPEALAP 207
Query: 197 EMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 234
E+I K + K VD ++ G++++E+ PF P Q
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-22
Identities = 46/206 (22%), Positives = 81/206 (39%), Gaps = 40/206 (19%)
Query: 58 FIGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH 115
+ G+ + + + I K ++ A K + + + + E+A+L
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILH----EIAVLELAKS 87
Query: 116 -PHIIT--EPYSVPLNLVL----------------------------KLALDIARGMQYL 144
P +I E Y ++L +L I G+ YL
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 145 HSQGILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE 201
H I+H DLK +N+LL +K+ DFG+S + GT ++APE++
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY 207
Query: 202 KRHTKKVDVYSFGIVLWELLTALTPF 227
T D+++ GI+ + LLT +PF
Sbjct: 208 DPITTATDMWNIGIIAYMLLTHTSPF 233
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 9e-22
Identities = 41/197 (20%), Positives = 88/197 (44%), Gaps = 41/197 (20%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVS-QPEEDASLASMLEKQFTSEVALLFRLNHPHIIT- 120
GR ++++ +A K++ + +D +++ +E++++ +L+H ++I
Sbjct: 99 GGRFGQVHKCEETATGLKLAAKIIKTRGMKD-------KEEVKNEISVMNQLDHANLIQL 151
Query: 121 -EPYSVPLNLVL---------------------------KLALDIARGMQYLHSQGILHR 152
+ + ++VL I G++++H ILH
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHL 211
Query: 153 DLKSENLLLG--EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 210
DLK EN+L + +K+ DFG++ K GT ++APE++ + D+
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDM 271
Query: 211 YSFGIVLWELLTALTPF 227
+S G++ + LL+ L+PF
Sbjct: 272 WSVGVIAYMLLSGLSPF 288
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-21
Identities = 42/154 (27%), Positives = 64/154 (41%), Gaps = 13/154 (8%)
Query: 136 DIARGMQYLHSQGILHRDLKSENLLLG--EDMCVKVADFGISCL-----ESQCGSAKGFT 188
I + YLH+QGI HRD+K EN L + +K+ DFG+S +
Sbjct: 176 QIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235
Query: 189 GTYRWMAPEMIK--EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN--- 243
GT ++APE++ + + K D +S G++L LL PF + V K
Sbjct: 236 GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF 295
Query: 244 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 277
P P A L+S + + D R +
Sbjct: 296 ENPNYNVLSPLARD-LLSNLLNRNVDERFDAMRA 328
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 42/203 (20%), Positives = 81/203 (39%), Gaps = 41/203 (20%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVS-QPEEDASLASMLEKQFTSEVALLFRLNH 115
I + +G ++R + + A K V E D ++ E+ + L H
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD-------KETVRKEIQTMSVLRH 213
Query: 116 PHIIT--EPYSVPLNLVL---------------------------KLALDIARGMQYLHS 146
P ++ + + +V+ + + +G+ ++H
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273
Query: 147 QGILHRDLKSENLLLG--EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH 204
+H DLK EN++ +K+ DFG++ S K TGT + APE+ + K
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 333
Query: 205 TKKVDVYSFGIVLWELLTALTPF 227
D++S G++ + LL+ L+PF
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSPF 356
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 34/98 (34%), Positives = 61/98 (62%), Gaps = 2/98 (2%)
Query: 134 ALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-AKGFTGTY 191
+I + YLHS+ +++RDLK ENL+L +D +K+ DFG+ + G+ K F GT
Sbjct: 254 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 229
++APE++++ + + VD + G+V++E++ PF N
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 46/203 (22%), Positives = 81/203 (39%), Gaps = 51/203 (25%)
Query: 65 SGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT- 120
G + ++ + K Q A+K++ + EV L +R PHI+
Sbjct: 72 LGINGKVLQIFNKRTQEKFALKMLQD-----------CPKARREVELHWRASQCPHIVRI 120
Query: 121 -----EPYSVPLNLVL----------------------------KLALDIARGMQYLHSQ 147
Y+ L++ ++ I +QYLHS
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 180
Query: 148 GILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH 204
I HRD+K ENLL + +K+ DFG + + S T ++APE++ +++
Sbjct: 181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 240
Query: 205 TKKVDVYSFGIVLWELLTALTPF 227
K D++S G++++ LL PF
Sbjct: 241 DKSCDMWSLGVIMYILLCGYPPF 263
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-21
Identities = 51/219 (23%), Positives = 88/219 (40%), Gaps = 69/219 (31%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVS-QPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT 120
G H+R+ I ++ A+K++ QP + EV +L++ H +++
Sbjct: 23 EGAHARVQTCINLITSQEYAVKIIEKQPGHI-------RSRVFREVEMLYQCQGHRNVLE 75
Query: 121 --EPYSVPLNLVL--------------------------KLALDIARGMQYLHSQGILHR 152
E + L + D+A + +LH++GI HR
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135
Query: 153 DLKSENLLL---GEDMCVKVADFGIS---------------CLESQCGSAKGFTGTYRWM 194
DLK EN+L + VK+ DF + L + CGSA Y M
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA-----EY--M 188
Query: 195 APEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFD 228
APE+++ + K+ D++S G++L+ LL+ PF
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 48/177 (27%), Positives = 86/177 (48%), Gaps = 37/177 (20%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII------------------ 119
+R+VAIK +S+P ++ + A K+ E+ L+ +NH +II
Sbjct: 50 ERNVAIKKLSRPFQNQTHA----KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105
Query: 120 ---TEPYSVPLNLVLKLALD----------IARGMQYLHSQGILHRDLKSENLLLGEDMC 166
E L V+++ LD + G+++LHS GI+HRDLK N+++ D
Sbjct: 106 YIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 165
Query: 167 VKVADFGISCLESQCGSAKGFTGTYRWM-APEMIKEKRHTKKVDVYSFGIVLWELLT 222
+K+ DFG++ + T R+ APE+I + + VD++S G ++ E++
Sbjct: 166 LKILDFGLARTAGTSFMMTPYVVT-RYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 221
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 51/193 (26%), Positives = 88/193 (45%), Gaps = 41/193 (21%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII--- 119
SG + R+VAIK +S+P ++ + A K+ E+ L+ +NH +II
Sbjct: 72 SGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMKCVNHKNIISLL 127
Query: 120 ------------------TEPYSVPLNLVLKLALD----------IARGMQYLHSQGILH 151
E L V+++ LD + G+++LHS GI+H
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 187
Query: 152 RDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT--YRWMAPEMIKEKRHTKKVD 209
RDLK N+++ D +K+ DFG++ + T YR APE+I + + VD
Sbjct: 188 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR--APEVILGMGYKENVD 245
Query: 210 VYSFGIVLWELLT 222
++S G ++ E++
Sbjct: 246 IWSVGCIMGEMVR 258
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-20
Identities = 27/125 (21%), Positives = 58/125 (46%), Gaps = 7/125 (5%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWM 194
+ + +H +HRD+K +N+L+ + +++ADFG + G+ + GT ++
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 195 APEMIKEK-----RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP 249
+PE+++ R+ + D +S G+ ++E+L TPF + + + R P
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303
Query: 250 PTCPK 254
Sbjct: 304 TQVTD 308
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 6e-20
Identities = 27/108 (25%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRW 193
I + +H G +HRD+K +N+LL +++ADFG SCL+ + + GT +
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFG-SCLKLRADGTVRSLVAVGTPDY 229
Query: 194 MAPEMIKEK-------RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 234
++PE+++ + + D ++ G+ +E+ TPF + +
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE 277
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 30/105 (28%), Positives = 57/105 (54%), Gaps = 8/105 (7%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRW 193
+ + +HS G +HRD+K +N+LL + +K+ADFG +C++ GT +
Sbjct: 177 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG-TCMKMNKEGMVRCDTAVGTPDY 235
Query: 194 MAPEMIKEK----RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 234
++PE++K + + ++ D +S G+ L+E+L TPF +
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 74/273 (27%), Positives = 100/273 (36%), Gaps = 102/273 (37%)
Query: 79 RDVAIKLVSQPEEDASLASMLEKQFTS-EVALLFRLNHPHIIT----------EPYSVPL 127
VAIK V Q +K+F + E+ ++ +L+H +I+ + V L
Sbjct: 80 ELVAIKKVLQ-----------DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128
Query: 128 NLVL-------------------KLALD--------IARGMQYLHSQGILHRDLKSENLL 160
NLVL L + + R + Y+HS GI HRD+K +NLL
Sbjct: 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 188
Query: 161 LGEDMCV-KVADFGISCLESQCGSAKGFTGT-----------YRWMAPE-MIKEKRHTKK 207
L D V K+ DF GSAK YR APE + +T
Sbjct: 189 LDPDTAVLKLCDF---------GSAKQLVRGEPNVSYICSRYYR--APELIFGATDYTSS 237
Query: 208 VDVYSFGIVLWELLT--AL------------------TP----FDNMTPEQAAFAVCQKN 243
+DV+S G VL ELL + TP M P F Q
Sbjct: 238 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 297
Query: 244 ARPP----VPPTCPKAFSYLISRCWSSSPDRRP 272
A P P T P+A + L SR +P R
Sbjct: 298 AHPWTKVFRPRTPPEAIA-LCSRLLEYTPTARL 329
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 45/187 (24%), Positives = 77/187 (41%), Gaps = 43/187 (22%)
Query: 77 KQRDVAIKLVSQPEEDASLASMLEKQFTS-----EVALLFRLNHPHIIT-----EPYSVP 126
+ VAIK V D ++L F E+ LL +HP+I+ + P
Sbjct: 45 EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEP 104
Query: 127 ---------------LNLVLK---LALD----------IARGMQYLHSQGILHRDLKSEN 158
L V+ + + I G+ LH G++HRDL N
Sbjct: 105 AMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGN 164
Query: 159 LLLGEDMCVKVADFGISCLESQCGSAKGFTGT--YRWMAPE-MIKEKRHTKKVDVYSFGI 215
+LL ++ + + DF ++ ++ + + YR APE +++ K TK VD++S G
Sbjct: 165 ILLADNNDITICDFNLAREDTADANKTHYVTHRWYR--APELVMQFKGFTKLVDMWSAGC 222
Query: 216 VLWELLT 222
V+ E+
Sbjct: 223 VMAEMFN 229
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 51/193 (26%), Positives = 86/193 (44%), Gaps = 42/193 (21%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII--- 119
SG + + I K+ VAIK +S+P + A K+ E+ LL + H ++I
Sbjct: 34 SGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFA----KRAYRELLLLKHMQHENVIGLL 89
Query: 120 ------------------TEPYSVPLNLVLKLALD----------IARGMQYLHSQGILH 151
L ++ L + +G++Y+HS G++H
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVH 149
Query: 152 RDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW-MAPE-MIKEKRHTKKVD 209
RDLK NL + ED +K+ DFG++ G+ T RW APE ++ + + VD
Sbjct: 150 RDLKPGNLAVNEDCELKILDFGLA--RHADAEMTGYVVT-RWYRAPEVILSWMHYNQTVD 206
Query: 210 VYSFGIVLWELLT 222
++S G ++ E+LT
Sbjct: 207 IWSVGCIMAEMLT 219
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-19
Identities = 59/196 (30%), Positives = 88/196 (44%), Gaps = 43/196 (21%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII--- 119
G + + VAIK +S P E + ++ E+ +L R H +II
Sbjct: 37 EGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYC----QRTLREIKILLRFRHENIIGIN 91
Query: 120 -----------TEPYSVP------LNLVLK---LALD--------IARGMQYLHSQGILH 151
+ Y V L +LK L+ D I RG++Y+HS +LH
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 152 RDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---RWM-APE-MIKEKRHTK 206
RDLK NLLL +K+ DFG++ + GF Y RW APE M+ K +TK
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 207 KVDVYSFGIVLWELLT 222
+D++S G +L E+L+
Sbjct: 212 SIDIWSVGCILAEMLS 227
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 50/193 (25%), Positives = 77/193 (39%), Gaps = 73/193 (37%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTS-EVALLFRLNHPHIIT----------EPYSVPLNL 129
VAIK V + +K+F + E+ ++ + HP+++ + V LNL
Sbjct: 67 VAIKKV-----------LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115
Query: 130 VL-----------------KLALD----------IARGMQYLHSQGILHRDLKSENLLL- 161
VL K + + R + Y+HS GI HRD+K +NLLL
Sbjct: 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD 175
Query: 162 GEDMCVKVADFGISCLESQCGSAKGFTGT-----------YRWMAPE-MIKEKRHTKKVD 209
+K+ DF GSAK YR APE + +T +D
Sbjct: 176 PPSGVLKLIDF---------GSAKILIAGEPNVSYICSRYYR--APELIFGATNYTTNID 224
Query: 210 VYSFGIVLWELLT 222
++S G V+ EL+
Sbjct: 225 IWSTGCVMAELMQ 237
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 9e-18
Identities = 49/179 (27%), Positives = 82/179 (45%), Gaps = 41/179 (22%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII------------------ 119
VAIK + +P + A K+ E+ LL + H ++I
Sbjct: 50 GAKVAIKKLYRPFQSELFA----KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105
Query: 120 ---TEPYSVPLNLVLK---LALD--------IARGMQYLHSQGILHRDLKSENLLLGEDM 165
L ++K L D + +G++Y+H+ GI+HRDLK NL + ED
Sbjct: 106 YLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC 165
Query: 166 CVKVADFGISCLESQCGSAKGFTGTYRWM-APE-MIKEKRHTKKVDVYSFGIVLWELLT 222
+K+ DFG++ G+ T RW APE ++ R+T+ VD++S G ++ E++T
Sbjct: 166 ELKILDFGLA--RQADSEMTGYVVT-RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 221
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-17
Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 48/192 (25%)
Query: 76 YKQRD------VAIKLVSQPEEDASLASMLEKQFTS--EVALLFRLNHPHIIT----EPY 123
+K ++ VA+K V ++D + S ++ E+ LL L H +I+
Sbjct: 19 FKAKNRETHEIVALKRVRLDDDDEGVPS------SALREICLLKELKHKNIVRLHDVLHS 72
Query: 124 SVPLNLV-------LKLALD-----------------IARGMQYLHSQGILHRDLKSENL 159
L LV LK D + +G+ + HS+ +LHRDLK +NL
Sbjct: 73 DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL 132
Query: 160 LLGEDMCVKVADFGIS---CLESQCGSAKGFTGTYRWMAPE-MIKEKRHTKKVDVYSFGI 215
L+ + +K+A+FG++ + +C SA+ T YR P+ + K ++ +D++S G
Sbjct: 133 LINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR--PPDVLFGAKLYSTSIDMWSAGC 190
Query: 216 VLWELLTALTPF 227
+ EL A P
Sbjct: 191 IFAELANAGRPL 202
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 56/194 (28%), Positives = 87/194 (44%), Gaps = 43/194 (22%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII--- 119
SG + + + VA+K +S+P + A K+ E+ LL + H ++I
Sbjct: 39 SGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA----KRTYRELRLLKHMKHENVIGLL 94
Query: 120 ------------------TEPYSVPLNLVLK---LALD--------IARGMQYLHSQGIL 150
T LN ++K L D I RG++Y+HS I+
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADII 154
Query: 151 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW-MAPE-MIKEKRHTKKV 208
HRDLK NL + ED +K+ DFG++ G+ T RW APE M+ + + V
Sbjct: 155 HRDLKPSNLAVNEDCELKILDFGLA--RHTADEMTGYVAT-RWYRAPEIMLNWMHYNQTV 211
Query: 209 DVYSFGIVLWELLT 222
D++S G ++ ELLT
Sbjct: 212 DIWSVGCIMAELLT 225
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 44/176 (25%), Positives = 63/176 (35%), Gaps = 51/176 (28%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCV-KVADFGISCLESQCGSAKGFTGT----- 190
+ R + ++HS GI HRD+K +NLL+ K+ DF GSAK +
Sbjct: 150 LFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDF---------GSAKKLIPSEPSVA 200
Query: 191 ------YRWMAPE-MIKEKRHTKKVDVYSFGIVLWELLT--AL----------------- 224
YR APE M+ +T +D++S G V EL+ L
Sbjct: 201 YICSRFYR--APELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIM 258
Query: 225 -TP----FDNMTPEQAAFAVCQKNARP---PVPPTCPKAFSYLISRCWSSSPDRRP 272
TP M P A+ +P P L+ + PD R
Sbjct: 259 GTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 36/171 (21%), Positives = 65/171 (38%), Gaps = 36/171 (21%)
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMC-VKVADFGISCLESQCGSAKGFTGTY---R 192
+ RG++Y+HS +LHRDLK NL + + +K+ DFG++ + S KG +
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 193 WM-APE-MIKEKRHTKKVDVYSFGIVLWELLTALTPF---DNM-----------TPEQAA 236
W +P ++ +TK +D+++ G + E+LT T F + +
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248
Query: 237 FAVCQKNAR------PPVPP---------TCPKAFSYLISRCWSSSPDRRP 272
P +A + + + SP R
Sbjct: 249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVD-FLEQILTFSPMDRL 298
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-17
Identities = 45/203 (22%), Positives = 71/203 (34%), Gaps = 72/203 (35%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT- 120
G + ++ + K+ A+K++ + EV L +R PHI+
Sbjct: 28 LGINGKVLQIFNKRTQEKFALKMLQD-----------CPKARREVELHWRASQCPHIVRI 76
Query: 121 -----EPYSVPLN--LVLKLA-----LD--IARGM-------------------QYLHSQ 147
Y+ +V++ RG QYLHS
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 136
Query: 148 GILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH 204
I HRD+K ENLL + +K+ DFG A E EK +
Sbjct: 137 NIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKETTGEK-Y 175
Query: 205 TKKVDVYSFGIVLWELLTALTPF 227
K D++S G++++ LL PF
Sbjct: 176 DKSCDMWSLGVIMYILLCGYPPF 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 6e-17
Identities = 55/186 (29%), Positives = 90/186 (48%), Gaps = 47/186 (25%)
Query: 76 YKQRD-----VAIKLVSQPEEDASLASMLEKQFTS--EVALLFRLNHPHIIT----EPYS 124
YK +D VA+K + ED + S T+ E++LL L+HP+I++
Sbjct: 38 YKAKDSQGRIVALKRIRLDAEDEGIPS------TAIREISLLKELHHPNIVSLIDVIHSE 91
Query: 125 VPLNLV-------LKLALD-----------------IARGMQYLHSQGILHRDLKSENLL 160
L LV LK LD + RG+ + H ILHRDLK +NLL
Sbjct: 92 RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLL 151
Query: 161 LGEDMCVKVADFGIS---CLESQCGSAKGFTGTYRWMAPE-MIKEKRHTKKVDVYSFGIV 216
+ D +K+ADFG++ + + + + T YR AP+ ++ K+++ VD++S G +
Sbjct: 152 INSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR--APDVLMGSKKYSTSVDIWSIGCI 209
Query: 217 LWELLT 222
E++T
Sbjct: 210 FAEMIT 215
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 7e-17
Identities = 60/260 (23%), Positives = 97/260 (37%), Gaps = 70/260 (26%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII--------------TEPY 123
+++VAIK V++ ED K+ E+ +L RL +II E Y
Sbjct: 51 EKNVAIKKVNRMFEDLIDC----KRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106
Query: 124 SVP------LNLVLK------------LALDIARGMQYLHSQGILHRDLKSENLLLGEDM 165
V L + K + ++ G ++H GI+HRDLK N LL +D
Sbjct: 107 IVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC 166
Query: 166 CVKVADFGIS-CLESQCGSAKGFTGTY---------------------RWM-APE-MIKE 201
VKV DFG++ + S+ + RW APE ++ +
Sbjct: 167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ 226
Query: 202 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 261
+ +TK +D++S G + ELL L N + P P + S +
Sbjct: 227 ENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR----------FPLFPGSSCFPLSPDRN 276
Query: 262 RCWSSSPDRRPHFDQIVSIL 281
R + I +I+
Sbjct: 277 SKKVHEKSNRDQLNIIFNII 296
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 9e-17
Identities = 47/188 (25%), Positives = 76/188 (40%), Gaps = 48/188 (25%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII--------------TEPY 123
VAIK + P + A + E+ +L H +II E Y
Sbjct: 36 GEIVAIKKIE-PFDKPLFA----LRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90
Query: 124 SVP------LNLVLK---LALD--------IARGMQYLHSQGILHRDLKSENLLLGEDMC 166
+ L+ V+ L+ D R ++ LH ++HRDLK NLL+ +
Sbjct: 91 IIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD 150
Query: 167 VKVADFGIS-CLESQCGSAKGFTGTYRWM----------APE-MIKEKRHTKKVDVYSFG 214
+KV DFG++ ++ TG M APE M+ ++++ +DV+S G
Sbjct: 151 LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG 210
Query: 215 IVLWELLT 222
+L EL
Sbjct: 211 CILAELFL 218
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 77.9 bits (193), Expect = 1e-16
Identities = 41/186 (22%), Positives = 81/186 (43%), Gaps = 47/186 (25%)
Query: 76 YKQRD-----VAIKLVSQPEEDASLASMLEKQFTS--EVALLFRLNHPHII--------- 119
YK ++ A+K + +ED + S T+ E+++L L H +I+
Sbjct: 19 YKAQNNYGETFALKKIRLEKEDEGIPS------TTIREISILKELKHSNIVKLYDVIHTK 72
Query: 120 -------------------TEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 160
+ L + G+ Y H + +LHRDLK +NLL
Sbjct: 73 KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL 132
Query: 161 LGEDMCVKVADFGIS---CLESQCGSAKGFTGTYRWMAPE-MIKEKRHTKKVDVYSFGIV 216
+ + +K+ADFG++ + + + + T YR AP+ ++ K+++ +D++S G +
Sbjct: 133 INREGELKIADFGLARAFGIPVRKYTHEIVTLWYR--APDVLMGSKKYSTTIDIWSVGCI 190
Query: 217 LWELLT 222
E++
Sbjct: 191 FAEMVN 196
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 62/266 (23%), Positives = 95/266 (35%), Gaps = 75/266 (28%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII--------------TEPY 123
+R VAIK + + ED K+ E+A+L RLNH H++ E Y
Sbjct: 78 KRVVAIKKILRVFEDLIDC----KRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133
Query: 124 SVP------LNLVLK----LALD--------IARGMQYLHSQGILHRDLKSENLLLGEDM 165
V + + L + G++Y+HS GILHRDLK N L+ +D
Sbjct: 134 VVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC 193
Query: 166 CVKVADFG----ISCLESQCGSAKGFTGTY-----------------------RWM-APE 197
VKV DFG + E+ RW APE
Sbjct: 194 SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPE 253
Query: 198 -MIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 256
++ ++ +T+ +DV+S G + ELL + ++ P P +
Sbjct: 254 LILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR----------GPLFPGSSCFPL 303
Query: 257 SYLISRCWSSSPDRRPHFDQIVSILE 282
S R + DQ+ I
Sbjct: 304 SPDQKAGNDFKFHTRGNRDQLNVIFN 329
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 53/282 (18%), Positives = 89/282 (31%), Gaps = 111/282 (39%)
Query: 79 RDVAIKLVSQPEEDASLASMLEKQFT----SEVALLFRLNHPHIIT-----------EPY 123
VAIK V Q + +F + L L+HP+I+ +
Sbjct: 49 MSVAIKKVIQ-----------DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97
Query: 124 SVPLNLVL-----------------KLALD----------IARGMQYLH--SQGILHRDL 154
+ LN+V+ ++A + R + LH S + HRD+
Sbjct: 98 DIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDI 157
Query: 155 KSENLLLGEDMCV-KVADFGISCLESQCGSAKGFTGT-----------YRWMAPE-MIKE 201
K N+L+ E K+ DF GSAK + + YR APE +
Sbjct: 158 KPHNVLVNEADGTLKLCDF---------GSAKKLSPSEPNVAYICSRYYR--APELIFGN 206
Query: 202 KRHTKKVDVYSFGIVLWELLT--AL------------------TP----FDNMTPEQAAF 237
+ +T VD++S G + E++ + P + P
Sbjct: 207 QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDV 266
Query: 238 AVCQKNARP-------PVPPTCPKAFSYLISRCWSSSPDRRP 272
+ P +A+ L+S P+ R
Sbjct: 267 DLYNSKGIPWSNVFSDHSLKDAKEAYD-LLSALLQYLPEERM 307
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 3e-16
Identities = 45/194 (23%), Positives = 79/194 (40%), Gaps = 62/194 (31%)
Query: 76 YKQRD------VAIKLVSQPEEDASLASMLEKQFTS--EVALLFRLNHPHII-------- 119
+K R+ VAIK + E+D + + E+ +L +L HP+++
Sbjct: 20 FKCRNRDTGQIVAIKKFLESEDDPVIKK------IALREIRMLKQLKHPNLVNLLEVFRR 73
Query: 120 --------------------TEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 159
VP +LV + + + + H +HRD+K EN+
Sbjct: 74 KRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENI 133
Query: 160 LLGEDMCVKVADFGISCLESQCGSAKGFTG---TY------RWM-APEMI-KEKRHTKKV 208
L+ + +K+ DFG A+ TG Y RW +PE++ + ++ V
Sbjct: 134 LITKHSVIKLCDFGF---------ARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPV 184
Query: 209 DVYSFGIVLWELLT 222
DV++ G V ELL+
Sbjct: 185 DVWAIGCVFAELLS 198
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 3e-16
Identities = 59/193 (30%), Positives = 87/193 (45%), Gaps = 57/193 (29%)
Query: 76 YKQRD------VAIK---LVSQPEEDASLASMLEKQFTS--EVALLFRLNHPHIIT---- 120
YK RD VAIK L + E + T+ E+ LL L+HP+II
Sbjct: 27 YKARDKNTNQIVAIKKIKLGHRSEAKDGINR------TALREIKLLQELSHPNIIGLLDA 80
Query: 121 EPYSVPLNLV-------LKLALD-----------------IARGMQYLHSQGILHRDLKS 156
+ ++LV L++ + +G++YLH ILHRDLK
Sbjct: 81 FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKP 140
Query: 157 ENLLLGEDMCVKVADFGISCLESQCGS-AKGFTGT-----YRWMAPEMI-KEKRHTKKVD 209
NLLL E+ +K+ADFG L GS + +T YR APE++ + + VD
Sbjct: 141 NNLLLDENGVLKLADFG---LAKSFGSPNRAYTHQVVTRWYR--APELLFGARMYGVGVD 195
Query: 210 VYSFGIVLWELLT 222
+++ G +L ELL
Sbjct: 196 MWAVGCILAELLL 208
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 59/238 (24%), Positives = 96/238 (40%), Gaps = 70/238 (29%)
Query: 41 EIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ----RDVAIKLVSQPEEDASLA 96
++K E E D+ + + GCK G + +Y+ K +D A+K + S++
Sbjct: 8 KVKLSSERERVEDLFE-YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMS 64
Query: 97 SMLEKQFTSEVALLFRLNHPHIIT------------------------------------ 120
+ E+ALL L HP++I+
Sbjct: 65 AC------REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKA 118
Query: 121 --EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM----CVKVADFGI 174
+P +P +V L I G+ YLH+ +LHRDLK N+L+ + VK+AD G
Sbjct: 119 NKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG- 177
Query: 175 SCLESQCGS-AKGFTGT--------YRWMAPE-MIKEKRHTKKVDVYSFGIVLWELLT 222
S K YR APE ++ + +TK +D+++ G + ELLT
Sbjct: 178 --FARLFNSPLKPLADLDPVVVTFWYR--APELLLGARHYTKAIDIWAIGCIFAELLT 231
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 54/197 (27%), Positives = 79/197 (40%), Gaps = 58/197 (29%)
Query: 76 YKQRD------VAIKLVSQPEEDASLASMLEKQFTS--EVALLFRLN---HPHIIT---- 120
YK RD VA+K V P + ++ EVALL RL HP+++
Sbjct: 26 YKARDPHSGHFVALKSVRVPNGGGGGGGL---PISTVREVALLRRLEAFEHPNVVRLMDV 82
Query: 121 -----EPYSVPLNLV-------LKLALD------------------IARGMQYLHSQGIL 150
+ + LV L+ LD RG+ +LH+ I+
Sbjct: 83 CATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIV 142
Query: 151 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT-----YRWMAPEMIKEKRHT 205
HRDLK EN+L+ VK+ADFG L T YR APE++ + +
Sbjct: 143 HRDLKPENILVTSGGTVKLADFG---LARIYSYQMALTPVVVTLWYR--APEVLLQSTYA 197
Query: 206 KKVDVYSFGIVLWELLT 222
VD++S G + E+
Sbjct: 198 TPVDMWSVGCIFAEMFR 214
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 9e-16
Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 47/198 (23%)
Query: 62 KFASGRHSRIYRGIYKQ--RDVAIKLVS-QPEEDASLASMLEKQFTS--EVALLFRLNHP 116
K G ++ +Y+G K VA+K + + EE A T+ EV+LL L H
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP--------CTAIREVSLLKDLKHA 60
Query: 117 HIIT----EPYSVPLNLV-------LKLALD-----------------IARGMQYLHSQG 148
+I+T L LV LK LD + RG+ Y H Q
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 149 ILHRDLKSENLLLGEDMCVKVADFGIS---CLESQCGSAKGFTGTYRWMAPE-MIKEKRH 204
+LHRDLK +NLL+ E +K+ADFG++ + ++ + T YR P+ ++ +
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR--PPDILLGSTDY 178
Query: 205 TKKVDVYSFGIVLWELLT 222
+ ++D++ G + +E+ T
Sbjct: 179 STQIDMWGVGCIFYEMAT 196
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 9e-16
Identities = 48/197 (24%), Positives = 83/197 (42%), Gaps = 56/197 (28%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHII-----------TEPYSV 125
VA+K + ++++ A ++ E+ +L L+ H +I+ + Y V
Sbjct: 34 GEVVAVKKIFDAFQNSTDA----QRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV 89
Query: 126 P------LNLVLK---LALD--------IARGMQYLHSQGILHRDLKSENLLLGEDMCVK 168
L+ V++ L + + ++YLHS G+LHRD+K N+LL + VK
Sbjct: 90 FDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVK 149
Query: 169 VADFGISCLESQCGSAKGFTGTY---------------------RWM-APE-MIKEKRHT 205
VADFG+S RW APE ++ ++T
Sbjct: 150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYT 209
Query: 206 KKVDVYSFGIVLWELLT 222
K +D++S G +L E+L
Sbjct: 210 KGIDMWSLGCILGEILC 226
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-15
Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 10/102 (9%)
Query: 126 PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK 185
P + + + RG+ +LHS ++HRDLK +N+L+ +K+ADFG L
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG---LARIYSFQM 174
Query: 186 GFTGT-----YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT 222
T YR APE++ + + VD++S G + E+
Sbjct: 175 ALTSVVVTLWYR--APEVLLQSSYATPVDLWSVGCIFAEMFR 214
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 4e-15
Identities = 45/194 (23%), Positives = 77/194 (39%), Gaps = 62/194 (31%)
Query: 76 YKQRD------VAIKLVSQPEEDASLASMLEKQFTS--EVALLFRLNHPHII-------- 119
K R+ VAIK + ++D + + E+ LL +L H +++
Sbjct: 42 MKCRNKDTGRIVAIKKFLESDDDKMVKK------IAMREIKLLKQLRHENLVNLLEVCKK 95
Query: 120 --------------------TEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 159
P + +V K I G+ + HS I+HRD+K EN+
Sbjct: 96 KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENI 155
Query: 160 LLGEDMCVKVADFGISCLESQCGSAKGFTG---TY------RWM-APEMI-KEKRHTKKV 208
L+ + VK+ DFG A+ Y RW APE++ + ++ K V
Sbjct: 156 LVSQSGVVKLCDFGF---------ARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAV 206
Query: 209 DVYSFGIVLWELLT 222
DV++ G ++ E+
Sbjct: 207 DVWAIGCLVTEMFM 220
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 47/133 (35%), Positives = 61/133 (45%), Gaps = 19/133 (14%)
Query: 111 FRLNHPHIITEPYS--------------VPLNLVLKLALDIARGMQYLHSQGILHRDLKS 156
FR NH + E S L LV K A I + + LH I+H DLK
Sbjct: 170 FR-NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKP 228
Query: 157 ENLLLGE--DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFG 214
EN+LL + +KV DFG SC E Q + YR APE+I R+ +D++S G
Sbjct: 229 ENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYR--APEVILGARYGMPIDMWSLG 286
Query: 215 IVLWELLTALTPF 227
+L ELLT
Sbjct: 287 CILAELLTGYPLL 299
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 1e-14
Identities = 38/154 (24%), Positives = 70/154 (45%), Gaps = 39/154 (25%)
Query: 106 EVALLFRLNHPHIIT---------------------------------EPYSVPLNLVLK 132
E++L+ L H +I+ P + LNLV
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 133 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS---CLESQCGSAKGFTG 189
+ +G+ + H ILHRDLK +NLL+ + +K+ DFG++ + S++ T
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL 172
Query: 190 TYRWMAPE-MIKEKRHTKKVDVYSFGIVLWELLT 222
YR AP+ ++ + ++ +D++S G +L E++T
Sbjct: 173 WYR--APDVLMGSRTYSTSIDIWSCGCILAEMIT 204
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 43/199 (21%), Positives = 76/199 (38%), Gaps = 60/199 (30%)
Query: 76 YKQRD------VAIKLVSQPEEDASLASMLEKQFTS--EVALLFRLNHPHIIT------- 120
+K R VA+K V E T+ E+ +L L H +++
Sbjct: 34 FKARHRKTGQKVALKKVLMENEKEGFP------ITALREIKILQLLKHENVVNLIEICRT 87
Query: 121 -----EPYSVPLNLV-------LKLALD-----------------IARGMQYLHSQGILH 151
+ LV L L + G+ Y+H ILH
Sbjct: 88 KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILH 147
Query: 152 RDLKSENLLLGEDMCVKVADFGI--SCLESQCGSAKGFTGT-----YRWMAPEMI-KEKR 203
RD+K+ N+L+ D +K+ADFG+ + ++ +T YR PE++ E+
Sbjct: 148 RDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR--PPELLLGERD 205
Query: 204 HTKKVDVYSFGIVLWELLT 222
+ +D++ G ++ E+ T
Sbjct: 206 YGPPIDLWGAGCIMAEMWT 224
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-14
Identities = 30/111 (27%), Positives = 57/111 (51%), Gaps = 9/111 (8%)
Query: 126 PLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGE------DMCVKVADFGISCLE 178
PL V +++ + G+ Y+H + GI+H D+K EN+L+ + +K+AD G +C
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 179 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 229
+ + T YR +PE++ D++S +++EL+T F+
Sbjct: 189 DEHYTNSIQTREYR--SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 9e-14
Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 52/191 (27%)
Query: 76 YKQRD------VAIKLVSQPEEDASLASMLEKQFTS--EVALLFRLNHPHIIT----EPY 123
YK D VAIK + E+ + T+ EV+LL L H +II +
Sbjct: 51 YKAIDTVTNETVAIKRIRLEHEEEGVPG------TAIREVSLLKELQHRNIIELKSVIHH 104
Query: 124 SVPLNLV-------LKLALD----------------IARGMQYLHSQGILHRDLKSENLL 160
+ L+L+ LK +D + G+ + HS+ LHRDLK +NLL
Sbjct: 105 NHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLL 164
Query: 161 L-----GEDMCVKVADFGIS---CLESQCGSAKGFTGTYRWMAPE-MIKEKRHTKKVDVY 211
L E +K+ DFG++ + + + + T YR PE ++ + ++ VD++
Sbjct: 165 LSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR--PPEILLGSRHYSTSVDIW 222
Query: 212 SFGIVLWELLT 222
S + E+L
Sbjct: 223 SIACIWAEMLM 233
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 42/199 (21%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 62 KFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHI 118
K G++S ++ I V +K++ +P + +K+ E+ +L L P+I
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKIL-KPVK--------KKKIKREIKILENLRGGPNI 93
Query: 119 IT------EPYSVPLNLVL-------------KLALD--------IARGMQYLHSQGILH 151
IT +P S LV L I + + Y HS GI+H
Sbjct: 94 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMH 153
Query: 152 RDLKSENLLLGEDMC-VKVADFGISCLESQCGSAKGFTGTYRWM-APE-MIKEKRHTKKV 208
RD+K N+++ + +++ D+G++ + R+ PE ++ + + +
Sbjct: 154 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RYFKGPELLVDYQMYDYSL 212
Query: 209 DVYSFGIVLWELLTALTPF 227
D++S G +L ++ PF
Sbjct: 213 DMWSLGCMLASMIFRKEPF 231
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 34/107 (31%), Positives = 53/107 (49%), Gaps = 6/107 (5%)
Query: 125 VPLNLVLKLALDIARGMQYLHSQ--GILHRDLKSENLLL--GEDMCVKVADFGISCLESQ 180
V LNL K A + + +L + I+H DLK EN+LL + +K+ DFG SC Q
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213
Query: 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
+ YR +PE++ + +D++S G +L E+ T F
Sbjct: 214 RIYQYIQSRFYR--SPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 37/150 (24%), Positives = 55/150 (36%), Gaps = 36/150 (24%)
Query: 111 FRLNHPHIITEPYS--------------VPLNLVLKLALDIARGMQYLHSQGILHRDLKS 156
F H I E PL V +A + +++LH + H DLK
Sbjct: 93 FH-GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKP 151
Query: 157 ENLLLGEDMC-------------------VKVADFGISCLESQCGSAKGFTGTYRWMAPE 197
EN+L ++VADFG + + + + T YR PE
Sbjct: 152 ENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYR--PPE 209
Query: 198 MIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
+I E + DV+S G +L+E T F
Sbjct: 210 VILELGWAQPCDVWSIGCILFEYYRGFTLF 239
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-11
Identities = 40/170 (23%), Positives = 73/170 (42%), Gaps = 17/170 (10%)
Query: 130 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC---VKVADFGISC--LESQCGS- 183
VL LA + ++Y+HS+ +HRD+K +N L+G V + DFG++ +++
Sbjct: 107 VLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166
Query: 184 -----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM---TPEQA 235
K TGT R+ + +++ D+ S G VL P+ + T Q
Sbjct: 167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 226
Query: 236 AFAVCQKNARPPVPPTC---PKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
+ +K P+ C P F+ ++ C S D +P + + +
Sbjct: 227 YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 276
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 6e-11
Identities = 34/172 (19%), Positives = 69/172 (40%), Gaps = 19/172 (11%)
Query: 130 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC-----VKVADFGIS--CLESQCG 182
V A + +Q +H + +++RD+K +N L+G + V DFG+ +
Sbjct: 108 VAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167
Query: 183 S------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM---TPE 233
K +GT R+M+ + +++ D+ + G V L P+ + T +
Sbjct: 168 QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK 227
Query: 234 QAAFAVCQKNARPPVPPTC---PKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
Q + +K P+ C P+ F + + + D P +D + +
Sbjct: 228 QKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 279
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 6e-11
Identities = 23/79 (29%), Positives = 38/79 (48%), Gaps = 10/79 (12%)
Query: 126 PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV--ADFGISC------- 176
+ VL+L + + ++Y+H +H D+K+ NLLLG +V AD+G+S
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208
Query: 177 -LESQCGSAKGFTGTYRWM 194
+ Q KG GT +
Sbjct: 209 HKQYQENPRKGHNGTIEFT 227
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 8e-11
Identities = 38/150 (25%), Positives = 57/150 (38%), Gaps = 36/150 (24%)
Query: 111 FRLNHPHIITEPYS--------------VPLNLVLKLALDIARGMQYLHSQGILHRDLKS 156
H I+ E L+ + K+A I + + +LHS + H DLK
Sbjct: 88 HH-GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKP 146
Query: 157 ENLLLGEDMC-------------------VKVADFGISCLESQCGSAKGFTGTYRWMAPE 197
EN+L + +KV DFG + + + S T YR APE
Sbjct: 147 ENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR--APE 204
Query: 198 MIKEKRHTKKVDVYSFGIVLWELLTALTPF 227
+I ++ DV+S G +L E T F
Sbjct: 205 VILALGWSQPCDVWSIGCILIEYYLGFTVF 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 32/123 (26%), Positives = 49/123 (39%), Gaps = 27/123 (21%)
Query: 125 VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC------------------ 166
+ + ++I + + YL + H DLK EN+LL +
Sbjct: 134 FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193
Query: 167 -------VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 219
+K+ DFG + +S + T YR APE+I D++SFG VL E
Sbjct: 194 YRTKSTGIKLIDFGCATFKSDYHGSIINTRQYR--APEVILNLGWDVSSDMWSFGCVLAE 251
Query: 220 LLT 222
L T
Sbjct: 252 LYT 254
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 3e-10
Identities = 19/79 (24%), Positives = 33/79 (41%), Gaps = 10/79 (12%)
Query: 126 PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV--ADFGISC------- 176
VL+L+L I ++Y+H +H D+K+ NLLL +V D+G++
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209
Query: 177 -LESQCGSAKGFTGTYRWM 194
+ GT +
Sbjct: 210 HKAYAADPKRCHDGTIEFT 228
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 3e-10
Identities = 14/79 (17%), Positives = 33/79 (41%), Gaps = 10/79 (12%)
Query: 126 PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV--ADFGISC------- 176
VL++A + +++LH +H ++ +EN+ + + +V A +G +
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
Query: 177 -LESQCGSAKGFTGTYRWM 194
+ GS G ++
Sbjct: 217 HVAYVEGSRSPHEGDLEFI 235
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 40/170 (23%), Positives = 71/170 (41%), Gaps = 17/170 (10%)
Query: 130 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC---VKVADFGISCL--ESQCGS- 183
VL LA + ++++HS+ LHRD+K +N L+G V + DFG++ ++
Sbjct: 105 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164
Query: 184 -----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM---TPEQA 235
K TGT R+ + +++ D+ S G VL L P+ + T +Q
Sbjct: 165 IPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224
Query: 236 AFAVCQKNARPPVPPTC---PKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
+ +K + C P F+ C S D +P + + +
Sbjct: 225 YEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFR 274
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 8e-10
Identities = 34/159 (21%), Positives = 59/159 (37%), Gaps = 52/159 (32%)
Query: 126 PLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLG---------------------- 162
PL V K+ + +G+ YLH++ I+H D+K EN+LL
Sbjct: 144 PLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP 203
Query: 163 ---------------------------EDMCVKVADFGISCLESQCGSAKGFTGTYRWMA 195
E + VK+AD G +C + + T YR +
Sbjct: 204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYR--S 261
Query: 196 PEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 234
E++ + D++S + +EL T F+ + E+
Sbjct: 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEE 300
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 37/180 (20%), Positives = 61/180 (33%), Gaps = 52/180 (28%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH- 115
+G K G + G VAIKL Q E +L
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--------APQLHLEYRFYKQLGSG 64
Query: 116 ---PHII----TEPYSV---------------------PLNLVLKLALDIARGMQYLHSQ 147
P + Y+ L VL +A+ + M+Y+HS+
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 148 GILHRDLKSENLLLGEDM-----CVKVADFGIS--CLESQCGS------AKGFTGTYRWM 194
+++RD+K EN L+G + + DF ++ ++ + K TGT R+M
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 3e-07
Identities = 51/296 (17%), Positives = 85/296 (28%), Gaps = 99/296 (33%)
Query: 11 SINAKPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLF-IGCKFASGRHS 69
SI A+ R+L + Y LV +A F + CK
Sbjct: 229 SIQAELRRLLKSKPYENC-----LLVL---------LNVQNAKAWNAFNLSCK------- 267
Query: 70 RIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITEPYSVPLNL 129
I L ++ + L T+ ++L +H +T +L
Sbjct: 268 -------------ILLTTR---FKQVTDFLSAATTTHISL---DHHSMTLTPDEV--KSL 306
Query: 130 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG 189
+LK YL +DL E + +S
Sbjct: 307 LLK----------YL---DCRPQDLPRE-------VL-TTNPRRLS-------------- 331
Query: 190 TYRWMAPEMIKEKRHT----KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 245
+ E I++ T K V+ ++ L L P +V +A
Sbjct: 332 ----IIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEP-AEYRKMFDRLSVFPPSA- 385
Query: 246 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPS 301
+P L+S W +V+ L YS +E+ P+ + IPS
Sbjct: 386 -HIPTI-------LLSLIWFDVIKSDV--MVVVNKLHKYS-LVEKQPKESTISIPS 430
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 332 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.81 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.75 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.7 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.59 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.22 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.79 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.73 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.69 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.67 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.23 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.21 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.16 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.98 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 96.86 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.85 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.83 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.86 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.66 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.54 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.28 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.22 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.74 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.08 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.1 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 92.0 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 91.28 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 90.84 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.47 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 82.88 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=399.37 Aligned_cols=239 Identities=31% Similarity=0.595 Sum_probs=199.1
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
....|+|+.++|.++++||+|+||+||+|.+++ .||||+++....... ..+.|.+|+.+|++++|||||+
T Consensus 27 ~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~----~~~~f~~E~~il~~l~HpNIV~l~g~~ 101 (307)
T 3omv_A 27 SSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPE----QFQAFRNEVAVLRKTRHVNILLFMGYM 101 (307)
T ss_dssp --CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHH----HHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 346799999999999999999999999998865 599999976543322 2467999999999999999997
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccc
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
....+++..+..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.
T Consensus 102 ~~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 102 TKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp CSSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred ECCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 346799999999999999999999999999999999999999999999999999976
Q ss_pred cccC---CCCCCcccccccCChhhhhc---CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-C---C
Q 020016 178 ESQC---GSAKGFTGTYRWMAPEMIKE---KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR-P---P 247 (332)
Q Consensus 178 ~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~-~---~ 247 (332)
.... ......+||+.|||||++.+ +.|+.++|||||||++|||+||+.||.+.+.............. + .
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~ 261 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSK 261 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTT
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccc
Confidence 5432 22345689999999999974 35899999999999999999999999987765555444443332 2 3
Q ss_pred CCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 248 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 248 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
.+..+++++.+|+.+||+.||++|||+.+|++.|+.+...+.
T Consensus 262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 456789999999999999999999999999999998876553
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=392.12 Aligned_cols=231 Identities=29% Similarity=0.524 Sum_probs=201.4
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-- 120 (332)
+.|+.++|.+.++||+|+||+||+|.+. +..||||+++..... ..+.|.+|+.+|++++|||||+
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~------~~~~f~~E~~il~~l~HpnIV~l~ 81 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN------ARKDFHREAELLTNLQHEHIVKFY 81 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHH------HHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChH------HHHHHHHHHHHHHhCCCCCCccEE
Confidence 3577889999999999999999999874 568999999764332 2467999999999999999997
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee
Q 020016 121 ---------------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 161 (332)
Q Consensus 121 ---------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll 161 (332)
....+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 82 g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl 161 (299)
T 4asz_A 82 GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV 161 (299)
T ss_dssp EEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE
Confidence 12468999999999999999999999999999999999999
Q ss_pred cCCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 020016 162 GEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAF 237 (332)
Q Consensus 162 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~ 237 (332)
+.++.+||+|||+|+...... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+...
T Consensus 162 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 241 (299)
T 4asz_A 162 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 241 (299)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999997654322 2234568999999999999999999999999999999999 999999999888877
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 238 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
.+.. ..+++.|..+|+++.+||.+||+.||++|||+.+|.+.|+.+.+.
T Consensus 242 ~i~~-~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 242 CITQ-GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 7654 556778889999999999999999999999999999999988654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-54 Score=393.30 Aligned_cols=233 Identities=27% Similarity=0.504 Sum_probs=198.4
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 120 (332)
..+.++.++|.+.++||+|+||+||+|.+. ++.||||+++..... ..+.|.+|+.+|++++|||||+
T Consensus 34 ~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~------~~~~f~~E~~il~~l~HpnIV~ 107 (329)
T 4aoj_A 34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES------ARQDFQREAELLTMLQHQHIVR 107 (329)
T ss_dssp CSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHH------HHHHHHHHHHHHTTCCCTTBCC
T ss_pred hhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHH------HHHHHHHHHHHHHhCCCCCCCc
Confidence 346678899999999999999999999874 578999999764332 2467999999999999999997
Q ss_pred -------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccccc
Q 020016 121 -------------------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 157 (332)
Q Consensus 121 -------------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~ 157 (332)
...++++..++.|+.||+.||.|||+++|+||||||+
T Consensus 108 l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~ 187 (329)
T 4aoj_A 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATR 187 (329)
T ss_dssp EEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred EEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHh
Confidence 0246899999999999999999999999999999999
Q ss_pred ceeecCCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHH
Q 020016 158 NLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPE 233 (332)
Q Consensus 158 NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~ 233 (332)
|||++.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..
T Consensus 188 NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~ 267 (329)
T 4aoj_A 188 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 267 (329)
T ss_dssp GEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH
T ss_pred hEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999999997654322 2234679999999999999999999999999999999999 99999999988
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 234 QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
+....+. ...+++.|..+++++.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 268 ~~~~~i~-~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 268 EAIDCIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHHH-HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHH-cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 8777665 4557788899999999999999999999999999999999988654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-54 Score=390.21 Aligned_cols=229 Identities=28% Similarity=0.513 Sum_probs=200.9
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-- 120 (332)
++++.+++++.++||+|+||+||+|.+. ++.||||+++....... .+.|.+|+.++++++|||||+
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~-----~~~f~~E~~il~~l~HpNIV~l~ 95 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL-----REEFRHEAMLRARLQHPNVVCLL 95 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-C-----HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHH-----HHHHHHHHHHHHhCCCCCCCCcc
Confidence 4677889999999999999999999873 47899999976543322 467999999999999999997
Q ss_pred --------------------------C----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccc
Q 020016 121 --------------------------E----------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 158 (332)
Q Consensus 121 --------------------------~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~N 158 (332)
. ...+++..+..|+.||+.||.|||+++|+||||||+|
T Consensus 96 g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~N 175 (308)
T 4gt4_A 96 GVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRN 175 (308)
T ss_dssp EEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccc
Confidence 0 1358999999999999999999999999999999999
Q ss_pred eeecCCCeEEEeecccccccccC---CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHH
Q 020016 159 LLLGEDMCVKVADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQ 234 (332)
Q Consensus 159 Ill~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~ 234 (332)
||++.++.+||+|||+++..... .......||+.|+|||++.++.++.++|||||||++|||+| |..||.+.+..+
T Consensus 176 ILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp EEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred eEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999765432 23345679999999999999999999999999999999999 999999999888
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 235 AAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
....+. ...+++.|..+++++.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 256 ~~~~i~-~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 256 VVEMIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHH-cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 777665 4566778899999999999999999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=394.45 Aligned_cols=237 Identities=24% Similarity=0.479 Sum_probs=206.7
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEECC-------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCC-Cce
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH-PHI 118 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ni 118 (332)
...|+|+.++|++++.||+|+||+||+|.+.+ +.||||.+........ .+.|.+|+.+|.+++| |||
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~-----~~~~~~E~~il~~l~hhpnI 130 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLNV 130 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCCCTTB
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHH-----HHHHHHHHHHHHHcCCCCcE
Confidence 35799999999999999999999999998753 5799999987544332 4679999999999976 899
Q ss_pred ec---------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 020016 119 IT---------------------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRD 153 (332)
Q Consensus 119 v~---------------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~d 153 (332)
|+ ....+++..+..++.||+.||.|||+++|+|||
T Consensus 131 V~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRD 210 (353)
T 4ase_A 131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 210 (353)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCc
Confidence 86 023478999999999999999999999999999
Q ss_pred ccccceeecCCCeEEEeecccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCC
Q 020016 154 LKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 229 (332)
Q Consensus 154 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~ 229 (332)
|||+|||++.++.+||+|||+|+....... .....||+.|||||++.+..|+.++|||||||++|||+| |..||.+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999986543322 234678999999999999999999999999999999998 9999998
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 020016 230 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 288 (332)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 288 (332)
....+..........++..|..+++++.++|.+||+.||++|||+.+|++.|+.+.++-
T Consensus 291 ~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 291 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 77655555666677788899999999999999999999999999999999999887653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=379.88 Aligned_cols=221 Identities=27% Similarity=0.390 Sum_probs=179.6
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|++++.||+|+||+||+|.+. ++.||||++.+..... ....+.+.+|+.+|++++|||||+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK---SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC---HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 368999999999999999999986 8999999998653322 112467899999999999999997
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 184 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 184 (332)
..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 89 ~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~ 168 (275)
T 3hyh_A 89 IMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL 168 (275)
T ss_dssp EEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCcc
Confidence 4678999999999999999999999999999999999999999999999999999876665556
Q ss_pred CCcccccccCChhhhhcCCC-CCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHc
Q 020016 185 KGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 263 (332)
...+||+.|+|||++.+..+ +.++||||+||++|+|+||+.||.+.+.......+... ...+|..+++++.+||.+|
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~ 246 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--VYTLPKFLSPGAAGLIKRM 246 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHHHHH
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHH
Confidence 67889999999999998876 57999999999999999999999998887777766543 4567788999999999999
Q ss_pred cccCCCCCCCHHHHHH
Q 020016 264 WSSSPDRRPHFDQIVS 279 (332)
Q Consensus 264 l~~dp~~Rps~~ell~ 279 (332)
|+.||++|||++|+++
T Consensus 247 L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 247 LIVNPLNRISIHEIMQ 262 (275)
T ss_dssp SCSSGGGSCCHHHHHH
T ss_pred ccCChhHCcCHHHHHc
Confidence 9999999999999987
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=391.44 Aligned_cols=222 Identities=25% Similarity=0.399 Sum_probs=190.6
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
.+++|++++.||+|+||+||+|++. |+.||||++........ ..+.|.+|+.+|++|+|||||+
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 97 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK----EREESRREVAVLANMKHPNIVQYRESFEENGS 97 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHH----HHHHHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence 3579999999999999999999997 89999999987544332 2467899999999999999997
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 334578999999999999999999999999999999999999999999999999976543
Q ss_pred CC-CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 020016 181 CG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 259 (332)
Q Consensus 181 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 259 (332)
.. .....+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+..+....+.... .++.+..+++++.+|
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~~~~~~s~~~~~l 256 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-FPPVSLHYSYDLRSL 256 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCCTTSCHHHHHH
T ss_pred CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCCccCCHHHHHH
Confidence 22 2235679999999999999999999999999999999999999999999888888776543 456778899999999
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 020016 260 ISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~ 279 (332)
|.+||+.||.+|||+.|+++
T Consensus 257 i~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 257 VSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHccCChhHCcCHHHHhc
Confidence 99999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-54 Score=390.92 Aligned_cols=236 Identities=21% Similarity=0.286 Sum_probs=200.7
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
++..+.+.|.+.++||+|+||+||+|+++ |+.||||+++.... +.+|+.+++.++|||||+
T Consensus 52 ~~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----------~~~E~~il~~l~HpnIV~l~~~~~ 120 (336)
T 4g3f_A 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----------RVEELVACAGLSSPRIVPLYGAVR 120 (336)
T ss_dssp BCCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----------CTHHHHTTTTCCCTTBCCEEEEEE
T ss_pred hhhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----------HHHHHHHHHhCCCCCCCcEEEEEE
Confidence 44556778999999999999999999997 88999999986432 246999999999999997
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC-eEEEeecccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVADFGISCL 177 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~a~~ 177 (332)
..+.+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||+|+.
T Consensus 121 ~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~ 200 (336)
T 4g3f_A 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC 200 (336)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred ECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence 346799999999999999999999999999999999999999998 699999999986
Q ss_pred cccCC------CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCCCC
Q 020016 178 ESQCG------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR-PPVPP 250 (332)
Q Consensus 178 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~-~~~~~ 250 (332)
..... .....+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+..+....+...... ..+++
T Consensus 201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 280 (336)
T 4g3f_A 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPP 280 (336)
T ss_dssp C------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCT
T ss_pred ccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCc
Confidence 54322 123457999999999999999999999999999999999999999987766666666544332 24678
Q ss_pred CCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCcccc
Q 020016 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFF 295 (332)
Q Consensus 251 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~ 295 (332)
.+++.+.+||.+||+.||.+|||+.|+++.|.........-..++
T Consensus 281 ~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw 325 (336)
T 4g3f_A 281 SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPW 325 (336)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCS
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCC
Confidence 899999999999999999999999999999998888777544443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-53 Score=381.91 Aligned_cols=220 Identities=25% Similarity=0.386 Sum_probs=194.3
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+++.||+|+||+||+|++. ++.||||++.+.... .....+.+.+|+++|++++|||||+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII---KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 468999999999999999999996 789999999763211 1112467899999999999999997
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC--
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-- 181 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 181 (332)
..+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|......
T Consensus 108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 3467999999999999999999999999999999999999999999999999999875432
Q ss_pred -CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 020016 182 -GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 260 (332)
Q Consensus 182 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 260 (332)
......+||+.|+|||++.+..|+.++|||||||++|+|+||..||.+.+..+....+... ...+|..+++++.+||
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli 265 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL--EYDFPEKFFPKARDLV 265 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTCCHHHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCcccCHHHHHHH
Confidence 2345678999999999999999999999999999999999999999999988888777654 3567888999999999
Q ss_pred HHccccCCCCCCCHHHHH
Q 020016 261 SRCWSSSPDRRPHFDQIV 278 (332)
Q Consensus 261 ~~cl~~dp~~Rps~~ell 278 (332)
.+||+.||.+|||++|++
T Consensus 266 ~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 266 EKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHSCSSGGGSTTSGGGT
T ss_pred HHHccCCHhHCcChHHHc
Confidence 999999999999999874
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-53 Score=386.06 Aligned_cols=220 Identities=24% Similarity=0.369 Sum_probs=193.2
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.+.|++.++||+|+||+||+|.++ |+.||||++....... .+.+.+|+.+|++++|||||+
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ 146 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR------RELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 146 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS------GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH------HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 357999999999999999999996 8899999997654332 256889999999999999997
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-CC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GS 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~ 183 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|...... ..
T Consensus 147 ~ivmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp EEEECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred EEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 3457999999999999999999999999999999999999999999999999999866543 34
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHH
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~ 262 (332)
....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+....+..... ....+..+++++.+||.+
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 5678899999999999999999999999999999999999999999888887777654322 223445789999999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~ 279 (332)
||+.||++|||+.|+++
T Consensus 307 ~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 307 LLVRDPAQRATAAELLK 323 (346)
T ss_dssp HSCSSTTTSCCHHHHTT
T ss_pred HcCCChhHCcCHHHHhc
Confidence 99999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=371.08 Aligned_cols=217 Identities=25% Similarity=0.455 Sum_probs=183.5
Q ss_pred eeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------
Q 020016 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------- 120 (332)
Q Consensus 57 y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 120 (332)
|++.++||+|+||+||+|.+. +..||||++........ ..+.|.+|+.+|++++|||||+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS----ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH----HHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH----HHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 478889999999999999997 78999999976543322 2467999999999999999986
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccccccceeecC-CCeEEEeecccccccc
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGE-DMCVKVADFGISCLES 179 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.||+.||.|||++| |+||||||+|||++. +|.+||+|||+|+...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 3457899999999999999999999998 999999999999974 7999999999997543
Q ss_pred cCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCcHHHHH
Q 020016 180 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-ARPPVPPTCPKAFSY 258 (332)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 258 (332)
. ......+||+.|+|||++.+ .|+.++|||||||++|||+||+.||.+.............. ....++..+++++.+
T Consensus 184 ~-~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (290)
T 3fpq_A 184 A-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261 (290)
T ss_dssp T-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred C-CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHH
Confidence 3 34456789999999999865 69999999999999999999999998765544444433333 333456778899999
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~ 279 (332)
||.+||+.||++|||+.++++
T Consensus 262 li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 262 IIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999985
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=387.05 Aligned_cols=220 Identities=24% Similarity=0.369 Sum_probs=194.5
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.+.|++.++||+|+||+||+|.+. |+.||||++....... .+.+.+|+.+|+.++|||||+
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ 223 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR------RELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 223 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS------GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH------HHHHHHHHHHHHhCCCCCCCceEEEEEECCEE
Confidence 367999999999999999999997 8999999998754433 256889999999999999997
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-CC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GS 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~ 183 (332)
....+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|...... ..
T Consensus 224 ~iVmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 224 WVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp EEEEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred EEEEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 3457999999999999999999999999999999999999999999999999999866543 34
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHH
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~ 262 (332)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+..... ....+..+++++.+||.+
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence 5678899999999999999999999999999999999999999999988887777655432 233456789999999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~ 279 (332)
||+.||++|||+.|+++
T Consensus 384 ~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 384 LLVRDPAQRATAAELLK 400 (423)
T ss_dssp HSCSSTTTSCCHHHHTT
T ss_pred HcCCChhHCcCHHHHhc
Confidence 99999999999999876
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=378.32 Aligned_cols=223 Identities=26% Similarity=0.388 Sum_probs=187.1
Q ss_pred ccccCCeeeeeeecccCceEEEEEEEC-----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
.++.++|++++.||+|+||+||+|++. ++.||||+++........ ...+.+|+.+|++++|||||+
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~l~~~~ 95 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD----RVRTKMERDILVEVNHPFIVKLHYAF 95 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE----CC------CCCCCCCCTTEECEEEEE
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH----HHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 456789999999999999999999873 578999999764322111 235788999999999999997
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccc
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
..+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 96 ~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 96 QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 346799999999999999999999999999999999999999999999999999976
Q ss_pred ccc-CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 020016 178 ESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 256 (332)
Q Consensus 178 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (332)
... .......+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+..+....+... ...+|..+|+++
T Consensus 176 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~ 253 (304)
T 3ubd_A 176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA--KLGMPQFLSPEA 253 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHH
T ss_pred ccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCCCCcCCHHH
Confidence 433 33445678999999999999999999999999999999999999999999988888777654 456788899999
Q ss_pred HHHHHHccccCCCCCCCH-----HHHHH
Q 020016 257 SYLISRCWSSSPDRRPHF-----DQIVS 279 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~-----~ell~ 279 (332)
.+||.+||+.||++|||+ +|+++
T Consensus 254 ~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 254 QSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 999999999999999984 56654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=371.49 Aligned_cols=221 Identities=23% Similarity=0.316 Sum_probs=188.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+++.||+|+||+||+|++. |+.||||++......... .+.+.+|+.+|+.++|||||+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN----AKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHH----HHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHH----HHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 57999999999999999999996 899999999765443322 356889999999999999986
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
..+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 130 ~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 130 EFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp TCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred cCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 45679999999999999999999999999999999999999999999999999997643
Q ss_pred cC-----CCCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC------
Q 020016 180 QC-----GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------ 247 (332)
Q Consensus 180 ~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~------ 247 (332)
.. ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+....+......+.
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 22 234567899999999998875 569999999999999999999999999888777766654322211
Q ss_pred -----------------------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 248 -----------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 248 -----------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..+.+++++.+||.+||..||.+|||+.|+++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 11356889999999999999999999999886
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=365.51 Aligned_cols=226 Identities=27% Similarity=0.506 Sum_probs=180.4
Q ss_pred CCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 120 (332)
.+|.+.++||+|+||+||+|.++|+.||||+++..... ...+..|+..+.+++|||||+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~-------~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-------SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHH-------HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchh-------hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 46899999999999999999999999999999764321 122345666777899999987
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCccccccccceeecCCCeEEEeecccc
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQ--------GILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 235688999999999999999999987 8999999999999999999999999999
Q ss_pred cccccCC-----CCCCcccccccCChhhhhcC------CCCCccchhHHHHHHHHHHhCCCCCCC----------C----
Q 020016 176 CLESQCG-----SAKGFTGTYRWMAPEMIKEK------RHTKKVDVYSFGIVLWELLTALTPFDN----------M---- 230 (332)
Q Consensus 176 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~il~elltG~~pf~~----------~---- 230 (332)
+...... .....+||+.|+|||++.+. .++.++|||||||++|||+||..||.. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 7654332 12345799999999999764 357799999999999999999765532 1
Q ss_pred -CHHHHHHHHHhcCCCCCCCCC-----CcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 231 -TPEQAAFAVCQKNARPPVPPT-----CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 231 -~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
........+.....++.+|.. ++..+.+|+.+||+.||++|||+.+|++.|+.+.++
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 223444445555666666643 335789999999999999999999999999988654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=362.31 Aligned_cols=217 Identities=28% Similarity=0.437 Sum_probs=166.3
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|++.+.||+|+||+||+|+++ ++.||||++....... ..+.+.+|+.+|++++|||||+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL-----AREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHH-----HHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHH-----HHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence 47999999999999999999997 8899999998654332 2467899999999999999986
Q ss_pred ----------------------------CC---CCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEE
Q 020016 121 ----------------------------EP---YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 169 (332)
Q Consensus 121 ----------------------------~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl 169 (332)
.. ...++..++.++.||+.||.|||++||+||||||+|||++.+|.+||
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence 11 12345668899999999999999999999999999999999999999
Q ss_pred eecccccccccCCC-------------CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 020016 170 ADFGISCLESQCGS-------------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA 236 (332)
Q Consensus 170 ~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~ 236 (332)
+|||+|+....... ....+||+.|+|||++.+..|+.++|||||||++|||++ ||.........
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~ 236 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT 236 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence 99999976543221 234579999999999999999999999999999999996 77653222111
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 237 FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.........++.....++.+.+||.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111222222223345667889999999999999999999886
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=341.21 Aligned_cols=244 Identities=35% Similarity=0.604 Sum_probs=199.8
Q ss_pred CCccccccccCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 45 EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 45 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
....+|.++.++|.+.+.||+|+||+||+|.+.++.||||++........ ..+.+.+|+.++++++||||++
T Consensus 27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~ 102 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAE----RVNEFLREVAIMKRLRHPNIVLFMGA 102 (309)
T ss_dssp -----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHH----HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHH----HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34577889999999999999999999999999999999999987554332 2467899999999999999987
Q ss_pred ------------------------CCC---CCCHHHHHHHHHHHHHHHHHHHHCC--CccccccccceeecCCCeEEEee
Q 020016 121 ------------------------EPY---SVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGEDMCVKVAD 171 (332)
Q Consensus 121 ------------------------~~~---~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~NIll~~~~~~kl~D 171 (332)
... .+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|
T Consensus 103 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp ECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred EEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECC
Confidence 111 2889999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCC-CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 020016 172 FGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP 250 (332)
Q Consensus 172 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (332)
||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.........+.
T Consensus 183 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (309)
T 3p86_A 183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPR 262 (309)
T ss_dssp CC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCT
T ss_pred CCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCc
Confidence 99987544322 23456799999999999999999999999999999999999999999998888777776777788889
Q ss_pred CCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCc
Q 020016 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 292 (332)
Q Consensus 251 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~ 292 (332)
.+++.+.+||.+||+.||.+|||+.++++.|+.+......++
T Consensus 263 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999999999999987765443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=369.95 Aligned_cols=220 Identities=21% Similarity=0.323 Sum_probs=194.7
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+++.||+|+||.||+|.++ |+.||||++....... .+.+.+|+.+|+.++|||||+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~------~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 229 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD------KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 229 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH------HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhh------HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 468999999999999999999997 8899999998754332 366889999999999999986
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC--CeEEEeeccccccccc
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED--MCVKVADFGISCLESQ 180 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~--~~~kl~Dfg~a~~~~~ 180 (332)
..+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 34578999999999999999999999999999999999999854 8999999999987766
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHHH
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCPKAFSY 258 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 258 (332)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+....... .....+++++.+
T Consensus 310 ~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d 389 (573)
T 3uto_A 310 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 389 (573)
T ss_dssp TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 555566789999999999999999999999999999999999999999999988887776544332 234678999999
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~ 279 (332)
||.+||+.||.+|||+.|+++
T Consensus 390 li~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 390 FIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=345.67 Aligned_cols=217 Identities=19% Similarity=0.288 Sum_probs=172.9
Q ss_pred CCeeeeeeecccCceEEEEEEEC-----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec--------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT-------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~-------- 120 (332)
++|++.++||+|+||+||+|.++ ++.||||++...... ..+.+|+++|+.+ +|||||+
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~--------~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP--------IRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCH--------HHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCH--------HHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 67999999999999999999873 578999998765432 4578899999998 6999987
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC-CeEEEeecccccccccCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGISCLESQCG 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~ 182 (332)
.-..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+......
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred CEEEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 11468999999999999999999999999999999999999877 899999999996433211
Q ss_pred -----------------------------CCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCC-
Q 020016 183 -----------------------------SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMT- 231 (332)
Q Consensus 183 -----------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~- 231 (332)
.....+||+.|+|||++.+. .++.++||||+||++|+|+||+.||...+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 12345799999999999875 48999999999999999999999995433
Q ss_pred HHHHHHHHHhc----------------------------------------------------CCCCCCCCCCcHHHHHH
Q 020016 232 PEQAAFAVCQK----------------------------------------------------NARPPVPPTCPKAFSYL 259 (332)
Q Consensus 232 ~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~l~~l 259 (332)
..+....+... .........+++++.+|
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 33322222110 00011224578999999
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 020016 260 ISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~ 279 (332)
|.+||+.||.+|||++|+++
T Consensus 333 l~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHCcCChhHCcCHHHHhc
Confidence 99999999999999999885
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=365.04 Aligned_cols=224 Identities=20% Similarity=0.284 Sum_probs=183.6
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
..++|.+++.||+|+||+||+|+++ |+.||||++.+.................++.+++.++|||||+
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 3679999999999999999999997 8899999997632211111111222344577888899999997
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 182 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 182 (332)
..+.+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|......
T Consensus 267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~- 345 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 345 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC-
Confidence 3467999999999999999999999999999999999999999999999999999766543
Q ss_pred CCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 020016 183 SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMT---PEQAAFAVCQKNARPPVPPTCPKAFSY 258 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~ 258 (332)
.....+||+.|+|||++.. ..|+.++|+|||||++|||++|..||.+.+ ...+...+. .....+|..+++++.+
T Consensus 346 ~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~--~~~~~~p~~~S~~a~d 423 (689)
T 3v5w_A 346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TMAVELPDSFSPELRS 423 (689)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH--HCCCCCCTTSCHHHHH
T ss_pred CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc--CCCCCCCccCCHHHHH
Confidence 3456789999999999964 579999999999999999999999997632 233333332 3455678899999999
Q ss_pred HHHHccccCCCCCCC-----HHHHHH
Q 020016 259 LISRCWSSSPDRRPH-----FDQIVS 279 (332)
Q Consensus 259 li~~cl~~dp~~Rps-----~~ell~ 279 (332)
||.+||+.||.+|++ +++|++
T Consensus 424 LI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 424 LLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 999999999999998 677765
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=323.52 Aligned_cols=233 Identities=27% Similarity=0.552 Sum_probs=202.8
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
...|.++.++|++.+.||+|+||+||+|.+. ++.||||++....... +.+.+|+.++++++||||++
T Consensus 2 ~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~ 74 (269)
T 4hcu_A 2 SGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-------EDFIEEAEVMMKLSHPKLVQLYGVC 74 (269)
T ss_dssp ---CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH-------HHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH-------HHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3569999999999999999999999999995 7889999998765442 56889999999999999987
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccc
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 75 LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR 154 (269)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred ecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccc
Confidence 34568999999999999999999999999999999999999999999999999987
Q ss_pred ccccC--CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 020016 177 LESQC--GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 253 (332)
Q Consensus 177 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (332)
..... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. .......+..++
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 233 (269)
T 4hcu_A 155 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLAS 233 (269)
T ss_dssp GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSC
T ss_pred cccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-cCccCCCCCcCC
Confidence 54332 12334556889999999999999999999999999999999 999999988877766654 345666777889
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 254 KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 254 ~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
+.+.+++.+||+.||.+||++.++++.|+.+.++
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 234 THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 9999999999999999999999999999988654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=321.03 Aligned_cols=231 Identities=33% Similarity=0.662 Sum_probs=192.9
Q ss_pred ccccCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
+++.++|.+.+.||+|+||.||+|.+.++.||||++........ ....+.+.+|+.+++.++||||++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDI--SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccH--HHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 46678999999999999999999999999999999876433221 122467889999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccccccceeecC--------CCeEEEeec
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQG---ILHRDLKSENLLLGE--------DMCVKVADF 172 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~NIll~~--------~~~~kl~Df 172 (332)
....+++..++.++.|++.||.|||++| ++||||||+||+++. ++.++|+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred eEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 4567999999999999999999999999 899999999999986 678999999
Q ss_pred ccccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 020016 173 GISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTC 252 (332)
Q Consensus 173 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (332)
|++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.+.................+..+
T Consensus 161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3dtc_A 161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239 (271)
T ss_dssp CC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred Cccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence 9987654432 234578999999999999999999999999999999999999999999888888777777777888899
Q ss_pred cHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 253 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
++.+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=332.71 Aligned_cols=220 Identities=28% Similarity=0.430 Sum_probs=194.0
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.+++.++||||++
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPT----SLQKLFREVRIMKILNHPNIVKLFEVIETEKTL 89 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 578999999999999999999985 89999999977543322 2466889999999999999987
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
..+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 169 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence 235689999999999999999999999999999999999999999999999999977665555
Q ss_pred CCCcccccccCChhhhhcCCCC-CccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHT-KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 262 (332)
....+||+.|+|||++.+..++ .++||||||+++|+|++|..||.+.+..+....+... ....|..+++++.+|+.+
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~ 247 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KYRIPFYMSTDCENLLKR 247 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHH
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHHHH
Confidence 5667899999999999988775 7999999999999999999999999888877776544 345667889999999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~ 279 (332)
||..||.+|||++++++
T Consensus 248 ~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 248 FLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HCCSSTTTSCCHHHHTT
T ss_pred HCCCChhHCcCHHHHhc
Confidence 99999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=321.70 Aligned_cols=236 Identities=26% Similarity=0.509 Sum_probs=201.6
Q ss_pred CCCccccccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--
Q 020016 44 GEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120 (332)
Q Consensus 44 ~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-- 120 (332)
......|.++.++|.+.+.||+|+||.||+|.+. +..||||++....... +.+.+|+.++.+++||||++
T Consensus 13 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~ 85 (283)
T 3gen_A 13 GLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-------DEFIEEAKVMMNLSHEKLVQLY 85 (283)
T ss_dssp ---CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH-------HHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCCCCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH-------HHHHHHHHHHhcCCCCCEeeEE
Confidence 3445789999999999999999999999999997 6789999998765432 56889999999999999986
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecc
Q 020016 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 121 ---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg 165 (283)
T 3gen_A 86 GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG 165 (283)
T ss_dssp EEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTT
T ss_pred EEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccc
Confidence 13568999999999999999999999999999999999999999999999999
Q ss_pred cccccccC--CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 020016 174 ISCLESQC--GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 250 (332)
Q Consensus 174 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (332)
++...... .......+|+.|+|||.+.+..++.++||||||+++|+|+| |..||...........+. .......+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 244 (283)
T 3gen_A 166 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPH 244 (283)
T ss_dssp GGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCT
T ss_pred ccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-cccCCCCCC
Confidence 98754332 12234456889999999999999999999999999999998 999999988877766654 445566677
Q ss_pred CCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 251 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
.+++.+.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus 245 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 245 LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 8899999999999999999999999999999988654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=344.74 Aligned_cols=238 Identities=28% Similarity=0.573 Sum_probs=208.2
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
....|+++.++|.+.+.||+|+||+||+|.++ +..||||++...... .+.|.+|+.+|++++||||++
T Consensus 179 ~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~ 251 (454)
T 1qcf_A 179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-------VEAFLAEANVMKTLQHDKLVKLHAV 251 (454)
T ss_dssp CTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC-------HHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc-------HHHHHHHHHHHhhCCCCCEeeEEEE
Confidence 35789999999999999999999999999997 788999999875432 367999999999999999987
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 252 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 252 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp ECSSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred EeCCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 1125788899999999999999999999999999999999999999999999999
Q ss_pred cccccCC--CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 020016 176 CLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 252 (332)
Q Consensus 176 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (332)
....... ......+|+.|+|||++....++.++||||||+++|||+| |..||.+.+..+....+. ...+.+.+..+
T Consensus 332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~ 410 (454)
T 1qcf_A 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENC 410 (454)
T ss_dssp GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTS
T ss_pred eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Confidence 7653321 2233456789999999999999999999999999999999 999999998887776664 45566778899
Q ss_pred cHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 020016 253 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 291 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~ 291 (332)
++.+.+||.+||+.||++|||+.+|++.|+.+..+.+.+
T Consensus 411 ~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~ 449 (454)
T 1qcf_A 411 PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449 (454)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccccc
Confidence 999999999999999999999999999999998776554
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=318.85 Aligned_cols=230 Identities=27% Similarity=0.534 Sum_probs=203.2
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
.+.++.++|.+.+.||+|+||.||+|.++++.||||++......... .+.|.+|+.++++++||||++
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRK----SRDFNEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHH----HHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHH----HHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence 46677899999999999999999999999999999999876433321 367899999999999999987
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccccccceeecCCCeEEEeeccc
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..++.++.|++.||.|||++| ++||||||+||+++.++.++|+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV 159 (271)
T ss_dssp TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccc
Confidence 1225899999999999999999999999 99999999999999999999999988
Q ss_pred ccccccCCCCCCcccccccCChhhhhcCCCCC---ccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 020016 175 SCLESQCGSAKGFTGTYRWMAPEMIKEKRHTK---KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 251 (332)
Q Consensus 175 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (332)
+.... .....+|+.|+|||.+.+..++. ++||||||+++|+|++|..||...+..............+..+..
T Consensus 160 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (271)
T 3kmu_A 160 KFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG 235 (271)
T ss_dssp CCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred eeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCC
Confidence 65422 23457899999999998765544 799999999999999999999999998888888778888888999
Q ss_pred CcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 020016 252 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 252 ~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 286 (332)
+++.+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 236 ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 99999999999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=335.12 Aligned_cols=241 Identities=24% Similarity=0.465 Sum_probs=206.0
Q ss_pred cCCCccccccccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-C
Q 020016 43 KGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-N 114 (332)
Q Consensus 43 ~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 114 (332)
.......|+++.++|.+++.||+|+||.||+|.+. ++.||||++........ .+.+.+|+.++.++ +
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~ 84 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGH 84 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHH-----HHHHHHHHHHHHhhcC
Confidence 34456789999999999999999999999999852 47899999986543322 36789999999999 7
Q ss_pred CCceec-----------------------------CC-------------------------------------------
Q 020016 115 HPHIIT-----------------------------EP------------------------------------------- 122 (332)
Q Consensus 115 h~niv~-----------------------------~~------------------------------------------- 122 (332)
||||++ ..
T Consensus 85 hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (359)
T 3vhe_A 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSAS 164 (359)
T ss_dssp CTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------
T ss_pred CcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccc
Confidence 899986 11
Q ss_pred -----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 123 -----------------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 123 -----------------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 165 SGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp -------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred cccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 118899999999999999999999999999999999999999999999999997543
Q ss_pred cCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 020016 180 QCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255 (332)
Q Consensus 180 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (332)
... ......+|+.|+|||++.+..++.++||||||+++|+|+| |..||.+...................+..++++
T Consensus 245 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (359)
T 3vhe_A 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE 324 (359)
T ss_dssp SCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHH
T ss_pred ccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHH
Confidence 322 2234568899999999999999999999999999999998 999999877666665666667777888889999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 020016 256 FSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 288 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 288 (332)
+.+++.+||+.||.+|||+.++++.|+.+..+.
T Consensus 325 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 325 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=328.48 Aligned_cols=235 Identities=31% Similarity=0.548 Sum_probs=200.6
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC-----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
+++..++|.+.+.||+|+||+||+|.+. +..||||++....... ..+.|.+|+.+++.++||||++
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~ 118 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER-----QRRDFLSEASIMGQFDHPNIIRLEGV 118 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHH-----HHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHH-----HHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 4566789999999999999999999985 3469999998654332 2467899999999999999986
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 119 VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198 (325)
T ss_dssp ECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred EEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcc
Confidence 3457899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC----CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 020016 176 CLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 250 (332)
Q Consensus 176 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (332)
........ .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .....+.+.
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 277 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPM 277 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCT
T ss_pred cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCCCCCCC
Confidence 76543221 223345778999999999999999999999999999999 999999988887776664 445667788
Q ss_pred CCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 020016 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 290 (332)
Q Consensus 251 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~ 290 (332)
.+++.+.+|+.+||+.||.+||++.++++.|+.+....+.
T Consensus 278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 8999999999999999999999999999999999876553
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=338.72 Aligned_cols=236 Identities=31% Similarity=0.578 Sum_probs=203.8
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--- 120 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--- 120 (332)
....|.++.++|.+++.||+|+||.||+|.+. ++.||||++....... ..+.|.+|+.++++++||||++
T Consensus 105 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~ 179 (377)
T 3cbl_A 105 PKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD-----LKAKFLQEARILKQYSHPNIVRLIG 179 (377)
T ss_dssp CCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHH-----HHTTTTHHHHHHTTCCCTTBCCEEE
T ss_pred cccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHH-----HHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 35689999999999999999999999999996 7899999997643322 2457889999999999999987
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+
T Consensus 180 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGM 259 (377)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred EEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCC
Confidence 123588999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 020016 175 SCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 250 (332)
Q Consensus 175 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (332)
+....... ......+++.|+|||.+.++.++.++||||||+++|||+| |..||......+....+ ....+.+.+.
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~ 338 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV-EKGGRLPCPE 338 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH-HTTCCCCCCT
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCC
Confidence 87543221 1122346788999999999999999999999999999999 99999998887765554 4556677888
Q ss_pred CCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 251 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
.+++.+.+||.+||+.||++|||+.++++.|+.+...
T Consensus 339 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 339 LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 8999999999999999999999999999999988654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=343.48 Aligned_cols=230 Identities=28% Similarity=0.542 Sum_probs=201.2
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
...|.++.++|.+.+.||+|+||.||+|.++++.||||+++.... .+.|.+|+.++++++||||++
T Consensus 185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~ 256 (450)
T 1k9a_A 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIV 256 (450)
T ss_dssp HTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTT--------SHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchH--------HHHHHHHHHHHHhccCCCEEEEEEEEE
Confidence 367999999999999999999999999999999999999986542 356899999999999999987
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
....+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++
T Consensus 257 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a 336 (450)
T 1k9a_A 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336 (450)
T ss_dssp CTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence 1233789999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 020016 176 CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254 (332)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (332)
...... .....+++.|+|||.+.+..++.++||||||+++|||+| |..||......+....+. ...+...|..+++
T Consensus 337 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~p~~~~~ 413 (450)
T 1k9a_A 337 KEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPP 413 (450)
T ss_dssp EECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCH
T ss_pred cccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCH
Confidence 754332 223467889999999999999999999999999999999 999999887766665553 4567778889999
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 255 AFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 255 ~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
.+.+||.+||+.||.+|||+.++++.|+.+...
T Consensus 414 ~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 414 AVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999999999987653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=320.03 Aligned_cols=239 Identities=30% Similarity=0.567 Sum_probs=205.3
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
-..+|+++.++|.+.+.||+|+||.||+|.+. +..||||++...... .+.+.+|+.+++.++||||++
T Consensus 4 ~~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~ 76 (279)
T 1qpc_A 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-------PDAFLAEANLMKQLQHQRLVRLYAV 76 (279)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC-------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred chhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc-------HHHHHHHHHHHHhCCCcCcceEEEE
Confidence 45789999999999999999999999999987 578999999765433 256889999999999999986
Q ss_pred ----------------------C---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccc
Q 020016 121 ----------------------E---PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 121 ----------------------~---~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus 77 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 156 (279)
T 1qpc_A 77 VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156 (279)
T ss_dssp ECSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EcCCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccc
Confidence 1 126899999999999999999999999999999999999999999999999998
Q ss_pred cccccCC--CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 020016 176 CLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 252 (332)
Q Consensus 176 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (332)
....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+. .......+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 235 (279)
T 1qpc_A 157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNC 235 (279)
T ss_dssp EECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTC
T ss_pred ccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-cccCCCCcccc
Confidence 7654322 2234456789999999998889999999999999999999 999999988877665554 44556677889
Q ss_pred cHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCc
Q 020016 253 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 292 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~ 292 (332)
++.+.+++.+||+.||++|||+.++++.|+.+......+.
T Consensus 236 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 275 (279)
T 1qpc_A 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQY 275 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC----
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCC
Confidence 9999999999999999999999999999999988877554
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=342.31 Aligned_cols=239 Identities=31% Similarity=0.575 Sum_probs=204.1
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
....|+++.++|.+.+.||+|+||.||+|.++ +..||||++...... .+.|.+|+.+|++++||||++
T Consensus 175 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~~~~~ 247 (452)
T 1fmk_A 175 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-------PEAFLQEAQVMKKLRHEKLVQLYAV 247 (452)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC-------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC-------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 35789999999999999999999999999998 578999999875432 256899999999999999986
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 248 ~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp ECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred EcCCceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccc
Confidence 1245889999999999999999999999999999999999999999999999999
Q ss_pred cccccCC--CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 020016 176 CLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 252 (332)
Q Consensus 176 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (332)
....... ......+++.|+|||.+.+..++.++||||||+++|||+| |..||.+....+....+. ...+.+.+..+
T Consensus 328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~ 406 (452)
T 1fmk_A 328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPEC 406 (452)
T ss_dssp C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTS
T ss_pred eecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Confidence 7654322 1233456789999999999999999999999999999999 999999988877766654 45667778899
Q ss_pred cHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCc
Q 020016 253 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 292 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~ 292 (332)
++.+.+||.+||+.||++|||++++++.|+.+..+.+.+.
T Consensus 407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~ 446 (452)
T 1fmk_A 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446 (452)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence 9999999999999999999999999999999987766544
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=318.07 Aligned_cols=231 Identities=28% Similarity=0.554 Sum_probs=200.0
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
.|++..++|++.+.||+|+||.||+|.+. +..||||++....... +.+.+|+.++.+++||||++
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-------DEFFQEAQTMMKLSHPKLVKFYGVCSK 74 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH-------HHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH-------HHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 46778899999999999999999999987 5689999998755432 56889999999999999987
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV 154 (268)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred CCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceec
Confidence 1235899999999999999999999999999999999999999999999999998755
Q ss_pred ccCC--CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 020016 179 SQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255 (332)
Q Consensus 179 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (332)
.... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...........+. .......+..+++.
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDT 233 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSCHH
T ss_pred chhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcChHH
Confidence 4322 1233456778999999999899999999999999999999 999999988877766654 34455667778999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 256 FSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 234 IYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 99999999999999999999999999998654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=321.31 Aligned_cols=236 Identities=32% Similarity=0.633 Sum_probs=186.7
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
....+++..++|++.+.||+|+||+||+|.+.+ .||||++........ ..+.|.+|+.++++++||||+.
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ----QLQAFKNEVGVLRKTRHVNILLFMGYS 89 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHH----HHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHH----HHHHHHHHHHHHHhCCCCcEEEEEeec
Confidence 346788889999999999999999999998866 499999987654332 2467899999999999999986
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccc
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
....+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccc
Confidence 345689999999999999999999999999999999999999999999999999875
Q ss_pred cccC---CCCCCcccccccCChhhhh---cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCC---C
Q 020016 178 ESQC---GSAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-ARP---P 247 (332)
Q Consensus 178 ~~~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~-~~~---~ 247 (332)
.... .......||+.|+|||.+. +..++.++||||||+++|+|++|..||......+......... ..+ .
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence 4321 2223457899999999986 5667889999999999999999999998866555444443332 222 2
Q ss_pred CCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 020016 248 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 248 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 286 (332)
....+++.+.+|+.+||+.||.+||++.++++.|+.+..
T Consensus 250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 345789999999999999999999999999999998754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=319.96 Aligned_cols=235 Identities=29% Similarity=0.612 Sum_probs=191.9
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEEC-----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT- 120 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~- 120 (332)
..+|++..++|.+++.||+|+||.||+|.+. +..||||++....... ..+.+.+|+.++++++||||++
T Consensus 7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~ 81 (281)
T 1mp8_A 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS-----VREKFLQEALTMRQFDHPHIVKL 81 (281)
T ss_dssp --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHH-----HHHHHHHHHHHHHTCCCTTBCCE
T ss_pred ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHH-----HHHHHHHHHHHHHhCCCCccceE
Confidence 3568888999999999999999999999985 3469999987643322 2467899999999999999986
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecc
Q 020016 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 121 ---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
....+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 161 (281)
T 1mp8_A 82 IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 161 (281)
T ss_dssp EEEECSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred EEEEccCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccc
Confidence 34468999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC--CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 020016 174 ISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 250 (332)
Q Consensus 174 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (332)
++........ .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+. .......+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-~~~~~~~~~ 240 (281)
T 1mp8_A 162 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPP 240 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCT
T ss_pred cccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-cCCCCCCCC
Confidence 9876543322 233456789999999999999999999999999999997 999999887766655554 344566788
Q ss_pred CCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 251 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
.+++.+.+++.+||+.||.+||++.++++.|+.+.+.
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 8999999999999999999999999999999988764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=322.43 Aligned_cols=234 Identities=25% Similarity=0.467 Sum_probs=191.7
Q ss_pred cccccCCeeeeeeecccCceEEEEEEE------CCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIY------KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--- 120 (332)
..+..++|++.+.||+|+||+||+|.+ .++.||||++....... .+.+.+|+.++++++||||++
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~ 78 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH------LRDFEREIEILKSLQHDNIVKYKG 78 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHH------HHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHH------HHHHHHHHHHHHhCCCCCEeeEEE
Confidence 345568999999999999999999985 37899999998654322 467899999999999999986
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeec
Q 020016 121 ----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 172 (332)
Q Consensus 121 ----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Df 172 (332)
....+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+||
T Consensus 79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 79 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp EECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred EEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccC
Confidence 2345899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC----CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHH--------------
Q 020016 173 GISCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-------------- 234 (332)
Q Consensus 173 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~-------------- 234 (332)
|++....... ......++..|+|||.+.+..++.++||||||+++|+|+||..||.......
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence 9997654322 1233457788999999999999999999999999999999999987532210
Q ss_pred -HHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 235 -AAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 235 -~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
..........+.+.+..+++++.+++.+||+.||.+|||+.++++.|+.+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 1222333455667788999999999999999999999999999999999988764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=331.89 Aligned_cols=236 Identities=25% Similarity=0.500 Sum_probs=202.0
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEEC---------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCc
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK---------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPH 117 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 117 (332)
..|.+..++|.+++.||+|+||.||+|.+. +..||||++........ .+.+.+|+.+++.+ +|||
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~hpn 148 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-----LSDLVSEMEMMKMIGKHKN 148 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHH-----HHHHHHHHHHHHHSCCCTT
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHH-----HHHHHHHHHHHHHhcCCCC
Confidence 457788899999999999999999999873 35799999987543322 46789999999999 8999
Q ss_pred eec-----------------------------C---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 020016 118 IIT-----------------------------E---------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRD 153 (332)
Q Consensus 118 iv~-----------------------------~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~d 153 (332)
|++ . ...+++..++.++.||+.||.|||++||+|||
T Consensus 149 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD 228 (370)
T 2psq_A 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRD 228 (370)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred EeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 986 1 13478999999999999999999999999999
Q ss_pred ccccceeecCCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCC
Q 020016 154 LKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 229 (332)
Q Consensus 154 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~ 229 (332)
|||+|||++.++.+||+|||++....... ......+|+.|+|||++.+..++.++||||||+++|||+| |..||.+
T Consensus 229 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~ 308 (370)
T 2psq_A 229 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308 (370)
T ss_dssp CCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999997554322 2234557889999999999999999999999999999999 9999998
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 230 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
....+....+ ....++..+..+++++.++|.+||+.||.+||++.++++.|+.+.....
T Consensus 309 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 309 IPVEELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp CCGGGHHHHH-HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CCHHHHHHHH-hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 8776655544 3455677788999999999999999999999999999999999876544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=314.73 Aligned_cols=231 Identities=27% Similarity=0.558 Sum_probs=201.7
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
.|.++.++|.+.+.||+|+||.||+|.+. ++.||||++....... +.+.+|+.+++.++||||++
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~ 74 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-------EDFIEEAEVMMKLSHPKLVQLYGVCLE 74 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH-------HHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH-------HHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 58899999999999999999999999996 7899999998765432 56889999999999999986
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 75 QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 154 (267)
T ss_dssp SSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred CCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccc
Confidence 3356899999999999999999999999999999999999999999999999998754
Q ss_pred ccC--CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 020016 179 SQC--GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255 (332)
Q Consensus 179 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (332)
... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. .......+..+++.
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 233 (267)
T 3t9t_A 155 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTH 233 (267)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSCHH
T ss_pred ccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh-cCCcCCCCccCcHH
Confidence 321 12234557889999999999999999999999999999999 999999988877766654 34455667788999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 256 FSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
+.+++.+||+.||.+||++.++++.|+.+.++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 234 VYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999998653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=321.63 Aligned_cols=239 Identities=26% Similarity=0.493 Sum_probs=205.9
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEEE-------CCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCc
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIY-------KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPH 117 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 117 (332)
....|.+..++|.+++.||+|+||.||+|.+ .++.||||++........ .+.+.+|+.++.++ +|||
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~h~~ 88 (313)
T 1t46_A 14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-----REALMSELKVLSYLGNHMN 88 (313)
T ss_dssp CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCCCTT
T ss_pred CccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHH-----HHHHHHHHHHHhhcccCCC
Confidence 3567899999999999999999999999986 257899999986543221 46789999999999 9999
Q ss_pred eec-----------------------------CC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 020016 118 IIT-----------------------------EP-----------------YSVPLNLVLKLALDIARGMQYLHSQGILH 151 (332)
Q Consensus 118 iv~-----------------------------~~-----------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH 151 (332)
|++ .. ..+++..++.++.||+.||.|||++|++|
T Consensus 89 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 168 (313)
T 1t46_A 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIH 168 (313)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred eeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 986 11 14899999999999999999999999999
Q ss_pred ccccccceeecCCCeEEEeecccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCC
Q 020016 152 RDLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPF 227 (332)
Q Consensus 152 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf 227 (332)
|||||+||+++.++.+||+|||++........ .....+|+.|+|||.+.+..++.++||||||+++|+|+| |..||
T Consensus 169 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 248 (313)
T 1t46_A 169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (313)
T ss_dssp SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999876544322 234557889999999999999999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 228 DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
.+...................+..+++.+.+++.+||+.||.+|||+.++++.|+.+..+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp TTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred CcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 98776665666666666777778899999999999999999999999999999999877644
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=329.86 Aligned_cols=244 Identities=25% Similarity=0.490 Sum_probs=208.4
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEEEC---------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CC
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK---------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NH 115 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 115 (332)
....|++..++|.+++.||+|+||+||+|.+. +..||||++........ .+.+.+|+.+++.+ +|
T Consensus 60 ~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~h 134 (382)
T 3tt0_A 60 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-----LSDLISEMEMMKMIGKH 134 (382)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCCC
T ss_pred cCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHH-----HHHHHHHHHHHHHhcCC
Confidence 34578899999999999999999999999973 25799999987544322 46789999999999 99
Q ss_pred Cceec-----------------------------C---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 020016 116 PHIIT-----------------------------E---------------PYSVPLNLVLKLALDIARGMQYLHSQGILH 151 (332)
Q Consensus 116 ~niv~-----------------------------~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH 151 (332)
|||++ . ...+++..++.++.||+.||.|||++||+|
T Consensus 135 pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 214 (382)
T 3tt0_A 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIH 214 (382)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred chhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 99987 1 135899999999999999999999999999
Q ss_pred ccccccceeecCCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCC
Q 020016 152 RDLKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPF 227 (332)
Q Consensus 152 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf 227 (332)
|||||+|||++.++.+||+|||++....... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 215 ~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~ 294 (382)
T 3tt0_A 215 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294 (382)
T ss_dssp SCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999997654322 2334567889999999999999999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCcccc
Q 020016 228 DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFF 295 (332)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~ 295 (332)
.+....+....+ ........+..+++++.+|+.+||+.||.+||++.++++.|+.+......+....
T Consensus 295 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~ 361 (382)
T 3tt0_A 295 PGVPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGY 361 (382)
T ss_dssp TTCCHHHHHHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC---
T ss_pred CCCCHHHHHHHH-HcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCC
Confidence 998877766555 3555677788899999999999999999999999999999999988877665443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=324.95 Aligned_cols=241 Identities=29% Similarity=0.508 Sum_probs=188.1
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEECC--e---eEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ--R---DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT- 120 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~--~---~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~- 120 (332)
..++.+..++|.+++.||+|+||+||+|.+.. . .||||++........ ..+.+.+|+.++++++||||++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~ 90 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS----DIEEFLREAACMKEFDHPHVAKL 90 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CH----HHHHHHHHHHHHTTCCCTTBCCC
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHH----HHHHHHHHHHHHHHCCCCceehh
Confidence 35667778999999999999999999999863 2 799999976532221 1467899999999999999986
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee
Q 020016 121 ---------------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 161 (332)
Q Consensus 121 ---------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll 161 (332)
....+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 91 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli 170 (323)
T 3qup_A 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML 170 (323)
T ss_dssp CEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred hceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE
Confidence 11158899999999999999999999999999999999999
Q ss_pred cCCCeEEEeecccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 020016 162 GEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAF 237 (332)
Q Consensus 162 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~ 237 (332)
+.++.+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+...
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~ 250 (323)
T 3qup_A 171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN 250 (323)
T ss_dssp CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH
Confidence 9999999999999976543221 223456789999999999999999999999999999999 999999888776665
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCc
Q 020016 238 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 292 (332)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~ 292 (332)
.+. .......+..+++.+.+|+.+||+.||.+|||+.++++.|+.+........
T Consensus 251 ~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 251 YLI-GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp HHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred HHh-cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 554 445567778899999999999999999999999999999999988776444
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=328.57 Aligned_cols=239 Identities=24% Similarity=0.467 Sum_probs=200.1
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEE-------CCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCce
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIY-------KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHI 118 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 118 (332)
..+|+++.++|.+++.||+|+||.||+|.+ .+..||||++....... ..+.+.+|+.++.++ +||||
T Consensus 37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~i 111 (344)
T 1rjb_A 37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-----EREALMSELKMMTQLGSHENI 111 (344)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTB
T ss_pred CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHH-----HHHHHHHHHHHHHhhcCCCCe
Confidence 357899999999999999999999999997 24689999998643221 246789999999999 99999
Q ss_pred ec-----------------------------CC----------------------CCCCHHHHHHHHHHHHHHHHHHHHC
Q 020016 119 IT-----------------------------EP----------------------YSVPLNLVLKLALDIARGMQYLHSQ 147 (332)
Q Consensus 119 v~-----------------------------~~----------------------~~l~~~~~~~i~~qi~~~L~~LH~~ 147 (332)
++ .. ..+++..++.++.||+.||.|||++
T Consensus 112 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 191 (344)
T 1rjb_A 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK 191 (344)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 86 11 2378999999999999999999999
Q ss_pred CCccccccccceeecCCCeEEEeecccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-C
Q 020016 148 GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-A 223 (332)
Q Consensus 148 ~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G 223 (332)
||+||||||+||+++.++.++|+|||++........ .....+|+.|+|||.+.+..++.++||||||+++|+|+| |
T Consensus 192 ~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 271 (344)
T 1rjb_A 192 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 271 (344)
T ss_dssp TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999976543322 234557889999999999999999999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 020016 224 LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 290 (332)
Q Consensus 224 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~ 290 (332)
..||.+...................+..+++.+.+|+.+||+.||.+||++.++++.|+.+......
T Consensus 272 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 272 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp CCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred CCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 9999987766666666666777778888999999999999999999999999999999998776553
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=325.64 Aligned_cols=237 Identities=30% Similarity=0.523 Sum_probs=201.4
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEECC-------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 120 (332)
..|.+..++|.+.+.||+|+||.||+|.+.+ +.||||++....... ..+.+.+|+.+++.++||||++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~ 114 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-----MQADFQREAALMAEFDNPNIVK 114 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHH-----HHHHHHHHHHHHHTCCCTTBCC
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHH-----HHHHHHHHHHHHHhCCCCCEEE
Confidence 4567788999999999999999999999863 789999998654322 2467899999999999999986
Q ss_pred -----------------------------C-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 020016 121 -----------------------------E-----------------------PYSVPLNLVLKLALDIARGMQYLHSQG 148 (332)
Q Consensus 121 -----------------------------~-----------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ 148 (332)
. ...+++..++.++.||+.||.|||++|
T Consensus 115 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 194 (343)
T 1luf_A 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 194 (343)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 0 157899999999999999999999999
Q ss_pred CccccccccceeecCCCeEEEeecccccccccC---CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CC
Q 020016 149 ILHRDLKSENLLLGEDMCVKVADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-AL 224 (332)
Q Consensus 149 iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~ 224 (332)
|+||||||+||+++.++.+||+|||++...... .......+|+.|+|||.+.+..++.++||||||+++|+|+| |.
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 999999999999999999999999998754332 22334567899999999999999999999999999999999 99
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 020016 225 TPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 290 (332)
Q Consensus 225 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~ 290 (332)
.||.+....+....+. .......+..+++.+.+++.+||+.||.+||++.++++.|+.+.+....
T Consensus 275 ~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~ 339 (343)
T 1luf_A 275 QPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG 339 (343)
T ss_dssp CTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC----
T ss_pred CcCCCCChHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhh
Confidence 9999988877766654 3445567788999999999999999999999999999999998776653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=331.64 Aligned_cols=239 Identities=27% Similarity=0.385 Sum_probs=193.0
Q ss_pred ccCCCccccccccCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-
Q 020016 42 IKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT- 120 (332)
Q Consensus 42 ~~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~- 120 (332)
.......+|.++.++|++.+.||+|+||+||+|.+.++.||||++...... ...+.+|+.++.+++||||++
T Consensus 11 ~~~~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~ 83 (322)
T 3soc_A 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQ-------SWQNEYEVYSLPGMKHENILQF 83 (322)
T ss_dssp ---CCCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHH-------HHHHHHHHHTSTTCCCTTBCCE
T ss_pred ccccCccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCchH-------HHHHHHHHHHHhcCCCCCchhh
Confidence 344456788899999999999999999999999999999999999764322 244567999999999999987
Q ss_pred ------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC----------CCcccccccccee
Q 020016 121 ------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQ----------GILHRDLKSENLL 160 (332)
Q Consensus 121 ------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~----------~iiH~dlkp~NIl 160 (332)
....+++..++.++.|++.||.|||+. ||+||||||+|||
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nil 163 (322)
T 3soc_A 84 IGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL 163 (322)
T ss_dssp EEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEE
T ss_pred cceeccCCCCCceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEE
Confidence 224588999999999999999999999 9999999999999
Q ss_pred ecCCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcC-----CCCCccchhHHHHHHHHHHhCCCCCCCCC-
Q 020016 161 LGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEK-----RHTKKVDVYSFGIVLWELLTALTPFDNMT- 231 (332)
Q Consensus 161 l~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~il~elltG~~pf~~~~- 231 (332)
++.++.+||+|||++....... ......||+.|+|||++.+. .++.++||||||+++|+|+||..||.+..
T Consensus 164 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 164 LKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp ECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred ECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 9999999999999997654322 23346789999999999863 45678899999999999999999997532
Q ss_pred ---------------HHHHHHHHHhcCCCCCCCCC-----CcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 232 ---------------PEQAAFAVCQKNARPPVPPT-----CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 232 ---------------~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
.............++..+.. .++++.+||.+||+.||.+|||+.++++.|+.+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 22333333333334433322 245699999999999999999999999999998764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=325.11 Aligned_cols=224 Identities=22% Similarity=0.320 Sum_probs=192.8
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
+..++|.+.+.||+|+||+||+|.++ ++.||||++...... .......+.+|+.++..++||||++
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 78 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII---AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh---hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC
Confidence 34679999999999999999999996 789999999753211 1111356889999999999999986
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc-c
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES-Q 180 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~-~ 180 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.... .
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 23568999999999999999999999999999999999999999999999999987533 3
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 260 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 260 (332)
.......+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+... ...+|..+++++.+||
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li 236 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLL 236 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHH
Confidence 33455678999999999999999999999999999999999999999998887777666543 4456788999999999
Q ss_pred HHccccCCCCCC-----CHHHHHHH
Q 020016 261 SRCWSSSPDRRP-----HFDQIVSI 280 (332)
Q Consensus 261 ~~cl~~dp~~Rp-----s~~ell~~ 280 (332)
.+||+.||.+|| ++.++++.
T Consensus 237 ~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 237 AGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 999999999999 89988763
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=322.04 Aligned_cols=220 Identities=23% Similarity=0.436 Sum_probs=190.7
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||+||+|.+. ++.||||++....... .+.+.+|+.+++.++||||++
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH------HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence 368999999999999999999885 7899999997654433 356889999999999999987
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-C
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-S 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~ 183 (332)
....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp EEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 22458899999999999999999999999999999999999999999999999987654332 3
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCcHHHHHHHHH
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-ARPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~ 262 (332)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+.... .....+..+++.+.+||.+
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 252 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHH
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHH
Confidence 345679999999999999999999999999999999999999999988777665554433 3344567889999999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~ 279 (332)
||+.||.+|||+.++++
T Consensus 253 ~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 253 CLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HSCSSTTTSCCHHHHTT
T ss_pred HccCChhHCcCHHHHhh
Confidence 99999999999999985
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=315.64 Aligned_cols=241 Identities=27% Similarity=0.513 Sum_probs=207.4
Q ss_pred cccccccCCeeeee-eecccCceEEEEEEEC----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--
Q 020016 48 EEWSADMSQLFIGC-KFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~-~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-- 120 (332)
.+|.++.++|.+.+ .||+|+||.||+|.+. +..||||++....... ..+.+.+|+.+++.++||||++
T Consensus 2 ~~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~ 76 (287)
T 1u59_A 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-----DTEEMMREAQIMHQLDNPYIVRLI 76 (287)
T ss_dssp CCCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHH-----HHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchh-----HHHHHHHHHHHHHhCCCCCEeEEE
Confidence 35777888999887 9999999999999863 6789999998754322 2467899999999999999986
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~ 156 (287)
T 1u59_A 77 GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL 156 (287)
T ss_dssp EEEESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred EEecCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccc
Confidence 345689999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC----CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 020016 175 SCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 249 (332)
Q Consensus 175 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (332)
+....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. ....+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-~~~~~~~~ 235 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECP 235 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCC
T ss_pred eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-cCCcCCCC
Confidence 87654322 1233456889999999998889999999999999999999 999999888766655543 45567778
Q ss_pred CCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCccc
Q 020016 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEF 294 (332)
Q Consensus 250 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 294 (332)
..+++.+.++|.+||+.||.+||++.++++.|+.+..+...+..+
T Consensus 236 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 280 (287)
T 1u59_A 236 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 280 (287)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccC
Confidence 899999999999999999999999999999999999998876644
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=328.16 Aligned_cols=237 Identities=31% Similarity=0.492 Sum_probs=194.1
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
+.+..++|.+++.||+|+||+||+|.+. ++.||+|++....... .+.|.+|+.++++++||||++
T Consensus 5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~------~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 78 (310)
T 3s95_A 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET------QRTFLKEVKVMRCLEHPNVLKFIGVLYK 78 (310)
T ss_dssp EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHH------HHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHH------HHHHHHHHHHHHhCCCcCcccEEEEEec
Confidence 4456789999999999999999999996 7899999986543222 467999999999999999987
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 79 DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLM 158 (310)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred CCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceec
Confidence 3567899999999999999999999999999999999999999999999999998764
Q ss_pred ccCCCC---------------CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhc
Q 020016 179 SQCGSA---------------KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA-VCQK 242 (332)
Q Consensus 179 ~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~-~~~~ 242 (332)
...... ....||+.|+|||++.+..++.++||||||+++|+|++|..||........... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~ 238 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence 332211 145799999999999999999999999999999999999999875332110000 0000
Q ss_pred CCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCc
Q 020016 243 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 292 (332)
Q Consensus 243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~ 292 (332)
......+..+++.+.+++.+||+.||++|||+.++++.|+.+...+....
T Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~ 288 (310)
T 3s95_A 239 FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL 288 (310)
T ss_dssp HHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCC
T ss_pred cccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCcc
Confidence 01122456788899999999999999999999999999999988877543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=330.95 Aligned_cols=225 Identities=23% Similarity=0.324 Sum_probs=192.5
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
+.|.+++.||+|+||+||+|.+. ++.||||++..............+.+.+|+.++++++||||++
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 67999999999999999999997 7899999998754322100001356889999999999999987
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC----eEEEeeccccccccc
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM----CVKVADFGISCLESQ 180 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~----~~kl~Dfg~a~~~~~ 180 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~ 171 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (361)
T ss_dssp EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence 346789999999999999999999999999999999999998776 799999999987665
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHH
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSY 258 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 258 (332)
........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+........ ....+++.+.+
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 251 (361)
T 2yab_A 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKD 251 (361)
T ss_dssp TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHH
T ss_pred CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHH
Confidence 5555667899999999999999999999999999999999999999999888877777654333221 23578999999
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~ 279 (332)
||.+||..||.+|||+.++++
T Consensus 252 li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 252 FIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHCCCChhHCcCHHHHhc
Confidence 999999999999999999985
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=317.66 Aligned_cols=232 Identities=25% Similarity=0.372 Sum_probs=192.8
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||.||+|.+. ++.||||++........ ...+.+.+|+.++.+++||||++
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKE---ETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCH---HHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccH---HHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 68999999999999999999986 78999999876443322 22467899999999999999987
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC--
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-- 182 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 182 (332)
....+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 23468999999999999999999999999999999999999999999999999997654332
Q ss_pred CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---CCCCCCcHHHHHH
Q 020016 183 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP---PVPPTCPKAFSYL 259 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l 259 (332)
......||+.|+|||.+.+..++.++||||||+++|+|+||..||.+.+............... ..+..+++.+.++
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 247 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNV 247 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHH
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHH
Confidence 2234578999999999999999999999999999999999999999988877665554333221 2456789999999
Q ss_pred HHHccccCCCCCC-CHHHHHHHHHhhhhhhc
Q 020016 260 ISRCWSSSPDRRP-HFDQIVSILEGYSESLE 289 (332)
Q Consensus 260 i~~cl~~dp~~Rp-s~~ell~~L~~~~~~~~ 289 (332)
+.+||+.||.+|| +++++.+.|+.+.....
T Consensus 248 i~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 248 ILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred HHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 9999999999998 99999999998765544
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=328.03 Aligned_cols=235 Identities=26% Similarity=0.479 Sum_probs=200.0
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT- 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~- 120 (332)
.+++..++|.+++.||+|+||+||+|.+. ++.||||++........ ...+.+|+.++++++||||++
T Consensus 65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~ 139 (367)
T 3l9p_A 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-----ELDFLMEALIISKFNHQNIVRC 139 (367)
T ss_dssp SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHH-----HHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhh-----HHHHHHHHHHHHhCCCCCCCeE
Confidence 35667789999999999999999999953 46899999976433322 356889999999999999986
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC-
Q 020016 121 ----------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM- 165 (332)
Q Consensus 121 ----------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~- 165 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 140 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 219 (367)
T 3l9p_A 140 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 219 (367)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred EEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCC
Confidence 124589999999999999999999999999999999999999555
Q ss_pred --eEEEeecccccccccC---CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 020016 166 --CVKVADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAV 239 (332)
Q Consensus 166 --~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~ 239 (332)
.+||+|||++...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+
T Consensus 220 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i 299 (367)
T 3l9p_A 220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299 (367)
T ss_dssp TCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 5999999999754322 22334567999999999999999999999999999999998 99999998887776665
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 240 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
. .......+..+++.+.+|+.+||+.||.+||++.+|++.|+.+....+
T Consensus 300 ~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 300 T-SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp H-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred H-cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 4 445566778899999999999999999999999999999998877654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=317.40 Aligned_cols=227 Identities=26% Similarity=0.368 Sum_probs=186.6
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHH--------------------HHHHHHHHHHHHHHH
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASL--------------------ASMLEKQFTSEVALL 110 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~--------------------~~~~~~~~~~E~~~l 110 (332)
..++|.+.+.||+|+||.||+|.+. ++.||||++......... .....+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 3579999999999999999999986 789999999765322110 011235689999999
Q ss_pred HcCCCCceec-----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee
Q 020016 111 FRLNHPHIIT-----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 161 (332)
Q Consensus 111 ~~l~h~niv~-----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll 161 (332)
++++||||++ ....+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 9999999986 23568999999999999999999999999999999999999
Q ss_pred cCCCeEEEeecccccccccCC-CCCCcccccccCChhhhhcCC---CCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 020016 162 GEDMCVKVADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKR---HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF 237 (332)
Q Consensus 162 ~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~ 237 (332)
+.++.+||+|||++....... ......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||..........
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 250 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS 250 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHH
Confidence 999999999999987654322 234567999999999997665 3778999999999999999999999888777666
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 238 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+.......+....+++.+.+||.+||+.||.+||++.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 251 KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 665555555555678999999999999999999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=326.30 Aligned_cols=222 Identities=26% Similarity=0.400 Sum_probs=192.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.+++.++||||++
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHH----HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 67999999999999999999996 78999999987544322 1366889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC---CeEEEeecccccccccC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED---MCVKVADFGISCLESQC 181 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 34568999999999999999999999999999999999999865 45999999999876655
Q ss_pred CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHH
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYL 259 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l 259 (332)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+.......+.+ ..+++++.+|
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 264 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHH
T ss_pred cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 55556789999999999999899999999999999999999999999988877777766554433322 4679999999
Q ss_pred HHHccccCCCCCCCHHHHHHH
Q 020016 260 ISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~~ 280 (332)
|.+||+.||.+||++.++++.
T Consensus 265 i~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 265 IDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999998863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=316.37 Aligned_cols=235 Identities=29% Similarity=0.579 Sum_probs=205.0
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
...|++..++|++.+.||+|+||+||+|.+. +..||||++...... .+.+.+|+.+++.++||||++
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~ 77 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLLGV 77 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH-------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH-------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4689999999999999999999999999997 789999999765432 367889999999999999986
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||+
T Consensus 78 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~ 157 (288)
T 3kfa_A 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 157 (288)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred EccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcc
Confidence 245589999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC--CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 020016 175 SCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 251 (332)
Q Consensus 175 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (332)
+........ .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+ ........+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (288)
T 3kfa_A 158 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEG 236 (288)
T ss_dssp GGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTCCCCCCTT
T ss_pred ceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-hccCCCCCCCC
Confidence 876543321 233456889999999999999999999999999999999 99999987766655444 34556677888
Q ss_pred CcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 252 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 252 ~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
+++.+.+++.+||..||.+||++.++++.|+.+.....
T Consensus 237 ~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 99999999999999999999999999999998877654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=343.09 Aligned_cols=239 Identities=31% Similarity=0.575 Sum_probs=208.3
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
....|+++.++|.+.+.||+|+||.||+|.+. +..||||++...... .+.|.+|+.+|++++||||++
T Consensus 258 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~ 330 (535)
T 2h8h_A 258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-------PEAFLQEAQVMKKLRHEKLVQLYAV 330 (535)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC-------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC-------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 45789999999999999999999999999998 578999999875432 256899999999999999986
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 331 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 331 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp ECSSSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred EeeccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 1245889999999999999999999999999999999999999999999999999
Q ss_pred cccccCC--CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 020016 176 CLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 252 (332)
Q Consensus 176 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (332)
....... ......++..|+|||++.+..++.++||||||+++|||++ |..||.+....+....+. ...+...+..+
T Consensus 411 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~ 489 (535)
T 2h8h_A 411 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPEC 489 (535)
T ss_dssp TTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTC
T ss_pred eecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Confidence 7654221 2234456789999999999999999999999999999999 999999988877766654 45566778899
Q ss_pred cHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCc
Q 020016 253 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 292 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~ 292 (332)
+..+.+||.+||+.||++||++.+|++.|+.+......+.
T Consensus 490 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~ 529 (535)
T 2h8h_A 490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 529 (535)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSS
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCccc
Confidence 9999999999999999999999999999999887666544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=322.75 Aligned_cols=218 Identities=17% Similarity=0.266 Sum_probs=191.1
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+++.||+|+||+||+|.+. ++.||+|++...... ...+.+|+.+++.++||||++
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-------QVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-------HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCccc-------HHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 78999999999999999999997 789999999765332 356889999999999999987
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC--CCeEEEeecccccccccC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE--DMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++......
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 2346899999999999999999999999999999999999987 789999999999776554
Q ss_pred CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHHH
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYL 259 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 259 (332)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+........ ....+++++.+|
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T 1tki_A 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHH
Confidence 444556789999999999988889999999999999999999999999888887777765443332 125789999999
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 020016 260 ISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~ 279 (332)
+.+||..||.+|||+.++++
T Consensus 238 i~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 238 VDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHhc
Confidence 99999999999999999998
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=316.56 Aligned_cols=231 Identities=28% Similarity=0.533 Sum_probs=193.0
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
....|.++.++|++.+.||+|+||+||+|.++++.||||++..... .+.+.+|+.++++++||||++
T Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (278)
T 1byg_A 12 YRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVI 83 (278)
T ss_dssp ---CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----------HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred hhccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhH--------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 4467889999999999999999999999999999999999976432 356889999999999999987
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~ 163 (278)
T 1byg_A 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 163 (278)
T ss_dssp CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccc
Confidence 011268888999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 020016 175 SCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 253 (332)
Q Consensus 175 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (332)
+...... .....+++.|+|||.+.+..++.++||||||+++|+|+| |..||......+....+. .......+..++
T Consensus 164 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 240 (278)
T 1byg_A 164 TKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCP 240 (278)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCC
T ss_pred ccccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCcccCC
Confidence 8654432 223467889999999999999999999999999999998 999999877666555443 445567778899
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 254 KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 254 ~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
+.+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 241 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 9999999999999999999999999999988653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=315.89 Aligned_cols=240 Identities=26% Similarity=0.500 Sum_probs=200.5
Q ss_pred ccccccccCCeeeee-eecccCceEEEEEEEC----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-
Q 020016 47 EEEWSADMSQLFIGC-KFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT- 120 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~-~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~- 120 (332)
..++.++.++|.+.+ .||+|+||+||+|.+. ++.||||++....... ...+.+.+|+.+++.++||||++
T Consensus 8 ~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~ 83 (291)
T 1xbb_A 8 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP----ALKDELLAEANVMQQLDNPYIVRM 83 (291)
T ss_dssp ---CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C----HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCH----HHHHHHHHHHHHHHhCCCCCEEEE
Confidence 456788889999998 9999999999999663 5789999998653322 22467899999999999999987
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||+
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 163 (291)
T 1xbb_A 84 IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 163 (291)
T ss_dssp EEEEESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEECCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCc
Confidence 345689999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC----CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 020016 175 SCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 249 (332)
Q Consensus 175 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (332)
+........ .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. ....+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 242 (291)
T 1xbb_A 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCP 242 (291)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCC
T ss_pred ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 876543221 123346788999999998889999999999999999999 999999988877665554 45566778
Q ss_pred CCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 020016 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 291 (332)
Q Consensus 250 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~ 291 (332)
..+++.+.+++.+||+.||.+||++.++++.|+.+..+....
T Consensus 243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 284 (291)
T 1xbb_A 243 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence 889999999999999999999999999999999998877644
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=315.35 Aligned_cols=234 Identities=28% Similarity=0.553 Sum_probs=197.4
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEECC-----eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-- 120 (332)
..|.+..++|.+.+.||+|+||+||+|.+.+ ..||||++........ .+.+.+|+.+++.++||||++
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~ 79 (281)
T 3cc6_A 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN-----KEKFMSEAVIMKNLDHPHIVKLI 79 (281)
T ss_dssp CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHH-----HHHHHHHHHHHHHHCCTTBCCEE
T ss_pred ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchH-----HHHHHHHHHHHHhCCCCCcceEE
Confidence 4577888999999999999999999998742 3599999987543221 467899999999999999987
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+
T Consensus 80 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 80 GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGL 159 (281)
T ss_dssp EEECSSSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred EEEcCCCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCC
Confidence 234589999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC--CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 020016 175 SCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 251 (332)
Q Consensus 175 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (332)
+....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. .......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 238 (281)
T 3cc6_A 160 SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDL 238 (281)
T ss_dssp GGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-HTCCCCCCTT
T ss_pred CcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-cCCCCCCCCC
Confidence 87654322 2234456889999999999999999999999999999998 999998777666554443 3455667788
Q ss_pred CcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 252 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 252 ~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
+++.+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 239 CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999999999999987654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=319.96 Aligned_cols=240 Identities=24% Similarity=0.473 Sum_probs=203.7
Q ss_pred CCccccccccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCC
Q 020016 45 EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHP 116 (332)
Q Consensus 45 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 116 (332)
.....|.+..++|.+++.||+|+||+||+|.+. ++.||||++........ .+.+.+|+.++.++ +||
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~hp 91 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHL 91 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCCCT
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHH-----HHHHHHHHHHHHhcccCC
Confidence 445678889999999999999999999999852 47899999987543321 35789999999999 789
Q ss_pred ceec-----------------------------CC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 020016 117 HIIT-----------------------------EP----------------YSVPLNLVLKLALDIARGMQYLHSQGILH 151 (332)
Q Consensus 117 niv~-----------------------------~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH 151 (332)
||++ .. ..+++..++.++.||+.||.|||++||+|
T Consensus 92 ~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H 171 (316)
T 2xir_A 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 171 (316)
T ss_dssp TBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred CeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 9986 11 12789999999999999999999999999
Q ss_pred ccccccceeecCCCeEEEeecccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCC
Q 020016 152 RDLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPF 227 (332)
Q Consensus 152 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf 227 (332)
|||||+||+++.++.+||+|||++........ .....+|+.|+|||++.+..++.++||||||+++|+|+| |..||
T Consensus 172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~ 251 (316)
T 2xir_A 172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251 (316)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999876543221 234567889999999999999999999999999999998 99999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 228 DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
.+...................+..+++.+.+++.+||+.||.+|||+.++++.|+.+.++..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 252 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp TTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 88765555545555566677788899999999999999999999999999999999877654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=324.00 Aligned_cols=230 Identities=27% Similarity=0.532 Sum_probs=191.1
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--Ce----eEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QR----DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
..++|.+.+.||+|+||+||+|.+. ++ .||+|.+....... ..+.|.+|+.++++++||||++
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 87 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-----ANKEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC------------CHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHH-----HHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence 3578999999999999999999985 33 46888876533221 2467899999999999999986
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 88 TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred cCCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 3567899999999999999999999999999999999999999999999999999765
Q ss_pred ccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 020016 179 SQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254 (332)
Q Consensus 179 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (332)
..... .....+|+.|+|||.+.+..++.++||||||+++|+|+| |..||.+.........+ ........+..++.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 246 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTI 246 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCCCCCCTTBCH
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH-HcCCCCCCCccCCH
Confidence 43322 223456889999999999999999999999999999999 99999987776654444 45556677888999
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 020016 255 AFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 288 (332)
Q Consensus 255 ~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 288 (332)
.+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 247 ~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 247 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp HHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 9999999999999999999999999999887654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=316.54 Aligned_cols=232 Identities=31% Similarity=0.588 Sum_probs=190.7
Q ss_pred ccccCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
.++.++|.+.+.||+|+||+||+|.+.++.||||++..... .+.|.+|+.++++++||||++
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 75 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESE--------RKAFIVELRQLSRVNHPNIVKLYGACLNPVC 75 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTTH--------HHHHHHHHHHHHHCCCTTBCCEEEBCTTTTE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChhH--------HHHHHHHHHHHhcCCCCCcCeEEEEEcCCcE
Confidence 35678999999999999999999999999999999975322 367899999999999999986
Q ss_pred ----------------CC---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccccccceeecCCCe-EEEeecccccc
Q 020016 121 ----------------EP---YSVPLNLVLKLALDIARGMQYLHS---QGILHRDLKSENLLLGEDMC-VKVADFGISCL 177 (332)
Q Consensus 121 ----------------~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~NIll~~~~~-~kl~Dfg~a~~ 177 (332)
.. ..+++..++.++.|++.||.|||+ +||+||||||+||+++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 11 236889999999999999999999 89999999999999998875 79999999865
Q ss_pred cccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCCCCCCCCCcHHH
Q 020016 178 ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-AAFAVCQKNARPPVPPTCPKAF 256 (332)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l 256 (332)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ...........+..+..+++.+
T Consensus 156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (307)
T 2eva_A 156 IQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHH
T ss_pred cccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHH
Confidence 4432 234568999999999999999999999999999999999999998643222 2222233455667778899999
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCc
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 292 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~ 292 (332)
.+++.+||+.||.+|||+.++++.|+.+........
T Consensus 234 ~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 234 ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred HHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence 999999999999999999999999999988776544
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=324.12 Aligned_cols=248 Identities=26% Similarity=0.433 Sum_probs=193.8
Q ss_pred cccCCeeeeeeecccCceEEEEEEE------CCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIY------KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
++.++|++.+.||+|+||.||+|.+ .++.||||++....... .+.+.+|+.++++++||||++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ------QRDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHH------HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHH------HHHHHHHHHHHHhcCCCceeEEEEEE
Confidence 4568999999999999999999985 26899999998754322 467899999999999999986
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccc
Confidence 134589999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC----CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHH--------------HHH
Q 020016 175 SCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE--------------QAA 236 (332)
Q Consensus 175 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~--------------~~~ 236 (332)
+....... ......+|+.|+|||.+.+..++.++||||||+++|+|++|..||...... ...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 97654322 223456788899999999999999999999999999999999998653322 223
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCcccccccCCCCCCc
Q 020016 237 FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHT 305 (332)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~~~~~~~ 305 (332)
............+..+++.+.+|+.+||+.||.+|||+.++++.|+.+............+..|++.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~p~~~~~ 322 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHH 322 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------------------
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccccccccCcCcccc
Confidence 334445666777889999999999999999999999999999999999888776665544555555544
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=318.90 Aligned_cols=222 Identities=25% Similarity=0.338 Sum_probs=181.5
Q ss_pred cCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
.++|.+.+.||+|+||+||+|.+. ++.||||++........ ..+.+.+|+.++++++||||++
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG----IPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------C----HHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccch----hhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 479999999999999999999996 78999999976533221 2467889999999999999987
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-CC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GS 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~ 183 (332)
....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 96 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 96 LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp EEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 3456999999999999999999999999999999999999999999999999999765432 23
Q ss_pred CCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---------------
Q 020016 184 AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--------------- 247 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~--------------- 247 (332)
.....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+......+.
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence 344578999999999876 5689999999999999999999999988766555444432111110
Q ss_pred -------------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 248 -------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 248 -------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..+.+++++.+||.+||+.||.+|||+.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 12346789999999999999999999999985
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=327.97 Aligned_cols=226 Identities=20% Similarity=0.349 Sum_probs=190.6
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
...+..++|.+.+.||+|+||.||++.+. ++.||||++...... .....+.+.+|+.+++.++|||||+
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~---~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV---ERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc---cHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 45667789999999999999999999997 688999999753211 1112367889999999999999987
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 4567999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCcccccccCChhhhhc---CCCCCccchhHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCCCCCCCC
Q 020016 179 SQCGSAKGFTGTYRWMAPEMIKE---KRHTKKVDVYSFGIVLWELLTALTPFDNMT---PEQAAFAVCQKNARPPVPPTC 252 (332)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~ 252 (332)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+ ......++..+
T Consensus 166 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~p~~~ 243 (384)
T 4fr4_A 166 PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--ETTVVTYPSAW 243 (384)
T ss_dssp CTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH--HHCCCCCCTTS
T ss_pred cCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH--hhcccCCCCcC
Confidence 66556667889999999999964 458999999999999999999999997533 33333333 23455677889
Q ss_pred cHHHHHHHHHccccCCCCCCC-HHHHHH
Q 020016 253 PKAFSYLISRCWSSSPDRRPH-FDQIVS 279 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~Rps-~~ell~ 279 (332)
++.+.+||.+||+.||.+||+ ++++++
T Consensus 244 s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 244 SQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 999999999999999999998 776664
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=318.67 Aligned_cols=237 Identities=30% Similarity=0.530 Sum_probs=202.8
Q ss_pred CCccccccccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCc
Q 020016 45 EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH 117 (332)
Q Consensus 45 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 117 (332)
....+|++..++|.+.+.||+|+||.||+|.+. ++.||||++........ ...+.+|+.+++.++|||
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~ 89 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE-----RIEFLNEASVMKEFNCHH 89 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHH-----HHHHHHHHHHGGGCCCTT
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHH-----HHHHHHHHHHHHhcCCCC
Confidence 456789999999999999999999999999875 47899999986543321 356899999999999999
Q ss_pred eec--------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccce
Q 020016 118 IIT--------------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 159 (332)
Q Consensus 118 iv~--------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NI 159 (332)
|++ ....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 90 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NI 169 (322)
T 1p4o_A 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 169 (322)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGE
T ss_pred EeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceE
Confidence 986 014568899999999999999999999999999999999
Q ss_pred eecCCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHH
Q 020016 160 LLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQA 235 (332)
Q Consensus 160 ll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~ 235 (332)
+++.++.+||+|||++....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+.
T Consensus 170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 249 (322)
T 1p4o_A 170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249 (322)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH
T ss_pred EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH
Confidence 99999999999999987544322 1233457889999999999999999999999999999999 8999999888776
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 236 AFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
...+.. ......+..+++.+.+++.+||+.||.+||++.++++.|+.....
T Consensus 250 ~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 250 LRFVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHHHHc-CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 665543 444566788999999999999999999999999999999887553
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=313.43 Aligned_cols=221 Identities=21% Similarity=0.309 Sum_probs=184.5
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||+||+|.+. ++.||||++......... .+.+.+|+.++++++||||++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV----PSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTH----HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCc----chHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEE
Confidence 68999999999999999999996 789999999875543322 356889999999999999987
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-CC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GS 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~ 183 (332)
....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 78 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 3578999999999999999999999999999999999999999999999999999765432 23
Q ss_pred CCCcccccccCChhhhhcCC-CCCccchhHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhcCCCC---------------
Q 020016 184 AKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTP-FDNMTPEQAAFAVCQKNARP--------------- 246 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~p-f~~~~~~~~~~~~~~~~~~~--------------- 246 (332)
.....+|+.|+|||++.+.. ++.++||||||+++|+|++|..| |.+.+..+....+......+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 34567899999999998766 79999999999999999987766 56666655555443311111
Q ss_pred ------------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 ------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 ------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...+.+++.+.+|+.+||+.||.+|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 122457899999999999999999999999985
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=318.53 Aligned_cols=236 Identities=28% Similarity=0.528 Sum_probs=201.7
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCce
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI 118 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 118 (332)
....|.++.++|.+++.||+|+||.||+|.+. ++.||||++....... ..+.+.+|+.+++.++||||
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~hp~i 88 (314)
T 2ivs_A 14 EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS-----ELRDLLSEFNVLKQVNHPHV 88 (314)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHH-----HHHHHHHHHHHHTTCCCTTB
T ss_pred CCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHH-----HHHHHHHHHHHHhhCCCCce
Confidence 34678889999999999999999999999872 3789999998654322 14678999999999999999
Q ss_pred ec----------------------------CC------------------------CCCCHHHHHHHHHHHHHHHHHHHH
Q 020016 119 IT----------------------------EP------------------------YSVPLNLVLKLALDIARGMQYLHS 146 (332)
Q Consensus 119 v~----------------------------~~------------------------~~l~~~~~~~i~~qi~~~L~~LH~ 146 (332)
++ .. ..+++..++.++.||+.||.|||+
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 168 (314)
T 2ivs_A 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE 168 (314)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH
T ss_pred eeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH
Confidence 87 00 237899999999999999999999
Q ss_pred CCCccccccccceeecCCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-
Q 020016 147 QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT- 222 (332)
Q Consensus 147 ~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt- 222 (332)
+|++||||||+||+++.++.++|+|||++....... ......+|+.|+|||.+.+..++.++||||||+++|+|++
T Consensus 169 ~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 248 (314)
T 2ivs_A 169 MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248 (314)
T ss_dssp TTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred CCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999987554322 2234557889999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 223 ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 223 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
|..||.+.........+ ........+..+++.+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 249 g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 249 GGNPYPGIPPERLFNLL-KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp SCCSSTTCCGGGHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCCCHHHHHHHh-hcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 99999988776655444 34556677888999999999999999999999999999999988654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=315.69 Aligned_cols=221 Identities=20% Similarity=0.306 Sum_probs=182.1
Q ss_pred CCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
++|.+.+.||+|+||+||+|.+. ++.||||++......... .+.+.+|+.+++.++||||++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI----PSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCC----CHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccccc----chhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEE
Confidence 68999999999999999999997 889999999765433211 256789999999999999987
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-CCC
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GSA 184 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~~ 184 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ...
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 2467899999999999999999999999999999999999999999999999998765432 223
Q ss_pred CCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----------------
Q 020016 185 KGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP----------------- 246 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~----------------- 246 (332)
....+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+......+
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 345789999999999764 58999999999999999999999999988776665544321110
Q ss_pred ----------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 ----------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 ----------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.....+++++.+||.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 112457899999999999999999999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=323.21 Aligned_cols=225 Identities=24% Similarity=0.331 Sum_probs=191.4
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
+.|.+.+.||+|+||.||+|.+. ++.||||++..............+.+.+|+.+++.++||||++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 57999999999999999999997 7899999997654321100001356889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC----eEEEeeccccccccc
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM----CVKVADFGISCLESQ 180 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~----~~kl~Dfg~a~~~~~ 180 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~ 170 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence 345689999999999999999999999999999999999998887 899999999987655
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHH
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSY 258 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 258 (332)
........||+.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+........ ....+++.+.+
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (326)
T 2y0a_A 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 250 (326)
T ss_dssp TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHH
Confidence 4455567899999999999999999999999999999999999999999888777666654333222 23578899999
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~ 279 (332)
||.+||+.||.+|||+.++++
T Consensus 251 li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 251 FIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCCCHHHHhc
Confidence 999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=317.73 Aligned_cols=239 Identities=31% Similarity=0.515 Sum_probs=195.3
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEEEC-----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 120 (332)
...++.++.++|.+++.||+|+||.||+|.+. +..||||++........ ..+.+.+|+.++++++||||++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~ 100 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR----EIEEFLSEAACMKDFSHPNVIR 100 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHH----HHHHHHHHHHHHHTCCCTTBCC
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchh----HHHHHHHHHHHHhcCCCCCeee
Confidence 34667788899999999999999999999874 34799999986543322 1467899999999999999986
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee
Q 020016 121 ---------------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 161 (332)
Q Consensus 121 ---------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll 161 (332)
....+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 101 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli 180 (313)
T 3brb_A 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML 180 (313)
T ss_dssp CCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE
T ss_pred eeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE
Confidence 12458899999999999999999999999999999999999
Q ss_pred cCCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 020016 162 GEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAF 237 (332)
Q Consensus 162 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~ 237 (332)
+.++.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..........
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 260 (313)
T 3brb_A 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260 (313)
T ss_dssp CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH
Confidence 999999999999987654322 2233457889999999999999999999999999999999 999999887766655
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 238 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
.+. .......+..+++.+.+++.+||+.||.+||++.++++.|+.+.+.++
T Consensus 261 ~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 261 YLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHH-TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHH-cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 544 445667778899999999999999999999999999999999988765
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=340.58 Aligned_cols=232 Identities=29% Similarity=0.589 Sum_probs=203.2
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
...|+++.++|.+.+.||+|+||.||+|.+. +..||||++...... .+.|.+|+.+|++++||||++
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~ 284 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLLGV 284 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC-------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc-------hHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 4679999999999999999999999999997 789999999865433 367899999999999999986
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 285 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 364 (495)
T 1opk_A 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGL 364 (495)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred EecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeeccc
Confidence 235688999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC--CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 020016 175 SCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 251 (332)
Q Consensus 175 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (332)
+....... ......+++.|+|||++.+..++.++||||||+++|||+| |..||.+.+..+....+ ....+...+..
T Consensus 365 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~ 443 (495)
T 1opk_A 365 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEG 443 (495)
T ss_dssp EECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTCCCCCCTT
T ss_pred ceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCC
Confidence 97654322 2233456789999999999999999999999999999999 99999988776655444 45667777889
Q ss_pred CcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 020016 252 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 252 ~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 286 (332)
+++.+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 444 ~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 444 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=320.28 Aligned_cols=237 Identities=25% Similarity=0.491 Sum_probs=203.7
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEECC-------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCce
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHI 118 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 118 (332)
...|+++.++|.+.+.||+|+||.||+|.+.+ ..||||++........ .+.+.+|+.+++.+ +||||
T Consensus 38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~h~~i 112 (333)
T 2i1m_A 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE-----KEALMSELKIMSHLGQHENI 112 (333)
T ss_dssp CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCCCTTB
T ss_pred cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHH-----HHHHHHHHHHHHhhcCCCCe
Confidence 45799999999999999999999999999852 3799999987543322 46789999999999 89999
Q ss_pred ec------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccc
Q 020016 119 IT------------------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKS 156 (332)
Q Consensus 119 v~------------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp 156 (332)
++ ....+++..++.++.||+.||.|||++||+||||||
T Consensus 113 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 192 (333)
T 2i1m_A 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAA 192 (333)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred eeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCccc
Confidence 86 034578999999999999999999999999999999
Q ss_pred cceeecCCCeEEEeecccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCH
Q 020016 157 ENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTP 232 (332)
Q Consensus 157 ~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~ 232 (332)
+||+++.++.++|+|||++........ .....+|+.|+|||.+.+..++.++||||||+++|+|+| |..||.+...
T Consensus 193 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp GGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred ceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 999999999999999999976543222 234557889999999999999999999999999999999 9999998776
Q ss_pred HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 020016 233 EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 288 (332)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 288 (332)
................+..+++.+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 273 NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 66666666666677778889999999999999999999999999999999876653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=314.82 Aligned_cols=231 Identities=33% Similarity=0.588 Sum_probs=193.5
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHH-HHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLA-SMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
+..++|.+.+.||+|+||+||+|.+. ++.||||++.......... ....+.+.+|+.++++++||||++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 44589999999999999999999995 7899999997654332211 111257899999999999999987
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccccccceeecCCCe-----EEEeeccc
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGEDMC-----VKVADFGI 174 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~NIll~~~~~-----~kl~Dfg~ 174 (332)
....+++..++.++.|++.||.|||++| ++||||||+||+++.++. +||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 96 PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 3457899999999999999999999999 999999999999988776 99999999
Q ss_pred ccccccCCCCCCcccccccCChhhhh--cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcCCCCCCCC
Q 020016 175 SCLESQCGSAKGFTGTYRWMAPEMIK--EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ--AAFAVCQKNARPPVPP 250 (332)
Q Consensus 175 a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~--~~~~~~~~~~~~~~~~ 250 (332)
+..... ......||+.|+|||.+. ...++.++||||||+++|+|++|..||....... ...........+..+.
T Consensus 176 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (287)
T 4f0f_A 176 SQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253 (287)
T ss_dssp CBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCT
T ss_pred cccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCc
Confidence 864333 234567899999999984 4556889999999999999999999998765433 3444555667778888
Q ss_pred CCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 251 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
.+++.+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 254 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 254 DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 9999999999999999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=330.70 Aligned_cols=221 Identities=23% Similarity=0.331 Sum_probs=190.5
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||+||+|.+. ++.||+|++........ ..+.+.+|+.+++.++||||++
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSAR----DHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHH----HHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHH----HHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 68999999999999999999986 89999999987654332 2467889999999999999987
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeec---CCCeEEEeecccccccccC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG---EDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 345689999999999999999999999999999999999998 4578999999999765543
Q ss_pred C-CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHH
Q 020016 182 G-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSY 258 (332)
Q Consensus 182 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ 258 (332)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+.......+.+ ..+++++.+
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 246 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence 2 2345679999999999999899999999999999999999999999998888877776655443332 578999999
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~ 279 (332)
||.+||+.||.+|||+.++++
T Consensus 247 li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 247 LINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCChhHCCCHHHHhc
Confidence 999999999999999999987
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=327.05 Aligned_cols=235 Identities=30% Similarity=0.546 Sum_probs=190.3
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC-----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--- 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--- 120 (332)
..+++.++|.+.+.||+|+||.||+|.+. +..||||++....... ..+.|.+|+.++.+++||||++
T Consensus 39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~ 113 (373)
T 2qol_A 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-----QRRDFLGEASIMGQFDHPNIIRLEG 113 (373)
T ss_dssp SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHH-----HHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHH-----HHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 34667789999999999999999999875 5679999998654322 2467999999999999999987
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 114 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 114 VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcc
Confidence 234689999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC----CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 020016 175 SCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 249 (332)
Q Consensus 175 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (332)
+........ .....+++.|+|||++.+..++.++||||||+++|||++ |..||......+....+. ...+.+.+
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-~~~~~~~~ 272 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPP 272 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-TTEECCCC
T ss_pred ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 876543221 122345778999999999999999999999999999998 999999988877766554 34455667
Q ss_pred CCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 250 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
..++..+.+++.+||+.||.+||++.++++.|+.+.....
T Consensus 273 ~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 273 MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 7899999999999999999999999999999999877654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=316.40 Aligned_cols=236 Identities=30% Similarity=0.519 Sum_probs=196.5
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEECC------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYKQ------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-- 120 (332)
.++++.++|.+.+.||+|+||+||+|.+.. ..||||++....... ....+.+|+.+++.++||||++
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~ 112 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-----QRVDFLGEAGIMGQFSHHNIIRLE 112 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHH-----HHHHHHHHHHHHHhCCCCCCCcEE
Confidence 356778999999999999999999998752 359999998654322 1457899999999999999986
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecc
Q 020016 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 121 ---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 113 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 192 (333)
T 1mqb_A 113 GVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG 192 (333)
T ss_dssp EEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred EEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCC
Confidence 34678999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC----CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 020016 174 ISCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 248 (332)
Q Consensus 174 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (332)
++........ .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. ...+.+.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~~~~~~~ 271 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPT 271 (333)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCC
T ss_pred cchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-CCCcCCC
Confidence 9876543221 123346788999999999999999999999999999999 999999988877766554 4455667
Q ss_pred CCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 020016 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 290 (332)
Q Consensus 249 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~ 290 (332)
+..+++.+.+++.+||+.||.+||++.++++.|+.+......
T Consensus 272 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 788999999999999999999999999999999988776553
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=325.80 Aligned_cols=223 Identities=21% Similarity=0.282 Sum_probs=186.0
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec--------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT-------- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~-------- 120 (332)
+..++|.+.+.||+|+||+||+|.++ ++.||||++...... .....+.+.+|..++..+ +||||++
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~---~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL---QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH---HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc---chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 44689999999999999999999986 789999999763211 111245678899999988 7999987
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc-
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES- 179 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~- 179 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 23568999999999999999999999999999999999999999999999999987533
Q ss_pred cCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 020016 180 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 259 (332)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 259 (332)
........+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+... ...+|..+++.+.+|
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~l 254 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVVYPTWLHEDATGI 254 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHH
T ss_pred CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHH
Confidence 223345678999999999999999999999999999999999999999999988887777654 445677899999999
Q ss_pred HHHccccCCCCCCCH------HHHHH
Q 020016 260 ISRCWSSSPDRRPHF------DQIVS 279 (332)
Q Consensus 260 i~~cl~~dp~~Rps~------~ell~ 279 (332)
|.+||+.||.+||++ .++++
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhh
Confidence 999999999999998 66665
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=333.23 Aligned_cols=222 Identities=24% Similarity=0.320 Sum_probs=181.6
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+++.||+|+||+||+|.+. ++.||||++........ ..+.+.+|+.+++.++||||++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHH----HHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChH----HHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc
Confidence 478999999999999999999986 78999999986533222 2467889999999999999986
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 137 ~~~~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 137 EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp TTCCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred ccCCeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 123488999999999999999999999999999999999999999999999999987666
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-------------
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------------- 247 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~------------- 247 (332)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......+.
T Consensus 217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~ 296 (464)
T 3ttj_A 217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 296 (464)
T ss_dssp CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence 5555667899999999999999999999999999999999999999999887766655543221110
Q ss_pred ----------------CCCC-----------CcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 248 ----------------VPPT-----------CPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 248 ----------------~~~~-----------~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
++.. .++++.+||.+||+.||.+|||++|+++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 1567899999999999999999999987
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=328.94 Aligned_cols=221 Identities=29% Similarity=0.403 Sum_probs=186.7
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||+||+|.+. ++.||||++....... ......+.+|+.+++.++||||++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK---SDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccc---hhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 478999999999999999999985 7899999987532111 111256889999999999999987
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 184 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 184 (332)
....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 85 ~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~ 164 (336)
T 3h4j_B 85 VMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL 164 (336)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTT
T ss_pred EEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccc
Confidence 3457899999999999999999999999999999999999999999999999999876665555
Q ss_pred CCcccccccCChhhhhcCCC-CCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHc
Q 020016 185 KGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 263 (332)
...+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.........+ .......|..+++.+.+||.+|
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li~~~ 242 (336)
T 3h4j_B 165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLIRRM 242 (336)
T ss_dssp CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHHHHHTT
T ss_pred ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHHHHHHH
Confidence 67789999999999988776 78999999999999999999999875433221111 1223456778899999999999
Q ss_pred cccCCCCCCCHHHHHH
Q 020016 264 WSSSPDRRPHFDQIVS 279 (332)
Q Consensus 264 l~~dp~~Rps~~ell~ 279 (332)
|+.||.+|||+.++++
T Consensus 243 L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 243 IVADPMQRITIQEIRR 258 (336)
T ss_dssp SCSSGGGSCCHHHHTT
T ss_pred cCCChhHCcCHHHHHh
Confidence 9999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=323.51 Aligned_cols=230 Identities=26% Similarity=0.464 Sum_probs=192.2
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--Ce----eEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QR----DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
..++|.+.+.||+|+||+||+|.+. ++ .||+|++........ .+.+.+|+.++.+++||||++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS-----FQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSC-----BCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHH-----HHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 4578999999999999999999986 43 388888765432211 245778999999999999987
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 2357889999999999999999999999999999999999999999999999999765
Q ss_pred ccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 020016 179 SQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254 (332)
Q Consensus 179 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (332)
.... ......+|..|+|||.+.+..++.++||||||+++|+|+| |..||.+....+....+ ........+..++.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 244 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-EKGERLAQPQICTI 244 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH-HTTCBCCCCTTBCT
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH-HcCCCCCCCCcCcH
Confidence 4332 2234567889999999999999999999999999999999 99999987766655444 34556677778899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 020016 255 AFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 288 (332)
Q Consensus 255 ~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 288 (332)
.+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 245 DVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 9999999999999999999999999999886654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=313.92 Aligned_cols=232 Identities=19% Similarity=0.296 Sum_probs=192.9
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT---------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~---------- 120 (332)
.++|.+.+.||+|+||.||+|.+. ++.||||++...... +.+.+|+.++..+ +|+|++.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc--------HHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 478999999999999999999974 899999999765432 3477899999999 7888765
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCe-----EEEeecccccc
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC-----VKVADFGISCL 177 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~-----~kl~Dfg~a~~ 177 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++. ++|+|||++..
T Consensus 81 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 81 NVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred eEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 3456999999999999999999999999999999999999987765 99999999976
Q ss_pred cccCCC--------CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCC--
Q 020016 178 ESQCGS--------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT---PEQAAFAVCQKNA-- 244 (332)
Q Consensus 178 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~---~~~~~~~~~~~~~-- 244 (332)
...... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.. .......+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 543321 345679999999999999999999999999999999999999998743 3333333322211
Q ss_pred -CCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCcc
Q 020016 245 -RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPE 293 (332)
Q Consensus 245 -~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 293 (332)
.......+++.+.+++.+||+.||++||++.+|++.|+.+...+.....
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~ 290 (298)
T 1csn_A 241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 290 (298)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSC
T ss_pred cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCC
Confidence 1223457899999999999999999999999999999999988875543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=309.66 Aligned_cols=221 Identities=26% Similarity=0.373 Sum_probs=191.8
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||.||+|.+. ++.||+|++........ ..+.+.+|+.++++++||||++
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHH----HHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 78999999999999999999986 78999999976543322 1366889999999999999987
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCe---EEEeecccccccccC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC---VKVADFGISCLESQC 181 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~---~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||++......
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 2345899999999999999999999999999999999999976654 999999999776655
Q ss_pred CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcHHHHHH
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSYL 259 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l 259 (332)
.......||+.|+|||.+.+..++.++||||||+++|+|++|..||...........+.......+. ...+++.+.++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHH
Confidence 5555678999999999999999999999999999999999999999998888777776655444333 25789999999
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 020016 260 ISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~ 279 (332)
+.+||+.||.+|||+.++++
T Consensus 242 i~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 242 IDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHcccChhhCCCHHHHhc
Confidence 99999999999999999987
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=318.89 Aligned_cols=230 Identities=27% Similarity=0.536 Sum_probs=190.1
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--Ce----eEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QR----DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
..++|.+.+.||+|+||+||+|.+. ++ .||+|.+........ .+.+.+|+.+++.++||||++
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~ 87 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-----NKEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCC-----HHHHHHHHHHHTTCCBTTBCCCCEEEE
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHH-----HHHHHHHHHHHHhCCCCCeeEEEEEEe
Confidence 3578999999999999999999985 44 357787765433222 367889999999999999986
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 88 ~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 88 TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SSSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred cCCceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 3567899999999999999999999999999999999999999999999999999765
Q ss_pred ccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 020016 179 SQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254 (332)
Q Consensus 179 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (332)
..... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+ ........+..++.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 246 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTI 246 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCCCCCCTTBCH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCCccCCH
Confidence 43222 223456789999999999999999999999999999999 99999988776655444 45556677888999
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 020016 255 AFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 288 (332)
Q Consensus 255 ~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 288 (332)
++.+++.+||+.||.+||++.++++.|+.+....
T Consensus 247 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 247 DVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 9999999999999999999999999999887554
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=319.01 Aligned_cols=220 Identities=28% Similarity=0.423 Sum_probs=191.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
+.|.+.+.||+|+||+||+|.+. ++.||||++........ ...+.+.+|+.++++++||||++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccch---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence 56999999999999999999985 89999999986543221 12467899999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 184 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 184 (332)
....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 131 lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~ 207 (348)
T 1u5q_A 131 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---A 207 (348)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---B
T ss_pred EEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---C
Confidence 346789999999999999999999999999999999999999999999999999876543 2
Q ss_pred CCcccccccCChhhhh---cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 020016 185 KGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 261 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 261 (332)
....||+.|+|||++. ++.++.++||||||+++|+|++|..||...+.......+.........+..+++.+.+||.
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 287 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 287 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHH
T ss_pred CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 3467999999999985 5678999999999999999999999999988877777766655555556788999999999
Q ss_pred HccccCCCCCCCHHHHHHH
Q 020016 262 RCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 262 ~cl~~dp~~Rps~~ell~~ 280 (332)
+||+.||.+|||+.++++.
T Consensus 288 ~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 288 SCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHTCSSGGGSCCHHHHTTC
T ss_pred HHcccChhhCcCHHHHhhC
Confidence 9999999999999999863
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=340.48 Aligned_cols=241 Identities=27% Similarity=0.517 Sum_probs=203.4
Q ss_pred cccccccCCeeeee-eecccCceEEEEEEEC----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--
Q 020016 48 EEWSADMSQLFIGC-KFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~-~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-- 120 (332)
..|.+..+++.+.+ .||+|+||.||+|.+. +..||||+++....... .+.|.+|+.+|++++|||||+
T Consensus 328 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~-----~~~~~~E~~il~~l~hpniv~l~ 402 (613)
T 2ozo_A 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-----TEEMMREAQIMHQLDNPYIVRLI 402 (613)
T ss_dssp CCSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTT-----HHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHH-----HHHHHHHHHHHHhCCCCCEeeEE
Confidence 45677778888877 8999999999999874 46799999987533222 367899999999999999987
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 403 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGl 482 (613)
T 2ozo_A 403 GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGL 482 (613)
T ss_dssp EEEESSSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCST
T ss_pred EEeccCCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccC
Confidence 345689999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC----CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 020016 175 SCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 249 (332)
Q Consensus 175 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (332)
+........ .....+++.|+|||++.+..++.++||||||+++|||++ |..||.+.+..+....+. ...+...+
T Consensus 483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p 561 (613)
T 2ozo_A 483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECP 561 (613)
T ss_dssp TTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-TTCCCCCC
T ss_pred cccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 976543221 122345689999999999999999999999999999998 999999988877666554 45667788
Q ss_pred CCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCccc
Q 020016 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEF 294 (332)
Q Consensus 250 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 294 (332)
..+++++.+||.+||+.||++||++.+|++.|+.+..+++...+.
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~ 606 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 606 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCC
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCC
Confidence 899999999999999999999999999999999999888766543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=314.53 Aligned_cols=225 Identities=26% Similarity=0.349 Sum_probs=183.8
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC---CCCceec--------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL---NHPHIIT-------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~-------- 120 (332)
.++|.+.+.||+|+||+||+|.+. ++.||||++......... ......+.+|+.+++.+ +||||++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGG-GGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTS-SCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccc-cccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 479999999999999999999975 789999999753321100 00013455677776666 5999986
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 123389999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-------
Q 020016 175 SCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------- 247 (332)
Q Consensus 175 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~------- 247 (332)
+.............||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+......+.
T Consensus 167 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (308)
T 3g33_A 167 ARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 246 (308)
T ss_dssp TTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSS
T ss_pred ccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccch
Confidence 9876655555667899999999999999999999999999999999999999999888777666544221111
Q ss_pred ------------------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 248 ------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 248 ------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 247 VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 12457899999999999999999999999885
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=319.45 Aligned_cols=230 Identities=20% Similarity=0.283 Sum_probs=189.8
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT---------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~---------- 120 (332)
.++|.+.+.||+|+||+||+|.+. ++.||||++...... +.+.+|+.+++.+ +||||+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--------PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS--------CCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch--------HHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence 378999999999999999999975 899999999765432 3478899999999 9999986
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCe-----EEEeecccccc
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC-----VKVADFGISCL 177 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~-----~kl~Dfg~a~~ 177 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 80 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 80 NAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred cEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 2568999999999999999999999999999999999999998887 99999999976
Q ss_pred cccCCC--------CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCC
Q 020016 178 ESQCGS--------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT---PEQAAFAVCQKNARP 246 (332)
Q Consensus 178 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~---~~~~~~~~~~~~~~~ 246 (332)
...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.. ..+....+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 443221 245679999999999999999999999999999999999999998743 223333332211111
Q ss_pred C---CCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCc
Q 020016 247 P---VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 292 (332)
Q Consensus 247 ~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~ 292 (332)
+ ....++ ++.+++..||+.||.+||++++|.+.|+.+........
T Consensus 240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 287 (330)
T 2izr_A 240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMF 287 (330)
T ss_dssp CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCC
Confidence 1 123355 99999999999999999999999999999888776443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=321.94 Aligned_cols=223 Identities=24% Similarity=0.295 Sum_probs=175.9
Q ss_pred ccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
..+.++|.+.+.||+|+||+||++.+. ++.||||++....... +.+.+|+.+++.++||||++
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~hpniv~~~~~~~~~ 88 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-------ENVQREIINHRSLRHPNIVRFKEVILTP 88 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC-------HHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc-------HHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence 445689999999999999999999996 7899999998754332 45789999999999999987
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCe--EEEeeccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC--VKVADFGISCLE 178 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~--~kl~Dfg~a~~~ 178 (332)
..+.+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||++...
T Consensus 89 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 89 THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 2356899999999999999999999999999999999999987765 999999998754
Q ss_pred ccCCCCCCcccccccCChhhhhcCCCCCc-cchhHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCCCCCCCCCCc
Q 020016 179 SQCGSAKGFTGTYRWMAPEMIKEKRHTKK-VDVYSFGIVLWELLTALTPFDNMTP----EQAAFAVCQKNARPPVPPTCP 253 (332)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlG~il~elltG~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~ 253 (332)
..........||+.|+|||++.+..++.+ +||||||+++|+|++|..||.+... ......+.......+....++
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 248 (361)
T 3uc3_A 169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS 248 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence 44444456679999999999988887655 8999999999999999999987543 333334433333344445689
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 254 KAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 254 ~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
+.+.+||.+||+.||.+|||+.++++.
T Consensus 249 ~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 249 PECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 999999999999999999999999873
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=310.34 Aligned_cols=226 Identities=23% Similarity=0.328 Sum_probs=176.6
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
|++..++|.+.+.||+|+||+||+|.+. ++.||||++........ ..+.+.++...++.++||||++
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~~~~~~~~h~~iv~~~~~~~~ 77 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE----QKRLLMDLDISMRTVDCPFTVTFYGALFR 77 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHH----HHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHH----HHHHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence 4567789999999999999999999994 89999999976543322 1344556666688899999986
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccccccceeecCCCeEEEeecccc
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++
T Consensus 78 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 78 EGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS 157 (290)
T ss_dssp SSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred cCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCc
Confidence 346799999999999999999999998 9999999999999999999999999999
Q ss_pred cccccCCCCCCcccccccCChhhh----hcCCCCCccchhHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCCCC
Q 020016 176 CLESQCGSAKGFTGTYRWMAPEMI----KEKRHTKKVDVYSFGIVLWELLTALTPFDNM-TPEQAAFAVCQKNARPPVPP 250 (332)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlG~il~elltG~~pf~~~-~~~~~~~~~~~~~~~~~~~~ 250 (332)
.............||+.|+|||.+ .+..++.++||||||+++|+|++|..||... ..................+.
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence 776555555556799999999996 5567899999999999999999999999873 44444444444444444456
Q ss_pred CCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 251 ~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+++.+.+++.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 78999999999999999999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=316.17 Aligned_cols=239 Identities=25% Similarity=0.493 Sum_probs=203.5
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEEEC---------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CC
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK---------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NH 115 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 115 (332)
....|.++.++|.+++.||+|+||.||+|.+. +..||||++........ .+.+.+|+.+++.+ +|
T Consensus 26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~h 100 (334)
T 2pvf_A 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-----LSDLVSEMEMMKMIGKH 100 (334)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHH-----HHHHHHHHHHHHHHCCC
T ss_pred CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHH-----HHHHHHHHHHHHHhhcC
Confidence 44678899999999999999999999999874 46799999986543322 46788999999999 99
Q ss_pred Cceec----------------------------C----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 020016 116 PHIIT----------------------------E----------------PYSVPLNLVLKLALDIARGMQYLHSQGILH 151 (332)
Q Consensus 116 ~niv~----------------------------~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH 151 (332)
|||++ . ...+++..++.++.||+.||.|||++||+|
T Consensus 101 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 180 (334)
T 2pvf_A 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIH 180 (334)
T ss_dssp TTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 99986 1 123889999999999999999999999999
Q ss_pred ccccccceeecCCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCC
Q 020016 152 RDLKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPF 227 (332)
Q Consensus 152 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf 227 (332)
|||||+||+++.++.+||+|||++....... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 181 ~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 260 (334)
T 2pvf_A 181 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260 (334)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCc
Confidence 9999999999999999999999987654322 2234457889999999999889999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 020016 228 DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 290 (332)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~ 290 (332)
.+....+....+. .......+..++..+.+++.+||+.||.+||++.++++.|+.+......
T Consensus 261 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 261 PGIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp TTCCHHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CcCCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 9988777665554 4455667788999999999999999999999999999999999876653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=316.17 Aligned_cols=237 Identities=28% Similarity=0.458 Sum_probs=195.9
Q ss_pred cccCCeeeeeeecccCceEEEEEEE------CCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIY------KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
++...|++++.||+|+||+||++.+ .++.||||++....... ..+.+.+|+.+++.++||||++
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ-----HRSGWKQEIDILRTLYHEHIIKYKGCC 102 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChH-----HHHHHHHHHHHHHhCCCcchhhEEEEE
Confidence 4444459999999999999999876 36889999998754322 2467899999999999999986
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccc
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 103 EDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EETTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred ecCCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 23458999999999999999999999999999999999999999999999999997
Q ss_pred ccccCC----CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHH--------------HHHHH
Q 020016 177 LESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE--------------QAAFA 238 (332)
Q Consensus 177 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~--------------~~~~~ 238 (332)
...... ......+|+.|+|||.+.+..++.++||||||+++|+|+||..||...... .....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 654432 123455788899999999989999999999999999999999999753221 11223
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCcc
Q 020016 239 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPE 293 (332)
Q Consensus 239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 293 (332)
..........+..+++.+.+||.+||+.||.+|||+.++++.|+.+.+.+..+.+
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence 3445666777889999999999999999999999999999999999998886653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=309.37 Aligned_cols=231 Identities=31% Similarity=0.542 Sum_probs=194.6
Q ss_pred CeeeeeeecccCceEEEEEEEC--C---eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--Q---RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~---~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
.|.+++.||+|+||+||+|.+. + ..||+|++........ .+.+.+|+.+++.++||||++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ-----VEAFLREGLLMRGLNHPNVLALIGIMLPPEG 96 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHH-----HHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHH-----HHHHHHHHHHHHhCCCCCeeeEEEEEecCCC
Confidence 5667899999999999999873 2 3799999986443322 467899999999999999987
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 346788999999999999999999999999999999999999999999999999865432
Q ss_pred C-----CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 020016 181 C-----GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254 (332)
Q Consensus 181 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (332)
. .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+ ........+..+++
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 255 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-AQGRRLPQPEYCPD 255 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH-HTTCCCCCCTTCCH
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh-hcCCCCCCCccchH
Confidence 1 22344567899999999999999999999999999999999 55566666555544443 34556667788999
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCc
Q 020016 255 AFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 292 (332)
Q Consensus 255 ~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~ 292 (332)
.+.+++.+||+.||.+|||+.++++.|+.+..++..+.
T Consensus 256 ~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 256 SLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 99999999999999999999999999999999887554
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=324.16 Aligned_cols=248 Identities=15% Similarity=0.182 Sum_probs=192.5
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHH-----HHHHHHHHHHHHHHHcCCCCcee
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLA-----SMLEKQFTSEVALLFRLNHPHII 119 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv 119 (332)
+..++|.+++.||+|+||.||+|.+. ++.||||++.......... ......+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 44679999999999999999999985 3689999998754322111 11113456677888899999997
Q ss_pred c--------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeec--CCC
Q 020016 120 T--------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG--EDM 165 (332)
Q Consensus 120 ~--------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~--~~~ 165 (332)
+ ....+++..++.++.||+.||.|||++||+||||||+|||++ .++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred eEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 5 346799999999999999999999999999999999999999 889
Q ss_pred eEEEeecccccccccCCC--------CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 020016 166 CVKVADFGISCLESQCGS--------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF 237 (332)
Q Consensus 166 ~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~ 237 (332)
.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|+||..||.+........
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 999999999976443221 134459999999999999999999999999999999999999998632221111
Q ss_pred HHHhcCCCC---------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCcccccccC
Q 020016 238 AVCQKNARP---------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFI 299 (332)
Q Consensus 238 ~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~ 299 (332)
......... ..+..+++++.+++..||+.||.+||++.+|++.|+.+...........-.+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 342 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLS 342 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC-
T ss_pred HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceE
Confidence 111100000 01256789999999999999999999999999999999988876654433343
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=314.85 Aligned_cols=220 Identities=25% Similarity=0.376 Sum_probs=191.1
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
..++|.+.+.||+|+||+||+|.+. ++.||||++....... ....+.+.+|+.+++.++||||++
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 80 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR---LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ 80 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCE
Confidence 3578999999999999999999996 7899999997632111 111356788999999999999987
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 182 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 182 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.....
T Consensus 81 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 345689999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 020016 183 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 262 (332)
.....+||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+... ...+|..+++++.++|.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~ 236 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLSR 236 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHHHH
Confidence 234568999999999999999999999999999999999999999998887777776654 345678899999999999
Q ss_pred ccccCCCCCC-----CHHHHHH
Q 020016 263 CWSSSPDRRP-----HFDQIVS 279 (332)
Q Consensus 263 cl~~dp~~Rp-----s~~ell~ 279 (332)
||..||.+|| +++++++
T Consensus 237 lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 237 LITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHT
T ss_pred HhccCHHHcCCCcCCCHHHHhc
Confidence 9999999999 8888875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=317.14 Aligned_cols=226 Identities=25% Similarity=0.360 Sum_probs=185.2
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCC--Cceec------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH--PHIIT------ 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~------ 120 (332)
..+..++|.+.+.||+|+||.||++.+. ++.||||++........ ..+.+.+|+.++..++| |||++
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 79 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ----TLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 79 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHH----HHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchH----HHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence 3455688999999999999999999886 78899999987544322 24678999999999987 89986
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 80 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 80 TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp CSSEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred eCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 346789999999999999999999999999999999999997 6789999999997654
Q ss_pred cCC---CCCCcccccccCChhhhhc-----------CCCCCccchhHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCC
Q 020016 180 QCG---SAKGFTGTYRWMAPEMIKE-----------KRHTKKVDVYSFGIVLWELLTALTPFDNMTP-EQAAFAVCQKNA 244 (332)
Q Consensus 180 ~~~---~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~il~elltG~~pf~~~~~-~~~~~~~~~~~~ 244 (332)
... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ............
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence 332 2235679999999999975 6788999999999999999999999987543 344444444555
Q ss_pred CCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 245 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 245 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
...++...+..+.+|+.+||+.||.+|||+.++++.
T Consensus 239 ~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 239 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 667788889999999999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=314.54 Aligned_cols=222 Identities=31% Similarity=0.539 Sum_probs=180.6
Q ss_pred cCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHc--CCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR--LNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||+||+|.+.++.||||++..... ..+.+|.+++.. ++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~---------~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~ 77 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDE---------KSWFRETELYNTVMLRHENILGFIASDMTSRHS 77 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGH---------HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccc---------hhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence 47899999999999999999999999999999976322 345566666666 89999986
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCccccccccceeecCCCeEEEeec
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLH--------SQGILHRDLKSENLLLGEDMCVKVADF 172 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~iiH~dlkp~NIll~~~~~~kl~Df 172 (332)
....+++..++.++.|++.||.||| +.||+||||||+|||++.++.+||+||
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred CceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 3457899999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCCC-----CCCcccccccCChhhhhcC------CCCCccchhHHHHHHHHHHhC----------CCCCCCCC
Q 020016 173 GISCLESQCGS-----AKGFTGTYRWMAPEMIKEK------RHTKKVDVYSFGIVLWELLTA----------LTPFDNMT 231 (332)
Q Consensus 173 g~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~il~elltG----------~~pf~~~~ 231 (332)
|++........ .....||+.|+|||++.+. .++.++||||||+++|+|+|| ..||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 99865443222 2345799999999999876 445799999999999999999 88886532
Q ss_pred -----HHHHHHHHHhcCCCCCCCC-----CCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 232 -----PEQAAFAVCQKNARPPVPP-----TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 232 -----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
..............+..+. .+++.+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2223223333333444432 2567899999999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=311.95 Aligned_cols=232 Identities=22% Similarity=0.326 Sum_probs=192.8
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||.||+|.+. ++.||||++...... +.+.+|+.+++.+.|++++.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--------CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--------hHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 78999999999999999999975 899999998765443 34788999999999988654
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee---cCCCeEEEeeccccccccc
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..++.++.|++.||.|||++|++||||||+||++ +.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 81 VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 35679999999999999999999999999999999999999 4788999999999876544
Q ss_pred CCC--------CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhc---CCCC
Q 020016 181 CGS--------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP---EQAAFAVCQK---NARP 246 (332)
Q Consensus 181 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~---~~~~~~~~~~---~~~~ 246 (332)
... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+... ....
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 322 2456799999999999999999999999999999999999999986432 1112222111 1111
Q ss_pred CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCccc
Q 020016 247 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEF 294 (332)
Q Consensus 247 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 294 (332)
..+..+++.+.+++.+||+.||.+||++.++++.|+.+..........
T Consensus 241 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~ 288 (296)
T 3uzp_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDY 288 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSC
T ss_pred HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccc
Confidence 234678999999999999999999999999999999999888766544
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=317.72 Aligned_cols=222 Identities=24% Similarity=0.351 Sum_probs=182.9
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|++.+.||+|+||+||+|.+. ++.||||++....... ..+.+.+|+.+++.++||||++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-----CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------CHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc-----hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 378999999999999999999987 7899999997654322 1356889999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC--
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-- 181 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 181 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 3456899999999999999999999999999999999999999999999999999754322
Q ss_pred -CCCCCcccccccCChhhhhcCCC-CCccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcCCCCCCCCCCcHHHHH
Q 020016 182 -GSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF-AVCQKNARPPVPPTCPKAFSY 258 (332)
Q Consensus 182 -~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~ 258 (332)
.......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.......... ..............+++.+.+
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHH
Confidence 22345679999999999988775 778999999999999999999998765543322 222233333334678999999
Q ss_pred HHHHccccCCCCCCCHHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~~ 280 (332)
||.+||+.||.+|||+.++++.
T Consensus 241 li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 241 LLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHccCChhhCcCHHHHhhC
Confidence 9999999999999999999863
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=319.47 Aligned_cols=220 Identities=22% Similarity=0.284 Sum_probs=191.6
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
..++|.+.+.||+|+||.||+|.+. ++.||||++...... .....+.+.+|+.++..++||||++
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV---KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc---cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 4579999999999999999999996 789999999753211 1112356889999999999999986
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 182 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 182 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~-- 193 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC--
Confidence 235689999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 020016 183 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 262 (332)
.....+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+... ...+|..+++.+.++|.+
T Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~ 271 (350)
T 1rdq_E 194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTCCHHHHHHHHH
T ss_pred CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHH
Confidence 234568999999999999999999999999999999999999999998888877777654 456678899999999999
Q ss_pred ccccCCCCCCC-----HHHHHH
Q 020016 263 CWSSSPDRRPH-----FDQIVS 279 (332)
Q Consensus 263 cl~~dp~~Rps-----~~ell~ 279 (332)
||+.||.+||+ ++++++
T Consensus 272 lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 272 LLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHT
T ss_pred HhhcCHHhccCCccCCHHHHHh
Confidence 99999999998 777775
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=310.92 Aligned_cols=231 Identities=26% Similarity=0.428 Sum_probs=191.8
Q ss_pred cccccCCeeeeeeecccCceEEEEEEE------CCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIY------KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--- 120 (332)
..+....|++.+.||+|+||.||+|.+ .++.||||++........ .+.+.+|+.+++.++||||++
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~ 90 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH-----IADLKKEIEILRNLYHENIVKYKG 90 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CC-----HHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchh-----HHHHHHHHHHHHhCCCCCeeeeee
Confidence 344567899999999999999999984 378999999986543221 366889999999999999986
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeec
Q 020016 121 ----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 172 (332)
Q Consensus 121 ----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Df 172 (332)
....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+||
T Consensus 91 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Df 170 (302)
T 4e5w_A 91 ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDF 170 (302)
T ss_dssp EEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred EEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcc
Confidence 2356899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC----CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCC--------------CCHHH
Q 020016 173 GISCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN--------------MTPEQ 234 (332)
Q Consensus 173 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~--------------~~~~~ 234 (332)
|++....... ......+|..|+|||.+.+..++.++||||||+++|+|++|..|+.. .....
T Consensus 171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred cccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence 9987654432 23345678889999999999999999999999999999999887643 12223
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 020016 235 AAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 285 (332)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~ 285 (332)
..............+..+++.+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 333444456677788899999999999999999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=312.63 Aligned_cols=218 Identities=24% Similarity=0.388 Sum_probs=188.0
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
.|...+.||+|+||.||+|.+. |+.||||++....... .+.+.+|+.+++.++||||++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 119 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR------RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWV 119 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS------HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH------HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEE
Confidence 4788889999999999999986 8999999998654433 356889999999999999986
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-CCCC
Q 020016 121 --------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GSAK 185 (332)
Q Consensus 121 --------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~~~ 185 (332)
....+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...... ....
T Consensus 120 v~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 120 LMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp EECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred EEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 3457899999999999999999999999999999999999999999999999998765433 2334
Q ss_pred CcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCCcHHHHHHHHHcc
Q 020016 186 GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR-PPVPPTCPKAFSYLISRCW 264 (332)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl 264 (332)
...||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+...... ...+..+++.+.+++.+||
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 567999999999999999999999999999999999999999988887766655443221 1233467899999999999
Q ss_pred ccCCCCCCCHHHHHH
Q 020016 265 SSSPDRRPHFDQIVS 279 (332)
Q Consensus 265 ~~dp~~Rps~~ell~ 279 (332)
+.||.+|||+.++++
T Consensus 280 ~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 280 VRDPQERATAQELLD 294 (321)
T ss_dssp CSSTTTSCCHHHHHT
T ss_pred cCChhhCcCHHHHhc
Confidence 999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=322.72 Aligned_cols=220 Identities=21% Similarity=0.317 Sum_probs=190.5
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.+.|.+.+.||+|+||.||+|.+. ++.||+|++....... ...+.+|+.+++.++||||++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD------KYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH------HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhh------HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence 368999999999999999999996 7899999998754322 356889999999999999986
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC--CCeEEEeeccccccccc
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE--DMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~--~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 2346899999999999999999999999999999999999974 47899999999987655
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHHH
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR--PPVPPTCPKAFSY 258 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~ 258 (332)
........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+...... ......+++++.+
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 283 (387)
T 1kob_A 204 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 283 (387)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence 44444567999999999999999999999999999999999999999998887777666554332 2334578999999
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~ 279 (332)
||.+||+.||.+|||+.++++
T Consensus 284 li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 284 FIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHcCCChhHCcCHHHHhh
Confidence 999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=319.22 Aligned_cols=236 Identities=27% Similarity=0.451 Sum_probs=190.7
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
..+.....++|.+.+.||+|+||+||+|.+. ++.||||++....... .+.+.+|+.+++.++||||++
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~ 104 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG------IEEFETEIETLSFCRHPHLVSLIGFC 104 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSH------HHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHH------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3444556789999999999999999999986 7899999987754432 367899999999999999986
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecc
Q 020016 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 121 ---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
....+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecc
Confidence 11258999999999999999999999999999999999999999999999999
Q ss_pred cccccccC---CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-cC
Q 020016 174 ISCLESQC---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ------AAFAVCQ-KN 243 (332)
Q Consensus 174 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~------~~~~~~~-~~ 243 (332)
++...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....+.+ ....... ..
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 98754322 12234568999999999999999999999999999999999999997643221 1111111 11
Q ss_pred --------CCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 020016 244 --------ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 288 (332)
Q Consensus 244 --------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 288 (332)
.....+..++..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 111223345677899999999999999999999999999886543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=307.69 Aligned_cols=222 Identities=27% Similarity=0.470 Sum_probs=187.8
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
..++|.+.+.||+|+||+||+|.+. +..||||++...... .......+.+|+.+++.++||||++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE---KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---HHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccc---hhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 3589999999999999999999997 678999998653221 1122466889999999999999987
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 182 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 182 (332)
....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~- 162 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 162 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence 2356899999999999999999999999999999999999999999999999988554332
Q ss_pred CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 020016 183 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 262 (332)
......+|+.|+|||.+.+..++.++||||||+++|+|++|..||......+....+.. ....++..+++.+.+||.+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~ 240 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISR 240 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--TCCCCCTTSCHHHHHHHHH
T ss_pred cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh--CCCCCCCcCCHHHHHHHHH
Confidence 23456789999999999999999999999999999999999999999888777666543 3455677899999999999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~~ 280 (332)
||+.||.+||++.++++.
T Consensus 241 ~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 241 LLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HCCSSGGGSCCHHHHHHC
T ss_pred HhccChhhCCCHHHHhhC
Confidence 999999999999999973
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=323.58 Aligned_cols=221 Identities=19% Similarity=0.334 Sum_probs=182.8
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec-----
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT----- 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----- 120 (332)
...+..++|.+.+.||+|+||+||+|.++ ++.||||++........ ...+.+.+|..++.++ +||||++
T Consensus 46 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~---~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 122 (396)
T 4dc2_A 46 SSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD---EDIDWVQTEKHVFEQASNHPFLVGLHSCF 122 (396)
T ss_dssp ---CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-------CCHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred ccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH---HHHHHHHHHHHHHHhcCCCCCcCeeEEEE
Confidence 34566789999999999999999999997 78999999986432211 1134577899999887 8999987
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccc
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 123 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 123 QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 235689999999999999999999999999999999999999999999999999975
Q ss_pred c-ccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHhcCCCCC
Q 020016 178 E-SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT---------PEQAAFAVCQKNARPP 247 (332)
Q Consensus 178 ~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~---------~~~~~~~~~~~~~~~~ 247 (332)
. .........+||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+. .....
T Consensus 203 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~--~~~~~ 280 (396)
T 4dc2_A 203 GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--EKQIR 280 (396)
T ss_dssp CCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH--HCCCC
T ss_pred cccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh--ccccC
Confidence 3 33344566789999999999999999999999999999999999999996432 122223332 34556
Q ss_pred CCCCCcHHHHHHHHHccccCCCCCCCH
Q 020016 248 VPPTCPKAFSYLISRCWSSSPDRRPHF 274 (332)
Q Consensus 248 ~~~~~~~~l~~li~~cl~~dp~~Rps~ 274 (332)
+|..+++++.+||.+||+.||.+||++
T Consensus 281 ~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 788899999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=324.31 Aligned_cols=223 Identities=22% Similarity=0.337 Sum_probs=175.9
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCceec----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIIT---------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~---------- 120 (332)
.++|.+.+.||+|+||.||+|.+. ++.||||++......... .+.+.+|+.++..+. ||||++
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTD----AQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHH----HHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHH----HHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 368999999999999999999986 789999998764332221 356789999999997 999986
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 181 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 181 (332)
....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 84 RDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp SCEEEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred CEEEEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 2346889999999999999999999999999999999999999999999999999754321
Q ss_pred ---------------------CCCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 020016 182 ---------------------GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV 239 (332)
Q Consensus 182 ---------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~ 239 (332)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 11234579999999999986 67899999999999999999999999998877666555
Q ss_pred HhcCCCCC---------------------------------------------CCCCCcHHHHHHHHHccccCCCCCCCH
Q 020016 240 CQKNARPP---------------------------------------------VPPTCPKAFSYLISRCWSSSPDRRPHF 274 (332)
Q Consensus 240 ~~~~~~~~---------------------------------------------~~~~~~~~l~~li~~cl~~dp~~Rps~ 274 (332)
......+. .+..+++++.+|+.+||+.||.+|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 43211111 122678899999999999999999999
Q ss_pred HHHHHH
Q 020016 275 DQIVSI 280 (332)
Q Consensus 275 ~ell~~ 280 (332)
.++++.
T Consensus 324 ~e~l~H 329 (388)
T 3oz6_A 324 NDALKH 329 (388)
T ss_dssp HHHTTS
T ss_pred HHHhCC
Confidence 999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=316.70 Aligned_cols=217 Identities=20% Similarity=0.347 Sum_probs=182.6
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec---------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT--------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------- 120 (332)
..++|.+.+.||+|+||.||+|.++ ++.||||++........ ...+.+.+|..++.++ +||||++
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD---EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSH---HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcch---HHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 4578999999999999999999997 78999999986532221 1245688999999988 8999987
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc-c
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES-Q 180 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~-~ 180 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.... .
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 23568999999999999999999999999999999999999999999999999997532 2
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHhcCCCCCCCCC
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM---------TPEQAAFAVCQKNARPPVPPT 251 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~ 251 (332)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||... ........+. .....+|..
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~--~~~~~~p~~ 241 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--EKQIRIPRS 241 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH--HCCCCCCTT
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH--cCCCCCCCC
Confidence 33445678999999999999999999999999999999999999999752 2222333333 234567788
Q ss_pred CcHHHHHHHHHccccCCCCCCCH
Q 020016 252 CPKAFSYLISRCWSSSPDRRPHF 274 (332)
Q Consensus 252 ~~~~l~~li~~cl~~dp~~Rps~ 274 (332)
+++.+.+||.+||+.||.+||++
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCHHHHHHHHHHhcCCHhHCCCC
Confidence 99999999999999999999995
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=309.22 Aligned_cols=232 Identities=26% Similarity=0.512 Sum_probs=194.2
Q ss_pred cCCeeeeeeecccCceEEEEEEECC-----eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYKQ-----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
..+|.+.+.||+|+||+||+|.+.+ ..||||.+........ .+.+.+|+.++++++||||++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHH-----HHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHH-----HHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 3579999999999999999998752 3589999986443322 467899999999999999987
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 3456889999999999999999999999999999999999999999999999998754
Q ss_pred ccCC-----CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 020016 179 SQCG-----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 252 (332)
Q Consensus 179 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (332)
.... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||......+....+. .......+..+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 257 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYC 257 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCCCCCCTTC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCCCCCCccC
Confidence 3321 2234567889999999999999999999999999999999 777887766655554443 44556667788
Q ss_pred cHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 020016 253 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 291 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~ 291 (332)
++.+.+++.+||+.||.+||++.++++.|+.+..++...
T Consensus 258 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 258 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 999999999999999999999999999999998876643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=316.04 Aligned_cols=225 Identities=22% Similarity=0.309 Sum_probs=190.9
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+++.||+|+||.||+|.+. ++.||||++..............+.+.+|+.++++++||||++
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 67999999999999999999996 7899999998754322100001356889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC----eEEEeeccccccccc
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM----CVKVADFGISCLESQ 180 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~----~~kl~Dfg~a~~~~~ 180 (332)
....+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~ 171 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence 345689999999999999999999999999999999999999887 799999999977665
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHHH
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCPKAFSY 258 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 258 (332)
........||+.|+|||.+.+..++.++||||||+++|+|++|..||.+....+....+....... ..+..+++.+.+
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (321)
T 2a2a_A 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKD 251 (321)
T ss_dssp TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHH
T ss_pred cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHH
Confidence 555556779999999999999999999999999999999999999999988877766664432221 122578899999
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~ 279 (332)
||.+||+.||.+|||+.++++
T Consensus 252 li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 252 FIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHhc
Confidence 999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=308.96 Aligned_cols=237 Identities=24% Similarity=0.383 Sum_probs=183.3
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
..++|.+.+.||+|+||.||+|.+. ++.||||++........ ...+.+.+|+.+++.++||||++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDA---KARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 3578999999999999999999985 78999999986432221 12467899999999999999986
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 2456899999999999999999999999999999999999999999999999998765
Q ss_pred ccCC-CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCCCCCCCCcHH
Q 020016 179 SQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT--PEQAAFAVCQKNARPPVPPTCPKA 255 (332)
Q Consensus 179 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 255 (332)
.... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.. .......+.........+..++++
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 266 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence 4322 2334578999999999999999999999999999999999999997642 333333443333333334678999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCc
Q 020016 256 FSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 292 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~ 292 (332)
+.+++.+||+.||.+||++.++++.|+.+.......+
T Consensus 267 l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 267 LRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 9999999999999999999999999999988887655
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=319.52 Aligned_cols=241 Identities=26% Similarity=0.452 Sum_probs=193.9
Q ss_pred CCccccccccCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 45 EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 45 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
....+|.++.++|.+.+.||+|+||.||+|.+.+ .||||++......... .+.+.+|+.++++++||||++
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~ 97 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQ----LKAFKREVMAYRQTRHENVVLFMGA 97 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCC----CCCCCTTGGGGTTCCCTTBCCCCEE
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHH----HHHHHHHHHHHhcCCCCCEeEEEEE
Confidence 3467899999999999999999999999999876 5999999764322111 245778999999999999986
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
....+++..++.++.||+.||.|||++|++||||||+||+++ ++.++|+|||++
T Consensus 98 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 98 CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp EECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred EecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCc
Confidence 234689999999999999999999999999999999999998 689999999997
Q ss_pred ccccc------CCCCCCcccccccCChhhhhc---------CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 020016 176 CLESQ------CGSAKGFTGTYRWMAPEMIKE---------KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC 240 (332)
Q Consensus 176 ~~~~~------~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~ 240 (332)
..... ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 256 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence 65321 112234568999999999975 346889999999999999999999999988887777665
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 020016 241 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 291 (332)
Q Consensus 241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~ 291 (332)
........+..++.++.+++.+||..||.+||++.++++.|+.+.......
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~ 307 (319)
T 2y4i_B 257 TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307 (319)
T ss_dssp TTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred cCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 544444444578899999999999999999999999999999988766543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=320.82 Aligned_cols=223 Identities=25% Similarity=0.387 Sum_probs=189.3
Q ss_pred ccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec-------
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT------- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~------- 120 (332)
.+..++|.+.+.||+|+||+||+|.++ ++.||||++...... .....+.+..|..++..+ +||||++
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~ 89 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL---MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 89 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh---hhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence 345689999999999999999999996 789999999763211 011135577899999877 9999987
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 23568999999999999999999999999999999999999999999999999987543
Q ss_pred c-CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 020016 180 Q-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 258 (332)
Q Consensus 180 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 258 (332)
. .......+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+... .+.++..+++++.+
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 247 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKD 247 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHH
T ss_pred cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CCCCCcccCHHHHH
Confidence 2 23445678999999999999999999999999999999999999999998888777776543 45667889999999
Q ss_pred HHHHccccCCCCCCCHH-HHH
Q 020016 259 LISRCWSSSPDRRPHFD-QIV 278 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~-ell 278 (332)
||.+||+.||.+||++. +++
T Consensus 248 li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 248 LLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHHHSCSSGGGSBTTBSCGG
T ss_pred HHHHHhcCCHhHcCCChHHHH
Confidence 99999999999999997 665
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=315.13 Aligned_cols=221 Identities=24% Similarity=0.355 Sum_probs=171.2
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|++.+.||+|+||+||+|.+. ++.||||++........ .+.+.+|+.++++++||||++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT-----PSTAIREISLMKELKHENIVRLYDVIHTENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCS-----CHHHHHHHHHHTTCCBTTBCCEEEEECCTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEEECCeE
Confidence 468999999999999999999986 78999999976543221 256788999999999999987
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 79 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 79 TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp EEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 1245899999999999999999999999999999999999999999999999999765
Q ss_pred ccC-CCCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----------
Q 020016 179 SQC-GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP---------- 246 (332)
Q Consensus 179 ~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~---------- 246 (332)
... .......+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+......+
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 432 233456789999999999764 68999999999999999999999999988777665554321110
Q ss_pred ----------------------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 ----------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 ----------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..+..+++++.+||.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 112357889999999999999999999999885
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=326.32 Aligned_cols=227 Identities=28% Similarity=0.392 Sum_probs=168.7
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
..|.+. ++|.+++.||+|+||+||+|.+. ++.||||++......... .+.+.+|+.+|+.++|||||+
T Consensus 47 ~~~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~ 121 (458)
T 3rp9_A 47 SDWQIP-DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID----CKRILREIAILNRLNHDHVVKVLDIV 121 (458)
T ss_dssp SSCCSC-TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHH----HHHHHHHHHHHHHCCCTTBCCEEEEC
T ss_pred CcCccC-CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHH----HHHHHHHHHHHHhCCCCCCCceEEEE
Confidence 345543 78999999999999999999987 789999999765433221 467889999999999999986
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecc
Q 020016 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 121 ---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 122 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFG 201 (458)
T 3rp9_A 122 IPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFG 201 (458)
T ss_dssp CCSCTTTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred ecCCcccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccc
Confidence 34568999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC----------------------------CCCCcccccccCChhhh-hcCCCCCccchhHHHHHHHHHHh--
Q 020016 174 ISCLESQCG----------------------------SAKGFTGTYRWMAPEMI-KEKRHTKKVDVYSFGIVLWELLT-- 222 (332)
Q Consensus 174 ~a~~~~~~~----------------------------~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~ellt-- 222 (332)
+++...... .....+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence 997653221 12345689999999986 55678999999999999999999
Q ss_pred ---------CCCCCCCCCH--------------------HHHHHHHHhcCCC----------------------------
Q 020016 223 ---------ALTPFDNMTP--------------------EQAAFAVCQKNAR---------------------------- 245 (332)
Q Consensus 223 ---------G~~pf~~~~~--------------------~~~~~~~~~~~~~---------------------------- 245 (332)
|.++|.+.+. .+....+......
T Consensus 282 ~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (458)
T 3rp9_A 282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTD 361 (458)
T ss_dssp TTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCC
T ss_pred cccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCC
Confidence 6777766431 1111111110000
Q ss_pred -CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 246 -PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 246 -~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
....+.+++++.+||.+||..||.+|||++|+++
T Consensus 362 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 362 LAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp GGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0112456899999999999999999999999987
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=310.22 Aligned_cols=221 Identities=22% Similarity=0.357 Sum_probs=180.5
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||+||+|.+. ++.||||++........ ..+.+.+|+.++++++||||++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV----IKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH 78 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchH----HHHHHHHHHHHHHhCCCCCccchhheeecCCeEE
Confidence 68999999999999999999996 78999999977544332 2467889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-CC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GS 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~ 183 (332)
....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... ..
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 4567999999999999999999999999999999999999999999999999999765432 23
Q ss_pred CCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------------------
Q 020016 184 AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA------------------ 244 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~------------------ 244 (332)
.....+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||.+....+....+.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 345678999999999976 5679999999999999999999999999887665544432111
Q ss_pred -CCCC----------CCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 245 -RPPV----------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 245 -~~~~----------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..+. .+.+++.+.+|+.+||+.||.+|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0010 1457889999999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=317.88 Aligned_cols=223 Identities=22% Similarity=0.312 Sum_probs=189.6
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec--------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT-------- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~-------- 120 (332)
+..++|.+.+.||+|+||+||+|.+. ++.||||++...... .....+.+..|..++..+ +||||++
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~---~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI---QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 93 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH---HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh---cchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence 34689999999999999999999997 678999999763211 111135678899999988 8999986
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc-
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES- 179 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~- 179 (332)
..+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 23568999999999999999999999999999999999999999999999999987533
Q ss_pred cCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 020016 180 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 259 (332)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 259 (332)
........+||+.|+|||++.+..++.++||||||+++|||++|..||.+.+..+....+... ...+|..+++++.+|
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~l 251 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKEAVAI 251 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHH
T ss_pred CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHH
Confidence 223445678999999999999999999999999999999999999999998888877777654 455778899999999
Q ss_pred HHHccccCCCCCCC-----HHHHHH
Q 020016 260 ISRCWSSSPDRRPH-----FDQIVS 279 (332)
Q Consensus 260 i~~cl~~dp~~Rps-----~~ell~ 279 (332)
|.+||+.||.+||+ +.++++
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 99999999999995 466654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=317.62 Aligned_cols=218 Identities=28% Similarity=0.380 Sum_probs=169.5
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.+.|.+.+.||+|+||.||+|.+. ++.||||++..... .+.+.+|+.++++++||||++
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--------KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh--------HHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 467999999999999999999997 67899999986432 256788999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC---CCeEEEeeccccccccc
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~---~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.....
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 3456899999999999999999999999999999999999975 78999999999976655
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCCC--CCCCCCcHHHH
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-AAFAVCQKNARP--PVPPTCPKAFS 257 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~l~ 257 (332)
........||+.|+|||++.+..++.++||||||+++|+|++|..||....... ....+....... +....++..+.
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 283 (349)
T 2w4o_A 204 QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAK 283 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHH
Confidence 444456779999999999999999999999999999999999999998766554 333343322221 23357899999
Q ss_pred HHHHHccccCCCCCCCHHHHHH
Q 020016 258 YLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 258 ~li~~cl~~dp~~Rps~~ell~ 279 (332)
+||.+||+.||++|||+.++++
T Consensus 284 ~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 284 DLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=312.94 Aligned_cols=229 Identities=24% Similarity=0.408 Sum_probs=185.6
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||.||+|.+. ++.||||++....... ......+.+|+.++.+++||||++
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARD---PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTS---HHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCC---HHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 78999999999999999999985 7899999998754332 122467899999999999999986
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 235689999999999999999999999999999999999999999999999999876543
Q ss_pred CC----CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcH
Q 020016 181 CG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPK 254 (332)
Q Consensus 181 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 254 (332)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+................+. ....+++
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 248 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCH
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCH
Confidence 22 22345689999999999999999999999999999999999999999888877766655443332 2356899
Q ss_pred HHHHHHHHccccCCCCCCCHH-HHHHHHHhhhh
Q 020016 255 AFSYLISRCWSSSPDRRPHFD-QIVSILEGYSE 286 (332)
Q Consensus 255 ~l~~li~~cl~~dp~~Rps~~-ell~~L~~~~~ 286 (332)
++.++|.+||+.||.+||+.. ++...|.....
T Consensus 249 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 249 DLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 999999999999999999554 55556665543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=313.73 Aligned_cols=226 Identities=20% Similarity=0.306 Sum_probs=182.2
Q ss_pred cccccCCeeeeeeecccCceEEEEEEE-----CCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIY-----KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
..+..++|.+.+.||+|+||.||++.+ .++.||||++........ ......+.+|+.+++.++||||++
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN--AKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC----------------HHHHHHHCCCTTBCCEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhh--hhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 345568999999999999999999987 378999999987532111 111356788999999999999987
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccc
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 23568899999999999999999999999999999999999999999999999986
Q ss_pred cccc-CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 020016 177 LESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255 (332)
Q Consensus 177 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (332)
.... ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+... ...++..+++.
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~ 247 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC--KLNLPPYLTQE 247 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CCCCCTTSCHH
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHH
Confidence 5332 22334567999999999999999999999999999999999999999998887777666543 44567789999
Q ss_pred HHHHHHHccccCCCCCC-----CHHHHHH
Q 020016 256 FSYLISRCWSSSPDRRP-----HFDQIVS 279 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rp-----s~~ell~ 279 (332)
+.+||.+||+.||.+|| ++.++++
T Consensus 248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 99999999999999999 6777765
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=339.24 Aligned_cols=237 Identities=26% Similarity=0.507 Sum_probs=199.4
Q ss_pred ccccccccCCeeeee-eecccCceEEEEEEEC----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-
Q 020016 47 EEEWSADMSQLFIGC-KFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT- 120 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~-~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~- 120 (332)
...|.++...+.+.. .||+|+||.||+|.+. ++.||||++........ ..+.|.+|+.+|.+++|||||+
T Consensus 360 ~~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~l 435 (635)
T 4fl3_A 360 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----LKDELLAEANVMQQLDNPYIVRM 435 (635)
T ss_dssp CSSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGG----GHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHH----HHHHHHHHHHHHHhCCCCCEeeE
Confidence 356777777777754 8999999999999763 57899999976433321 1467999999999999999987
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 436 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGl 515 (635)
T 4fl3_A 436 IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 515 (635)
T ss_dssp EEEEESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTH
T ss_pred EEEEecCCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCC
Confidence 345789999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC----CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 020016 175 SCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 249 (332)
Q Consensus 175 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (332)
+....... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.+....+....+. ...+...+
T Consensus 516 a~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p 594 (635)
T 4fl3_A 516 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCP 594 (635)
T ss_dssp HHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCC
T ss_pred ccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 97654322 1223456789999999999999999999999999999999 999999998877666554 55677788
Q ss_pred CCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 020016 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 288 (332)
Q Consensus 250 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 288 (332)
..+++++.+||.+||+.||++||++.+|++.|+++...+
T Consensus 595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 595 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 899999999999999999999999999999999987654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=315.10 Aligned_cols=238 Identities=25% Similarity=0.345 Sum_probs=180.5
Q ss_pred CCccccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCceec-
Q 020016 45 EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIIT- 120 (332)
Q Consensus 45 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~- 120 (332)
.....+++...+|.+.+.||+|+||.||+|.+. ++.||||++....... .+.+.+|+.++.++. ||||++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~e~~~l~~l~~h~~iv~~ 91 (337)
T 3ll6_A 18 FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEK------NRAIIQEVCFMKKLSGHPNIVQF 91 (337)
T ss_dssp STTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHH------HHHHHHHHHHHHHHTTSTTBCCE
T ss_pred hhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHH------HHHHHHHHHHHHHhccCCChhhc
Confidence 345567777789999999999999999999995 7899999986643322 367889999999995 999985
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC--Cccccccccceee
Q 020016 121 -------------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLL 161 (332)
Q Consensus 121 -------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~NIll 161 (332)
....+++..++.++.||+.||.|||+.| |+||||||+|||+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~ 171 (337)
T 3ll6_A 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL 171 (337)
T ss_dssp EEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE
T ss_pred cccccccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE
Confidence 3456999999999999999999999999 9999999999999
Q ss_pred cCCCeEEEeecccccccccCCCC-------------CCcccccccCChhhh---hcCCCCCccchhHHHHHHHHHHhCCC
Q 020016 162 GEDMCVKVADFGISCLESQCGSA-------------KGFTGTYRWMAPEMI---KEKRHTKKVDVYSFGIVLWELLTALT 225 (332)
Q Consensus 162 ~~~~~~kl~Dfg~a~~~~~~~~~-------------~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~il~elltG~~ 225 (332)
+.++.+||+|||++......... ....+|+.|+|||++ .+..++.++||||||+++|+|++|..
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~ 251 (337)
T 3ll6_A 172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251 (337)
T ss_dssp CTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCC
Confidence 99999999999999765432211 144589999999998 56678899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCc
Q 020016 226 PFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 292 (332)
Q Consensus 226 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~ 292 (332)
||........ .........+...+..+.+|+.+||+.||.+||++.++++.|+.+.......+
T Consensus 252 p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~ 314 (337)
T 3ll6_A 252 PFEDGAKLRI----VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314 (337)
T ss_dssp CC----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCT
T ss_pred CCcchhHHHh----hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCC
Confidence 9986544332 22333444556778889999999999999999999999999999987766444
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=314.58 Aligned_cols=225 Identities=25% Similarity=0.389 Sum_probs=185.7
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
..|++. ++|.+.+.||+|+||+||+|.+. ++.||||++........ ..+.+.+|+.+++.++||||++
T Consensus 36 ~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~ 110 (371)
T 4exu_A 36 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI----FAKRAYRELLLLKHMQHENVIGLLDVF 110 (371)
T ss_dssp EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHH----HHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred ceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchh----HHHHHHHHHHHHHhcCCCCchhhhhhe
Confidence 455554 79999999999999999999986 89999999987544332 2467889999999999999986
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 111 TPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CSCSSSTTCCCCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eccCCcccceeEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 234589999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------
Q 020016 175 SCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------- 246 (332)
Q Consensus 175 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~------- 246 (332)
+..... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+......+
T Consensus 191 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 191 ARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp C----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 875543 2345678999999999987 678999999999999999999999999988766655543311111
Q ss_pred ----------------------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 ----------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 ----------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..++.+++.+.+||.+||+.||.+|||+.++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 112467899999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=309.17 Aligned_cols=232 Identities=22% Similarity=0.321 Sum_probs=189.1
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||+||+|.+. ++.||||++...... ..+.+|+.++..++|++++.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--------CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--------hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 68999999999999999999975 889999987664332 34778999999999988664
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee---cCCCeEEEeeccccccccc
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 81 VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 35679999999999999999999999999999999999999 7889999999999976544
Q ss_pred CCC--------CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh---cCCCC
Q 020016 181 CGS--------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE---QAAFAVCQ---KNARP 246 (332)
Q Consensus 181 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~---~~~~~~~~---~~~~~ 246 (332)
... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.... .....+.. .....
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 322 23567899999999999999999999999999999999999999864321 11111111 11111
Q ss_pred CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCccc
Q 020016 247 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEF 294 (332)
Q Consensus 247 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 294 (332)
.....+++.+.+++.+||+.||++||++.++++.|+.+......+...
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~ 288 (296)
T 4hgt_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDY 288 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTC
T ss_pred hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccC
Confidence 233667899999999999999999999999999999999988865533
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=313.89 Aligned_cols=226 Identities=20% Similarity=0.328 Sum_probs=185.7
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||+||+|.+. ++.||||++........ .+.+.+|+.++++++||||++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-----VDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch-----HHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence 378999999999999999999997 78999999976433222 356789999999999999986
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee----cCCCeEEEeeccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL----GEDMCVKVADFGI 174 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll----~~~~~~kl~Dfg~ 174 (332)
....+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 11238999999999999999999999999999999999999 7788999999999
Q ss_pred ccccccCCCCCCcccccccCChhhhh--------cCCCCCccchhHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhc
Q 020016 175 SCLESQCGSAKGFTGTYRWMAPEMIK--------EKRHTKKVDVYSFGIVLWELLTALTPFDNMTP----EQAAFAVCQK 242 (332)
Q Consensus 175 a~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlG~il~elltG~~pf~~~~~----~~~~~~~~~~ 242 (332)
+.............||+.|+|||++. +..++.++||||||+++|+|++|..||..... .+....+...
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 98766655555677999999999987 46789999999999999999999999975332 3333333332
Q ss_pred CCCC-----------------------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 243 NARP-----------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 243 ~~~~-----------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
.... .++..++..+.+++.+||+.||++|||++|+++...+.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 2110 12223456788999999999999999999999988764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=317.30 Aligned_cols=225 Identities=23% Similarity=0.361 Sum_probs=182.6
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
..|.+ .++|.+.+.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.+++.++||||++
T Consensus 19 ~~~~~-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~l~~~~ 93 (367)
T 1cm8_A 19 TAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL----FAKRAYRELRLLKHMRHENVIGLLDVF 93 (367)
T ss_dssp SEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHH----HHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred ceeee-cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHH----HHHHHHHHHHHHHhCCCcCCCCceeeE
Confidence 34444 378999999999999999999986 78999999976543322 2467889999999999999986
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecc
Q 020016 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 121 ---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 94 TPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CSCSSTTTCCCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ecCCccccCceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeee
Confidence 12458899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------
Q 020016 174 ISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------ 246 (332)
Q Consensus 174 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~------ 246 (332)
++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 174 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 174 LARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp TCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9976543 2345678999999999987 678999999999999999999999999888766555443321111
Q ss_pred -----------------------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 -----------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 -----------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.....+++.+.+|+.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 123467899999999999999999999999987
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=329.56 Aligned_cols=221 Identities=25% Similarity=0.395 Sum_probs=192.5
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+++.||+|+||.||+|.+. |+.||||++....... ....+.+.+|+.+++.++||||++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS---LDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHH---TTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 579999999999999999999996 8899999997532111 112356889999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
..+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 456799999999999999999999999999999999999999999999999999987665555
Q ss_pred CCCcccccccCChhhhhcCCC-CCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 020016 184 AKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 262 (332)
....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+... ....|..+++++.+||.+
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~ 249 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQYLNPSVISLLKH 249 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT--CCCCCTTCCHHHHHHHHH
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CcCCCccCCHHHHHHHHH
Confidence 566789999999999988765 68999999999999999999999988777766666433 345667889999999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~ 279 (332)
||+.||.+|||+.++++
T Consensus 250 ~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 250 MLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HTCSSTTTSCCHHHHHT
T ss_pred HcCCCchhCcCHHHHHh
Confidence 99999999999999987
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=310.74 Aligned_cols=234 Identities=26% Similarity=0.479 Sum_probs=190.0
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC---C--eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK---Q--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~---~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
..+..++|++.+.||+|+||+||+|.+. + ..||||++....... ....+.+.+|+.++++++||||++
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ---PEAMDDFIREVNAMHSLDHRNLIRLYGV 89 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-----------CHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCC---HHHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence 3455689999999999999999999863 2 369999987643221 112467899999999999999987
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccc
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 90 VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp ECSSSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EccCCceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccc
Confidence 13458899999999999999999999999999999999999999999999999987
Q ss_pred ccccCCC----CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 020016 177 LESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 251 (332)
Q Consensus 177 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (332)
....... .....+|..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.......+.+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcC
Confidence 6543321 223457788999999998889999999999999999999 99999999988888777766667777888
Q ss_pred CcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 020016 252 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 252 ~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 286 (332)
++..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 99999999999999999999999999999998754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=315.88 Aligned_cols=220 Identities=24% Similarity=0.359 Sum_probs=182.8
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||.||+|.+. ++.||||++....... ..+.+.+|+.++.+++||||++
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT-----YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHH-----HHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcH-----HHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 68999999999999999999986 7899999997643322 2467889999999999999986
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 102 ~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 102 MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CCCEEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred cceEEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 2245899999999999999999999999999999999999999999999999999765432
Q ss_pred CC----CCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----------
Q 020016 182 GS----AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP---------- 246 (332)
Q Consensus 182 ~~----~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~---------- 246 (332)
.. .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+......+
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 21 244579999999998765 458999999999999999999999998876555444433211111
Q ss_pred -------------------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 -------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 -------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...+.+++++.+||.+||+.||.+|||+.++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 012567899999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=310.47 Aligned_cols=230 Identities=21% Similarity=0.422 Sum_probs=186.8
Q ss_pred ccccCCeeeeeeecccCceEEEEEEEC--C-------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYK--Q-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~- 120 (332)
++..++|.+.+.||+|+||+||+|.+. + ..||+|++....... .+.+.+|+.++++++||||++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~ 77 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY------SESFFEAASMMSKLSHKHLVLN 77 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGG------HHHHHHHHHHHHTSCCTTBCCE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHH------HHHHHHHHHHHHhCCCCCEeEE
Confidence 455689999999999999999999886 3 469999997644332 367899999999999999986
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCe------
Q 020016 121 ----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC------ 166 (332)
Q Consensus 121 ----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~------ 166 (332)
....+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 78 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 78 YGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp EEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred EEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccc
Confidence 2234899999999999999999999999999999999999988876
Q ss_pred --EEEeecccccccccCCCCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 020016 167 --VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQK 242 (332)
Q Consensus 167 --~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~ 242 (332)
++|+|||++..... .....+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||............
T Consensus 158 ~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~--- 231 (289)
T 4fvq_A 158 PFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY--- 231 (289)
T ss_dssp CEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---
T ss_pred ceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh---
Confidence 99999999854432 223568899999999987 678999999999999999999 56666666655444333
Q ss_pred CCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCc
Q 020016 243 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 292 (332)
Q Consensus 243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~ 292 (332)
......+...++++.+++.+||+.||.+|||+.++++.|+.+...-...+
T Consensus 232 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~ 281 (289)
T 4fvq_A 232 EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281 (289)
T ss_dssp HTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred hccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence 23445566778899999999999999999999999999999877554433
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=329.23 Aligned_cols=226 Identities=23% Similarity=0.323 Sum_probs=183.9
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
.+.+..++|.+.+.||+|+||.||+|.+. ++.||||++....... ......+.+|+.++..++||||+.
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 218 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA---KDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC----------------CCCCCSCTTSCCEEEEEE
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhh---hHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence 34566789999999999999999999986 7899999997532111 112356788999999999999986
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccccccceeecCCCeEEEeecccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++..
T Consensus 219 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 219 THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp ETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred eCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 23568999999999999999999998 9999999999999999999999999999875
Q ss_pred cc-cCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 020016 178 ES-QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 256 (332)
Q Consensus 178 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (332)
.. ........+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+... ...+|..+++++
T Consensus 299 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~ 376 (446)
T 4ejn_A 299 GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLGPEA 376 (446)
T ss_dssp TCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHH
T ss_pred ccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHH
Confidence 33 223345678999999999999999999999999999999999999999998888777766544 345677899999
Q ss_pred HHHHHHccccCCCCCC-----CHHHHHH
Q 020016 257 SYLISRCWSSSPDRRP-----HFDQIVS 279 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rp-----s~~ell~ 279 (332)
.+||.+||+.||.+|| ++.++++
T Consensus 377 ~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 9999999999999999 9999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=305.82 Aligned_cols=219 Identities=26% Similarity=0.399 Sum_probs=180.8
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||+||++.+. +..||+|++........ .+.+.+|+.+++.++||||++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-----MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC-----HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh-----HHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 68999999999999999999986 78999999977543322 366889999999999999987
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee---cCCCeEEEeecccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCL 177 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll---~~~~~~kl~Dfg~a~~ 177 (332)
....+++..++.++.|++.||.|||++||+||||||+||++ +.++.++|+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 23678999999999999999999999999999999999999 4567899999999977
Q ss_pred cccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-CCCCCcHHH
Q 020016 178 ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-VPPTCPKAF 256 (332)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l 256 (332)
...........+|+.|+|||.+. +.++.++||||||+++|+|++|..||.+....+............. ....+++.+
T Consensus 177 ~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (285)
T 3is5_A 177 FKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHH
T ss_pred cCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHH
Confidence 65555555677999999999986 5689999999999999999999999999888777666554433322 224578999
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+|+.+||+.||.+|||+.++++
T Consensus 256 ~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 256 VDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999999999999985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=313.87 Aligned_cols=232 Identities=29% Similarity=0.495 Sum_probs=194.7
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC--Cee--EEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRD--VAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT------ 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~--vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~------ 120 (332)
++.++|.+.+.||+|+||.||+|.+. +.. ||||.+....... ..+.+.+|+.++.++ +||||++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 96 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-----DHRDFAGELEVLCKLGHHPNIINLLGACE 96 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-----------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchH-----HHHHHHHHHHHHHhccCCCchhhhceeee
Confidence 45689999999999999999999885 554 5999987543222 135688999999999 9999986
Q ss_pred ----------------------CC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeec
Q 020016 121 ----------------------EP----------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 162 (332)
Q Consensus 121 ----------------------~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~ 162 (332)
.. ..+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc
Confidence 11 3689999999999999999999999999999999999999
Q ss_pred CCCeEEEeecccccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 020016 163 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQ 241 (332)
Q Consensus 163 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~ 241 (332)
.++.+||+|||++.............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+.
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~- 255 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 255 (327)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-
T ss_pred CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh-
Confidence 999999999999875444344445567889999999998889999999999999999998 999999988877665543
Q ss_pred cCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 242 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
.......+..+++.+.+|+.+||+.||.+||++.++++.|+.+.....
T Consensus 256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 445566778899999999999999999999999999999999887654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=305.86 Aligned_cols=218 Identities=21% Similarity=0.314 Sum_probs=188.6
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||.||+|.+. +..||+|++....... .+.+.+|+.++++++||||++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED------VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 67999999999999999999997 5689999997654332 356889999999999999987
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee---cCCCeEEEeecccccccccC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||++......
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 23458999999999999999999999999999999999999 77899999999999776655
Q ss_pred CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHH
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYL 259 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l 259 (332)
.......+|+.|+|||.+.+. ++.++||||||+++|+|++|..||......+....+.......+.. ..+++.+.++
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHH
T ss_pred cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHH
Confidence 555667899999999998754 8999999999999999999999999988887777765543332211 3689999999
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 020016 260 ISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~ 279 (332)
+.+||+.||.+||++.++++
T Consensus 242 i~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 242 IRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHccCChhhCcCHHHHhc
Confidence 99999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=318.04 Aligned_cols=236 Identities=27% Similarity=0.445 Sum_probs=182.7
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHH--HHcCCCCceec-----
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVAL--LFRLNHPHIIT----- 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~----- 120 (332)
.++.++.++|.+.+.||+|+||.||+|.+.++.||||++..... ..+..|.++ +..++||||++
T Consensus 6 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~---------~~~~~e~~~~~~~~~~h~~i~~~~~~~ 76 (336)
T 3g2f_A 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR---------QNFINEKNIYRVPLMEHDNIARFIVGD 76 (336)
T ss_dssp ---CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGH---------HHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred cCCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccch---------hhHHHHHHHHHHHhccCcchhhheecc
Confidence 34567789999999999999999999999999999999975432 223344444 45589999976
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCccccccccceeecCC
Q 020016 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQ---------GILHRDLKSENLLLGED 164 (332)
Q Consensus 121 ---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~---------~iiH~dlkp~NIll~~~ 164 (332)
.....++..+..++.||+.||.|||+. ||+||||||+|||++.+
T Consensus 77 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 77 ERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp EEECTTSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred cccccCCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC
Confidence 123457888999999999999999999 99999999999999999
Q ss_pred CeEEEeecccccccccC---------CCCCCcccccccCChhhhhc-------CCCCCccchhHHHHHHHHHHhCCCCCC
Q 020016 165 MCVKVADFGISCLESQC---------GSAKGFTGTYRWMAPEMIKE-------KRHTKKVDVYSFGIVLWELLTALTPFD 228 (332)
Q Consensus 165 ~~~kl~Dfg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~elltG~~pf~ 228 (332)
+.+||+|||++...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 99999999999764322 11234569999999999986 456779999999999999999966653
Q ss_pred CC-C-----------------HHHHHHHHHhcCCCCCCCCC------CcHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 229 NM-T-----------------PEQAAFAVCQKNARPPVPPT------CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 229 ~~-~-----------------~~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
.. . .............++.++.. +++.+.+||.+||+.||.+|||+.++++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp TTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 21 1 12222223334444555544 345899999999999999999999999999999
Q ss_pred hhhhcCCc
Q 020016 285 SESLEQDP 292 (332)
Q Consensus 285 ~~~~~~~~ 292 (332)
......+.
T Consensus 317 l~~~~~~~ 324 (336)
T 3g2f_A 317 MMIWERNK 324 (336)
T ss_dssp HHCCCC--
T ss_pred HHHHHhcc
Confidence 98887665
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=323.76 Aligned_cols=216 Identities=26% Similarity=0.320 Sum_probs=182.5
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
..+|.+.+.||+|+||.||+|.+. ++.||||++..... .+.+|+.+|+.++|||||+
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----------~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 122 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----------FKNRELQIMRKLDHCNIVRLRYFFYSSGEK 122 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----------SCCHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----------hHHHHHHHHHHcCCCCccceeeEEeccCCC
Confidence 357999999999999999999995 78999999876422 2346999999999999986
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC-CeEEEeecc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFG 173 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~-~~~kl~Dfg 173 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 123 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 123 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp TTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence 24678899999999999999999999999999999999999965 678999999
Q ss_pred cccccccCCCCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------
Q 020016 174 ISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------ 246 (332)
Q Consensus 174 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~------ 246 (332)
++.............+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+......+
T Consensus 203 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 203 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp TCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99876554455567889999999999765 78999999999999999999999999988766655544321110
Q ss_pred ---------C------------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 ---------P------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 ---------~------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
. ++..+++++.+||.+||+.||.+||++.++++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 1 23567899999999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=316.16 Aligned_cols=230 Identities=23% Similarity=0.336 Sum_probs=182.4
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||+||+|.+. ++.||||++........ ...+.+|+.+++.++||||++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc-----chhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEE
Confidence 68999999999999999999996 78999999976432211 124567999999999999987
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-CC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GS 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~ 183 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 77 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 77 LVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred EEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 3456899999999999999999999999999999999999999999999999998754432 22
Q ss_pred CCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---------------
Q 020016 184 AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--------------- 247 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~--------------- 247 (332)
.....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+......+.
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 344578999999999876 5679999999999999999999999999888776655544221111
Q ss_pred -------------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH--HHHhhhhhhc
Q 020016 248 -------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYSESLE 289 (332)
Q Consensus 248 -------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~--~L~~~~~~~~ 289 (332)
..+.+++++.+||.+||+.||.+|||+.++++ .+..+.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 293 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH 293 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTS
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccc
Confidence 12356889999999999999999999999987 4555444433
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=315.11 Aligned_cols=227 Identities=25% Similarity=0.349 Sum_probs=179.5
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchh-----HHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDA-----SLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
-.++|.+++.||+|+||.||+|.+. ++.||||++....... .......+.+.+|+.++++++||||++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 3589999999999999999999886 8899999986543221 011223467899999999999999986
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecc
Q 020016 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 121 ---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 179 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179 (362)
T ss_dssp ECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred eccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecC
Confidence 33468999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------
Q 020016 174 ISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------ 246 (332)
Q Consensus 174 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~------ 246 (332)
++.............+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+......+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 259 (362)
T 3pg1_A 180 LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVV 259 (362)
T ss_dssp C---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhh
Confidence 9976555555556778999999999987 678999999999999999999999999988766655543321111
Q ss_pred ------------------------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 ------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 ------------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..++.+++.+.+||.+||+.||.+|||+.++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 260 MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 112456889999999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=320.32 Aligned_cols=235 Identities=18% Similarity=0.296 Sum_probs=186.5
Q ss_pred ccccccccCCeeeeeeeccc--CceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--
Q 020016 47 EEEWSADMSQLFIGCKFASG--RHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G--~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-- 120 (332)
...+..+.++|.+.+.||+| +||+||+|.+. ++.||||++........ ..+.+.+|+.+++.++|||||+
T Consensus 17 ~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~ 92 (389)
T 3gni_B 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE----MVTFLQGELHVSKLFNHPNIVPYR 92 (389)
T ss_dssp -CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHH----HHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChH----HHHHHHHHHHHHHhCCCCCCCcEe
Confidence 34566677999999999999 99999999997 78999999987543322 2467889999999999999987
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeec
Q 020016 121 ----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 172 (332)
Q Consensus 121 ----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Df 172 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~df 172 (389)
T 3gni_B 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGL 172 (389)
T ss_dssp EEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCG
T ss_pred EEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccc
Confidence 2367899999999999999999999999999999999999999999999999
Q ss_pred ccccccccC--------CCCCCcccccccCChhhhhc--CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 020016 173 GISCLESQC--------GSAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 242 (332)
Q Consensus 173 g~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~ 242 (332)
|.+...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+........
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 252 (389)
T 3gni_B 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 252 (389)
T ss_dssp GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 987543211 12233578999999999987 57899999999999999999999999875543333222111
Q ss_pred CC--------------------------------------------CCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHH
Q 020016 243 NA--------------------------------------------RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 278 (332)
Q Consensus 243 ~~--------------------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell 278 (332)
.. ..+.+..+++.+.+||.+||+.||.+|||+.+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 00 1123456789999999999999999999999998
Q ss_pred HH--HHhhh
Q 020016 279 SI--LEGYS 285 (332)
Q Consensus 279 ~~--L~~~~ 285 (332)
+. ++.+.
T Consensus 333 ~hp~f~~~~ 341 (389)
T 3gni_B 333 NHSFFKQIK 341 (389)
T ss_dssp TSGGGGGC-
T ss_pred cCHHHHHHh
Confidence 63 44443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=317.95 Aligned_cols=220 Identities=20% Similarity=0.271 Sum_probs=184.1
Q ss_pred eeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------------
Q 020016 58 FIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------------- 120 (332)
Q Consensus 58 ~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------------- 120 (332)
...+.||+|+||.||+|.+. ++.||||++....... .+.+.+|+.++.+++||||++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 165 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD------KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHH------HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccccc------HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 33678999999999999986 7899999998754322 367899999999999999987
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee--cCCCeEEEeecccccccccCCCC
Q 020016 121 --------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL--GEDMCVKVADFGISCLESQCGSA 184 (332)
Q Consensus 121 --------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll--~~~~~~kl~Dfg~a~~~~~~~~~ 184 (332)
....+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.........
T Consensus 166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~ 245 (373)
T 2x4f_A 166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245 (373)
T ss_dssp ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence 23468999999999999999999999999999999999999 56789999999999876655555
Q ss_pred CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHHHHHH
Q 020016 185 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLISR 262 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~ 262 (332)
....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+........ ....+++++.+||.+
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 325 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK 325 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHT
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHH
Confidence 566799999999999999999999999999999999999999999888877777665433322 235789999999999
Q ss_pred ccccCCCCCCCHHHHHH--HHHh
Q 020016 263 CWSSSPDRRPHFDQIVS--ILEG 283 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~--~L~~ 283 (332)
||+.||.+||++.++++ .+..
T Consensus 326 ~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 326 LLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp TSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HcCCChhhCCCHHHHhcCcCcCC
Confidence 99999999999999997 5554
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=315.77 Aligned_cols=223 Identities=24% Similarity=0.363 Sum_probs=182.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||+||+|.+. ++.||||++......... ....+.+.+|+.+++.++||||++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP-GLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSS-SCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccc-cchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 67999999999999999999986 789999998652211000 001356889999999999999987
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCe---EEEeecccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC---VKVADFGISCL 177 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~---~kl~Dfg~a~~ 177 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 2335899999999999999999999999999999999999986654 99999999976
Q ss_pred cccCCC-CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcH
Q 020016 178 ESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPK 254 (332)
Q Consensus 178 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 254 (332)
...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.. ......+........ ....+++
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~ 261 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISE 261 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCH
Confidence 554332 345679999999999999999999999999999999999999998753 344444433332221 1256899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 020016 255 AFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 255 ~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
++.+||.+||+.||.+||++.++++
T Consensus 262 ~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 262 SAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=309.42 Aligned_cols=235 Identities=24% Similarity=0.372 Sum_probs=183.4
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||.||+|.+. ++.||||++....... ....+.+.+|+.+++.++||||++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD---PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccC---HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 579999999999999999999986 7899999997653322 223467899999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 182 (332)
....+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 23568999999999999999999999999999999999999999999999999986654322
Q ss_pred -CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCCcHHHHHHH
Q 020016 183 -SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR-PPVPPTCPKAFSYLI 260 (332)
Q Consensus 183 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li 260 (332)
......+++.|+|||.+.+..++.++||||||+++|+|++|..||...........+...... ...+..+++.+.++|
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 269 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVI 269 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHH
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHH
Confidence 223457899999999999999999999999999999999999999987665443333222211 234577899999999
Q ss_pred HHccccCCCCCC-CHHHHHHHHHhhhhhhcCC
Q 020016 261 SRCWSSSPDRRP-HFDQIVSILEGYSESLEQD 291 (332)
Q Consensus 261 ~~cl~~dp~~Rp-s~~ell~~L~~~~~~~~~~ 291 (332)
.+||+.||.+|| +++++++.|+.+.......
T Consensus 270 ~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~ 301 (309)
T 2h34_A 270 ARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301 (309)
T ss_dssp HHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred HHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence 999999999999 9999999999887666543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=319.35 Aligned_cols=224 Identities=23% Similarity=0.308 Sum_probs=183.2
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHH-HHcCCCCceec--------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVAL-LFRLNHPHIIT-------- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~-------- 120 (332)
...++|.+.+.||+|+||.||+|.++ ++.||||++........ .....+.+|..+ ++.++||||++
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~---~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~ 111 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK---KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 111 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC----------------CCBCCCCCTTBCCEEEEEECS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhh---HHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence 44689999999999999999999997 68899999987543221 113456677776 57789999987
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc-
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES- 179 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~- 179 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 23568899999999999999999999999999999999999999999999999997533
Q ss_pred cCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 020016 180 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 259 (332)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 259 (332)
........+||+.|+|||++.+..++.++||||||+++|||++|..||.+.+..+....+... ...++..++..+.+|
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~l 269 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKPNITNSARHL 269 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS--CCCCCSSSCHHHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--ccCCCCCCCHHHHHH
Confidence 333455678999999999999999999999999999999999999999998888877777654 345677899999999
Q ss_pred HHHccccCCCCCCCHHHHHHH
Q 020016 260 ISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~~ 280 (332)
|.+||+.||.+||++.+.+..
T Consensus 270 i~~lL~~dp~~R~~~~~~~~~ 290 (373)
T 2r5t_A 270 LEGLLQKDRTKRLGAKDDFME 290 (373)
T ss_dssp HHHHTCSSGGGSTTTTTTHHH
T ss_pred HHHHcccCHHhCCCCCCCHHH
Confidence 999999999999998644333
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=311.45 Aligned_cols=234 Identities=25% Similarity=0.467 Sum_probs=195.0
Q ss_pred cccccCCeeeeeeecccCceEEEEEEE------CCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIY------KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--- 120 (332)
..+..++|++.+.||+|+||.||+|.+ .++.||||++....... .+.+.+|+.++++++||||++
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~ 109 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH------LRDFEREIEILKSLQHDNIVKYKG 109 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHH------HHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHH------HHHHHHHHHHHHhCCCCCeeeEEE
Confidence 344568899999999999999999985 37899999998754322 467899999999999999986
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeec
Q 020016 121 ----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 172 (332)
Q Consensus 121 ----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Df 172 (332)
....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+||
T Consensus 110 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Df 189 (326)
T 2w1i_A 110 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 189 (326)
T ss_dssp EECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred EEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecC
Confidence 2345899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCC----CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHH---------------
Q 020016 173 GISCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE--------------- 233 (332)
Q Consensus 173 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~--------------- 233 (332)
|++........ .....++..|+|||.+.+..++.++||||||+++|+|+||..||......
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHH
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhH
Confidence 99876544321 23345778899999999988999999999999999999999988642111
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 234 QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
.............+.+..+++++.++|.+||+.||.+||++.++++.|+.+.+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 01122333455566778899999999999999999999999999999999988764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=320.27 Aligned_cols=232 Identities=26% Similarity=0.506 Sum_probs=187.4
Q ss_pred CCeeeeeeecccCceEEEEEEEC---C--eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK---Q--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~---~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
..|.+.+.||+|+||+||+|.+. + ..||||.+........ .+.|.+|+.++++++||||++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 163 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSHPNVLSLLGICLRSE 163 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHH-----HHHHHHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHH-----HHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 35788999999999999999874 2 4689999876443322 467999999999999999986
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 23457889999999999999999999999999999999999999999999999997543
Q ss_pred cCC-----CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 020016 180 QCG-----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 253 (332)
Q Consensus 180 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (332)
... ......+|+.|+|||.+.+..++.++||||||+++|+|+| |.+||...+..+....+. ...+...+..++
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-~~~~~~~p~~~~ 322 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCP 322 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-TTCCCCCCTTCC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 321 1233457789999999999999999999999999999999 788998766555544443 445566678899
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCc
Q 020016 254 KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 292 (332)
Q Consensus 254 ~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~ 292 (332)
+.+.+++.+||+.||++||++.++++.|+.+...+....
T Consensus 323 ~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 323 DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 999999999999999999999999999999998877554
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=319.46 Aligned_cols=227 Identities=26% Similarity=0.374 Sum_probs=176.7
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
..|.+ .++|.+.+.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.+|+.++||||++
T Consensus 20 ~~~~i-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~nIv~l~~~~ 94 (432)
T 3n9x_A 20 KNVHV-PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI----DCKRILREITILNRLKSDYIIRLYDLI 94 (432)
T ss_dssp GGCCC-CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHH----HHHHHHHHHHHHHHCCCTTBCCEEEEC
T ss_pred Cccee-cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChH----HHHHHHHHHHHHHHcCCCCcceEEEEE
Confidence 34444 378999999999999999999996 78999999976543322 2467899999999999999986
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecc
Q 020016 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 121 ---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 95 IPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp CCSCTTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ecCCCCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCC
Confidence 34568999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC-----------------------CCCCcccccccCChhhh-hcCCCCCccchhHHHHHHHHHHhC------
Q 020016 174 ISCLESQCG-----------------------SAKGFTGTYRWMAPEMI-KEKRHTKKVDVYSFGIVLWELLTA------ 223 (332)
Q Consensus 174 ~a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~elltG------ 223 (332)
++....... .....+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 997654322 12456789999999986 556689999999999999999984
Q ss_pred -----CCCCCCCC-----------------HHHHHHHHHh------------------------cCCCCCC-----CCCC
Q 020016 224 -----LTPFDNMT-----------------PEQAAFAVCQ------------------------KNARPPV-----PPTC 252 (332)
Q Consensus 224 -----~~pf~~~~-----------------~~~~~~~~~~------------------------~~~~~~~-----~~~~ 252 (332)
.++|.+.+ ..+....+.. ....... .+.+
T Consensus 255 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (432)
T 3n9x_A 255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSI 334 (432)
T ss_dssp SGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTS
T ss_pred ccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCC
Confidence 44444432 0111111111 0011111 1457
Q ss_pred cHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 253 PKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
++++.+||.+||+.||.+|||+.++++
T Consensus 335 s~~~~dLl~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 335 SDDGINLLESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 899999999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=307.67 Aligned_cols=224 Identities=25% Similarity=0.371 Sum_probs=184.0
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
.|.+ .++|.+.+.||+|+||.||+|.+. |+.||||++........ ..+.+.+|+.+++.++||||++
T Consensus 19 ~~~l-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 93 (353)
T 3coi_A 19 AWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI----FAKRAYRELLLLKHMQHENVIGLLDVFT 93 (353)
T ss_dssp EEEE-ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHH----HHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cccc-CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchH----HHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence 4444 368999999999999999999986 89999999977543322 2467889999999999999986
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
....+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 94 PASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp SCSSGGGCCCCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred cccccccceeEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence 1235899999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------
Q 020016 176 CLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA---------- 244 (332)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~---------- 244 (332)
...... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+.....
T Consensus 174 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 174 RHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp TC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred cCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence 764432 334578999999999987 6789999999999999999999999998877665544332110
Q ss_pred -------------------CCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 245 -------------------RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 245 -------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.......+++.+.+||.+||+.||++|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11233567899999999999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=318.56 Aligned_cols=225 Identities=24% Similarity=0.361 Sum_probs=185.0
Q ss_pred ccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC--CCceec-------
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN--HPHIIT------- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~------- 120 (332)
.+...+|.+.+.||+|+||+||+|.+. ++.||||++........ ..+.+.+|+.++..+. ||||++
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~ 127 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ----TLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 127 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHH----HHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHH----HHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence 344567999999999999999999987 78999999987543322 2467899999999996 499986
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 128 ~~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 128 DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp SSEEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred CCEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 345788999999999999999999999999999999999995 58999999999976543
Q ss_pred CC---CCCCcccccccCChhhhhc-----------CCCCCccchhHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCC
Q 020016 181 CG---SAKGFTGTYRWMAPEMIKE-----------KRHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQKNAR 245 (332)
Q Consensus 181 ~~---~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~il~elltG~~pf~~~~-~~~~~~~~~~~~~~ 245 (332)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+......
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~ 286 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence 22 2345679999999999975 368899999999999999999999998754 33444455545555
Q ss_pred CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 246 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 246 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
..++...+..+.+||.+||+.||.+||++.++++.
T Consensus 287 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 66777788999999999999999999999999863
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=327.15 Aligned_cols=229 Identities=22% Similarity=0.299 Sum_probs=192.1
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
++.+..++|.+.+.||+|+||+||+|.+. ++.||||++....... ....+.+.+|+.++..++||||++
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK---RSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH---TCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh---hHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 45566789999999999999999999997 7899999997521100 001234788999999999999987
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 23468999999999999999999999999999999999999999999999999997654
Q ss_pred cCC--CCCCcccccccCChhhhhcCC----CCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCC
Q 020016 180 QCG--SAKGFTGTYRWMAPEMIKEKR----HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPT 251 (332)
Q Consensus 180 ~~~--~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~--~~~~~ 251 (332)
... .....+||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+.......+....... +....
T Consensus 220 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 299 (410)
T 3v8s_A 220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 299 (410)
T ss_dssp TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCC
T ss_pred cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccc
Confidence 432 234678999999999998765 7899999999999999999999999998888777776543223 33357
Q ss_pred CcHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 020016 252 CPKAFSYLISRCWSSSPDR--RPHFDQIVSI 280 (332)
Q Consensus 252 ~~~~l~~li~~cl~~dp~~--Rps~~ell~~ 280 (332)
+++++.+||.+||..+|.+ ||++++|++.
T Consensus 300 ~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 300 ISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 8999999999999999988 9999999873
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=312.04 Aligned_cols=217 Identities=21% Similarity=0.276 Sum_probs=175.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec-----------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT----------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----------- 120 (332)
++|.+.++||+|+||+||+|.+. ++.||||++......... ...+..|+..+..+ +||||++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD----RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH----HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 68999999999999999999996 789999998765433221 23445566555555 9999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 133 ~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 133 YLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp EEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred EEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence 235699999999999999999999999999999999999999999999999999877665555
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHc
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 263 (332)
.....||+.|+|||++.+ .++.++||||||+++|+|++|..|+.... ....+......+.++..+++++.+++.+|
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 288 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGLSSELRSVLVMM 288 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCCCHHHHHHHHHH
Confidence 556679999999999875 78999999999999999999977665422 22233333333345567899999999999
Q ss_pred cccCCCCCCCHHHHHH
Q 020016 264 WSSSPDRRPHFDQIVS 279 (332)
Q Consensus 264 l~~dp~~Rps~~ell~ 279 (332)
|+.||++|||+.++++
T Consensus 289 L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 289 LEPDPKLRATAEALLA 304 (311)
T ss_dssp SCSSTTTSCCHHHHHT
T ss_pred cCCChhhCcCHHHHHh
Confidence 9999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=317.09 Aligned_cols=225 Identities=25% Similarity=0.339 Sum_probs=174.0
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
..|.+. ++|.+.+.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.+++.++||||++
T Consensus 23 ~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~ 97 (367)
T 2fst_X 23 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII----HAKRTYRELRLLKHMKHENVIGLLDVF 97 (367)
T ss_dssp EEEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHH----HHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred cccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHH----HHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 455554 78999999999999999999986 88999999976543322 2467889999999999999986
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecc
Q 020016 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 121 ---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 98 TPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CSCSSGGGCCCCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--
T ss_pred ecCCccccCCeEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecc
Confidence 22468999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------
Q 020016 174 ISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------ 246 (332)
Q Consensus 174 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~------ 246 (332)
++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 178 ~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 178 LARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred cccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 98764432 345678999999999987 678999999999999999999999999988766555443311111
Q ss_pred ------------------C-----CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 ------------------P-----VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 ------------------~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
. ....+++.+.+||.+||+.||.+|||+.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0 11356788999999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=313.90 Aligned_cols=236 Identities=23% Similarity=0.309 Sum_probs=189.1
Q ss_pred CCccccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--
Q 020016 45 EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120 (332)
Q Consensus 45 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-- 120 (332)
.....+.++.++|.+.+.||+|+||.||++.+. ++.||||++....... .+.+.+|+.+++.++||||++
T Consensus 19 ~~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~ 92 (317)
T 2buj_A 19 FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD------REEAQREADMHRLFNHPNILRLV 92 (317)
T ss_dssp EEEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHH------HHHHHHHHHHHHTCCCTTBCCCC
T ss_pred ecccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHH------HHHHHHHHHHHhhcCCCCeeeEE
Confidence 345667788899999999999999999999985 7899999987643322 467889999999999999986
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCe
Q 020016 121 ----------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 166 (332)
Q Consensus 121 ----------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~ 166 (332)
....+++..++.++.||+.||.|||++|++||||||+||+++.++.
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~ 172 (317)
T 2buj_A 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ 172 (317)
T ss_dssp EEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC
T ss_pred EEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC
Confidence 2466899999999999999999999999999999999999999999
Q ss_pred EEEeecccccccccCCC----------CCCcccccccCChhhhhcCC---CCCccchhHHHHHHHHHHhCCCCCCCCCHH
Q 020016 167 VKVADFGISCLESQCGS----------AKGFTGTYRWMAPEMIKEKR---HTKKVDVYSFGIVLWELLTALTPFDNMTPE 233 (332)
Q Consensus 167 ~kl~Dfg~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~elltG~~pf~~~~~~ 233 (332)
++|+|||++........ .....||+.|+|||.+.+.. ++.++||||||+++|+|++|..||......
T Consensus 173 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 252 (317)
T 2buj_A 173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252 (317)
T ss_dssp EEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT
T ss_pred EEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc
Confidence 99999998765332111 01234699999999987554 689999999999999999999999642110
Q ss_pred -HHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 020016 234 -QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 286 (332)
.............+.+..+++.+.++|.+||+.||.+||++.++++.|+.+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 253 GDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp TSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred cchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 01111222344445567789999999999999999999999999999998753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=313.32 Aligned_cols=222 Identities=23% Similarity=0.306 Sum_probs=176.6
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||+||+|.+. ++.||||++........ ..+.+.+|+.++++++||||++
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG----VPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC------------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccc----cchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 579999999999999999999986 78999999976543321 2456789999999999999987
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeec-----CCCeEEEeecccccccc
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG-----EDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~-----~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 109 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 109 HLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 345799999999999999999999999999999999999994 45669999999997654
Q ss_pred cC-CCCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC---------
Q 020016 180 QC-GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--------- 248 (332)
Q Consensus 180 ~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--------- 248 (332)
.. .......+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+....+....+......+..
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence 32 233455789999999999875 4799999999999999999999999998887776665543221110
Q ss_pred -------------------CCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 249 -------------------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 249 -------------------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+..+++++.+||.+||+.||.+|||+.++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 1126789999999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=315.52 Aligned_cols=222 Identities=23% Similarity=0.314 Sum_probs=176.0
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.+++.++||||++
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHH----HHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChH----HHHHHHHHHHHHHhcCCCCccceEEeecccccc
Confidence 478999999999999999999986 78999999986543322 2466889999999999999986
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 100 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 100 EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp TTCCEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred ccccceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 013578999999999999999999999999999999999999999999999999976655
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------------
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP-------------- 246 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~-------------- 246 (332)
........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+......+
T Consensus 180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 259 (371)
T 2xrw_A 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 259 (371)
T ss_dssp ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 444456789999999999999999999999999999999999999999988776665554322111
Q ss_pred ------CC--------------CC------CCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 ------PV--------------PP------TCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 ------~~--------------~~------~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+ +. ..++.+.+||.+||+.||.+|||++++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00 00 01567899999999999999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=316.91 Aligned_cols=233 Identities=21% Similarity=0.269 Sum_probs=179.9
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC-----CeeEEEEEecCCCchhHHH-----HHHHHHHHHHHHHHHcCCCCceec-
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLA-----SMLEKQFTSEVALLFRLNHPHIIT- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~- 120 (332)
+..++|.+++.||+|+||.||+|.+. +..||||++.......... ......+.+|+.++..++||||++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 33578999999999999999999995 4789999998764322111 111245778999999999999976
Q ss_pred ------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC--eEE
Q 020016 121 ------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM--CVK 168 (332)
Q Consensus 121 ------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~--~~k 168 (332)
....+++..++.++.||+.||.|||++||+||||||+||+++.++ .+|
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred ecccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 233789999999999999999999999999999999999998887 999
Q ss_pred EeecccccccccCCC--------CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCC--CHHHHHHH
Q 020016 169 VADFGISCLESQCGS--------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM--TPEQAAFA 238 (332)
Q Consensus 169 l~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~--~~~~~~~~ 238 (332)
|+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||... ........
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 999999976533211 13457899999999999999999999999999999999999999652 22222111
Q ss_pred HHhcCCCCCC---------CCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 020016 239 VCQKNARPPV---------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 239 ~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 286 (332)
. ....... ...+++++.+++.+||+.||++||++.+|++.|+.+..
T Consensus 274 ~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 274 K--TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp H--HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred H--HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1 1111111 12788999999999999999999999999999998654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=327.41 Aligned_cols=228 Identities=19% Similarity=0.243 Sum_probs=190.7
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
++.+..++|.+.+.||+|+||+||+|.+. ++.||||++....... ......+.+|..++..++||||++
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK---RAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH---TTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh---HHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 44566789999999999999999999997 6899999997521111 111234788999999999999986
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccc
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 246799999999999999999999999999999999999999999999999999965
Q ss_pred cccCCC--CCCcccccccCChhhhh-----cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--
Q 020016 178 ESQCGS--AKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV-- 248 (332)
Q Consensus 178 ~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~-- 248 (332)
...... ....+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+..+....+........+
T Consensus 225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 304 (437)
T 4aw2_A 225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304 (437)
T ss_dssp CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS
T ss_pred cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc
Confidence 543322 23468999999999997 456899999999999999999999999999888877777543323333
Q ss_pred -CCCCcHHHHHHHHHccccCCCC--CCCHHHHHH
Q 020016 249 -PPTCPKAFSYLISRCWSSSPDR--RPHFDQIVS 279 (332)
Q Consensus 249 -~~~~~~~l~~li~~cl~~dp~~--Rps~~ell~ 279 (332)
...+++++.+||.+||..+|++ ||+++++++
T Consensus 305 ~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 3458999999999999888888 999999987
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=303.44 Aligned_cols=222 Identities=25% Similarity=0.439 Sum_probs=190.9
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
+..++|.+.+.||+|+||.||+|.+. ++.||||++....... ....+.+.+|+.+++.++||||++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK---EGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch---HHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence 34679999999999999999999996 6889999997532111 112356889999999999999986
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~- 166 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS- 166 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS-
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc-
Confidence 234689999999999999999999999999999999999999999999999999865443
Q ss_pred CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 261 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 261 (332)
.......|++.|+|||.+.+..++.++||||||+++|+|++|..||......+....+.. ....++..++..+.++|.
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~ 244 (284)
T 2vgo_A 167 LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN--VDLKFPPFLSDGSKDLIS 244 (284)
T ss_dssp SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--TCCCCCTTSCHHHHHHHH
T ss_pred cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc--cccCCCCcCCHHHHHHHH
Confidence 223456789999999999999999999999999999999999999998887776665543 345677889999999999
Q ss_pred HccccCCCCCCCHHHHHH
Q 020016 262 RCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 262 ~cl~~dp~~Rps~~ell~ 279 (332)
+||+.||.+||++.++++
T Consensus 245 ~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 245 KLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHSCSSGGGSCCHHHHHT
T ss_pred HHhhcCHhhCCCHHHHhh
Confidence 999999999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=316.73 Aligned_cols=230 Identities=15% Similarity=0.249 Sum_probs=189.2
Q ss_pred cCCeeeeeeecccCceEEEEEEEC----------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK----------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~----------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--- 120 (332)
.++|.+.+.||+|+||.||+|.+. ++.||||++... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~ 109 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----------GRLFNEQNFFQRAAKPLQVNKWK 109 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----------STHHHHHHHHHHHCCHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----------chHHHHHHHHHHhcccchhhhhh
Confidence 479999999999999999999985 578999999764 24778999999999999863
Q ss_pred ----------------------------------------C--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccc
Q 020016 121 ----------------------------------------E--PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 158 (332)
Q Consensus 121 ----------------------------------------~--~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~N 158 (332)
. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 110 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 189 (352)
T 2jii_A 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189 (352)
T ss_dssp HHTTCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred hhccCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 1 2679999999999999999999999999999999999
Q ss_pred eeecCCC--eEEEeecccccccccCC--------CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCC
Q 020016 159 LLLGEDM--CVKVADFGISCLESQCG--------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 228 (332)
Q Consensus 159 Ill~~~~--~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~ 228 (332)
|+++.++ .+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 99999999997644321 1234579999999999999999999999999999999999999998
Q ss_pred CCC--HHHHHHHHHh-cCCCCCCC------CCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCccc
Q 020016 229 NMT--PEQAAFAVCQ-KNARPPVP------PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEF 294 (332)
Q Consensus 229 ~~~--~~~~~~~~~~-~~~~~~~~------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 294 (332)
... .......... ......+. ..+++.+.+|+.+||+.||.+||+++++++.|+.+..........
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~ 344 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYD 344 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCc
Confidence 753 3222222111 11111111 256899999999999999999999999999999999888766543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=329.05 Aligned_cols=220 Identities=26% Similarity=0.406 Sum_probs=187.6
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||+||+|.+. ++.||||++........ ....+.+|+.++++++||||++
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK----DTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch----HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 78999999999999999999996 78999999865321111 1356889999999999999987
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeec---CCCeEEEeecccccccccC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG---EDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 235689999999999999999999999999999999999995 4568999999999876655
Q ss_pred CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHH
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYL 259 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l 259 (332)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+.........+ ..+++++.+|
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 55566789999999999875 58999999999999999999999999999888877776655444333 4689999999
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 020016 260 ISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~ 279 (332)
|.+||+.||.+|||+.++++
T Consensus 257 i~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 257 IRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp HHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHhc
Confidence 99999999999999999987
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=306.23 Aligned_cols=231 Identities=25% Similarity=0.362 Sum_probs=188.3
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||.||+|.+. ++.||||++..............+.+.+|+.++++++||||++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 57999999999999999999997 7899999997653321100001356889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC----eEEEeeccccccccc
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM----CVKVADFGISCLESQ 180 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~----~~kl~Dfg~a~~~~~ 180 (332)
....+++..+..++.||+.||.|||++|++||||||+||+++.++ .++|+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 234689999999999999999999999999999999999998876 899999999976655
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHHH
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCPKAFSY 258 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 258 (332)
........+|+.|+|||.+.+..++.++||||||+++|+|++|..||......+....+....... .....+++.+.+
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (283)
T 3bhy_A 165 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKD 244 (283)
T ss_dssp -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHH
T ss_pred CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHH
Confidence 444455678999999999999999999999999999999999999999988777666554332221 122567899999
Q ss_pred HHHHccccCCCCCCCHHHHHH--HHHhhh
Q 020016 259 LISRCWSSSPDRRPHFDQIVS--ILEGYS 285 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~--~L~~~~ 285 (332)
++.+||+.||.+||++.++++ .++.+.
T Consensus 245 li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 245 FIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred HHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 999999999999999999997 455543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=316.63 Aligned_cols=228 Identities=23% Similarity=0.338 Sum_probs=187.9
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
++...++|.+++.||+|+||+||+|.+. ++.||||++...... ..+|+.+++.++||||++
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----------~~~E~~il~~l~hpnIv~l~~~~~~ 71 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----------KNRELDIMKVLDHVNIIKLVDYFYT 71 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----------CCHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----------HHHHHHHHHHcCCCCccchhheeee
Confidence 3445689999999999999999999985 789999998764322 346999999999999874
Q ss_pred --------------------------------------------------------------CCCCCCHHHHHHHHHHHH
Q 020016 121 --------------------------------------------------------------EPYSVPLNLVLKLALDIA 138 (332)
Q Consensus 121 --------------------------------------------------------------~~~~l~~~~~~~i~~qi~ 138 (332)
....+++..+..++.||+
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLF 151 (383)
T ss_dssp C-------------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred cCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence 135688899999999999
Q ss_pred HHHHHHHHCCCccccccccceeec-CCCeEEEeecccccccccCCCCCCcccccccCChhhhhcC-CCCCccchhHHHHH
Q 020016 139 RGMQYLHSQGILHRDLKSENLLLG-EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIV 216 (332)
Q Consensus 139 ~~L~~LH~~~iiH~dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~i 216 (332)
.||.|||++||+||||||+||+++ .++.+||+|||++.............+|+.|+|||.+.+. .++.++||||+||+
T Consensus 152 ~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 152 RAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 999999999999999999999998 5799999999999876655556667889999999998775 48999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------------------------CCCCCCcHHHHHHHHHccccCCC
Q 020016 217 LWELLTALTPFDNMTPEQAAFAVCQKNARP---------------------------PVPPTCPKAFSYLISRCWSSSPD 269 (332)
Q Consensus 217 l~elltG~~pf~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dp~ 269 (332)
+|+|++|..||.+.+..+....+......+ .++..+++++.+||.+||+.||.
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 999999999999988877666554321111 13556889999999999999999
Q ss_pred CCCCHHHHHH--HHHhhhhh
Q 020016 270 RRPHFDQIVS--ILEGYSES 287 (332)
Q Consensus 270 ~Rps~~ell~--~L~~~~~~ 287 (332)
+|||+.++++ .++.+...
T Consensus 312 ~R~t~~e~l~hp~f~~~~~~ 331 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDHLRNS 331 (383)
T ss_dssp GSCCHHHHHTSGGGHHHHHC
T ss_pred hCCCHHHHhcCHHHHHHHhh
Confidence 9999999985 45555443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=329.85 Aligned_cols=222 Identities=24% Similarity=0.364 Sum_probs=191.9
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||.||+|.+. ++.||||++......... ..+.+.+|+.++++++||||++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKT---DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSS---CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccch---HHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 368999999999999999999996 789999999764321110 1366889999999999999987
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee---cCCCeEEEeeccccccccc
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 45678999999999999999999999999999999999999 4678999999999977655
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHH
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSY 258 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ 258 (332)
........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+.........+ ..+++.+.+
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 260 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence 444455679999999999876 68999999999999999999999999999888888777665544433 568999999
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~ 279 (332)
||.+||+.||.+|||+.++++
T Consensus 261 li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 261 LIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHCCCChhHCcCHHHHhh
Confidence 999999999999999999987
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=313.19 Aligned_cols=225 Identities=24% Similarity=0.291 Sum_probs=179.8
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||.||+|.+. ++.||||++........ .....+.+.+|+.+++.++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA-KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC-------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchh-hhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 478999999999999999999996 78999999976432211 1112346789999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-C
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-G 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~ 182 (332)
....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 88 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 88 SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred EEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence 3346889999999999999999999999999999999999999999999999999765432 2
Q ss_pred CCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--------------
Q 020016 183 SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-------------- 247 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~-------------- 247 (332)
......+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+......+.
T Consensus 168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T 1ua2_A 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 247 (346)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccc
Confidence 33456789999999999764 478999999999999999999999999888777666554221111
Q ss_pred ------------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 248 ------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 248 ------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
....+++++.+||.+||+.||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 248 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 01456789999999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=312.96 Aligned_cols=225 Identities=25% Similarity=0.399 Sum_probs=191.5
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCch--hHHHHHHHHHHHHHHHHHHcC-CCCceec---------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEED--ASLASMLEKQFTSEVALLFRL-NHPHIIT--------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------- 120 (332)
++|.+.+.||+|+||.||+|.+. |+.||||++...... ........+.+.+|+.++.++ +||||++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 67999999999999999999996 889999999775421 122234457789999999999 8999986
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 2346899999999999999999999999999999999999999999999999998776655
Q ss_pred CCCCCcccccccCChhhhhcC------CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCc
Q 020016 182 GSAKGFTGTYRWMAPEMIKEK------RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCP 253 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~ 253 (332)
.......||+.|+|||++.+. .++.++||||||+++|+|++|..||...........+.........+ ..++
T Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 333 (365)
T 2y7j_A 254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRS 333 (365)
T ss_dssp CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSC
T ss_pred cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCC
Confidence 555667899999999998643 57889999999999999999999999888777766665544433222 4678
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 254 KAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 254 ~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..+.++|.+||+.||.+||++.++++
T Consensus 334 ~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 334 STVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 99999999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=303.80 Aligned_cols=221 Identities=29% Similarity=0.497 Sum_probs=193.2
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.+.|.+.+.||+|+||.||+|.+. ++.||||++........ .+.+.+|+.+++.++||||++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-----IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTT-----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHH-----HHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 367999999999999999999986 78999999987544332 367899999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-C
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-S 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~ 183 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 96 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp EEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred EEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 45678999999999999999999999999999999999999999999999999987654332 2
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHc
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 263 (332)
.....+|+.|+|||.+.+..++.++||||||+++|+|++|..||...........+. ....+..+..++..+.+|+.+|
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~ 254 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEAC 254 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSCCCCCCSSCCHHHHHHHHHH
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh-cCCCCCCccccCHHHHHHHHHH
Confidence 345678999999999999999999999999999999999999999888777665554 3455667788999999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 020016 264 WSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 264 l~~dp~~Rps~~ell~~ 280 (332)
|+.||.+||++.++++.
T Consensus 255 l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 255 LNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCSSGGGSCCHHHHTTC
T ss_pred cCCChhhCcCHHHHhhC
Confidence 99999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=310.77 Aligned_cols=226 Identities=24% Similarity=0.366 Sum_probs=184.8
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
+....++|.+.+.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.++++++||||++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 95 (331)
T 4aaa_A 20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM----VKKIAMREIKLLKQLRHENLVNLLEVCKK 95 (331)
T ss_dssp CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchH----HHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence 3445789999999999999999999997 78999999976554332 2466889999999999999987
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 45679999999999999999999999999999999999999999999999999987644
Q ss_pred cC-CCCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------------
Q 020016 180 QC-GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR------------ 245 (332)
Q Consensus 180 ~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~------------ 245 (332)
.. .......+|+.|+|||.+.+. .++.++||||||+++|+|++|..||.+....+....+......
T Consensus 176 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 32 233456789999999999875 6899999999999999999999999998876655544321110
Q ss_pred --------CC---------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 246 --------PP---------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 246 --------~~---------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+. ..+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 11357899999999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=303.66 Aligned_cols=224 Identities=25% Similarity=0.374 Sum_probs=190.2
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|++.+.||+|+||.||+|.+. ++.||+|++........ ..+.+.+|+.++++++||||++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA----EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHH----HHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence 478999999999999999999996 78999999987543322 2467899999999999999986
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CccccccccceeecCCCeEEEeec
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQG-----ILHRDLKSENLLLGEDMCVKVADF 172 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----iiH~dlkp~NIll~~~~~~kl~Df 172 (332)
....+++..++.++.|++.||.|||+.| ++||||||+||+++.++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 2345899999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCC-CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 020016 173 GISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 251 (332)
Q Consensus 173 g~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (332)
|++........ .....+|+.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.. .....++..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~ 239 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYR 239 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-TCCCCCCTT
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh-cccccCCcc
Confidence 99866443211 1234689999999999999999999999999999999999999999887776665543 444567788
Q ss_pred CcHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 020016 252 CPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282 (332)
Q Consensus 252 ~~~~l~~li~~cl~~dp~~Rps~~ell~~L~ 282 (332)
+++.+.+++.+||+.||.+||++.++++.+.
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 9999999999999999999999999997654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=307.47 Aligned_cols=234 Identities=26% Similarity=0.490 Sum_probs=194.0
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-- 120 (332)
.++..++|.+.+.||+|+||.||+|.+. +..||||++........ ...+.+|+.++++++||||++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~ 99 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-----ELDFLMEALIISKFNHQNIVRCI 99 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHH-----HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhh-----HHHHHHHHHHHhhCCCCCCCeEE
Confidence 3466789999999999999999999842 56899999975433222 357889999999999999986
Q ss_pred ---------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC---
Q 020016 121 ---------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED--- 164 (332)
Q Consensus 121 ---------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~--- 164 (332)
....+++..++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 100 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~ 179 (327)
T 2yfx_A 100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 179 (327)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred EEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCc
Confidence 11458899999999999999999999999999999999999844
Q ss_pred CeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 020016 165 MCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVC 240 (332)
Q Consensus 165 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~ 240 (332)
..++|+|||++....... ......+|+.|+|||.+.+..++.++||||||+++|+|+| |..||......+....+.
T Consensus 180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 259 (327)
T 2yfx_A 180 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259 (327)
T ss_dssp CCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred ceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence 469999999986543221 2234567899999999999999999999999999999998 999999888776665554
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 241 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
.......+..+++.+.++|.+||+.||.+||++.++++.|+.+.....
T Consensus 260 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 260 -SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 445566778899999999999999999999999999999998876544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=311.20 Aligned_cols=223 Identities=22% Similarity=0.303 Sum_probs=184.1
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
..++|.+.+.||+|+||+||+|.+. ++.||||++......... ...+.+|+.+++.++||||++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF----PITALREIKILQLLKHENVVNLIEICRTKAS 90 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS----CHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc----hHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence 3589999999999999999999995 789999998765433211 245788999999999999975
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp ------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 235689999999999999999999999999999999999999999999999999
Q ss_pred cccccc-----CCCCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--C
Q 020016 175 SCLESQ-----CGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR--P 246 (332)
Q Consensus 175 a~~~~~-----~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~--~ 246 (332)
+..... ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+.......+...... +
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 876442 122345678999999999876 45799999999999999999999999998877766555432211 1
Q ss_pred CCCCC----------------------------CcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 PVPPT----------------------------CPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 ~~~~~----------------------------~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...+. .++.+.+||.+||+.||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 11111 2677999999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=312.20 Aligned_cols=223 Identities=21% Similarity=0.287 Sum_probs=182.9
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-----CCceec
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-----HPHIIT 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~ 120 (332)
.+..+-.++|.+.++||+|+||+||+|.+. ++.||||++...... .+.+..|+.+++.+. ||||++
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY-------TRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHH-------HHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhh-------hhhhHHHHHHHHHhcccCCCCCCeec
Confidence 333444689999999999999999999995 789999999753221 356778999999996 999986
Q ss_pred -----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC--------
Q 020016 121 -----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-------- 163 (332)
Q Consensus 121 -----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~-------- 163 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred ccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccccc
Confidence 2345899999999999999999999999999999999999975
Q ss_pred -----------------CCeEEEeecccccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCC
Q 020016 164 -----------------DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP 226 (332)
Q Consensus 164 -----------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p 226 (332)
++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence 78999999999976443 23456789999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcCCCCC------------------------CC--------------------CCCcHHHHHHHHH
Q 020016 227 FDNMTPEQAAFAVCQKNARPP------------------------VP--------------------PTCPKAFSYLISR 262 (332)
Q Consensus 227 f~~~~~~~~~~~~~~~~~~~~------------------------~~--------------------~~~~~~l~~li~~ 262 (332)
|...+..+....+.......+ .+ ...++.+.+||.+
T Consensus 259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 338 (360)
T 3llt_A 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS 338 (360)
T ss_dssp CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence 998877665554433221111 01 1123678899999
Q ss_pred ccccCCCCCCCHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~ 279 (332)
||+.||.+|||+.++++
T Consensus 339 ~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 339 ILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HCCSSGGGSCCHHHHTT
T ss_pred HhcCChhhCCCHHHHhc
Confidence 99999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=316.82 Aligned_cols=215 Identities=24% Similarity=0.336 Sum_probs=183.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
.+|.+.+.||+|+||+||+|.+. +..||+|++...... ..+|+.+++.++||||++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----------HHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 67999999999999999999996 566999988654322 236999999999999986
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeec-CCCeEEEeecccc
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG-EDMCVKVADFGIS 175 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~-~~~~~kl~Dfg~a 175 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 256789999999999999999999999999999999999999 7899999999999
Q ss_pred cccccCCCCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------
Q 020016 176 CLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP-------- 246 (332)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~-------- 246 (332)
.............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 190 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 190 KILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp EECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 876555555667889999999998765 58999999999999999999999999988776665554321111
Q ss_pred -------------------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 -------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 -------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.++..+++++.+||.+||+.||.+|||+.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 123458899999999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=322.16 Aligned_cols=227 Identities=19% Similarity=0.248 Sum_probs=187.6
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
++.+..++|.+.+.||+|+||+||++.++ ++.||||++.+.... .....+.+.+|..++..++||||++
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~---~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML---KRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH---HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh---hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 44566789999999999999999999996 789999999752211 1111345789999999999999986
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccc
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLK 211 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhee
Confidence 234799999999999999999999999999999999999999999999999999976
Q ss_pred cccCCC--CCCcccccccCChhhhh-------cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---CC
Q 020016 178 ESQCGS--AKGFTGTYRWMAPEMIK-------EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN---AR 245 (332)
Q Consensus 178 ~~~~~~--~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~---~~ 245 (332)
...... ....+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+..+....+.... ..
T Consensus 212 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 291 (412)
T 2vd5_A 212 LRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291 (412)
T ss_dssp CCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred ccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCC
Confidence 544332 23468999999999997 3568999999999999999999999999988887776665432 22
Q ss_pred CCCCCCCcHHHHHHHHHccccCCCCC---CCHHHHHH
Q 020016 246 PPVPPTCPKAFSYLISRCWSSSPDRR---PHFDQIVS 279 (332)
Q Consensus 246 ~~~~~~~~~~l~~li~~cl~~dp~~R---ps~~ell~ 279 (332)
+..+..+++++.+||.+||. +|.+| |+++++++
T Consensus 292 p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 292 PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 33346799999999999999 99998 58888876
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=303.77 Aligned_cols=222 Identities=24% Similarity=0.383 Sum_probs=191.4
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+++.||+|+||.||++.+. ++.||+|++........ ...+.+.+|+.+++.++||||++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP---HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCH---HHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 468999999999999999999997 78999999976432221 12467889999999999999987
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-C
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-G 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~ 182 (332)
....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... .
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 2356899999999999999999999999999999999999999999999999998765432 2
Q ss_pred CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 020016 183 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 262 (332)
......+|+.|+|||.+.+..++.++||||||+++|+|++|..||......+....+. ......+..+++.+.+++.+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASLIQK 248 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hccCCCccccCHHHHHHHHH
Confidence 3345678999999999998889999999999999999999999999988777665554 33456677899999999999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~~ 280 (332)
||+.||++||++.++++.
T Consensus 249 ~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 249 MLQTDPTARPTINELLND 266 (294)
T ss_dssp HTCSSGGGSCCGGGGGGS
T ss_pred HcccChhhCcCHHHHhhC
Confidence 999999999999999873
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=308.47 Aligned_cols=220 Identities=22% Similarity=0.315 Sum_probs=181.6
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||.||+|.+. ++.||||++....... ....+.+|+.+++.++||||++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL-----FALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHH-----HHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccch-----HHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 78999999999999999999997 8899999997543322 2356889999999999999986
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 86 FNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp CCCEEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred cceEEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 1245899999999999999999999999999999999999999999999999998764422
Q ss_pred CC-----------CCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--
Q 020016 182 GS-----------AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-- 247 (332)
Q Consensus 182 ~~-----------~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~-- 247 (332)
.. .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+.......+......+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 11 123568999999998765 6789999999999999999999999998876655443322111110
Q ss_pred ----------------------------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 248 ----------------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 248 ----------------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..+.+++++.+||.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 12467899999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=320.00 Aligned_cols=235 Identities=26% Similarity=0.400 Sum_probs=185.7
Q ss_pred CCCccccccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--
Q 020016 44 GEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120 (332)
Q Consensus 44 ~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-- 120 (332)
.....++.+..++|.+.+.||+|+||+||+|.+. ++.||||++........ ...+.+|+.+++.++||||++
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG-----ELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C-----CCHHHHHHHGGGTCCCTTBCCCC
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH-----HHHHHHHHHHHHhccCCCccceE
Confidence 3445666777899999999999999999999876 78999999976433221 235889999999999999986
Q ss_pred ------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccccccceeecCCCeE
Q 020016 121 ------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQ---GILHRDLKSENLLLGEDMCV 167 (332)
Q Consensus 121 ------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~NIll~~~~~~ 167 (332)
....+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 223489999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccccCC--CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHh
Q 020016 168 KVADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP----EQAAFAVCQ 241 (332)
Q Consensus 168 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~----~~~~~~~~~ 241 (332)
||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... .........
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 999999997654322 22345689999999999999999999999999999999999999962110 000001111
Q ss_pred cC-------------CCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 020016 242 KN-------------ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 283 (332)
Q Consensus 242 ~~-------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~ 283 (332)
.. .....+...+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 00 0111222334779999999999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=301.63 Aligned_cols=222 Identities=25% Similarity=0.376 Sum_probs=181.2
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
..++|.+++.||+|+||.||+|.+. ++.||||++...... .....+.+.+|+.+++.++||||++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR---SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc---chhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 3579999999999999999999996 889999999753211 1112357889999999999999986
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 182 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 182 (332)
....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 23467899999999999999999999999999999999999999999999999997765544
Q ss_pred CCCCcccccccCChhhhhcCCC-CCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 020016 183 SAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 261 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 261 (332)
......+|+.|+|||.+.+..+ +.++||||||+++|+|++|..||...........+.. .....+..++..+.+++.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~ 243 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG--GVFYIPEYLNRSVATLLM 243 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHH
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc--CcccCchhcCHHHHHHHH
Confidence 4455678999999999987765 6899999999999999999999998887776665543 234567788999999999
Q ss_pred HccccCCCCCCCHHHHHH
Q 020016 262 RCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 262 ~cl~~dp~~Rps~~ell~ 279 (332)
+||+.||.+|||+.++++
T Consensus 244 ~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 244 HMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHccCChhhCCCHHHHHh
Confidence 999999999999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=305.72 Aligned_cols=225 Identities=26% Similarity=0.449 Sum_probs=185.3
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec----
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT---- 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~---- 120 (332)
..+....++|.+.+.||+|+||.||+|.+. ++.||||++....... +.+.+|+.+++++ +||||++
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-------EEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTT-------HHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccH-------HHHHHHHHHHHhccCCCCeeeeeeE
Confidence 344455689999999999999999999994 8899999998654432 5688999999999 8999976
Q ss_pred --------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEE
Q 020016 121 --------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 168 (332)
Q Consensus 121 --------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~k 168 (332)
....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEE
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEE
Confidence 124688999999999999999999999999999999999999999999
Q ss_pred EeecccccccccC-CCCCCcccccccCChhhhh-----cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 020016 169 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 242 (332)
Q Consensus 169 l~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~ 242 (332)
|+|||++...... .......||+.|+|||++. +..++.++||||||+++|+|++|..||...........+...
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 249 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 249 (326)
T ss_dssp ECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred EeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence 9999998765432 2234557899999999997 566899999999999999999999999998887776666555
Q ss_pred CCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 243 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
......+..++..+.++|.+||..||.+||++.++++
T Consensus 250 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 250 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 5444556778999999999999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=310.14 Aligned_cols=230 Identities=22% Similarity=0.384 Sum_probs=166.5
Q ss_pred CCccccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHH-HHHcCCCCceec-
Q 020016 45 EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVA-LLFRLNHPHIIT- 120 (332)
Q Consensus 45 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~- 120 (332)
.....|.+..++|.+.+.||+|+||.||+|.+. ++.||||++........ ...+..|+. +++.++||||++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~e~~~~~~~~~h~niv~~ 86 (327)
T 3aln_A 12 SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-----QKQLLMDLDVVMRSSDCPYIVQF 86 (327)
T ss_dssp CCCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH-----HHHHHHHHHHHHSSCCCTTBCCE
T ss_pred ChHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH-----HHHHHHHHHHHHHcCCCCcEeee
Confidence 456789999999999999999999999999997 89999999987543322 244555665 777889999987
Q ss_pred -------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccccccceeecCCCeEE
Q 020016 121 -------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVK 168 (332)
Q Consensus 121 -------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~NIll~~~~~~k 168 (332)
....+++..+..++.|++.||.|||+. |++||||||+||+++.++.+|
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~k 166 (327)
T 3aln_A 87 YGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIK 166 (327)
T ss_dssp EEEEECSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEE
T ss_pred eeEEEeCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEE
Confidence 256789999999999999999999999 999999999999999999999
Q ss_pred EeecccccccccCCCCCCcccccccCChhhh----hcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Q 020016 169 VADFGISCLESQCGSAKGFTGTYRWMAPEMI----KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 244 (332)
Q Consensus 169 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~ 244 (332)
|+|||++.............||+.|+|||++ .+..++.++||||||+++|+|++|..||.................
T Consensus 167 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 246 (327)
T 3aln_A 167 LCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246 (327)
T ss_dssp ECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSC
T ss_pred EccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCC
Confidence 9999999766554444455799999999998 456789999999999999999999999987543221111111122
Q ss_pred CCCC----CCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 245 RPPV----PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 245 ~~~~----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+.+ ...+++.+.+|+.+||+.||.+||++.++++
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 2222 2468999999999999999999999999987
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=313.94 Aligned_cols=218 Identities=23% Similarity=0.384 Sum_probs=184.0
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHH--HHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASL--ASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
++|.+.+.||+|+||+||+|.+. ++.||||++......... .....+.+.+|+.+++.++||||++
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 68999999999999999999986 789999999875321100 0000235678999999999999987
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 183 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence 3457899999999999999999999999999999999999999999999999999876665
Q ss_pred CCCCCcccccccCChhhhhcCCC-CCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 260 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 260 (332)
.......||+.|+|||++.+..+ +.++||||||+++|+|++|..||..... ........+..+++++.+||
T Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~~l~~li 255 (335)
T 3dls_A 184 KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------TVEAAIHPPYLVSKELMSLV 255 (335)
T ss_dssp CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------GTTTCCCCSSCCCHHHHHHH
T ss_pred CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------HHhhccCCCcccCHHHHHHH
Confidence 55556779999999999988776 7899999999999999999999976322 12233345667899999999
Q ss_pred HHccccCCCCCCCHHHHHHH
Q 020016 261 SRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 261 ~~cl~~dp~~Rps~~ell~~ 280 (332)
.+||+.||.+|||+.++++.
T Consensus 256 ~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 256 SGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHTCSSGGGSCCHHHHHHC
T ss_pred HHHccCChhhCcCHHHHhcC
Confidence 99999999999999999984
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=310.01 Aligned_cols=221 Identities=24% Similarity=0.377 Sum_probs=184.4
Q ss_pred CCeeee-eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec----------
Q 020016 55 SQLFIG-CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT---------- 120 (332)
Q Consensus 55 ~~y~i~-~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~---------- 120 (332)
+.|.+. +.||+|+||+||+|.+. ++.||||++......... ...+.+|+.++..+ .||||++
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC----RAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEEC----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHH----HHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 668877 89999999999999997 789999999864332211 35688999999999 5699986
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC---CCeEEEeecccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DMCVKVADFGISCL 177 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~---~~~~kl~Dfg~a~~ 177 (332)
....+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++..
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 2367899999999999999999999999999999999999987 78999999999987
Q ss_pred cccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHH
Q 020016 178 ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCPKA 255 (332)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 255 (332)
...........||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+....... .....+++.
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 263 (327)
T 3lm5_A 184 IGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263 (327)
T ss_dssp C---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred cCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHH
Confidence 665544556789999999999999999999999999999999999999999988877766665543332 334678999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 020016 256 FSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+.+||.+||+.||.+|||+.++++
T Consensus 264 ~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 264 ATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHcCCChhhCcCHHHHhC
Confidence 999999999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=303.47 Aligned_cols=221 Identities=28% Similarity=0.424 Sum_probs=162.9
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||.||+|.+. ++.||||++...... .....+.+.+|+.++++++||||++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY---KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh---hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 468999999999999999999984 789999999753211 1112367889999999999999986
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 181 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 181 (332)
....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 2367899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 261 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 261 (332)
.......+|+.|+|||.+.+..++.++||||||+++|+|++|..||...........+ .......+..++.++.++|.
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~ 244 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--VLADYEMPSFLSIEAKDLIH 244 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C--CSSCCCCCTTSCHHHHHHHH
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH--hhcccCCccccCHHHHHHHH
Confidence 2233467899999999999888999999999999999999999999876543333222 12233456778999999999
Q ss_pred HccccCCCCCCCHHHHHH
Q 020016 262 RCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 262 ~cl~~dp~~Rps~~ell~ 279 (332)
+||+.||.+||++.++++
T Consensus 245 ~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 245 QLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp HHSCSSGGGSCCHHHHTT
T ss_pred HHcccCHhhCCCHHHHhc
Confidence 999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=301.16 Aligned_cols=226 Identities=27% Similarity=0.386 Sum_probs=192.1
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCc---hhHHHHHHHHHHHHHHHHHHcCC-CCceec-------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEE---DASLASMLEKQFTSEVALLFRLN-HPHIIT------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~-h~niv~------- 120 (332)
.++|.+.+.||+|+||.||+|.+. ++.||||++..... .........+.+.+|+.+++++. ||||++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 479999999999999999999996 78999999976542 11222344577899999999995 999986
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence 23468999999999999999999999999999999999999999999999999997766
Q ss_pred cCCCCCCcccccccCChhhhh------cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CC
Q 020016 180 QCGSAKGFTGTYRWMAPEMIK------EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PT 251 (332)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~~ 251 (332)
.........+++.|+|||++. ...++.++||||||+++|+|++|..||...+.......+.........+ ..
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (298)
T 1phk_A 176 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 255 (298)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred CCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccc
Confidence 555555677999999999985 3457899999999999999999999999888877766665554443332 46
Q ss_pred CcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 252 CPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 252 ~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
++..+.+++.+||+.||.+||++.++++
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 256 YSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 8899999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=303.47 Aligned_cols=222 Identities=23% Similarity=0.357 Sum_probs=188.3
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+++.||+|+||.||++.+. ++.||||++........ ....+.+.+|+.+++.++||||++
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRI--PNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHS--TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccccc--chhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 68999999999999999999996 78999999976422110 112467899999999999999986
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 3467899999999999999999999999999999999999999999999999998765422
Q ss_pred ---CCCCCcccccccCChhhhhcCCC--CCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 020016 182 ---GSAKGFTGTYRWMAPEMIKEKRH--TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 256 (332)
Q Consensus 182 ---~~~~~~~gt~~y~aPE~~~~~~~--~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (332)
.......||+.|+|||++.+... +.++||||||+++|+|++|..||...+.......+... ...++..+++.+
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~~~~~~~~l 240 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGDCGPPL 240 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--CCCCCSSSCHHH
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC--CCCCCCccCHHH
Confidence 12234568999999999986543 77999999999999999999999998877766665433 445677899999
Q ss_pred HHHHHHccccCCCCCCCHHHHHHH
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
.+++.+||+.||.+||++.++++.
T Consensus 241 ~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 241 SDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHccCChhhCCCHHHHhcC
Confidence 999999999999999999999963
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=325.89 Aligned_cols=225 Identities=27% Similarity=0.380 Sum_probs=187.6
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+++.||+|+||+||+|.+. +..||||++......... ...+.+|+.+++.++||||++
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS----NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT----THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH----HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 57999999999999999999996 789999999865322111 356889999999999999987
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC---CeEEEeecccccccccC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED---MCVKVADFGISCLESQC 181 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.. +.+||+|||++......
T Consensus 113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 23468899999999999999999999999999999999999764 56999999999876655
Q ss_pred CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHH
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYL 259 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l 259 (332)
.......||+.|+|||++. +.++.++|||||||++|+|++|..||.+.+..+....+.........+ ..+++.+.+|
T Consensus 193 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 271 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHH
T ss_pred ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHH
Confidence 5556678999999999986 568999999999999999999999999999888877776655443332 5789999999
Q ss_pred HHHccccCCCCCCCHHHHHH--HHHhh
Q 020016 260 ISRCWSSSPDRRPHFDQIVS--ILEGY 284 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~--~L~~~ 284 (332)
|.+||+.||.+|||+.++++ .+...
T Consensus 272 i~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 272 IKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHCCCChhhCccHHHHhcCcccccC
Confidence 99999999999999999986 35544
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=321.08 Aligned_cols=226 Identities=23% Similarity=0.348 Sum_probs=174.3
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHH--HHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASL--ASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
.++|.+.+.||+|+||+||+|.+. ++.||||++......... .......+.+|+.+|++++||||++
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 213 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 213 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESSE
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecCc
Confidence 478999999999999999999996 689999999764321110 1111235789999999999999986
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC---CeEEEeecccccccc
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED---MCVKVADFGISCLES 179 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~---~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~ 293 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC
T ss_pred eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecC
Confidence 34678999999999999999999999999999999999999754 459999999998766
Q ss_pred cCCCCCCcccccccCChhhhhc---CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---CCCCCc
Q 020016 180 QCGSAKGFTGTYRWMAPEMIKE---KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP---VPPTCP 253 (332)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~ 253 (332)
.........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.................... ....++
T Consensus 294 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 373 (419)
T 3i6u_A 294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 373 (419)
T ss_dssp -----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSC
T ss_pred CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccC
Confidence 6555566789999999999853 5678899999999999999999999987543322222222222222 225689
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 254 KAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 254 ~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+.+.+||.+||+.||.+||++.++++
T Consensus 374 ~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 374 EKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhC
Confidence 99999999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=316.99 Aligned_cols=217 Identities=26% Similarity=0.355 Sum_probs=180.1
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC------CCCceec-----
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL------NHPHIIT----- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~----- 120 (332)
..+|.+.+.||+|+||+||+|.+. ++.||||++..... ..+.+.+|+.++..+ +|+||+.
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~-------~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~ 168 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR-------FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF 168 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH-------HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc-------hHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence 467999999999999999999986 78999999976422 135567788888777 5678876
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCe--EEEeeccc
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC--VKVADFGI 174 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~--~kl~Dfg~ 174 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 169 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 169 TFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred ccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 2345899999999999999999999999999999999999999887 99999999
Q ss_pred ccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-------
Q 020016 175 SCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------- 247 (332)
Q Consensus 175 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~------- 247 (332)
+..... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+.
T Consensus 249 a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~ 326 (429)
T 3kvw_A 249 SCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326 (429)
T ss_dssp CEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTB
T ss_pred ceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 865443 23456789999999999999999999999999999999999999999887766554433211100
Q ss_pred --------------------------------------------------CCCCCcHHHHHHHHHccccCCCCCCCHHHH
Q 020016 248 --------------------------------------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 277 (332)
Q Consensus 248 --------------------------------------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~el 277 (332)
++...++.+.+||.+||+.||.+|||+.|+
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~ 406 (429)
T 3kvw_A 327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA 406 (429)
T ss_dssp TTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHH
Confidence 112347889999999999999999999999
Q ss_pred HH
Q 020016 278 VS 279 (332)
Q Consensus 278 l~ 279 (332)
++
T Consensus 407 L~ 408 (429)
T 3kvw_A 407 LR 408 (429)
T ss_dssp HT
T ss_pred hC
Confidence 86
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=309.00 Aligned_cols=221 Identities=24% Similarity=0.394 Sum_probs=191.1
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+++.||+|+||.||++.+. ++.||+|++....... ....+.+.+|+.+++.++||||++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK---PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 478999999999999999999997 6899999997643222 112467889999999999999987
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-C
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-G 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~ 182 (332)
....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... .
T Consensus 117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 2356899999999999999999999999999999999999999999999999998765432 2
Q ss_pred CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 020016 183 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 262 (332)
......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+... ...++..+++.+.+||.+
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~ 274 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQK 274 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHHHH
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--CCCCCccCCHHHHHHHHH
Confidence 334567899999999999988999999999999999999999999988877766655433 345677899999999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 020016 263 CWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 263 cl~~dp~~Rps~~ell~ 279 (332)
||+.||.+||++.++++
T Consensus 275 ~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 275 MLQTDPTARPTINELLN 291 (335)
T ss_dssp HTCSSGGGSCCGGGGGG
T ss_pred HccCChhHCcCHHHHhc
Confidence 99999999999999987
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=301.13 Aligned_cols=223 Identities=25% Similarity=0.436 Sum_probs=184.9
Q ss_pred ccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
..+...|.+.+.||+|+||+||+|.+. +..||+|++........ ..+.+.+|+.+++.++||||++
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 97 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS----ERQRFKEEAEMLKGLQHPNIVRFYDSWEST 97 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH----HHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHH----HHHHHHHHHHHHHhCCCCCeeeeeeeeccc
Confidence 344567999999999999999999996 67899999976543322 2467899999999999999986
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC--Cccccccccceeec-CCCeEEEeecc
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLG-EDMCVKVADFG 173 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~NIll~-~~~~~kl~Dfg 173 (332)
....+++..++.++.||+.||.|||+.| ++||||||+||+++ .++.++|+|||
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 98 VKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred cCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 2256889999999999999999999999 99999999999997 78999999999
Q ss_pred cccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCCCCCCC
Q 020016 174 ISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK-NARPPVPPTC 252 (332)
Q Consensus 174 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~ 252 (332)
++..... .......||+.|+|||++. +.++.++||||||+++|+|++|..||............... .....++...
T Consensus 178 ~~~~~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (290)
T 1t4h_A 178 LATLKRA-SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 255 (290)
T ss_dssp GGGGCCT-TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred Ccccccc-cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCC
Confidence 9865433 2334457899999999887 45899999999999999999999999885554444333333 3333456677
Q ss_pred cHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 253 PKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
++++.++|.+||+.||.+|||+.++++
T Consensus 256 ~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 256 IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 899999999999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=304.26 Aligned_cols=218 Identities=24% Similarity=0.362 Sum_probs=186.1
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||+||++.+. ++.||||++....... .+.+.+|+.+++.++||||++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR------DSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc------hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence 68999999999999999999996 7899999998653322 256889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee---cCCCeEEEeecccccccccC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||++......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 23467899999999999999999999999999999999999 77889999999998654332
Q ss_pred CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHHHH
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCPKAFSYL 259 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 259 (332)
......||+.|+|||.+.+..++.++||||||+++|+|++|..||...........+....... ..+..+++.+.++
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 241 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHH
T ss_pred -ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHH
Confidence 2334568999999999999999999999999999999999999999988877776665544332 3446789999999
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 020016 260 ISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~ 279 (332)
|.+||+.||.+||++.++++
T Consensus 242 i~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 242 ICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHcCCChhHCcCHHHHhc
Confidence 99999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=325.04 Aligned_cols=225 Identities=25% Similarity=0.363 Sum_probs=188.2
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhH-------HHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDAS-------LASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
.++|.+++.||+|+||+||+|.+. ++.||||++........ ......+.+.+|+.++++++||||++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 378999999999999999999996 68999999987532210 00122467899999999999999987
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC---eEEEeecc
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM---CVKVADFG 173 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~---~~kl~Dfg 173 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 194 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence 235689999999999999999999999999999999999998775 69999999
Q ss_pred cccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CC
Q 020016 174 ISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PT 251 (332)
Q Consensus 174 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~~ 251 (332)
++.............||+.|+|||++. +.++.++||||||+++|+|++|..||.+.+..+....+.........+ ..
T Consensus 195 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 273 (504)
T 3q5i_A 195 LSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKN 273 (504)
T ss_dssp TCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTT
T ss_pred CCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCC
Confidence 998766655556678999999999987 468999999999999999999999999999888887776554433322 57
Q ss_pred CcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 252 CPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 252 ~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+++++.+||.+||+.||.+|||+.++++
T Consensus 274 ~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 274 ISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 8999999999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=308.92 Aligned_cols=231 Identities=23% Similarity=0.309 Sum_probs=186.5
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||.||+|.+. ++.||||++........ .....+.+.+|+.+++.++||||++
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQI-NPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC----CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhccc-CHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 378999999999999999999996 67999999875321110 1112467899999999999999987
Q ss_pred -------CCC--------------------------------------------------CCCHHHHHHHHHHHHHHHHH
Q 020016 121 -------EPY--------------------------------------------------SVPLNLVLKLALDIARGMQY 143 (332)
Q Consensus 121 -------~~~--------------------------------------------------~l~~~~~~~i~~qi~~~L~~ 143 (332)
..+ .+++..++.++.||+.||.|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 111 12567788999999999999
Q ss_pred HHHCCCccccccccceeecCCC--eEEEeecccccccccCC-----CCCCcccccccCChhhhhc--CCCCCccchhHHH
Q 020016 144 LHSQGILHRDLKSENLLLGEDM--CVKVADFGISCLESQCG-----SAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFG 214 (332)
Q Consensus 144 LH~~~iiH~dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG 214 (332)
||++||+||||||+||+++.++ .+||+|||++....... ......||+.|+|||++.+ ..++.++||||||
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 9999999999999999998776 89999999997543322 1245678999999999975 6789999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHccccCCCCCCCHHHHHH--HHHhhh
Q 020016 215 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYS 285 (332)
Q Consensus 215 ~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rps~~ell~--~L~~~~ 285 (332)
+++|+|++|..||.+....+....+.........+ ..+++.+.+||.+||+.||.+||++.++++ .+..+.
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 99999999999999999888877776655544333 347899999999999999999999999987 444443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=302.60 Aligned_cols=229 Identities=24% Similarity=0.423 Sum_probs=173.5
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--- 120 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--- 120 (332)
....|....++|.+.+.||+|+||.||+|.+. ++.||||++......... .+.+.++..+++.++||||++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~~~~~~~~h~~i~~~~~ 91 (318)
T 2dyl_A 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN----KRILMDLDVVLKSHDCPYIVQCFG 91 (318)
T ss_dssp SSSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHH----HHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred cchhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHH----HHHHHHHHHHHHhcCCCceeeEEE
Confidence 34677888899999999999999999999996 789999999876443321 244555666788899999987
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccccccceeecCCCeEEEeeccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..+..++.|++.||.|||++ |++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~~~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 171 (318)
T 2dyl_A 92 TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI 171 (318)
T ss_dssp EEECSSEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecCCcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCC
Confidence 246789999999999999999999996 999999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCChhhhh-----cCCCCCccchhHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCC
Q 020016 175 SCLESQCGSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQKNARPPV 248 (332)
Q Consensus 175 a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~pf~~~~-~~~~~~~~~~~~~~~~~ 248 (332)
+.............+|+.|+|||.+. ...++.++||||||+++|+|++|..||.... ..+....+.. ...+..
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~ 250 (318)
T 2dyl_A 172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ-EEPPLL 250 (318)
T ss_dssp C--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH-SCCCCC
T ss_pred chhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc-cCCCCC
Confidence 87655544445567999999999994 5567899999999999999999999998744 4344444433 333333
Q ss_pred C--CCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 249 P--PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 249 ~--~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+ ..+++.+.++|.+||+.||.+||++.++++
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 3 468999999999999999999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=317.68 Aligned_cols=229 Identities=20% Similarity=0.320 Sum_probs=187.1
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||+||+|.+. ++.||||++........ .+.+.+|+.++++++||||++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-----VDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch-----HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence 368999999999999999999997 78999999976433222 356789999999999999986
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee----cCCCeEEEeeccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL----GEDMCVKVADFGI 174 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll----~~~~~~kl~Dfg~ 174 (332)
....+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 11238999999999999999999999999999999999999 7788899999999
Q ss_pred ccccccCCCCCCcccccccCChhhhhc--------CCCCCccchhHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhc
Q 020016 175 SCLESQCGSAKGFTGTYRWMAPEMIKE--------KRHTKKVDVYSFGIVLWELLTALTPFDNMT----PEQAAFAVCQK 242 (332)
Q Consensus 175 a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlG~il~elltG~~pf~~~~----~~~~~~~~~~~ 242 (332)
+.............||+.|+|||++.+ ..++.++||||||+++|+|++|..||.... ..+....+...
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 987655544556779999999999875 567889999999999999999999997432 23444444332
Q ss_pred CCCC-----------------------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 243 NARP-----------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 243 ~~~~-----------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
.... .++..++..+.+++.+||+.||++||++.++++.++.+...
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 2110 11123456788999999999999999999999999887654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=298.61 Aligned_cols=220 Identities=24% Similarity=0.348 Sum_probs=183.0
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|++.+.||+|+||.||+|.+. ++.||||++........ .+.+.+|+.+++.++||||++
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-----PENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTH-----HHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhh-----hHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence 68999999999999999999996 78999999976443221 367889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC---
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC--- 181 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--- 181 (332)
....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 3456899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCCCcccccccCChhhhhcCCC-CCccchhHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCCCCCCCCCCcHHHHHH
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAA-FAVCQKNARPPVPPTCPKAFSYL 259 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l 259 (332)
.......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||......... ...............+++.+.++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence 22345678999999999987665 77999999999999999999999876543222 22222222223335689999999
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 020016 260 ISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~ 279 (332)
+.+||+.||.+|||+.++++
T Consensus 242 i~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 242 LHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHCCCCchhCCCHHHHhc
Confidence 99999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=299.66 Aligned_cols=221 Identities=26% Similarity=0.388 Sum_probs=186.3
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
.+|.+.+.||+|+||.||+|.+. ++.||||++..... .+.+|+.+++.++||||++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----------KAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----------GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----------HHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 67999999999999999999996 88999999986532 3568999999999999874
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCe
Q 020016 121 ----------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 166 (332)
Q Consensus 121 ----------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~ 166 (332)
....+++..++.++.||+.||.|||++|++|+||||+||+++.++.
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC
Confidence 1246889999999999999999999999999999999999999999
Q ss_pred EEEeecccccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Q 020016 167 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 246 (332)
Q Consensus 167 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~ 246 (332)
++|+|||++.............+|+.|+|||.+.+..++.++||||||+++|+|++|..|+... ......+. ..
T Consensus 161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~----~~ 234 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLR----DG 234 (284)
T ss_dssp EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHH----TT
T ss_pred EEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhh----cc
Confidence 9999999987766555555667999999999999999999999999999999999999887531 11112221 23
Q ss_pred CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 020016 247 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 291 (332)
Q Consensus 247 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~ 291 (332)
.++..++..+.+++.+||+.||.+||++.++++.|..+....+..
T Consensus 235 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 235 IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 355678999999999999999999999999999999987766543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=306.88 Aligned_cols=227 Identities=28% Similarity=0.517 Sum_probs=182.2
Q ss_pred cCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC--CCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL--NHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~----------- 120 (332)
.++|.+.+.||+|+||.||+|.++++.||||++..... ..+.+|.+++..+ +||||++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~---------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEE---------ASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGH---------HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccceEEEeEeecCCCeEEEEEEECCceEEEEEEecccc---------chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 37899999999999999999999999999999965322 2345566666555 9999986
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCccccccccceeecCCCeEEEeec
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQ--------GILHRDLKSENLLLGEDMCVKVADF 172 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~iiH~dlkp~NIll~~~~~~kl~Df 172 (332)
....+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred CCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 224578999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCC-----CCCcccccccCChhhhhcCCCCCc------cchhHHHHHHHHHHhC----------CCCCCCCC
Q 020016 173 GISCLESQCGS-----AKGFTGTYRWMAPEMIKEKRHTKK------VDVYSFGIVLWELLTA----------LTPFDNMT 231 (332)
Q Consensus 173 g~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~------sDvwSlG~il~elltG----------~~pf~~~~ 231 (332)
|++........ .....||+.|+|||++.+...+.. +||||||+++|||+|| ..||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 99865433221 224579999999999988777665 9999999999999999 77776532
Q ss_pred -----HHHHHHHHHhcCCCCCCCC-----CCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 232 -----PEQAAFAVCQKNARPPVPP-----TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 232 -----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
..............+.++. .+++.+.+|+.+||+.||.+|||+.++++.|+.+.++.+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred CCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 2233333333444455543 456789999999999999999999999999999987654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=330.33 Aligned_cols=235 Identities=29% Similarity=0.609 Sum_probs=200.4
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEEC-----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT- 120 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~- 120 (332)
..+|.+..++|.+++.||+|+||+||+|.+. +..||||.+....... ..+.|.+|+.++++++||||++
T Consensus 382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l 456 (656)
T 2j0j_A 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS-----VREKFLQEALTMRQFDHPHIVKL 456 (656)
T ss_dssp GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHH-----HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHH-----HHHHHHHHHHHHHhCCCCCCCeE
Confidence 3567788899999999999999999999985 3579999987643322 2467999999999999999986
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecc
Q 020016 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 121 ---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 457 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 457 IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp EEEECSSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred EEEEecCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecC
Confidence 33468999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC--CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 020016 174 ISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 250 (332)
Q Consensus 174 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (332)
++........ .....+|+.|+|||++.+..++.++||||||+++|||++ |..||.+....+....+. ...+...+.
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~ 615 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPP 615 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-HTCCCCCCT
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCCCCCCc
Confidence 9976543322 223456789999999999999999999999999999997 999999988877766664 345667788
Q ss_pred CCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 251 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
.+++.+.++|.+||+.||.+||++.++++.|+.+.+.
T Consensus 616 ~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 616 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999988654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=307.36 Aligned_cols=228 Identities=26% Similarity=0.463 Sum_probs=181.7
Q ss_pred CeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------------- 120 (332)
.|..++.||+|+||.||+|.+.++.||||++........ ....+.+.+|+.+++.++||||++
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT--EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCT--TTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ccccCCccccCCCeEEEEEEECCceEEEEEEecccCcch--HHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence 455679999999999999999999999999976432110 112467899999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC-
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS- 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 183 (332)
....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 234589999999999999999999999999999999999999999999999999875443221
Q ss_pred --CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHh---------cCCCCCC
Q 020016 184 --AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA----FAVCQ---------KNARPPV 248 (332)
Q Consensus 184 --~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~----~~~~~---------~~~~~~~ 248 (332)
.....||+.|+|||.+.+ .++.++||||||+++|+|++|..||......... ..+.. .......
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 234578999999998875 5789999999999999999999999865432211 11111 0111223
Q ss_pred CCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 020016 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 249 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 286 (332)
+..++..+.+++.+||+.||.+||++.++++.|+.+.+
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 33456789999999999999999999999999998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=327.51 Aligned_cols=223 Identities=21% Similarity=0.297 Sum_probs=188.8
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
+..++|.+.+.||+|+||.||+|.+. ++.||||++....... ......+.+|+.+|..++||||++
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~---~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---RKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 257 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence 55688999999999999999999996 8899999997532111 111356889999999999999986
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 12348999999999999999999999999999999999999999999999999997765
Q ss_pred cCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCCCCCCCCcHH
Q 020016 180 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT----PEQAAFAVCQKNARPPVPPTCPKA 255 (332)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 255 (332)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+. .....++..++++
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~--~~~~~~p~~~s~~ 415 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK--EVPEEYSERFSPQ 415 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH--HCCCCCCTTSCHH
T ss_pred cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh--cccccCCccCCHH
Confidence 5444456689999999999999899999999999999999999999998753 333333332 3345667889999
Q ss_pred HHHHHHHccccCCCCCC-----CHHHHHH
Q 020016 256 FSYLISRCWSSSPDRRP-----HFDQIVS 279 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rp-----s~~ell~ 279 (332)
+.+||.+||+.||.+|| ++.++++
T Consensus 416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 416 ARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred HHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 99999999999999999 6788875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=305.81 Aligned_cols=222 Identities=22% Similarity=0.322 Sum_probs=183.9
Q ss_pred cCCeeeeeeecccCceEEEEEEEC---CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC---CCCceec-------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL---NHPHIIT------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~------- 120 (332)
.++|.+.+.||+|+||.||+|.+. ++.||||++......... ...+.+|+.+++.+ +||||++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM----PLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC----BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC----CchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 478999999999999999999983 689999999754322110 12355677777666 8999986
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecc
Q 020016 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 121 ---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
....+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence 23448999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--------
Q 020016 174 ISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR-------- 245 (332)
Q Consensus 174 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~-------- 245 (332)
++.............+|+.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (326)
T 1blx_A 166 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245 (326)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred ccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence 997665444445567899999999999999999999999999999999999999998877766555432111
Q ss_pred -----------------CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 246 -----------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 246 -----------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..+...++..+.+|+.+||+.||.+||++.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0123568899999999999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=298.53 Aligned_cols=226 Identities=26% Similarity=0.443 Sum_probs=186.0
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
..+..+.++|.....||+|+||.||+|.+. ++.||||++....... .+.+.+|+.+++.++||||++
T Consensus 15 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~ 88 (295)
T 2clq_A 15 LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY------SQPLHEEIALHKHLKHKNIVQYLGSF 88 (295)
T ss_dssp CCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---------HHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHH------HHHHHHHHHHHHhCCCCCEeeEeeEE
Confidence 455666777777889999999999999985 7899999998754322 366889999999999999986
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC-CCeEEEeecc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMCVKVADFG 173 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~-~~~~kl~Dfg 173 (332)
....+++..+..++.|++.||.|||++|++|+||||+||+++. ++.++|+|||
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg 168 (295)
T 2clq_A 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFG 168 (295)
T ss_dssp EETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTT
T ss_pred EeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecc
Confidence 1235678899999999999999999999999999999999987 8999999999
Q ss_pred cccccccCC-CCCCcccccccCChhhhhcCC--CCCccchhHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCCC
Q 020016 174 ISCLESQCG-SAKGFTGTYRWMAPEMIKEKR--HTKKVDVYSFGIVLWELLTALTPFDNMTP-EQAAFAVCQKNARPPVP 249 (332)
Q Consensus 174 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltG~~pf~~~~~-~~~~~~~~~~~~~~~~~ 249 (332)
++....... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||..... .............+.++
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (295)
T 2clq_A 169 TSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIP 248 (295)
T ss_dssp TCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC
T ss_pred cccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccccc
Confidence 987654322 234567899999999997654 78999999999999999999999976443 23333333345566778
Q ss_pred CCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 250 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..+++.+.+++.+||+.||++||++.++++
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 249 ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 889999999999999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=299.69 Aligned_cols=220 Identities=26% Similarity=0.399 Sum_probs=188.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||.||+|.+. ++.||||++......... .+.+.+|+.++++++||||++
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD----TSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHH----HHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 68999999999999999999996 789999999764332111 356889999999999999986
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC---CeEEEeecccccccccC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED---MCVKVADFGISCLESQC 181 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..++.++.||+.||.|||++|++||||+|+||+++.+ +.+||+|||++......
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 23468899999999999999999999999999999999999764 47999999998776554
Q ss_pred CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHH
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYL 259 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l 259 (332)
.......+|+.|+|||.+.+ .++.++||||||+++|+|++|..||...+..+....+.........+ ..+++++.++
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (287)
T 2wei_A 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (287)
T ss_dssp SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence 44555678999999999875 48999999999999999999999999988887777666554443333 5789999999
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 020016 260 ISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~ 279 (332)
|.+||+.||.+|||+.++++
T Consensus 257 i~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 257 IRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcccChhhCcCHHHHhc
Confidence 99999999999999999987
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=314.94 Aligned_cols=216 Identities=22% Similarity=0.325 Sum_probs=170.7
Q ss_pred cCCeeee-eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHH-HcCCCCceec---------
Q 020016 54 MSQLFIG-CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALL-FRLNHPHIIT--------- 120 (332)
Q Consensus 54 ~~~y~i~-~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~--------- 120 (332)
.++|.+. +.||.|+||+||+|.+. ++.||||++... ..+.+|+.++ +..+||||++
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 4678776 78999999999999997 789999999642 3456788887 4458999976
Q ss_pred -----------------------C--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC---CCeEEEeec
Q 020016 121 -----------------------E--PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DMCVKVADF 172 (332)
Q Consensus 121 -----------------------~--~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~---~~~~kl~Df 172 (332)
. ...+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 1 235899999999999999999999999999999999999987 789999999
Q ss_pred ccccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcCCCCC-
Q 020016 173 GISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ----AAFAVCQKNARPP- 247 (332)
Q Consensus 173 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~----~~~~~~~~~~~~~- 247 (332)
|++............+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+.......+
T Consensus 209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp TTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred ccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 99986655444556789999999999999999999999999999999999999997654321 2223332332222
Q ss_pred -CCCCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 248 -VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 248 -~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
....+++++.+||.+||+.||.+|||+.++++.
T Consensus 289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 225689999999999999999999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=310.81 Aligned_cols=222 Identities=23% Similarity=0.267 Sum_probs=176.5
Q ss_pred ccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
....++|.+.+.||+|+||+||+|.+. ++.||||++....... ..+.+++..+..++||||++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~l~~l~h~niv~~~~~~~~~ 91 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-------NRELQIMQDLAVLHHPNIVQLQSYFYTL 91 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC-------CHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc-------HHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence 344689999999999999999999996 7899999986643322 34667888899999999986
Q ss_pred ------------------------------CCCCCCHHHHHHHHHHHHHHHHHHH--HCCCccccccccceeecC-CCeE
Q 020016 121 ------------------------------EPYSVPLNLVLKLALDIARGMQYLH--SQGILHRDLKSENLLLGE-DMCV 167 (332)
Q Consensus 121 ------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH--~~~iiH~dlkp~NIll~~-~~~~ 167 (332)
....+++..+..++.|++.||.||| ++||+||||||+|||++. ++.+
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 92 GERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEE
T ss_pred ccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcE
Confidence 2356788899999999999999999 999999999999999997 8999
Q ss_pred EEeecccccccccCCCCCCcccccccCChhhhhcCC-CCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-
Q 020016 168 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR- 245 (332)
Q Consensus 168 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~- 245 (332)
||+|||++.............||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+.......+......
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp EECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 999999998776655556678899999999987654 899999999999999999999999998877766655432111
Q ss_pred -----------------------------CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 246 -----------------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 246 -----------------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1122336789999999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=304.45 Aligned_cols=217 Identities=17% Similarity=0.279 Sum_probs=178.4
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCceec----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIIT---------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~---------- 120 (332)
.++|++.+.||+|+||+||+|.+. ++.||||++.... .+.+.+|+.++++++ ||||++
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 105 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---------KKKIKREIKILENLRGGPNIITLADIVKDPVS 105 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence 478999999999999999999985 7899999997543 256889999999997 999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC-eEEEeecccccccccCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVADFGISCLESQCG 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~ 182 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 106 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 106 RTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp CCEEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred CceEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 112478999999999999999999999999999999999999776 89999999998766555
Q ss_pred CCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHh-------------cC----
Q 020016 183 SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNM-TPEQAAFAVCQ-------------KN---- 243 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~-~~~~~~~~~~~-------------~~---- 243 (332)
......+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||... ...+....+.. ..
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 5566789999999999987 66899999999999999999999999543 22222211110 00
Q ss_pred ------------------CCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 244 ------------------ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 244 ------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.....+..+++++.+||.+||+.||.+|||+.++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 001112237899999999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=300.37 Aligned_cols=219 Identities=23% Similarity=0.371 Sum_probs=177.3
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||.||+|.+. ++.||||++....... .+.+.+|+.+++.++||||++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS------VKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHH------HHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHH------HHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 78999999999999999999997 7999999997654322 467889999999999999975
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeec-CCCeEEEee
Q 020016 121 ----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG-EDMCVKVAD 171 (332)
Q Consensus 121 ----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~-~~~~~kl~D 171 (332)
....+++..++.++.|++.||.|||++|++||||||+||+++ .++.+||+|
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp CC----CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccccccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 235688999999999999999999999999999999999997 567999999
Q ss_pred cccccccccC----CCCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-
Q 020016 172 FGISCLESQC----GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR- 245 (332)
Q Consensus 172 fg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~- 245 (332)
||++...... .......+|..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+......
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9998765322 12234567999999999876 67899999999999999999999999998876655544332111
Q ss_pred ----------------------C-----CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 246 ----------------------P-----PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 246 ----------------------~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+ ...+.+++++.+||.+||+.||.+||++.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0 122468999999999999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=307.85 Aligned_cols=217 Identities=27% Similarity=0.428 Sum_probs=172.6
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceecC-------C---
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITE-------P--- 122 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~-------~--- 122 (332)
++|.+.+.||+|+||.||+|.+. ++.||||++........ .+.+.+|+.++++++||||++. .
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-----REKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTH-----HHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 68999999999999999999996 78999999986543322 4678999999999999999851 0
Q ss_pred ------------------------------------------------------------------------------CC
Q 020016 123 ------------------------------------------------------------------------------YS 124 (332)
Q Consensus 123 ------------------------------------------------------------------------------~~ 124 (332)
..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 11
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-------------CCCCccccc
Q 020016 125 VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-------------SAKGFTGTY 191 (332)
Q Consensus 125 l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~gt~ 191 (332)
.++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ......||+
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 2344588999999999999999999999999999999999999999999987654431 223457999
Q ss_pred ccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCC
Q 020016 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 271 (332)
Q Consensus 192 ~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 271 (332)
.|+|||++.+..++.++||||||+++|+|++|..|+.. ........ .....+......++.+.+|+.+||+.||.+|
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDV-RNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHH-HTTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHh-hccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence 99999999999999999999999999999998776432 11111111 2222222234456788999999999999999
Q ss_pred CCHHHHHH
Q 020016 272 PHFDQIVS 279 (332)
Q Consensus 272 ps~~ell~ 279 (332)
|++.++++
T Consensus 318 ps~~~~l~ 325 (332)
T 3qd2_B 318 PEATDIIE 325 (332)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHhh
Confidence 99999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=308.17 Aligned_cols=215 Identities=26% Similarity=0.400 Sum_probs=181.0
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec-----------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT----------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----------- 120 (332)
++|.+.+.||+|+||.||+|.++ ++.||||++...... +.+|++++.++ +||||++
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----------PTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----------CHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 68999999999999999999997 789999999875432 34688888887 7999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC----CeEEEeecccccccc
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED----MCVKVADFGISCLES 179 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~----~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.||+.||.|||++||+||||||+|||+..+ +.+||+|||++....
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 45678999999999999999999999999999999999998433 359999999997654
Q ss_pred cC-CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhcCCCC--CCCCCCc
Q 020016 180 QC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN---MTPEQAAFAVCQKNARP--PVPPTCP 253 (332)
Q Consensus 180 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~---~~~~~~~~~~~~~~~~~--~~~~~~~ 253 (332)
.. ......+||+.|+|||++.+..++.++||||||+++|+|++|..||.. .+..+....+....... ..+..++
T Consensus 172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 251 (342)
T 2qr7_A 172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251 (342)
T ss_dssp CTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSC
T ss_pred CCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCC
Confidence 33 334456789999999999988889999999999999999999999986 34555555555443332 2346789
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 254 KAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 254 ~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+++.+||.+||..||.+||++.++++
T Consensus 252 ~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 252 DTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 99999999999999999999999987
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=308.53 Aligned_cols=222 Identities=21% Similarity=0.382 Sum_probs=183.8
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
+..++|.+.+.||+|+||+||+|.+. ++.||+|++....... ..+.+.+|+.+++.++||||++
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 104 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-----IRNQIIRELQVLHECNSPYIVGFYGAFYSDG 104 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHH-----HHHHHHHHHGGGGGCCCTTBCCEEEEEEETT
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHH-----HHHHHHHHHHHHHHCCCCCEEEEeEEEEECC
Confidence 44579999999999999999999997 7899999998754322 2467899999999999999987
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..+..++.|++.||.|||++ ||+||||||+||+++.++.++|+|||++.....
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 234688999999999999999999996 999999999999999999999999999865433
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH----------------------
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA---------------------- 238 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~---------------------- 238 (332)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....
T Consensus 185 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 185 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp H-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred c-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 2 23356789999999999999999999999999999999999999987665443221
Q ss_pred --------------------HHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 239 --------------------VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 239 --------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+.........+..++.++.+||.+||+.||.+|||+.++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 11112222223457899999999999999999999999987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=304.40 Aligned_cols=228 Identities=28% Similarity=0.507 Sum_probs=168.1
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
...|.++.++|.+.+.||+|+||.||+|.+. ++.||||++....... ..+.+.+|+.++++++||||++
T Consensus 7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~ 81 (303)
T 2vwi_A 7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT-----SMDELLKEIQAMSQCHHPNIVSYYTS 81 (303)
T ss_dssp ------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC---------------------CCCCCCCTTBCCEEEE
T ss_pred ccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcch-----hHHHHHHHHHHHhhcCCCCEeeEEEE
Confidence 3568888999999999999999999999885 7899999987643222 2466889999999999999986
Q ss_pred --------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEE
Q 020016 121 --------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 168 (332)
Q Consensus 121 --------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~k 168 (332)
....+++..++.++.||+.||.|||++|++||||+|+||+++.++.++
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k 161 (303)
T 2vwi_A 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ 161 (303)
T ss_dssp EESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEE
T ss_pred EeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEE
Confidence 134589999999999999999999999999999999999999999999
Q ss_pred EeecccccccccCC------CCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 020016 169 VADFGISCLESQCG------SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 241 (332)
Q Consensus 169 l~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~ 241 (332)
|+|||++....... ......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||..............
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 241 (303)
T 2vwi_A 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ 241 (303)
T ss_dssp ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT
T ss_pred EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc
Confidence 99999986543221 1234568999999999876 5689999999999999999999999998776555444332
Q ss_pred cCCC--------CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 242 KNAR--------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 242 ~~~~--------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.... ......++..+.+++.+||+.||.+||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 2211 1233567899999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=308.01 Aligned_cols=227 Identities=28% Similarity=0.543 Sum_probs=186.5
Q ss_pred cCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHc--CCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR--LNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||.||+|.++++.||||++.... .+.+.+|++++.. ++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG---------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh---------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 3689999999999999999999999999999997532 2457788888887 79999986
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCccccccccceeecCCCeEEEeec
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLH--------SQGILHRDLKSENLLLGEDMCVKVADF 172 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~iiH~dlkp~NIll~~~~~~kl~Df 172 (332)
....+++..++.++.|++.||.||| +.||+||||||+||+++.++.+||+||
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred cceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 1235788999999999999999999 899999999999999999999999999
Q ss_pred ccccccccCC-----CCCCcccccccCChhhhhcCC------CCCccchhHHHHHHHHHHhC----------CCCCCCCC
Q 020016 173 GISCLESQCG-----SAKGFTGTYRWMAPEMIKEKR------HTKKVDVYSFGIVLWELLTA----------LTPFDNMT 231 (332)
Q Consensus 173 g~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlG~il~elltG----------~~pf~~~~ 231 (332)
|++....... ......||+.|+|||++.+.. ++.++||||||+++|+|+|| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 9987654433 234557999999999998653 33689999999999999999 78887642
Q ss_pred -----HHHHHHHHHhcCCCCCCCC-----CCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 232 -----PEQAAFAVCQKNARPPVPP-----TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 232 -----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
.......+.....++.++. .++..+.+|+.+||+.||++|||+.++++.|+.+.++..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 3334444444444555543 345689999999999999999999999999999877643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=306.70 Aligned_cols=225 Identities=23% Similarity=0.353 Sum_probs=176.8
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhH--HHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDAS--LASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
++|.+.+.||+|+||.||+|.+. ++.||||++........ ........+.+|+.+++.++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY 89 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSSE
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCce
Confidence 68999999999999999999996 78999999976432110 01112345889999999999999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCe---EEEeeccccccccc
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC---VKVADFGISCLESQ 180 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~---~kl~Dfg~a~~~~~ 180 (332)
....+++..+..++.||+.||.|||++|++||||||+||+++.++. +||+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 169 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169 (322)
T ss_dssp EEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCC
T ss_pred EEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceeccc
Confidence 4567899999999999999999999999999999999999987654 99999999876544
Q ss_pred CCCCCCcccccccCChhhhh---cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---CCCCCCcH
Q 020016 181 CGSAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP---PVPPTCPK 254 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 254 (332)
........||+.|+|||++. ...++.++||||||+++|+|++|..||................... .....+++
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (322)
T 2ycf_A 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249 (322)
T ss_dssp CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCH
Confidence 32223456899999999974 4567899999999999999999999997654322222221222221 12356889
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 020016 255 AFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 255 ~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+.+|+.+||+.||.+||++.++++
T Consensus 250 ~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 250 KALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHcccCHhhCCCHHHHhh
Confidence 9999999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=298.45 Aligned_cols=218 Identities=25% Similarity=0.446 Sum_probs=183.0
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||.||+|.+. ++.||||++..... .+.+.+|+.++..++||||++
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--------LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC--------CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH--------HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 478999999999999999999997 78999999987543 246889999999999999986
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 181 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 181 (332)
....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 2467899999999999999999999999999999999999999999999999998665432
Q ss_pred CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHH
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYLI 260 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 260 (332)
.......+|+.|+|||.+.+..++.++||||||+++|+|++|..||...........+..... ....+..++..+.++|
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 259 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFV 259 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHH
Confidence 223456789999999999998999999999999999999999999998887666555443322 2233556789999999
Q ss_pred HHccccCCCCCCCHHHHHH
Q 020016 261 SRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 261 ~~cl~~dp~~Rps~~ell~ 279 (332)
.+||+.||.+||++.++++
T Consensus 260 ~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 260 KQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHTCSCTTTSCCHHHHTT
T ss_pred HHHccCChhhCcCHHHHHh
Confidence 9999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=301.52 Aligned_cols=217 Identities=23% Similarity=0.358 Sum_probs=173.5
Q ss_pred CCeeee-eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec----------
Q 020016 55 SQLFIG-CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT---------- 120 (332)
Q Consensus 55 ~~y~i~-~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~---------- 120 (332)
+.|.+. +.||+|+||+||+|.+. ++.||||++....... .+.+.+|+.++.++ +||||++
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI------RSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC------HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh------HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 678885 78999999999999985 7899999997754332 35688999999985 7999987
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCe---EEEeecccccccc
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC---VKVADFGISCLES 179 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~---~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 2356899999999999999999999999999999999999988765 9999999986543
Q ss_pred cCC--------CCCCcccccccCChhhhhc-----CCCCCccchhHHHHHHHHHHhCCCCCCCCCH--------------
Q 020016 180 QCG--------SAKGFTGTYRWMAPEMIKE-----KRHTKKVDVYSFGIVLWELLTALTPFDNMTP-------------- 232 (332)
Q Consensus 180 ~~~--------~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltG~~pf~~~~~-------------- 232 (332)
... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+...
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 211 1223458999999999975 5578999999999999999999999987532
Q ss_pred -HHHHHHHHhcCCCCCCC----CCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 233 -EQAAFAVCQKNARPPVP----PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 233 -~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
......+.... ..++ ..+++.+.+||.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 246 QNMLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 22233333222 2222 468899999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=299.55 Aligned_cols=228 Identities=24% Similarity=0.357 Sum_probs=185.0
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC--CCceec---
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN--HPHIIT--- 120 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~--- 120 (332)
.....+..++|.+.+.||+|+||.||++.+. ++.||||++........ ..+.+.+|+.++.+++ ||||++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ----TLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHH----HHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccccc----chHHHHHHHHHHHhccccCCceEEEEE
Confidence 4455666789999999999999999999987 78899999987544322 2467899999999997 599986
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccc
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
....+++..+..++.||+.||.|||++|++||||||+||+++. +.+||+|||++.
T Consensus 96 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 96 YEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEECSSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred EeecCCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccc
Confidence 3457899999999999999999999999999999999999964 899999999987
Q ss_pred ccccCCC---CCCcccccccCChhhhhc-----------CCCCCccchhHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHh
Q 020016 177 LESQCGS---AKGFTGTYRWMAPEMIKE-----------KRHTKKVDVYSFGIVLWELLTALTPFDNMTP-EQAAFAVCQ 241 (332)
Q Consensus 177 ~~~~~~~---~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~il~elltG~~pf~~~~~-~~~~~~~~~ 241 (332)
....... .....||+.|+|||.+.+ ..++.++||||||+++|+|++|..||..... .........
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 254 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence 6543221 234568999999999875 4678899999999999999999999987543 334444444
Q ss_pred cCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 242 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
......++...+..+.+++.+||+.||.+||++.++++
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 255 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 45556677788999999999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=299.86 Aligned_cols=220 Identities=23% Similarity=0.428 Sum_probs=182.5
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||.||+|.+. ++.||+|++....... .+.+.+|+.++..++||||++
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 91 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE------LEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC------HHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH------HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence 478999999999999999999997 7899999997654332 367889999999999999987
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc-C
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-C 181 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~ 181 (332)
....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++..... .
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 246689999999999999999999999999999999999999999999999998754221 1
Q ss_pred CCCCCcccccccCChhhhh-----cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCCcHH
Q 020016 182 GSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR-PPVPPTCPKA 255 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 255 (332)
.......||+.|+|||.+. +..++.++||||||+++|+|++|..||...+.......+...... ...+..++..
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVE 251 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHH
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHH
Confidence 2233457899999999984 567889999999999999999999999998887766665544332 2345678999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 020016 256 FSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+.+++.+||+.||.+|||+.++++
T Consensus 252 l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 252 FRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHcccChhhCCCHHHHhc
Confidence 999999999999999999999875
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=332.46 Aligned_cols=225 Identities=22% Similarity=0.303 Sum_probs=190.3
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT------ 120 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~------ 120 (332)
..+..++|.+.+.||+|+||.||+|.+. ++.||||++...... .....+.+..|..++..+ +||||+.
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~---~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~ 412 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI---QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 412 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH---HTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc---cHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE
Confidence 3455789999999999999999999997 678999999753211 111135678899999988 7898875
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 413 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 413 TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred eCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 2357899999999999999999999999999999999999999999999999999753
Q ss_pred c-cCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 020016 179 S-QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 257 (332)
Q Consensus 179 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 257 (332)
. ........+||+.|+|||++.+..++.++||||||+++|||++|..||.+.+..+....+.. ....+|..+++++.
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~ 570 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEAV 570 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS--SCCCCCTTSCHHHH
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHH
Confidence 3 23345567899999999999999999999999999999999999999999988888777754 34567889999999
Q ss_pred HHHHHccccCCCCCCCH-----HHHHH
Q 020016 258 YLISRCWSSSPDRRPHF-----DQIVS 279 (332)
Q Consensus 258 ~li~~cl~~dp~~Rps~-----~ell~ 279 (332)
+||.+||+.||.+||++ ++|++
T Consensus 571 ~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 571 AICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 99999999999999987 56654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=321.92 Aligned_cols=218 Identities=21% Similarity=0.313 Sum_probs=184.4
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
+..++|.+.+.||+|+||.||+|.+. ++.||||++....... ....+.+.+|+.++..++||||++
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~---~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 258 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK---RKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT 258 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh---hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC
Confidence 44688999999999999999999996 7899999997632111 111356889999999999999986
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccc
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 134689999999999999999999999999999999999999999999999999976
Q ss_pred cccCCC-CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcCCCCCCCCCC
Q 020016 178 ESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM----TPEQAAFAVCQKNARPPVPPTC 252 (332)
Q Consensus 178 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~ 252 (332)
...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||... ........+.. ....+|..+
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~--~~~~~p~~~ 416 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE--QAVTYPDKF 416 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH--CCCCCCTTS
T ss_pred ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh--cccCCCccc
Confidence 554332 34468999999999999999999999999999999999999999875 33444444433 345667889
Q ss_pred cHHHHHHHHHccccCCCCCCCH
Q 020016 253 PKAFSYLISRCWSSSPDRRPHF 274 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~Rps~ 274 (332)
++.+.+||.+||+.||.+||++
T Consensus 417 s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 417 SPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCC
T ss_pred CHHHHHHHHHhccCCHhHCCCC
Confidence 9999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=320.64 Aligned_cols=228 Identities=17% Similarity=0.160 Sum_probs=175.9
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHH---HHHHcCCCCceecC--
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEV---ALLFRLNHPHIITE-- 121 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~~-- 121 (332)
.|....++|.+.+.||+|+||+||+|.+. ++.||||++......... ..+.+.+|+ .++++++|||||+.
T Consensus 67 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~~l~hpniv~~~~ 143 (377)
T 3byv_A 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN---AIKQMKEEVLRLRLLRGIKNQKQAKVHL 143 (377)
T ss_dssp SSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTT---HHHHHHHHHHGGGGSTTCCSHHHHHHHH
T ss_pred ecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchH---HHHHHHHHHHHHHhccccCCHHHHHHHh
Confidence 45555688999999999999999999975 889999999754221111 146788999 55666689998640
Q ss_pred ---------------------------------------C----------CCCC-------HHHHHHHHHHHHHHHHHHH
Q 020016 122 ---------------------------------------P----------YSVP-------LNLVLKLALDIARGMQYLH 145 (332)
Q Consensus 122 ---------------------------------------~----------~~l~-------~~~~~~i~~qi~~~L~~LH 145 (332)
. ..++ +..++.++.||+.||.|||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 223 (377)
T 3byv_A 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 223 (377)
T ss_dssp CBCCCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 0 0122 3777889999999999999
Q ss_pred HCCCccccccccceeecCCCeEEEeecccccccccCCCCCCcccccccCChhhhhcC-----------CCCCccchhHHH
Q 020016 146 SQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK-----------RHTKKVDVYSFG 214 (332)
Q Consensus 146 ~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlG 214 (332)
++||+||||||+|||++.++.+||+|||++..... ......| +.|+|||++.+. .++.++||||||
T Consensus 224 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 224 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 99999999999999999999999999999875332 2334567 999999999988 899999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH--HHHhhhhhh
Q 020016 215 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYSESL 288 (332)
Q Consensus 215 ~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~--~L~~~~~~~ 288 (332)
+++|+|++|+.||.+.........+ ......+++++.+||.+||+.||.+||++.++++ .+..+.+.+
T Consensus 301 ~il~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~ 370 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 370 (377)
T ss_dssp HHHHHHHHSSCCC------CCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCcccccccchhhh------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHHH
Confidence 9999999999999765443221111 1223578999999999999999999999999996 555555443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=319.29 Aligned_cols=227 Identities=24% Similarity=0.348 Sum_probs=188.6
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+++.||+|+||.||+|.+. ++.||||++...... ..+.+|+.+++.+.|++.+.
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--------PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--------CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 78999999999999999999986 889999998765443 34778999999998865432
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee---cCCCeEEEeeccccccccc
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++.....
T Consensus 79 ~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 79 VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 35679999999999999999999999999999999999999 5789999999999976544
Q ss_pred CCC--------CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcC---CCC
Q 020016 181 CGS--------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP---EQAAFAVCQKN---ARP 246 (332)
Q Consensus 181 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~---~~~~~~~~~~~---~~~ 246 (332)
... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+... .+....+.... ...
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 322 2256799999999999999999999999999999999999999987543 22222222211 111
Q ss_pred CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 247 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 247 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
.+...++.++.+||..||+.+|++||++.+|++.|+.+.....
T Consensus 239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 2335788999999999999999999999999999999877654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=310.32 Aligned_cols=217 Identities=21% Similarity=0.298 Sum_probs=176.2
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC--------CCceec---
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN--------HPHIIT--- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~--- 120 (332)
.++|.+.+.||+|+||+||+|.+. ++.||||++..... ..+.+.+|+.+++.+. |+||++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH-------YTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-------HHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCc-------chHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 378999999999999999999986 78999999975421 2366889999999985 677775
Q ss_pred ------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccccccceeecCCC----
Q 020016 121 ------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDM---- 165 (332)
Q Consensus 121 ------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~NIll~~~~---- 165 (332)
....+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 109 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHH
T ss_pred ceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhh
Confidence 235699999999999999999999998 999999999999999776
Q ss_pred ---------------------------------------------eEEEeecccccccccCCCCCCcccccccCChhhhh
Q 020016 166 ---------------------------------------------CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK 200 (332)
Q Consensus 166 ---------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 200 (332)
.+||+|||++...... .....||+.|+|||++.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhc
Confidence 7999999999765442 34457899999999999
Q ss_pred cCCCCCccchhHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhcCCC-----------------------------
Q 020016 201 EKRHTKKVDVYSFGIVLWELLTALTPFDNMT------PEQAAFAVCQKNAR----------------------------- 245 (332)
Q Consensus 201 ~~~~~~~sDvwSlG~il~elltG~~pf~~~~------~~~~~~~~~~~~~~----------------------------- 245 (332)
+..++.++|||||||++|+|++|..||...+ .......+......
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 9999999999999999999999999998654 22222222110000
Q ss_pred -----------CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 246 -----------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 246 -----------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...+...++.+.+||.+||+.||.+|||+.++++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0112334567899999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=310.81 Aligned_cols=217 Identities=27% Similarity=0.413 Sum_probs=161.3
Q ss_pred CCeee-eeeecccCceEEEEEEEC----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 55 SQLFI-GCKFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 55 ~~y~i-~~~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
+.|.+ +++||+|+||+||+|.+. ++.||||++...... ..+.+|+.+|+.++||||++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--------MSACREIALLRELKHPNVISLQKVFLSHA 91 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--------HHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--------HHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence 45666 668999999999999975 678999999865432 35788999999999999986
Q ss_pred -----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee----cCCCeE
Q 020016 121 -----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL----GEDMCV 167 (332)
Q Consensus 121 -----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll----~~~~~~ 167 (332)
....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 92 DRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp TTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred CCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 11248999999999999999999999999999999999999 677899
Q ss_pred EEeecccccccccC----CCCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHH---------
Q 020016 168 KVADFGISCLESQC----GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPE--------- 233 (332)
Q Consensus 168 kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~--------- 233 (332)
||+|||++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 99999999765432 223456789999999999874 5899999999999999999999999765442
Q ss_pred HHHHHHHhcCCCCC------------------------------------CCCCCcHHHHHHHHHccccCCCCCCCHHHH
Q 020016 234 QAAFAVCQKNARPP------------------------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 277 (332)
Q Consensus 234 ~~~~~~~~~~~~~~------------------------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~el 277 (332)
+....+......+. .....++.+.+||.+||+.||.+|||+.++
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 22222221111110 011226778999999999999999999999
Q ss_pred HH
Q 020016 278 VS 279 (332)
Q Consensus 278 l~ 279 (332)
++
T Consensus 332 L~ 333 (405)
T 3rgf_A 332 MQ 333 (405)
T ss_dssp HT
T ss_pred hc
Confidence 87
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=292.32 Aligned_cols=214 Identities=22% Similarity=0.324 Sum_probs=178.9
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec-----------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT----------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----------- 120 (332)
++|.+.+.||+|+||+||+|.+. ++.||||++......... ...+.+|+..+..+ +||||++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHH----HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHH----HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 68999999999999999999996 899999999875433321 36688999999999 9999986
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC---------------
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED--------------- 164 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~--------------- 164 (332)
....+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 12568999999999999999999999999999999999999844
Q ss_pred ----CeEEEeecccccccccCCCCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 020016 165 ----MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV 239 (332)
Q Consensus 165 ----~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~ 239 (332)
..++|+|||++...... ....+|+.|+|||.+.+. .++.++||||||+++|+|++|..++..... ...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~- 239 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHE- 239 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHH-
T ss_pred cCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHH-
Confidence 47999999998765442 334689999999999866 556899999999999999999887755432 222
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 240 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
......+..+..+++.+.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 240 IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 2345556778889999999999999999999999999985
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=304.78 Aligned_cols=214 Identities=21% Similarity=0.340 Sum_probs=157.7
Q ss_pred CCeeee---eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCceec--------
Q 020016 55 SQLFIG---CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIIT-------- 120 (332)
Q Consensus 55 ~~y~i~---~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~-------- 120 (332)
++|.+. +.||+|+||+||+|.+. ++.||||++.... ...+.+|+.+++.+. ||||++
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~ 78 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---------EANTQKEITALKLCEGHPNIVKLHEVFHDQ 78 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG---------HHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh---------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 355553 78999999999999997 7899999997532 245778999999997 999987
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC---eEEEeecccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM---CVKVADFGISCL 177 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~---~~kl~Dfg~a~~ 177 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 345689999999999999999999999999999999999998765 899999999975
Q ss_pred cccC-CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcCCCCCCC
Q 020016 178 ESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP-------EQAAFAVCQKNARPPVP 249 (332)
Q Consensus 178 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~-------~~~~~~~~~~~~~~~~~ 249 (332)
.... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||..... .+....+... ...++
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~--~~~~~ 236 (325)
T 3kn6_A 159 KPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG--DFSFE 236 (325)
T ss_dssp CCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT--CCCCC
T ss_pred cCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC--CCCCC
Confidence 4432 233456789999999999999999999999999999999999999986443 2333333222 22222
Q ss_pred ----CCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 250 ----PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 250 ----~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..+++++.+||.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 357899999999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=302.82 Aligned_cols=218 Identities=22% Similarity=0.351 Sum_probs=174.0
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-----------CCcee
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-----------HPHII 119 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv 119 (332)
..++|.+.+.||+|+||+||+|.+. ++.||||++...... .+.+.+|+.++.+++ ||||+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~ 89 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-------TEAAEDEIKLLQRVNDADNTKEDSMGANHIL 89 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH-------HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccc-------hhhhhHHHHHHHHhhcccccchhccccchHH
Confidence 3578999999999999999999985 899999999753221 356788999999886 78887
Q ss_pred c---------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccccccceeec---
Q 020016 120 T---------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLG--- 162 (332)
Q Consensus 120 ~---------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~NIll~--- 162 (332)
+ ....+++..+..++.||+.||.|||++ ||+||||||+|||++
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 90 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 5 235689999999999999999999998 999999999999994
Q ss_pred ---CCCeEEEeecccccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCH------H
Q 020016 163 ---EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP------E 233 (332)
Q Consensus 163 ---~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~------~ 233 (332)
..+.+||+|||++...... .....+|+.|+|||++.+..++.++||||||+++|+|++|..||..... .
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4458999999999765442 3345789999999999999999999999999999999999999986542 1
Q ss_pred HHHHHHHhcCC----------------------------------------CCCCCCCCcHHHHHHHHHccccCCCCCCC
Q 020016 234 QAAFAVCQKNA----------------------------------------RPPVPPTCPKAFSYLISRCWSSSPDRRPH 273 (332)
Q Consensus 234 ~~~~~~~~~~~----------------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps 273 (332)
+....+..... ...++..+++.+.+||.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 22222111000 11233455678999999999999999999
Q ss_pred HHHHHH
Q 020016 274 FDQIVS 279 (332)
Q Consensus 274 ~~ell~ 279 (332)
+.++++
T Consensus 328 ~~ell~ 333 (373)
T 1q8y_A 328 AGGLVN 333 (373)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=301.51 Aligned_cols=224 Identities=20% Similarity=0.311 Sum_probs=185.0
Q ss_pred ccCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHH-----------HHHHHHHHHHHHHHHHcCCCCceec-
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASL-----------ASMLEKQFTSEVALLFRLNHPHIIT- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~niv~- 120 (332)
..++|.+.+.||+|+||.||+|.+.++.||||++......... .....+.+.+|+.++.+++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 3579999999999999999999999999999999753221100 0000156889999999999999986
Q ss_pred ------------------------C-----------CCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccccccceeecCC
Q 020016 121 ------------------------E-----------PYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGED 164 (332)
Q Consensus 121 ------------------------~-----------~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~NIll~~~ 164 (332)
. ...+++..++.++.|++.||.|||+ .|++||||+|+||+++.+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN 188 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence 1 4678999999999999999999999 999999999999999999
Q ss_pred CeEEEeecccccccccCCCCCCcccccccCChhhhhcC-CCCC-ccchhHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHh
Q 020016 165 MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTK-KVDVYSFGIVLWELLTALTPFDNMTP-EQAAFAVCQ 241 (332)
Q Consensus 165 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwSlG~il~elltG~~pf~~~~~-~~~~~~~~~ 241 (332)
+.++|+|||++...... ......+|+.|+|||.+.+. .++. ++||||||+++|+|++|..||..... .+....+..
T Consensus 189 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~ 267 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267 (348)
T ss_dssp SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTS
T ss_pred CcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc
Confidence 99999999998765432 33456789999999999877 5555 99999999999999999999998766 454444432
Q ss_pred cCCCCCCC-------------------CCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 242 KNARPPVP-------------------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 242 ~~~~~~~~-------------------~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
. ...++ ..+++.+.+|+.+||+.||.+||++.++++
T Consensus 268 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 268 K--NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp C--CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred c--CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2 22333 568999999999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=297.95 Aligned_cols=216 Identities=23% Similarity=0.327 Sum_probs=177.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC---CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCc------eec-----
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH------IIT----- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~----- 120 (332)
++|.+.+.||+|+||+||+|.+. ++.||||++..... ..+.+.+|+.++..++|++ +++
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR-------YCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHH-------HHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCc-------hhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 68999999999999999999882 78999999975321 1356788999999987665 543
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC-------------
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE------------- 163 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~------------- 163 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 87 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 87 EHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred ccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 2236889999999999999999999999999999999999987
Q ss_pred ------CCeEEEeecccccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 020016 164 ------DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF 237 (332)
Q Consensus 164 ------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~ 237 (332)
++.+||+|||++..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+...
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred ccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 66799999999876443 2345678999999999999999999999999999999999999999887766544
Q ss_pred HHHhcCCCC------------------------------------------CCCCCCcHHHHHHHHHccccCCCCCCCHH
Q 020016 238 AVCQKNARP------------------------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFD 275 (332)
Q Consensus 238 ~~~~~~~~~------------------------------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 275 (332)
.+....... ..+...++.+.+||.+||+.||.+|||+.
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 324 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR 324 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence 332211100 11223457789999999999999999999
Q ss_pred HHHH
Q 020016 276 QIVS 279 (332)
Q Consensus 276 ell~ 279 (332)
++++
T Consensus 325 ell~ 328 (339)
T 1z57_A 325 EALK 328 (339)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=303.88 Aligned_cols=228 Identities=14% Similarity=0.197 Sum_probs=185.3
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEE-----E--CCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC---C
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGI-----Y--KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN---H 115 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~-----~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h 115 (332)
...++.+..++|.+.+.||+|+||+||+|. + .++.||||++..... ..+..|+.++..+. |
T Consensus 56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~e~~~~~~l~~~~~ 126 (365)
T 3e7e_A 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---------WEFYIGTQLMERLKPSMQ 126 (365)
T ss_dssp SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---------HHHHHHHHHHHHSCGGGG
T ss_pred cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---------hHHHHHHHHHHHhhhhhh
Confidence 346777888999999999999999999994 2 278999999976532 45777888888886 8
Q ss_pred Cceec---------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeec
Q 020016 116 PHIIT---------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 162 (332)
Q Consensus 116 ~niv~---------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~ 162 (332)
+||+. ....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 127 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~ 206 (365)
T 3e7e_A 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILG 206 (365)
T ss_dssp GGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC
T ss_pred hhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEec
Confidence 99875 245699999999999999999999999999999999999998
Q ss_pred C-----------CCeEEEeeccccccccc---CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCC
Q 020016 163 E-----------DMCVKVADFGISCLESQ---CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 228 (332)
Q Consensus 163 ~-----------~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~ 228 (332)
. ++.+||+|||++..... ........||+.|+|||++.+..++.++||||||+++|+|+||+.||.
T Consensus 207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence 8 89999999999965432 222345679999999999999999999999999999999999999996
Q ss_pred CCCHHHHHHHHHhcCCCCCC-CCCCcHHHHHHHHHccccCCCCC-CCHHHHHHHHHhhhhhhc
Q 020016 229 NMTPEQAAFAVCQKNARPPV-PPTCPKAFSYLISRCWSSSPDRR-PHFDQIVSILEGYSESLE 289 (332)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~R-ps~~ell~~L~~~~~~~~ 289 (332)
...... ......+ ....++.+.+++..||..+|.+| |++.++.+.|+.+.....
T Consensus 287 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 287 KNEGGE-------CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp EEETTE-------EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred cCCCCc-------eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 532211 0011111 11346789999999999999999 588999999998876643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=307.65 Aligned_cols=232 Identities=15% Similarity=0.153 Sum_probs=170.7
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHH---HHHHcCCCCceecC--
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEV---ALLFRLNHPHIITE-- 121 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~~-- 121 (332)
.|.....+|.+.+.||+|+||.||+|.+. ++.||||++........ ...+.+.+|+ .+|+. +||||++.
T Consensus 56 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~~~~l~~-~hp~iv~~~~ 131 (371)
T 3q60_A 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSR---SELERLHEATFAAARLLG-ESPEEARDRR 131 (371)
T ss_dssp TTTCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHH---HHHHHHHHHHHHHHHHHC-----------
T ss_pred cCCCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccc---cHHHHHHHHHHHHHHhcc-cChhhhhhce
Confidence 34445567999999999999999999986 78999999998654322 1245677784 55555 79996540
Q ss_pred --------------------------------------------------CCCCCHHHH------HHHHHHHHHHHHHHH
Q 020016 122 --------------------------------------------------PYSVPLNLV------LKLALDIARGMQYLH 145 (332)
Q Consensus 122 --------------------------------------------------~~~l~~~~~------~~i~~qi~~~L~~LH 145 (332)
...+.+..+ ..++.||+.||.|||
T Consensus 132 ~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH 211 (371)
T 3q60_A 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ 211 (371)
T ss_dssp CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence 011233344 677799999999999
Q ss_pred HCCCccccccccceeecCCCeEEEeecccccccccCCCCCCcccccccCChhhhhc--CCCCCccchhHHHHHHHHHHhC
Q 020016 146 SQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTA 223 (332)
Q Consensus 146 ~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG 223 (332)
++||+||||||+|||++.++.+||+|||++...... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|
T Consensus 212 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 212 SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999999765432 114567799999999987 6789999999999999999999
Q ss_pred CCCCCCCCHHHHHHH-----HHh--cCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH--HHHhhhh
Q 020016 224 LTPFDNMTPEQAAFA-----VCQ--KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYSE 286 (332)
Q Consensus 224 ~~pf~~~~~~~~~~~-----~~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~--~L~~~~~ 286 (332)
+.||....+...... ... .....+....+++.+.+||.+||+.||++||++.++++ .++.+..
T Consensus 290 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 290 FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp SCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred CCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence 999987643211000 000 01112223578999999999999999999999999985 4444433
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=307.45 Aligned_cols=222 Identities=26% Similarity=0.384 Sum_probs=179.2
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC--CCceec----
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN--HPHIIT---- 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~---- 120 (332)
+...-.++|.+++.||+|+||.||+|.+. ++.||||++..............+.+.+|+.+++.++ |+||++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 33444688999999999999999999985 7899999997643211000000134677999999996 599986
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeec-CCCeEEEeeccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG-EDMCVKVADFGI 174 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~-~~~~~kl~Dfg~ 174 (332)
....+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 235689999999999999999999999999999999999999 679999999999
Q ss_pred ccccccCCCCCCcccccccCChhhhhcCCC-CCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 020016 175 SCLESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 253 (332)
Q Consensus 175 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (332)
+...... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||..... .. .....++..++
T Consensus 197 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~--~~~~~~~~~~~ 267 (320)
T 3a99_A 197 GALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II--RGQVFFRQRVS 267 (320)
T ss_dssp CEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH--HCCCCCSSCCC
T ss_pred ccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hh--cccccccccCC
Confidence 8765542 3345678999999999987766 6889999999999999999999976321 11 22345667889
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 254 KAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 254 ~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+++.+||.+||+.||.+||++.++++
T Consensus 268 ~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 268 SECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999999999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=302.91 Aligned_cols=227 Identities=24% Similarity=0.357 Sum_probs=182.4
Q ss_pred ccccCCeeeeeeecccCceEEEEEEE-----CCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec----
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIY-----KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT---- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~---- 120 (332)
.+..++|.+.+.||+|+||.||++.+ .++.||||++......... ...+.+.+|+.++..+ +||||++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 127 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA--KTTEHTRTERQVLEHIRQSPFLVTLHYA 127 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE--SSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhh--hHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence 44568999999999999999999998 4789999998753210000 0024467899999999 6999986
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccc
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 23468999999999999999999999999999999999999999999999999987
Q ss_pred ccccC--CCCCCcccccccCChhhhhcC--CCCCccchhHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCCCC
Q 020016 177 LESQC--GSAKGFTGTYRWMAPEMIKEK--RHTKKVDVYSFGIVLWELLTALTPFDNMT----PEQAAFAVCQKNARPPV 248 (332)
Q Consensus 177 ~~~~~--~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltG~~pf~~~~----~~~~~~~~~~~~~~~~~ 248 (332)
..... .......||+.|+|||++.+. .++.++||||||+++|+|++|..||.... .......+. ...+.+
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~ 285 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL--KSEPPY 285 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH--HCCCCC
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh--ccCCCC
Confidence 54322 223346799999999999863 46899999999999999999999997532 333333332 335567
Q ss_pred CCCCcHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 020016 249 PPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVSIL 281 (332)
Q Consensus 249 ~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~~L 281 (332)
+..++..+.+||.+||..||.+|| +++++++..
T Consensus 286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 788999999999999999999999 899988743
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=298.02 Aligned_cols=217 Identities=19% Similarity=0.315 Sum_probs=177.0
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--C-eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCc------eec----
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--Q-RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH------IIT---- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~-~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~---- 120 (332)
.++|.+.+.||+|+||+||+|.+. + +.||||++..... ..+.+.+|+.+++.+.|++ ++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK-------YREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHH-------HHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccccc-------chhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 379999999999999999999986 3 7899999975322 1356788999999997665 432
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee--------------
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL-------------- 161 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll-------------- 161 (332)
....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 91 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 91 FNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence 23469999999999999999999999999999999999999
Q ss_pred -----cCCCeEEEeecccccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 020016 162 -----GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA 236 (332)
Q Consensus 162 -----~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~ 236 (332)
+.++.+||+|||++..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+..
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 5678999999999876443 234567899999999999999999999999999999999999999988776554
Q ss_pred HHHHhcCCCC------------------------------------------CCCCCCcHHHHHHHHHccccCCCCCCCH
Q 020016 237 FAVCQKNARP------------------------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHF 274 (332)
Q Consensus 237 ~~~~~~~~~~------------------------------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~ 274 (332)
..+....... ......+..+.+||.+||+.||.+|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 4332211110 0111234678999999999999999999
Q ss_pred HHHHH
Q 020016 275 DQIVS 279 (332)
Q Consensus 275 ~ell~ 279 (332)
.++++
T Consensus 329 ~e~l~ 333 (355)
T 2eu9_A 329 AEALL 333 (355)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99984
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=295.87 Aligned_cols=217 Identities=26% Similarity=0.428 Sum_probs=176.8
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC----CCCceec-------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL----NHPHIIT------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~h~niv~------- 120 (332)
.++|.+.+.||+|+||.||+|.+. ++.||||++................+.+|+.++.++ +||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 478999999999999999999985 789999999765432211111234567799999998 8999986
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeec-CCCeEEEeecccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG-EDMCVKVADFGISCL 177 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~-~~~~~kl~Dfg~a~~ 177 (332)
....+++..++.++.||+.||.|||++|++||||||+||+++ .++.++|+|||++..
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~ 189 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL 189 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEE
T ss_pred CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhh
Confidence 234589999999999999999999999999999999999999 789999999999876
Q ss_pred cccCCCCCCcccccccCChhhhhcCCC-CCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 020016 178 ESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 256 (332)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (332)
.... ......+|+.|+|||++.+..+ +.++||||||+++|+|++|+.||.... . +. .....++..++..+
T Consensus 190 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~----~~--~~~~~~~~~~~~~~ 260 (312)
T 2iwi_A 190 LHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--E----IL--EAELHFPAHVSPDC 260 (312)
T ss_dssp CCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HH--HTCCCCCTTSCHHH
T ss_pred cccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--H----Hh--hhccCCcccCCHHH
Confidence 5543 3345678999999999987766 458999999999999999999997632 1 11 22345677899999
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.++|.+||+.||++||++.++++
T Consensus 261 ~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 261 CALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=311.96 Aligned_cols=218 Identities=17% Similarity=0.138 Sum_probs=171.2
Q ss_pred cccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCC-Ccee-------
Q 020016 50 WSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH-PHII------- 119 (332)
Q Consensus 50 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv------- 119 (332)
+.....+|.+++.||+|+||+||+|.+. ++.||||++........ ...+.|.+|+.++..+.| +|..
T Consensus 73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~ 149 (413)
T 3dzo_A 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS---NAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 149 (413)
T ss_dssp SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-------CCHHHHHHHHGGGGSTTCCSHHHHHHHTC
T ss_pred CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH---HHHHHHHHHHHHHHhhccCCCHHHHHHhcc
Confidence 3445567999999999999999999987 89999999985433221 113668899999999987 2110
Q ss_pred --------c---------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHH
Q 020016 120 --------T---------------------------------------------EPYSVPLNLVLKLALDIARGMQYLHS 146 (332)
Q Consensus 120 --------~---------------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~ 146 (332)
. ....+++..++.++.||+.||.|||+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 229 (413)
T 3dzo_A 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229 (413)
T ss_dssp BCCCCEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccchhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 0 02235567888999999999999999
Q ss_pred CCCccccccccceeecCCCeEEEeecccccccccCCCCCCcccccccCChhhh----------hcCCCCCccchhHHHHH
Q 020016 147 QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI----------KEKRHTKKVDVYSFGIV 216 (332)
Q Consensus 147 ~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwSlG~i 216 (332)
+||+||||||+|||++.++.+||+|||++...... .....| +.|+|||++ .+..++.++|||||||+
T Consensus 230 ~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 230 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred CCcccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999998765443 344567 999999999 45557889999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 217 LWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 217 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+|+|++|+.||...+.......+ ......+++.+.+||.+||+.||.+||++.++++
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCCCcchhhhHHHH------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999999875543221111 1122467899999999999999999999776644
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=288.08 Aligned_cols=215 Identities=26% Similarity=0.386 Sum_probs=168.8
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||.||+|.+. ++.||||++..... ..+.+.+|+.+++.++||||++
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-------KLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHH-------HHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHH-------HHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence 67999999999999999999985 78999999965321 1467889999999999999974
Q ss_pred ------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEe
Q 020016 121 ------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVA 170 (332)
Q Consensus 121 ------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~ 170 (332)
....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEe
Confidence 22346778899999999999999999999999999999999999999999
Q ss_pred ecccccccccC---------------CCCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCH-H
Q 020016 171 DFGISCLESQC---------------GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTP-E 233 (332)
Q Consensus 171 Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~-~ 233 (332)
|||++...... .......||+.|+|||++.+. .++.++||||||+++|+|++ ||..... .
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 99998754321 122345689999999999864 68999999999999999998 5543222 2
Q ss_pred HHHHHHHhc--CCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 234 QAAFAVCQK--NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 234 ~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.....+... ...+.++...++.+.+++.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 222222221 1223345667888999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=299.57 Aligned_cols=217 Identities=27% Similarity=0.372 Sum_probs=175.9
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCc-----eec-----
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPH-----IIT----- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n-----iv~----- 120 (332)
.++|.+.+.||+|+||+||+|.+. ++.||||++..... ....+..|+.++..++ |+| |+.
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA-------FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHH-------HHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHH-------HHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 479999999999999999999987 78999999975321 1356778888888885 554 443
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHH--HCCCccccccccceeec--CCCeEEEeec
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLH--SQGILHRDLKSENLLLG--EDMCVKVADF 172 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH--~~~iiH~dlkp~NIll~--~~~~~kl~Df 172 (332)
....+++..+..++.|++.||.||| ..||+||||||+|||++ .++.+||+||
T Consensus 126 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 126 MFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred ccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 2256899999999999999999999 57999999999999995 4688999999
Q ss_pred ccccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-----
Q 020016 173 GISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP----- 247 (332)
Q Consensus 173 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~----- 247 (332)
|++..... ......+|+.|+|||++.+..++.++|||||||++|+|+||..||.+.+..+....+......++
T Consensus 206 G~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (382)
T 2vx3_A 206 GSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283 (382)
T ss_dssp TTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred cCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99976543 23456789999999999999999999999999999999999999999887776655543211110
Q ss_pred -----------C------------------CCC----------------------------CcHHHHHHHHHccccCCCC
Q 020016 248 -----------V------------------PPT----------------------------CPKAFSYLISRCWSSSPDR 270 (332)
Q Consensus 248 -----------~------------------~~~----------------------------~~~~l~~li~~cl~~dp~~ 270 (332)
+ ++. .++.+.+||.+||+.||.+
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 363 (382)
T 2vx3_A 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKT 363 (382)
T ss_dssp TCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTT
T ss_pred hhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhh
Confidence 0 000 0147899999999999999
Q ss_pred CCCHHHHHH
Q 020016 271 RPHFDQIVS 279 (332)
Q Consensus 271 Rps~~ell~ 279 (332)
|||+.++++
T Consensus 364 Rpta~e~L~ 372 (382)
T 2vx3_A 364 RIQPYYALQ 372 (382)
T ss_dssp SCCHHHHTT
T ss_pred CCCHHHHhc
Confidence 999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=289.98 Aligned_cols=215 Identities=22% Similarity=0.314 Sum_probs=149.8
Q ss_pred cCCeeeee-eecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 54 MSQLFIGC-KFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 54 ~~~y~i~~-~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
.++|.+.+ .||+|+||+||+|.+. ++.||||++..... ...+....+..+.||||++
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----------ARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----------HHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----------HHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 47899855 6999999999999997 88999999976321 1122333456779999875
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC---CCeEEEeecc
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DMCVKVADFG 173 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~---~~~~kl~Dfg 173 (332)
....+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 2246999999999999999999999999999999999999976 4569999999
Q ss_pred cccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hc--CCCCC
Q 020016 174 ISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC----QK--NARPP 247 (332)
Q Consensus 174 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~----~~--~~~~~ 247 (332)
++...... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||............. .. .....
T Consensus 177 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3fhr_A 177 FAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255 (336)
T ss_dssp TCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred cceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence 98765432 2345678999999999988888999999999999999999999998765443321111 11 11222
Q ss_pred CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 248 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 248 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
....+++.+.+||.+||+.||.+|||+.++++
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 23578999999999999999999999999997
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=301.56 Aligned_cols=223 Identities=25% Similarity=0.370 Sum_probs=168.2
Q ss_pred cccccccCCeeeeeeecccCceE-EEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec-----
Q 020016 48 EEWSADMSQLFIGCKFASGRHSR-IYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT----- 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~-Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----- 120 (332)
..+.+...+|.+.+.||+|+||+ ||++...++.||||++...... .+.+|+.+|+.+ +|||||+
T Consensus 17 ~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---------~~~~E~~~l~~l~~HpnIv~l~~~~ 87 (432)
T 3p23_A 17 SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---------FADREVQLLRESDEHPNVIRYFCTE 87 (432)
T ss_dssp -CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---------ECHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred CcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---------HHHHHHHHHHhccCCCCcCeEEEEE
Confidence 34566667899999999999998 5556666999999999764432 246799999999 8999987
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC-----CeEEEeec
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-----MCVKVADF 172 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~-----~~~kl~Df 172 (332)
......+..+..++.||+.||.|||++||+||||||+|||++.+ ..++|+||
T Consensus 88 ~~~~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DF 167 (432)
T 3p23_A 88 KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDF 167 (432)
T ss_dssp EETTEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred ecCCEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence 22344555678999999999999999999999999999999532 36889999
Q ss_pred ccccccccC----CCCCCcccccccCChhhhh---cCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCC
Q 020016 173 GISCLESQC----GSAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 244 (332)
Q Consensus 173 g~a~~~~~~----~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~ 244 (332)
|++...... .......||+.|+|||++. ...++.++|||||||++|+|++ |..||.................
T Consensus 168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~ 247 (432)
T 3p23_A 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL 247 (432)
T ss_dssp TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCC
T ss_pred cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCc
Confidence 999765432 1234567999999999997 4567889999999999999999 9999976554443222211111
Q ss_pred CC-CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 245 RP-PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 245 ~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.. ..+...+..+.+||.+||+.||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 248 DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 11 112234566899999999999999999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=295.19 Aligned_cols=214 Identities=24% Similarity=0.359 Sum_probs=160.1
Q ss_pred CCeeeeeeecccCceEEEEE-EECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRG-IYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~------------ 120 (332)
+.|.+.+.||+|+||+||.+ ...|+.||||++.... .+.+.+|+.++.++ +||||++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 85 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY 85 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence 34556788999999999755 4458999999987532 23567899999876 8999987
Q ss_pred ---------------CCCC-------CCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC-------------C
Q 020016 121 ---------------EPYS-------VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-------------M 165 (332)
Q Consensus 121 ---------------~~~~-------l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~-------------~ 165 (332)
.... .++..++.++.||+.||.|||++||+||||||+|||++.+ +
T Consensus 86 lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 86 IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 1111 1223456799999999999999999999999999999754 4
Q ss_pred eEEEeecccccccccCCC-----CCCcccccccCChhhhhc-------CCCCCccchhHHHHHHHHHHh-CCCCCCCCCH
Q 020016 166 CVKVADFGISCLESQCGS-----AKGFTGTYRWMAPEMIKE-------KRHTKKVDVYSFGIVLWELLT-ALTPFDNMTP 232 (332)
Q Consensus 166 ~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~ 232 (332)
.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|+| |..||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 899999999976544321 234579999999999976 568999999999999999999 9999987554
Q ss_pred HHHHHHHHhcCCCCCC-----CCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 233 EQAAFAVCQKNARPPV-----PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 233 ~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
... .+......... +..+++++.+||.+||+.||.+|||+.++++
T Consensus 246 ~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 RES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 332 22222222111 1234678999999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=307.61 Aligned_cols=227 Identities=23% Similarity=0.329 Sum_probs=176.7
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+.+.||+|+||+||+|.+. ++.||||++....... ..+.+.+|+.++++++||||++
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~-----~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~ 87 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK-----NRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHH-----HHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHH-----HHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence 378999999999999999999985 7899999997653322 2467899999999999999985
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCe---EEEee
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC---VKVAD 171 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~---~kl~D 171 (332)
....+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 1125888999999999999999999999999999999999987664 99999
Q ss_pred cccccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH---------HH-h
Q 020016 172 FGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA---------VC-Q 241 (332)
Q Consensus 172 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~---------~~-~ 241 (332)
||++.............||+.|+|||.+.+..++.++||||||+++|+|++|..||........... .. .
T Consensus 168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 168 LGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred cccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 9999877665555667899999999999999999999999999999999999999976543221100 00 0
Q ss_pred c--C------CC----CCCCCCCcHHHHHHHHHccccCCCCCCCHHH-----HHHHHHhhh
Q 020016 242 K--N------AR----PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQ-----IVSILEGYS 285 (332)
Q Consensus 242 ~--~------~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e-----ll~~L~~~~ 285 (332)
. . .. ..+...+++.+.++|.+||..||.+|||+.+ +.+.++.+.
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 0 0 00 0122346788999999999999999999988 444554443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=275.09 Aligned_cols=204 Identities=13% Similarity=0.138 Sum_probs=163.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||.||+|.+. ++.||||++........ ...+.+.+|+.++.+++||||++
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPD---DVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCH---HHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 68999999999999999999997 79999999987544321 12467899999999999999986
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCCC
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK 185 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 185 (332)
.. ......+..++.|++.||.|||++||+||||||+||+++.+|.++|+++|.
T Consensus 108 lv~e~~~g~~L~~~l~~-~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~----------- 175 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT-SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT----------- 175 (286)
T ss_dssp EEEECCCEEEHHHHHTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC-----------
T ss_pred EEEEecCCCCHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc-----------
Confidence 22 246667899999999999999999999999999999999999999985542
Q ss_pred CcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC----CCCCCCcHHHHHHH
Q 020016 186 GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK-NARP----PVPPTCPKAFSYLI 260 (332)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~l~~li 260 (332)
++ .++.++||||||+++|+|+||+.||.+.+..+........ .... .....+++++.++|
T Consensus 176 --------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 240 (286)
T 3uqc_A 176 --------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVA 240 (286)
T ss_dssp --------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHH
T ss_pred --------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHH
Confidence 22 3688999999999999999999999875542211000000 0001 12357899999999
Q ss_pred HHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 261 SRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 261 ~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
.+||+.||.+| |+.++++.|+.+.....
T Consensus 241 ~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 241 ARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred HHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 99999999999 99999999999876544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=298.61 Aligned_cols=216 Identities=23% Similarity=0.328 Sum_probs=176.0
Q ss_pred cCCeeeeeeecccCceEEEEEEEC---CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
.++|.+.+.||+|+||+||+|.+. ++.||||++....... ....+.+|+.++.+++||||++
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 153 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAE-----AQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHH-----HHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHH-----HHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence 478999999999999999999984 6899999987643322 2467889999999999999986
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++....
T Consensus 154 ~~~~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 154 HGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp TSCEEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred CCCceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 12368999999999999999999999999999999999999875 89999999987654
Q ss_pred cCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-CCCCCcHHHHH
Q 020016 180 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-VPPTCPKAFSY 258 (332)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~ 258 (332)
.. ....||+.|+|||++.++. +.++||||||+++|+|++|..||.+... ...... .....++.+.+
T Consensus 233 ~~---~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~l~~ 299 (681)
T 2pzi_A 233 SF---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV---------DGLPEDDPVLKTYDSYGR 299 (681)
T ss_dssp CC---SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC---------SSCCTTCHHHHHCHHHHH
T ss_pred cC---CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc---------ccccccccccccCHHHHH
Confidence 42 4567999999999998654 8899999999999999999998875211 000000 00123578999
Q ss_pred HHHHccccCCCCCC-CHHHHHHHHHhhhhhh
Q 020016 259 LISRCWSSSPDRRP-HFDQIVSILEGYSESL 288 (332)
Q Consensus 259 li~~cl~~dp~~Rp-s~~ell~~L~~~~~~~ 288 (332)
||.+||+.||.+|| +++++.+.|..+....
T Consensus 300 li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 300 LLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp HHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred HHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 99999999999999 6778888887765443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=270.33 Aligned_cols=194 Identities=22% Similarity=0.359 Sum_probs=154.4
Q ss_pred cCCeeee-eeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHH-HcCCCCceec---------
Q 020016 54 MSQLFIG-CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALL-FRLNHPHIIT--------- 120 (332)
Q Consensus 54 ~~~y~i~-~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~--------- 120 (332)
.++|.+. +.||+|+||.||+|.+. ++.||||++... ..+.+|+.++ +.++||||++
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 84 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLY 84 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----------HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence 3678877 78999999999999995 789999999752 3466788887 6669999986
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC---CCeEEEeec
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DMCVKVADF 172 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~---~~~~kl~Df 172 (332)
....+++..++.++.|++.||.|||++|++||||||+||+++. ++.++|+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 2246899999999999999999999999999999999999998 789999999
Q ss_pred ccccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--CCCCCC-
Q 020016 173 GISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN--ARPPVP- 249 (332)
Q Consensus 173 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~--~~~~~~- 249 (332)
|++.... +..++.++||||||+++|+|++|..||................ .....+
T Consensus 165 g~a~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (299)
T 3m2w_A 165 GFAKETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223 (299)
T ss_dssp TTCEECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred ccccccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence 9885432 2346778999999999999999999998755433221111111 111222
Q ss_pred ---CCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 250 ---PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 250 ---~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..+++++.+++.+||+.||.+|||+.++++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 568999999999999999999999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=276.22 Aligned_cols=217 Identities=15% Similarity=0.121 Sum_probs=164.4
Q ss_pred cccCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhH--HHHHHHHHHHHHHHHHHcCC---------CCcee-
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDAS--LASMLEKQFTSEVALLFRLN---------HPHII- 119 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~---------h~niv- 119 (332)
++.++|.+.+.||+|+||+||+|.++++.||||++........ ......+.+.+|+.+++.++ |||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 4457899999999999999999999999999999987532100 00001255778888888875 44442
Q ss_pred ----------------c----------------------------------------CCCCCCHHHHHHHHHHHHHHHHH
Q 020016 120 ----------------T----------------------------------------EPYSVPLNLVLKLALDIARGMQY 143 (332)
Q Consensus 120 ----------------~----------------------------------------~~~~l~~~~~~~i~~qi~~~L~~ 143 (332)
+ ....+++..+..++.||+.||.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 1 22457999999999999999999
Q ss_pred HH-HCCCccccccccceeecCCC--------------------eEEEeecccccccccCCCCCCcccccccCChhhhhcC
Q 020016 144 LH-SQGILHRDLKSENLLLGEDM--------------------CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK 202 (332)
Q Consensus 144 LH-~~~iiH~dlkp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 202 (332)
|| ++||+||||||+|||++.++ .+||+|||+++.... ....||+.|+|||++.+.
T Consensus 177 lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~~g~ 252 (336)
T 2vuw_A 177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLFTGD 252 (336)
T ss_dssp HHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGGCCC
T ss_pred HHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhhcCC
Confidence 99 99999999999999999887 999999999976553 245799999999999876
Q ss_pred CCCCccchhHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHhcCCCC-C----CCCCCcHHHHHHHHHccccCCCCCCCHH
Q 020016 203 RHTKKVDVYSFGIV-LWELLTALTPFDNMTP-EQAAFAVCQKNARP-P----VPPTCPKAFSYLISRCWSSSPDRRPHFD 275 (332)
Q Consensus 203 ~~~~~sDvwSlG~i-l~elltG~~pf~~~~~-~~~~~~~~~~~~~~-~----~~~~~~~~l~~li~~cl~~dp~~Rps~~ 275 (332)
. +.++||||++++ .+++++|..||..... ......+....... . .+..+++++.+||.+||+.| |+.
T Consensus 253 ~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~ 326 (336)
T 2vuw_A 253 G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT 326 (336)
T ss_dssp S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence 6 889999998777 7778889999854211 11222222111111 1 12346889999999999976 888
Q ss_pred HHH
Q 020016 276 QIV 278 (332)
Q Consensus 276 ell 278 (332)
+++
T Consensus 327 e~l 329 (336)
T 2vuw_A 327 DLL 329 (336)
T ss_dssp HHH
T ss_pred HHH
Confidence 887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.8e-27 Score=228.27 Aligned_cols=158 Identities=15% Similarity=0.111 Sum_probs=105.2
Q ss_pred eecccCceEEEEEEEC--CeeEEEEEecCCCc----hhHHHHHHHHHHHHHHHHHHcC-CCCceec--------------
Q 020016 62 KFASGRHSRIYRGIYK--QRDVAIKLVSQPEE----DASLASMLEKQFTSEVALLFRL-NHPHIIT-------------- 120 (332)
Q Consensus 62 ~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~----~~~~~~~~~~~~~~E~~~l~~l-~h~niv~-------------- 120 (332)
..+.|+.|.+..++.. |+.||||++..... .....+...++|.+|+++|+++ .|+||++
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4567777777766553 89999999976422 2223344567899999999999 7999986
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-CCCC
Q 020016 121 --------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GSAK 185 (332)
Q Consensus 121 --------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~~~ 185 (332)
..+++++. .|+.||+.||.|+|++||+||||||+|||++.+|.+||+|||+++..... ....
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~ 397 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPT 397 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSH
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcccc
Confidence 55667664 48899999999999999999999999999999999999999999765443 3344
Q ss_pred CcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhC
Q 020016 186 GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA 223 (332)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG 223 (332)
..+||+.|+|||++.+ .+..++|+||+|++++++.++
T Consensus 398 t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 398 NLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp HHHHHHHHHHHHHC------------------CCCCTT
T ss_pred CceechhhccHHHhCC-CCCCcccccccccchhhhccc
Confidence 5789999999999875 467789999999988776544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8e-25 Score=212.84 Aligned_cols=169 Identities=17% Similarity=0.141 Sum_probs=126.2
Q ss_pred eeeeeecccCceEEEEEEECCeeEEEEEecCCCch--hHHHHHHHHHHHHHHHHHHcCCCCceec---------------
Q 020016 58 FIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEED--ASLASMLEKQFTSEVALLFRLNHPHIIT--------------- 120 (332)
Q Consensus 58 ~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~niv~--------------- 120 (332)
...+.||+|+||+||+|.+.++.+++|........ ........+.+.+|+.++++++||||+.
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 34679999999999999888999999987653322 1122333567899999999999999993
Q ss_pred -CCCCCCHHH----HHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC--------CCCc
Q 020016 121 -EPYSVPLNL----VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS--------AKGF 187 (332)
Q Consensus 121 -~~~~l~~~~----~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--------~~~~ 187 (332)
.-..-+... +..++.|++.||.|||++||+||||||+|||++. .+||+|||+++....... ....
T Consensus 419 E~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~ 496 (540)
T 3en9_A 419 SYINGKLAKDVIEDNLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAV 496 (540)
T ss_dssp ECCCSEEHHHHSTTCTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHH
T ss_pred ECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhh
Confidence 000011111 5689999999999999999999999999999998 999999999976544221 1356
Q ss_pred ccccccCChhhhhc--CCCCCccchhHHHHHHHHHHhCCCCCC
Q 020016 188 TGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFD 228 (332)
Q Consensus 188 ~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~pf~ 228 (332)
.||+.|+|||++.. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 497 ~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 497 LSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 79999999999987 567888999999998888888777764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=175.07 Aligned_cols=144 Identities=16% Similarity=0.161 Sum_probs=106.5
Q ss_pred CeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhH------------HHHHHHHHHHHHHHHHHcCCCCceec--
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDAS------------LASMLEKQFTSEVALLFRLNHPHIIT-- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~------------~~~~~~~~~~~E~~~l~~l~h~niv~-- 120 (332)
.|.+++.||+|+||.||+|.+. ++.||||+++....... ........+.+|+.+++.++|+++..
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~~~ 170 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 170 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCeEE
Confidence 3456699999999999999995 88999999975322110 00122467899999999998544432
Q ss_pred ------------CCCC---CCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCCC
Q 020016 121 ------------EPYS---VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK 185 (332)
Q Consensus 121 ------------~~~~---l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 185 (332)
.++. +.......++.|++.||.|||+.||+||||||+|||++ ++.++|+|||++..
T Consensus 171 ~~~~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~-------- 241 (282)
T 1zar_A 171 AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE-------- 241 (282)
T ss_dssp EEETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEE--------
T ss_pred eccceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE--------
Confidence 1111 33355678999999999999999999999999999999 99999999999852
Q ss_pred CcccccccCChhhhhc----------CCCCCccchhH
Q 020016 186 GFTGTYRWMAPEMIKE----------KRHTKKVDVYS 212 (332)
Q Consensus 186 ~~~gt~~y~aPE~~~~----------~~~~~~sDvwS 212 (332)
+..+.|||++.. ..+...+|+|.
T Consensus 242 ----~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 242 ----VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp ----TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 345688998853 33455556654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=7.3e-19 Score=155.12 Aligned_cols=121 Identities=14% Similarity=0.110 Sum_probs=91.8
Q ss_pred CeeeeeeecccCceEEEEEEE--CCee--EEEEEecCCCchhHH------------------HHHHHHHHHHHHHHHHcC
Q 020016 56 QLFIGCKFASGRHSRIYRGIY--KQRD--VAIKLVSQPEEDASL------------------ASMLEKQFTSEVALLFRL 113 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~--~~~~--vAvK~~~~~~~~~~~------------------~~~~~~~~~~E~~~l~~l 113 (332)
-|.+.+.||+|+||.||+|.+ .|+. ||||+++........ .......+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 377899999999999999998 5888 999998654211100 112234688999999998
Q ss_pred CCCceec--------------CC---C----C-------CCHHHHHHHHHHHHHHHHHHH-HCCCccccccccceeecCC
Q 020016 114 NHPHIIT--------------EP---Y----S-------VPLNLVLKLALDIARGMQYLH-SQGILHRDLKSENLLLGED 164 (332)
Q Consensus 114 ~h~niv~--------------~~---~----~-------l~~~~~~~i~~qi~~~L~~LH-~~~iiH~dlkp~NIll~~~ 164 (332)
.|+++.. .- + . .++..+..++.|++.+|.||| +.||+||||||.|||++.
T Consensus 128 ~~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~- 206 (258)
T 1zth_A 128 KEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID- 206 (258)
T ss_dssp HHTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS-
T ss_pred HhCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC-
Confidence 7765311 11 1 1 113367889999999999999 999999999999999998
Q ss_pred CeEEEeeccccccc
Q 020016 165 MCVKVADFGISCLE 178 (332)
Q Consensus 165 ~~~kl~Dfg~a~~~ 178 (332)
.++|+|||++...
T Consensus 207 -~~~liDFG~a~~~ 219 (258)
T 1zth_A 207 -KVYFIDMGQAVTL 219 (258)
T ss_dssp -SEEECCCTTCEET
T ss_pred -cEEEEECcccccC
Confidence 8999999998643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3.3e-16 Score=144.71 Aligned_cols=122 Identities=16% Similarity=0.155 Sum_probs=87.7
Q ss_pred CeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCch----------------hHHHHHHHHHHHHHHHHHHcCCCCce
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEED----------------ASLASMLEKQFTSEVALLFRLNHPHI 118 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~----------------~~~~~~~~~~~~~E~~~l~~l~h~ni 118 (332)
=|.+++.||.|++|.||+|.+. |+.||||+++..... .......+-...+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3899999999999999999986 899999998643111 01111112233567777777743332
Q ss_pred -------------ec-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC----------eEE
Q 020016 119 -------------IT-------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM----------CVK 168 (332)
Q Consensus 119 -------------v~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~----------~~k 168 (332)
|. ............++.|++.+|.+||+.||+||||||.|||++.+| .+.
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~ 255 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPI 255 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEE
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceE
Confidence 11 011122334667899999999999999999999999999998776 489
Q ss_pred Eeecccccc
Q 020016 169 VADFGISCL 177 (332)
Q Consensus 169 l~Dfg~a~~ 177 (332)
|+||+.+..
T Consensus 256 iID~~Q~V~ 264 (397)
T 4gyi_A 256 IIXFPQMVS 264 (397)
T ss_dssp ECCCTTCEE
T ss_pred EEEeCCccc
Confidence 999997743
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=3.3e-09 Score=92.83 Aligned_cols=116 Identities=14% Similarity=0.174 Sum_probs=85.1
Q ss_pred CCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCC----Cceec----------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH----PHIIT---------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~---------- 120 (332)
..|.+...++.|+.+.||++...++.+++|+........ ...+.+|+.++..+.. |.++.
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT------TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS------TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC------HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 468888899999999999998888999999987522111 1246788888887742 33331
Q ss_pred -----CCCCC-----CHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 020016 121 -----EPYSV-----PLNLVLKLALDIARGMQYLHS-------------------------------------------- 146 (332)
Q Consensus 121 -----~~~~l-----~~~~~~~i~~qi~~~L~~LH~-------------------------------------------- 146 (332)
.+..+ +......++.+++.+|..||+
T Consensus 88 v~e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 88 LMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp EEECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred EEEecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 11111 122345788999999999998
Q ss_pred ---------------CCCccccccccceeecCCCeEEEeeccccc
Q 020016 147 ---------------QGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 147 ---------------~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
..++|||++|.||+++.++.+.|+||+.+.
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876667799999763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.75 E-value=1.5e-08 Score=88.03 Aligned_cols=113 Identities=13% Similarity=0.039 Sum_probs=79.1
Q ss_pred CCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCce-ec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI-IT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~------------ 120 (332)
..|.+....+.|..+.||++... |+.++||+...... ..+.+|+.+++.+.+.++ +.
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~---------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~ 90 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 90 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcccc---------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence 45666544456667999999765 67899999865411 235678888887754343 22
Q ss_pred -------CCCCCC--HHHHHHHHHHHHHHHHHHHHCC-------------------------------------------
Q 020016 121 -------EPYSVP--LNLVLKLALDIARGMQYLHSQG------------------------------------------- 148 (332)
Q Consensus 121 -------~~~~l~--~~~~~~i~~qi~~~L~~LH~~~------------------------------------------- 148 (332)
.+..+. ......++.+++..|..||+..
T Consensus 91 ~~v~e~i~G~~l~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 91 WLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp EEEEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred EEEEEecCCcccCcCcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 122221 1123367888999999999753
Q ss_pred ---------------CccccccccceeecCCCeEEEeeccccc
Q 020016 149 ---------------ILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 149 ---------------iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
++|+|++|.||+++.++.+.|+||+.+.
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 8999999999999887777899999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.70 E-value=4.6e-08 Score=89.70 Aligned_cols=114 Identities=13% Similarity=0.194 Sum_probs=83.3
Q ss_pred eeeeecccCceEEEEEEECCeeEEEEEec--CCCchhHHHHHHHHHHHHHHHHHHcCCCCce-----ec-----------
Q 020016 59 IGCKFASGRHSRIYRGIYKQRDVAIKLVS--QPEEDASLASMLEKQFTSEVALLFRLNHPHI-----IT----------- 120 (332)
Q Consensus 59 i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~--~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~----------- 120 (332)
-.+.|+.|.++.||+....+..+++|+.. ...... ....+.+|+.++..+...++ +.
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~-----~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLP-----SAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC---------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCC-----cHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 46788999999999998888889999886 322111 12457789999988864322 21
Q ss_pred -------C--------CCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 020016 121 -------E--------PYSVPLNLVLKLALDIARGMQYLHS--------------------------------------- 146 (332)
Q Consensus 121 -------~--------~~~l~~~~~~~i~~qi~~~L~~LH~--------------------------------------- 146 (332)
. ...++......++.+++..|+.||+
T Consensus 117 ~~vme~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEEEECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEEEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 1 1234678889999999999999997
Q ss_pred -------------------CCCccccccccceeecCCC--eEEEeecccccc
Q 020016 147 -------------------QGILHRDLKSENLLLGEDM--CVKVADFGISCL 177 (332)
Q Consensus 147 -------------------~~iiH~dlkp~NIll~~~~--~~kl~Dfg~a~~ 177 (332)
.+++|||+++.||+++.++ .+.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 3589999999999998775 368999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.59 E-value=3.1e-08 Score=88.76 Aligned_cols=154 Identities=19% Similarity=0.286 Sum_probs=100.2
Q ss_pred eeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCc-----eec--------------
Q 020016 61 CKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPH-----IIT-------------- 120 (332)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n-----iv~-------------- 120 (332)
+.++.|..+.||+.. ..+++|+.... . ....+.+|+.+|..+ .+.. ++.
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~---~-----~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS---R-----GSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH---H-----HHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc---c-----hHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 458999999999873 67999986542 1 135678899999877 3322 221
Q ss_pred ----CCC--------CCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 020016 121 ----EPY--------SVPLNLVLKLALDIARGMQYLHS------------------------------------------ 146 (332)
Q Consensus 121 ----~~~--------~l~~~~~~~i~~qi~~~L~~LH~------------------------------------------ 146 (332)
.+. .++......++.+++..|+.||+
T Consensus 95 m~~i~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp EECCCCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred EcccCCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 111 23455567899999999999996
Q ss_pred ----------------CCCccccccccceeecC--CCeEEEeecccccccccCCC---CCCc------------cccccc
Q 020016 147 ----------------QGILHRDLKSENLLLGE--DMCVKVADFGISCLESQCGS---AKGF------------TGTYRW 193 (332)
Q Consensus 147 ----------------~~iiH~dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~---~~~~------------~gt~~y 193 (332)
..++|+|++|.||+++. .+.+.|+||+.+........ .... ....+.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 13699999999999998 56789999998754322100 0000 000111
Q ss_pred CC-hhhhhcCCCCCccchhHHHHHHHHHHhCCCCC
Q 020016 194 MA-PEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 227 (332)
Q Consensus 194 ~a-PE~~~~~~~~~~sDvwSlG~il~elltG~~pf 227 (332)
.. |+..... ....+.|+++.++|.+.+|..+|
T Consensus 255 ~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 12 2222111 22368999999999999998775
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00021 Score=60.00 Aligned_cols=132 Identities=10% Similarity=0.080 Sum_probs=87.8
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccccccceeecCCCeEEEeecccccccccCCCCCCcccccccCChhhh
Q 020016 121 EPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI 199 (332)
Q Consensus 121 ~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 199 (332)
.+.+++++++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.|.+.+ +.+. .....+.|||..
T Consensus 42 ~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~~~~~pe~~ 109 (229)
T 2yle_A 42 YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEPPPVAGKLG 109 (229)
T ss_dssp HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------------CCS
T ss_pred cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------ccccCCCChhhc
Confidence 56789999999999999999877632 1212333457899999999887764 1110 112345577765
Q ss_pred hcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHcccc-------------
Q 020016 200 KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS------------- 266 (332)
Q Consensus 200 ~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~------------- 266 (332)
. ...+.+.=|||||+++|..+- -+.....+..+|+.|..||..|...
T Consensus 110 ~-~~~te~~~IysLG~tLY~ALD-------------------ygL~e~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~ 169 (229)
T 2yle_A 110 Y-SQCMETEVIESLGIIIYKALD-------------------YGLKENEERELSPPLEQLIDHMANTVEADGSNDEGYEA 169 (229)
T ss_dssp S-SSSCHHHHHHHHHHHHHHHHT-------------------TTCCTTEEECCCHHHHHHHHHHTTCCC-----------
T ss_pred c-ccchHHHHHHHHHHHHHHHhh-------------------cCCCcccchhhCHHHHHHHHHHHhcccccccccccccc
Confidence 3 344678899999999998763 2334445567899999999999765
Q ss_pred ------------CCCCCCCHHHHHHHHHhh
Q 020016 267 ------------SPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 267 ------------dp~~Rps~~ell~~L~~~ 284 (332)
.+..|+++.+|++.-+.-
T Consensus 170 ~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~h 199 (229)
T 2yle_A 170 AEEGLGDEDEKRKISAIRSYRDVMKLCAAH 199 (229)
T ss_dssp ---------CCSCCCCCCSHHHHHHHHHTT
T ss_pred cccccccccccccccCcCCHHHHHHHHHhh
Confidence 235778888887766653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00014 Score=64.87 Aligned_cols=107 Identities=19% Similarity=0.205 Sum_probs=75.7
Q ss_pred eeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCC------ceec-------------
Q 020016 60 GCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP------HIIT------------- 120 (332)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~------------- 120 (332)
.+.++.|....||+. +..++||+.... . ....+.+|+.+|..+.+. .++.
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~~---~-----~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~ 92 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKSQ---Q-----GADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGY 92 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESSH---H-----HHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEE
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCCc---h-----HHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEE
Confidence 346788999999998 788999985321 1 135688999999998642 2111
Q ss_pred ---CC--------CCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------------
Q 020016 121 ---EP--------YSVPLNLVLKLALDIARGMQYLHSQ------------------------------------------ 147 (332)
Q Consensus 121 ---~~--------~~l~~~~~~~i~~qi~~~L~~LH~~------------------------------------------ 147 (332)
.+ ..++......++.++...|+.||+.
T Consensus 93 e~i~G~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 93 RKVQGQILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp ECCCSEECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eccCCeECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 11 1234556677788888888888753
Q ss_pred ------------------CCccccccccceeecC---CCe-EEEeecccccc
Q 020016 148 ------------------GILHRDLKSENLLLGE---DMC-VKVADFGISCL 177 (332)
Q Consensus 148 ------------------~iiH~dlkp~NIll~~---~~~-~kl~Dfg~a~~ 177 (332)
.++|+|+.+.||+++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2489999999999987 344 58999997754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0035 Score=56.09 Aligned_cols=30 Identities=30% Similarity=0.438 Sum_probs=26.9
Q ss_pred CCCccccccccceeecCCCeEEEeeccccc
Q 020016 147 QGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 147 ~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
.+++|||+.+.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00037 Score=64.42 Aligned_cols=30 Identities=23% Similarity=0.382 Sum_probs=25.0
Q ss_pred CCCccccccccceeecCCCeEEEeecccccc
Q 020016 147 QGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 147 ~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
..++|||+.+.||+++.+ .+.++||..+..
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 358999999999999876 489999987643
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0011 Score=58.31 Aligned_cols=54 Identities=13% Similarity=0.094 Sum_probs=40.0
Q ss_pred CCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN 114 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 114 (332)
.+..-.+.+|.|..+.||+.... |+.|.||+........ ...|..|+..|+.|.
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~------~~~~~~Ea~~L~~L~ 69 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL------DGLFRAEALGLDWLG 69 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC------TTHHHHHHHHHHHHT
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch------hhHHHHHHHHHHHHH
Confidence 34556788999999999999986 7899999876543221 134677888888773
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0015 Score=57.80 Aligned_cols=106 Identities=15% Similarity=0.215 Sum_probs=68.9
Q ss_pred eeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCC----Cceec--------------C
Q 020016 60 GCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH----PHIIT--------------E 121 (332)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~--------------~ 121 (332)
.+.|+.|....+|+. ..+++|+........ ....+|+.++..+.. |.++. .
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~-------~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEY-------INRANEAVAAREAAKAGVSPEVLHVDPATGVMVTRYIAG 91 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----C-------CCHHHHHHHHHHHHHTTSSCCEEEECTTTCCEEEECCTT
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccce-------eCHHHHHHHHHHHHHcCCCCceEEEECCCCEEEEeecCC
Confidence 678889999999998 678999887532111 012346655555421 44332 2
Q ss_pred CCCCCHHHHH---HHHHHHHHHHHHHHHCC--------------------------------------------------
Q 020016 122 PYSVPLNLVL---KLALDIARGMQYLHSQG-------------------------------------------------- 148 (332)
Q Consensus 122 ~~~l~~~~~~---~i~~qi~~~L~~LH~~~-------------------------------------------------- 148 (332)
...++..... .++.+++..|+-||+.+
T Consensus 92 g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~ 171 (301)
T 3dxq_A 92 AQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPL 171 (301)
T ss_dssp CEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCC
T ss_pred CccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCC
Confidence 2234443333 26777888888888532
Q ss_pred ---CccccccccceeecCCCeEEEeecccccc
Q 020016 149 ---ILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 149 ---iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 589999999999 5567789999987753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0016 Score=56.49 Aligned_cols=106 Identities=22% Similarity=0.193 Sum_probs=69.2
Q ss_pred eecccCce-EEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCC----Cceec--------------
Q 020016 62 KFASGRHS-RIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH----PHIIT-------------- 120 (332)
Q Consensus 62 ~lg~G~~g-~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~-------------- 120 (332)
.+..|..| .||+.... +..+++|+..... ...+.+|..+|+.+.. |.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~---------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~ 101 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV---------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTA 101 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHH---------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCC---------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEe
Confidence 34456555 69988765 5689999876421 2456788888887742 33332
Q ss_pred -CCCC------CCHHHHHHHHHHHHHHHHHHHHC----------------------------------------------
Q 020016 121 -EPYS------VPLNLVLKLALDIARGMQYLHSQ---------------------------------------------- 147 (332)
Q Consensus 121 -~~~~------l~~~~~~~i~~qi~~~L~~LH~~---------------------------------------------- 147 (332)
.+.. ........+..+++..|..||+.
T Consensus 102 l~G~~~~~~~~~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 102 IPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp CCSEEHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred eCCccccccccCCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 0000 01123345666777777777731
Q ss_pred ------------CCccccccccceeecCCCeEEEeeccccc
Q 020016 148 ------------GILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 148 ------------~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
.++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 16899999999999988878899999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0053 Score=55.55 Aligned_cols=29 Identities=24% Similarity=0.272 Sum_probs=24.9
Q ss_pred CCccccccccceeecCCCeEEEeeccccc
Q 020016 148 GILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 148 ~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
.++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 223 ~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 223 VLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp EEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred eEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 57999999999999965568999999874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.83 E-value=0.002 Score=57.46 Aligned_cols=29 Identities=31% Similarity=0.598 Sum_probs=25.5
Q ss_pred CCccccccccceeecCCCeEEEeeccccc
Q 020016 148 GILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 148 ~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 68999999999999987767899998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.86 E-value=0.01 Score=53.95 Aligned_cols=28 Identities=25% Similarity=0.424 Sum_probs=23.7
Q ss_pred CCccccccccceeecCCCeEEEeeccccc
Q 020016 148 GILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 148 ~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
.++|+|+.+.||+++.++ +.|+||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 489999999999998655 8999998774
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.66 E-value=0.044 Score=48.84 Aligned_cols=46 Identities=22% Similarity=0.169 Sum_probs=35.5
Q ss_pred eeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC
Q 020016 59 IGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL 113 (332)
Q Consensus 59 i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 113 (332)
-.+.|+.|....+|+....+..++||+..... ...+..|+..|+.|
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~---------~~~~~~E~~~L~~L 85 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERSY---------RSMFRAEADQLALL 85 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGGG---------HHHHHHHHHHHHHH
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCccc---------HHHHHHHHHHHHHH
Confidence 35678999999999998878899999976531 24567787777776
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.54 E-value=0.053 Score=50.56 Aligned_cols=47 Identities=15% Similarity=0.275 Sum_probs=32.4
Q ss_pred eeeecccCceEEEEEEEC---------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC
Q 020016 60 GCKFASGRHSRIYRGIYK---------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN 114 (332)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 114 (332)
.+.|+.|....||+.... ++.+++|+...... ...+.+|..++..|.
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--------~~~li~E~~~l~~L~ 133 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--------ESHLVAESVIFTLLS 133 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--------HHHHHHHHHHHHHHH
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--------HHHHHHHHHHHHHHH
Confidence 457888999999999874 46899999854211 022346777777663
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.28 E-value=0.063 Score=50.50 Aligned_cols=52 Identities=12% Similarity=0.024 Sum_probs=33.0
Q ss_pred eeeecccCceEEEEEEECC--eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCce
Q 020016 60 GCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI 118 (332)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 118 (332)
.+.|+.|-...+|+....+ ..+++|+......... .-.+|..++..|...++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-------dR~~E~~vl~~L~~~gl 166 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-------NREREKKISCILYNKNI 166 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-------CHHHHHHHHHHHTTSSS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-------CHHHHHHHHHHHHhcCC
Confidence 4578889999999999876 8899999854321110 01367777777754333
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.22 E-value=0.041 Score=50.43 Aligned_cols=30 Identities=27% Similarity=0.400 Sum_probs=26.2
Q ss_pred CCccccccccceeecCC----CeEEEeecccccc
Q 020016 148 GILHRDLKSENLLLGED----MCVKVADFGISCL 177 (332)
Q Consensus 148 ~iiH~dlkp~NIll~~~----~~~kl~Dfg~a~~ 177 (332)
.++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 48999999999999876 7899999998753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.74 E-value=0.019 Score=53.26 Aligned_cols=33 Identities=24% Similarity=0.430 Sum_probs=28.0
Q ss_pred HHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 145 HSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 145 H~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
+...++|||+++.||+++.++ +.|+||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 345799999999999998876 999999987543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.10 E-value=0.088 Score=48.95 Aligned_cols=29 Identities=28% Similarity=0.485 Sum_probs=25.6
Q ss_pred CCccccccccceeecCCCeEEEeecccccc
Q 020016 148 GILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 148 ~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
.++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 4799999999999 7788999999998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.00 E-value=0.11 Score=45.94 Aligned_cols=29 Identities=24% Similarity=0.143 Sum_probs=24.7
Q ss_pred CCCccccccccceeecCCCeEEEeecccccc
Q 020016 147 QGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 147 ~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
..++|||+++.||+++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 3589999999999998 4 899999987643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=91.28 E-value=0.084 Score=47.02 Aligned_cols=31 Identities=35% Similarity=0.425 Sum_probs=26.8
Q ss_pred CCCccccccccceeecCC----CeEEEeecccccc
Q 020016 147 QGILHRDLKSENLLLGED----MCVKVADFGISCL 177 (332)
Q Consensus 147 ~~iiH~dlkp~NIll~~~----~~~kl~Dfg~a~~ 177 (332)
..++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 369999999999999874 6899999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=90.84 E-value=0.13 Score=46.16 Aligned_cols=30 Identities=23% Similarity=0.494 Sum_probs=26.7
Q ss_pred CCccccccccceeecCCCeEEEeecccccc
Q 020016 148 GILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 148 ~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
.++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 589999999999999888899999987644
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.47 E-value=0.057 Score=50.87 Aligned_cols=56 Identities=11% Similarity=-0.057 Sum_probs=13.8
Q ss_pred eeeeeecccCceEEEEEEECC--eeEEE------EEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec
Q 020016 58 FIGCKFASGRHSRIYRGIYKQ--RDVAI------KLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120 (332)
Q Consensus 58 ~i~~~lg~G~~g~Vy~~~~~~--~~vAv------K~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 120 (332)
.+.+.|| ||.||+|.+.+ .+||| |...... ........|.+|..++..++|||+++
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~----~~~e~~~~~~rea~l~~~~~H~niv~ 208 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDG----VSEKRLTSLVRRATLKENEQIPKYEK 208 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC---------------------------------------CB
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCcccccccc----ccccccccccccccccccccccccCC
Confidence 4556776 99999999974 58888 5544321 12222456888999999999999987
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=82.88 E-value=0.52 Score=43.25 Aligned_cols=29 Identities=31% Similarity=0.450 Sum_probs=24.6
Q ss_pred Cccccccccceee------cCCCeEEEeecccccc
Q 020016 149 ILHRDLKSENLLL------GEDMCVKVADFGISCL 177 (332)
Q Consensus 149 iiH~dlkp~NIll------~~~~~~kl~Dfg~a~~ 177 (332)
++|+|+.+.||++ ++++.+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 3456799999998754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 332 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-58 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-49 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-48 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-45 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-44 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-44 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-34 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-31 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-30 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-28 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-13 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 8e-63
Identities = 78/281 (27%), Positives = 133/281 (47%), Gaps = 43/281 (15%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEV 107
++W Q+ +G + SG +Y+G + DVA+K+++ + F +EV
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH-GDVAVKMLNVTAPTPQQ----LQAFKNEV 55
Query: 108 ALLFRLNHPHIIT----------------------------EPYSVPLNLVLKLALDIAR 139
+L + H +I+ + ++ +A A+
Sbjct: 56 GVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 115
Query: 140 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAP 196
GM YLH++ I+HRDLKS N+ L ED+ VK+ DFG++ + S + +G+ WMAP
Sbjct: 116 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 197 EMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP----VP 249
E+I+ + ++ + DVY+FGIVL+EL+T P+ N+ + + P V
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235
Query: 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 290
CPKA L++ C D RP F QI++ +E + SL +
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 6e-58
Identities = 64/264 (24%), Positives = 110/264 (41%), Gaps = 41/264 (15%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVAL 109
W+ +M +L + G + G Y+ VA+K + + F +E ++
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASV 53
Query: 110 LFRLNHPHIIT-------------------------------EPYSVPLNLVLKLALDIA 138
+ +L H +++ + + +LK +LD+
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 139 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEM 198
M+YL +HRDL + N+L+ ED KV+DFG++ S + +W APE
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--TQDTGKLPVKWTAPEA 171
Query: 199 IKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 258
++EK+ + K DV+SFGI+LWE+ + P + +K + P CP A
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231
Query: 259 LISRCWSSSPDRRPHFDQIVSILE 282
++ CW RP F Q+ LE
Sbjct: 232 VMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 9e-58
Identities = 70/275 (25%), Positives = 120/275 (43%), Gaps = 39/275 (14%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTS 105
E+EW L + + +G+ ++ G Y VA+K + Q SM F +
Sbjct: 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-------GSMSPDAFLA 57
Query: 106 EVALLFRLNHPHIIT-----------------------------EPYSVPLNLVLKLALD 136
E L+ +L H ++ + +N +L +A
Sbjct: 58 EANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 137 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWM 194
IA GM ++ + +HRDL++ N+L+ + + K+ADFG++ L +++ + +G +W
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 195 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254
APE I T K DV+SFGI+L E++T ++ R P CP+
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237
Query: 255 AFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289
L+ CW P+ RP FD + S+LE + + E
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-55
Identities = 73/282 (25%), Positives = 121/282 (42%), Gaps = 39/282 (13%)
Query: 44 GEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-RDVAIKLVSQPEEDASLASMLEKQ 102
G ++ W L + K G ++ G + VAIK + +M +
Sbjct: 6 GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-------GTMSPEA 58
Query: 103 FTSEVALLFRLNHPHIIT-----------------------------EPYSVPLNLVLKL 133
F E ++ +L H ++ + L ++ +
Sbjct: 59 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 118
Query: 134 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTY 191
A IA GM Y+ +HRDL++ N+L+GE++ KVADFG++ L +++ + +G
Sbjct: 119 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 178
Query: 192 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 251
+W APE R T K DV+SFGI+L EL T + ++ R P PP
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 238
Query: 252 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPE 293
CP++ L+ +CW P+ RP F+ + + LE Y S E +
Sbjct: 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-52
Identities = 65/269 (24%), Positives = 117/269 (43%), Gaps = 43/269 (15%)
Query: 62 KFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH 117
+ G + +G+Y+ Q DVAIK++ Q E A ++ E ++ +L++P+
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-----EEMMREAQIMHQLDNPY 70
Query: 118 IIT----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGI 149
I+ + +P++ V +L ++ GM+YL +
Sbjct: 71 IVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 130
Query: 150 LHRDLKSENLLLGEDMCVKVADFGISCL----ESQCGSAKGFTGTYRWMAPEMIKEKRHT 205
+HRDL + N+LL K++DFG+S +S + +W APE I ++ +
Sbjct: 131 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 190
Query: 206 KKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 264
+ DV+S+G+ +WE L+ P+ M + + ++ R PP CP L+S CW
Sbjct: 191 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPPECPPELYALMSDCW 249
Query: 265 SSSPDRRPHFDQIVSILEGYSESLEQDPE 293
+ RP F + + SL E
Sbjct: 250 IYKWEDRPDFLTVEQRMRACYYSLASKVE 278
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-52
Identities = 64/267 (23%), Positives = 115/267 (43%), Gaps = 39/267 (14%)
Query: 53 DMSQLFIGCKFASGRHSRIYRGIYKQRD-VAIKLVSQPEEDASLASMLEKQFTSEVALLF 111
D S+L + SG+ ++ G + +D VAIK + + +M E+ F E ++
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-------GAMSEEDFIEEAEVMM 55
Query: 112 RLNHPHIIT-----------------------------EPYSVPLNLVLKLALDIARGMQ 142
+L+HP ++ + +L + LD+ GM
Sbjct: 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 143 YLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIK 200
YL ++HRDL + N L+GE+ +KV+DFG++ + Q S+ G +W +PE+
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 201 EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 260
R++ K DV+SFG+++WE+ + R P ++
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM 235
Query: 261 SRCWSSSPDRRPHFDQIVSILEGYSES 287
+ CW P+ RP F +++ L +ES
Sbjct: 236 NHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 6e-52
Identities = 64/261 (24%), Positives = 112/261 (42%), Gaps = 38/261 (14%)
Query: 49 EWSADMSQLFIGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSE 106
+W+ + IG G+ +Y KQ +A+K++ + + + + +E Q E
Sbjct: 2 QWA--LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA---GVEHQLRRE 56
Query: 107 VALLFRLNHPHII---------TEPYSV-------------------PLNLVLKLALDIA 138
V + L HP+I+ T Y + ++A
Sbjct: 57 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 116
Query: 139 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEM 198
+ Y HS+ ++HRD+K ENLLLG +K+ADFG S + GT ++ PEM
Sbjct: 117 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTLCGTLDYLPPEM 175
Query: 199 IKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 258
I+ + H +KVD++S G++ +E L PF+ T ++ + P +
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARD 233
Query: 259 LISRCWSSSPDRRPHFDQIVS 279
LISR +P +RP +++
Sbjct: 234 LISRLLKHNPSQRPMLREVLE 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-51
Identities = 59/254 (23%), Positives = 110/254 (43%), Gaps = 41/254 (16%)
Query: 65 SGRHSRIYRGIYKQ----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
SG + +G Y+ + VA+K++ D +L + + +E ++ +L++P+I+
Sbjct: 17 SGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL----KDELLAEANVMQQLDNPYIVR 72
Query: 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRD 153
+ V +++L ++ GM+YL +HRD
Sbjct: 73 MIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 132
Query: 154 LKSENLLLGEDMCVKVADFGISCL----ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVD 209
L + N+LL K++DFG+S E+ + +W APE I + + K D
Sbjct: 133 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSD 192
Query: 210 VYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 268
V+SFG+++WE + P+ M + + +K R P CP+ L++ CW+
Sbjct: 193 VWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-EKGERMGCPAGCPREMYDLMNLCWTYDV 251
Query: 269 DRRPHFDQIVSILE 282
+ RP F + L
Sbjct: 252 ENRPGFAAVELRLR 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (430), Expect = 2e-51
Identities = 70/279 (25%), Positives = 124/279 (44%), Gaps = 42/279 (15%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTS 105
++W + + + + K G++ +Y G++K+ VA+K + + +M ++F
Sbjct: 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-------DTMEVEEFLK 62
Query: 106 EVALLFRLNHPHII------------------------------TEPYSVPLNLVLKLAL 135
E A++ + HP+++ V ++L +A
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 136 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRW 193
I+ M+YL + +HRDL + N L+GE+ VKVADFG+S L + G +W
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182
Query: 194 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 253
APE + + + K DV++FG++LWE+ T + + +K+ R P CP
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 242
Query: 254 KAFSYLISRCWSSSPDRRPHFDQIVSILEG-YSESLEQD 291
+ L+ CW +P RP F +I E + ES D
Sbjct: 243 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-50
Identities = 62/263 (23%), Positives = 114/263 (43%), Gaps = 41/263 (15%)
Query: 53 DMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLF 111
D L + +G+ + G ++ Q DVAIK++ + SM E +F E ++
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-------GSMSEDEFIEEAKVMM 54
Query: 112 RLNHPHIIT-----------------------------EPYSVPLNLVLKLALDIARGMQ 142
L+H ++ + +L++ D+ M+
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 114
Query: 143 YLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIK 200
YL S+ LHRDL + N L+ + VKV+DFG+S + + S+ G RW PE++
Sbjct: 115 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174
Query: 201 EKRHTKKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 259
+ + K D+++FG+++WE+ + P++ T + A + Q R P + +
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTI 233
Query: 260 ISRCWSSSPDRRPHFDQIVSILE 282
+ CW D RP F ++S +
Sbjct: 234 MYSCWHEKADERPTFKILLSNIL 256
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (424), Expect = 3e-50
Identities = 63/248 (25%), Positives = 97/248 (39%), Gaps = 39/248 (15%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120
G +Y + VAIK +S ++ + EV L +L HP+ I
Sbjct: 25 HGSFGAVYFARDVRNSEVVAIKKMSY---SGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 121 -------EPYSV-------------------PLNLVLKLALDIARGMQYLHSQGILHRDL 154
+ V + + +G+ YLHS ++HRD+
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDV 141
Query: 155 KSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI---KEKRHTKKVDVY 211
K+ N+LL E VK+ DFG + + + S F GT WMAPE+I E ++ KVDV+
Sbjct: 142 KAGNILLSEPGLVKLGDFGSASIMAPANS---FVGTPYWMAPEVILAMDEGQYDGKVDVW 198
Query: 212 SFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 271
S GI EL P NM A + + Q + + F + C P R
Sbjct: 199 SLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 258
Query: 272 PHFDQIVS 279
P + ++
Sbjct: 259 PTSEVLLK 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 3e-50
Identities = 63/274 (22%), Positives = 117/274 (42%), Gaps = 46/274 (16%)
Query: 65 SGRHSRIYRGIYKQRD------VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI 118
SG +Y+G++ VAIK + + + K+ E ++ +++PH+
Sbjct: 19 SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-----NKEILDEAYVMASVDNPHV 73
Query: 119 IT----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGIL 150
++ +L + IA+GM YL + ++
Sbjct: 74 CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLV 133
Query: 151 HRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 207
HRDL + N+L+ VK+ DFG++ L E + A+G +WMA E I + +T +
Sbjct: 134 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 193
Query: 208 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 267
DV+S+G+ +WEL+T + + P ++ +K R P PP C ++ +CW
Sbjct: 194 SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 253
Query: 268 PDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPS 301
D RP F +++ + +DP+ +
Sbjct: 254 ADSRPKFRELIIEF----SKMARDPQRYLVIQGD 283
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-49
Identities = 53/244 (21%), Positives = 104/244 (42%), Gaps = 37/244 (15%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120
G +Y + ++VAI+ ++ ++ ++ +E+ ++ +P+I+
Sbjct: 30 QGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYL 83
Query: 121 -------EPYSV------------------PLNLVLKLALDIARGMQYLHSQGILHRDLK 155
E + V + + + + +++LHS ++HRD+K
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 156 SENLLLGEDMCVKVADFGISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFG 214
S+N+LLG D VK+ DFG + S GT WMAPE++ K + KVD++S G
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203
Query: 215 IVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYLISRCWSSSPDRRPH 273
I+ E++ P+ N P +A + + P F ++RC ++R
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS 263
Query: 274 FDQI 277
++
Sbjct: 264 AKEL 267
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-49
Identities = 70/272 (25%), Positives = 111/272 (40%), Gaps = 47/272 (17%)
Query: 65 SGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI 118
+G +Y+G+ K + VAIK + + F E ++ + +H +I
Sbjct: 17 AGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ-----RVDFLGEAGIMGQFSHHNI 71
Query: 119 IT-----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGI 149
I + + ++ + IA GM+YL +
Sbjct: 72 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY 131
Query: 150 LHRDLKSENLLLGEDMCVKVADFGISCL----ESQCGSAKGFTGTYRWMAPEMIKEKRHT 205
+HRDL + N+L+ ++ KV+DFG+S + + G RW APE I ++ T
Sbjct: 132 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 191
Query: 206 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 265
DV+SFGIV+WE++T R P P CP A L+ +CW
Sbjct: 192 SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQ 251
Query: 266 SSPDRRPHFDQIVSILEGY---SESLEQDPEF 294
RRP F IVSIL+ +SL+ +F
Sbjct: 252 QERARRPKFADIVSILDKLIRAPDSLKTLADF 283
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-49
Identities = 66/269 (24%), Positives = 114/269 (42%), Gaps = 40/269 (14%)
Query: 49 EWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEKQF 103
++ ++ +G G+ +++GIY + VAIK D+ + ++F
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS-----VREKF 55
Query: 104 TSEVALLFRLNHPHIIT----------------------------EPYSVPLNLVLKLAL 135
E + + +HPHI+ YS+ L ++ A
Sbjct: 56 LQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 115
Query: 136 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK--GFTGTYRW 193
++ + YL S+ +HRD+ + N+L+ + CVK+ DFG+S K +W
Sbjct: 116 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 175
Query: 194 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 253
MAPE I +R T DV+ FG+ +WE+L + R P+PP CP
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 235
Query: 254 KAFSYLISRCWSSSPDRRPHFDQIVSILE 282
L+++CW+ P RRP F ++ + L
Sbjct: 236 PTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 5e-49
Identities = 61/262 (23%), Positives = 100/262 (38%), Gaps = 41/262 (15%)
Query: 59 IGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEKQFTSEVALLFRL 113
+ K G + RG + VA+K + D F EV + L
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK---PDVLSQPEAMDDFIREVNAMHSL 68
Query: 114 NHPHIIT----------------------------EPYSVPLNLVLKLALDIARGMQYLH 145
+H ++I L + + A+ +A GM YL
Sbjct: 69 DHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 146 SQGILHRDLKSENLLLGEDMCVKVADFGISCL----ESQCGSAKGFTGTYRWMAPEMIKE 201
S+ +HRDL + NLLL VK+ DFG+ + + + W APE +K
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 202 KRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 260
+ + D + FG+ LWE+ T P+ + Q + ++ R P P CP+ ++
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVM 248
Query: 261 SRCWSSSPDRRPHFDQIVSILE 282
+CW+ P+ RP F + L
Sbjct: 249 VQCWAHKPEDRPTFVALRDFLL 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 7e-49
Identities = 55/257 (21%), Positives = 97/257 (37%), Gaps = 44/257 (17%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
I + G ++Y+ K+ A K++ E+ + + E+ +L +HP
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE------LEDYMVEIDILASCDHP 69
Query: 117 HIIT---------EPYSV--------------------PLNLVLKLALDIARGMQYLHSQ 147
+I+ + + + + + + YLH
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 148 GILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMI-----KE 201
I+HRDLK+ N+L D +K+ADFG+S F GT WMAPE++ K+
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189
Query: 202 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYLI 260
+ + K DV+S GI L E+ P + P + + + P F +
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 249
Query: 261 SRCWSSSPDRRPHFDQI 277
+C + D R Q+
Sbjct: 250 KKCLEKNVDARWTTSQL 266
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 163 bits (414), Expect = 7e-49
Identities = 73/274 (26%), Positives = 121/274 (44%), Gaps = 47/274 (17%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEKQFT 104
D+S + I +G + G K VAIK + + + F
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-----KSGYTEKQRRDFL 75
Query: 105 SEVALLFRLNHPHII---------TEPYSV--------------------PLNLVLKLAL 135
SE +++ + +HP++I T + + ++ +
Sbjct: 76 SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR 135
Query: 136 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS------AKGFTG 189
IA GM+YL +HRDL + N+L+ ++ KV+DFG+S S A G
Sbjct: 136 GIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 195
Query: 190 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 248
RW APE I+ ++ T DV+S+GIV+WE+++ P+ +MT + A+ +++ R P
Sbjct: 196 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI-EQDYRLPP 254
Query: 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
P CP A L+ CW + RP F QIV+ L+
Sbjct: 255 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-48
Identities = 56/262 (21%), Positives = 103/262 (39%), Gaps = 47/262 (17%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+ +G + R + K + + K + S+ ++ SEV LL L HP
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDY----GSMTEAEKQMLVSEVNLLRELKHP 63
Query: 117 HIIT----------------------------------EPYSVPLNLVLKLALDIARGMQ 142
+I+ E + VL++ + ++
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 143 YLHSQG-----ILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAP 196
H + +LHRDLK N+ L VK+ DFG++ L AK F GT +M+P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 197 EMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 256
E + + +K D++S G +L+EL + PF + ++ A + + +P
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDEL 242
Query: 257 SYLISRCWSSSPDRRPHFDQIV 278
+ +I+R + RP ++I+
Sbjct: 243 NEIITRMLNLKDYHRPSVEEIL 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 6e-48
Identities = 61/267 (22%), Positives = 111/267 (41%), Gaps = 45/267 (16%)
Query: 65 SGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
G +Y G D A+K +++ + + QF +E ++ +HP+++
Sbjct: 37 RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-----SQFLTEGIIMKDFSHPNVL 91
Query: 120 T------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGI 149
+ E ++ + ++ L +A+GM++L S+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 150 LHRDLKSENLLLGEDMCVKVADFGISCL-----ESQCGSAKGFTGTYRWMAPEMIKEKRH 204
+HRDL + N +L E VKVADFG++ + G +WMA E ++ ++
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 211
Query: 205 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 264
T K DV+SFG++LWEL+T P + R P CP ++ +CW
Sbjct: 212 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 271
Query: 265 SSSPDRRPHFDQIVSILEGYSESLEQD 291
+ RP F ++VS + + +
Sbjct: 272 HPKAEMRPSFSELVSRISAIFSTFIGE 298
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 9e-48
Identities = 56/299 (18%), Positives = 111/299 (37%), Gaps = 68/299 (22%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASML 99
+ +W L G SG ++ VA+K++ + + +
Sbjct: 29 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE----- 83
Query: 100 EKQFTSEVALLFRL-NHPHII--------------------------------------- 119
+ SE+ ++ +L +H +I+
Sbjct: 84 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 143
Query: 120 ------------TEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 167
+ + +L A +A+GM++L + +HRDL + N+L+ V
Sbjct: 144 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVV 203
Query: 168 KVADFGISCLESQCGSAK---GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA- 223
K+ DFG++ + +WMAPE + E +T K DV+S+GI+LWE+ +
Sbjct: 204 KICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263
Query: 224 LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
+ P+ + + + + Q + P + ++ CW+ +RP F + S L
Sbjct: 264 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 4e-47
Identities = 57/259 (22%), Positives = 103/259 (39%), Gaps = 44/259 (16%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+ G +Y+G+ + +VA + D L ++F E +L L HP
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQ----DRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 117 HIIT--------------------------------EPYSVPLNLVLKLALDIARGMQYL 144
+I+ + + ++ I +G+Q+L
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 128
Query: 145 HSQG--ILHRDLKSENLLL-GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE 201
H++ I+HRDLK +N+ + G VK+ D G++ L+ AK GT +MAPEM +E
Sbjct: 129 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE 187
Query: 202 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-VPPTCPKAFSYLI 260
K + + VDVY+FG+ + E+ T+ P+ + +P +I
Sbjct: 188 K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246
Query: 261 SRCWSSSPDRRPHFDQIVS 279
C + D R +++
Sbjct: 247 EGCIRQNKDERYSIKDLLN 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-46
Identities = 71/298 (23%), Positives = 115/298 (38%), Gaps = 58/298 (19%)
Query: 53 DMSQLFIGCKFASGRHSRIYRGIYKQ----RDVAIKLVSQPEEDASLASMLEKQFTSEVA 108
D + + G ++ + K+ D AIK + + + F E+
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-----HRDFAGELE 62
Query: 109 LLFRL-NHPHIIT---------EPYSV--------------------------------- 125
+L +L +HP+II Y
Sbjct: 63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122
Query: 126 --PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183
+L A D+ARGM YL + +HRDL + N+L+GE+ K+ADFG+S +
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 182
Query: 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTAL-TPFDNMTPEQAAFAVCQK 242
RWMA E + +T DV+S+G++LWE+++ TP+ MT + + +
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-PQ 241
Query: 243 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ--DPEFFSSF 298
R P C L+ +CW P RP F QI+ L E + + + F
Sbjct: 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKF 299
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 156 bits (395), Expect = 2e-45
Identities = 47/254 (18%), Positives = 92/254 (36%), Gaps = 41/254 (16%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
I + +G ++R + + A K V P E ++ E+ + L HP
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD------KETVRKEIQTMSVLRHP 83
Query: 117 HIIT-----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQ 147
++ E + + ++ + +G+ ++H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 148 GILHRDLKSENLLLG--EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT 205
+H DLK EN++ +K+ DFG++ S K TGT + APE+ + K
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 203
Query: 206 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLISRC 263
D++S G++ + LL+ L+PF ++ V + + I +
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 263
Query: 264 WSSSPDRRPHFDQI 277
+ P+ R Q
Sbjct: 264 LLADPNTRMTIHQA 277
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-45
Identities = 56/256 (21%), Positives = 98/256 (38%), Gaps = 40/256 (15%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+ G + + + + VA+K+V D A + E+ + LNH
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNHE 63
Query: 117 HIIT----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQG 148
+++ +P + + G+ YLH G
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 149 ILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEKR-H 204
I HRD+K ENLLL E +K++DFG++ + ++ GT ++APE++K + H
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 205 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA-VCQKNARPPVPPTCPKAFSYLISRC 263
+ VDV+S GIVL +L P+D + ++ +K A L+ +
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 243
Query: 264 WSSSPDRRPHFDQIVS 279
+P R I
Sbjct: 244 LVENPSARITIPDIKK 259
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 154 bits (391), Expect = 6e-45
Identities = 53/285 (18%), Positives = 105/285 (36%), Gaps = 46/285 (16%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
I + SG ++R + K R K ++ P + +E++++ +L+HP
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD------KYTVKNEISIMNQLHHP 86
Query: 117 HII-----------------------------TEPYSVPLNLVLKLALDIARGMQYLHSQ 147
+I E Y + V+ G++++H
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 148 GILHRDLKSENLLL--GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT 205
I+H D+K EN++ + VK+ DFG++ + K T T + APE++ +
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 206
Query: 206 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLISRC 263
D+++ G++ + LL+ L+PF + V + + + I
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 266
Query: 264 WSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILR 308
P +R + L+ D +S IPS + +R
Sbjct: 267 LQKEPRKRLTVHDALE-----HPWLKGDHSNLTSRIPSSRYNKIR 306
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 1e-44
Identities = 71/302 (23%), Positives = 114/302 (37%), Gaps = 69/302 (22%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLE 100
+ + G R+++ VA+K++ + ++ ++
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-----EASADMQ 60
Query: 101 KQFTSEVALLFRLNHPH---------------IITE------------------------ 121
F E AL+ ++P+ ++ E
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 122 -------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 168
P + L +A +A GM YL + +HRDL + N L+GE+M VK
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVK 180
Query: 169 VADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-AL 224
+ADFG+S + RWM PE I R+T + DV+++G+VLWE+ + L
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 225 TPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284
P+ M E+ + V N P CP L+ CWS P RP F I IL+
Sbjct: 241 QPYYGMAHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299
Query: 285 SE 286
E
Sbjct: 300 CE 301
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-44
Identities = 73/299 (24%), Positives = 126/299 (42%), Gaps = 55/299 (18%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLE 100
+EW ++ + + G +Y G+ K + VAIK V++
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE-----R 67
Query: 101 KQFTSEVALLFRLNHPHIITEPYSV----------------------------------- 125
+F +E +++ N H++ V
Sbjct: 68 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 126 ---PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 182
L+ ++++A +IA GM YL++ +HRDL + N ++ ED VK+ DFG++ +
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 187
Query: 183 SAKGFT---GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFA 238
+ RWM+PE +K+ T DV+SFG+VLWE+ T A P+ ++ EQ
Sbjct: 188 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247
Query: 239 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSS 297
V + P CP L+ CW +P RP F +I+S ++ E ++ F+ S
Sbjct: 248 VMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 305
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-44
Identities = 66/300 (22%), Positives = 116/300 (38%), Gaps = 64/300 (21%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASML 99
+ +W ++L G +G ++ VA+K++
Sbjct: 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE----- 69
Query: 100 EKQFTSEVALLFRL-NHPHIIT-------------------------------------- 120
+ SE+ +L L NH +I+
Sbjct: 70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129
Query: 121 --------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 172
+ ++ L +L + +A+GM +L S+ +HRDL + N+LL K+ DF
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDF 189
Query: 173 GISCL---ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP-FD 228
G++ +S +WMAPE I +T + DV+S+GI LWEL + + +
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249
Query: 229 NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY-SES 287
M + + + ++ R P P ++ CW + P +RP F QIV ++E SES
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-43
Identities = 55/279 (19%), Positives = 104/279 (37%), Gaps = 45/279 (16%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120
+G +++ +K +A KL+ + A + Q E+ +L N P+I+
Sbjct: 16 AGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-----IRNQIIRELQVLHECNSPYIVGFY 70
Query: 121 -------EPYSV-------------------PLNLVLKLALDIARGMQYLHSQ-GILHRD 153
E P ++ K+++ + +G+ YL + I+HRD
Sbjct: 71 GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 130
Query: 154 LKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSF 213
+K N+L+ +K+ DFG+S A F GT +M+PE ++ ++ + D++S
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSM 189
Query: 214 GIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPH 273
G+ L E+ P ++ P S D RP
Sbjct: 190 GLSLVEMAVGRYPIPPPDAKELELMF--GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPP 247
Query: 274 FDQIVSILEGYSESLEQDPEFFSSFIPSPD--HTILRCL 310
+I E + + P S + S + + +CL
Sbjct: 248 M----AIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 282
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-43
Identities = 62/293 (21%), Positives = 112/293 (38%), Gaps = 77/293 (26%)
Query: 65 SGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120
GR ++RG ++ +VA+K+ S EE +E+ L H +I+
Sbjct: 13 KGRFGEVWRGKWRGEEVAVKIFSSREER-------SWFREAEIYQTVMLRHENILGFIAA 65
Query: 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQ------ 147
Y+V + ++KLAL A G+ +LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 148 --GILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-----SAKGFTGTYRWMAPEMIK 200
I HRDLKS+N+L+ ++ +AD G++ + GT R+MAPE++
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 201 EKRH------TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF---------------AV 239
+ + K+ D+Y+ G+V WE+ + Q + V
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245
Query: 240 CQKNARPPVP-----PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287
C++ RP +P + + ++ CW ++ R +I L S+
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 8e-43
Identities = 60/273 (21%), Positives = 105/273 (38%), Gaps = 44/273 (16%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
G G S + R+ AIK++ + + T E ++ RL+HP
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEK---RHIIKENKVPYVTRERDVMSRLDHP 68
Query: 117 HIIT---------EPYSV-------------------PLNLVLKLALDIARGMQYLHSQG 148
+ + Y +I ++YLH +G
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 149 ILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEKRHT 205
I+HRDLK EN+LL EDM +++ DFG + + ES+ A F GT ++++PE++ EK
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188
Query: 206 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 265
K D+++ G ++++L+ L PF + P L+ +
Sbjct: 189 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLV 246
Query: 266 SSPDRRPHFDQIVSILEGYSESLEQDPEFFSSF 298
+R +++ L+ P FF S
Sbjct: 247 LDATKRLGCEEMEGYGP-----LKAHP-FFESV 273
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-42
Identities = 37/254 (14%), Positives = 79/254 (31%), Gaps = 42/254 (16%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
I G ++R + + K V D + E+++L H
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-------QVLVKKEISILNIARHR 61
Query: 117 HII-----------------------------TEPYSVPLNLVLKLALDIARGMQYLHSQ 147
+I+ T + + ++ + +Q+LHS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 148 GILHRDLKSENLLLG--EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT 205
I H D++ EN++ +K+ +FG + + + + APE+ + +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 206 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLISRC 263
D++S G +++ LL+ + PF T +Q + + R
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241
Query: 264 WSSSPDRRPHFDQI 277
R +
Sbjct: 242 LVKERKSRMTASEA 255
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 145 bits (366), Expect = 4e-42
Identities = 58/255 (22%), Positives = 104/255 (40%), Gaps = 42/255 (16%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEK---QFTSEVALLFRLN-HPH- 117
G S + R I+K ++ A+K++ + A +++ EV +L +++ HP+
Sbjct: 13 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 72
Query: 118 ---------------------------IITEPYSVPLNLVLKLALDIARGMQYLHSQGIL 150
+TE ++ K+ + + LH I+
Sbjct: 73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIV 132
Query: 151 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI------KEKRH 204
HRDLK EN+LL +DM +K+ DFG SC + GT ++APE+I +
Sbjct: 133 HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY 192
Query: 205 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYLISR 262
K+VD++S G++++ LL PF + + N + P L+SR
Sbjct: 193 GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSR 252
Query: 263 CWSSSPDRRPHFDQI 277
P +R ++
Sbjct: 253 FLVVQPQKRYTAEEA 267
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 1e-41
Identities = 57/297 (19%), Positives = 110/297 (37%), Gaps = 62/297 (20%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLE 100
+W +L +G G ++ R VA+K++ + +
Sbjct: 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----H 60
Query: 101 KQFTSEVALLFRLNHPHIITEPYSV----------------------------------- 125
+ SE+ +L + H +
Sbjct: 61 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120
Query: 126 -----------PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174
L ++ + +A+GM++L S+ +HRDL + N+LL E VK+ DFG+
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 180
Query: 175 SCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 230
+ + +WMAPE I ++ +T + DV+SFG++LWE+ + +P+ +
Sbjct: 181 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240
Query: 231 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287
++ ++ R P + CW P +RP F ++V L ++
Sbjct: 241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 143 bits (361), Expect = 3e-41
Identities = 57/254 (22%), Positives = 99/254 (38%), Gaps = 43/254 (16%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+G G S ++ + RDVA+K++ D + +F E LNHP
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRA---DLARDPSFYLRFRREAQNAAALNHP 67
Query: 117 HIIT-------------EPYSV-------------------PLNLVLKLALDIARGMQYL 144
I+ PY V +++ D + + +
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 127
Query: 145 HSQGILHRDLKSENLLLGEDMCVKVADFGISCL----ESQCGSAKGFTGTYRWMAPEMIK 200
H GI+HRD+K N+++ VKV DFGI+ + GT ++++PE +
Sbjct: 128 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187
Query: 201 EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSY 258
+ DVYS G VL+E+LT PF +P A+ +++ PP
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDA 247
Query: 259 LISRCWSSSPDRRP 272
++ + + +P+ R
Sbjct: 248 VVLKALAKNPENRY 261
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-41
Identities = 64/291 (21%), Positives = 111/291 (38%), Gaps = 62/291 (21%)
Query: 49 EWSADMSQLFIGCKFASGRHSRIYRGIYKQRD---------VAIKLVSQPEEDASLASML 99
W +L +G G ++ D VA+K++ + L
Sbjct: 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL---- 62
Query: 100 EKQFTSEVALLFRL-NHPHIITEPY----------------------------------- 123
SE+ ++ + H +II
Sbjct: 63 -SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121
Query: 124 ---------SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174
+ ++ A +ARGM+YL S+ +HRDL + N+L+ ED +K+ADFG+
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 181
Query: 175 SCL---ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT 231
+ +WMAPE + ++ +T + DV+SFG++LWE+ T
Sbjct: 182 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241
Query: 232 PEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
P + F + ++ R P C ++ CW + P +RP F Q+V L+
Sbjct: 242 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 143 bits (362), Expect = 5e-41
Identities = 58/257 (22%), Positives = 106/257 (41%), Gaps = 39/257 (15%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEV 107
+S + I +G R++ + R A+K++ + + + + E
Sbjct: 1 YS--LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK---EIVVRLKQVEHTNDER 55
Query: 108 ALLFRLNHPHIIT----------------------------EPYSVPLNLVLKLALDIAR 139
+L + HP II + P + A ++
Sbjct: 56 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 115
Query: 140 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI 199
++YLHS+ I++RDLK EN+LL ++ +K+ DFG + GT ++APE++
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVV 173
Query: 200 KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 259
K + K +D +SFGI+++E+L TPF + + + NA PP + L
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL--NAELRFPPFFNEDVKDL 231
Query: 260 ISRCWSSSPDRRPHFDQ 276
+SR + +R Q
Sbjct: 232 LSRLITRDLSQRLGNLQ 248
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 8e-41
Identities = 56/245 (22%), Positives = 104/245 (42%), Gaps = 35/245 (14%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+ G +++ +K+ + AIK + + + + +E + L HP
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKK--DVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 117 HI----------------------------ITEPYSVPLNLVLKLALDIARGMQYLHSQG 148
+ I + L+ A +I G+Q+LHS+G
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 149 ILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 207
I++RDLK +N+LL +D +K+ADFG+ F GT ++APE++ +++
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS 183
Query: 208 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 267
VD +SFG++L+E+L +PF E+ + P P K L+ + +
Sbjct: 184 VDWWSFGVLLYEMLIGQSPFHGQDEEELFH--SIRMDNPFYPRWLEKEAKDLLVKLFVRE 241
Query: 268 PDRRP 272
P++R
Sbjct: 242 PEKRL 246
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (359), Expect = 1e-40
Identities = 57/248 (22%), Positives = 102/248 (41%), Gaps = 40/248 (16%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120
+G S + K+ + VAIK +++ + E +E+A+L ++ HP+I+
Sbjct: 19 TGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-----EGSMENEIAVLHKIKHPNIVALD 73
Query: 121 -------EPYSV-------------------PLNLVLKLALDIARGMQYLHSQGILHRDL 154
Y + +L + ++YLH GI+HRDL
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDL 133
Query: 155 KSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVY 211
K ENLL ED + ++DFG+S +E GT ++APE++ +K ++K VD +
Sbjct: 134 KPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCW 193
Query: 212 SFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYLISRCWSSSPD 269
S G++ + LL PF + + + + P + I P+
Sbjct: 194 SIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPE 253
Query: 270 RRPHFDQI 277
+R +Q
Sbjct: 254 KRFTCEQA 261
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 139 bits (352), Expect = 6e-40
Identities = 47/280 (16%), Positives = 88/280 (31%), Gaps = 58/280 (20%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+G + G I+ G + VAIK + + Q E L
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--------PQLRDEYRTYKLLAGC 60
Query: 117 HIITEPYSV-----------------------------PLNLVLKLALDIARGMQYLHSQ 147
I Y + V A + +Q +H +
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 148 GILHRDLKSENLLLGEDMC-----VKVADFGISCLESQCGS--------AKGFTGTYRWM 194
+++RD+K +N L+G + V DFG+ + K +GT R+M
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 195 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE---QAAFAVCQKNARPPV--- 248
+ + +++ D+ + G V L P+ + Q + +K P+
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 249 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 288
P+ F + + + D P +D + + E L
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 8e-40
Identities = 54/255 (21%), Positives = 95/255 (37%), Gaps = 36/255 (14%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
G + SG+ + + + K A K + + +S + + EV++L + HP
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 117 HIIT----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQG 148
++IT E S+ + I G+ YLHS
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 133
Query: 149 ILHRDLKSENLLLGEDMC----VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH 204
I H DLK EN++L + +K+ DFG++ K GT ++APE++ +
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 193
Query: 205 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLISR 262
+ D++S G++ + LL+ +PF T ++ V N I R
Sbjct: 194 GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 253
Query: 263 CWSSSPDRRPHFDQI 277
P +R
Sbjct: 254 LLVKDPKKRMTIQDS 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (346), Expect = 6e-39
Identities = 50/272 (18%), Positives = 87/272 (31%), Gaps = 56/272 (20%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+G K SG IY G +VAIKL + Q E + +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGG 62
Query: 117 HIITEPYSV-----------------------------PLNLVLKLALDIARGMQYLHSQ 147
I L VL LA + ++Y+HS+
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 148 GILHRDLKSENLL---LGEDMCVKVADFGISCLESQCGS--------AKGFTGTYRWMAP 196
+HRD+K +N L + V + DFG++ + K TGT R+ +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 197 EMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR------PPVPP 250
+++ D+ S G VL P+ + + + + +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 282
P F+ ++ C S D +P + + +
Sbjct: 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 139 bits (350), Expect = 7e-39
Identities = 49/272 (18%), Positives = 101/272 (37%), Gaps = 40/272 (14%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+ G +Y + A+K + + L ++L+ + P
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67
Query: 117 HI----------------------------ITEPYSVPLNLVLKLALDIARGMQYLHSQG 148
I +++ + A +I G++++H++
Sbjct: 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF 127
Query: 149 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI-KEKRHTKK 207
+++RDLK N+LL E V+++D G++C S+ GT+ +MAPE++ K +
Sbjct: 128 VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAYDSS 186
Query: 208 VDVYSFGIVLWELLTALTPFDNMTP-EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 266
D +S G +L++LL +PF ++ +P + L+
Sbjct: 187 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 246
Query: 267 SPDRRPHFDQIVSILEGYSESLEQDPEFFSSF 298
+RR L ++ +++ P FF S
Sbjct: 247 DVNRRL------GCLGRGAQEVKESP-FFRSL 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-38
Identities = 56/254 (22%), Positives = 94/254 (37%), Gaps = 44/254 (17%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+G SG +Y GI VAIK V + + EV LL +++
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 117 H-------------------------------IITEPYSVPLNLVLKLALDIARGMQYLH 145
ITE ++ L + +++ H
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 146 SQGILHRDLKSENLLLGED-MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK-EKR 203
+ G+LHRD+K EN+L+ + +K+ DFG L F GT + PE I+ +
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRY 186
Query: 204 HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263
H + V+S GI+L++++ PF++ + +LI C
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFEHDEE--------IIRGQVFFRQRVSSECQHLIRWC 238
Query: 264 WSSSPDRRPHFDQI 277
+ P RP F++I
Sbjct: 239 LALRPSDRPTFEEI 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-37
Identities = 49/239 (20%), Positives = 95/239 (39%), Gaps = 36/239 (15%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI---- 118
G ++ K R A+K++ + + +A +E +L HP +
Sbjct: 15 KGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 119 ------------------------ITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 154
++ +I ++YLHS+ +++RD+
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 155 KSENLLLGEDMCVKVADFGISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSF 213
K ENL+L +D +K+ DFG+ G+ K F GT ++APE++++ + + VD +
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 214 GIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 272
G+V++E++ PF N E+ + P T L++ P +R
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 248
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-36
Identities = 48/259 (18%), Positives = 90/259 (34%), Gaps = 57/259 (22%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT- 120
G + ++ + K+ A+K++ + EV L +R PHI+
Sbjct: 22 LGINGKVLQIFNKRTQEKFALKMLQD-----------CPKARREVELHWRASQCPHIVRI 70
Query: 121 ---------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQ 147
+ ++ I +QYLHS
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 148 GILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH 204
I HRD+K ENLL + +K+ DFG + + S T ++APE++ +++
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 190
Query: 205 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------PVPPTCPKAFSY 258
K D++S G++++ LL PF + + + + P +
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 250
Query: 259 LISRCWSSSPDRRPHFDQI 277
LI + P +R +
Sbjct: 251 LIRNLLKTEPTQRMTITEF 269
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (320), Expect = 1e-34
Identities = 47/238 (19%), Positives = 86/238 (36%), Gaps = 37/238 (15%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI---- 118
+G R+ +K+ A+K++ + + + +E +L +N P +
Sbjct: 51 TGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 119 ------------------------ITEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 154
+ A I +YLHS +++RDL
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 155 KSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFG 214
K ENLL+ + ++V DFG + G GT +APE+I K + K VD ++ G
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALG 225
Query: 215 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 272
++++E+ PF P Q + + + P L+ +R
Sbjct: 226 VLIYEMAAGYPPFFADQPIQIYEKIV--SGKVRFPSHFSSDLKDLLRNLLQVDLTKRF 281
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 8e-34
Identities = 48/284 (16%), Positives = 94/284 (33%), Gaps = 69/284 (24%)
Query: 59 IGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-- 113
+ G + ++++ R VA+K V + + EVA+L L
Sbjct: 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE----EGMPLSTIREVAVLRHLET 66
Query: 114 -NHPHIIT----------------------------------EPYSVPLNLVLKLALDIA 138
HP+++ VP + + +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 139 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEM 198
RG+ +LHS ++HRDLK +N+L+ +K+ADFG++ + S + T + APE+
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 186
Query: 199 IKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP----------- 247
+ + + VD++S G + E+ F + + P
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 248 --------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 277
+ L+ +C + +P +R
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-32
Identities = 56/271 (20%), Positives = 95/271 (35%), Gaps = 59/271 (21%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120
G+ + +Y+ K + VAIK + + + + E+ LL L+HP+II
Sbjct: 8 EGQFATVYKARDKNTNQIVAIKKIK-LGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 66
Query: 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 154
+ + + L +G++YLH ILHRDL
Sbjct: 67 DAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDL 126
Query: 155 KSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYS 212
K NLLL E+ +K+ADFG++ S + T + APE++ R + VD+++
Sbjct: 127 KPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWA 186
Query: 213 FGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------------------------- 247
G +L ELL + + + + P
Sbjct: 187 VGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLH 246
Query: 248 -VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 277
+ LI + +P R Q
Sbjct: 247 HIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 3e-31
Identities = 50/254 (19%), Positives = 100/254 (39%), Gaps = 42/254 (16%)
Query: 59 IGCKFASGRHSRIYRGIYKQ-----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL 113
+ +G + +++ + A+K++ + + + +E +L +
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL--KKATIVQKAKTTEHTRTERQVLEHI 85
Query: 114 NHPHII-----------------------------TEPYSVPLNLVLKLALDIARGMQYL 144
+ ++ + V +I +++L
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHL 145
Query: 145 HSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS--AKGFTGTYRWMAPEMI--K 200
H GI++RD+K EN+LL + V + DFG+S + A F GT +MAP+++
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205
Query: 201 EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK--NARPPVPPTCPKAFSY 258
+ H K VD +S G++++ELLT +PF + + + ++ + PP P
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKD 265
Query: 259 LISRCWSSSPDRRP 272
LI R P +R
Sbjct: 266 LIQRLLMKDPKKRL 279
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-30
Identities = 55/273 (20%), Positives = 96/273 (35%), Gaps = 64/273 (23%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120
G + +Y+ K VA+K + E + E++LL LNHP+I+
Sbjct: 12 EGTYGVVYKARNKLTGEVVALKKIRLDTETEGV----PSTAIREISLLKELNHPNIVKLL 67
Query: 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRD 153
+PL L+ + +G+ + HS +LHRD
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 154 LKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW-MAPEMI-KEKRHTKKVDVY 211
LK +NLL+ + +K+ADFG++ W APE++ K ++ VD++
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 212 SFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------------------------ 247
S G + E++T F + F + + P
Sbjct: 188 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 247
Query: 248 ---VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 277
V P + L+S+ P++R
Sbjct: 248 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 5e-30
Identities = 54/280 (19%), Positives = 94/280 (33%), Gaps = 72/280 (25%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120
G + + VAIK +S E ++ E+ +L R H +II
Sbjct: 18 EGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC-----QRTLREIKILLRFRHENIIGIN 72
Query: 121 -----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILH 151
+ + + + I RG++Y+HS +LH
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 132
Query: 152 RDLKSENLLLGEDMCVKVADFGISCL----ESQCGSAKGFTGTYRWMAPEMI-KEKRHTK 206
RDLK NLLL +K+ DFG++ + G + T + APE++ K +TK
Sbjct: 133 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 192
Query: 207 KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------------------- 247
+D++S G +L E+L+ F + P
Sbjct: 193 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 252
Query: 248 ----------VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 277
+ P L+ + + +P +R +Q
Sbjct: 253 PHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 110 bits (275), Expect = 8e-29
Identities = 42/271 (15%), Positives = 86/271 (31%), Gaps = 62/271 (22%)
Query: 65 SGRHSRIYRGIYKQ-RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII---- 119
G + +Y+ A+K + +ED + E+++L L H +I+
Sbjct: 12 EGTYGVVYKAQNNYGETFALKKIRLEKEDEGI----PSTTIREISILKELKHSNIVKLYD 67
Query: 120 ------------------------TEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 155
+ L + G+ Y H + +LHRDLK
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 156 SENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI--KEKRHTKKVDVYSF 213
+NLL+ + +K+ADFG++ W + K+++ +D++S
Sbjct: 128 PQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSV 187
Query: 214 GIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-------------------------- 247
G + E++ F ++ + + P
Sbjct: 188 GCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWE 247
Query: 248 -VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 277
++ L+S+ P++R Q
Sbjct: 248 SFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 9e-29
Identities = 45/273 (16%), Positives = 87/273 (31%), Gaps = 64/273 (23%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITEP 122
G + +++ ++ VA+K V ++D + E+ LL L H +I+
Sbjct: 12 EGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV----PSSALREICLLKELKHKNIVRLH 67
Query: 123 YSV----------------------------PLNLVLKLALDIARGMQYLHSQGILHRDL 154
+ +V + +G+ + HS+ +LHRDL
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 155 KSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAP--EMIKEKRHTKKVDVYS 212
K +NLL+ + +K+A+FG++ W P + K ++ +D++S
Sbjct: 128 KPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187
Query: 213 FGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------------------------- 247
G + EL A P + P
Sbjct: 188 AGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTS 247
Query: 248 ---VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 277
V P L+ +P +R ++
Sbjct: 248 LVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-28
Identities = 49/294 (16%), Positives = 93/294 (31%), Gaps = 80/294 (27%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
K G +++ +++ + VA+K V E E+ +L L H
Sbjct: 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF----PITALREIKILQLLKHE 69
Query: 117 HIITEPYSV------------------------------------PLNLVLKLALDIARG 140
+++ L+ + ++ + G
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 141 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL-----ESQCGSAKGFTGTYRWMA 195
+ Y+H ILHRD+K+ N+L+ D +K+ADFG++ SQ T +
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 196 PEMI-KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254
PE++ E+ + +D++ G ++ E+ T T + + Q P P
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT-PEVWPN 248
Query: 255 AFSY-------------------------------LISRCWSSSPDRRPHFDQI 277
+Y LI + P +R D
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 4e-28
Identities = 54/281 (19%), Positives = 90/281 (32%), Gaps = 78/281 (27%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120
+G +Y+ VAIK V Q + + E+ ++ +L+H +I+
Sbjct: 30 NGSFGVVYQAKLCDSGELVAIKKVLQDK----------RFKNRELQIMRKLDHCNIVRLR 79
Query: 121 -----------------------------------EPYSVPLNLVLKLALDIARGMQYLH 145
++P+ V + R + Y+H
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 146 SQGILHRDLKSENLLLGED-MCVKVADFGISCLESQCGSAKGFTGTYRWMAP-EMIKEKR 203
S GI HRD+K +NLLL D +K+ DFG + + + + + AP +
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD 199
Query: 204 HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP---------------- 247
+T +DV+S G VL ELL F + + + P
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 259
Query: 248 -----------VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 277
P P L SR +P R +
Sbjct: 260 PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 1e-27
Identities = 55/277 (19%), Positives = 102/277 (36%), Gaps = 70/277 (25%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII--- 119
SG + + + + VAIK + +P + + K+ E+ LL + H ++I
Sbjct: 28 SGAYGAVCSAVDGRTGAKVAIKKLYRPFQS----ELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 120 ------------TEPYSV-----------------PLNLVLKLALDIARGMQYLHSQGIL 150
T+ Y V + + L + +G++Y+H+ GI+
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII 143
Query: 151 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI-KEKRHTKKVD 209
HRDLK NL + ED +K+ DFG++ G+ T + APE+I R+T+ VD
Sbjct: 144 HRDLKPGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVD 201
Query: 210 VYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP---------------------- 247
++S G ++ E++T T F + + PP
Sbjct: 202 IWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPEL 261
Query: 248 -------VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 277
+ L+ + ++R +
Sbjct: 262 EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 2e-25
Identities = 56/279 (20%), Positives = 102/279 (36%), Gaps = 43/279 (15%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII--- 119
SG + R+VAIK +S+P ++ + A K+ E+ L+ +NH +II
Sbjct: 27 SGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMKCVNHKNIISLL 82
Query: 120 ------------TEPYSV----------------PLNLVLKLALDIARGMQYLHSQGILH 151
+ Y V + L + G+++LHS GI+H
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 142
Query: 152 RDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVY 211
RDLK N+++ D +K+ DFG++ + T + APE+I + + VD++
Sbjct: 143 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 202
Query: 212 SFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 271
S G ++ E++ F V ++ P F + + + R
Sbjct: 203 SVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP------CPEFMKKLQPTVRNYVENR 256
Query: 272 PHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCL 310
P + + D E + + L
Sbjct: 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 295
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 1e-24
Identities = 59/314 (18%), Positives = 102/314 (32%), Gaps = 71/314 (22%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
SG + + + VA+K +S+P + A K+ E+ LL + H
Sbjct: 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA----KRTYRELRLLKHMKHE 77
Query: 117 HIIT--------------------------------EPYSVPLNLVLKLALDIARGMQYL 144
++I + + + V L I RG++Y+
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 145 HSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH 204
HS I+HRDLK NL + ED +K+ DFG++ + T Y M+ +
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWY-RAPEIMLNWMHY 196
Query: 205 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP----------------- 247
+ VD++S G ++ ELLT T F + + P
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 248 ------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS---ILEGYSESLEQDP 292
V L+ + D+R Q ++ + + E
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA 316
Query: 293 EFFSSFIPSPDHTI 306
+ + S D I
Sbjct: 317 DPYDQSFESRDLLI 330
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 99.5 bits (247), Expect = 2e-24
Identities = 42/247 (17%), Positives = 89/247 (36%), Gaps = 41/247 (16%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-H 115
+ K G++S ++ I V +K++ ++ K+ E+ +L L
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---------KKIKREIKILENLRGG 89
Query: 116 PHIIT------EPYSVPLNLVL---------------------KLALDIARGMQYLHSQG 148
P+IIT +P S LV +I + + Y HS G
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG 149
Query: 149 ILHRDLKSENLLLG-EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE-MIKEKRHTK 206
I+HRD+K N+++ E +++ D+G++ + + PE ++ + +
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 209
Query: 207 KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 266
+D++S G +L ++ PF + K ++ + ++
Sbjct: 210 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 269
Query: 267 SPDRRPH 273
R
Sbjct: 270 ILGRHSR 276
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 81.6 bits (200), Expect = 4e-18
Identities = 44/296 (14%), Positives = 90/296 (30%), Gaps = 44/296 (14%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLA----SMLEKQFTSEVALLFR 112
+ K G S ++ VA+K+V + A +L++ ++
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 113 LNHPHIIT---------------------------------EPYSVPLNLVLKLALDIAR 139
+ HI+ E +PL V +++ +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 140 GMQYLH-SQGILHRDLKSENLLL-GEDMCVKVADFGISCLESQCGSAKG---FTGTYRWM 194
G+ Y+H GI+H D+K EN+L+ D + I+ L + C + T +
Sbjct: 137 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 195 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 254
+PE++ D++S +++EL+T F+ + P
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256
Query: 255 AFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCL 310
+ R + + L + +F + L
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 64.8 bits (157), Expect = 5e-13
Identities = 23/194 (11%), Positives = 57/194 (29%), Gaps = 53/194 (27%)
Query: 59 IGCKFASGRHSRIYRGIYKQ-RDVAIKLV------------SQPEEDASLASMLEKQFTS 105
IG G+ S ++ ++ + +K + D + + + +
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 106 EVALLFRLNHPHIITEPYSVPLNLV-----------------LKLALDIARGMQYLHSQG 148
E L +L + ++ ++ I + + +G
Sbjct: 64 EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG 123
Query: 149 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK-------- 200
I+H DL N+L+ + + + DF S E+++
Sbjct: 124 IVHGDLSQYNVLVS-EEGIWIIDFPQS------------VEVGEEGWREILERDVRNIIT 170
Query: 201 --EKRHTKKVDVYS 212
+ + + D+ S
Sbjct: 171 YFSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 332 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.49 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.41 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.13 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.42 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.77 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.47 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-55 Score=388.93 Aligned_cols=237 Identities=32% Similarity=0.620 Sum_probs=199.1
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
++|+++.++|.+++.||+|+||+||+|.+++ .||||+++........ .+.|.+|+.+|++++|||||+
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 75 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILLFMGYSTA 75 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTH----HHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHH----HHHHHHHHHHHHhCCCCCEeeeeEEEec
Confidence 5799999999999999999999999998765 5999999765433221 467999999999999999997
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccc
Q 020016 121 ---------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 76 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 76 PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 45679999999999999999999999999999999999999999999999999997654
Q ss_pred cCC---CCCCcccccccCChhhhhcC---CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----CCC
Q 020016 180 QCG---SAKGFTGTYRWMAPEMIKEK---RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP----PVP 249 (332)
Q Consensus 180 ~~~---~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~----~~~ 249 (332)
... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||.+.+............... ..+
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 235 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSC
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcc
Confidence 322 23456799999999999643 47899999999999999999999999877665554444433332 346
Q ss_pred CCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 250 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
..+++++.+||.+||+.||++|||+.+|++.|+.+.++++
T Consensus 236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 7789999999999999999999999999999999987764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.2e-54 Score=384.71 Aligned_cols=233 Identities=29% Similarity=0.575 Sum_probs=202.6
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--- 120 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--- 120 (332)
..+.|+++.++|++++.||+|+||+||+|.+. ++.||||+++..... .++|.+|+.+|++++|||||+
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-------~~~~~~E~~il~~l~HpnIv~~~~ 80 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLLG 80 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC-------HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch-------HHHHHHHHHHHHhCCCCCEecCCc
Confidence 45789999999999999999999999999996 789999999765443 356899999999999999997
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecc
Q 020016 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 121 ---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 81 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred cEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEcccc
Confidence 34678999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC--CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhcCCCCCCCC
Q 020016 174 ISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP-FDNMTPEQAAFAVCQKNARPPVPP 250 (332)
Q Consensus 174 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p-f~~~~~~~~~~~~~~~~~~~~~~~ 250 (332)
+++....... .....||+.|+|||++.+..++.++|||||||++|||++|..| |.+.+... .........++..+.
T Consensus 161 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~ 239 (287)
T d1opja_ 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRMERPE 239 (287)
T ss_dssp CTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHHTTCCCCCCT
T ss_pred ceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHHHHhcCCCCCCCc
Confidence 9986544322 2334588999999999999999999999999999999996555 55555544 444555677888889
Q ss_pred CCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 020016 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 251 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 286 (332)
.+++++.+|+.+||+.||.+|||+++|++.|+.+..
T Consensus 240 ~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 999999999999999999999999999999988744
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-54 Score=381.56 Aligned_cols=234 Identities=30% Similarity=0.585 Sum_probs=204.8
Q ss_pred CccccccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 46 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
-.++|+|+.++|++++.||+|+||+||+|.++ ++.||||+++..... .+.|.+|+.++++++|||||+
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~-------~~~~~~E~~~l~~l~HpnIv~~~g~ 76 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-------PDAFLAEANLMKQLQHQRLVRLYAV 76 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC-------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC-------HHHHHHHHHHHHhCCCCCEeEEEee
Confidence 35789999999999999999999999999997 688999999765443 356999999999999999997
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla 156 (272)
T d1qpca_ 77 VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156 (272)
T ss_dssp ECSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred eccCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccce
Confidence 1235899999999999999999999999999999999999999999999999999
Q ss_pred cccccCC--CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 020016 176 CLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 252 (332)
Q Consensus 176 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (332)
+...... ......||+.|+|||++.++.++.++|||||||++|||+| |.+||...+..+....+ ....++..|..+
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i-~~~~~~~~p~~~ 235 (272)
T d1qpca_ 157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-ERGYRMVRPDNC 235 (272)
T ss_dssp EECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTTC
T ss_pred EEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH-HhcCCCCCcccC
Confidence 8765432 2345678999999999999999999999999999999999 56666776666665555 456677888899
Q ss_pred cHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 253 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
++++.+|+.+||+.||++|||+++|++.|+++..+
T Consensus 236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 99999999999999999999999999999987654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-53 Score=375.99 Aligned_cols=239 Identities=31% Similarity=0.591 Sum_probs=201.9
Q ss_pred cCCCccccccccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-
Q 020016 43 KGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT- 120 (332)
Q Consensus 43 ~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~- 120 (332)
.+...++|+|+.++|++++.||+|+||+||+|.++ ++.||||++...... .+.|.+|+.++++++|||||+
T Consensus 5 ~~~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~-------~~~~~~E~~~l~~l~h~nIv~~ 77 (285)
T d1fmka3 5 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-------PEAFLQEAQVMKKLRHEKLVQL 77 (285)
T ss_dssp SSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC-------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC-------HHHHHHHHHHHHhcccCCEeEE
Confidence 34456789999999999999999999999999997 568999999765443 257999999999999999997
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeec
Q 020016 121 ----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 172 (332)
Q Consensus 121 ----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Df 172 (332)
....+++..++.++.||+.||+|||+.||+||||||+||||+.++.+||+||
T Consensus 78 ~g~~~~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~Df 157 (285)
T d1fmka3 78 YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF 157 (285)
T ss_dssp EEEECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred EEEEecCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEccc
Confidence 2346899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC--CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCCCCCCC
Q 020016 173 GISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNARPPVP 249 (332)
Q Consensus 173 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (332)
|+++...... ......||+.|+|||++.++.++.++||||||+++|||+|| .+|+......+....+ ....+.+.+
T Consensus 158 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i-~~~~~~~~~ 236 (285)
T d1fmka3 158 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCP 236 (285)
T ss_dssp CTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCCCCC
T ss_pred chhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH-HhcCCCCCC
Confidence 9997654332 23346689999999999999999999999999999999995 5556666666665554 456677788
Q ss_pred CCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 250 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
..+++++.+||.+||+.||++||++++|++.|+....+..
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 9999999999999999999999999999999999876654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=371.36 Aligned_cols=228 Identities=28% Similarity=0.550 Sum_probs=192.1
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
+|.++|++++.||+|+||+||+|.+. ++.||||+++..... .++|.+|+.++++++|||||+
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 74 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC-------HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc-------HHHHHHHHHHHHhcCCCCcccccceeccCCc
Confidence 57789999999999999999999997 678999999865443 256899999999999999997
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred eEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCC
Confidence 4466899999999999999999999999999999999999999999999999999765443
Q ss_pred C--CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 020016 182 G--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 258 (332)
Q Consensus 182 ~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 258 (332)
. ......||+.|+|||++.+..++.++||||||+++|||+| |.+||...+..+....+. ...++..|..+++++.+
T Consensus 155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~ 233 (263)
T d1sm2a_ 155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQ 233 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH-HTCCCCCCTTSCHHHHH
T ss_pred CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHH
Confidence 2 2234678999999999999999999999999999999999 677787777777666554 45667778889999999
Q ss_pred HHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 259 LISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
|+.+||+.||++|||+++|++.|+++.++
T Consensus 234 li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 234 IMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 99999999999999999999999998764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-52 Score=370.97 Aligned_cols=231 Identities=30% Similarity=0.532 Sum_probs=193.0
Q ss_pred ccccCCeeeeeeecccCceEEEEEEECC------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYKQ------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
+|+.+.|.+.+.||+|+||+||+|.+++ ..||||++........ ...|.+|+.++++++|||||+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~-----~~~~~~E~~il~~l~H~nIv~~~g~ 77 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ-----RVDFLGEAGIMGQFSHHNIIRLEGV 77 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHH-----HHHHHHHHHHHHhcCCCCEeeeeEE
Confidence 4677899999999999999999998852 4699999976544332 457899999999999999997
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus 78 ~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla 157 (283)
T d1mqba_ 78 ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 157 (283)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchh
Confidence 5567999999999999999999999999999999999999999999999999999
Q ss_pred cccccCC----CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 020016 176 CLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNARPPVPP 250 (332)
Q Consensus 176 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (332)
+...... ......||+.|+|||++.++.++.++|||||||++|||++| .+|+...+..+.... .....+++.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~-i~~~~~~~~~~ 236 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-INDGFRLPTPM 236 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCCT
T ss_pred hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHH-HhccCCCCCch
Confidence 7654322 22345689999999999999999999999999999999995 555666666655544 45667788889
Q ss_pred CCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 251 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
.++..+.+||.+||+.||++|||+.+|++.|+.+.+.
T Consensus 237 ~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 237 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 9999999999999999999999999999999988764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.5e-52 Score=372.72 Aligned_cols=231 Identities=31% Similarity=0.550 Sum_probs=192.5
Q ss_pred ccccCCeeeeeeecccCceEEEEEEEC--C---eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYK--Q---RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~---~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
+++.++|.+.+.||+|+||+||+|.++ + ..||||.+........ .+.|.+|+.+|++++|||||+
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ-----RRDFLSEASIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHH-----HHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHH-----HHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 467789999999999999999999985 2 3589999876544332 467999999999999999997
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccc
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 97 TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccce
Confidence 35679999999999999999999999999999999999999999999999999997
Q ss_pred ccccCCC------CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 020016 177 LESQCGS------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 249 (332)
Q Consensus 177 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (332)
....... .....+|+.|+|||.+.++.++.++|||||||++|||+| |..||.+.+..+....+. ...+++.+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~~ 255 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPP 255 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCC
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 6543222 123457899999999999999999999999999999998 899999998887776664 45667788
Q ss_pred CCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 250 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 250 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
..+++++.+|+.+||+.||++|||+.+|++.|+.+.++
T Consensus 256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 89999999999999999999999999999999988664
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=368.58 Aligned_cols=223 Identities=27% Similarity=0.493 Sum_probs=195.1
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
.|. .++|.+++.||+|+||+||+|.++ ++.||||++....... ....+.+.+|+.++++++|||||+
T Consensus 2 ~~~--l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 76 (263)
T d2j4za1 2 QWA--LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK---AGVEHQLRREVEIQSHLRHPNILRLYGYFH 76 (263)
T ss_dssp CCC--GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred Ccc--hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC---hHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence 355 468999999999999999999996 7899999987532111 112467889999999999999997
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 156 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred ECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeec
Confidence 3467999999999999999999999999999999999999999999999999999765
Q ss_pred ccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 020016 179 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 258 (332)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 258 (332)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....+|..+++++.+
T Consensus 157 ~~~-~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~ 233 (263)
T d2j4za1 157 PSS-RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARD 233 (263)
T ss_dssp CCC-CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHH
T ss_pred CCC-cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHH
Confidence 442 3345679999999999999999999999999999999999999999988888777664 3445678889999999
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~ 279 (332)
||.+||+.||++|||++|+++
T Consensus 234 li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 234 LISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHccCCHhHCcCHHHHHc
Confidence 999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-52 Score=369.73 Aligned_cols=233 Identities=30% Similarity=0.620 Sum_probs=195.3
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEEC-----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--- 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--- 120 (332)
+|+|+.++|.+++.||+|+||+||+|.+. +..||||.+....... ..+.|.+|+.++++++|||||+
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~ 75 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS-----VREKFLQEALTMRQFDHPHIVKLIG 75 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHH-----HHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHH-----HHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 69999999999999999999999999885 2468999887644332 2467999999999999999997
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
....+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 76 VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp EECSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred EEecCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhh
Confidence 5567999999999999999999999999999999999999999999999999999
Q ss_pred cccccCC--CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 020016 176 CLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 252 (332)
Q Consensus 176 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (332)
+...... ......||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..+....+. ...+++.++.+
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~ 234 (273)
T d1mp8a_ 156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNC 234 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTC
T ss_pred eeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Confidence 7654332 2334568999999999999999999999999999999998 999999988877776664 45667788999
Q ss_pred cHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 253 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
|+.+.+||.+||+.||++|||+.+|++.|+.+.+.
T Consensus 235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999987654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-52 Score=364.59 Aligned_cols=225 Identities=26% Similarity=0.506 Sum_probs=200.8
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
+|.++|+++++||+|+||+||+|+++ ++.||||+++..... .++|.+|+.++.+++|||||+
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~ 73 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 73 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC-------HHHHHHHHHHHHTCCCTTBCCEEEEECCSSS
T ss_pred CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC-------HHHHHHHHHHHHhcCCCceeeEEEEEeeCCc
Confidence 46789999999999999999999997 679999999876544 257999999999999999997
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..+..++.|+++||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 74 ~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 74 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp EEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred eEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 4567899999999999999999999999999999999999999999999999999765443
Q ss_pred C--CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 020016 182 G--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 258 (332)
Q Consensus 182 ~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 258 (332)
. ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.+.+..+....+. ...++..|..+++++.+
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~ 232 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYT 232 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHH
T ss_pred CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-hCCCCCCcccccHHHHH
Confidence 2 2334678999999999999999999999999999999998 899999999888777665 45677888899999999
Q ss_pred HHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 259 LISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
||.+||+.||++|||++++++.|.++
T Consensus 233 li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 233 IMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 99999999999999999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=368.92 Aligned_cols=238 Identities=27% Similarity=0.522 Sum_probs=206.6
Q ss_pred ccccccCCeeeeee-ecccCceEEEEEEEC----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---
Q 020016 49 EWSADMSQLFIGCK-FASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--- 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~-lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--- 120 (332)
.|.++.++|.+.+. ||+|+||+||+|.++ +..||||+++...... ..+.|.+|+.+|++++|||||+
T Consensus 2 ~l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~g 76 (285)
T d1u59a_ 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-----DTEEMMREAQIMHQLDNPYIVRLIG 76 (285)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHH-----HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ceeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHH-----HHHHHHHHHHHHHhCCCCCEeeEee
Confidence 35667789999985 999999999999875 3579999998654332 2467999999999999999997
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccc
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 77 ~~~~~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla 156 (285)
T d1u59a_ 77 VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 156 (285)
T ss_dssp EEESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred eeccCeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhh
Confidence 3467999999999999999999999999999999999999999999999999999
Q ss_pred cccccCC----CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 020016 176 CLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 250 (332)
Q Consensus 176 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (332)
+...... ......||+.|+|||++.++.++.++|||||||++|||+| |..||.+.+..+....+ ..+.++..|+
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i-~~~~~~~~p~ 235 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPP 235 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH-HTTCCCCCCT
T ss_pred hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCC
Confidence 7654322 2234568999999999999999999999999999999998 99999998877766555 4566788889
Q ss_pred CCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCc
Q 020016 251 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 292 (332)
Q Consensus 251 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~ 292 (332)
.+|+++.+||.+||+.||++|||+.+|++.|+....++....
T Consensus 236 ~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~ 277 (285)
T d1u59a_ 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277 (285)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhcc
Confidence 999999999999999999999999999999998887776554
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-52 Score=378.20 Aligned_cols=232 Identities=24% Similarity=0.474 Sum_probs=200.0
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEECC-------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCce
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHI 118 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 118 (332)
...|+++.++|.+++.||+|+||+||+|.+.+ ..||||.+....... ....|.+|+.+|.++ +||||
T Consensus 29 ~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~HpnI 103 (325)
T d1rjba_ 29 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-----EREALMSELKMMTQLGSHENI 103 (325)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTB
T ss_pred CccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHH-----HHHHHHHHHHHHHHhcCCCcE
Confidence 35699999999999999999999999999852 369999987643322 146789999999998 89999
Q ss_pred ec----------------------------C-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 020016 119 IT----------------------------E-----------------------PYSVPLNLVLKLALDIARGMQYLHSQ 147 (332)
Q Consensus 119 v~----------------------------~-----------------------~~~l~~~~~~~i~~qi~~~L~~LH~~ 147 (332)
|+ . ...+++..++.++.||+.||.|||++
T Consensus 104 v~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~ 183 (325)
T d1rjba_ 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK 183 (325)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 87 0 13488999999999999999999999
Q ss_pred CCccccccccceeecCCCeEEEeecccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-C
Q 020016 148 GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-A 223 (332)
Q Consensus 148 ~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G 223 (332)
||+||||||+||+++.++.+||+|||+|+....... .....||+.|+|||++.++.++.++|||||||++|||+| |
T Consensus 184 ~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g 263 (325)
T d1rjba_ 184 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263 (325)
T ss_dssp TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCC
Confidence 999999999999999999999999999976554332 234568999999999999999999999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 020016 224 LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 283 (332)
Q Consensus 224 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~ 283 (332)
..||.+.+..+....+.....+++.|..+++++.+||.+||+.||++|||++||++.|..
T Consensus 264 ~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 264 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 999998877777777777888888999999999999999999999999999999999863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=366.26 Aligned_cols=221 Identities=24% Similarity=0.386 Sum_probs=184.8
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|++.+.||+|+||+||+|+++ |+.||||++........ ..+.+.+|+.++++++|||||+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 78 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA----EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHH----HHHHHHHHHHHTTSCCCTTBCCEEEEEEC----
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHH----HHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCC
Confidence 368999999999999999999996 78999999987644332 1467899999999999999987
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CccccccccceeecCCCeEEEeec
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQG-----ILHRDLKSENLLLGEDMCVKVADF 172 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----iiH~dlkp~NIll~~~~~~kl~Df 172 (332)
....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+||
T Consensus 79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF 158 (269)
T d2java1 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158 (269)
T ss_dssp CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence 2457999999999999999999999976 999999999999999999999999
Q ss_pred ccccccccC-CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 020016 173 GISCLESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 251 (332)
Q Consensus 173 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (332)
|++...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..+....+... ..+.++..
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 237 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-KFRRIPYR 237 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCCCCTT
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCCCCCcc
Confidence 999775543 2345678999999999999999999999999999999999999999999888877776543 44567788
Q ss_pred CcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 252 CPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 252 ~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
+++++.+||.+||+.||.+|||++|+++
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 9999999999999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=370.12 Aligned_cols=219 Identities=23% Similarity=0.442 Sum_probs=193.0
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||+||+|.+. |+.||||++....... .+.+.+|+.+|++++|||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH------HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE
Confidence 57999999999999999999986 8999999998654333 356899999999999999997
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-CCC
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GSA 184 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~~ 184 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... ...
T Consensus 94 ivmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp EEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EEEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence 3457999999999999999999999999999999999999999999999999999865433 344
Q ss_pred CCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCcHHHHHHHHHc
Q 020016 185 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-ARPPVPPTCPKAFSYLISRC 263 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~c 263 (332)
...+||+.|+|||++.+..++.++|||||||++|+|+||..||.+.+..+....+.... .....+..+++++.+||.+|
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 253 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHH
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHH
Confidence 56779999999999999999999999999999999999999999988877766655443 33455678999999999999
Q ss_pred cccCCCCCCCHHHHHH
Q 020016 264 WSSSPDRRPHFDQIVS 279 (332)
Q Consensus 264 l~~dp~~Rps~~ell~ 279 (332)
|+.||.+|||+.|+++
T Consensus 254 L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 254 LDMDVEKRGSAKELLQ 269 (293)
T ss_dssp TCSSTTTSCCHHHHTT
T ss_pred ccCChhHCcCHHHHhc
Confidence 9999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-51 Score=368.94 Aligned_cols=232 Identities=30% Similarity=0.525 Sum_probs=200.7
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEECC-------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 120 (332)
.+|+++.++|.+.+.||+|+||+||+|.+++ +.||||+++...... ..+.|.+|+.+|++++||||++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~E~~il~~l~h~niv~ 80 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-----MQADFQREAALMAEFDNPNIVK 80 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHH-----HHHHHHHHHHHHHTCCCTTBCC
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChH-----HHHHHHHHHHHHHhcCCCCccc
Confidence 4588889999999999999999999998753 689999998654432 2467999999999999999986
Q ss_pred ----------------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 020016 121 ----------------------------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQG 148 (332)
Q Consensus 121 ----------------------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 148 (332)
....+++..++.++.|++.||+|||+++
T Consensus 81 ~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ 160 (301)
T d1lufa_ 81 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 160 (301)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC
Confidence 1234889999999999999999999999
Q ss_pred CccccccccceeecCCCeEEEeecccccccccC---CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhC-C
Q 020016 149 ILHRDLKSENLLLGEDMCVKVADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA-L 224 (332)
Q Consensus 149 iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG-~ 224 (332)
++||||||+|||++.++.+||+|||++...... .......+|+.|+|||.+.+..++.++|||||||++|||++| .
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence 999999999999999999999999999754332 223356788999999999999999999999999999999997 5
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 020016 225 TPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 285 (332)
Q Consensus 225 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~ 285 (332)
+||.+.+..+....+. ...++..|..+++++.+||.+||+.||++|||+.+|+++|+.+.
T Consensus 241 ~p~~~~~~~e~~~~v~-~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 241 QPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 7899988888877765 45567788899999999999999999999999999999999874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=365.35 Aligned_cols=220 Identities=24% Similarity=0.360 Sum_probs=183.9
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|++++.||+|+||+||+|.++ ++.||||++....... ..+.+.+|+.+|++++|||||+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ 79 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-----CPENIKKEICINKMLNHENVVKFYGHRREGNIQY 79 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-----HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeE
Confidence 68999999999999999999996 7899999998754322 1356899999999999999997
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC---
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC--- 181 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--- 181 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 4567999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCCcccccccCChhhhhcCCC-CCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcCCCCCCCCCCcHHHHHH
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA-VCQKNARPPVPPTCPKAFSYL 259 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l 259 (332)
......+||+.|+|||++.+..+ +.++|||||||++|+|+||+.||........... .............+++++.+|
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence 23456789999999999988776 6789999999999999999999987654433333 322333333446789999999
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 020016 260 ISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~ 279 (332)
|.+||+.||.+|||++|+++
T Consensus 240 i~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 240 LHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHcCCChhHCcCHHHHhc
Confidence 99999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-51 Score=367.54 Aligned_cols=219 Identities=28% Similarity=0.422 Sum_probs=193.4
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
+.|.+.+.||+|+||+||+|.+. ++.||||++........ ...+.+.+|+.+|++++|||||+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCH---HHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEE
Confidence 35999999999999999999986 78999999987543322 22467899999999999999997
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 184 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 184 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~ 168 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---A 168 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---B
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---C
Confidence 457899999999999999999999999999999999999999999999999999976543 3
Q ss_pred CCcccccccCChhhhhc---CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 020016 185 KGFTGTYRWMAPEMIKE---KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 261 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 261 (332)
....||+.|+|||++.+ +.++.++|||||||++|||++|..||.+.+..+....+.........+..+++++.+||.
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~ 248 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHH
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 45689999999999864 457899999999999999999999999998888888777666656666789999999999
Q ss_pred HccccCCCCCCCHHHHHH
Q 020016 262 RCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 262 ~cl~~dp~~Rps~~ell~ 279 (332)
+||+.||.+|||++++++
T Consensus 249 ~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 249 SCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHTCSSGGGSCCHHHHTT
T ss_pred HHCcCChhHCcCHHHHHh
Confidence 999999999999999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=362.68 Aligned_cols=227 Identities=29% Similarity=0.547 Sum_probs=196.4
Q ss_pred ccccccCCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 49 EWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 49 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
.|+++.++|++++.||+|+||.||+|.++|+.||||+++.... .+.|.+|++++++++|||||+
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~--------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIVEE 72 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----------HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred CCccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHH--------HHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence 3999999999999999999999999999999999999976432 356899999999999999997
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccc
Q 020016 121 -----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 121 -----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
....+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+|||++..
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~ 152 (262)
T d1byga_ 73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 152 (262)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccccccee
Confidence 112479999999999999999999999999999999999999999999999999976
Q ss_pred cccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 020016 178 ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 256 (332)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (332)
.... .....+|..|+|||++.++.++.++||||||+++|||+| |++||...+..+....+. ...+++++..+++++
T Consensus 153 ~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~ 229 (262)
T d1byga_ 153 ASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAV 229 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHH
T ss_pred cCCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHH
Confidence 5432 334567899999999999999999999999999999998 899999888777766654 467788899999999
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 286 (332)
.+||.+||+.||.+|||+.++++.|+.+..
T Consensus 230 ~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 230 YEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999998754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=361.37 Aligned_cols=229 Identities=27% Similarity=0.521 Sum_probs=192.4
Q ss_pred ccCCeeee-eeecccCceEEEEEEEC----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------
Q 020016 53 DMSQLFIG-CKFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------- 120 (332)
Q Consensus 53 ~~~~y~i~-~~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 120 (332)
|...+.+. ++||+|+||+||+|.++ ++.||||+++....+. ...+.|.+|+.+|++++|||||+
T Consensus 4 d~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~g~~~~ 79 (277)
T d1xbba_ 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP----ALKDELLAEANVMQQLDNPYIVRMIGICEA 79 (277)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C----HHHHHHHHHHHHHHTCCCTTBCCEEEEEES
T ss_pred chhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCH----HHHHHHHHHHHHHHhCCCCCCceEEEEecc
Confidence 33445554 47999999999999874 3679999997643322 22467999999999999999997
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 80 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CCEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccc
Confidence 456799999999999999999999999999999999999999999999999999976543
Q ss_pred CC----CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 020016 181 CG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 255 (332)
Q Consensus 181 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (332)
.. ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..+....+. ...+++.|..+|++
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~ 238 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPRE 238 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHH
Confidence 22 2234568999999999999999999999999999999998 999999988877666554 56678888999999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 020016 256 FSYLISRCWSSSPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 256 l~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 286 (332)
+.+||.+||+.||++|||+++|++.|+....
T Consensus 239 ~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 239 MYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 9999999999999999999999999987644
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-50 Score=366.44 Aligned_cols=220 Identities=26% Similarity=0.390 Sum_probs=176.7
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
+.|++++.||+|+||+||+|.++ ++.||||++........ .+.+.+|+.+|++++|||||+
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 83 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-----EGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC---------------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 56999999999999999999996 78999999987543321 356889999999999999997
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeec---CCCeEEEeecccccccccC
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG---EDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~ 181 (332)
..+.+++..+..++.||+.||.|||++||+||||||+||++. .++.+||+|||++......
T Consensus 84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred EEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 556899999999999999999999999999999999999994 4789999999999877665
Q ss_pred CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHHHH
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCPKAFSYL 259 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 259 (332)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+....... +.+..+|+++.+|
T Consensus 164 ~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 243 (307)
T d1a06a_ 164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHH
Confidence 55567789999999999999999999999999999999999999999988888877776654443 3446799999999
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 020016 260 ISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~ 279 (332)
|.+||+.||++|||++|+++
T Consensus 244 i~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 244 IRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHccCCHhHCcCHHHHhc
Confidence 99999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=366.22 Aligned_cols=221 Identities=24% Similarity=0.383 Sum_probs=190.7
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|++++.||+|+||+||+|.+. ++.||||++...... .....+.+.+|+++|++++|||||+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII---KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc---CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 368999999999999999999996 789999999753211 1112467899999999999999997
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 182 (332)
..+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 45679999999999999999999999999999999999999999999999999997654322
Q ss_pred --CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 020016 183 --SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 260 (332)
Q Consensus 183 --~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 260 (332)
.....+||+.|+|||++.+..++.++|||||||++|+|+||..||.+.+..+....+.. ....+|..+++++.+||
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li 241 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLV 241 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT--TCCCCCTTCCHHHHHHH
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc--CCCCCCccCCHHHHHHH
Confidence 23456799999999999999999999999999999999999999999888887777653 34567888999999999
Q ss_pred HHccccCCCCCCCHHHHHH
Q 020016 261 SRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 261 ~~cl~~dp~~Rps~~ell~ 279 (332)
.+||+.||.+|||++|+++
T Consensus 242 ~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 242 EKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HTTSCSSGGGSTTSGGGTC
T ss_pred HHHccCCHhHCcCHHHHcC
Confidence 9999999999999999754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=365.56 Aligned_cols=236 Identities=24% Similarity=0.481 Sum_probs=193.5
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCce
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHI 118 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 118 (332)
...|+++.++|++++.||+|+||.||+|.+. ++.||||++........ .+.+.+|..++.++ +|+||
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~-----~~~~~~e~~~l~~~~~h~~i 79 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLNV 79 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHH-----HHHHHHHHHHHHHHCCCTTB
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHH-----HHHHHHHHHHHHhhcCCCeE
Confidence 3579999999999999999999999999874 26799999976443322 35678888888887 67888
Q ss_pred ec---------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 020016 119 IT---------------------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRD 153 (332)
Q Consensus 119 v~---------------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~d 153 (332)
|. ....+++..+..++.||+.||.|||++||+|||
T Consensus 80 v~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrD 159 (299)
T d1ywna1 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 159 (299)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCc
Confidence 75 123478999999999999999999999999999
Q ss_pred ccccceeecCCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhC-CCCCCC
Q 020016 154 LKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA-LTPFDN 229 (332)
Q Consensus 154 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG-~~pf~~ 229 (332)
|||+|||++.++.+||+|||+|+...... ......||+.|+|||++.+..++.++|||||||++|||+|| ..||.+
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999997644322 23456799999999999999999999999999999999995 678988
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 230 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
....+..........++..|..+++++.+||.+||+.||++|||+.++++.|+.+.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 7665666666667778888999999999999999999999999999999999988654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=365.98 Aligned_cols=219 Identities=25% Similarity=0.445 Sum_probs=189.6
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
+.|++++.||+|+||+||+|.+. ++.||||++....... .+.|.+|+.+|++++|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~------~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 85 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE------LEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 85 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG------GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH------HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEE
Confidence 46899999999999999999996 7899999998754433 356889999999999999997
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-C
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-G 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~ 182 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|...... .
T Consensus 86 lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence 3467999999999999999999999999999999999999999999999999998654332 2
Q ss_pred CCCCcccccccCChhhhh-----cCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHH
Q 020016 183 SAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAF 256 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 256 (332)
......||+.|+|||++. +..++.++|||||||++|+|+||+.||.+.+..+....+..... ....+..+++++
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 245 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHH
Confidence 234567999999999984 45678999999999999999999999999888887777665433 234457889999
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.+||.+||+.||.+|||++|+++
T Consensus 246 ~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 246 KDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHccCChhHCcCHHHHhc
Confidence 99999999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-51 Score=362.96 Aligned_cols=230 Identities=27% Similarity=0.492 Sum_probs=192.0
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC---C--eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK---Q--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------ 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~---~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 120 (332)
|+.++|++.+.||+|+||+||+|.+. + ..||||++....... ....+.|.+|+.+|++++|||||+
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ---PEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCC---HHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 55688999999999999999999874 2 479999987643322 122467999999999999999997
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 82 TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred ecchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 3456999999999999999999999999999999999999999999999999999875
Q ss_pred ccCCC----CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 020016 179 SQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 253 (332)
Q Consensus 179 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (332)
..... .....++..|+|||.+.+..++.++||||||+++|||+| |..||.+.+..+....+.....+++.+..++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccccc
Confidence 44322 234457889999999999999999999999999999998 8999999999998888888888888889999
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 020016 254 KAFSYLISRCWSSSPDRRPHFDQIVSILEGY 284 (332)
Q Consensus 254 ~~l~~li~~cl~~dp~~Rps~~ell~~L~~~ 284 (332)
+.+.+||.+||+.||++|||+.+|++.|++.
T Consensus 242 ~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 242 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 9999999999999999999999999999865
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=365.06 Aligned_cols=227 Identities=27% Similarity=0.548 Sum_probs=193.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--Ce----eEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QR----DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 120 (332)
++|++++.||+|+||+||+|.+. |+ .||||.+........ .+.|.+|+.++++++|||||+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-----NKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CT-----HHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 57999999999999999999986 33 689998875433222 467999999999999999997
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 567899999999999999999999999999999999999999999999999999976544
Q ss_pred CCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 020016 181 CGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 256 (332)
Q Consensus 181 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (332)
... .....||+.|+|||++.++.++.++|||||||++|||+| |..||.+.+..+....+ ..+.+++.|..+++.+
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i-~~~~~~~~p~~~~~~~ 242 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDV 242 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH-HHTCCCCCCTTBCHHH
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCCcccCHHH
Confidence 322 234568999999999999999999999999999999999 89999988776655444 4567778889999999
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus 243 ~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 243 YMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 9999999999999999999999999887543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.7e-50 Score=368.12 Aligned_cols=221 Identities=21% Similarity=0.316 Sum_probs=194.9
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+++.||+|+||+||+|.+. |+.||||++....... .+.+.+|+.+|++++|||||+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD------KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHH------HHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhh------HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 368999999999999999999996 8999999997754332 367889999999999999997
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC--CCeEEEeeccccccccc
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE--DMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~--~~~~kl~Dfg~a~~~~~ 180 (332)
..+.+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 3457999999999999999999999999999999999999964 58899999999987766
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHH
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSY 258 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 258 (332)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+........ ....+++++.+
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 258 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 5555667899999999999999999999999999999999999999999988888877765544332 23568999999
Q ss_pred HHHHccccCCCCCCCHHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~~ 280 (332)
||.+||+.||.+|||+.|+++.
T Consensus 259 li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 259 FIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999873
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=359.96 Aligned_cols=234 Identities=29% Similarity=0.536 Sum_probs=203.7
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCcee
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 119 (332)
.++|+|+.++|.+++.||+|+||+||+|.++ ++.||||+++....... ...|.+|+.++++++|||||
T Consensus 12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~-----~~~~~~E~~il~~l~h~nIv 86 (308)
T d1p4oa_ 12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE-----RIEFLNEASVMKEFNCHHVV 86 (308)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHH-----HHHHHHHHHHGGGCCCTTBC
T ss_pred ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHH-----HHHHHHHHHHHHHcCCCCEe
Confidence 3579999999999999999999999999885 36899999976543322 35789999999999999999
Q ss_pred c--------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee
Q 020016 120 T--------------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 161 (332)
Q Consensus 120 ~--------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll 161 (332)
+ ....+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 87 ~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 87 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 166 (308)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred eeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee
Confidence 7 22346888999999999999999999999999999999999
Q ss_pred cCCCeEEEeecccccccccCCC---CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhC-CCCCCCCCHHHHHH
Q 020016 162 GEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAF 237 (332)
Q Consensus 162 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG-~~pf~~~~~~~~~~ 237 (332)
+.++.+||+|||++........ .....+|+.|+|||.+.++.++.++||||||+++|||+|| ..||.+.+..+...
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~ 246 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999976543322 3345689999999999999999999999999999999997 68899988888777
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 020016 238 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 286 (332)
.+. ...++..+..+++.+.+||.+||+.||++|||+++|++.|+...+
T Consensus 247 ~i~-~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 247 FVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHH-hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 665 455677888999999999999999999999999999999987644
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=363.19 Aligned_cols=223 Identities=22% Similarity=0.321 Sum_probs=195.1
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
+..++|.+++.||+|+||+||+|+++ ++.||||++++..... ....+.+.+|+.+|+.++|||||+
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 78 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA---KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC---HHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc
Confidence 45679999999999999999999986 8899999997632111 112466889999999999999997
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc-
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ- 180 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~- 180 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred ccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 346789999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 260 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 260 (332)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+... ...+|..+++++.+||
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli 236 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLL 236 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--CCCCCccCCHHHHHHH
Confidence 33455678999999999999999999999999999999999999999999988877766543 4667889999999999
Q ss_pred HHccccCCCCCCC-----HHHHHH
Q 020016 261 SRCWSSSPDRRPH-----FDQIVS 279 (332)
Q Consensus 261 ~~cl~~dp~~Rps-----~~ell~ 279 (332)
.+||+.||.+|++ ++++++
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 237 AGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HhhccCCchhhcccccccHHHHHc
Confidence 9999999999995 777776
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.7e-50 Score=366.62 Aligned_cols=219 Identities=21% Similarity=0.316 Sum_probs=195.1
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
+.|++.+.||+|+||+||+|.+. |+.||||++....... .+.+.+|+.+|++++|||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~------~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD------KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH------HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH------HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 67999999999999999999986 8899999998754322 356889999999999999997
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeec--CCCeEEEeecccccccccC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG--EDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 344699999999999999999999999999999999999997 5689999999999887765
Q ss_pred CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHHHH
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCPKAFSYL 259 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 259 (332)
.......||+.|+|||++.+..++.++|||||||++|+|+||..||.+.+..+....+....... ..+..+++++.+|
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 262 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 55666789999999999999999999999999999999999999999999888887776654433 3446789999999
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 020016 260 ISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~ 279 (332)
|.+||+.||.+|||+.|+++
T Consensus 263 i~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 263 IKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHccCChhHCcCHHHHhc
Confidence 99999999999999999987
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-50 Score=354.30 Aligned_cols=217 Identities=25% Similarity=0.445 Sum_probs=182.6
Q ss_pred eeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------
Q 020016 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------- 120 (332)
Q Consensus 57 y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 120 (332)
|++.++||+|+||+||+|.+. ++.||||++........ ..+.|.+|+++|++++|||||+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS----ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH----HHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH----HHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 478889999999999999997 67899999976543322 1467899999999999999986
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC--Cccccccccceeec-CCCeEEEeecccccccc
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLG-EDMCVKVADFGISCLES 179 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~NIll~-~~~~~kl~Dfg~a~~~~ 179 (332)
....+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 3357899999999999999999999998 99999999999996 57899999999997644
Q ss_pred cCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCCCCCCCCCCcHHHHH
Q 020016 180 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA-FAVCQKNARPPVPPTCPKAFSY 258 (332)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~ 258 (332)
. .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....... ..+........++..+++++.+
T Consensus 167 ~-~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (270)
T d1t4ha_ 167 A-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244 (270)
T ss_dssp T-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred C-CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHH
Confidence 3 23446689999999999875 5999999999999999999999999876554444 3443333334456778999999
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~ 279 (332)
||.+||+.||++|||++|+++
T Consensus 245 li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 245 IIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHccCCHhHCcCHHHHhC
Confidence 999999999999999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=360.99 Aligned_cols=225 Identities=24% Similarity=0.331 Sum_probs=194.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
+.|++++.||+|+||+||+|.++ |+.||||++..............+.|.+|+.+|++++|||||+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57999999999999999999996 7899999997643322111112467899999999999999997
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC----eEEEeeccccccccc
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM----CVKVADFGISCLESQ 180 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~----~~kl~Dfg~a~~~~~ 180 (332)
..+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence 345799999999999999999999999999999999999998776 599999999987766
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHH
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSY 258 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 258 (332)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+........ .+..+|+.+.+
T Consensus 170 ~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 249 (293)
T d1jksa_ 170 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 249 (293)
T ss_dssp SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHH
T ss_pred CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHH
Confidence 5556677899999999999999999999999999999999999999999988888777655433322 34678999999
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~ 279 (332)
||.+||+.||++|||++++++
T Consensus 250 li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 250 FIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-50 Score=363.57 Aligned_cols=222 Identities=22% Similarity=0.397 Sum_probs=182.8
Q ss_pred cccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec---------
Q 020016 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--------- 120 (332)
Q Consensus 52 ~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 120 (332)
+..++|++.+.||+|+||+||+|.+. |+.||||+++....... .+.+.+|+.+|++++|||||+
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 77 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI-----RNQIIRELQVLHECNSPYIVGFYGAFYSDG 77 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTH-----HHHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 34578999999999999999999996 79999999987543322 467899999999999999997
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
..+.+++..+..++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+|.....
T Consensus 78 ~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 78 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 345799999999999999999999975 999999999999999999999999999986544
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH----------------------
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA---------------------- 238 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~---------------------- 238 (332)
. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......
T Consensus 158 ~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 158 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp H-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred C-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 2 23457899999999999999999999999999999999999999976543211000
Q ss_pred -------------------HHhcCCCCCCC-CCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 239 -------------------VCQKNARPPVP-PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 239 -------------------~~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.......+..+ ..++.++.+||.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00011111222 246889999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=356.07 Aligned_cols=233 Identities=27% Similarity=0.516 Sum_probs=198.7
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEECC---------eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCc
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQ---------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPH 117 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 117 (332)
..|+++.++|.+++.||+|+||.||+|++.+ ..||||+++....... ...+.+|+..+.++ +|||
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~-----~~~~~~e~~~l~~~~~Hpn 80 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-----LSDLISEMEMMKMIGKHKN 80 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHH-----HHHHHHHHHHHHHHCCCTT
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHH-----HHHHHHHHHHHHHhcCCCe
Confidence 4599999999999999999999999998742 4699999987554332 36688899999888 8999
Q ss_pred eec--------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 020016 118 IIT--------------------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRD 153 (332)
Q Consensus 118 iv~--------------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~d 153 (332)
||+ ....+++..++.++.||+.||+|||+.+|+|||
T Consensus 81 Iv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrD 160 (299)
T d1fgka_ 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD 160 (299)
T ss_dssp BCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeee
Confidence 997 124589999999999999999999999999999
Q ss_pred ccccceeecCCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCCC
Q 020016 154 LKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 229 (332)
Q Consensus 154 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~~ 229 (332)
|||+|||++.++.+||+|||++....... ......+|+.|+|||.+.++.++.++||||||+++|||++ |.+||.+
T Consensus 161 iKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~ 240 (299)
T d1fgka_ 161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240 (299)
T ss_dssp CSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence 99999999999999999999998665433 2344678999999999999999999999999999999998 7999998
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 020016 230 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 286 (332)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 286 (332)
.+..+....+ ....++..|..+++++.+||.+||+.||.+|||+.||++.|+.+.+
T Consensus 241 ~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 241 VPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp CCHHHHHHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHH-HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 8887665544 4577888899999999999999999999999999999999998854
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.6e-49 Score=352.46 Aligned_cols=228 Identities=23% Similarity=0.384 Sum_probs=191.9
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||+||+|.+. ++.||||+++....... ...+.|.+|+.+++.++|||||+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP---SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCH---HHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 67999999999999999999986 89999999987544321 22467999999999999999987
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
..+.+++..++.++.||+.||.|||++||+||||||+|||++.++..+|+|||.+.....
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 445799999999999999999999999999999999999999999999999998765432
Q ss_pred C----CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcH
Q 020016 181 C----GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCPK 254 (332)
Q Consensus 181 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 254 (332)
. .......||+.|+|||++.+..++.++|||||||++|+|+||..||.+.+..+....+......+ .....+|+
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 243 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCH
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 2 22345679999999999999999999999999999999999999999999888877776654443 24467899
Q ss_pred HHHHHHHHccccCCCCCC-CHHHHHHHHHhhh
Q 020016 255 AFSYLISRCWSSSPDRRP-HFDQIVSILEGYS 285 (332)
Q Consensus 255 ~l~~li~~cl~~dp~~Rp-s~~ell~~L~~~~ 285 (332)
++.++|.+||+.||.+|| |++++++.|..+.
T Consensus 244 ~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 244 DLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 999999999999999999 8999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-49 Score=354.52 Aligned_cols=236 Identities=27% Similarity=0.505 Sum_probs=205.7
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEEC-------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCce
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHI 118 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 118 (332)
...|+++.++|.+++.||+|+||.||+|.+. ++.||||+++....... ...|.+|+.+++.+ +||||
T Consensus 15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~E~~~~~~l~~HpnI 89 (311)
T d1t46a_ 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-----REALMSELKVLSYLGNHMNI 89 (311)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCCCTTB
T ss_pred cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHH-----HHHHHHHHHHHHhccCCCCE
Confidence 4579999999999999999999999999863 36899999987544322 46789999999999 79999
Q ss_pred ec----------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 020016 119 IT----------------------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHR 152 (332)
Q Consensus 119 v~----------------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~ 152 (332)
|+ ....+++..+..++.||+.||+|||++|++||
T Consensus 90 v~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHr 169 (311)
T d1t46a_ 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 169 (311)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 97 12358999999999999999999999999999
Q ss_pred cccccceeecCCCeEEEeecccccccccCC---CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHh-CCCCCC
Q 020016 153 DLKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFD 228 (332)
Q Consensus 153 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~pf~ 228 (332)
||||+||+++.++.++|+|||.+....... ......||+.|+|||.+.++.++.++||||||+++|||+| |.+||.
T Consensus 170 DLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 999999999999999999999997654332 2234678999999999999999999999999999999999 777787
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 020016 229 NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 287 (332)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 287 (332)
.....+....+.....++..+..+++.+.+||.+||+.||.+|||+++|+++|++...+
T Consensus 250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp TCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 77776777777777888888899999999999999999999999999999999976544
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.9e-49 Score=356.75 Aligned_cols=219 Identities=25% Similarity=0.379 Sum_probs=192.8
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|++++.||+|+||+||+|+++ |+.||||+++...... ....+.+.+|+.+++.++|||||+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 79 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR---LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 79 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccC---HHHHHHHHHHHHHHHhccCcChhheeeeEeeCCee
Confidence 468999999999999999999986 7899999997532111 112467889999999999999997
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 80 ~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 4567889999999999999999999999999999999999999999999999999776542
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHc
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 263 (332)
....+||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+..+....+... ...+|+.+++++.+++.+|
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~ 235 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRL 235 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHH
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHH
Confidence 34578999999999999999999999999999999999999999999988887777654 3467788999999999999
Q ss_pred cccCCCCCC-----CHHHHHH
Q 020016 264 WSSSPDRRP-----HFDQIVS 279 (332)
Q Consensus 264 l~~dp~~Rp-----s~~ell~ 279 (332)
|..||.+|+ |++++++
T Consensus 236 L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 236 ITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp TCSCTTTCTTSSTTTTHHHHT
T ss_pred hhhCHHhccccchhhHHHHHc
Confidence 999999996 8999886
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-49 Score=363.23 Aligned_cols=219 Identities=22% Similarity=0.284 Sum_probs=192.7
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|++++.||+|+||+||+|.++ |+.||||++....... ....+.+.+|+.+|+.++|||||+
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK---LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC---HHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence 468999999999999999999996 8899999987532111 112366889999999999999987
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
..+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... .
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--~ 194 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--R 194 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--C
T ss_pred ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--c
Confidence 346799999999999999999999999999999999999999999999999999977653 2
Q ss_pred CCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHc
Q 020016 184 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 263 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 263 (332)
.....||+.|+|||++.+..++.++|||||||++|+|+||..||.+.+.......+... ....+..+++++.+||.+|
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~ 272 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNL 272 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTCCHHHHHHHHHH
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC--CCCCCccCCHHHHHHHHHH
Confidence 34578999999999999999999999999999999999999999999888877777544 4556788999999999999
Q ss_pred cccCCCCCC-----CHHHHHH
Q 020016 264 WSSSPDRRP-----HFDQIVS 279 (332)
Q Consensus 264 l~~dp~~Rp-----s~~ell~ 279 (332)
|+.||.+|+ +++++++
T Consensus 273 L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 273 LQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp SCSCTTTCTTSSTTTTHHHHT
T ss_pred hhhCHHhccccccccHHHHHc
Confidence 999999994 8999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=356.82 Aligned_cols=232 Identities=30% Similarity=0.501 Sum_probs=197.8
Q ss_pred ccccCCeeeeeeecccCceEEEEEEEC--Ce--eEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC-CCCceec-----
Q 020016 51 SADMSQLFIGCKFASGRHSRIYRGIYK--QR--DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT----- 120 (332)
Q Consensus 51 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~--~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----- 120 (332)
.||.++|++++.||+|+||+||+|.++ +. .||||.+........ .+.|.+|+++|.++ +|||||+
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~ 80 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-----HRDFAGELEVLCKLGHHPNIINLLGAC 80 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-----------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHH-----HHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence 367789999999999999999999986 33 578888765433221 46799999999999 7999997
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceee
Q 020016 121 ---------------------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 161 (332)
Q Consensus 121 ---------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll 161 (332)
....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 81 ~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~ 160 (309)
T d1fvra_ 81 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 160 (309)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE
Confidence 13568999999999999999999999999999999999999
Q ss_pred cCCCeEEEeecccccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhC-CCCCCCCCHHHHHHHHH
Q 020016 162 GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVC 240 (332)
Q Consensus 162 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG-~~pf~~~~~~~~~~~~~ 240 (332)
+.++.+||+|||++.............||..|+|||.+.++.++.++||||||+++|||++| .+||.+.+..+....+.
T Consensus 161 ~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 161 GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240 (309)
T ss_dssp CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred cCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 99999999999999876665555667799999999999999999999999999999999995 56888888877766654
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 020016 241 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 288 (332)
Q Consensus 241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 288 (332)
...++..+..+++++.+||.+||+.||++|||+++|++.|+++.+..
T Consensus 241 -~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 241 -QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp -GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 45677888899999999999999999999999999999999987643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.7e-48 Score=346.84 Aligned_cols=225 Identities=26% Similarity=0.360 Sum_probs=195.9
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchh---HHHHHHHHHHHHHHHHHHcCC-CCceec--------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDA---SLASMLEKQFTSEVALLFRLN-HPHIIT-------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~-h~niv~-------- 120 (332)
++|++.+.||+|+||+||+|++. ++.||||+++...... ...+...+.+.+|+.++++++ |||||+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 78999999999999999999985 7999999998754322 223445678999999999997 999987
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccccc
Q 020016 121 --------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 --------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (332)
..+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 162 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 162 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccC
Confidence 456799999999999999999999999999999999999999999999999999987766
Q ss_pred CCCCCCcccccccCChhhhhc------CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCC
Q 020016 181 CGSAKGFTGTYRWMAPEMIKE------KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTC 252 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~ 252 (332)
........||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+.......+........ ....+
T Consensus 163 ~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (277)
T d1phka_ 163 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 242 (277)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGS
T ss_pred CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccC
Confidence 556667789999999999964 2357899999999999999999999999998888777776654433 33478
Q ss_pred cHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 253 PKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
|+++.+|+.+||+.||++|||++|+++
T Consensus 243 s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 243 SDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 999999999999999999999999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=352.40 Aligned_cols=219 Identities=16% Similarity=0.263 Sum_probs=192.5
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
+++|.+++.||+|+||+||+|.++ ++.||||+++....+ ...+.+|+++|+.++|||||+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-------~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-------QVLVKKEISILNIARHRNILHLHESFESMEEL 76 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-------HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-------HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 478999999999999999999996 789999999875433 245789999999999999997
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC--CeEEEeeccccccccc
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED--MCVKVADFGISCLESQ 180 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~--~~~kl~Dfg~a~~~~~ 180 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 23479999999999999999999999999999999999999854 5899999999977655
Q ss_pred CCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHH
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSY 258 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 258 (332)
........+|+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+.......+ ....+++++.+
T Consensus 157 ~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T d1tkia_ 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence 4445566789999999999999999999999999999999999999999999888887766544332 22478999999
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 020016 259 LISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 259 li~~cl~~dp~~Rps~~ell~ 279 (332)
||.+||..||.+|||++|+++
T Consensus 237 li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 237 FVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=350.09 Aligned_cols=221 Identities=22% Similarity=0.328 Sum_probs=186.2
Q ss_pred CCeeeeeeecccCceEEEEEEEC---CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcC---CCCceec--------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL---NHPHIIT-------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~-------- 120 (332)
++|+++++||+|+||+||+|.+. ++.||||++......... ...+.+|+.+|+.| +||||++
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM----PLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC----BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH----HHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 68999999999999999999984 567999998764322211 12355677776655 8999986
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 456789999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------
Q 020016 175 SCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR--------- 245 (332)
Q Consensus 175 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~--------- 245 (332)
+.............||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+....+......
T Consensus 163 ~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 87766555566788999999999999999999999999999999999999999998887776655432111
Q ss_pred ----------------CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 246 ----------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 246 ----------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..++..+++.+.+||.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1134567899999999999999999999999885
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=346.15 Aligned_cols=227 Identities=26% Similarity=0.482 Sum_probs=188.5
Q ss_pred eeeeeecccCceEEEEEEECC-----eeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 58 FIGCKFASGRHSRIYRGIYKQ-----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 58 ~i~~~lg~G~~g~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
.+.++||+|+||+||+|.+.+ ..||||+++....... .++|.+|+++|++++|||||+
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 104 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 104 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHH-----HHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHH-----HHHHHHHHHHHHhCCCCCEeEEeEEEEecCCce
Confidence 347899999999999999852 3689999975433322 467999999999999999987
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC
Q 020016 121 ------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 182 (332)
Q Consensus 121 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 182 (332)
....+++..++.++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++......
T Consensus 105 ~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 44567788999999999999999999999999999999999999999999999997654332
Q ss_pred -----CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCCCCCCcHHH
Q 020016 183 -----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQKNARPPVPPTCPKAF 256 (332)
Q Consensus 183 -----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l 256 (332)
......||+.|+|||.+.++.++.++||||||+++|||+||..||.... ..+.... ...+.++..|..+++.+
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~-i~~g~~~~~p~~~~~~l 263 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-LLQGRRLLQPEYCPDPL 263 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHH-HHTTCCCCCCTTCCHHH
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCCCCcccCcHHH
Confidence 1223568999999999999999999999999999999999767665543 3333333 34566778888999999
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 020016 257 SYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 290 (332)
Q Consensus 257 ~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~ 290 (332)
.+||.+||+.||++||++.||++.|+.+..+...
T Consensus 264 ~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 264 YEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 9999999999999999999999999999776443
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.8e-48 Score=356.65 Aligned_cols=225 Identities=20% Similarity=0.276 Sum_probs=183.1
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 120 (332)
.++|.+++.||+|+||+||+|++. |+.||||++..................+|+.+++.++|||||+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 578999999999999999999996 7899999997532211111111222345578888889999987
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 183 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|...... .
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-~ 161 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-K 161 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-C
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-c
Confidence 3456889999999999999999999999999999999999999999999999999766543 3
Q ss_pred CCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhcCCCCCCCCCCcHHHHHHHH
Q 020016 184 AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV-CQKNARPPVPPTCPKAFSYLIS 261 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~ 261 (332)
.....||+.|+|||++.. ..++.++|||||||++|+|+||+.||.+....+..... ........++..+++++.+||.
T Consensus 162 ~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 241 (364)
T d1omwa3 162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241 (364)
T ss_dssp CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHH
T ss_pred ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHH
Confidence 445689999999999975 56899999999999999999999999875433222111 2234455677889999999999
Q ss_pred HccccCCCCCCC-----HHHHHH
Q 020016 262 RCWSSSPDRRPH-----FDQIVS 279 (332)
Q Consensus 262 ~cl~~dp~~Rps-----~~ell~ 279 (332)
+||+.||.+||| ++++++
T Consensus 242 ~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 242 GLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHcccCHHHhCCCcccCHHHHHc
Confidence 999999999999 688875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=345.20 Aligned_cols=221 Identities=25% Similarity=0.376 Sum_probs=184.8
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.+.+.||+|+||+||+|.+. ++.||||++....... ...+.+.+|+.+|++++|||||+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~ 77 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE----GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 77 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh----HHHHHHHHHHHHHHhCCCCcEEEecccccccccee
Confidence 68999999999999999999996 8899999997643221 12467899999999999999997
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-C
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-G 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~ 182 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 4567999999999999999999999999999999999999999999999999999765432 3
Q ss_pred CCCCcccccccCChhhhhcCC-CCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--------------
Q 020016 183 SAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-------------- 247 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~-------------- 247 (332)
......||+.|+|||.+.... ++.++|||||||++|+|++|+.||.+.+..+....+......+.
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 445568999999999987665 48899999999999999999999999888776665543211110
Q ss_pred -------------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 248 -------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 248 -------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
....+++++.+|+.+||+.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 01356788999999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-47 Score=342.95 Aligned_cols=221 Identities=19% Similarity=0.291 Sum_probs=184.6
Q ss_pred CCeeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
++|.+.++||+|+||+||+|.++ ++.||||++........ ..+.+.+|+.+|++++|||||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG----IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGC----CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChH----HHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeE
Confidence 68999999999999999999997 78999999977543321 1367899999999999999997
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-CC
Q 020016 121 ---------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-SA 184 (332)
Q Consensus 121 ---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~ 184 (332)
..+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||.+....... ..
T Consensus 78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 56789999999999999999999999999999999999999999999999999987654332 23
Q ss_pred CCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------------------
Q 020016 185 KGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR------------------ 245 (332)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~------------------ 245 (332)
....+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+....+......
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 455689999999998764 5699999999999999999999999998877766654431111
Q ss_pred ---------CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 246 ---------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 246 ---------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
......+++.+.+||.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1123557889999999999999999999999974
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-48 Score=350.16 Aligned_cols=220 Identities=25% Similarity=0.394 Sum_probs=188.8
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHH-cCCCCceec-----------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLF-RLNHPHIIT----------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~----------- 120 (332)
++|.+++.||+|+||+||+|.+. ++.||||++++.... .....+.+..|..++. .++|||||+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~---~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~ 78 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL---MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 78 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhcc---ChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCce
Confidence 68999999999999999999996 899999999753211 1111245666777665 689999997
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC-C
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-G 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~ 182 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 3467899999999999999999999999999999999999999999999999999765432 3
Q ss_pred CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 020016 183 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 262 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 262 (332)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+..+....+.. ..+.+|..+++++.+||.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~dli~~ 236 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRWLEKEAKDLLVK 236 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCccCCHHHHHHHHH
Confidence 34457899999999999999999999999999999999999999999998888777754 3567788899999999999
Q ss_pred ccccCCCCCCCHH-HHHH
Q 020016 263 CWSSSPDRRPHFD-QIVS 279 (332)
Q Consensus 263 cl~~dp~~Rps~~-ell~ 279 (332)
||+.||.+||++. ++++
T Consensus 237 ~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 237 LFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HSCSSGGGSBTTBSCGGG
T ss_pred hcccCCCCCcCHHHHHHh
Confidence 9999999999995 6764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=342.85 Aligned_cols=220 Identities=25% Similarity=0.304 Sum_probs=178.9
Q ss_pred eeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------------
Q 020016 59 IGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------------- 120 (332)
Q Consensus 59 i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------------- 120 (332)
.++.||+|+||+||+|.++ |+.||||+++....... .....+.+.+|+.+|++++|||||+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA-KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC-------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhh-hHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 3578999999999999986 78999999976433221 1222356889999999999999997
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-CCCCc
Q 020016 121 ------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-SAKGF 187 (332)
Q Consensus 121 ------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 187 (332)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~ 160 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 160 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence 46679999999999999999999999999999999999999999999999999997654432 33456
Q ss_pred ccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-------------------
Q 020016 188 TGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------------------- 247 (332)
Q Consensus 188 ~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~------------------- 247 (332)
+||+.|+|||++.+. .++.++|||||||++|||+||..||.+.+..+....+......+.
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ua2a_ 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240 (299)
T ss_dssp CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC
T ss_pred ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccC
Confidence 799999999998754 579999999999999999999999999888777666543211110
Q ss_pred -------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 248 -------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 248 -------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..+.+++++.+||.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 01356889999999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=347.87 Aligned_cols=216 Identities=26% Similarity=0.403 Sum_probs=178.8
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC--CCceec----------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN--HPHIIT---------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~---------- 120 (332)
++|++++.||+|+||+||+|++. ++.||||++................+.+|+.+|++++ |||||+
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 68999999999999999999996 7899999987532111000000123668999999986 899987
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC-CeEEEeeccccccccc
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGISCLESQ 180 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~a~~~~~ 180 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence 34678999999999999999999999999999999999999865 7999999999976544
Q ss_pred CCCCCCcccccccCChhhhhcCCC-CCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 020016 181 CGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 259 (332)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 259 (332)
.......||+.|+|||++.+..+ +.++|||||||++|+|+||+.||...+ . +. .....++..+|+++.+|
T Consensus 164 -~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~----i~--~~~~~~~~~~s~~~~~l 234 (273)
T d1xwsa_ 164 -TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----II--RGQVFFRQRVSSECQHL 234 (273)
T ss_dssp -SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HH--HCCCCCSSCCCHHHHHH
T ss_pred -ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--H----Hh--hcccCCCCCCCHHHHHH
Confidence 23446789999999999987765 677999999999999999999998632 1 22 23455778899999999
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 020016 260 ISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 260 i~~cl~~dp~~Rps~~ell~ 279 (332)
|.+||+.||++|||++|+++
T Consensus 235 i~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 235 IRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHccCCHhHCcCHHHHhc
Confidence 99999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-46 Score=341.22 Aligned_cols=226 Identities=23% Similarity=0.343 Sum_probs=184.3
Q ss_pred cccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-----
Q 020016 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----- 120 (332)
Q Consensus 48 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 120 (332)
..|++ .++|+++++||+|+||+||+|.+. |+.||||+++....... ..+.+.+|+.+|++++|||||+
T Consensus 12 ~~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~Ei~il~~l~hpniv~l~~~~ 86 (346)
T d1cm8a_ 12 TAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL----FAKRAYRELRLLKHMRHENVIGLLDVF 86 (346)
T ss_dssp SEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHH----HHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred ceeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChH----HHHHHHHHHHHHHhcCCCCeeEEEEEe
Confidence 45666 479999999999999999999986 89999999986543332 2467899999999999999986
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecc
Q 020016 121 ---------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 173 (332)
Q Consensus 121 ---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg 173 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 87 TPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CSCSSTTTCCCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ccCccccccceEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccccccc
Confidence 34579999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------
Q 020016 174 ISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR------- 245 (332)
Q Consensus 174 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~------- 245 (332)
++..... ......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..............
T Consensus 167 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 167 LARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp TCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 9976544 23457799999999998764 5689999999999999999999999988766554433221111
Q ss_pred ----------------------CCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHH
Q 020016 246 ----------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 280 (332)
Q Consensus 246 ----------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 280 (332)
......+++.+.+||.+||..||.+|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 11235678999999999999999999999999873
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-46 Score=337.29 Aligned_cols=227 Identities=22% Similarity=0.317 Sum_probs=186.5
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|++++.||+|+||+||+|.+. ++.||||++...... ..+..|+++++.++|+|+|.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--------HHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence 57999999999999999999986 789999998875433 34778999999999887664
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC---CCeEEEeeccccccccc
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DMCVKVADFGISCLESQ 180 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~---~~~~kl~Dfg~a~~~~~ 180 (332)
....+++..+..++.|++.||+|||++||+||||||+|||++. +..++|+|||+|.....
T Consensus 79 ~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 79 VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 5678999999999999999999999999999999999999864 45799999999986543
Q ss_pred CC--------CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---h---cCCCC
Q 020016 181 CG--------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC---Q---KNARP 246 (332)
Q Consensus 181 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~---~---~~~~~ 246 (332)
.. ......||+.|+|||.+.+..++.++|||||||++|||+||..||............. . ....+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 22 1234579999999999999999999999999999999999999998866544332221 1 11122
Q ss_pred CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 020016 247 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 289 (332)
Q Consensus 247 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 289 (332)
.....+|+++.+++.+||+.+|++||+++++.+.|+.+.....
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 3456789999999999999999999999999999998766544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=336.85 Aligned_cols=223 Identities=21% Similarity=0.291 Sum_probs=181.7
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---------- 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 120 (332)
+.++|++.++||+|+||+||+|++. |+.||||++........ ..+++.+|+.+|++++||||++
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG----FPITALREIKILQLLKHENVVNLIEICRTKAS 83 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTS----SCHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchH----HHHHHHHHHHHHHHhcCCCccceEeeeecccc
Confidence 3689999999999999999999996 78999999876533321 1356889999999999999986
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccc
Q 020016 121 --------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 174 (332)
Q Consensus 121 --------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~ 174 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred cccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecce
Confidence 456789999999999999999999999999999999999999999999999999
Q ss_pred ccccccC-----CCCCCcccccccCChhhhhcC-CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-
Q 020016 175 SCLESQC-----GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP- 247 (332)
Q Consensus 175 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~- 247 (332)
+...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+......+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9654322 223346799999999998765 689999999999999999999999998887766555433211111
Q ss_pred -CCC----------------------------CCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 248 -VPP----------------------------TCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 248 -~~~----------------------------~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
... ..++.+.+||.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 000 12567789999999999999999999984
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-47 Score=344.95 Aligned_cols=215 Identities=23% Similarity=0.365 Sum_probs=177.6
Q ss_pred cCCeeeee-eecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHc-CCCCceec---------
Q 020016 54 MSQLFIGC-KFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR-LNHPHIIT--------- 120 (332)
Q Consensus 54 ~~~y~i~~-~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~--------- 120 (332)
.++|.+.. .||+|+||+||+|.+. ++.||||+++.. ..+.+|+.++.+ ++|||||+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~ 78 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLY 78 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence 36898865 6999999999999986 789999999752 346789988655 58999986
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC---CCeEEEeec
Q 020016 121 -------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DMCVKVADF 172 (332)
Q Consensus 121 -------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~---~~~~kl~Df 172 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+||
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence 2346999999999999999999999999999999999999975 467999999
Q ss_pred ccccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--CCCCCC-
Q 020016 173 GISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN--ARPPVP- 249 (332)
Q Consensus 173 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~--~~~~~~- 249 (332)
|++.............||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+.......+.... ....+|
T Consensus 159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~ 238 (335)
T d2ozaa1 159 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238 (335)
T ss_dssp TTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred ceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 99987766666677889999999999999999999999999999999999999998765444333332221 122222
Q ss_pred ---CCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 250 ---PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 250 ---~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
..+++++.+||.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 357899999999999999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=341.34 Aligned_cols=220 Identities=24% Similarity=0.354 Sum_probs=180.4
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|.++++||+|+||+||+|.+. |+.||||++....... ..+.+.+|+.+|++++||||++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT-----YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHH-----HHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChH-----HHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence 57999999999999999999986 8999999997654322 2467899999999999999986
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 83 MKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp CCCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred cceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 2357999999999999999999999999999999999999999999999999998754332
Q ss_pred C----CCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----------
Q 020016 182 G----SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP---------- 246 (332)
Q Consensus 182 ~----~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~---------- 246 (332)
. .....+||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+.+..+...........+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 2 2345679999999999854 567899999999999999999999999877655444332211100
Q ss_pred -------------------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 -------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 -------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
...+.+++++.+|+.+||+.||.+|||++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 113467889999999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-46 Score=340.24 Aligned_cols=219 Identities=25% Similarity=0.306 Sum_probs=185.5
Q ss_pred CeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec-------------
Q 020016 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------- 120 (332)
Q Consensus 56 ~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------- 120 (332)
+|+..++||+|+||+||+|++. ++.||||++...... +.+|+.+|++++|||||+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~ 90 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----------HHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence 6999999999999999999996 789999999765332 347999999999999986
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCC-eEEEeecccc
Q 020016 121 ------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVADFGIS 175 (332)
Q Consensus 121 ------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~a 175 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccch
Confidence 355799999999999999999999999999999999999999875 8999999999
Q ss_pred cccccCCCCCCcccccccCChhhhhc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------
Q 020016 176 CLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR--------- 245 (332)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~--------- 245 (332)
.............||+.|+|||.+.+ ..++.++||||+||++|||++|..||...+..+....+......
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 171 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp EECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred hhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 87766566667789999999998875 46899999999999999999999999988876665554321100
Q ss_pred ------C------------CCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH--HHHhh
Q 020016 246 ------P------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGY 284 (332)
Q Consensus 246 ------~------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~--~L~~~ 284 (332)
. .....+++++.+||.+||+.||++|||+.|+++ +|+.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0 123457899999999999999999999999986 34444
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=335.58 Aligned_cols=227 Identities=27% Similarity=0.483 Sum_probs=180.0
Q ss_pred CCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec--------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-------------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 120 (332)
.+|.+.+.||+|+||+||+|+++|+.||||+++..... ...+..|+..+.+++|||||+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~-------~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-------SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHH-------HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchh-------HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 57999999999999999999999999999999754321 122234566667889999997
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCccccccccceeecCCCeEEEeecccc
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHS--------QGILHRDLKSENLLLGEDMCVKVADFGIS 175 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~--------~~iiH~dlkp~NIll~~~~~~kl~Dfg~a 175 (332)
....+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 23468999999999999999999996 59999999999999999999999999998
Q ss_pred cccccCC-----CCCCcccccccCChhhhhcCC------CCCccchhHHHHHHHHHHhCCCCCCC---------------
Q 020016 176 CLESQCG-----SAKGFTGTYRWMAPEMIKEKR------HTKKVDVYSFGIVLWELLTALTPFDN--------------- 229 (332)
Q Consensus 176 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlG~il~elltG~~pf~~--------------- 229 (332)
....... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 7654332 233567999999999987643 56789999999999999999877632
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCC-----cHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 020016 230 MTPEQAAFAVCQKNARPPVPPTC-----PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 288 (332)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 288 (332)
...............++.++... ...+.+|+.+||+.||.+|||+.||++.|+.+.++-
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 12334444444455555554432 346899999999999999999999999999887654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=323.81 Aligned_cols=221 Identities=20% Similarity=0.281 Sum_probs=183.1
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|++.++||+|+||+||+|.+. ++.||||+++....... ....+.+|+.+|+.++||||++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 77 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTT----HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChH----HHHHHHHHHHHHHhcCcCCEEeecccccccccee
Confidence 68999999999999999999996 78999999976544332 2467899999999999999987
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCC-C
Q 020016 121 ----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-S 183 (332)
Q Consensus 121 ----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~ 183 (332)
..+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||.+....... .
T Consensus 78 iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred EEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 56788999999999999999999999999999999999999999999999999997655433 3
Q ss_pred CCCcccccccCChhhhhcCC-CCCccchhHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhcCC-----------------
Q 020016 184 AKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPF-DNMTPEQAAFAVCQKNA----------------- 244 (332)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~pf-~~~~~~~~~~~~~~~~~----------------- 244 (332)
.....+++.|+|||.+.+.. ++.++|||||||++|||++|..|| .+.+..+....+.....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 34456788999999987665 589999999999999999998885 44444444443322111
Q ss_pred ----------CCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 245 ----------RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 245 ----------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
.......+++.+.+|+.+||+.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11133456889999999999999999999999875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-45 Score=333.98 Aligned_cols=226 Identities=25% Similarity=0.332 Sum_probs=186.5
Q ss_pred ccccccccCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec----
Q 020016 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT---- 120 (332)
Q Consensus 47 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 120 (332)
...|++ .++|++.+.||+|+||+||+|++. |+.||||++......... .+.+.+|+.+|++++|||||+
T Consensus 11 ~~~~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~Ei~il~~l~h~~iv~~~~~ 85 (348)
T d2gfsa1 11 KTIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH----AKRTYRELRLLKHMKHENVIGLLDV 85 (348)
T ss_dssp SSEEEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHH----HHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred CccccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHH----HHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 345766 478999999999999999999986 899999999875443322 356889999999999999986
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeec
Q 020016 121 ----------------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 172 (332)
Q Consensus 121 ----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Df 172 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++||
T Consensus 86 ~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~df 165 (348)
T d2gfsa1 86 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDF 165 (348)
T ss_dssp ECSCSSTTTCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred EeeccccccCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccccccccc
Confidence 4567999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCcccccccCChhhhhcCC-CCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC----
Q 020016 173 GISCLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP---- 247 (332)
Q Consensus 173 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~---- 247 (332)
|++..... ......||+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+.......+......+.
T Consensus 166 g~a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 166 GLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp ----CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred chhcccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 99865543 234567999999999877654 58999999999999999999999998887666555433221110
Q ss_pred -------------------------CCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 248 -------------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 248 -------------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
....+++++.+||.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 11357889999999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-44 Score=324.90 Aligned_cols=229 Identities=20% Similarity=0.298 Sum_probs=187.6
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCC-Cceec-----------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH-PHIIT----------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~----------- 120 (332)
++|++++.||+|+||+||+|++. ++.||||++...... ..+.+|++++..+.| +|++.
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc--------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 68999999999999999999986 789999998765432 346678888888876 66654
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecC-----CCeEEEeeccccccc
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-----DMCVKVADFGISCLE 178 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~-----~~~~kl~Dfg~a~~~ 178 (332)
....+++..+..++.|++.||.|||++||+||||||+|||++. ++.++|+|||+|+..
T Consensus 77 ~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 77 VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 4567999999999999999999999999999999999999974 578999999999765
Q ss_pred ccCC--------CCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhc---CC
Q 020016 179 SQCG--------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT---PEQAAFAVCQK---NA 244 (332)
Q Consensus 179 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~---~~~~~~~~~~~---~~ 244 (332)
.... ......||+.|+|||++.+..++.++||||||+++|||+||..||.+.. .......+... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 4321 2334679999999999999999999999999999999999999998643 22222222221 11
Q ss_pred CCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 020016 245 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 291 (332)
Q Consensus 245 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~ 291 (332)
...+...+|+++.+++..|+..+|++||+++.+.+.|+++.......
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~ 283 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence 22234678999999999999999999999999999999887766543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.9e-44 Score=328.52 Aligned_cols=217 Identities=17% Similarity=0.280 Sum_probs=179.7
Q ss_pred cCCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC-CCceec----------
Q 020016 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIIT---------- 120 (332)
Q Consensus 54 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~---------- 120 (332)
.++|+++++||+|+||+||+|++. ++.||||+++... .+.+.+|+.+|+.+. ||||++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---------KKKIKREIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence 478999999999999999999996 8999999997643 245789999999995 999986
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCC-CeEEEeecccccccccCC
Q 020016 121 -----------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGISCLESQCG 182 (332)
Q Consensus 121 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~ 182 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 105 ~~~~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp CSEEEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred CceeEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 34579999999999999999999999999999999999999865 479999999998776666
Q ss_pred CCCCcccccccCChhhhhcCC-CCCccchhHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh-------------cC----
Q 020016 183 SAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-AAFAVCQ-------------KN---- 243 (332)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~pf~~~~~~~-~~~~~~~-------------~~---- 243 (332)
......+|+.|+|||.+.+.. ++.++|+||+||++|+|++|..||....... ....+.. ..
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 666778999999999987654 7999999999999999999999997654321 1111100 00
Q ss_pred ------------------CCCCCCCCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 244 ------------------ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 244 ------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
........+++++.+||.+||+.||.+|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000112346889999999999999999999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=332.50 Aligned_cols=221 Identities=24% Similarity=0.317 Sum_probs=174.3
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCCceec------------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT------------ 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 120 (332)
++|++.++||+|+||+||+|.+. |+.||||++........ ..+.+.+|+.++++++|||||+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~----~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHH----HHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHH----HHHHHHHHHHHHHhcCCCCeeEEEEEEecccccc
Confidence 68999999999999999999997 89999999987544322 2356889999999999999987
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccC
Q 020016 121 -------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 181 (332)
Q Consensus 121 -------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (332)
....+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||++......
T Consensus 93 ~~~~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 93 EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp TCCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred cCceeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 2356899999999999999999999999999999999999999999999999998877766
Q ss_pred CCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------------
Q 020016 182 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--------------- 246 (332)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~--------------- 246 (332)
.......+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+......+
T Consensus 173 ~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 252 (355)
T d2b1pa1 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252 (355)
T ss_dssp --------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHH
T ss_pred cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHH
Confidence 66677789999999999999999999999999999999999999999877665544332211100
Q ss_pred -----C--------------CC------CCCcHHHHHHHHHccccCCCCCCCHHHHHH
Q 020016 247 -----P--------------VP------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 279 (332)
Q Consensus 247 -----~--------------~~------~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 279 (332)
. .+ ...++++.+||.+||+.||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 00 113567899999999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-45 Score=329.41 Aligned_cols=225 Identities=24% Similarity=0.361 Sum_probs=180.9
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC-----CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCC-Cceec------
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH-PHIIT------ 120 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~------ 120 (332)
..++|++++.||+|+||+||+|.+. |+.||||++........ ....+.+.+|+.++++++| |||++
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~--~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK--AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE--ESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc--hHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 4578999999999999999999872 67899999875421110 0002457899999999977 78986
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeeccccccc
Q 020016 121 ----------------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 178 (332)
Q Consensus 121 ----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (332)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 3456789999999999999999999999999999999999999999999999998754
Q ss_pred ccC--CCCCCcccccccCChhhhhcC--CCCCccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCCCCCCCCC
Q 020016 179 SQC--GSAKGFTGTYRWMAPEMIKEK--RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ--KNARPPVPPTC 252 (332)
Q Consensus 179 ~~~--~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltG~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~ 252 (332)
... .......|++.|++||.+.+. .++.++|||||||++|+|++|..||.+.+..+....+.. ....+.++..+
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence 332 233456799999999999765 468899999999999999999999987543332222221 23456677889
Q ss_pred cHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 020016 253 PKAFSYLISRCWSSSPDRRPH-----FDQIVS 279 (332)
Q Consensus 253 ~~~l~~li~~cl~~dp~~Rps-----~~ell~ 279 (332)
++++.+||.+||+.||.+||| ++|+++
T Consensus 260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 999999999999999999994 788875
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.9e-41 Score=309.54 Aligned_cols=216 Identities=23% Similarity=0.346 Sum_probs=169.9
Q ss_pred CCeeeeeeecccCceEEEEEEEC--CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCCCC-----------ceec-
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP-----------HIIT- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-----------niv~- 120 (332)
++|+++++||+|+||+||+|++. |+.||||+++..... .+.+.+|+.+++.++|+ ||++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~-------~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-------TEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH-------HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc-------hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 46999999999999999999986 899999999864321 35677899999888764 4543
Q ss_pred --------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccccccceeecCCC--
Q 020016 121 --------------------------------EPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDM-- 165 (332)
Q Consensus 121 --------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~NIll~~~~-- 165 (332)
....+++..+..++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence 45678999999999999999999998 8999999999999998654
Q ss_pred ----eEEEeecccccccccCCCCCCcccccccCChhhhhcCCCCCccchhHHHHHHHHHHhCCCCCCCCCHH------HH
Q 020016 166 ----CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE------QA 235 (332)
Q Consensus 166 ----~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~pf~~~~~~------~~ 235 (332)
.++++|||.+..... ......||+.|+|||++.+..++.++|+||+||++++|++|+.||...... +.
T Consensus 166 ~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp TTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 499999999875543 334567999999999999999999999999999999999999999754321 11
Q ss_pred HHHHHhc-C------------------------C---------------CCCCCCCCcHHHHHHHHHccccCCCCCCCHH
Q 020016 236 AFAVCQK-N------------------------A---------------RPPVPPTCPKAFSYLISRCWSSSPDRRPHFD 275 (332)
Q Consensus 236 ~~~~~~~-~------------------------~---------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 275 (332)
....... + . ........++.+.+|+.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 1111000 0 0 0011223467889999999999999999999
Q ss_pred HHHH
Q 020016 276 QIVS 279 (332)
Q Consensus 276 ell~ 279 (332)
|+++
T Consensus 324 e~L~ 327 (362)
T d1q8ya_ 324 GLVN 327 (362)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=6.4e-25 Score=183.32 Aligned_cols=152 Identities=17% Similarity=0.170 Sum_probs=109.8
Q ss_pred eeeeeeecccCceEEEEEEEC-CeeEEEEEecCCCch------------hHHHHHHHHHHHHHHHHHHcCCCCceec---
Q 020016 57 LFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEED------------ASLASMLEKQFTSEVALLFRLNHPHIIT--- 120 (332)
Q Consensus 57 y~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~------------~~~~~~~~~~~~~E~~~l~~l~h~niv~--- 120 (332)
+.++++||+|+||+||+|.+. |+.||||+++..... ..........+.+|...+.++.|.+++.
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 468999999999999999986 899999987642211 0111222345677899999999988764
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccccccceeecCCCeEEEeecccccccccCCCCCC
Q 020016 121 --------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG 186 (332)
Q Consensus 121 --------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 186 (332)
....++...+..++.|++.+|.|||++||+||||||+|||+++++ ++|+|||++........
T Consensus 82 ~~~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~--- 157 (191)
T d1zara2 82 WEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGW--- 157 (191)
T ss_dssp EETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTCEETTSTTH---
T ss_pred ecCCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCcccCCCCCc---
Confidence 223356677889999999999999999999999999999999654 88999999865432211
Q ss_pred cccccccCC------hhhhhcCCCCCccchhHHHHHH
Q 020016 187 FTGTYRWMA------PEMIKEKRHTKKVDVYSFGIVL 217 (332)
Q Consensus 187 ~~gt~~y~a------PE~~~~~~~~~~sDvwSlG~il 217 (332)
..|.. .+.+ ...|+.++|+||+.--+
T Consensus 158 ----~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 158 ----REILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ----HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred ----HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 11111 1112 35678899999976544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.49 E-value=6.1e-05 Score=65.26 Aligned_cols=30 Identities=30% Similarity=0.576 Sum_probs=27.0
Q ss_pred CCCccccccccceeecCCCeEEEeeccccc
Q 020016 147 QGILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 147 ~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
.|+||+|+.++||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 379999999999999998888999999874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.41 E-value=7.6e-05 Score=62.58 Aligned_cols=116 Identities=14% Similarity=0.177 Sum_probs=71.6
Q ss_pred CCeeeeeeecccCceEEEEEEECCeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC----CCceec----------
Q 020016 55 SQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN----HPHIIT---------- 120 (332)
Q Consensus 55 ~~y~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----h~niv~---------- 120 (332)
+.|.+.+..+.++.+.||+....++.+.||+........ ...+.+|...+..+. -|.++.
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~------~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT------TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS------TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc------hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 466666665555567899998778889999886543221 123556777766552 354442
Q ss_pred -----CCC-----CCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 020016 121 -----EPY-----SVPLNLVLKLALDIARGMQYLHS-------------------------------------------- 146 (332)
Q Consensus 121 -----~~~-----~l~~~~~~~i~~qi~~~L~~LH~-------------------------------------------- 146 (332)
.+. ..+......++.+++..++.||+
T Consensus 88 v~~~l~G~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp EEECCSSEEHHHHTTTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSH
T ss_pred EEEecccccccccccccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHH
Confidence 000 01111123344455555555552
Q ss_pred ---------C------CCccccccccceeecCCCeEEEeeccccc
Q 020016 147 ---------Q------GILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 147 ---------~------~iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
. .++|+|+.|.||++++++.+-|+||+.+.
T Consensus 168 ~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1 26899999999999987777899999764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.13 E-value=0.00038 Score=60.48 Aligned_cols=42 Identities=19% Similarity=0.238 Sum_probs=29.8
Q ss_pred cCceEEEEEEEC-CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC
Q 020016 66 GRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN 114 (332)
Q Consensus 66 G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 114 (332)
+.--.||++... |+.|++|+.+...... +++..|...+..|.
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s~-------~~i~~E~~~l~~L~ 75 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERWTA-------DQILEEHQFALQLV 75 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTSCH-------HHHHHHHHHHHHHH
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCCCH-------HHHHHHHHHHHHHH
Confidence 445789999876 7889999997654332 44666777777663
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.42 E-value=0.0009 Score=55.38 Aligned_cols=28 Identities=18% Similarity=0.181 Sum_probs=24.8
Q ss_pred CccccccccceeecCCCeEEEeeccccc
Q 020016 149 ILHRDLKSENLLLGEDMCVKVADFGISC 176 (332)
Q Consensus 149 iiH~dlkp~NIll~~~~~~kl~Dfg~a~ 176 (332)
++|+|+.|.||+++.++.+-|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 6999999999999987778899999764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.77 E-value=0.0077 Score=53.33 Aligned_cols=29 Identities=24% Similarity=0.387 Sum_probs=25.0
Q ss_pred CCccccccccceeecCCCeEEEeecccccc
Q 020016 148 GILHRDLKSENLLLGEDMCVKVADFGISCL 177 (332)
Q Consensus 148 ~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (332)
.++|||+.+.|||+++++ ++|+||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 589999999999998765 89999987743
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.47 E-value=0.044 Score=48.16 Aligned_cols=53 Identities=15% Similarity=0.302 Sum_probs=34.4
Q ss_pred ccCCeeeeeeecccCceEEEEEEEC---------CeeEEEEEecCCCchhHHHHHHHHHHHHHHHHHHcCC
Q 020016 53 DMSQLFIGCKFASGRHSRIYRGIYK---------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN 114 (332)
Q Consensus 53 ~~~~y~i~~~lg~G~~g~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 114 (332)
+.+++.+ +.|+.|-.-.+|+.... .+.|.++++..... . ....+|..+++.+.
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~-~-------idr~~E~~i~~~ls 102 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-E-------SHLVAESVIFTLLS 102 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-H-------HHHHHHHHHHHHHH
T ss_pred CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch-h-------hHHHHHHHHHHHHH
Confidence 3455555 57888999999999864 24577888764322 1 12346777777664
|